<SEC-DOCUMENT>0000937098-25-000073.txt : 20250425
<SEC-HEADER>0000937098-25-000073.hdr.sgml : 20250425
<ACCEPTANCE-DATETIME>20250425081753
ACCESSION NUMBER:		0000937098-25-000073
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		101
CONFORMED PERIOD OF REPORT:	20250331
FILED AS OF DATE:		20250425
DATE AS OF CHANGE:		20250425

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TRINET GROUP, INC.
		CENTRAL INDEX KEY:			0000937098
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				953359658
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36373
		FILM NUMBER:		25870093

	BUSINESS ADDRESS:	
		STREET 1:		ONE PARK PLACE., SUITE 600
		CITY:			DUBLIN
		STATE:			CA
		ZIP:			94568
		BUSINESS PHONE:		5103525000

	MAIL ADDRESS:	
		STREET 1:		ONE PARK PLACE., SUITE 600
		CITY:			DUBLIN
		STATE:			CA
		ZIP:			94568

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRINET GROUP INC
		DATE OF NAME CHANGE:	20000306

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRINET EMPLOYER GROUP INC
		DATE OF NAME CHANGE:	20000126
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>tnet-20250331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:104eff25-bde6-411e-ba54-56469600d7a1,g:ffef9025-6e41-425a-998c-b582f585f1c3,d:45ccd64735a14c1db738ff1d6adbd5ef-->
<html xmlns:srt="http://fasb.org/srt/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:tnet="http://www.trinet.com/20250331" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>tnet-20250331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-26">0000937098</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-27">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-28">2025</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-29">Q1</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-30">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-141" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:duryear" id="f-598">1</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="tnet-20250331.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>tnet:segment</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:ProfessionalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:ProfessionalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:InsuranceServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:InsuranceServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">tnet:TriNetTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">us-gaap:HealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">us-gaap:HealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2029NotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2031NotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2029NotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2031NotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tnet:SystemsDevelopmentAndProgrammingCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tnet:SystemsDevelopmentAndProgrammingCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOfFinancialPositionLocationActivityAccrualAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOfFinancialPositionLocationActivityAccrualAxis">tnet:AccruedSalariesCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOfFinancialPositionLocationActivityAccrualAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOfFinancialPositionLocationActivityAccrualAxis">tnet:AccruedSalariesCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:ProfessionalServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tnet:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:ProfessionalServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tnet:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:InsuranceServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tnet:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:InsuranceServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tnet:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tnet:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tnet:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_1"></div><div style="min-height:27pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED STATES</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WASHINGTON, DC 20549</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Mark One) </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">March 31, 2025</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the transition period from </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-36373</ix:nonNumeric> </span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><img src="tnet-20250331_g1.jpg" alt="Logo.jpg" style="height:62px;margin-bottom:5pt;vertical-align:text-bottom;width:170px"/></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">TRINET GROUP, INC.</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:18.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.170%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.340%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">95-3359658</ix:nonNumeric></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">One Park Place,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-10">Suite 600</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Dublin,</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-12">CA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">94568</ix:nonNumeric></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">510</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">352-5000</ix:nonNumeric> </span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common stock par value $0.000025 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">TNET</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">New York Stock Exchange</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-19">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-20">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:27.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.510%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-21">Large accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-23">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-24">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The number of shares of Registrant&#8217;s Common Stock outstanding as of April&#160;18, 2025 was <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-25">48,399,165</ix:nonFraction>.</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e67222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</span></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TRINET GROUP, INC.</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form 10-Q - Quarterly Report </span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarterly Period Ended March&#160;31, 2025 </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.131%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.197%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form 10-Q</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross Reference</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_10">Glossary</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_10">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_13">Cautionary Note Regarding Forward-Looking Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_13">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_91">Unaudited Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part I, Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_91">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_94">Condensed Consolidated Statements of Income and Comprehensive Income</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_94">25</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_103">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_103">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_112">Condensed Consolidated Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_112">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_115">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_118">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_121">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_121">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_124">Note 1. Description of Business and Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_124">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_130">Note 2. Cash, Cash Equivalents and Investments - Unrestricted and Restricted</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_130">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_133">Note 3. Financial Instruments and Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_133">33</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_148">Note 4. Accrued Workers' Compensation Costs</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_148">34</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_154">Note 5. Commitments and Contingencies</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_154">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_157">Note 6. Stock Based Compensation</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_157">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_163">Note 7. Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_163">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_166">Note 8. Income Taxes</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_166">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_169">Note 9. Earnings Per Share</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_169">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_1640">Note 10. Restructuring </a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_1640">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_1633">Note 11. Segment Information</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_1633">38</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_16">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part I, Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_16">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_85">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part I, Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_85">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_88">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part I, Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_88">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_181">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II, Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_181">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_184">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II, Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_184">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_187">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II, Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_187">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_190">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II, Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_190">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_193">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II, Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_193">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_196">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II, Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_196">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_202">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II, Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_202">42</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:32.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:64.930%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e67222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLOSSARY</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div><div><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%">Glossary of Acronyms and Abbreviations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acronyms and abbreviations are used throughout this report, particularly in Part I, Item 1. Unaudited Condensed Consolidated Financial Statements and Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 Credit Agreement</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Our credit agreement dated February 26, 2021, as amended, supplemented or modified from time to time, most recently on August 16, 2023.</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 Revolver</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Our $700 million revolving line of credit included in our 2021 Credit Agreement, as amended on August 16, 2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2029 Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Our $500 million senior unsecured notes maturing in March 2029</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2031 Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Our $400 million senior unsecured notes maturing in August 2031</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">AFS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available-for-sale</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Administrative Services Offering</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASO User</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">An employee of a client that is using our ASO services</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CEO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CFO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">COBRA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Omnibus Budget Reconciliation Act</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Colleague</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">TriNet's internal employees (as distinguished from WSEs)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">COPS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of providing services </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">D&amp;A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization expenses</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EBITDA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings before interest expense, taxes, depreciation and amortization of intangible assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EPLI</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employment Practices Liability Insurance</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EPS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings Per Share</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ERISA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee Retirement Income Security Act</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ERP</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Enterprise resource planning</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ETR</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax rate</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FASB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">G&amp;A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Generally Accepted Accounting Principles in the United States</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">HCM</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Human capital management</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">HR</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Human Resources</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">HRIS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Human resources information system</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">HRIS User</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">A client employee who is a user of our HR Platform (for example, employees of an HRIS client)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICR</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance cost ratio</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, bank fees and other</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ISR</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance service revenues</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses (includes G&amp;A, S&amp;M, SD&amp;P and D&amp;A)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PEO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional Employer Organization</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PEO Platform Users</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Individuals authorized by our clients to access and use the PEO platform</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PFC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll funds collected</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSR</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional service revenues</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reg FD</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Regulation Fair Disclosure</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ROU</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted Stock Unit</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">S&amp;M</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SaaS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Software as a Service</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">S&amp;P</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standard &amp; Poor's</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SD&amp;P</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Systems development and programming</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:32.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:64.930%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e67222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLOSSARY</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SBC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock Based Compensation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SEC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Senior Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The 2029 Notes and the 2031 Notes</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SMB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Small and medium-size business</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TriNet Clarus R+D</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clarus R+D Solutions, LLC, which was sold in the first quarter of 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TriNet Trust</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trust which was created for the purpose of holding funds provided by ASO clients for the remittance to ASO Users, tax authorities and other recipients</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States of America</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">VIE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable interest entity</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">WSE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">A worksite employee who is co-employed by, or otherwise receiving services from a TriNet PEO</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-right:-2.25pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FORWARD LOOKING STATEMENTS AND OTHER FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this Quarterly Report on Form 10-Q (Form 10-Q), the terms &#8220;TriNet,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to TriNet Group, Inc., and its subsidiaries. This Form 10-Q contains statements that are not historical in nature, are predictive in nature, or that depend upon or refer to future events or conditions or otherwise contain forward-looking statements within the meaning of Section 21 of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by the use of words such as, but not limited to, "ability," &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;can,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;design,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;hope,&#8221; "impact," &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;outlook,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;strategy,&#8221; &#8220;target,&#8221; "value," &#8220;will,&#8221; &#8220;would&#8221; and similar expressions or variations intended to identify forward-looking statements. Examples of forward-looking statements include, among others, TriNet&#8217;s expectations regarding: our ability to successfully diversify our overall service and technology offerings to support SMBs throughout their lifecycle; our plans and ability to grow our client base; our expectations regarding medical utilization rates by our WSEs and the impact of inflation on our insurance costs; the impact of planned improvements to our technology platform and whether it will meet the needs of our current clients and attract new ones; our ability to improve operating efficiencies; our strategic realignment and related restructuring initiatives; the impact of our client service initiatives and whether they enhance client experience and satisfaction; our continued ability to provide access to a broad range of benefit programs on a cost-effective basis; our expectations regarding the volume and severity of insurance claims and insurance claim trends; the effectiveness of our risk strategies for, and management of, workers' compensation, health benefit insurance costs and deductibles; the metrics that may be indicators of future financial performance; the relative value of our benefit offerings versus those SMBs can independently obtain; the impact that our benefit offerings have for SMBs seeking to attract and retain employees; the principal competitive drivers in our market; our plans to grow net new clients and manage client attrition; our investment strategy and its impact on our ability to generate future interest income, net income, and Adjusted EBITDA; seasonal trends and their impact on our business; the payment of dividends of $0.275 per share in the second quarter of 2025; fluctuations in the period-to-period timing of when we incur certain operating expenses; the impact of increases and decreases in interest rates on our investments and borrowings; the estimates and assumptions we use to prepare our financial statements; our belief we can meet our present and reasonably foreseeable cash needs and future commitments through existing liquid assets and continuing cash flows from corporate operating activities; and other expectations, outlooks and forecasts on our future business, operational and financial performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Important factors that could cause actual results, level of activity, performance or achievements to differ materially from those expressed or implied by these forward-looking statements are discussed above and throughout our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 13, 2025 (our 2024 Form 10-K), including those appearing under the heading &#8220;Risk Factors&#8221; in Item 1A, and under the heading &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Part II, Item 7 of our 2024 Form 10-K, those appearing under the heading &#8220;Risk Factors&#8221; in Part II, Item 1A of this Form 10-Q and under the heading &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in this Form 10-Q, and those appearing in the other periodic filings we make with the SEC, and including risk factors associated with: our ability to manage unexpected changes in workers&#8217; compensation and health insurance claims and costs by WSEs; our ability to mitigate the unique business risks we face as a co-employer; the effects of volatility in the financial and economic environment on the businesses that make up our client base; our inability to realize or sustain the expected benefits from our business realignment initiatives; loss of clients for reasons beyond our control and the short-term contracts we typically use with our clients; the impact of regional or industry-specific economic and health factors on our operations; the impact of failures or limitations in the business systems and centers we rely upon; the impact of discontinuing our discretionary credits on our business and client loyalty and retention; changes in our insurance coverage or our relationships with key insurance carriers; our ability to improve our services and technology to satisfy client and regulatory expectations; our ability to effectively integrate businesses we have acquired or may acquire in the future; our ability to effectively manage and improve our operational effectiveness and resiliency; our ability to attract and retain qualified personnel; the effects of increased competition and our ability to compete effectively; the impact on our business of cyber-attacks, breaches, disclosures and other data-related incidents; our ability to comply with evolving data privacy, AI and security laws; our ability to manage changes in, uncertainty regarding, or adverse application of the complex laws and regulations that govern our business; changing laws and regulations governing health insurance and employee benefits; our ability to keep pace with changes in technology or provide timely enhancements to our solutions and support; risks associated with our international operations; our ability to operate a business subject to numerous complex laws; changing laws and regulations governing health insurance and other traditional employee benefits at the federal, state, and local levels; our ability to be recognized as an employer of worksite employees and for our benefits plans </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FORWARD LOOKING STATEMENTS AND OTHER FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to satisfy all requirements under federal and state regulations; changes in the laws and regulations that govern what it means to be an employer, employee or independent contractor; the impact of new and changing laws regarding remote work; our ability to comply with the licensing requirements that govern our solutions; the failure of third-party service providers performing their functions; the failure to comply with anti-corruption laws and regulations, economic and trade sanctions, and similar laws; the outcome of existing and future legal and tax proceedings; fluctuation in our results of operations and stock price due to factors outside of our control; our ability to comply with the restrictions of our indebtedness and meet our debt obligations; the need for additional capital or to restructure our existing debt; the continuation of our stock repurchase program; the  impact of concentrated ownership in our stock by Atairos and other large stockholders; and the anti-takeover provisions in our charter documents and under Delaware law. Any of these factors could cause our actual results to differ materially from our anticipated results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are not guarantees of future performance but are based on management&#8217;s expectations as of the date of this Form 10-Q and assumptions that are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from our current expectations and any past results, performance or achievements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information provided in this Form 10-Q is based upon the facts and circumstances known as of the date of this Form 10-Q, and any forward-looking statements made by us in this Form 10-Q speak only as of the date of this Form 10-Q. We undertake no obligation to revise or update any of the information provided in this Form 10-Q, except as required by law.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MD&amp;A of this Form 10-Q includes references to our performance measures presented in conformity with GAAP and other non-GAAP financial measures that we use to manage our business, to make planning decisions, to allocate resources and to use as performance measures in our executive compensation plans. Refer to the Non-GAAP Financial Measures within our MD&amp;A for definitions and reconciliations from GAAP measures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%">Website Disclosures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use our website (www.trinet.com) to announce material non-public information to the public and to comply with our disclosure obligations under Reg FD. We also use our website to communicate with the public about our Company, our services, and other matters. Our SEC filings, press releases and recent public conference calls and webcasts can also be found on our website. The information we post on our website could be deemed to be material information under Reg FD. We encourage investors and others interested in our Company to review the information we post on our website. Information contained in or accessible through our website is not a part of this report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Company is the sole owner of the trademark &#8220;TriNet&#8221; and other trademarks appearing in this report. Our Company does not intend to use or display trade names or trademarks owned by others in a manner that would imply any form of association with any of those companies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:12pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_19"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TriNet is a leading provider of HR solutions for SMBs. We offer advanced technology-enabled services that include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We deliver a comprehensive suite of HCM services that help our clients administer and manage various HR-related needs and functions, such as compensation, benefits, payroll processing, tax credit support, employee data, health insurance, workers' compensation, EPLI and other employment risk mitigation programs, employee performance management and training, on-boarding and off-boarding, and other transactional HR needs using our PEO technology platform and benefits and compliance expertise.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We deliver our services primarily through our PEO services that we provide via our co-employment model, and to a lesser extent, through our ASO-only services, which provides payroll processing, HR administration and compliance management solutions outside of the co-employment model. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Operational Highlights</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated results for the quarter ended March&#160;31, 2025 reflect our continuing efforts to serve our clients, attract new clients and invest in our platform.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">So far in 2025, we:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">continued to grow our total revenues, supported primarily by growth in ISR,</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">made progress on the strategic restructuring initiatives to focus our business on our core value proposition, growing ASO, and the efficiency and effectiveness of our operations, including the sale of TriNet Clarus R+D,</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">demonstrated disciplined expense management, in light of rising insurance costs,</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announced plans to establish a new corporate center in Atlanta, Georgia over the next five years, and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">declared common stock dividends of $0.275 per share, up 10%, to be paid in April 2025.</span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_22"></div><div style="margin-top:9pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Performance Highlights</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results for the quarter ended March&#160;31, 2025, when compared to the same period of 2024, are noted below:</span></div><div style="margin-top:10pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q1 2025 </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.923%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.610%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">$1.3B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">$115M</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">88%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance cost ratio</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">increase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">decrease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">increase</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">$85M</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">$1.71</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">$99M</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Net income *</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">decrease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">decrease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">decrease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">340,744</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">339,625</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average WSEs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total WSEs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">decrease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">decrease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-GAAP measure. See definitions below under the heading "</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">".</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total revenues increased by 1% in the first quarter of 2025, compared to the same period in 2024, driven primarily by insurance services rate increases, partially offset by lower Average co-employed WSEs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2025, our Average WSEs and Total WSEs decreased by 2% and 3%, respectively, compared to the same period in 2024, primarily due to WSE decreases in our Technology, Professional Services, Main Street, and Life Sciences verticals.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results are highly influenced by health care cost and utilization trends. Our ICR in the first quarter of 2025 was 2 points higher compared to the same period in 2024, driven by more severe medical service utilization, higher rates paid for services, and increasing specialty drug utilization which collectively outpaced the rates we charge our clients.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Higher insurance costs, partially offset by higher revenues and lower expenses, resulted in decreases of net income and Adjusted Net income of 7% and 11%, respectively, in the first quarter of 2025, as compared to the same period in 2024.</span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_28"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the first quarter ended March&#160;31, 2025, when compared to the same period of 2024. For details of the critical accounting judgments and estimates that could affect our Results of Operations, see the </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_82">Critical Accounting Judgments and Estimates</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section within the MD&amp;A in Item 7 of our 2024 Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions, except operating metrics data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional service revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">209</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance service revenues</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,065</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenues</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,292</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,282</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">942</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">221</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, bank fees and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total costs and operating expenses</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,177</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income before tax</span></td><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">115</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Data:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(494)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(243)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-GAAP measures </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">162</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted Net income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Metrics:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance Cost Ratio</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">88</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average WSEs </span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">340,744</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total WSEs</span></div></td><td colspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">339,625</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351,919&#160;</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:24.75pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Refer to Non-GAAP measures definitions and reconciliations from GAAP measures under the heading "</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">".</span></div><div style="margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our balance sheet data as of March&#160;31, 2025 compared to December&#160;31, 2024. </span></div><div style="margin-top:5pt;padding-left:24.75pt;text-indent:-22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:62.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.409%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.409%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.978%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">349</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Working capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">211</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,775</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">983</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">63</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to financial measures presented in accordance with GAAP, we monitor other non-GAAP financial measures that we use to manage our business, to make planning decisions, to allocate resources and to use as performance measures in our executive compensation plan. These key financial measures provide an additional view of our operational performance over the long-term and provide information that we use to maintain and grow our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The presentation of these non-GAAP financial measures is used to enhance the understanding of certain aspects of our financial performance. It is not meant to be considered in isolation from, superior to, or as a substitute for the directly comparable financial measures prepared in accordance with GAAP.</span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.076%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP Measure</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definition</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">How We Use The Measure</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Adjusted EBITDA</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226; Net income, excluding the effects of: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- income tax provision, </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- interest expense, bank fees and other,</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- depreciation, </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- amortization of intangible assets, </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- stock based compensation expense,</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- amortization of cloud computing arrangements, and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- restructuring costs.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226; Provides period-to-period comparisons on a consistent basis and an understanding as to how our management evaluates the effectiveness of our business strategies by excluding certain non-recurring costs, which include restructuring costs, as well as certain non-cash charges such as depreciation and amortization, and stock-based compensation and certain impairment charges recognized based on the estimated fair values. We believe these charges are either not directly resulting from our core operations or not indicative of our ongoing operations.<br/>&#8226; Enhances comparisons to the prior period and, accordingly, facilitates the development of future projections and earnings growth prospects.<br/>&#8226; Provides a measure, among others, used in the determination of incentive compensation for management.<br/>&#8226; We also sometimes refer to Adjusted EBITDA margin, which is the ratio of Adjusted EBITDA to total revenues.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Adjusted Net Income</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226; Net income, excluding the effects of: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- effective income tax rate </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- stock based compensation expense, </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- amortization of intangible assets, net,</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- non-cash interest expense, </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- restructuring costs, and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- the income tax effect (at our effective tax rate </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of these pre-tax adjustments.)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226; Provides information to our stockholders and board of directors to understand how our management evaluates our business, to monitor and evaluate our operating results, and analyze profitability of our ongoing operations and trends on a consistent basis by excluding certain non-cash charges.</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Non-GAAP effective tax rate is 25.0% and 25.6% for the first quarters of 2025 and 2024, respectively, which excludes the income tax impact from stock-based compensation, changes in uncertain tax positions, and nonrecurring benefits or expenses from federal legislative changes.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reconciliation of GAAP to Non-GAAP Measures</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents a reconciliation of Net income to Adjusted EBITDA: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.866%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock based compensation</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, bank fees and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of cloud computing arrangements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">162</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBITDA Margin</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents a reconciliation of Net income to Adjusted Net Income: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.866%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate adjustment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of other intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash interest expense </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax impact of pre-tax adjustments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Net Income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_31"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.491%"><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:7.017%;min-width:6.017%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.492%"></div></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:12pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Operating Metrics</span></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Worksite Employees (WSE)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Average WSE change is a volume measure we use to monitor the performance of our PEO business. Our PEO clients generally change their payroll service providers at the beginning of the payroll tax and benefits enrollment year; as a result, we have historically experienced our highest volumes of new PEO clients joining and existing clients terminating in the month of January. PEO client attrition, new PEO client additions and changes in employment levels within our installed PEO client base all impact our Average WSEs and Total WSEs as we move through a calendar year. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We support WSEs from the date on which their co-employment with TriNet commences through the end of their co-employment with TriNet and also after their co-employment period. We define WSEs to include co-employees and other individuals receiving PEO services, such as individuals who receive COBRA benefits or are subject to partnership tax reporting as well as individuals who utilize our PEO platform on behalf of TriNet PEO clients. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charge a platform user access fee to clients for those users of our PEO platform that may not be co-employed by us as well as for co-employees for whom payroll may not be regularly run. In addition to co-employees for whom payroll may not be regularly run, such as partners in a partnership, this group of users also includes individuals authorized by our clients to access and use the PEO platform for functions such as bookkeeping and benefits management. We refer to these users as PEO Platform Users. Starting in 2023 and continuing through 2024, we began billing clients in groups over time, driving a large increase in PEO Platform Users over that period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of this fee is that we receive revenue from two types of users on our PEO platform, those that are co-employed in our PEO business and those that are utilizing our PEO platform, albeit in a more limited capacity. The table below illustrates how those two components comprise our Total WSE and Average WSE metrics.</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average WSEs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">340,744</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Co-Employed</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">312,573</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330,566&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;PEO Platform Users</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">28,171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,598&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total WSEs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">339,625</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351,919&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Co-Employed</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">311,165</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">332,361&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;PEO Platform Users</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">28,460</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,558&#160;</span></td><td style="border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Average WSEs decreased 2% when comparing the first quarter of 2025 to the same period in 2024 driven by both client attrition outpacing new client additions and lower hiring in our installed base over the past twelve months. From a vertical perspective, declines in our Technology, Professional Services, Main Street, and Life Sciences verticals were partially offset by small increases in our Financial Services and Non-Profit verticals.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total WSEs can be used to estimate our beginning WSEs for the next period and, as a result, can be used as an indicator of our potential future success in generating revenue, growing our business and retaining clients. Total WSEs decreased 3% when compared to the same period in 2024, primarily due to declines in our Technology, Professional Services, Main Street, and Life Sciences verticals.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anticipated revenues for future periods can diverge from the revenue expectation derived from Average WSEs or Total WSEs due to pricing differences across our HCM solutions and services and the degree to which clients and WSEs elect to participate in our solutions during future periods. In addition to focusing on growing our Average WSE and Total WSE counts, we also focus on pricing strategies, benefit participation and service differentiation to expand the value we provide to our clients and our resulting revenue opportunities. We report the impact of client and WSE participation differences as a change in mix.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to invest in efforts intended to enhance client experience, improve our new sales performance, and manage client attrition, through product development as well as operational and process improvements. In addition to focusing on retaining and growing our WSE base, we continue to review acquisition or other opportunities to expand our product offering and provide further scale.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><img src="tnet-20250331_g2.jpg" alt="Screenshot 2025-04-11 132059.jpg" style="height:302px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_43"></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Insurance Cost Ratio (ICR)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICR is a performance measure calculated as the ratio of insurance costs to insurance service revenues. We believe that ICR promotes an understanding of our insurance cost trends and our ability to align our relative pricing to risk performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase workers' compensation and health benefits coverage for our WSEs. Under the insurance policies for this coverage, we bear claims costs up to a defined deductible amount. Our insurance costs, which comprise a significant portion of our overall costs, are significantly affected by our WSEs&#8217; health and workers' compensation insurance claims experience. We set our insurance service fees for workers&#8217; compensation and health benefits in advance for fixed benefit periods. As a result, any increases in insurance costs above our projections, will be reflected as a higher ICR, and result in lower net income. Any decreases in insurance costs below our projections, will be reflected as a lower ICR and result in higher net income.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our fully-insured workers' compensation insurance policies, we assume the risk for losses up to $1 million per claim occurrence (deductible layer). The ultimate cost of the workers&#8217; compensation services provided cannot be known until all the claims are settled. Our ability to predict these costs is limited by unexpected increases in frequency or severity of claims, which can vary due to changes in the cost of treatments or claim settlements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our risk-based health insurance policies, we assume some of the risk of variability in future health claims costs for our enrollees. This variability typically results from changing trends in the volume, severity and ultimate cost of medical and pharmaceutical claims, due to changes to the components of medical cost trend, which we define as changes in participant use of services, including the introduction of new treatment options, changes in treatment guidelines and mandates, and changes in the mix, cost of providing treatment and timing of services provided to plan participants. These trends change, and other seasonal trends and variability may develop. As a result, it is difficult for us to predict our insurance costs with accuracy and a significant increase in these costs could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.913%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance costs</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">942</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance service revenues</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,065</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Insurance Cost Ratio</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">88</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ICR increased for the first quarter of 2025 as compared to the same period in 2024, primarily driven by higher insurance costs that outpaced the growth in ISR. The increase in insurance costs was primarily due to more severe medical service utilization in all categories (inpatient, outpatient and professional services), higher rates paid for those services, as well as pharmacy costs including specialty drugs and other high-cost prescriptions, particularly medications for diabetes and obesity. </span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_49"></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Total Revenues</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues consist of PSR, ISR and interest income. PSR represents fees charged to clients for processing payroll-related transactions on behalf of our PEO and ASO clients, access to our HR expertise and technology, employment and benefit law compliance services, other HR-related and tax credit filing services and fees charged to access our cloud-based ASO services. ISR consists of insurance-related billings and administrative fees collected from PEO clients and withheld from WSEs for workers' compensation insurance and health benefit insurance plans provided by third-party insurance carriers.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Monthly revenues per co-employed Average WSE is a measure we use to monitor our PEO pricing strategies. This measure increased by 7% during the first quarter of 2025 compared to the same period in 2024.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use the following measures to further analyze changes in total revenue:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volume - the percentage change in period over period co-employed Average WSEs,</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rate - the combined weighted average percentage changes in service fees for each vertical service and changes in service fees associated with each insurance service offering, </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Mix - </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the change in composition of co-employed Average WSEs within our verticals combined with the composition of our enrolled co-employed WSEs within our insurance service offerings and the composition of products and services our clients receive, such as PEO Platform Users,</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HRIS - cloud services revenue, which includes our new ASO services revenue, and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest income.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div><img src="tnet-20250331_g3.jpg" alt="1489" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><img src="tnet-20250331_g4.jpg" alt="1493" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><img src="tnet-20250331_g5.jpg" alt="549755815610" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:38.011%"><tr><td style="width:1.0%"/><td style="width:6.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.670%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">PSR</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#0073cf;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ISR - % represents proportion of insurance service revenues to total revenues</span></td><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#e37222;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">*Total revenues generated from PEO services only, excluding interest income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in total revenue for the first quarter was primarily driven by rate increases, partially offset by lower co-employed Average WSEs.</span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_55"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Professional Service Revenues</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our PEO and ASO clients are primarily billed on a fee per WSE or HRIS User per month per transaction. Our vertical approach provides us the flexibility to offer our PEO clients in different industries with varied services at different prices, which we believe potentially reduces the value of solely using Average WSE and Total WSE counts as indicators of future potential revenue performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSR from PEO Services customers and HRIS and ASO services clients was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.174%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.106%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PEO Services</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">199</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HRIS and ASO Services </span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">209</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also analyze changes in PSR with the following measures:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volume - the percentage change in period over period co-employed Average WSEs,</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rate - the weighted average percentage change in fees for each vertical, </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mix - the change in composition of co-employed Average WSEs across our verticals and</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the composition of products and services our clients receive, including PEO Platform Users, and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HRIS - cloud services revenue, which includes our new ASO services revenue.</span></div><div style="margin-top:3pt"><img src="tnet-20250331_g6.jpg" alt="980" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><img src="tnet-20250331_g7.jpg" alt="981" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><img src="tnet-20250331_g8.jpg" alt="549755815241" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/></div><div style="margin-top:3pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSR for the first quarter of 2025 decreased compared to prior period, primarily driven by lower co-employed Average WSEs, the discontinuance of a client-level technology fee, and less favorable vertical mix, partially offset by rate increases.</span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_58"></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Insurance Service Revenues </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ISR consists of insurance services-related billings and administrative fees collected from PEO clients and withheld from WSE payroll for health benefits and workers' compensation insurance provided by third-party insurance carriers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the following measures to analyze changes in ISR:</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volume - the percentage change in period over period co-employed Average WSEs,</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rate - the weighted average percentage change in fees associated with each of our insurance service offerings, and</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mix - all other changes including the composition of our enrolled co-employed WSEs within our insurance service offerings (health plan enrollment).</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-top:3pt"><img src="tnet-20250331_g9.jpg" alt="669" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><img src="tnet-20250331_g10.jpg" alt="670" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><img src="tnet-20250331_g11.jpg" alt="549755814689" style="height:237px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The increase in ISR for the first quarter of 2025 was primarily driven by rate increases, partially offset by lower co-employed Average WSEs.</span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_1610"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Interest Income</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income primarily includes interest income earned from cash held for our PEO and ASO clients as a result of the requirement of our clients to prefund their payroll and related taxes and other withholding liabilities before payroll is processed or due for payment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><img src="tnet-20250331_g12.jpg" alt="1099511628069" style="height:224px;margin-bottom:5pt;vertical-align:text-bottom;width:180px"/></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income for the first quarter was consistent with the prior period as a decrease in interest earned on our cash and investments was offset by higher interest received related to payroll tax refunds.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Insurance Costs</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance costs include insurance premiums for coverage provided by insurance carriers, payments for claims costs and expenses for other risk management and administrative services, reimbursement of claims payments made by insurance carriers or third-party administrators below a predefined deductible limit, and changes in accrued costs related to contractual obligations with our workers' compensation and health benefit carriers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the following measures to analyze changes in insurance costs:</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volume - the percentage change in period over period co-employed Average WSEs,</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rate - the weighted average percentage change in cost trend associated with each of our insurance service offerings, and</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mix - all other changes including the composition of our enrolled co-employed WSEs within our insurance service offerings (health plan enrollment).</span></div><div style="margin-top:3pt;text-align:justify"><img src="tnet-20250331_g13.jpg" alt="873" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><img src="tnet-20250331_g14.jpg" alt="874" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><img src="tnet-20250331_g15.jpg" alt="549755815166" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Insurance costs increased for the first quarter, primarily due to more severe medical service utilization, higher rates paid for all categories of service (inpatient, outpatient and professional services) and increased specialty drugs utilization, particularly medications for diabetes and obesity. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses include COPS, S&amp;M, G&amp;A, SD&amp;P, D&amp;A, collectively referred to as OE, as well as IE.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We had approximately 3,400 colleagues as of March&#160;31, 2025 primarily across the U.S. but also in India and Canada, down approximately 270 colleagues from March 31, 2024. Compensation costs for our colleagues include payroll, payroll taxes, SBC, bonuses, commissions and other payroll- and benefits-related costs. Compensation-related expense represented 68% and 67% of our expenses in the first quarters of 2025 and 2024, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the first quarter, expenses decreased 6% when compared to the same period in 2024 driven largely by lower compensation expense from our reduced headcount. The ratio of expenses to total revenues was 18% and 20% for the first quarters of 2025 and 2024, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><img src="tnet-20250331_g16.jpg" alt="804" style="height:224px;margin-bottom:5pt;vertical-align:text-bottom;width:232px"/><img src="tnet-20250331_g17.jpg" alt="805" style="height:224px;margin-bottom:5pt;vertical-align:text-bottom;width:232px"/><img src="tnet-20250331_g18.jpg" alt="806" style="height:224px;margin-bottom:5pt;vertical-align:text-bottom;width:218px"/></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"/><td style="width:169.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:24.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:25.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:22.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:24.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:22.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:24.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:27.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:39.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:112.75pt"/><td style="width:1.0pt"/></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">% represents portion of compensation related expense included in operating expenses</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e37222;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Compensation related expense</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We analyze and present our expenses based upon the functional categories of COPS, S&amp;M, G&amp;A, SD&amp;P, D&amp;A and IE. The charts below provide a view of the expenses of the business functions. Dollars are presented in millions and percentages represent year-over-year change.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><img src="tnet-20250331_g19.jpg" alt="1070" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:110px"/><img src="tnet-20250331_g20.jpg" alt="1071" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:110px"/><img src="tnet-20250331_g21.jpg" alt="1072" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:110px"/><img src="tnet-20250331_g22.jpg" alt="1073" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:110px"/><img src="tnet-20250331_g23.jpg" alt="1074" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:110px"/><img src="tnet-20250331_g24.jpg" alt="549755815066" style="height:297px;margin-bottom:5pt;vertical-align:text-bottom;width:110px"/></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.790%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$251</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Q1 2024 Expenses</span></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-8&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COPS decreased primarily due to lower expense in compensation and tax and licenses.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">S&amp;M decreased primarily due to lower conferences and events expenses and advertising expenses.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G&amp;A decreased primarily due to lower compensation expense.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SD&amp;P increased primarily due to higher compensation expense driven by lower capitalized spend.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D&amp;A was consistent with prior period.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IE decreased driven primarily by lower debt balances.</span></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$235</span></td><td colspan="3" style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Q1 2025 Expenses</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary spend type drivers to the changes in our expenses are presented below:</span></div><div style="margin-top:10pt"><img src="tnet-20250331_g25.jpg" alt="1157" style="height:268px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_73"></div><div style="margin-bottom:6pt;margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our ETR was 26% and 27% for the first quarters of 2025 and 2024, respectively. The decrease in the rate was primarily attributable to an increase in tax benefits related to excludable income for state tax purposes and a decrease in the state tax rate, offset by a decrease in tax benefits for stock-based compensation.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquidity is a measure of our ability to access sufficient cash flows to meet the short-term and long-term cash requirements of our business operations. Our principal source of liquidity for operations is derived from cash provided by operating activities. We rely on cash provided by operating activities to meet our short-term liquidity requirements, which primarily relate to the payment of corporate payroll and other operating costs, and capital expenditures. Our cash flow related to WSE payroll and benefits is generally matched by advance collection from our PEO clients. To minimize the credit risk associated with remitting the payroll and associated taxes and benefits costs, we require PEO clients to prefund the payroll and related payroll taxes and benefits costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our balance sheets are assets and liabilities resulting from transactions directly or indirectly associated with WSEs, including payroll and related taxes and withholdings, our sponsored workers' compensation and health insurance programs, and other benefit programs. Although we are not subject to regulatory restrictions that require us to do so, we distinguish and manage our corporate assets and liabilities separately from those current assets and liabilities held by us to satisfy our employer obligations associated with our WSEs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">TriNet Trust, which is consolidated into our financial statements, holds funds provided by ASO clients for the remittance to ASO Users, tax authorities and other recipients. TriNet Trust also holds ownership and responsibility of certain bank accounts that hold ASO client funds.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The associated cash is reflected on our Condensed consolidated balance sheets as restricted cash and the associated liabilities are classified as accrued wages, payroll tax liabilities and other payroll withholdings, and client deposits and other client liabilities and assumed related liabilities.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of March&#160;31, 2025, the balance of restricted cash in TriNet Trust was $101 million. Beginning in the second quarter of 2024, we include the assets and liabilities related to the TriNet Trust in the "WSE &amp; TriNet Trust" category because the underlying cash flows of TriNet Trust are related to the same type of payroll and payroll related liabilities as our WSE cash flows. This trust structure will continue to be used as we transition our HRIS services to ASO services.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:51.176%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.687%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">WSE &amp; TriNet Trust</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">WSE &amp; TriNet Trust</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">347</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">349</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">22</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">1,002</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">1,024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">83</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">1,401</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">1,484</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,407&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total current assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">452</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2,405</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2,857</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,703&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,180&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">241</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2,405</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2,646</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,703&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,981&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Working capital</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">211</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">211</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, we did not have any material off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Working capital for WSEs and TriNet Trust related activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designate funds to ensure that we have adequate current assets to satisfy our current obligations associated with WSEs. We manage our WSE payroll and benefits obligations through collections of payments from our clients which generally occur two to three days in advance of client payroll dates. We regularly review our short-term obligations associated with our WSEs (such as payroll and related taxes, insurance premium and claim payments) and designate funds required to fulfill these short-term obligations, which we refer to as PFC. PFC is included in current assets as restricted cash, cash equivalents and investments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our sponsored benefit and workers' compensation insurance obligations by maintaining collateral funds in restricted cash, cash equivalents and investments. These collateral amounts are generally determined at the beginning of each plan year and we may be required by our insurance carriers to adjust our collateral balances when facts and circumstances change. We regularly review our collateral balances with our insurance carriers and anticipate funding further collateral in the future based upon our capital requirements. We classify our restricted cash, cash equivalents and investments as current and noncurrent assets to match against the anticipated timing of payments to carriers. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Working capital for corporate purposes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate working capital as of March&#160;31, 2025 increased $12 million from December&#160;31, 2024, primarily due to the decreases in our corporate current liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We use our available cash and cash equivalents to satisfy our operational and regulatory requirements and to fund capital expenditures. We believe that we can meet our present and reasonably foreseeable operating cash needs and future commitments through existing liquid assets, continuing cash flows from corporate operating activities and the potential issuance of debt or equity securities. We hold both corporate cash and cash associated with WSEs across multiple financial institutions to reduce concentrations of counterparty risk. We believe our existing corporate cash and cash equivalents and positive working capital will be sufficient to meet our working capital expenditure needs for at least the next twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our cash flow activities for the stated periods:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">WSE &amp; TriNet Trust</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">WSE &amp; TriNet Trust</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(106)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(388)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(494)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(213)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(243)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents, unrestricted and restricted</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(16)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(391)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(407)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(213)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(199)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents, unrestricted and restricted:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of period</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">415</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,276</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,691</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">399</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">885</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,284</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,267&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrestricted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(392)</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(396)</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(213)</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(210)</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The year-over-year change in net cash provided by operating activities was primarily driven by the timing of our payments of corporate obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by (used in) investing activities for the periods presented below primarily consisted of purchases of investments and capital expenditures, partially offset by proceeds from the sale and maturity of investments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.249%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(27)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale and maturity of marketable securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash used in investments</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions of property and equipment and software</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash used in capital expenditures</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(16)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of business</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash used in investing activities</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(8)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest a portion of available cash in investment-grade securities with effective maturities less than five years that are classified on our Condensed consolidated balance sheets as investments. We consider industry and issuer concentrations in our investment policy. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also invest funds held as collateral to satisfy our long-term obligation towards workers' compensation liabilities. These investments are classified on our balance sheets as restricted cash, cash equivalents and investments. We review the amount and the anticipated holding period of these investments regularly in conjunction with our estimated long-term workers' compensation liabilities and anticipated claims payment trend. At March&#160;31, 2025, our investments had a weighted average duration of two years and an average S&amp;P credit rating of AA+.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, we held approximately $1.5 billion in restricted and unrestricted cash, cash equivalents and investments, of which $349 million was unrestricted cash and cash equivalents. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_130">Note 2</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated financial statements and related notes included in this Form 10-Q.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital Expenditures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2025 and 2024, we continued to make investments in software and hardware as we enhanced our existing service offerings and technology platform. We expect capital investments in our software and hardware to continue in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities in the three months ended March&#160;31, 2025 and 2024 consisted of our debt and equity-related activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in WSE and TriNet Trust related assets and liabilities, net</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(388)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(213)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock, net of issuance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(94)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash used in financing activities</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(494)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(243)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2025, we repurchased 1,210,403 shares of our common stock for approximately $90 million through our existing stock repurchase program in addition to 46,827 shares acquired to satisfy tax withholding obligations related to SBC vesting. As of March&#160;31, 2025, approximately $162 million remained available for repurchase under all authorizations by our board of directors. We plan to use current cash and cash generated from ongoing operating activities to fund this stock repurchase program.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid a common stock dividend of $0.25 per share in January 2025. We also declared a common stock dividend of $0.275 per share to be paid in the second quarter of 2025.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, $500 million and $400 million aggregate principal of our 2029 Notes and 2031 Notes was outstanding, respectively. The indenture governing our 2029 Notes and 2031 Notes each includes restrictive covenants limiting our ability to: (i) create liens on certain assets to secure debt; (ii) grant a subsidiary guarantee of certain debt without also providing a guarantee of the 2029 Notes or 2031 Notes, as applicable; and (iii) consolidate or merge with or into, or sell or otherwise dispose of all or substantially all of our assets to, another person, subject, in each case, to certain customary exceptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2021 Credit Agreement includes a $700 million revolver. In September of 2023, we drew down $200 million of this revolver to partially fund our third quarter of 2023 share repurchases. As of March&#160;31, 2025, $90 million remains outstanding under our 2021 Revolver. The 2021 Credit Agreement includes negative covenants that limit our ability to incur indebtedness and liens, sell assets and make restricted payments, including dividends and investments, subject to certain exceptions. In addition, the 2021 Credit Agreement also contains other customary affirmative and negative covenants and customary events of default. The 2021 Credit Agreement also contains a financial covenant that requires the Company to maintain certain maximum total net leverage ratios.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were in compliance with all financial covenants under our 2021 Credit Agreement, 2029 Notes and 2031 Notes at March&#160;31, 2025.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Critical Accounting Policies, Estimates and Judgments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our critical accounting policies, estimates and judgments as discussed in our 2024 Form&#160;10-K.</span></div><div style="margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_124">Note 1</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Item 1 of this Form 10-Q.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_85"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AND CONTROLS AND PROCEDURES</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:12pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risks in connection with our business, which primarily relate to fluctuations in interest rates. Our exposure to changes in interest rates relates primarily to our investment portfolio and outstanding borrowings under our floating rate 2021 Revolver. Changes in interest rates affect the interest earned on the Company's cash, cash equivalents and the fair value of our investments as well as the cost of borrowing under our 2021 Revolver.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash equivalents consist primarily of money market mutual funds, which are not significantly exposed to interest rate risk. Our investments are subject to interest rate risk because these securities generally include a fixed interest rate. As a result, the market values of these securities are affected by changes in prevailing interest rates. We attempt to limit our exposure to interest rate risk and credit risk by investing in instruments that meet the minimum credit quality, liquidity, diversification and other requirements of our investment policy. Our investments consist of liquid, investment-grade securities. The risk of interest rate changes on investment balances was not material at March&#160;31, 2025 and December&#160;31, 2024.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, we issued $500 million aggregate principal of 3.50% senior unsecured notes maturing in March 2029 (our 2029 Notes) and in August 2023, we issued $400 million aggregate principal of 7.125% senior unsecured notes maturing in August 2031 (our 2031 Notes). Our 2029 Notes and 2031 Notes are carried at their cost, net of issuance costs. Since our 2029 Notes and 2031 Notes bear interest at fixed rates, we have no financial statement risk to these notes associated with changes in interest rates. However, the fair value of our 2029 Notes and our 2031 Notes fluctuates when interest rates change.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, $90 million remains outstanding under our floating rate 2021 Revolver.  The impact of a 100 basis point increase or decrease in market interest rates to interest expense on our 2021 Revolver as of March&#160;31, 2025 over the next twelve months was approximately $1 million.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_88"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AND CONTROLS AND PROCEDURES</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have, with the participation of our CEO and our CFO, evaluated the effectiveness of our disclosure controls and procedures as of March&#160;31, 2025, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the evaluation of our disclosure controls and procedures as of March&#160;31, 2025, our CEO and CFO have concluded that the Company&#8217;s disclosure controls and procedures were effective as of such date in ensuring that (i) information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is accumulated and communicated to the Company&#8217;s management, including the CEO and CFO, to allow timely decisions regarding required disclosure and (ii) such information is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have concluded that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with GAAP.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended March&#160;31, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Limitations on Effectiveness of Controls and Procedures </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_94"></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRINET GROUP, INC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited)</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional service revenues</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-31">209</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-32">214</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance service revenues</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-33">1,065</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-34">1,050</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestIncomeOperating" scale="6" id="f-35">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:InterestIncomeOperating" scale="6" id="f-36">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenues</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-37">1,292</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-38">1,282</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance costs</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingInsuranceAndClaimsCostsProduction" scale="6" id="f-39">942</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OperatingInsuranceAndClaimsCostsProduction" scale="6" id="f-40">907</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of providing services</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="tnet:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" scale="6" id="f-41">71</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="tnet:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" scale="6" id="f-42">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SellingAndMarketingExpense" scale="6" id="f-43">67</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:SellingAndMarketingExpense" scale="6" id="f-44">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-45">46</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-46">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Systems development and programming</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-47">20</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-48">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" scale="6" id="f-49">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" scale="6" id="f-50">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, bank fees and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="tnet:InterestExpenseBankFeesAndOther" scale="6" id="f-51">14</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="tnet:InterestExpenseBankFeesAndOther" scale="6" id="f-52">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total costs and operating expenses</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="f-53">1,177</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="f-54">1,158</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income before tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-55">115</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-56">124</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-57">30</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-58">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-59">85</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-60">91</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of income taxes</span></td><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-61">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-62">3</ix:nonFraction>)</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive income</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-63">87</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-64">88</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per share:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-65">1.72</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-66">1.80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-67">1.71</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-68">1.78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average shares:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-69">49</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-70">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-71">49</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-72">51</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRINET GROUP, INC.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions, except share and per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-73">349</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-74">360</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-75">1,024</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-76">1,413</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-77">21</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-78">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll funds receivable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="f-79">478</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="f-80">349</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-81">60</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-82">64</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payroll assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:OtherPayrollAssetsCurrent" scale="6" id="f-83">881</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:OtherPayrollAssetsCurrent" scale="6" id="f-84">916</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-85">44</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-86">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-87">2,857</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-88">3,180</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments, noncurrent</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-89">134</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-90">145</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-91">9</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-92">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-93">22</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-94">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:Goodwill" scale="6" id="f-95">461</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:Goodwill" scale="6" id="f-96">461</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software and other intangible assets, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-97">146</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-98">156</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-99">146</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-100">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-101">3,775</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-102">4,119</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities and stockholders' equity</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="f-103">82</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="f-104">89</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolving credit agreement borrowings</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LinesOfCreditCurrent" scale="6" id="f-105">74</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LinesOfCreditCurrent" scale="6" id="f-106">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Client deposits and other client liabilities </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-107">49</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-108">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued wages</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AccruedSalariesCurrent" scale="6" id="f-109">544</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AccruedSalariesCurrent" scale="6" id="f-110">580</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued health insurance costs, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" scale="6" id="f-111">189</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" scale="6" id="f-112">189</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued workers' compensation costs, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="6" id="f-113">45</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="6" id="f-114">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll tax liabilities and other payroll withholdings</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" format="ixt:num-dot-decimal" scale="6" id="f-115">1,645</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" format="ixt:num-dot-decimal" scale="6" id="f-116">1,906</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-117">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-118">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Insurance premiums and other payables</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:InsurancePremiumsAndOtherPayables" scale="6" id="f-119">6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:InsurancePremiumsAndOtherPayables" scale="6" id="f-120">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-121">2,646</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-122">2,981</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, noncurrent</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-123">909</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-124">908</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued workers' compensation costs, noncurrent, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:WorkersCompensationLiabilityNoncurrent" scale="6" id="f-125">111</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:WorkersCompensationLiabilityNoncurrent" scale="6" id="f-126">110</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred taxes</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-127">10</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-128">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities, noncurrent</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-129">24</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-130">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current liabilities</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-131">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-132">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-133">3,712</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-134">4,050</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies (see </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_154">Note 5</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-8" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-135"></ix:nonFraction></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-9" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-136"></ix:nonFraction></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-137">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-138">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-139"><ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-140">0.000025</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-141"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-142">20,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt-sec:numwordsen" scale="0" id="f-143"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt-sec:numwordsen" scale="0" id="f-144"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt-sec:numwordsen" scale="0" id="f-145"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt-sec:numwordsen" scale="0" id="f-146">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding at March&#160;31, 2025 and December&#160;31, 2024)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock and additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-147">1,070</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-148">1,056</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-149"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-150">0.000025</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-151"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-152">750,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-153"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-154">48,397,519</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-155"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-156">49,527,506</ix:nonFraction></ix:nonFraction> shares issued and outstanding at March&#160;31, 2025 and December&#160;31, 2024, respectively)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-157">1,006</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-158">984</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-159">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-160">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-161">63</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-162">69</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities &amp; stockholders' equity</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-163">3,775</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-164">4,119</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRINET GROUP, INC.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)<br/></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Stockholders' Equity, beginning balance</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-165">69</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-166">78</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common Stock and Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-167">1,056</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-168">976</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock based compensation expense</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-169">14</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-170">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-171">1,070</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-172">996</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained Earnings (Accumulated Deficit)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-173">984</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-174">896</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-175">85</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-176">91</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-6" name="us-gaap:DividendsCommonStockStock" scale="6" id="f-177">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-6" name="us-gaap:DividendsCommonStockStock" scale="6" id="f-178">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="f-179">90</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="f-180">23</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Awards effectively repurchased for required employee withholding taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-181">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-182">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-183">1,006</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-184">848</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-185">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-186">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-187">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-188">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-189">1</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-190">5</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Stockholders' Equity, ending balance</span></div></td><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-191">63</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-192">143</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRINET GROUP, INC.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-193">85</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-194">91</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments to reconcile net income to net cash used in operating activities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherDepreciationAndAmortization" scale="6" id="f-195">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OtherDepreciationAndAmortization" scale="6" id="f-196">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of deferred costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherAmortizationOfDeferredCharges" scale="6" id="f-197">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OtherAmortizationOfDeferredCharges" scale="6" id="f-198">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of ROU asset, lease modification, impairment, and abandonment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-199">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-200">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="f-201">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:fixed-zero" scale="6" id="f-202">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-203">13</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-204">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Losses on investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="f-205">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:GainLossOnInvestments" format="ixt:fixed-zero" scale="6" id="f-206">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss from disposition of assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:GainLossOnDispositionOfAssets1" scale="6" id="f-207">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:GainLossOnDispositionOfAssets1" format="ixt:fixed-zero" scale="6" id="f-208">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-209">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-210">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-211">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-212">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses, net </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="6" id="f-213">7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="6" id="f-214">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="f-215">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="f-216">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payroll assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="tnet:IncreaseDecreaseInOtherPayrollAssets" format="ixt:fixed-zero" scale="6" id="f-217">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="tnet:IncreaseDecreaseInOtherPayrollAssets" scale="6" id="f-218">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="6" id="f-219">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="6" id="f-220">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Client deposits and other client liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:fixed-zero" scale="6" id="f-221">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="f-222">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued wages</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedSalaries" scale="6" id="f-223">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedSalaries" scale="6" id="f-224">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued health insurance costs, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" scale="6" id="f-225">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" format="ixt:fixed-zero" scale="6" id="f-226">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued workers' compensation costs, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities" scale="6" id="f-227">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities" format="ixt:fixed-zero" scale="6" id="f-228">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll taxes liabilities and other payroll withholdings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities" scale="6" id="f-229">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities" scale="6" id="f-230">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="f-231">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="f-232">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-233">95</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-234">91</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="f-235">27</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="f-236">95</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale and maturity of marketable securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="f-237">34</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="f-238">66</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions of property and equipment and software</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-239">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-240">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of business</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="f-241">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="6" id="f-242">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></div></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-243">8</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-244">47</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in WSE and TriNet Trust related assets and liabilities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet" scale="6" id="f-245">388</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet" scale="6" id="f-246">213</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-247">90</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-248">23</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Awards effectively repurchased for required employee withholding taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-249">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-250">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="f-251">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:fixed-zero" scale="6" id="f-252">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-253">494</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-254">243</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents, unrestricted and restricted</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-255">407</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-256">199</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents, unrestricted and restricted:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beginning of period</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-257">1,691</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-258">1,466</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">End of period</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-259">1,284</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-260">1,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosures of cash flow information</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest paid</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-261">25</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-262">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes paid, net</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:fixed-zero" scale="6" id="f-263">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-264">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental schedule of noncash investing and financing activities</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividend declared, but not yet paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-265">13</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-266">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payable for purchase of property and equipment</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-267">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-268">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receivable from sale of business</span></td><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="tnet:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable" scale="6" id="f-269">6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="tnet:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable" format="ixt:fixed-zero" scale="6" id="f-270">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_124"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 1. <ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock" id="f-271" continuedAt="f-271-1" escape="true">DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="f-271-1" continuedAt="f-271-2"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TriNet Group, Inc. (TriNet, or the Company, we, our and us) provides comprehensive HCM solutions for small and medium-size businesses under both a PEO model and an HRIS services model. These HCM solutions include multi-state payroll processing and tax administration, employee benefits programs, including health insurance and retirement plans, workers' compensation insurance and claims management, employment and benefit law compliance, and other HR-related services. Through our PEO service model, we are the employer of record for certain employment-related administrative and regulatory purposes for WSEs, including:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compensation through wages and salaries,</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain employer payroll-related tax payments, </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employee payroll-related tax withholdings and payments,</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employee benefit programs, including health and life insurance, and </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">workers' compensation coverage. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our PEO clients are responsible for the day-to-day job responsibilities of the WSEs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our HRIS and ASO services models, we provide cloud-based HCM services to SMBs that allows them to manage hiring, onboarding, employee information, payroll processing, payroll tax administration, health insurance, and other benefits, from a single cloud-based software platform. We are not the co-employer or employer of record for such employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-272" escape="true">We operate in <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-273">one</ix:nonFraction> reportable segment. All of our service revenues are generated from external clients. Less than <ix:nonFraction unitRef="number" contextRef="c-30" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-274">1</ix:nonFraction>% of our revenue is generated outside of the U.S.</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Basis of Presentation and Basis of Consolidation</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-276" continuedAt="f-276-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-275" continuedAt="f-275-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Rules and Regulations of the Securities and Exchange Commission. The unaudited condensed consolidated financial statements include the accounts of the Company and an entity consolidated under the variable interest model. Intercompany balances and transactions have been eliminated. Certain information and note disclosures included in our annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, that are normal and recurring in nature, necessary for fair financial statement presentation. The results of operations for the three months ended March&#160;31, 2025 are not necessarily indicative of the operating results anticipated for the full year. These financial statements should be read in conjunction with the audited Consolidated Financial Statements included in Part II, Item 8. Financial Statements and Supplementary Data of our Annual Report on Form 10-K for the year ended December&#160;31, 2024. Certain prior year amounts have been reclassified to conform to current period presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When entering into contractual arrangements with other entities, we assess whether we have a variable interest. If we determine that we have a variable interest, we then determine whether the arrangement is with a variable interest entity ("VIE"). If the arrangement is with a VIE, we assess whether we are the primary beneficiary of the VIE by identifying the most significant activities and determining who has the power over those activities and who has the obligation to absorb the majority of the losses or benefits of the VIE. We consolidate a VIE when we have the power to direct activities that most significantly affect the economic performance of the VIE and have the obligation to absorb the majority of their losses or benefits, making us the primary beneficiary. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, we assess whether any changes in our interest or relationship with the entity affect our determination of whether the entity is a VIE and, if so, whether we are the primary beneficiary.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, we created a trust ("TriNet Trust") for the purpose of holding ASO clients' payroll funds for the remittance to ASO Users, tax authorities and other recipients. TriNet Trust's assets are restricted and can only be used for payments on behalf of ASO clients, repayments of any advances from TriNet, or payments to TriNet of interest income earned on the balances of TriNet Trust. In the event of any losses, creditors to the Trust have </span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="f-271-2" continuedAt="f-271-3"><ix:continuation id="f-276-1"><ix:continuation id="f-275-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recourse to TriNet Trust's property and not that of TriNet overall. The risks associated with the Trust are similar to those that currently exist for the Company such as banking losses in excess of FDIC insurance levels, interest rate and market conditions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that TriNet Trust meets the definition of a variable interest entity and as the primary beneficiary we have both the power to direct TriNet Trust&#8217;s activities that most significantly affect its performance and we have the right to receive benefits from TriNet Trust, in the form of interest income. As a result, TriNet Trust is consolidated into our financial statements.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024, TriNet Trust assumed ownership and responsibility of certain bank accounts that hold HRIS client funds and assumed related liabilities.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the assets and liabilities of TriNet Trust which are included in our consolidated balance sheet. These amounts on any particular date can vary due to timing of cash receipts and remittances.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="f-277" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TriNet Trust</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-278">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-279">101</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:AssetsCurrent" scale="6" id="f-280">103</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:Assets" scale="6" id="f-281">103</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="f-282">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued wages</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:AccruedSalariesCurrent" scale="6" id="f-283">15</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll tax liabilities and other payroll withholdings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" scale="6" id="f-284">87</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:LiabilitiesCurrent" scale="6" id="f-285">103</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:Liabilities" scale="6" id="f-286">103</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Statement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts on the Condensed Consolidated Statement of Income have been reclassified to conform to current period presentation. Specifically, interest income previously included in the former Other income (expense) category is now classified as a component of Total revenue. Similarly, Interest expense, bank fees and other has been reclassified as part of total expenses. These reclassifications eliminate the profitability measure of Operating Income on our Condensed Consolidated Statement of Income, which is not a key measure of profitability used by management.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Statement of Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts on the Condensed Consolidated Statement of Cash Flows have also been reclassified to conform to current period presentation, with no impact on the Condensed Consolidated Statements of Income and Comprehensive Income, Condensed Consolidated Statement of Balance Sheets and Condensed Consolidated Statements of Stockholders' Equity. <ix:nonNumeric contextRef="c-1" name="tnet:ScheduleOfWorksiteEmployeeChangesTableTextBlock" id="f-287" continuedAt="f-287-1" escape="true">In particular, changes in WSE related assets and liabilities were previously reported within operating activities and are now reclassified into financing activities to better reflect operating activities excluding the impact of client cash flows.</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="f-271-3" continuedAt="f-271-4"><ix:continuation id="f-287-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.943%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As previously reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reclassified<br/>amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As revised</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-288">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-289">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-290">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll funds receivable</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" scale="6" id="f-291">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" scale="6" id="f-292">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:fixed-zero" scale="6" id="f-293">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="6" id="f-294">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="6" id="f-295">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="6" id="f-296">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payroll assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="tnet:IncreaseDecreaseInOtherPayrollAssets" scale="6" id="f-297">410</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" sign="-" name="tnet:IncreaseDecreaseInOtherPayrollAssets" scale="6" id="f-298">413</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="tnet:IncreaseDecreaseInOtherPayrollAssets" scale="6" id="f-299">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="6" id="f-300">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="6" id="f-301">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="6" id="f-302">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Client deposits and other client liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="f-303">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="f-304">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="f-305">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued wages</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedSalaries" scale="6" id="f-306">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedSalaries" scale="6" id="f-307">51</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedSalaries" scale="6" id="f-308">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued health insurance costs, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" scale="6" id="f-309">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" scale="6" id="f-310">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" format="ixt:fixed-zero" scale="6" id="f-311">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued workers' compensation costs, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities" scale="6" id="f-312">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities" scale="6" id="f-313">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities" format="ixt:fixed-zero" scale="6" id="f-314">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll taxes payable and other payroll withholdings</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities" scale="6" id="f-315">173</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities" scale="6" id="f-316">180</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities" scale="6" id="f-317">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" sign="-" name="tnet:NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified" scale="6" id="f-318">240</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="tnet:NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified" scale="6" id="f-319">213</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="tnet:NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified" scale="6" id="f-320">27</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in WSE and TriNet Trust related assets and liabilities, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet" format="ixt:fixed-zero" scale="6" id="f-321">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet" scale="6" id="f-322">213</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet" scale="6" id="f-323">213</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in financing activities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="tnet:NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified" format="ixt:fixed-zero" scale="6" id="f-324">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" sign="-" name="tnet:NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified" scale="6" id="f-325">213</ix:nonFraction>)</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="tnet:NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified" scale="6" id="f-326">213</ix:nonFraction>)</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:continuation><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Use of Estimates</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-327" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect certain reported amounts and related disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates are based on historical experience and on various other assumptions that we believe to be reasonable from the facts available to us. Some of the assumptions are highly uncertain at the time of estimation. To the extent actual experience differs from the assumptions used, our condensed consolidated financial statements could be materially affected.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Accrued Health Insurance Costs </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sponsor and administer a number of employee benefit plans for our PEO WSEs, including group health, dental, and vision as an employer plan sponsor under section 3(5) of the ERISA. <ix:nonNumeric contextRef="c-1" name="us-gaap:LiabilityReserveEstimatePolicy" id="f-328" continuedAt="f-328-1" escape="true">In the three months ended March&#160;31, 2025, the majority of our group health insurance costs were related to risk-based plans. Our remaining group health insurance costs were for guaranteed-cost policies. </ix:nonNumeric></span></div><ix:continuation id="f-328-1" continuedAt="f-328-2"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued health insurance costs are established to provide for the estimated unpaid costs of reimbursing the carriers for paying claims within the deductible layer in accordance with risk-based health insurance policies. These accrued costs include estimates for claims incurred but not paid. We assess accrued health insurance costs regularly based upon actuarial studies that include other relevant factors such as current and historical claims payment patterns, plan enrollment and medical trend rates. </span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-328-2">In certain carrier contracts we are required to prepay our obligations for the expected claims activity for subsequent periods. These prepaid balances by agreement permit net settlement of obligations and offset the accrued health insurance costs.</ix:continuation> As of March&#160;31, 2025 and December&#160;31, 2024, prepayments and miscellaneous receivables offsetting accrued health insurance costs were $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:PrepaidInsurance" scale="6" id="f-329">59</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PrepaidInsurance" scale="6" id="f-330">60</ix:nonFraction> million, respectively. When the prepaid amount is in excess of our recorded liability, the net asset position is included in prepaid expenses. As of March&#160;31, 2025 and December&#160;31, 2024, accrued health insurance costs offsetting prepaid expenses were $<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" name="us-gaap:PrepaidInsurance" scale="6" id="f-331">89</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" name="us-gaap:PrepaidInsurance" scale="6" id="f-332">90</ix:nonFraction> million, respectively.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:11pt;text-align:justify"><span><br/></span></div><div style="margin-top:11pt;text-align:justify"><span><br/></span></div><div style="margin-top:11pt;text-align:justify"><span><br/></span></div><div style="margin-top:11pt;text-align:justify"><span><br/></span></div><div style="margin-top:11pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="f-271-4" continuedAt="f-271-5"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-333" continuedAt="f-333-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently issued accounting guidance</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2024-03, Disaggregation of Income Statement Expenses, is to enhance the transparency and decision-usefulness of financial reporting by requiring public business entities to provide more detailed disclosures about the components of certain expense captions in their income statements. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2027. The Company is currently evaluating the provisions of this ASU.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-333-1"><ix:continuation id="f-271-5">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances income tax disclosure requirements. The ASU mandates additional details in the income tax rate reconciliation, including quantitative thresholds for reconciling items, and requires disaggregation of income taxes paid by federal, state, and foreign jurisdictions, with further breakdowns for significant individual jurisdictions. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2024. The Company is currently evaluating the provisions of this ASU.</ix:continuation></ix:continuation> </span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_130"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 2. <ix:nonNumeric contextRef="c-1" name="tnet:CashCashEquivalentsAndInvestmentsTextBlock" id="f-334" continuedAt="f-334-1" escape="true">CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED</ix:nonNumeric></span></div><ix:continuation id="f-334-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreements with certain of our workers' compensation and health benefit insurance carriers, we are required to maintain collateral in trust accounts for the benefit of specified insurance carriers and to reimburse the carriers&#8217; claim payments within our deductible layer. We invest a portion of the collateral amounts in marketable securities. We report the current and noncurrent portions of these trust accounts as restricted cash, cash equivalents and investments on the condensed consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We require our clients to prefund their payroll and related taxes and other withholding liabilities before payroll is processed or due for payment. This prefund, for PEO customers, as well as amounts held by our statutory trust for our HRIS Users, is included in restricted cash, cash equivalents and investments as payroll funds collected, which is designated to pay pending payrolls, payroll tax liabilities and other payroll withholdings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also invest available corporate funds, primarily in fixed income securities which meet the requirements of our corporate investment policy and are classified as AFS.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" id="f-335" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total cash, cash equivalents and investments are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Available-for-sale marketable securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Available-for-sale marketable securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-336">349</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-337">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-338">349</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-339">360</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-340">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-341">360</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll funds collected</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-342">726</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-343">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-344">726</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-345">1,131</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-44" xsi:nil="true" name="us-gaap:RestrictedCashAndInvestmentsCurrent" id="f-346"></ix:nonFraction></td><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-347">1,131</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for health benefits claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-348">33</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-349">113</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-350">146</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-351">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-352">110</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-353">144</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for workers' compensation claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-354">50</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-355">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-356">50</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-357">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-358">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-359">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trust for our HRIS Users</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-360">101</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-361">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-362">101</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-363">87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-364">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-365">87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other security deposits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-366">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-367">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-368">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-369">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-370">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-371">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total restricted cash, cash equivalents and investments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-372">911</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-373">113</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-374">1,024</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-375">1,303</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-376">110</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-377">1,413</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments, noncurrent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for workers' compensation claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-378">24</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-379">110</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-380">134</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-381">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-382">117</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-383">145</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" name="us-gaap:RestrictedCashAndInvestments" format="ixt:num-dot-decimal" scale="6" id="f-384">1,284</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" name="us-gaap:RestrictedCashAndInvestments" scale="6" id="f-385">223</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RestrictedCashAndInvestments" format="ixt:num-dot-decimal" scale="6" id="f-386">1,507</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-6" name="us-gaap:RestrictedCashAndInvestments" format="ixt:num-dot-decimal" scale="6" id="f-387">1,691</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-6" name="us-gaap:RestrictedCashAndInvestments" scale="6" id="f-388">227</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestrictedCashAndInvestments" format="ixt:num-dot-decimal" scale="6" id="f-389">1,918</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 3. <ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="f-390" continuedAt="f-390-1" escape="true">INVESTMENTS</ix:nonNumeric></span></div><ix:continuation id="f-390-1" continuedAt="f-390-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-391" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our financial instruments by significant categories and fair value measurement on a recurring basis as of March&#160;31, 2025 and December&#160;31, 2024 and the amortized cost, gross unrealized gains, gross unrealized losses, fair value of our AFS investments: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Level</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Cash, Cash Equivalents and Investments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-392">226</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-393">226</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-394">116</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-395">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-396">110</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-397">226</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-398">226</ix:nonFraction></span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-399">116</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-400">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-401">110</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AFS Investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-402">34</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-403">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-404">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-405">34</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-406">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-407">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-408">34</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-409">13</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-410">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-411">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-412">13</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-413">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-414">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-415">13</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-416">175</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-417">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-418">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-419">176</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-420">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-421">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-422">176</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AFS Investments</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-423">222</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-424">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-425">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-426">223</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-427">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-428">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-429">223</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:20.715%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Level</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Cash, Cash Equivalents and Investments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-430">570</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-431">570</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-432">257</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-433">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-434">313</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-435">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-436">1</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-437">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-438">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-439">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-440">571</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-441">571</ix:nonFraction></span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-442">257</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-443">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-444">314</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AFS Investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-445">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-102" xsi:nil="true" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="f-446"></ix:nonFraction></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-447">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-448">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-449">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-104" xsi:nil="true" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="f-450"></ix:nonFraction></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-451">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-452">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-453">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-454">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-455">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-456">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-108" xsi:nil="true" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="f-457"></ix:nonFraction></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-458">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-459">176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-110" xsi:nil="true" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="f-460"></ix:nonFraction></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-461">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-462">174</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-463">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-112" xsi:nil="true" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="f-464"></ix:nonFraction></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-465">174</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-466">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-467">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-468">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-469">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-470">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-471">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-472">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AFS Investments</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-473">230</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-474">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-475">3</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-476">227</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-477">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-478">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-479">227</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use an independent pricing source to determine the fair value of our securities. The independent pricing source utilizes various pricing models for each asset class, including the market approach. The inputs and assumptions for the pricing models are market observable inputs including trades of comparable securities, dealer quotes, credit spreads, yield curves and other market-related data.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not adjusted the prices obtained from the independent pricing service and we believe the prices received from the independent pricing service are representative of the prices that would be received to sell the assets at the measurement date (exit price).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company's cash equivalents and restricted cash equivalents approximate their fair values due to their short-term maturities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have any Level 3 financial instruments recognized in our condensed consolidated balance sheets as of March&#160;31, 2025 and December&#160;31, 2024. There were no transfers between levels as of March&#160;31, 2025 and December&#160;31, 2024. </span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="f-390-2"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Sales and Maturities</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="f-480" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of debt investments by contractual maturity are shown below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.436%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One year or less</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="f-481">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over one year through five years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="f-482">199</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over five years through ten years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="f-483">5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over ten years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="f-484">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" scale="6" id="f-485">223</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="f-486" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross proceeds from sales and maturities of AFS securities and gross realized losses for the three months ended March&#160;31, 2025 and 2024 are presented below. We had <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" format="ixt:fixed-zero" scale="0" id="f-487"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" format="ixt:fixed-zero" scale="0" id="f-488">immaterial</ix:nonFraction></ix:nonFraction> gross realized gains from sales of investments for the three months ended March&#160;31, 2025 and 2024.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross realized losses</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="f-489">1</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" format="ixt:fixed-zero" scale="6" id="f-490">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross proceeds from sales</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="f-491">31</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="f-492">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross proceeds from maturities</span></td><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="f-493">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="f-494">27</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Fair Value of Long-Term Debt</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our 2029 Notes and 2031 Notes was obtained from a third-party pricing service and is based on observable market inputs. As such, the fair value of the Senior Notes is considered Level 2 in the hierarchy for fair value measurement. As of March&#160;31, 2025, our 2029 Notes and 2031 Notes were carried at their cost, net of issuance costs, and had a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-6" name="us-gaap:NotesPayableFairValueDisclosure" scale="6" id="f-495">454</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-6" name="us-gaap:NotesPayableFairValueDisclosure" scale="6" id="f-496">407</ix:nonFraction> million, respectively. As of December&#160;31, 2024, our 2029 Notes and 2031 Notes were carried at their cost, net of issuance costs, and had a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-6" name="us-gaap:NotesPayableFairValueDisclosure" scale="6" id="f-497">453</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-6" name="us-gaap:NotesPayableFairValueDisclosure" scale="6" id="f-498">408</ix:nonFraction> million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2021 Revolver is a floating rate debt. At March&#160;31, 2025 and December&#160;31, 2024, the fair value of our 2021 Revolver approximated its carrying value (exclusive of issuance costs). The fair value of our floating rate debt is estimated based on a discounted cash flow, which incorporates credit spreads, market interest rates and contractual maturities to estimate the fair value and is considered Level 3 in the hierarchy for fair value measurement.</span></div></ix:continuation><div id="i45ccd64735a14c1db738ff1d6adbd5ef_148"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 4. <ix:nonNumeric contextRef="c-1" name="us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" id="f-499" continuedAt="f-499-1" escape="true">ACCRUED WORKERS' COMPENSATION COSTS</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="f-500" continuedAt="f-500-1" escape="true"><ix:continuation id="f-499-1" continuedAt="f-499-2"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the accrued workers&#8217; compensation cost activity for the three months ended March&#160;31, 2025 and 2024:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accrued costs, beginning of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" scale="6" id="f-501">158</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" scale="6" id="f-502">175</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incurred</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-503">14</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-504">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-505">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-506">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="f-507">13</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="f-508">12</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Paid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:fixed-zero" scale="6" id="f-509">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="f-510">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="f-511">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="f-512">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="f-513">11</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="f-514">12</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" scale="6" id="f-515">160</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" scale="6" id="f-516">175</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="f-499-2"><ix:continuation id="f-500-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes workers' compensation liabilities on the condensed consolidated balance sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:75.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, end of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" scale="6" id="f-517">160</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" scale="6" id="f-518">158</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral paid to carriers and offset against accrued costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" scale="6" id="f-519">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" scale="6" id="f-520">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, net of carrier collateral offset</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent" scale="6" id="f-521">156</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent" scale="6" id="f-522">154</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payable in less than 1 year<br/>(net of collateral paid to carriers of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" scale="6" id="f-523"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" scale="6" id="f-524">1</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> at March&#160;31, 2025 and December&#160;31, 2024)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="6" id="f-525">45</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="6" id="f-526">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payable in more than 1 year <br/>(net of collateral paid to carriers of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" scale="6" id="f-527"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" scale="6" id="f-528">3</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> at March&#160;31, 2025 and December&#160;31, 2024)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:WorkersCompensationLiabilityNoncurrent" scale="6" id="f-529">111</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:WorkersCompensationLiabilityNoncurrent" scale="6" id="f-530">110</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, net of carrier collateral offset</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent" scale="6" id="f-531">156</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent" scale="6" id="f-532">154</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incurred claims related to prior years represent changes in estimates for ultimate losses on workers' compensation claims. For the three months ended March&#160;31, 2025, the favorable development is due to lower than expected reported claim frequency and severity for the more recent years. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025 and December&#160;31, 2024, we had $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:CollateralHeldByInsuranceCarriers" scale="6" id="f-533">25</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:CollateralHeldByInsuranceCarriers" format="ixt:num-dot-decimal" scale="6" id="f-534">26</ix:nonFraction>&#160;million of collateral held by insurance carriers, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" scale="6" id="f-535"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" scale="6" id="f-536">4</ix:nonFraction></ix:nonFraction> million was offset against accrued workers' compensation costs as the agreements permit and are net settled of insurance obligations against collateral held.</span></div></ix:continuation><div id="i45ccd64735a14c1db738ff1d6adbd5ef_154"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 5. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-537" continuedAt="f-537-1" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="f-537-1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Contingencies </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are and, from time to time, have been and may in the future become involved in various litigation matters, legal proceedings, regulatory investigations and claims arising in the ordinary course of our business, including disputes with our clients or various class action, collective action, representative action, and other proceedings arising from the nature of our co-employment relationship with our clients and WSEs in which we are named as a defendant. In addition, due to the nature of our co-employment relationship with our clients and WSEs, we could be subject to liability for federal and state law violations, even if we do not participate in such violations. While our agreements with our clients contain indemnification provisions related to the conduct of our clients, we may not be able to avail ourselves of such provisions in every instance. We have accrued our current best estimates of probable losses with respect to these matters, which are individually and in aggregate immaterial to our condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the outcome of the matters described above cannot be predicted with certainty, management currently does not believe that any such claims or proceedings will have a materially adverse effect on our condensed consolidated financial position, results of operations, or cash flows. However, the unfavorable resolution of any particular matter or our reassessment of our exposure for any of the above matters based on additional information obtained in the future could have a material impact on our condensed consolidated financial position, results of operations, or cash flows.</span></div></ix:continuation><div id="i45ccd64735a14c1db738ff1d6adbd5ef_157"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 6. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-538" continuedAt="f-538-1" escape="true">STOCK BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="f-538-1" continuedAt="f-538-2"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Restricted Stock Units (RSUs)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Time-based RSUs generally vest over a <ix:nonNumeric contextRef="c-122" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-539">four-year</ix:nonNumeric> term. Performance-based RSUs are subject to vesting requirements and are earned, in part, based on certain financial performance metrics as defined in the grant notice. Actual number of shares earned under performance-based RSUs may range from <ix:nonFraction unitRef="number" contextRef="c-123" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="f-540">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-124" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="f-541">200</ix:nonFraction>% of the target award. Performance-based awards granted in 2025 and 2024 are earned based on a single-year performance period subject to subsequent multi-year time-based vesting with <ix:nonFraction unitRef="number" contextRef="c-125" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-542">50</ix:nonFraction>% of the shares earned vesting in <ix:nonNumeric contextRef="c-125" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-543">one year</ix:nonNumeric> after the performance period and the remaining shares in the year after. RSUs are generally forfeited if the participant terminates service prior to vesting.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="f-538-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="f-544" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize RSU activity for the three months ended March&#160;31, 2025:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Time-based RSUs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.174%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.030%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">of Shares</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-126" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-545">1,100,001</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-546">97.21</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-122" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-547">696,745</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-122" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-548">76.73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-122" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-549">127,243</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-122" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-550">90.59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-122" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-551">97,243</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-122" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-552">65.83</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at March&#160;31, 2025</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-127" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-553">1,572,260</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-127" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-554">89.48</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance-based RSUs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:67.128%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-128" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-555">179,907</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-128" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-556">106.50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-129" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-557">74,840</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-129" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-558">76.69</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-129" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-559">22,728</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-129" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-560">124.31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at March&#160;31, 2025</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-130" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-561">232,019</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-130" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-562">83.37</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options are granted to eligible employees at exercise prices equal to the fair market value of our common stock on the dates of grant. Stock options generally have a maximum contractual term of <ix:nonNumeric contextRef="c-131" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="f-563">10</ix:nonNumeric> years. Stock options vest after <ix:nonNumeric contextRef="c-132" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="f-564">3</ix:nonNumeric> years, and are generally forfeited if the employee terminates service prior to vesting.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-565" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity for the three months ended March&#160;31, 2025:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number<br/>of Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in&#160;millions)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:fixed-zero" scale="0" id="f-566">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-567">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:fixed-zero" scale="6" id="f-568">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-569">270,144</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-570">76.69</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="tnet:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="f-571">9.98</ix:nonNumeric></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="tnet:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" scale="6" id="f-572">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at March&#160;31, 2025</span></div></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-573">270,144</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-574">76.69</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-575">9.98</ix:nonNumeric></span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="f-576">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimated the fair value of stock options using the Black-Scholes option-pricing model. Because we do not have significant exercise history for our stock options, we estimate the expected term using the simplified method.  We estimate expected volatility using the daily historical trading data of our common shares. The table below summarizes the assumptions used.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-577" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our RSUs and PSUs is equal to the fair value of our common stock on the grant date. The fair value of stock options is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Option Assumptions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected Term (in Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected Volatility</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Risk-Free Interest Rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected Dividend Yield</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2025</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-578">6.5</ix:nonNumeric></span></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-579">42.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-580">4.09</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-581">1.43</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-top:1pt;padding-left:24.75pt;text-indent:-22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="f-582" escape="true"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:83.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Disclosures for Stock Options (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of stock options</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-583">31.65</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total fair value of options granted </span></td><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="f-584">9</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Based Compensation</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-585" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock based compensation expense for stock-based awards made to our employees pursuant to our equity plans were as follows:&#160;&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of providing services</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-586">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-587">4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-588">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-589">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-590">6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-591">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Systems development and programming costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-592">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-593">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stock based compensation expense</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-594">13</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-595">20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stock based compensation capitalized</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="6" id="f-596">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="6" id="f-597">1</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div id="i45ccd64735a14c1db738ff1d6adbd5ef_163"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 7. <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-599" continuedAt="f-599-1" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="f-599-1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Common Stock</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" id="f-600" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the beginning and ending balances of our issued and outstanding common stock for the three months ended March&#160;31, 2025 and 2024:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.597%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares issued and outstanding, beginning balance</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-601"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-602">49,527,506</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-603"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-604">50,664,471</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from vested restricted stock units</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-142" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-605">127,243</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-143" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-606">160,118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from exercise of stock options</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-144" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="0" id="f-607">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-145" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-608">5,708</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-609">1,210,403</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-610">197,872</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awards effectively repurchased for required employee withholding taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-611">46,827</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-612">59,249</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares issued and outstanding, ending balance</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-613"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-614">48,397,519</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-615"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-616">50,573,176</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Repurchases </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, there was $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="f-617">162</ix:nonFraction> million remaining in the total authorization of $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="srt:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-618">2,715</ix:nonFraction>&#160;million of our ongoing stock repurchase program.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We paid a common stock dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-619">0.25</ix:nonFraction> per share in January 2025. We also declared common stock dividends of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="3" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="f-620">0.275</ix:nonFraction> per share to be paid in the second quarter of 2025.</span></div></ix:continuation><div id="i45ccd64735a14c1db738ff1d6adbd5ef_166"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 8. <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-621" continuedAt="f-621-1" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="f-621-1"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our ETR was <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-622">26</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-7" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-623">27</ix:nonFraction>% for the first quarter of 2025 and 2024, respectively. The decrease in the rate was primarily attributable to an increase in tax benefits related to excludable income for state tax purposes and a decrease in the state tax rate, offset by a decrease in tax benefits for stock-based compensation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have capital loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-6" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="f-624">3</ix:nonFraction>&#160;million. As a result of the sale of Clarus this quarter, we generated approximately $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-6" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-625">9</ix:nonFraction>&#160;million of capital loss carryforwards totaling $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-626">12</ix:nonFraction>&#160;million which will begin to expire in 2027.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have recorded an increase in the valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-627">9</ix:nonFraction>&#160;million this quarter to reflect the estimated amount of deferred tax assets that may not be realized related to these capital loss carryforwards. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are subject to tax in U.S. federal and various state and local jurisdictions, as well as Canada and India. We are open to federal and significant state income tax examinations for tax years 2019 and subsequent years.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 9. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-628" continuedAt="f-628-1" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="f-628-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic EPS is computed based on the weighted average shares of common stock outstanding during the period. Diluted EPS is computed based on those shares used in the basic EPS computation, plus potentially dilutive shares issuable under our equity-based compensation plans using the treasury stock method. Shares that are potentially anti-dilutive are excluded.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-629" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of our basic and diluted EPS attributable to our common stock:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.158%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-630">85</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-631">91</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-632">49</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-633">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic EPS</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-634">1.72</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-635">1.80</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="f-636">85</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="f-637">91</ix:nonFraction>&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-638">49</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-639">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of stock options and restricted stock units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="f-640">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="f-641">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-642">49</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-643">51</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-644">1.71</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-645">1.78</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-646">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-647">1</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i45ccd64735a14c1db738ff1d6adbd5ef_1640"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 10. <ix:nonNumeric contextRef="c-1" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="f-648" continuedAt="f-648-1" escape="true">RESTRUCTURING</ix:nonNumeric></span></div><ix:continuation id="f-648-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2024, we completed a detailed review of our strategy and made several decisions that will narrow and intensify our focus on our U.S. PEO business. This will include winding down the software-only HRIS product as well as other immaterial products not directly related to our U.S. PEO business.  In place of our software-only HRIS product, we will focus our ASO services to include both the software component, but also a significant service component similar to the types of services we provide to PEO clients. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with this adjustment to our product offerings, we have implemented changes to our operating expense structure, including our staffing and office footprint.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the restructuring initiatives, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="f-649">1</ix:nonFraction> million of restructuring costs for the three months ended March&#160;31, 2025. These expenses are classified in G&amp;A in our Condensed consolidated statement of income and comprehensive income.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Severance costs include payments to colleagues, estimated reimbursements for COBRA payments and outplacement services. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="f-650" continuedAt="f-650-1" escape="true">The following table is a summary of accrued severance and exit and disposal costs included within accounts payable and other current liabilities and accrued wages:</ix:nonNumeric></span></div><ix:continuation id="f-650-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.223%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accounts payable and other current liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued wages</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-651">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-652">14</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(+) Additions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-6" name="tnet:RestructuringChargesAdditions" format="ixt:fixed-zero" scale="6" id="f-653">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-6" name="tnet:RestructuringChargesAdditions" format="ixt:fixed-zero" scale="6" id="f-654">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(-) Payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-6" name="tnet:RestructuringChargesPayments" format="ixt:fixed-zero" scale="6" id="f-655">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-6" sign="-" name="tnet:RestructuringChargesPayments" scale="6" id="f-656">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at March&#160;31, 2025</span></div></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-657">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-658">10</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to make payments for these liabilities during 2025. We expect the restructuring efforts to continue through 2026 and may recognize additional expenses as they are incurred.</span></div></ix:continuation><div id="i45ccd64735a14c1db738ff1d6adbd5ef_1633"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 11. <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-659" continuedAt="f-659-1" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><ix:continuation id="f-659-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-660">one</ix:nonFraction> reportable segment. Our chief operating decision maker for segment reporting purposes is our CEO, who uses the profitability and significant expense detail to allocate resources and assess performance based on key functions such as customer acquisition, customer service, and indirect costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary measure of profit or loss that the CEO uses is net income. The significant expenses used in these profit or loss reports align with the primary functions of the corresponding teams, with the exception of non-cash expenses such as depreciation, amortization and stock-based compensation as these expenses are not necessarily indicative of our ongoing operations. In this expense reporting methodology, overhead-type expenses, such as facilities and technology support for colleagues, are classified consistent with the primary function of the corresponding teams and not allocated to other significant expenses.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-661" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides the primary measure of profitability and detail regarding the significant expenses reviewed by our CEO.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.414%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.644%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional service revenues</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-662">209</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-663">214</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance service revenues</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-664">1,065</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-665">1,050</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="us-gaap:InterestIncomeOperating" scale="6" id="f-666">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="us-gaap:InterestIncomeOperating" scale="6" id="f-667">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenues</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-668">1,292</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-669">1,282</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Workers' compensation costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="tnet:WorkersCompensationCosts" scale="6" id="f-670">23</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="tnet:WorkersCompensationCosts" scale="6" id="f-671">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health insurance costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="tnet:HealthInsuranceCosts" scale="6" id="f-672">919</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="tnet:HealthInsuranceCosts" scale="6" id="f-673">886</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales &amp; marketing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="tnet:SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther" scale="6" id="f-674">60</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="tnet:SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther" scale="6" id="f-675">65</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Client support costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="tnet:ClientSupportCosts" scale="6" id="f-676">43</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="tnet:ClientSupportCosts" scale="6" id="f-677">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate administration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="tnet:CorporateAdministrationExpenses" scale="6" id="f-678">35</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="tnet:CorporateAdministrationExpenses" scale="6" id="f-679">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">System support &amp; development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="tnet:SystemSupportAndDevelopmentExpenses" scale="6" id="f-680">52</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="tnet:SystemSupportAndDevelopmentExpenses" scale="6" id="f-681">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" scale="6" id="f-682">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" scale="6" id="f-683">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-684">13</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-685">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="us-gaap:OtherExpenses" scale="6" id="f-686">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="us-gaap:OtherExpenses" format="ixt:fixed-zero" scale="6" id="f-687">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, bank fees and other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="tnet:InterestExpenseBankFeesAndOther" scale="6" id="f-688">14</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="tnet:InterestExpenseBankFeesAndOther" scale="6" id="f-689">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income Taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-690">30</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-691">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-692">85</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-693">91</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other includes certain costs that are considered non-recurring such as restructuring costs.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_181"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the information required in this section, refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_154">Note 5</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated financial statements and related notes included in this Form 10-Q.</span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_184"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risk Factors </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the risk factor below, there have been no material changes in our risk factors disclosed in Part 1, Item 1A, of our 2024 Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our SMB clients are particularly affected by volatility in the economic environment.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SMBs can be particularly susceptible to changes in the level of overall economic activity in the markets in which they operate. These businesses are often exposed to credit and cash liquidity risks, including exposure as a result of the failure of their financial institutions, that larger businesses may be able to avoid, and during periods of weak economic conditions, including periods of increased inflation and increased borrowing costs, SMB failures tend to increase, and employment levels tend to decrease. During these periods, our clients can and do freeze hiring, terminate their employees, and reduce compensation and benefits levels, any of which would negatively affect our revenues and margins if we are unable to reduce our operating expenses sufficiently or quickly enough. During these periods, we have also seen and expect to see, reduced demand for our services, increased client terminations, fewer new clients, and clients seeking to renegotiate our contracts and prices. When our clients leave us or reduce their headcount, we typically see increases in the volume and severity of unemployment claims, COBRA claims, disability claims, and workers&#8217; compensation claims. We may be unable to recover costs related to these claims based on the fees established in our client service agreements, and any failure to recover such costs may have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, trade policies, including tariffs or other import restrictions, could directly or indirectly have a material adverse effect on our customers' businesses, as well as result in an economic downturn more generally. For example, increased tariffs or input restrictions, or even uncertainty with respect to such increases, could result in cost inflation or supply chain disruption, which could in turn result in companies generally taking actions, including reducing payroll expenses, delaying hiring, or cutting jobs. In addition, an economic downturn could result in a weakening of the market for our services as a result of fewer new companies being formed or funded, as well as a reluctance of companies to spend on PEO or ASO services. The results of any of these could negatively impact our revenue, as well as our ability to grow and retain clients, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_187"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(a) Sales of Unregistered Securities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(b) Use of Proceeds from Sales of Unregistered Securities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(c) Issuer Purchases of Equity Securities </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about our purchases of TriNet common stock during the quarter ended March&#160;31, 2025:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.617%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of<br/>Shares</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Price<br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number of<br/>Shares<br/>Purchased as&#160;Part&#160;of&#160;Publicly<br/> Announced&#160;Plans </span><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar Value ($ millions)<br/>of&#160;Shares&#160;that&#160;May Yet&#160;be&#160;Purchased<br/>Under&#160;the&#160;Plans </span><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 1 - January 31, 2025</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.91&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 1 - February 28, 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">521,584&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474,855&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 1 - March 31, 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">735,626&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">735,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,257,230&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,210,403&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) In May 2014, our board of directors approved a stock repurchase program pursuant to which we are authorized to repurchase our common stock in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934. From time to time, our board of directors authorizes increases to our stock repurchase program and approved an aggregate total of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$2,715 million as of March&#160;31, 2025. The total remaining authorization for future stock repurchases under our stock repurchase program was $162 million as of March&#160;31, 2025. The program does not have an expiration date. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Includes shares surrendered by employees to us to satisfy tax withholding obligations that arose upon vesting of restricted stock units granted pursuant to approved plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) We repurchased a total of approximately $90&#160;million of our outstanding stock during the three months ended March&#160;31, 2025.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We use our stock repurchase program to return value to our stockholders and to offset dilution from the issuance of stock under our equity-based incentive plans and employee purchase plan. We plan to use current cash and cash generated from ongoing operating activities to fund our stock repurchase program.</span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_190"></div><div style="margin-top:9pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Defaults Upon Senior Securities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_193"></div><div style="margin-top:9pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Mine Safety Disclosures</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_196"></div><div style="margin-top:9pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Information</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-694"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-695"><ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-696"><ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-697">Not applicable.</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_202"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBITS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibits</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incorporated herein by reference is a list of the exhibits contained in the Exhibit Index below.</span></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_205"></div><div style="-sec-extract:summary;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBITS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.118%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/937098/000119312514126010/d705140dex31.htm">Amended and Restated Certificate of Incorporation of TriNet Group, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-36373</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/30/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/937098/000119312514081006/d655973dex34.htm">Amended and Restated Bylaws of TriNet Group, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-36373</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/24/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/937098/000093709817000007/ex41.htm">Registration Rights Agreement, by and between TriNet Group, Inc. and AGI-T, L.P., dated as of February 1, 2017.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-36373</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/2/2017</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/937098/000110465923092611/tm2323813d1_ex4-1.htm">Indenture, dated August 16, 2023, among the Company, the guarantors listed therein and U.S. Bank Trust Company, National Association, as trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-36373</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/16/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/937098/000093709823000199/exhibit43.htm">First Supplemental Indenture, dated August 16, 2023, to the Indenture dated February 26, 2021, among the guarantors listed therein and U.S. Bank Trust Company, National Association as trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-36373</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10/25/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit44.htm">Second Supplemental Indenture, dated March 5, 2025, to the Indenture dated February 26, 2021, among the guarantors listed therein and U.S.Bank Trust Company, National Association as trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm">First Supplemental Indenture,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm">dated March 5,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm">2025, to the Indenture dated</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm">August 16, 2023,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm">among the</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm">guarantors listed therein and U.S.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm">Bank Trust Company, National, as</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit45.htm">trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit101.htm">Form of Option Agreement and</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit101.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit101.htm">Option Grant Notice under the</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit101.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit101.htm">Amended and Restated 2019</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit101.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit101.htm">Equity</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit101.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit101.htm">Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit102.htm">Form of Restricted Stock Unit Grant</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit102.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit102.htm">Notice</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit102.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit102.htm">under the TriNet Group, Inc.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit102.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit102.htm">2019 Equity</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit102.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit102.htm">Incentive Plan effective as</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit102.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit102.htm">of March 19, 2025</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm">Form of Performance-Based Restricted</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm">Stock Unit Grant Notice and</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm">Performance-Based</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm">Restricted Stock</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm">Unit Award Agreement under the</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm">TriNet Group, Inc. 2019 Equity</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm">Incentive</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm">Plan effective as of March</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-33125xexhibit103.htm">19, 2025</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-033125xexhibit311.htm">Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-033125xexhibit312.htm">Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>32.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-033125xexhibit321.htm">Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded with the Inline XBRL document)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.137%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBITS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.024%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:77.525%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Document has been furnished, is deemed not filed and is not to be incorporated by reference into any of TriNet Group, Inc.&#8217;s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, irrespective of any general incorporation language contained in any such filing.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">**</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Constitutes a management contract or compensatory plan or arrangement.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.137%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i45ccd64735a14c1db738ff1d6adbd5ef_208"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SIGNATURES</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45ccd64735a14c1db738ff1d6adbd5ef_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.365%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRINET GROUP, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: April 25, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael Q. Simonds</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Q. Simonds</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: April 25, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kelly Tuminelli</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kelly Tuminelli</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>2
<FILENAME>tnet-33125xexhibit44.htm
<DESCRIPTION>EX-4.4
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i4d638a77ec12484889a17767ba4d784f_37"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">SECOND SUPPLEMENTAL INDENTURE</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">Second Supplemental Indenture (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;), dated as of March 5, 2025 between TriNet Group, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Issuer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;) and U.S. Bank Trust Company, National Association, as successor in interest to U.S. Bank National Association, as trustee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;).</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">WITNESSETH</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">WHEREAS, each of the Issuer and the Guarantors (as defined in the Indenture referred to below) has heretofore executed and delivered to the Trustee an indenture (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;), dated as of February 26, 2021, as supplemented by the first supplemental indenture dated as of August 16, 2023, providing for the issuance of an unlimited aggregate principal amount of 3.500% Senior Notes due 2029 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;)&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">WHEREAS, Clarus R&#38;D Solutions, LLC is a wholly owned subsidiary of the Issuer and a Guarantor (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Released Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;)&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">WHEREAS, the Issuer has agreed to sell 100% of its interest in the Released Guarantor to an unaffiliated third party in a transaction that is permitted by the Indenture (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;), which Disposition is expected to close on the date hereof.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">WHEREAS, in connection with the Disposition, Section 10.5(a) of the Indenture permits the release and discharge of the Guarantee of the Released Guarantor (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;)&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">WHEREAS, in connection with the Release, the Issuer has delivered to the Trustee (1) an Officer&#8217;s Certificate pursuant to Sections 9.7, 10.5, 11.3 and 11.4 of the Indenture and (2) an Opinion of Counsel pursuant to Sections 9.7, 10.5, 11.3 and 11.4 of the Indenture&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">WHEREAS, pursuant to Section 9.1(g) of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture without the consent of Holders of the Notes.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of the Holders as follows&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:9pt;text-decoration:underline">Capitalized Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.  Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:9pt;text-decoration:underline">Release of Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.  The Released Guarantor is hereby fully and unconditionally released from its Guarantee of the Notes and such Guarantee is hereby terminated.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:9pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.  THIS SUPPLEMENTAL INDENTURE WILL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:9pt;text-decoration:underline">Waiver of Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.  THE ISSUER AND THE TRUSTEE HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE INDENTURE, THE NOTES, THE GUARANTEES OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:9pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.  The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:9pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.  The headings of the Sections of this Supplemental Indenture have been inserted for convenience of reference only, are not to be considered a part of this Supplemental Indenture and shall in no way modify or restrict any of the terms or provisions hereof. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:9pt;text-decoration:underline">The Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.  The Trustee makes no representation or warranty as to the validity or sufficiency of this Supplemental Indenture or with respect to the recitals contained herein, all of which recitals are made solely by the other parties hereto.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Signature page follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the date first above written.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">TRINET GROUP, INC., as Issuer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">&#47;s&#47; Kelly Tuminelli</font></div><div style="text-indent:21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Name&#58; Kelly Tuminelli</font></div><div style="text-indent:21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Title&#58; Executive Vice President and Chief   Financial Office</font></div></td></tr></table></div><div><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">&#47;s&#47; David Jason</font></div><div style="text-indent:21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Name&#58; David Jason</font></div><div style="text-indent:21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Title&#58; Vice President</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>3
<FILENAME>tnet-33125xexhibit45.htm
<DESCRIPTION>EX-4.5
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i710c9f6047454c519977224dcfe4be05_37"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">FIRST SUPPLEMENTAL INDENTURE</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">First Supplemental Indenture (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;), dated as of March 5, 2025 between TriNet Group, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Issuer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;) and U.S. Bank Trust Company, National Association, as trustee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;).</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">WITNESSETH</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">WHEREAS, each of the Issuer and the Guarantors (as defined in the Indenture referred to below) has heretofore executed and delivered to the Trustee an indenture (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;), dated as of August 16, 2023, providing for the issuance of an unlimited aggregate principal amount of 7.125% Senior Notes due 2031 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;)&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">WHEREAS, Clarus R&#38;D Solutions, LLC is a wholly owned subsidiary of the Issuer and a Guarantor (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Released Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;)&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">WHEREAS, the Issuer has agreed to sell 100% of its interest in the Released Guarantor to an unaffiliated third party in a transaction that is permitted by the Indenture (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;), which Disposition is expected to close on the date hereof.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">WHEREAS, in connection with the Disposition, Section 10.5(a) of the Indenture permits the release and discharge of the Guarantee of the Released Guarantor (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8221;)&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">WHEREAS, in connection with the Release, the Issuer has delivered to the Trustee (1) an Officer&#8217;s Certificate pursuant to Sections 9.7, 10.5, 11.3 and 11.4 of the Indenture and (2) an Opinion of Counsel pursuant to Sections 9.7, 10.5, 11.3 and 11.4 of the Indenture&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">WHEREAS, pursuant to Section 9.1(g) of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture without the consent of Holders of the Notes.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of the Holders as follows&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:9pt;text-decoration:underline">Capitalized Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.  Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:9pt;text-decoration:underline">Release of Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.  The Released Guarantor is hereby fully and unconditionally released from its Guarantee of the Notes and such Guarantee is hereby terminated.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:9pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.  THIS SUPPLEMENTAL INDENTURE WILL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:9pt;text-decoration:underline">Waiver of Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.  THE ISSUER AND THE TRUSTEE HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE INDENTURE, THE NOTES, THE GUARANTEES OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:9pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.  The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:9pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.  The headings of the Sections of this Supplemental Indenture have been inserted for convenience of reference only, are not to be considered a part of this Supplemental Indenture and shall in no way modify or restrict any of the terms or provisions hereof. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:9pt;text-decoration:underline">The Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.  The Trustee makes no representation or warranty as to the validity or sufficiency of this Supplemental Indenture or with respect to the recitals contained herein, all of which recitals are made solely by the other parties hereto.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Signature page follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the date first above written.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">TRINET GROUP, INC., as Issuer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">&#47;s&#47; Kelly Tuminell</font></div><div style="text-indent:21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Name&#58; Kelly Tuminelli</font></div><div style="text-indent:21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Title&#58; Executive Vice President and Chief Financial Office</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">&#47;s&#47; David Jason</font></div><div style="text-indent:21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Name&#58; David Jason</font></div><div style="text-indent:21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Title&#58; Vice Presiden</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>tnet-33125xexhibit101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i9540337186fc4e35b6fe012344837798_37"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">TRINET GROUP, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">STOCK OPTION GRANT NOTICE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(AMENDED AND RESTATED 2019 EQUITY INCENTIVE PLAN)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">TriNet Group, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), pursuant to its Amended and Restated 2019 Equity Incentive Plan (as may be amended and restated from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), hereby grants to the Participant an option to purchase the number of shares of the Company&#8217;s Common Stock (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) set forth below. This option is subject to all of the terms and conditions as set forth in this Stock Option Grant Notice (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), including the vesting schedule set forth below, the Plan, the Stock Option Agreement (including any country-specific addendum attached thereto), the Restrictive Covenant Agreement (all of which are attached hereto), and the Notice of Exercise in such  form as  provided  by the  Company to the Participant  at  the  time  of  exercise, all of which are incorporated herein in their entirety (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). Except as otherwise indicated, any capitalized term used but not defined shall have the meaning ascribed to such term in the Plan.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.987%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;text-indent:3pt;vertical-align:top">Participant&#58;</td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;text-indent:3pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Option Number&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;text-indent:3pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Date of Grant&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;text-indent:3pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Exercise Price (Per Share)&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;text-indent:3pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Number of Shares Subject to Option&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;text-indent:3pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Expiration Date&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;text-indent:3pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Type of Option&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Vesting Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#58;      &#91;_____________&#93;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Acceptance, Acknowledgment and Receipt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">    </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">By accepting the Award Agreement, the Participant hereby&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:117%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:13.8pt">acknowledges receipt of, and represents that the Participant understands, this Notice, the Stock Option Agreement (including any addenda attached thereto), the Restrictive Covenant Agreement and the Plan&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:13.8pt">acknowledges and agrees that this Notice, the Stock Option Agreement (including any addenda attached thereto), the Restrictive Covenant Agreement and the Plan set forth the entire understanding between the Participant and the Company regarding this Option and supersede all prior oral or written agreements, promises and&#47;or representations on that subject with the exception of (i) equity awards previously granted and delivered to the Participant, (ii) any compensation recovery policy that is adopted by the Company or is otherwise required by applicable law or listing standards applicable to the Company, and (iii) any written employment or severance arrangement that would provide for vesting acceleration&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">acknowledges and confirms the Participant&#8217;s consent to receive electronically the Award Agreement, the Plan and any other Plan documents or other related communications that the Company wishes or is required to deliver&#59;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">acknowledges that a copy of the Plan and the related Plan documents were made available to the Participant, and that among such documents were the Plan&#8217;s prospectus which the Participant acknowledges having read&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">agrees that the electronic acceptance of the Award Agreement constitutes a legally binding acceptance of the Award Agreement, and that the electronic acceptance of the Award Agreement shall have the same force and effect as if the Award Agreement was physically signed.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center;text-indent:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">TRINET GROUP, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">AMENDED AND RESTATED 2019 EQUITY INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">STOCK OPTION AGREEMENT </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            The Participant has been granted an option to purchase Shares (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) pursuant to the TriNet Group, Inc. Amended and Restated 2019 Equity Incentive Plan (as it may be amended and restated from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), the Stock Option Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and this Stock Option Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), dated as of the Date of Grant set forth in the Notice. Except as otherwise indicated, any capitalized term used but not defined herein shall have the meaning ascribed to such term in the Plan.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:117%;padding-left:9pt;text-decoration:underline"> Number of Shares and Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:117%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">The Option represents the right to purchase a number of Shares, as determined in accordance with and subject to the terms of this Agreement, the Plan and the Notice. The number of Shares that may be purchased and the exercise price per share is set forth in the Notice. The Option may be exercised only for whole Shares.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">      2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Vesting Dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Sections 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, the Option shall vest and become exercisable on the dates set forth in the Notice. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">      3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Term&#59; Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Except as otherwise provided for in any employment-related agreement between the Participant and the Company or any Subsidiary or Affiliate, upon a Termination of Service, the Committee, in its sole discretion, shall determine whether and to what extent any unvested Option may become vested, exercisable or forfeited and the time period during which any vested portion of the Option may be exercised. Absent such other agreement or exercise of discretion&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.7pt">the Option shall cease vesting in the event of the Participant&#8217;s Termination of Service for any reason and any portion thereof that is not vested as of the date of such Termination of Service will be forfeited without payment of any consideration to the Participant&#59; provided that in the event of Participant&#8217;s Termination of Service due to death or Disability, the Option shall immediately become fully vested and exercisable. For this purpose, Disability or Disabled shall mean that the Participant meets the eligibility requirements for receiving benefits under the Company&#8217;s or applicable employer&#8217;s long term disability plan. In the event the Participant is not eligible to or has elected not to enroll in the Company or applicable employer&#8217;s long term disability plan, the Participant is deemed Disabled if the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months. An individual shall not be considered Disabled unless the individual furnishes proof of the existence thereof in such form and manner, and at such times, as the Company may require.  Further, the Company may retain a physician or other third party to assist in determining whether the Participant is Disabled.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b)  In the event of a Termination of Service, the Option may be exercised to the extent (and only to the extent) that it would have been exercisable upon the date of the Participant&#8217;s Termination of Service upon the earliest of the following&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-24.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:18pt">in the event of a Termination of Service for any reason except Cause, or due to the Participant&#8217;s death or Disability, within three (3) months after the date of Termination of Service, but in no event later than the Expiration Date&#59; provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">however </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">that if during any part of such three (3) month period the Option is not exercisable solely because  of  the  condition  set  forth  in  Section 6 below, the Option shall not expire until the earlier of the Expiration Date or until it shall have been exercisable for an aggregate period of three (3) months after the Termination of Service&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, if during any part of such three (3) month period, the sale of any Shares received upon exercise of the Option would violate the Company&#8217;s insider trading policy, then the Option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three (3) months after the Termination of Service during which the sale of the Shares received upon exercise of the Option would not be in violation of the Company&#8217;s insider trading policy&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  ii.  in the event of a Termination of Service due to the Participant&#8217;s Disability, within twelve (12) months after the date of Termination of Service, but in no event no later than the Expiration Date&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> iii.  in the event of a Termination of Service due to the Participant&#8217;s death, or in the event the Participant dies within three (3) months following a Termination of Service for any reason other than Cause, within eighteen (18) months after the date of Termination of Service, but in any event no later than the Expiration Date&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">iv.  immediately upon a Termination of Service for Cause.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">For the avoidance of doubt and for purposes of this Option only, Termination of Service will be deemed to occur as of the date the Participant is no longer actively providing services as an Employee or Consultant (except, in certain circumstances at the sole discretion of the Company, to the extent the Participant is on a Company approved leave of absence) and will not be extended by any notice period or &#8220;garden leave&#8221; that may be required contractually or under applicable laws, unless otherwise determined by the Company in its sole discretion.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">     4.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Manner of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Option may only be exercised to the extent vested by delivery to the Company of a Notice of Exercise in such form as provided by the Company to the Participant at the time of exercise, stating the number of Shares being purchased, the restrictions imposed on the Shares, if any, and such representations and agreements, as may be required by the Company to comply with applicable laws, together with payment of the exercise price and applicable Tax-Related Items in a form allowed under the Plan.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Method of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Payment of the exercise price is due in full upon exercise of the Option. The Participant may elect to make payment of the exercise price (i) in cash or by check, bank draft or money order payable to the order of the Company or its designee&#59; (ii) if permitted </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">by the Company, surrender of Shares (including, without limitation, Shares otherwise issuable upon exercise of the Option) having a fair market value equal to the aggregate exercise price of the Option or the exercised portion thereof&#59; (iii) through a procedure whereby the Participant delivers irrevocable instructions to a broker reasonably acceptable to the Committee to sell Shares then issuable upon exercise of the Option and to deliver promptly to the Company an amount of the proceeds of such sale equal to the amount of the Option exercise price, or (iv) any other method determined by the Company and permitted by applicable law&#59; provided that unless otherwise determined by the Committee, if the Participant is an &#8220;officer&#8221; as defined under Section 16 of the Exchange Act, the exercise price shall be satisfied by clause (ii) above.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Securities Law Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The issuance and transfer of Shares upon exercise of the Option shall be subject to compliance by the Company and the Participant with all applicable requirements of federal, state, local or foreign securities and other laws and with all applicable requirements of any stock exchange or national market system on which the Shares may be listed at the time of such issuance or transfer. The Option may not be exercised if the Company determines that such exercise would not be in compliance with such laws or other requirements.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">7.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  In the event of a Change in Control, the Option will be treated in accordance with Section 12(b) of the Plan.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">8.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  As a condition precedent to the grant of the Option, the Participant agrees to be subject to the restrictive covenants as set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Restrictive Covenants Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%;padding-left:4.7pt">General Prohibition on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Except as may be permitted by the Committee, neither the Option nor any right under the Option shall be pledged, assignable, alienable, saleable or transferable by the Participant except as provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This provision shall not apply to any portion of the Option that has been fully exercised and for which Shares have been delivered and shall not preclude forfeiture of any portion of the Option in accordance with the terms herein.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">    (b)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Option may be transferable by will or pursuant to the laws of descent and distribution. In addition, upon receiving written permission from the Committee or its duly authorized designee, the Participant may, by delivering written notice to the Company, in a form provided by or otherwise satisfactory to the Company and any broker designated by the Company to effect transactions under the Plan, designate a third party who, in the event of the Participant&#8217;s death, will thereafter be entitled to exercise that portion of the Option which was exercisable at the time of the Participant&#8217;s death pursuant to this Agreement. In the absence of such a designation, the Participant&#8217;s executor or administrator of the Participant&#8217;s estate will be entitled to exercise the Option (to the extent exercisable pursuant to this Agreement), on behalf of the Participant&#8217;s estate.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  (c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Certain Trusts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Upon receiving written permission from the Committee or its duly authorized designee, the Participant may transfer the Option to a trust if that Participant is considered to be the sole beneficial owner (determined under Section 671 of the Code and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">applicable law) while the Option is held in the trust, provided that the Participant and the trustee enter into transfer and other agreements required by the Company.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> 10.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Participant shall have no voting rights, rights to dividends, or any other rights as a stockholder of the Company with respect to the Option unless and until the Participant becomes the record owner of the Shares underlying the Option.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">11.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Responsibility for Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.7pt">The Participant acknowledges that, regardless of any action taken by the Company or the Participant&#8217;s employer (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Tax-Related Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) is and remains the Participant&#8217;s responsibility and may exceed the amount actually withheld by the Company or the Employer. The Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Option, including, but not limited to, the grant, vesting or exercise of the Option, the subsequent sale of Shares acquired upon exercise of the Option and the receipt of any dividends in respect of such Shares (if any)&#59; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Option to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   (b)  As a condition to the grant, vesting and exercise of the Option, prior to any relevant taxable or tax withholding event, as applicable, the Participant agrees to make adequate arrangements satisfactory to the Company and&#47;or the Employer to satisfy (and will indemnify the Company and any Subsidiary or Affiliate with respect to) any and all Tax-Related Items which arise upon the grant, vesting or exercise of the Option, ownership or disposition of Shares, receipt of dividends, if any, or otherwise in connection with the Options or Shares. In this regard, the Participant authorizes the Company and&#47;or the Employer, or their respective agents, at their discretion, to satisfy any applicable withholding obligations with regard to all Tax-Related Items in the manner determined by the Company and&#47;or the Employer from time to time, which may include&#58; (i) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Company and&#47;or the Employer&#59; (ii) requiring the Participant to remit the aggregate amount of such Tax-Related Items to the Company in full, in cash or by check, bank draft or money order payable to the order of the Company or the Employer&#59; (iii) through a procedure whereby the Participant delivers irrevocable instructions to a broker reasonably acceptable to the Committee to sell Shares obtained upon exercise of the Option and to deliver promptly to the Company an amount of the proceeds of such sale equal to the amount of the Tax-Related Items&#59; (iv) by a &#8220;net withholding&#8221; under which the Company reduces the number of Shares then issuable on exercise of the Option by the number of Shares with an aggregate fair market value that equals the amount of the Tax-Related Items associated with such exercise&#59; or (v) any other method of withholding determined by the Company and permitted by applicable law&#59; provided that unless otherwise determined by the Committee, if the Participant is an </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;officer&#8221; as defined under Section 16 of the Exchange Act, the exercise price shall be satisfied by clause (iv) above.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">    (c)  Depending on the withholding method, the Company or the Employer may withhold or account for Tax-Related Items by considering applicable statutory withholding rates or other applicable withholding rates, including maximum applicable rates, in which case the Participant will receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent number of Shares. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant is deemed to have been issued the full number of Shares subject to the exercised Option, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   (d)  The Participant agrees to pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if the Participant fails to comply with the Participant&#8217;s obligations in connection with the Tax-Related Items.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  (e)  The Participant further acknowledges and agrees that the Participant is solely responsible for filing all relevant documentation that may be required in relation to the Award or any Tax-Related Items (other than filings or documentation that is the specific obligation of the Company or any Subsidiary or Affiliate pursuant to applicable laws), such as but not limited to personal income tax returns or reporting statements in relation to the grant, vesting or exercise of the Option, the holding of Shares or any bank or brokerage account, the subsequent sale of Shares, and the receipt of any dividends.  The Participant further acknowledges that the Company makes no representations or undertakings regarding the treatment of any Tax-Related Items and does not commit to and is under no obligation to structure the terms or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  The Participant also understands that applicable laws may require varying Share or Option valuation methods for purposes of calculating Tax-Related Items, and the Company assumes no responsibility or liability in relation to any such valuation or for any calculation or reporting of income or Tax-Related Items that may be required of the Participant under applicable laws.  Further, if the Participant has become subject to tax in more than one jurisdiction between the date of grant and the date of any relevant taxable event, the Participant acknowledges that the Company or any Subsidiary or Affiliate may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  (f)  To the extent the Option is designated as an Incentive Stock Option under Section 422 of the Code, the Participant also acknowledges that an Incentive Stock Option exercised more than three (3) months after the Participant&#8217;s Termination of Service, other than by reason of death or Disability, will be taxed as a Nonqualified Stock Option. Moreover, if the Option is designated as an Incentive Stock Option under Section 422 of the Code, the Participant shall give prompt notice to the Company of any disposition or other transfer of any Shares acquired under this Agreement if such disposition or transfer is made (a) within two years from the Date of Grant with respect to such Shares or (b) within one (1) year after the transfer of such Shares to the Participant. Such notice shall specify the date of such disposition or other transfer and the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">amount realized, in cash, other property, assumption of indebtedness or other consideration, by the Participant in such disposition or other transfer.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Company makes no representation that the Option will be exempt from, or will comply with, Section 409A of the Code, and makes no undertakings to preclude Section 409A of the Code from applying to the Option or to ensure that it complies with Section 409A of the Code. For the avoidance of doubt, the Participant hereby acknowledges and agrees, that the Company will have no liability to the Participant or any other party if the grant, vesting, or exercise of the Option, the issuance of Shares or any other transaction under this Agreement is not exempt from, or compliant with, Code Section 409A, or for any action taken by the Company with respect thereto.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  13.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Not Salary, Pensionable Earnings or Base Pay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Participant acknowledges that the Option shall not be included in or deemed to be a part of (a) salary, normal salary or other ordinary compensation, (b) any definition of pensionable or other earnings (however defined) for the purpose of calculating any benefits payable to or on behalf of the Participant under any pension, retirement, termination or dismissal indemnity, severance benefit, retirement indemnity or other benefit arrangement of the Company or any Subsidiary or Affiliate (including the Employer) or (c) any calculation of base pay or regular pay for any purpose.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> 14.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Cancellation&#47;Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Participant hereby acknowledges and agrees that the Participant and the Option are subject to the terms and conditions of Section 19 (Cancellation or &#8220;Clawback&#8221; of Awards) of the Plan, subject to applicable law.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  15.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Provisions of Plan Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This Agreement is subject to all the terms, conditions and provisions of the Plan, including the amendment provisions thereof, and to such rules, regulations and interpretations relating to the Plan as may be adopted by the Committee and as may be in effect from time to time. The Plan is incorporated herein by reference. If and to the extent that this Agreement conflicts or is inconsistent with the Plan, the Plan shall control, and this Agreement shall be deemed to be modified accordingly.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  16.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Any notice required or permitted to be given under this Agreement shall be in writing and shall be deemed to have been given when delivered personally or by courier, or sent by certified or registered mail, postage prepaid, return receipt requested, duly addressed to the party concerned at the address indicated below or to such changed address as such party may subsequently by similar process give notice of&#58;</font></div><div style="text-align:justify;text-indent:38.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If to the Company&#58;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">TriNet Group, Inc.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">One Park Place</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Suite 600</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Dublin, CA 94568</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Attention&#58; Chief Legal Officer</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:38.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If to the Participant, to the address of the Participant on file with the Company.</font></div><div style="text-align:justify;text-indent:38.8pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  17.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">No Right to Continued Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The grant of the Option shall not be construed as giving the Participant the right to be retained in the employ of, or to continue to provide services to, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Company or any Subsidiary or Affiliate (including the Employer). Nothing in the Plan or in this Agreement shall interfere with or limit in any way the right of the Company or a Subsidiary or Affiliate thereof to terminate the Participant&#8217;s service at any time, subject to applicable laws.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  18.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">No Right to Future Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. In accepting the Award, the Participant acknowledges that the Plan is established voluntarily by the Company, is discretionary in nature, and may be modified, amended, suspended or terminated by the Company at any time.  Any Option granted under the Plan shall be a one-time award that does not constitute a promise of future grants. The Company, in its sole discretion, maintains the right to make available future grants under the Plan. The grant of Option is voluntary and occasional and does not create any contractual or other right to receive future grants of Options, other Awards or benefits in lieu of Options, even if Options have been granted repeatedly in the past, and all decisions with respect to future grants of Options or other Awards, if any, will be at the sole discretion of the Company.  In addition, the Participant&#8217;s participation in the Plan is voluntary, and the Options and the Shares subject to the Options are extraordinary items that do not constitute regular compensation for services rendered to the Company or any Subsidiary or Affiliate and are outside the scope of the Participant&#8217;s employment contract, if any.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  19.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Restrictive Legends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The shares issued under the Option will be endorsed with appropriate legends as determined by the Company.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> 20.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Agreement, the Plan, the Notice and any other agreements, schedules, addenda, appendices, exhibits and other documents referred to herein or therein constitute the entire agreement and understanding between the parties in respect of the subject matter hereof and supersede all prior and contemporaneous arrangements, agreements and understandings, both oral and written, whether in term sheets, presentations or otherwise, between the parties with respect to the subject matter hereof.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  21.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If any provision of this Agreement is or becomes or is deemed to be invalid, illegal or unenforceable in any jurisdiction, or would disqualify the Plan or this Agreement under any law deemed applicable by the Board, such provision shall be construed or deemed amended to conform to applicable laws, or if it cannot be so construed or deemed amended without, in the determination of the Board, materially altering the intent of this Agreement, such provision shall be stricken as to such jurisdiction, and the remainder of this Agreement shall remain in full force and effect.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  22.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Amendment&#59; Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">No amendment or modification of any provision of this Agreement that has a material adverse effect on the Participant shall be effective unless signed in writing by or on behalf of the Company and the Participant&#59; provided that the Company may amend or modify this Agreement without the Participant&#8217;s consent in accordance with the provisions of the Plan or as otherwise set forth in this Agreement. No waiver of any breach or condition of this Agreement shall be deemed to be a waiver of any other or subsequent breach or condition, whether of like or different nature. Any amendment or modification of or to any provision of this Agreement, or any waiver of any provision of this Agreement, shall be effective only in the specific instance and for the specific purpose for which such amendment, modification or waiver is made or given.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  23.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Neither this Agreement nor any right, remedy, obligation or liability arising hereunder or by reason hereof shall be assignable by the Participant.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  24.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Successors and Assigns&#59; No Third-Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Agreement shall inure to the benefit of and be binding upon the Company and the Participant and their respective heirs, successors, legal representatives and permitted assigns. Nothing in this Agreement, express or implied, is intended to confer on any Person other than the Company and the Participant, and their respective heirs, successors, legal representatives and permitted assigns, any rights, remedies, obligations or liabilities under or by reason of this Agreement.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  25.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">No Advice Regarding Grant&#59; Opportunity to Obtain Advice of Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant&#8217;s participation in the Plan, or the Participant&#8217;s acquisition or sale of the underlying Shares. The Participant is hereby advised to consult with the Participant&#8217;s own personal tax, financial and&#47;or legal advisors regarding the Tax-Related Items arising in connection with the Option. By accepting the Option, the Participant acknowledges and agrees that he or she has done so or knowingly and voluntarily declined to do so. The Participant acknowledges and agrees that he or she has reviewed the Agreement, the Notice and the Plan in their entirety, including any addenda or other documents referred to herein or therein, and have had the opportunity to obtain the advice of counsel prior to executing and accepting the Option, and fully understood the provisions of the Option.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  26. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Dispute Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">All controversies and claims arising out of or relating to this Agreement, or the breach hereof, shall be settled by the Company&#8217;s or the Employer&#8217;s mandatory dispute resolution procedures, if any, as may be in effect from time to time with respect to matters arising out of or relating to the Participant&#8217;s employment with the Company or the Employer.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   27. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Governing Law&#59; Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">All matters arising out of or relating to this Agreement and the transactions contemplated hereby, including its validity, interpretation, construction, performance and enforcement, shall be governed by and construed in accordance with the internal laws of the State of Delaware, without giving effect to its principles of conflict of laws. Notwithstanding any arbitration agreement that otherwise may exist between the Participant and the Company, the Participant and the Company agree that, in the event of any dispute arising under this Agreement, any such dispute is not subject to arbitration, and the Participant and the Company instead hereby submit and consent to the exclusive jurisdiction of the State of Delaware and agree that any such litigation shall be conducted only in the courts of Delaware or the federal courts of the United States located in Delaware and no other courts.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  28. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Imposition of other Requirements and Participant Undertaking</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Company reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on the Option and on any Shares to be issued upon exercise of the Option, or take any other action, to the extent the Company determines it is necessary or advisable for legal or administrative reasons. The Participant agrees to take whatever additional action and execute whatever additional documents the Company may deem necessary or advisable to accomplish the foregoing or to carry out or give effect to any of the obligations or restrictions imposed on either the Participant or the Option pursuant to this Agreement. Furthermore, the Participant acknowledges that the applicable laws of the country in which the Participant is residing or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">working at the time of grant, vesting and exercise of the Options or the ownership or sale of Shares received pursuant to the Options (including any rules or regulations governing securities, foreign exchange, tax, labor, or other matters) may subject the Participant to additional procedural or regulatory requirements that the Participant is and will be solely responsible for and must fulfill.  Such requirements may be outlined in but are not limited to the Country-Specific Addendum (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Addendum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) attached hereto, which forms part of this Agreement.  Notwithstanding any provision herein, the Participant&#8217;s participation in the Plan shall be subject to any applicable special terms and conditions or disclosures as set forth in the Addendum.  The Participant also understands and agrees that if the Participant works, resides, moves to, or otherwise is or becomes subject to applicable laws or company policies of another jurisdiction at any time, certain country-specific notices, disclaimers and&#47;or terms and conditions may apply to the Participant as from the date of grant, unless otherwise determined by the Company in its sole discretion.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  29.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">References</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">References herein to rights and obligations of the Participant shall apply, where appropriate, to the Participant&#8217;s legal representative or estate without regard to whether specific reference to such legal representative or estate is contained in a particular provision of this Agreement.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  30. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant&#8217;s Personal Data (as described below) by and among, as applicable, the Company, any Subsidiary, Affiliate or third parties as may be selected by the Company for the exclusive purpose of implementing, administering and managing the Participant&#8217;s participation in the Plan.  The Participant understands that refusal or withdrawal of consent will affect the Participant&#8217;s ability to participate in the Plan&#59; without providing consent, the Participant will not be able to participate in the Plan or realize benefits (if any) from the Options.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">The Participant understands that the Company and any Subsidiary, Affiliate or designated third parties may hold personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company or any Subsidiary or Affiliate, details of all Options or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Participant&#8217;s favor (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:117%;text-decoration:underline">Personal Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">&#8221;).  The Participant understands that Personal Data may be transferred to any Subsidiary, Affiliate or third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the United States, the Participant&#8217;s country (if different than the United States), or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than the Participant&#8217;s country.  In particular, the Company may transfer Personal Data to the broker or stock plan administrator assisting with the Plan, to its legal counsel and tax&#47;accounting advisor, and to the affiliate or entity that is the Participant&#8217;s employer and its payroll provider.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">The Participant should also refer to any data privacy policy implemented by the Company (which will be available to the Participant separately and may be updated from time to time) for more information regarding the collection, use, storage, and transfer of the Participant&#8217;s Personal Data.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  31.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Foreign Exchange Fluctuations and Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Participant understands and agrees that, if required by the Company or applicable laws, any cross-border funds transfers in connection with the Options (including proceeds from the sale of Shares or receipt of any dividends) must be made through a locally authorized financial institution or registered foreign exchange agency and may require the Participant to provide to such entity certain information regarding the transaction.  Moreover, the Participant understands and agrees that the future value of the underlying Shares is unknown and cannot be predicted with certainty and may decrease in value.  The Participant understands that neither the Company nor any Subsidiary or Affiliate is responsible for any foreign exchange fluctuation between local currency and the United States Dollar or the selection by the Company or any Subsidiary or Affiliate in its sole discretion of an applicable foreign currency exchange rate that may affect the value of the Options (or the calculation of income or Tax-Related Items thereunder).</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  32.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Communications and Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Company may, in its sole discretion, decide to deliver any documents related to the Participant&#8217;s current or future participation in the Plan, shares, or any other Company-related documents by electronic means.  By accepting this Agreement, whether electronically or otherwise, the Participant hereby consents to receive such documents by electronic delivery and agree to participate in the Plan through an online or electronic system established and maintained by the Company or a third party designated by the Company, including but not limited to the use of electronic signatures or click-through electronic acceptance of terms and conditions.  To the extent the Participant has been provided with a copy of this Agreement, the Plan, or any other documents relating to the Options in a language other than English, the English language documents will prevail in case of any ambiguities or divergences as a result of translation.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Country-Specific Addendum</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Addendum includes additional country-specific notices, disclaimers, and&#47;or terms and conditions that apply to individuals who work or reside in the countries listed below and that may be material to the Participant&#8217;s participation in the Plan.  Such notices, disclaimers, and&#47;or terms and conditions may also apply, as from the date of grant, if the Participant moves to or otherwise is or becomes subject to the applicable laws or Company policies of the country listed.  However, because foreign exchange regulations and other local laws are subject to frequent change, the Participant is advised to seek advice from his or her own personal legal and tax advisor prior to accepting a Stock Option or holding or selling Shares acquired under the Plan.  The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant&#8217;s acceptance of the Stock Option or participation in the Plan.  Unless otherwise noted below, capitalized terms shall have the same meaning assigned to them under the Plan and the Stock Option Grant Notice and Stock Option Agreement. This Addendum forms part of the Stock Option Agreement and should be read in conjunction with the Stock Option Agreement and the Plan. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Securities Law Notice&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Unless otherwise noted, neither the Company nor the Shares are registered with any local stock exchange or under the control of any local securities regulator outside the United States.  The Stock Option Agreement (of which this Addendum is a part), the Plan, and any other communications or materials that you may receive regarding participation in the Plan do not constitute advertising or an offering of securities outside the United States, and the issuance of securities described in any Plan-related documents is not intended for public offering or circulation in the Participant&#8217;s jurisdiction.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:18.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.804%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Canada</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Securities Law Notice. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The security represented by the Stock Option was issued pursuant to an exemption from the prospectus requirements of applicable securities legislation in Canada. The Participant acknowledges that, as long as the Company is not a reporting issuer in any jurisdiction in Canada, the Stock Option and the underlying Shares will be subject to an indefinite hold period in Canada and subject to restrictions on their transfer in Canada. Subject to the terms and conditions of the Agreement and applicable securities laws, the Participant is permitted to sell Shares acquired through the designated broker appointed under the Plan, assuming the sale of such Shares takes place outside Canad</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Settlement in Shares Only. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Notwithstanding any discretion in the Plan to the contrary, settlement of the Stock Option shall only be made in Shares issued by the Company from treasury and not, in whole or in part, in the form of cash (other than as explicitly consented to by you in Section 10 of the Agreement for tax withholding and payment purposes) or other consideration.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Foreign Ownership Reporting. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If the Participant is a Canadian resident, his or her ownership of certain foreign property (including shares of foreign corporations) in excess of $100,000 may be subject to ongoing annual reporting obligations. The Participant should please refer to CRA</font><font style="color:#0563c1;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Form T113</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5 (Foreign Income Verification Statement) and consult their tax advisor for further details</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Quebec&#58; Consent to Receive Information in English. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The following applies if the Participant is a resident of Quebec&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The parties acknowledge that it is their express wish that this Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Les parties reconnaissent avoir exig&#233; la redaction en anglais de cette convention, ainsi que de tous documents ex&#233;cut&#233;s, avis donn&#233;s et procedures judiciaries intent&#233;es, directement ou indirectement, relativement &#224; la pr&#233;sente convention.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:18.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">India</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> The Participant understands that he or she must repatriate to India and convert to local currency any proceeds from the sale of Shares acquired under the Plan within 90 days of receipt and any dividends received in relation to the Shares within 60 days of receipt. The Participant will receive a foreign inward remittance certificate (&#8220;FIRC&#8221;) from the bank where the Participant deposits the foreign currency. The Participant should maintain the FIRC as evidence of the repatriation of funds in case the Reserve Bank of India, the Company, or any Subsidiary or Affiliate requests proof of repatriati</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Share Valuation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> The amount of the Award subject to tax, including for reporting and withholding, will partially depend upon a valuation that the Company will obtain from a Category I Merchant Banker in India. The Company has no responsibility or obligation to obtain the most favorable valuation possible nor obtain valuations more frequently than required under Indian tax law</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:107%">Appendix A</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">RESTRICTIVE COVENANT AGREEMENT</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            As a material condition to the grant of the Award provided for under the Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement  by and between the grant recipient (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and TriNet Group, Inc. (collectively with its Subsidiaries and Affiliates, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">TriNet</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), Employee enters into and agrees to be bound by this Restrictive Covenant Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">RCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), made by and between Employee and TriNet effective as of the date Employee accepts the Award.  Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to them in the Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement or the TriNet Group, Inc. Amended and Restated 2019 Equity Incentive Plan.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 1.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">1.1  Non-Disclosure. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Employee agrees that during and after employment with TriNet, Employee will not (i) directly or indirectly disclose to any person or entity, or use, except for the sole benefit of TriNet, any of TriNet&#8217;s confidential or proprietary information or trade secrets (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Company Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) or (ii) publish or submit for publication, any article or book relating to TriNet, its development projects, or other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">aspects of TriNet business. By way of illustration and not limitation, Company Information shall include TriNet&#8217;s trade secrets&#59; research and development plans or projects&#59; data and reports&#59; computer materials such as software programs, instructions, source and object code, and printouts&#59; products prospective products, inventions, developments, and discoveries&#59; data compilations, development databases&#59; business improvements&#59; business plans (whether pursued or not)&#59; ideas&#59; budgets&#59; unpublished financial statements&#59; licenses&#59; pricing strategy and cost data&#59; information regarding the skills and compensation of any employees, non-employee directors or consultants of TriNet (other than Employee)&#59; the personally identifying and protected health information of any employee, non-employee director or consultant of TriNet (other than Employee), including worksite employees of TriNet customers&#59; lists of current and potential customers of TriNet&#59; information about customers&#8217; purchasing history, pricing, preferences and profitability&#59; strategies, forecasts and other marketing information and techniques&#59; employment and recruiting strategies and processes&#59; sales practices, strategies, methods, forecasts, compensation plans, and other sales information&#59; investor information&#59; and the identities of TriNet&#8217;s suppliers, vendors,  and contractors, and all information about those supplier, vendor and contractor relationships such as contact person(s), pricing and other terms.  The definition of Company Information shall include both &#8220;know-how&#8221; (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">i.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">., information about what works well) and &#8220;negative know-how&#8221; (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">i.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">., information about what does not work well).  Employee further acknowledges and agrees that all Company Information is confidential and proprietary and shall remain the exclusive property of TriNet.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  1.1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">    Wisconsin.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If Employee last worked for TriNet in Wisconsin, the restrictions set forth in Section 1.1 shall apply during Employee&#8217;s employment with TriNet and for eighteen (18) months after Employee&#8217;s employment with TriNet ends.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> 1.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"> Improper Use of Trade Secret Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  In furtherance of Employee&#8217;s promises in this Section 1, Employee agrees that during Employee&#8217;s employment and for a period of one year following termination of employment with TriNet, Employee will not, for Employee&#8217;s own benefit or for the benefit of a competitor of TriNet, use TriNet&#8217;s trade secrets, or use Employee&#8217;s knowledge of TriNet&#8217;s trade secret customer information, directly or indirectly, to (i) identify TriNet customers for solicitation&#59; (ii) facilitate the solicitation of TriNet&#8217;s customers&#59; (iii) target any employee, non-employee director(s) or consultant(s) of TriNet for solicitation or recruitment to discontinue, in whole or in part, his&#47;her employment or other relationship with TriNet, or using trade secrets to facilitate any such solicitation or recruitment&#59; or (iv) otherwise compete unfairly with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Permitted Disclosures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Nothing in this RCA limits Employee&#8217;s ability to communicate directly with and provide information, including documents, not otherwise protected from disclosure by any applicable law or privilege, to the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) or any other federal, provincial, state or local governmental agency or commission or self-regulatory organization regarding possible legal violations, without disclosure to TriNet.  TriNet may not retaliate against Employee for any of these activities, and nothing in the RCA requires Employee to waive any monetary award or other payment to which Employee might become entitled from the SEC or any other government agency or self-regulatory organization as a result of such communication.  Nothing contained in this Agreement restricts or limits Employee&#8217;s right to discuss or disclose information about unlawful acts in the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">workplace, at work-related events, or between TriNet employees or TriNet and Employee, such as harassment, discrimination, retaliation, sexual assault, a wage and hour violation, or any other conduct that Employee has reason to believe is unlawful or that is otherwise recognized as against a clear mandate of public policy, nor does this Agreement prohibit Employee from discussing Employee&#8217;s employment or reporting possible violations of law or regulation with the Equal Employment Opportunity Commission, United States Department of Labor, the Occupational Safety and Health Administration, the National Labor Relations Board, the Securities and Exchange Commission, or other federal government agency or state or local government agency. This Agreement does not prohibit Employee from discussing the terms and conditions of Employee&#8217;s employment with others to the extent expressly permitted by Section 7 of the National Labor Relations Act or to the extent that such disclosure is protected under the applicable provisions of law or regulation, including but not limited to &#8220;whistleblower&#8221; statutes or other similar provisions that protect such disclosure.  Nor does this Agreement require Employee not to disclose or discuss conduct or the existence of a settlement involving conduct relating to a dispute&#58; (1) involving a nonconsensual sexual act or sexual contact, as such terms are defined in section 2246 of title 18, United States Code, or similar applicable tribal or state law&#59; or (2) relating to conduct that is alleged to constitute sexual harassment under applicable federal, tribal, or state law. Further, pursuant to the Defend Trade Secrets Act of 2016 or applicable law, Employee shall not have criminal or civil liability under any federal, provincial or state trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a federal, provincial, state, or local government official, either directly or indirectly, or to an attorney and (ii) solely for the purpose of reporting or investigating a suspected violation of law&#59; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  In addition and without limiting the preceding sentence, if Employee files a lawsuit for retaliation by TriNet for reporting a suspected violation of law, Employee may disclose the trade secret to Employee&#8217;s attorney and may use the trade secret information in the court proceeding, if Employee (X) files any document containing the trade secret under seal and (Y) does not disclose the trade secret, except pursuant to court order.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Notice of Resignation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> In the event Employee resigns Employee&#8217;s employment with TriNet and is immediately prior to such resignation employed (1) in any position in the Field Sales, Virtual Sales, and Channel and Partnership Sales departments, or (2) in any other part of TriNet with a job code of Executive Director or above, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">excluding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">any &#8220;officers&#8221; of the Company (as such term is defined by Section 16 of the Securities Exchange Act of 1934, as amended) to help effectuate and ensure an orderly transition </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Employee shall provide TriNet with thirty (30) days&#8217; notice of Employee&#8217;s resignation from TriNet</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> as more specifically set forth in Sub-sections 3.1 through 3.4, below.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            3.1.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Thirty (30) Days&#8217; Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Employee will provide thirty days&#8217; notice of Employee&#8217;s resignation in writing submitted to Employee&#8217;s direct manager and the Human Resources Department via email to MYHR&#64;trinet.com, and such written notice shall include a disclosure and identification of any new position, affiliation and&#47;or employment Employee has accepted, intends to accept or is considering accepting upon expiration of the Notice Period. (The first thirty (30) days following submission of a resignation in compliance with this RCA as outlined below shall be the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Notice Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.&#8221;) </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  3.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Duties and Cooperation During Notice Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. During the Notice Period Employee&#8217;s manager may ask Employee to take steps to help transition responsibility for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ongoing projects and&#47;or other job duties.  Employee agrees to perform these duties and tasks, as Employee&#8217;s manager in the manager&#8217;s sole discretion may direct, including without limitation any or all of the following&#58;  (i) organize files and notes of any projects for transition&#59; (ii) meet with Employee&#8217;s managers or their designee to review files and other data to help ensure that TriNet personnel are aware of and understand any files, projects or other business related data&#59; (iii) meet with Employee&#8217;s manager or the manager&#8217;s designee to review the status of any projects, work, clients or personnel for which Employee was assigned responsibility, in order to help ensure that business needs may be seamlessly transitioned to and serviced by other TriNet personnel&#59; (iv) otherwise being available to TriNet, as requested by Employee&#8217;s managers, to provide reasonable assistance to effectuate an orderly transition of knowledge, files, projects, data, client service or personnel responsibilities, and any other job duties, prior to Employee&#8217;s last day of employment.  The foregoing list is neither intended to be an exhaustive list of the transition-related tasks Employee may be required to perform, nor is it a promise that TriNet will have Employee engage in any or all of the listed tasks.  There may be times during the Notice Period when TriNet is preparing for the transition in a way that does not involve Employee&#8217;s active engagement, and as such TriNet at its sole discretion may instruct Employee not to work or enter TriNet&#8217;s premises on some or all days of the Notice Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> 3.3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Conduct During Notice Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. During the Notice Period, Employee will be a TriNet employee, will remain on TriNet&#8217;s payroll, will receive the same base rate of pay, and will continue to be eligible for all employee benefits just as in the period prior to Employee&#8217;s giving Notice of Resignation to TriNet. Employee&#8217;s primary job duties during the Notice Period will involve assisting TriNet to effectuate an orderly transition of duties to other TriNet personnel as assigned by Employee&#8217;s manager. During the Notice Period, Employee shall&#58; (i) not discuss or communicate about Employee&#8217;s impending departure from TriNet with clients or others who are not employees of TriNet unless authorized in writing to do so by Employee&#8217;s manager&#59; (ii) not take, remove or transfer any TriNet data, records or information off the premises of any TriNet office or facility&#59; (iii) access TriNet systems only with express permission of Employee&#8217;s manager (Employee understands that such accessibility may be terminated during the Notice Period)&#59; (iv) return to Employee&#8217;s TriNet manager, within one business day of tendering Employee&#8217;s notice of resignation, all files, data and information relating to TriNet clients or business which Employee may have had off premises during the course of Employee&#8217;s employment&#59; (v) not use any social networking system or function to update any clients about Employee&#8217;s employment status with TriNet and&#47;or any impending change of such status&#59; and (vi) if Employee has had remote access to TriNet computer systems or if Employee has ever used a non-TriNet issued computer or electronic device for work, Employee will, upon TriNet&#8217;s request, make such personal computer(s) or other electronic devices available to TriNet and&#47;or its computer forensic experts for imaging and searching to verify that all TriNet client data and any other non-public information has been removed. Employee understands and agrees that a core purpose of the Notice Period is to enable the orderly transition of knowledge, files, data and client responsibility to other TriNet employees, and accordingly Employee understands and agrees that TriNet is free to and may elect to engage in a variety of transition-related activities, including but not limited to notifying clients of Employee&#8217;s intent to leave TriNet, informing clients of the identity of other TriNet employees being assigned to service their accounts, introducing the clients to other TriNet personnel, and&#47;or holding meetings with clients that may or may not include Employee, as Employee&#8217;s manager may elect. Employee agrees and understands that during the Notice Period, Employee owes TriNet an unmitigated duty of loyalty, and that Employee shall do nothing during the Notice </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Period that Employee intends or reasonably expects to further Employee&#8217;s personal interests or the interests of Employee&#8217;s new employer to the actual or potential detriment of TriNet.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> 3.4.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">At Will (United States Employees)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Employees in the United States are employed by TriNet on an at-will basis only. Employee understands and agrees that nothing in the Restricted Stock Unit Award Agreement or this RCA changes the Employee&#8217;s &#34;at will&#34; employment status, and that TriNet may end the employment relationship at any time, with or without notice, for any reason or no reason at all. Likewise, Employee is free to end the employment relationship at any time, subject only to Employee&#8217;s obligation to provide notice in the manner described herein. Without limitation of the foregoing, Employee understands that TriNet retains the right in its absolute and sole discretion to terminate Employee&#8217;s employment after receiving notice from Employee pursuant to this RCA, at which point Employee&#8217;s employment and the Notice Period will come to an end (including any associated obligation by TriNet to continue Employee&#8217;s salary and benefits during the Notice Period), but in no event shall TriNet terminate Employee&#8217;s employment or the Notice Period sooner than two (2) weeks after the date on which Employee gives notice of resignation pursuant to Section 3 (provided, however, that TriNet retains the right as set forth above to determine what duties, if any, will be performed  during such two-week period).</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.4.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Canada</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The foregoing paragraph 3.4 shall not apply to Canada employees,  and TriNet shall not terminate the Employee&#8217;s employment or the Notice Period sooner than the lesser of only&#58; (i) the minimum period of notice prescribed by applicable employment standards legislation, and (ii) two (2) weeks after the date on which Employee gives notice of resignation pursuant to section 3.  TriNet may provide payment in lieu of such notice at its discretion.  In no event will Employee receive less than the minimum requirements prescribed by applicable employment standards legislation and, should such legislation provide for any minimum benefit or entitlement in excess of the payment or benefits provided pursuant to this paragraph, Employee will receive such greater minimum entitlement and nothing more.   </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">3.4.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">India</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This Section 3.4.2 shall apply to India employees in lieu of the first paragraph of Section 3.4. Subject to the Notice Period requirement above in Section 3.3, either party may terminate the employment without cause by giving prior written notice to the other party as specified in the Employee&#8217;s applicable offer letter from the Company or its Subsidiary or Affiliate that employs Employee (&#8220;TriNet&#8221;), or payment in lieu of such notice by TriNet.  Further, TriNet reserves the right to terminate Employee&#8217;s employment for cause without giving any prior notice or payment in lieu of notice in accordance with its internal policies and the offer letter.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 4.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Non-Solicitation. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  4.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Customer Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Employee will not, directly or indirectly, during employment with TriNet and for twelve (12) months following termination or separation of such employment, solicit or attempt to solicit any of TriNet&#8217;s customers or business or patronage of such customers, either for themselves or on behalf of any other person, partnership, corporation, or other entity for the purpose of (i) providing or selling services, goods or products that are the same as or similar to the kinds or types of services, goods or products being provided or sold by TriNet, or (ii) entering into or seeking to enter into any contract or other arrangement with any such entity for the performance or sale of services or goods and products of a nature being </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">provided or sold by TriNet. Employee understands that Employee&#8217;s agreement &#8220;not to solicit&#8221; as set forth in this Section 4.1 means that Employee will not, directly or indirectly, initiate any contact or communication with any entity that, at the time, has a contractual relationship with TriNet for the purpose of soliciting, inviting, encouraging, recommending or requesting any such entity to do business with Employee and&#47;or any other person or entity.  This restriction is limited to (a) customers Employee serviced, solicited or interacted with at any time during the 24 months immediately preceding termination of employment with TriNet&#59; (b) customers serviced or solicited by other TriNet employees whom Employee directly supervised during the 24 months immediately preceding termination of employment with TriNet&#59; and (c) customers about whom Employee had access to Confidential Information during the 24 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.1.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Alabama.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Sub-section 4.1, above, does not apply if the state in which Employee last worked for TriNet was Alabama, in which case Employee will not directly or indirectly, during employment with TriNet and for twelve (12) months following termination or separation of such employment for any reason, solicit any of TriNet&#8217;s current customers, either for Employee&#8217;s own benefit or advantage or on behalf of any other person, partnership, corporation, or other entity, so long as TriNet carries on a like business. This restriction is limited to (a) current customers Employee serviced, solicited or interacted with at any time during the 24 months immediately preceding termination of employment with TriNet&#59; (b) current customers serviced or solicited by other TriNet employees whom Employee directly supervised during the 24 months immediately preceding termination of employment with TriNet&#59; and (c) current customers about whom Employee had access to Confidential Information during the 24 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">California &#38; North Dakota</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.1, above, does not apply if the state in which Employee primarily resides or primarily works for TriNet in California or North Dakota, provided, however, that with respect to Notice of Resignation and Non-Solicitation of customers Employee nevertheless is bound by the terms of Sections 3 and 1.2 above.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. If at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in Colorado while working for TriNet, see Sub-section 6.1 below for important limitations and acknowledgments relating to the restrictions contained in the above Sub-section 4.1.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.4.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Illinois</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Subsection 4.1, above, does not apply if the state in which Employee last worked for TriNet was Illinois unless, as of the time of execution of the Restricted Stock Unit Award Agreement, Employee&#8217;s actual or expected annualized rate of earnings with TriNet exceed Forty-five thousand dollars ($45,000) per year (or such other amount established by existing statutory terms or subsequent statutory modifications).    </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            4.1.5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Nebraska.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Sub-section 4.1 does not apply if the state in which Employee last worked for TriNet was Nebraska, in which case Employee will not, during employment with TriNet and for twelve (12) months following termination or separation of employment, solicit any TriNet current customers with which Employee actually did business and had personal contact during the 18 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.6.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Oklahoma.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Sub-section 4.1 does not apply if the state in which Employee last worked for TriNet was Oklahoma, in which case Employee will not, during employment with TriNet and for twelve (12) months following termination or separation of employment for any reason, directly solicit TriNet&#8217;s established customers or the business or patronage of such established customers either for Employee&#8217;s own purposes or on behalf of any other person, partnership, corporation, or other entity. This restriction on direct solicitation of established customers is further limited to (a) established customers that Employee serviced, solicited, or interacted with at any time during the 24 months immediately preceding Employee&#8217;s termination of employment with TriNet&#59; and (b) established customers serviced or solicited by other TriNet employees whom Employee supervised during the 24 months immediately preceding Employee&#8217;s termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.7.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">South Dakota</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. If the state in which Employee last worked for TriNet was South Dakota, enforcement of the restrictions in Section 4.1 will be limited to the geographic area or areas for which Employee was responsible at any time during the twelve (12) months immediately preceding Employee&#8217;s termination of employment with TriNet.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Employee Non-Solicitation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Employee will not, directly or indirectly, during employment with TriNet and for twelve (12) months following termination or separation of employment, solicit or recruit any TriNet employee(s), non-employee director(s) or consultant(s) of TriNet to accept a position with another company or entity, nor otherwise encourage or induce any TriNet employee, non-employee director or consultant to terminate their employment or affiliation with TriNet. This restriction applies only to (a) employees Employee supervised at any time during the 24 months immediately preceding termination of employment with TriNet, (b) employees with whom Employee worked in the same office at any time during the 24 months immediately preceding termination of employment with TriNet, and (c) employees with whom Employee otherwise had material contact at any time during the 24 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Alabama</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was Alabama, in which case Employee will not directly or indirectly, during employment with TriNet and for twelve (12) months following termination or separation of employment, hire or employ any agent, servant or employee of TriNet who holds a position uniquely essential to the management, organization, or service of the business of TriNet.  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">California</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee primarily resides or primarily works for TriNet is California, provided, however, that with respect to Non-Solicitation of employees, Employee nevertheless is bound by the terms of Section 1.2 above.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in Colorado while working for TriNet, in which case Employee will not solicit, directly or indirectly, any TriNet employee(s) to leave his&#47;her employment with TriNet. This restriction applies only to (a) employees Employee supervised at any time during the 24 months immediately preceding termination of employment with TriNet, (b) employees with whom Employee worked in the same office at any time during the 24 </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">months immediately preceding termination of employment with TriNet, and (c) employees with whom Employee otherwise had material contact at any time during the 24 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  4.2.4.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Illinois</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was Illinois unless, as of the time of execution of the Restricted Stock Unit Award Agreement, Employee&#8217;s actual or expected annualized rate of earnings with TriNet exceeds forty-five thousand dollars ($45,000) per year (or such other amount established by existing statutory terms or subsequent statutory modifications).</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Nebraska</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was Nebraska, in which case Employee will not, during employment with TriNet and for twelve (12) months following termination or separation of employment, solicit any TriNet current employee with whom Employee had personal contact during the 18 months immediately preceding termination of employment with TriNet. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.6.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">North Dakota</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was North Dakota, in which case Employee will not, during employment with TriNet and for twelve (12) months following the end of Employee&#8217;s employment with TriNet, solicit an employee of TriNet to leave TriNet&#8217;s employment.  This restriction is limited to employees of TriNet with whom Employee had business-related contact or dealings.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Oklahoma</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was Oklahoma, in which case, during employment and for a period of twelve (12) months following the end of Employee&#8217;s employment with TriNet, Employee shall not, directly or indirectly, actively or inactively, solicit any employees or independent contractors of TriNet to become employees or independent contractors of another person or business.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. During Employee&#8217;s employment with TriNet, and for a period of twelve (12) months immediately following termination or separation of such employment for any reason, Employee will not, directly or indirectly, perform on behalf of a competitor the same or similar job duties that Employee performed in Employee&#8217;s last twelve (12) months of employment with TriNet. This restriction will only apply in the geographic territory for which Employee had responsibility in Employee&#8217;s last twelve (12) months of employment with TriNet. Additionally, this restriction will only apply to the performance of job duties competitive with a segment or business line of TriNet&#8217;s business in which Employee worked in his&#47;her last twelve (12) months of employment with TriNet. Employee has the right to consult with Employee&#8217;s counsel prior to accepting the Restricted Stock Unit Award Agreement containing this RCA.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Notwithstanding the foregoing, where applicable, this Section 5 will apply only to the extent permissible under (i) the ABA Model Rules of Professional Conduct&#8217;s provisions regarding restrictions on the right to practice law, and&#47;or (ii) any applicable state counterpart similarly addressing restrictions on the right to practice law. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">California, Oklahoma, Minnesota, Nebraska, North Dakota</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Section 5, above, does not apply if the state in which Employee last worked for TriNet was California, Oklahoma, Minnesota, Nebraska or North Dakota.  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in Colorado while working for TriNet, see Sub-section 6.1 below for important limitations and acknowledgments relating to the restrictions contained in the above Section 5.  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Illinois.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Section 5, above, does not apply if the state in which Employee last worked for TriNet was Illinois unless, as of the time of execution of the Restricted Stock Unit Award Agreement, Employee&#8217;s actual or expected annualized rate of earnings with TriNet exceeds seventy-five thousand dollars ($75,000) per year (or such other amount established by existing statutory terms or subsequent statutory modifications).</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Massachusetts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If Employee is, and has been for at least 30 days immediately preceding Employee&#8217;s cessation of employment, a resident of or employed in Massachusetts at the time of Employee&#8217;s termination of employment, then Employee hereby agrees that Employee&#8217;s acceptance of the Award identified in the Restricted Stock Unit Award Agreement, and Employee&#8217;s enjoyment of the financial opportunities flowing from such participation, provide Employee with a valuable investment opportunity which constitutes other mutually agreed consideration supporting Employee&#8217;s agreement to abide by the restrictions contained herein for purposes of compliance with Massachusetts law relating to non-competition agreements.    </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">The restrictions contained in this Section 5 will not apply in the event Employee is (i) laid off, or (ii) involuntarily terminated by TriNet without Cause. In the event of a termination for Cause (as defined below), however, this Section 5 shall be in full force and effect to the same extent as it would if Employee resigned voluntarily.  The definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:103%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8221; means any of the following&#58; (i) an unsatisfactory level of performance&#59; (ii) a violation of any legal or contractual obligation to TriNet&#59; (iii) non-compliance with TriNet policies or procedures&#59; (iv) substantiated violation of the TriNet Code of Business Conduct and Ethics&#59; (v) the conviction of a felony involving fraud or dishonesty directed against TriNet&#59; or (vi) any willful act or failure to act that adversely affects the business of TriNet in any material respect. For purposes of this definition, &#8220;unsatisfactory level of performance&#8221; means a serious or repeated performance failure, including, without limitation, serious conduct, behavior, or attendance failures that are subject to formal corrective action up to and including termination of employment. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Maine.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If Employee last worked for TriNet in Maine, then Employee acknowledges and agrees that Employee received a copy of this RCA at least three business days before Employee was required to sign the Restricted Stock Unit Award Agreement.  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Oregon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If Employee last worked for TriNet in Oregon and entered the Restricted Stock Unit Award Agreement after the commencement of employment, then Employee hereby agrees that Employee&#8217;s acceptance of the Award identified in the Restricted Stock Unit Award Agreement, and Employee&#8217;s enjoyment of the financial opportunities flowing from such participation, provide Employee with a valuable investment opportunity which constitutes a bona fide advancement of the Employee by TriNet supporting Employee&#8217;s agreement to abide by the restrictions contained herein for purposes of compliance with Oregon law relating to non-</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">competition agreements. Section 5, above, does not apply if Employee last worked for TriNet in Oregon and the total amount of Employee&#8217;s annual gross salary and commissions, calculated on an annual basis, at the time of Employee&#8217;s termination does not exceed $116,427, adjusted annually for inflation pursuant to the Consumer Price Index for All Urban Consumers, West Region (All Items), as published by the Bureau of Labor Statistics of the United States Department of Labor immediately preceding the calendar year of Employee&#8217;s termination.</font><font style="background-color:#ffffff;color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Washington</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If Employee last worked for TriNet in Washington and entered the Restricted Stock Unit Award Agreement at the outset of Employee&#8217;s employment, then Employee hereby acknowledges and agrees that Employee received written notice of the terms in Section 5 prior to accepting the offer of employment with TriNet. If Employee last worked for TriNet in Washington and entered the Restricted Stock Unit Award Agreement after the commencement of employment, then Employee hereby agrees that Employee&#8217;s acceptance of the Award identified in the Restricted Stock Unit Award Agreement, and Employee&#8217;s enjoyment of the financial opportunities flowing from such participation, provide Employee with a valuable investment opportunity which constitutes independent consideration supporting Employee&#8217;s agreement to abide by the restrictions contained herein for purposes of compliance with Washington law relating to non-competition agreements. Section 5, above, does not apply if Employee last worked for TriNet in Washington and the total amount of Employee&#8217;s annualized Earnings does not exceed $123,394.17, adjusted annually for inflation by the Washington Department of Labor and Industries on September 30 of each year, calculated based on the federal Bureau of Labor Statistics&#8217; Consumer Price Index for Urban Wage Earners and Clerical Workers (CPI-W).  Earnings for purposes of this Section 5.3 means the compensation reflected on box 1 of Employee&#8217;s United States Internal Revenue Service Form W-2 that is paid to Employee over the prior year, or portion thereof for which Employee was employed, annualized and calculated as of the earlier of the date enforcement of the noncompetition covenant is sought or the date of separation from employment. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 6.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Reasonableness of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Employee acknowledges and agrees that compliance with the non-disclosure, non-solicitation, and non-competition covenants above is both reasonable and necessary to protect TriNet&#8217;s legitimate business interests, including its confidential business information and trade secrets, its goodwill, its customer and employee relationships and investment therein, and its reputation, and that Employee&#8217;s violation of these covenants is inconsistent with TriNet&#8217;s provision of equity ownership incentive grants as contemplated by the Restricted Stock Unit Award Agreement. Employee further acknowledges and agrees that Employee&#8217;s post-employment competition, and&#47;or Employee&#8217;s solicitation of TriNet customers or personnel during this limited period of time, in violation of the non-competition and non-solicitation covenants above, would be contrary to the purpose, goal, and intent of TriNet&#8217;s agreement to provide Employee with the equity incentive award provided to Employee in the Restricted Stock Unit Award Agreement, and that but for Employee&#8217;s consent to such post-employment restrictions, the equity incentive award herein would not otherwise be awarded to Employee. Employee further acknowledges that Employee&#8217;s participation in equity ownership incentive grants is fully optional on the part of Employee, and that Employee opts to participate fully understanding that the foregoing covenants and restrictions would be conditions of such participation. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.1.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Colorado while working for TriNet, then the restrictions contained in Sections 4 and 5, above, shall apply and be enforceable only if at the time this Agreement is entered into and at the time it is enforced, Employee earns (a) as to Section 5, an amount of Annualized Cash Compensation equivalent to or greater than the threshold amount to qualify as a Highly Compensated Worker, as the terms Annualized Cash Compensation, Highly Compensated Worker, and Threshold Amount for Highly Compensated Workers are defined in Colorado Revised Statutes Section 8-2-113 or any equivalent Colorado statutory provision that may be in effect at the time of Employee&#8217;s termination of employment with TriNet, or (b) as to Section 4, 60% of the amount set forth immediately above in Sub-section 6.1(a). Employee hereby agrees and acknowledges that&#58; (i) during the course of Employee&#8217;s employment with TriNet, Employee has had access to, gained knowledge of and&#47;or contributed to the development of  trade secret business information  of TriNet&#59; and (ii) the restrictions contained in Sections 1, 3, 4 and 5 are necessary to, and designed for, the protection of TriNet&#8217;s trade secrets by preventing such trade secrets from being disclosed to a competitor or used by a competitor in competition with TriNet.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Illinois</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If Employee last worked for TriNet in Illinois, then TriNet advises Employee to have this RCA reviewed by an attorney of Employee&#8217;s own choosing to receive legal advice about the RCA prior to Employee signing the Restricted Stock Unit Award Agreement.  Employee acknowledges and agrees that Employee received at least 14 days to review this RCA before Employee was required to sign the Restricted Stock Unit Award Agreement, although Employee may choose to sign in fewer than 14 days.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 7.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Irreparable Harm&#47;Injunctive Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Employee acknowledges and agrees that any breach of Employee&#8217;s obligations under the Non-Disclosure, Notice of Resignation, Non-Solicitation, and&#47;or Non-Competition covenants above, as applicable, will result in irreparable and continuing harm and injury to TriNet for which there is no adequate remedy at law. Employee further agrees that in the event Employee breaches or threatens to breach the non-disclosure, non-solicitation, and&#47;or non-competition covenants, in addition to any other rights, remedies or damages available to TriNet, TriNet shall be entitled to seek and obtain temporary, preliminary, and permanent injunctive relief to enforce the specific terms of these covenants. Employee further agrees and consents that in any action seeking temporary or preliminary injunctive relief to enforce any of the foregoing restrictions, TriNet and Employee shall be entitled to engage in expedited discovery in aid of proceedings seeking temporary and&#47;or preliminary injunctive relief, including expedited document production, interrogatories, and depositions limited at the expedited stage to those topics that are relevant to temporary and&#47;or preliminary injunctive relief.   </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 8.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Other Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If any provision of this RCA is found to be invalid or unenforceable, the parties hereto agree that a court may modify, alter or amend such provision to the extent necessary to make it enforceable. If a court declines to modify, alter or amend the provision to make it enforceable, then the remaining provisions of this RCA shall remain in full force and effect.  This RCA is assignable by TriNet and will be binding upon and inure to the benefit of TriNet&#8217;s successors, assigns and affiliated entities.  Employee agrees that, should TriNet, or any subsidiary or unit of TriNet in which Employee works, be acquired by, merge with, or otherwise combine with another business entity, TriNet&#8217;s rights under this RCA will be automatically assigned to the surviving entity, and such entity will have all rights to enforce this Agreement.  Employee hereby consents to any such actual or deemed automatic assignment. Notwithstanding the foregoing, Employee may not assign this RCA.  Nothing in this RCA shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">be interpreted to limit any obligations owing by Employee to TriNet as a matter of common law, to the extent applicable. Nothing contained in this RCA shall be construed to reduce or limit TriNet&#8217;s right, title or interest in any Company Information or trade secrets so as to be less in any respect than TriNet would have had in the absence of this RCA. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 9.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Governing Law&#59; Venue&#59; Integration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The terms of this RCA and any disputes arising out of it shall be governed by, and construed in accordance with, the laws of the state or province in which Employee was last employed by TriNet, without giving effect to such state or province&#8217;s conflict of law principles.  Employee agrees and understands that such state or province&#8217;s laws will govern as set forth herein regardless of whether Employee moves Employee&#8217;s residence or place of employment to another state or location after termination of employment with TriNet. Notwithstanding any arbitration agreement that otherwise may exist between Employee and TriNet, Employee and TriNet agree that in the event of any dispute arising under this RCA, any such dispute is not subject to arbitration, and Employee and TriNet instead hereby mutually confer exclusive jurisdiction and venue for any dispute in any way related to this RCA on the state, provincial or federal court having original jurisdiction for the location in which Employee last worked for TriNet, and Employee and TriNet both agree not to bring any litigation in any way related to this RCA in any other court or forum. </font><font style="background-color:#ffffff;color:#232222;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">RCA </font><font style="background-color:#ffffff;color:#232222;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">replaces and supersedes any conflicting provision of any Restrictive Covenant Agreement contained in a prior </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement entered into by the parties under the TriNet Group, Inc. Amended and Restated 2019 Equity Incentive Plan</font><font style="background-color:#ffffff;color:#232222;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="background-color:#ffffff;color:#232222;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">         </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.1.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">California.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  If Employee primarily resides in or primarily works for TriNet in California, notwithstanding anything contained in Section 9 of this RCA, this RCA shall be governed, construed, and enforced in accordance with California law, and the state and&#47;or federal courts of California shall be the sole and exclusive jurisdiction and venue for resolution of any disputes arising under this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.2.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in Colorado while working for TriNet, then notwithstanding anything contained in Section 9 of this RCA, this RCA shall be governed, construed, and enforced in accordance with Colorado law, and the state and&#47;or federal courts of Colorado shall be the sole and exclusive jurisdiction and venue for resolution of any disputes arising under this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.3.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Massachusetts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. If Employee is, and has been for at least 30 days immediately preceding Employee&#8217;s cessation of employment, a resident of or employed in Massachusetts at the time of Employee&#8217;s termination of employment, then notwithstanding anything contained in Section 9 of this RCA&#58;  (1) this RCA shall be governed by and construed according to the laws of the Commonwealth of Massachusetts&#59; and (2) Employee consents to the personal jurisdiction of the court located in the county in which Employee resides as of the date of Employee&#8217;s termination of employment and the business litigation session of the Superior Court in Suffolk County, Massachusetts with respect to all matters arising out of or related to this RCA.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">***</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Employee understands and acknowledges that Employee has the right to consult and is encouraged to consult with Employee&#8217;s attorney to obtain legal counsel prior to making the choice to accept the Restricted Stock Unit Award Agreement and this RCA and the restrictions contained herein.  Employee acknowledges that Employee was given at least fourteen (14) days&#8217; notice together with the language of the covenants contained hereinabove, prior to the effective date of the covenants, in which to review the covenants.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">IN WITNESS WHEREOF, Employee accepts the obligations under this Restrictive Covenant Agreement and will be deemed to have accepted and signed this RCA upon Employee&#8217;s acceptance of the Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement to which it is attached.    </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>tnet-33125xexhibit102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i6225b1d8c1a243f8a035e6f35ca16683_37"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">TRINET GROUP, INC.  RESTRICTED STOCK UNIT GRANT NOTICE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">FOR COLLEAGUES (AMENDED AND RESTATED 2019 EQUITY INCENTIVE PLAN) </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">TriNet Group, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), pursuant to the TriNet Group, Inc. Amended and Restated 2019 Equity Incentive Plan (as may be amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), hereby awards to the Participant a time-based Restricted Stock Unit (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) Award for the number of shares of the Company&#8217;s Common Stock (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  The Award is subject to all of the terms and conditions as set forth in this Notice of Restricted Stock Unit Award (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), including the vesting schedule set forth below, the Plan and the Restricted Stock Unit Award Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">RSU Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and the Restrictive Covenant Agreement, all of which are attached hereto and incorporated herein in their entirety (this Notice, the RSU Agreement, including any country-specific addendum attached thereto, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  Except as otherwise indicated, any capitalized term used but not defined shall have the meaning ascribed to such term in Plan.  </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.115%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top">Participant&#58;</td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Award Number&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Date of Grant&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Number of Shares Subject to Award&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Vesting Schedule&#58; </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Acceptance, Acknowledgment and Receipt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">           </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">By accepting the Award Agreement, the Participant hereby&#58; </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">acknowledges receipt of, and represents that Participant understands, this Notice, the RSU Agreement (including any addenda attached thereto), the Restrictive Covenant Agreement and the Plan&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">acknowledges and agrees that this Notice, the RSU Agreement (including any addenda attached thereto), the Restrictive Covenant Agreement and the Plan set forth the entire understanding between the Participant and the Company regarding this Award and supersede all prior oral or written agreements, promises and&#47;or representations on that subject with the exception of (i) equity awards previously granted and delivered to the Participant, (ii) any compensation recovery policy that is adopted by the Company or is otherwise required by applicable law or listing standards applicable to the Company, and (iii) any written employment or severance arrangement that would provide for vesting acceleration&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">acknowledges and confirms the Participant&#8217;s consent to receive electronically the Award Agreement, the Plan and any other Plan documents or other related communications that the Company wishes or is required to deliver&#59;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">acknowledges that a copy of the Plan and the related Plan documents were made available to the Participant, and that among such documents were the Plan&#8217;s prospectus which the Participant acknowledges having read&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">agrees that the electronic acceptance of the Award Agreement constitutes a legally binding acceptance of the Award Agreement, and that the electronic acceptance of the Award Agreement shall have the same force and effect as if the Award Agreement was physically signed.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">TRINET GROUP, INC. AMENDED AND RESTATED 2019 EQUITY INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">RESTRICTED STOCK UNIT AWARD AGREEMENT </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">FOR COLLEAGUES</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Participant has been granted an Award (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) of Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) pursuant to the TriNet Group, Inc. Amended and Restated 2019 Equity Incentive Plan (as it may be amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), the Notice of Restricted Stock Unit Award (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and this Restricted Stock Unit Award Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), dated as of the Date of Grant set forth in the Grant Notice for this Award (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). Except as otherwise indicated, any capitalized term used but not defined herein shall have the meaning ascribed to such term in the Plan. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Issuance of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Each RSU shall represent the right to receive one Share upon the vesting of such RSU, as determined in accordance with and subject to the terms of this Agreement, the Plan and the Notice. The number of RSUs is set forth in the Notice.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Vesting Dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Subject to Sections 3 and 4, the Award shall vest on the dates set forth in the Notice.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> 3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Except as otherwise provided for in any employment-related agreement between the Participant and the Company or any Subsidiary or Affiliate, upon a Termination of Service, the Committee, in its sole discretion, shall determine whether and to what extent any unvested RSUs may vest, settle, be paid or forfeited&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> that in the event of a Termination of Service for Cause, the Committee may determine whether and to what extent any vested RSUs may be forfeited.  Absent such exercise of discretion, in the event of the Participant&#8217;s Termination of Service for any reason, any RSUs that are not vested as of the date of such Termination of Service will be forfeited without payment of any consideration to Participant.   For the avoidance of doubt and for purposes of this Award only, Termination of Service will be deemed to occur as of the date the Participant is no longer actively providing services as an Employee or Consultant (except, in certain circumstances at the sole discretion of the Company, to the extent the Participant is on a Company approved leave of absence) and will not be extended by any notice period or &#8220;garden leave&#8221; that may be required contractually or under applicable laws, unless otherwise determined by the Company in its sole discretion.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Notwithstanding the foregoing, in the event of death or Disability, the Award shall fully vest and be distributed as soon as practicable but in no event later than 60 days following the Participant&#8217;s death or Disability.  For this purpose, Disability or Disabled shall mean that the Participant meets the eligibility requirements for receiving benefits under the Employer&#8217;s long term disability plan. In the event the Participant is not eligible to or has elected not to enroll in the Employer&#8217;s long term disability plan, the Participant is deemed Disabled by the Company if the Participant is</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">has lasted or can be expected to last for a continuous period of not less than 12 months. An individual shall not be considered Disabled unless the individual furnishes proof of the existence thereof in such form and manner, and at such times, as the Company may require.  Further, the Company may retain a physician or other third party to assist in determining whether the Participant is Disabled.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  4.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. In the event of a Change in Control, the RSUs will be treated in accordance with Section 12(b) of the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. As a condition precedent to the grant of the Award, the Participant agrees to be subject to the restrictive covenants as set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Restrictive Covenants Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Transfer of RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">    (a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">General Prohibition on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Except as may be permitted by the Committee, neither the Award nor any right under the Award shall be pledged, assignable, alienable, saleable or transferable by the Participant except as provided in this Section 6.  This provision shall not apply to any portion of the Award that has been fully settled and shall not preclude forfeiture of any portion of the Award in accordance with the terms herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   (b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Award may be transferable by will or pursuant to the laws of descent and distribution. In addition, upon receiving written permission from the Board or its duly authorized designee, the Participant may, by delivering written notice to the Company, in a form provided by or otherwise satisfactory to the Company and any broker designated by the Company to effect transactions under the Plan, designate a third party who, in the event of the Participant&#8217;s death, will thereafter be entitled to receive any distribution of Shares or other consideration to which the Participant was entitled at the time of the Participant&#8217;s death pursuant to this Agreement. In the absence of such a designation, the Participant&#8217;s executor or administrator of the Participant&#8217;s estate will be entitled to receive, on behalf of the Participant&#8217;s estate, such Shares or other consideration.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  (c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Certain Trusts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Upon receiving written permission from the Board or its duly authorized designee, the Participant may transfer the Award to a trust if that Participant is considered to be the sole beneficial owner (determined under Section 671 of the U.S. Internal Revenue Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and applicable law) while the Award is held in the trust, provided that the Participant and the trustee enter into transfer and other agreements required by the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Participant shall have no voting rights or any other rights as a stockholder of the Company with respect to the RSUs unless and until the Participant becomes the record owner of the Shares underlying the RSUs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Except as provided in the Notice, if a cash dividend is declared on Shares during the period commencing on the Grant Date and ending on the date on which the Shares underlying the RSUs are distributed to the Participant pursuant to this Agreement, the Committee shall determine, in its sole discretion, whether the Participant will be eligible to receive an amount in cash (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Dividend Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) equal to the dividend that the Participant would have received had the Shares underlying the RSUs been held by the Participant as of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">time at which such dividend was declared. If applicable, each Dividend Equivalent will be paid to the Participant in cash as soon as reasonably practicable (and in no event later than 30 days) after the applicable Vesting Date of the corresponding RSUs. For clarity, no Dividend Equivalent will be paid with respect to any RSUs that are forfeited.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Distribution of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">    (a)  Subject to the provisions of this Agreement, upon the vesting of any of the RSUs, the Company shall deliver to the Participant, as soon as reasonably practicable (and in no event later than 30 days) after the applicable Vesting Date, one Share for each such RSU. Upon the delivery of Shares, such Shares shall be fully assignable, alienable, saleable and transferrable by the Participant&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> that any such assignment, alienation, sale, transfer or other alienation with respect to such Shares shall be in accordance with applicable securities laws and any applicable Company policy.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   (b) Notwithstanding the foregoing, in the event that (i) the Participant is subject to the Company&#8217;s policy permitting certain individuals to sell Shares only during certain &#8220;window&#8221; periods, in effect from time to time or the Participant is otherwise prohibited from selling Shares in the public market and any Shares covered by the Award are scheduled to be delivered on a day (the &#8220;Original Distribution Date&#8221;) that does not occur during an open &#8220;window period&#8221; applicable to the Participant, as determined by the Company in accordance with such policy, or does not occur on a date when the Participant is otherwise permitted to sell Shares on the open market, and (ii) the Company elects not to satisfy its obligations for Tax-Related Items (as defined in Section 10(a) below) by withholding Shares from the Participant&#8217;s distribution, then such Shares will not be delivered on such Original Distribution Date and will instead be delivered on the first business day of the next occurring open &#8220;window period&#8221; applicable to the Participant pursuant to such policy (regardless of whether the Participant is still providing continuous services at such time) or the next business day when the Participant is not prohibited from selling Shares  in the open market, but in no event later than the fifteenth (15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">) day of the third calendar month of the calendar year following the calendar year in which the Shares originally became vested.  The form of such delivery (e.g., a stock certificate or electronic entry evidencing such Shares) will be determined by the Company.  In all cases, the delivery of Shares under this Award is intended to comply with Treasury Regulation Section 1.409A-1(b)(4) and will be construed and administered in such manner.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  10.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Responsibility for Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">     (a)  The Participant acknowledges that, regardless of any action taken by the Company or the Participant&#8217;s employer (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Tax-Related Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) is and remains the Participant&#8217;s responsibility and may exceed the amount actually withheld by the Company or the Employer. The Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including, but not limited to, the grant, vesting or settlement of the Award, the subsequent sale of Shares acquired upon settlement of the Award and the receipt of any dividends and&#47;or Dividend Equivalents&#59; and (ii) do not commit to and are under no obligation to structure the terms of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">    (b) As a condition to the grant, vesting and settlement of the Award, prior to any relevant taxable or tax withholding event, as applicable, the Participant agrees to make adequate arrangements satisfactory to the Company and&#47;or the Employer to satisfy (and will indemnify the Company and any Subsidiary or Affiliate) with respect to any and all Tax-Related Items which arise upon the grant, vesting or settlement of the Award, ownership or disposition of Shares, receipt of dividends, if any, or otherwise in connection with the Award or Shares. In this regard, the Participant authorizes the Company and&#47;or the Employer, or their respective agents, at their discretion, to satisfy any applicable withholding obligations with regard to all Tax-Related Items in the manner determined by the Company and&#47;or the Employer from time to time, which may include&#58; (i) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Company and&#47;or the Employer&#59; (ii) requiring the Participant to remit the aggregate amount of such Tax-Related Items to the Company in full, in cash or by check, bank draft or money order payable to the order of the Company or the Employer&#59; (iii) through a procedure whereby the Participant delivers irrevocable instructions to a broker reasonably acceptable to the Committee to sell Shares obtained upon settlement of the Award and to deliver promptly to the Company an amount of the proceeds of such sale equal to the amount of the Tax-Related Items&#59; (iv) by a &#8220;net settlement&#8221; under which the Company reduces the number of Shares issued on settlement of the Award by the number of Shares with an aggregate fair market value that equals the amount of the Tax-Related Items associated with such settlement&#59; or (v) any other method of withholding determined by the Company and permitted by applicable law. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   (c)  The Participant acknowledges and agrees that, absent an affirmative election otherwise, such Tax-Related Items shall be satisfied through &#8220;net settlement&#8221; as set forth in Section 10(b)(iv).  </font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   (d) Depending on the withholding method, the Company or the Employer may withhold or account for Tax-Related Items by considering applicable statutory withholding rates or other applicable withholding rates, including maximum applicable rates, in which case the Participant will receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent number of Shares. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant is deemed to have been issued the full number of Shares subject to the settled Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">    (e) The Participant agrees to pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if the Participant fails to comply with the Participant&#8217;s obligations in connection with the Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   (f) The Participant further acknowledges and agrees that the Participant is solely responsible for filing all relevant documentation that may be required in relation to the Award or any Tax-Related Items (other than filings or documentation that is the specific obligation of the Company or any Subsidiary or Affiliate pursuant to applicable laws), such as but not limited to personal income tax returns or reporting statements in relation to the grant, vesting or settlement of the Award, the holding of Shares or any bank or brokerage account, the subsequent sale of Shares, and the receipt of any dividends.  The Participant further acknowledges that the Company makes no representations or undertakings regarding the treatment of any Tax-Related Items and does not commit to and is under no obligation to structure the terms or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  The Participant also understands that applicable laws may require varying Share or Restricted Stock Unit valuation methods for purposes of calculating Tax-Related Items, and the Company assumes no responsibility or liability in relation to any such valuation or for any calculation or reporting of income or Tax-Related Items that may be required of the Participant under applicable laws.  Further, if the Participant has become subject to tax in more than one jurisdiction between the date of grant and the date of any relevant taxable event, the Participant acknowledges that the Company or any Subsidiary or Affiliate may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  11. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Not Salary, Pensionable Earnings or Base Pay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> The Participant acknowledges that the Award shall not be included in or deemed to be a part of (a) salary, normal salary or other ordinary compensation, (b) any definition of pensionable or other earnings (however defined) for the purpose of calculating any benefits payable to or on behalf of the Participant under any pension, retirement, termination or dismissal indemnity, severance benefit, retirement indemnity or other benefit arrangement of the Company or any Subsidiary or Affiliate (including the Employer) or (c) any calculation of base pay or regular pay for any purpose.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> 12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Cancellation&#47;Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Participant hereby acknowledges and agrees that the Participant and the Award are subject to the terms and conditions of Section 19 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Cancellation or &#8220;Clawback&#8221; of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">) of the Plan, subject to applicable law</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  13. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Provisions of Plan Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Agreement is subject to all the terms, conditions and provisions of the Plan, including the amendment provisions thereof, and to such rules, regulations and interpretations relating to the Plan as may be adopted by the Committee and as may be in effect from time to time.  The Plan is incorporated herein by reference.  If and to the extent that this Agreement conflicts or is inconsistent with the Plan, the Plan shall control, and this Agreement shall be deemed to be modified accordingly.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  14. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Any notice required or permitted to be given under this Agreement shall be in writing and shall be deemed to have been given when delivered personally or by courier, or sent by certified or registered mail, postage prepaid, return receipt requested, duly addressed to the party concerned at the address indicated below or to such changed address as such party may subsequently by similar process give notice of&#58;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If to the Company&#58;</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">TriNet Group, Inc.</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">One Park Place</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Suite 600</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Dublin, CA 94568</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Attention&#58; Chief Legal Officer</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If to the Participant, to the address of the Participant on file with the Company.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  15. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">No Right to Continued Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The grant of the Award shall not be construed as giving the Participant the right to be retained in the employ of, or to continue to provide services to, the Company or any Subsidiary or Affiliate (including the Employer). Nothing in the Plan or in this Agreement shall interfere with or limit in any way the right of the Company or a Subsidiary or Affiliate thereof to terminate the Participant&#8217;s service at any time, subject to applicable laws.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  16. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">No Right to Future Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> In accepting the Award, the Participant acknowledges that the Plan is established voluntarily by the Company, is discretionary in nature, and may be modified, amended, suspended or terminated by the Company at any time.  Any Award granted under the Plan shall be a one-time Award that does not constitute a promise of future grants. The Company, in its sole discretion, maintains the right to make available future grants under the Plan. The grant of RSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, other Awards or benefits in lieu of RSUs, even if RSUs have been granted repeatedly in the past, and all decisions with respect to future grants of RSUs or other Awards, if any, will be at the sole discretion of the Company.  In addition, the Participant&#8217;s participation in the Plan is voluntary, and the RSUs and the Shares subject to the RSUs are extraordinary items that do not constitute regular compensation for services rendered to the Company or any Subsidiary or Affiliate and are outside the scope of the Participant&#8217;s employment contract, if any.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  17. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Restrictive Legends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The shares issued under the Award will be endorsed with appropriate legends as determined by the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> 18. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> This Agreement, the Plan, the Notice and any other agreements, schedules, addenda, appendices, exhibits and other documents referred to herein or therein constitute the entire agreement and understanding between the parties in respect of the subject matter hereof and supersede all prior and contemporaneous arrangements, agreements and understandings, both oral and written, whether in term sheets, presentations or otherwise, between the parties with respect to the subject matter hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  20. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> If any provision of this Agreement is or becomes or is deemed to be invalid, illegal or unenforceable in any jurisdiction, or would disqualify the Plan or this Agreement under any law deemed applicable by the Board, such provision shall be construed or deemed amended to conform to applicable laws, or if it cannot be so construed or deemed amended without, in the determination of the Board, materially altering the intent of this Agreement, such provision shall be stricken as to such jurisdiction, and the remainder of this Agreement shall remain in full force and effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  21. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Amendment&#59; Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> No amendment or modification of any provision of this Agreement that has a material adverse effect on the Participant shall be effective unless signed in writing by or on behalf of the Company and the Participant&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> that the Company may amend or modify this Agreement without the Participant&#8217;s consent in accordance with the provisions of the Plan or as otherwise set forth in this Agreement. No waiver of any breach or condition of this Agreement shall be deemed to be a waiver of any other or subsequent breach or condition, whether of like or different nature. Any amendment or modification of or to any provision of this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Agreement, or any waiver of any provision of this Agreement, shall be effective only in the specific instance and for the specific purpose for which such amendment, modification or waiver is made or given.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  21. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Neither this Agreement nor any right, remedy, obligation or liability arising hereunder or by reason hereof shall be assignable by the Participant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  22. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Successors and Assigns&#59; No Third-Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Agreement shall inure to the benefit of and be binding upon the Company and the Participant and their respective heirs, successors, legal representatives and permitted assigns. Nothing in this Agreement, express or implied, is intended to confer on any Person other than the Company and the Participant, and their respective heirs, successors, legal representatives and permitted assigns, any rights, remedies, obligations or liabilities under or by reason of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  23. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">No Advice Regarding Grant&#59; Opportunity to Obtain Advice of Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant&#8217;s participation in the Plan, or the Participant&#8217;s acquisition or sale of the underlying Shares. The Participant is hereby advised to consult with the Participant&#8217;s own personal tax, financial and&#47;or legal advisors regarding the Tax-Related Items arising in connection with the Award.  By accepting the Award, the Participant acknowledges and agrees that he or she has done so or knowingly and voluntarily declined to do so.  The Participant acknowledges and agrees that he or she has reviewed the Agreement, the Notice and the Plan in their entirety, including any addenda or other documents referred to herein or therein, and have had the opportunity to obtain the advice of counsel prior to executing and accepting the Award, and fully understood the provisions of the Award.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> 24. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Dispute Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">All controversies and claims arising out of or relating to this Agreement, or the breach hereof, shall be settled by the Company&#8217;s or the Employer&#8217;s mandatory dispute resolution procedures, if any, as may be in effect from time to time with respect to matters arising out of or relating to the Participant&#8217;s employment with the Company or the Employer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  25. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Governing Law&#59; Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">All matters arising out of or relating to this Agreement and the transactions contemplated hereby, including its validity, interpretation, construction, performance and enforcement, shall be governed by and construed in accordance with the internal laws of the State of Delaware, without giving effect to its principles of conflict of laws. Notwithstanding any arbitration agreement that otherwise may exist between the Participant and the Company, the Participant and the Company agree that, in the event of any dispute arising under this Agreement, any such dispute is not subject to arbitration, and the Participant and the Company instead hereby submit and consent to the exclusive jurisdiction of the State of Delaware and agree that any such litigation shall be conducted only in the courts of Delaware or the federal courts of the United States located in Delaware and no other courts.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  26. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Imposition of other Requirements and Participant Undertaking</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> The Company reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on the Award and on any Shares to be issued upon settlement of the Award, or take any other action, to the extent the Company determines it is necessary or advisable for legal or administrative reasons.  The Participant agrees to take whatever additional action and execute whatever </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">additional documents the Company may deem necessary or advisable to accomplish the foregoing or to carry out or give effect to any of the obligations or restrictions imposed on either the Participant or the RSU pursuant to this Agreement. Furthermore, the Participant acknowledges that the applicable laws of the country in which the Participant is residing or working at the time of grant, vesting and settlement of the RSUs or the ownership or sale of Shares received pursuant to the RSUs (including any rules or regulations governing securities, foreign exchange, tax, labor, or other matters) may subject the Participant to additional procedural or regulatory requirements that the Participant is and will be solely responsible for and must fulfill.  Such requirements may be outlined in but are not limited to the Country-Specific Addendum (the &#8220;Addendum&#8221;) attached hereto, which forms part of this Agreement.  Notwithstanding any provision herein, the Participant&#8217;s participation in the Plan shall be subject to any applicable special terms and conditions or disclosures as set forth in the Addendum.  The Participant also understands and agrees that if the Participant works, resides, moves to, or otherwise is or becomes subject to applicable laws or company policies of another jurisdiction at any time, certain country-specific notices, disclaimers and&#47;or terms and conditions may apply to the Participant as from the date of grant, unless otherwise determined by the Company in its sole discretion.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  27. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">References</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">References herein to rights and obligations of the Participant shall apply, where appropriate, to the Participant&#8217;s legal representative or estate without regard to whether specific reference to such legal representative or estate is contained in a particular provision of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> 28. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant&#8217;s Personal Data (as described below) by and among, as applicable, the Company, any Subsidiary, Affiliate or third parties as may be selected by the Company for the exclusive purpose of implementing, administering and managing the Participant&#8217;s participation in the Plan.  The Participant understands that refusal or withdrawal of consent will affect the Participant&#8217;s ability to participate in the Plan&#59; without providing consent, the Participant will not be able to participate in the Plan or realize benefits (if any) from the RSUs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Participant understands that the Company and any Subsidiary, Affiliate or designated third parties may hold personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company or any Subsidiary or Affiliate, details of all RSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Participant&#8217;s favor (&#8220;Personal Data&#8221;).  The Participant understands that Personal Data may be transferred to any Subsidiary, Affiliate or third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the United States, the Participant&#8217;s country (if different than the United States), or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than the Participant&#8217;s country.  In particular, the Company may transfer Personal Data to the broker or stock plan administrator assisting with the Plan, to its legal counsel and tax&#47;accounting advisor, and to the affiliate or entity that is the Participant&#8217;s employer and its payroll provider.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Participant should also refer to any data privacy policy implemented by the Company (which will be available to the Participant separately and may be updated from time to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">time) for more information regarding the collection, use, storage, and transfer of the Participant&#8217;s Personal Data.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  29. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Foreign Exchange Fluctuations and Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Participant understands and agrees that, if required by the Company or applicable laws, any cross-border funds transfers in connection with the RSUs (including proceeds from the sale of Shares or receipt of any dividends) must be made through a locally authorized financial institution or registered foreign exchange agency and may require the Participant to provide to such entity certain information regarding the transaction.  Moreover, the Participant understands and agrees that the future value of the underlying Shares is unknown and cannot be predicted with certainty and may decrease in value.  The Participant understands that neither the Company nor any Subsidiary or Affiliate is responsible for any foreign exchange fluctuation between local currency and the United States Dollar or the selection by the Company or any Subsidiary or Affiliate in its sole discretion of an applicable foreign currency exchange rate that may affect the value of the RSUs (or the calculation of income or Tax-Related Items thereunder).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  30. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Communications and Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Company may, in its sole discretion, decide to deliver any documents related to the Participant&#8217;s current or future participation in the Plan, shares, or any other Company-related documents by electronic means.  By accepting this Agreement, whether electronically or otherwise, the Participant hereby consents to receive such documents by electronic delivery and agree to participate in the Plan through an online or electronic system established and maintained by the Company or a third party designated by the Company, including but not limited to the use of electronic signatures or click-through electronic acceptance of terms and conditions.  To the extent the Participant has been provided with a copy of this Agreement, the Plan, or any other documents relating to the RSUs in a language other than English, the English language documents will prevail in case of any ambiguities or divergences as a result of translation.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Country-Specific Addendum</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Addendum includes additional country-specific notices, disclaimers, and&#47;or terms and conditions that apply to individuals who work or reside in the countries listed below and that may be material to the Participant&#8217;s participation in the Plan.  Such notices, disclaimers, and&#47;or terms and conditions may also apply, as from the date of grant, if the Participant moves to or otherwise is or becomes subject to the applicable laws or Company policies of the country listed.  However, because foreign exchange regulations and other local laws are subject to frequent change, the Participant is advised to seek advice from his or her own personal legal and tax advisor prior to accepting an RSU or holding or selling Shares acquired under the Plan.  The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant&#8217;s acceptance of the RSUs or participation in the Plan.  Unless otherwise noted below, capitalized terms shall have the same meaning assigned to them under the Plan and the Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement. This Addendum forms part of the Restricted Stock Unit Award Agreement and should be read in conjunction with the Restricted Stock Unit Award Agreement and the Plan. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Securities Law Notice&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Unless otherwise noted, neither the Company nor the Shares are registered with any local stock exchange or under the control of any local securities regulator outside the United States.  The Restricted Stock Unit Award Agreement (of which this Addendum is a part), the Plan, and any other communications or materials that you may receive regarding participation in the Plan do not constitute advertising or an offering of securities outside the United States, and the issuance of securities described in any Plan-related documents is not intended for public offering or circulation in the Participant&#8217;s jurisdiction.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:18.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.804%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Canada</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Securities Law Notice. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The security represented by the RSUs was issued pursuant to an exemption from the prospectus requirements of applicable securities legislation in Canada. The Participant acknowledges that, as long as the Company is not a reporting issuer in any jurisdiction in Canada, the RSUs and the underlying Shares will be subject to an indefinite hold period in Canada and subject to restrictions on their transfer in Canada. Subject to the terms and conditions of the Agreement and applicable securities laws, the Participant is permitted to sell Shares acquired through the designated broker appointed under the Plan, assuming the sale of such Shares takes place outside Canad</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Settlement in Shares Only. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Notwithstanding any discretion in the Plan to the contrary, settlement of the RSUs shall only be made in Shares issued by the Company from treasury and not, in whole or in part, in the form of cash (other than as explicitly consented to by you in Section 10 of the Agreement for tax withholding and payment purposes) or other consideration.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Employee Tax Treatment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">For Canadian federal income tax purposes, the RSUs are intended to be treated as an agreement by the Company to sell or issue Shares to the employee and, as such, is intended to be subject to the rules in section 7 of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Income Tax Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> (Canada). Under those rules, the employee will be considered to have received an employment benefit at the time of settlement of the vested RSUs equal to the full value of the Shares received, which amount will be taxed as employment income and will be subject to withholding at source</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Foreign Ownership Reporting. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If the Participant is a Canadian resident, his or her ownership of certain foreign property (including shares of foreign corporations) in excess of $100,000 may be subject to ongoing annual reporting obligations. The Participant should please refer to CRA</font><font style="color:#0563c1;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Form T113</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5 (Foreign Income Verification Statement) and consult their tax advisor for further details</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Quebec&#58; Consent to Receive Information in English. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The following applies if the Participant is a resident of Quebec&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The parties acknowledge that it is their express wish that this Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Les parties reconnaissent avoir exig&#233; la redaction en anglais de cette convention, ainsi que de tous documents ex&#233;cut&#233;s, avis donn&#233;s et procedures judiciaries intent&#233;es, directement ou indirectement, relativement &#224; la pr&#233;sente convention.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:18.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">India</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> The Participant understands that he or she must repatriate to India and convert to local currency any proceeds from the sale of Shares acquired under the Plan within 90 days of receipt and any dividends received in relation to the Shares within 60 days of receipt. The Participant will receive a foreign inward remittance certificate (&#8220;FIRC&#8221;) from the bank where the Participant deposits the foreign currency. The Participant should maintain the FIRC as evidence of the repatriation of funds in case the Reserve Bank of India, the Company, or any Subsidiary or Affiliate requests proof of repatriati</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Share Valuation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> The amount of the Award subject to tax, including for reporting and withholding, will partially depend upon a valuation that the Company will obtain from a Category I Merchant Banker in India. The Company has no responsibility or obligation to obtain the most favorable valuation possible nor obtain valuations more frequently than required under Indian tax law.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:107%">Appendix A</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">RESTRICTIVE COVENANT AGREEMENT</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            As a material condition to the grant of the Award provided for under the Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement  by and between the grant recipient (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and TriNet Group, Inc. (collectively with its Subsidiaries and Affiliates, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">TriNet</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), Employee enters into and agrees to be bound by this Restrictive Covenant Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">RCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), made by and between Employee and TriNet effective as of the date Employee accepts the Award.  Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to them in the Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement or the TriNet Group, Inc. Amended and Restated 2019 Equity Incentive Plan.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%;padding-left:27.36pt">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">    1.1  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Non-Disclosure. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Employee agrees that during and after employment with TriNet, Employee will not (i) directly or indirectly disclose to any person or entity, or use, except for the sole benefit of TriNet, any of TriNet&#8217;s confidential or proprietary information or trade secrets (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Company Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) or (ii) publish or submit for publication, any article or book relating to TriNet, its development projects, or other aspects of TriNet business. By way of illustration and not limitation, Company Information shall include TriNet&#8217;s trade secrets&#59; research and development plans or projects&#59; data and reports&#59; computer materials such as software programs, instructions, source and object code, and printouts&#59; products prospective products, inventions, developments, and discoveries&#59; data compilations, development databases&#59; business improvements&#59; business plans (whether pursued or not)&#59; ideas&#59; budgets&#59; unpublished financial statements&#59; licenses&#59; pricing strategy and cost data&#59; information regarding the skills and compensation of any employees, non-employee directors or consultants of TriNet (other than Employee)&#59; the personally identifying and protected health information of any employee, non-employee director or consultant of TriNet (other than Employee), including worksite employees of TriNet customers&#59; lists of current and potential customers of TriNet&#59; information about customers&#8217; purchasing history, pricing, preferences and profitability&#59; strategies, forecasts and other marketing information and techniques&#59; employment and recruiting strategies and processes&#59; sales practices, strategies, methods, forecasts, compensation plans, and other sales information&#59; investor information&#59; and the identities of TriNet&#8217;s suppliers, vendors,  and contractors, and all information about those supplier, vendor and contractor relationships such as contact person(s), pricing and other terms.  The definition of Company Information shall include both &#8220;know-how&#8221; (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">i.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">., information about what works well) and &#8220;negative know-how&#8221; (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">i.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">., information about what does not work well).  Employee further acknowledges and agrees that all Company Information is confidential and proprietary and shall remain the exclusive property of TriNet.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">                     1.1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">    Wisconsin.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If Employee last worked for TriNet in Wisconsin, the restrictions set forth in Section 1.1 shall apply during Employee&#8217;s employment with TriNet and for eighteen (18) months after Employee&#8217;s employment with TriNet ends.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">      1.2  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Improper Use of Trade Secret Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  In furtherance of Employee&#8217;s promises in this Section 1, Employee agrees that during Employee&#8217;s employment and for a period of one year following termination of employment with TriNet, Employee will not, for Employee&#8217;s own benefit or for the benefit of a competitor of TriNet, use TriNet&#8217;s trade secrets, or use Employee&#8217;s knowledge of TriNet&#8217;s trade secret customer information, directly or indirectly, to (i) identify TriNet customers for solicitation&#59; (ii) facilitate the solicitation of TriNet&#8217;s customers&#59; (iii) target any employee, non-employee director(s) or consultant(s) of TriNet for solicitation or recruitment to discontinue, in whole or in part, his&#47;her employment or other relationship with TriNet, or using trade secrets to facilitate any such solicitation or recruitment&#59; or (iv) otherwise compete unfairly with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Permitted Disclosures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Nothing in this RCA limits Employee&#8217;s ability to communicate directly with and provide information, including documents, not otherwise protected from disclosure by any applicable law or privilege, to the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) or any other federal, provincial, state or local governmental agency or commission or self-regulatory organization regarding possible legal violations, without disclosure to TriNet.  TriNet may not retaliate against Employee for any of these activities, and nothing in the RCA requires Employee to waive any monetary award or other payment to which Employee might become entitled from the SEC or any other government agency or self-regulatory organization as a result of such communication.  Nothing contained in this Agreement restricts or limits Employee&#8217;s right to discuss or disclose information about unlawful acts in the workplace, at work-related events, or between TriNet employees or TriNet and Employee, such as harassment, discrimination, retaliation, sexual assault, a wage and hour violation, or any other conduct that Employee has reason to believe is unlawful or that is otherwise recognized as against a clear mandate of public policy, nor does this Agreement prohibit Employee from discussing Employee&#8217;s employment or reporting possible violations of law or regulation with the Equal Employment Opportunity Commission, United States Department of Labor, the Occupational Safety and Health Administration, the National Labor Relations Board, the Securities and Exchange Commission, or other federal government agency or state or local government agency. This Agreement does not prohibit Employee from discussing the terms and conditions of Employee&#8217;s employment with others to the extent expressly permitted by Section 7 of the National Labor Relations Act or to the extent that such disclosure is protected under the applicable provisions of law or regulation, including but not limited to &#8220;whistleblower&#8221; statutes or other similar provisions that protect such disclosure.  Nor does this Agreement require Employee not to disclose or discuss conduct or the existence of a settlement involving conduct relating to a dispute&#58; (1) involving a nonconsensual sexual act or sexual contact, as such terms are defined in section 2246 of title 18, United States Code, or similar applicable tribal or state law&#59; or (2) relating to conduct that is alleged to constitute sexual harassment under applicable federal, tribal, or state law. Further, pursuant to the Defend Trade Secrets Act of 2016 or applicable law, Employee shall not have criminal or civil liability under any federal, provincial or state trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a federal, provincial, state, or local government official, either directly or indirectly, or to an attorney and (ii) solely for the purpose of reporting or investigating a suspected violation of law&#59; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  In addition and without limiting the preceding sentence, if Employee files a lawsuit for retaliation by TriNet for reporting a suspected violation of law, Employee may disclose the trade secret to Employee&#8217;s attorney and may use the trade secret information in the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">court proceeding, if Employee (X) files any document containing the trade secret under seal and (Y) does not disclose the trade secret, except pursuant to court order.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Notice of Resignation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> In the event Employee resigns Employee&#8217;s employment with TriNet and is immediately prior to such resignation employed (1) in any position in the Field Sales, Virtual Sales, and Channel and Partnership Sales departments, or (2) in any other part of TriNet with a job code of Executive Director or above, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">excluding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">any &#8220;officers&#8221; of the Company (as such term is defined by Section 16 of the Securities Exchange Act of 1934, as amended) to help effectuate and ensure an orderly transition </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Employee shall provide TriNet with thirty (30) days&#8217; notice of Employee&#8217;s resignation from TriNet</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> as more specifically set forth in Sub-sections 3.1 through 3.4, below.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            3.1.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Thirty (30) Days&#8217; Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Employee will provide thirty days&#8217; notice of Employee&#8217;s resignation in writing submitted to Employee&#8217;s direct manager and the Human Resources Department via email to MYHR&#64;trinet.com, and such written notice shall include a disclosure and identification of any new position, affiliation and&#47;or employment Employee has accepted, intends to accept or is considering accepting upon expiration of the Notice Period. (The first thirty (30) days following submission of a resignation in compliance with this RCA as outlined below shall be the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Notice Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.&#8221;) </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            3.2.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Duties and Cooperation During Notice Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. During the Notice Period Employee&#8217;s manager may ask Employee to take steps to help transition responsibility for ongoing projects and&#47;or other job duties.  Employee agrees to perform these duties and tasks, as Employee&#8217;s manager in the manager&#8217;s sole discretion may direct, including without limitation any or all of the following&#58;  (i) organize files and notes of any projects for transition&#59; (ii) meet with Employee&#8217;s managers or their designee to review files and other data to help ensure that TriNet personnel are aware of and understand any files, projects or other business related data&#59; (iii) meet with Employee&#8217;s manager or the manager&#8217;s designee to review the status of any projects, work, clients or personnel for which Employee was assigned responsibility, in order to help ensure that business needs may be seamlessly transitioned to and serviced by other TriNet personnel&#59; (iv) otherwise being available to TriNet, as requested by Employee&#8217;s managers, to provide reasonable assistance to effectuate an orderly transition of knowledge, files, projects, data, client service or personnel responsibilities, and any other job duties, prior to Employee&#8217;s last day of employment.  The foregoing list is neither intended to be an exhaustive list of the transition-related tasks Employee may be required to perform, nor is it a promise that TriNet will have Employee engage in any or all of the listed tasks.  There may be times during the Notice Period when TriNet is preparing for the transition in a way that does not involve Employee&#8217;s active engagement, and as such TriNet at its sole discretion may instruct Employee not to work or enter TriNet&#8217;s premises on some or all days of the Notice Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Conduct During Notice Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. During the Notice Period, Employee will be a TriNet employee, will remain on TriNet&#8217;s payroll, will receive the same base rate of pay, and will continue to be eligible for all employee benefits just as in the period prior to Employee&#8217;s giving Notice of Resignation to TriNet. Employee&#8217;s primary job duties during the Notice Period will involve assisting TriNet to effectuate an orderly transition of duties to other TriNet personnel as assigned by Employee&#8217;s manager. During the Notice Period, Employee shall&#58; (i) not discuss or communicate about Employee&#8217;s impending departure from TriNet with clients or others who are not employees of TriNet unless authorized in writing to do so by Employee&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">manager&#59; (ii) not take, remove or transfer any TriNet data, records or information off the premises of any TriNet office or facility&#59; (iii) access TriNet systems only with express permission of Employee&#8217;s manager (Employee understands that such accessibility may be terminated during the Notice Period)&#59; (iv) return to Employee&#8217;s TriNet manager, within one business day of tendering Employee&#8217;s notice of resignation, all files, data and information relating to TriNet clients or business which Employee may have had off premises during the course of Employee&#8217;s employment&#59; (v) not use any social networking system or function to update any clients about Employee&#8217;s employment status with TriNet and&#47;or any impending change of such status&#59; and (vi) if Employee has had remote access to TriNet computer systems or if Employee has ever used a non-TriNet issued computer or electronic device for work, Employee will, upon TriNet&#8217;s request, make such personal computer(s) or other electronic devices available to TriNet and&#47;or its computer forensic experts for imaging and searching to verify that all TriNet client data and any other non-public information has been removed. Employee understands and agrees that a core purpose of the Notice Period is to enable the orderly transition of knowledge, files, data and client responsibility to other TriNet employees, and accordingly Employee understands and agrees that TriNet is free to and may elect to engage in a variety of transition-related activities, including but not limited to notifying clients of Employee&#8217;s intent to leave TriNet, informing clients of the identity of other TriNet employees being assigned to service their accounts, introducing the clients to other TriNet personnel, and&#47;or holding meetings with clients that may or may not include Employee, as Employee&#8217;s manager may elect. Employee agrees and understands that during the Notice Period, Employee owes TriNet an unmitigated duty of loyalty, and that Employee shall do nothing during the Notice Period that Employee intends or reasonably expects to further Employee&#8217;s personal interests or the interests of Employee&#8217;s new employer to the actual or potential detriment of TriNet.    </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.4.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">At Will (United States Employees)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Employees in the United States are employed by TriNet on an at-will basis only. Employee understands and agrees that nothing in the Restricted Stock Unit Award Agreement or this RCA changes the Employee&#8217;s &#34;at will&#34; employment status, and that TriNet may end the employment relationship at any time, with or without notice, for any reason or no reason at all. Likewise, Employee is free to end the employment relationship at any time, subject only to Employee&#8217;s obligation to provide notice in the manner described herein. Without limitation of the foregoing, Employee understands that TriNet retains the right in its absolute and sole discretion to terminate Employee&#8217;s employment after receiving notice from Employee pursuant to this RCA, at which point Employee&#8217;s employment and the Notice Period will come to an end (including any associated obligation by TriNet to continue Employee&#8217;s salary and benefits during the Notice Period), but in no event shall TriNet terminate Employee&#8217;s employment or the Notice Period sooner than two (2) weeks after the date on which Employee gives notice of resignation pursuant to Section 3 (provided, however, that TriNet retains the right as set forth above to determine what duties, if any, will be performed  during such two-week period).</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.4.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Canada</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The foregoing paragraph 3.4 shall not apply to Canada employees,  and TriNet shall not terminate the Employee&#8217;s employment or the Notice Period sooner than the lesser of only&#58; (i) the minimum period of notice prescribed by applicable employment standards legislation, and (ii) two (2) weeks after the date on which Employee gives notice of resignation pursuant to section 3.  TriNet may provide payment in lieu of such notice at its discretion.  In no event will Employee receive less than the minimum requirements prescribed by applicable employment standards legislation and, should such legislation provide for any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">minimum benefit or entitlement in excess of the payment or benefits provided pursuant to this paragraph, Employee will receive such greater minimum entitlement and nothing more.   </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.4.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">India</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This Section 3.4.2 shall apply to India employees in lieu of the first paragraph of Section 3.4. Subject to the Notice Period requirement above in Section 3.3, either party may terminate the employment without cause by giving prior written notice to the other party as specified in the Employee&#8217;s applicable offer letter from the Company or its Subsidiary or Affiliate that employs Employee (&#8220;TriNet&#8221;), or payment in lieu of such notice by TriNet.  Further, TriNet reserves the right to terminate Employee&#8217;s employment for cause without giving any prior notice or payment in lieu of notice in accordance with its internal policies and the offer letter.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 4.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Non-Solicitation. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Customer Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Employee will not, directly or indirectly, during employment with TriNet and for twelve (12) months following termination or separation of such employment, solicit or attempt to solicit any of TriNet&#8217;s customers or business or patronage of such customers, either for themselves or on behalf of any other person, partnership, corporation, or other entity for the purpose of (i) providing or selling services, goods or products that are the same as or similar to the kinds or types of services, goods or products being provided or sold by TriNet, or (ii) entering into or seeking to enter into any contract or other arrangement with any such entity for the performance or sale of services or goods and products of a nature being provided or sold by TriNet. Employee understands that Employee&#8217;s agreement &#8220;not to solicit&#8221; as set forth in this Section 4.1 means that Employee will not, directly or indirectly, initiate any contact or communication with any entity that, at the time, has a contractual relationship with TriNet for the purpose of soliciting, inviting, encouraging, recommending or requesting any such entity to do business with Employee and&#47;or any other person or entity.  This restriction is limited to (a) customers Employee serviced, solicited or interacted with at any time during the 24 months immediately preceding termination of employment with TriNet&#59; (b) customers serviced or solicited by other TriNet employees whom Employee directly supervised during the 24 months immediately preceding termination of employment with TriNet&#59; and (c) customers about whom Employee had access to Confidential Information during the 24 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> 4.1.1.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Alabama.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Sub-section 4.1, above, does not apply if the state in which Employee last worked for TriNet was Alabama, in which case Employee will not directly or indirectly, during employment with TriNet and for twelve (12) months following termination or separation of such employment for any reason, solicit any of TriNet&#8217;s current customers, either for Employee&#8217;s own benefit or advantage or on behalf of any other person, partnership, corporation, or other entity, so long as TriNet carries on a like business. This restriction is limited to (a) current customers Employee serviced, solicited or interacted with at any time during the 24 months immediately preceding termination of employment with TriNet&#59; (b) current customers serviced or solicited by other TriNet employees whom Employee directly supervised during the 24 months immediately preceding termination of employment with TriNet&#59; and (c) current customers about whom Employee had access to Confidential Information during the 24 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">California &#38; North Dakota</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.1, above, does not apply if the state in which Employee primarily resides or primarily works for TriNet in California or North Dakota, provided, however, that with respect to Notice of Resignation and Non-Solicitation of customers Employee nevertheless is bound by the terms of Sections 3 and 1.2 above.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. If at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in Colorado while working for TriNet, see Sub-section 6.1 below for important limitations and acknowledgments relating to the restrictions contained in the above Sub-section 4.1.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.4.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Illinois</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Subsection 4.1, above, does not apply if the state in which Employee last worked for TriNet was Illinois unless, as of the time of execution of the Restricted Stock Unit Award Agreement, Employee&#8217;s actual or expected annualized rate of earnings with TriNet exceed Forty-five thousand dollars ($45,000) per year (or such other amount established by existing statutory terms or subsequent statutory modifications).    </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            4.1.5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Nebraska.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Sub-section 4.1 does not apply if the state in which Employee last worked for TriNet was Nebraska, in which case Employee will not, during employment with TriNet and for twelve (12) months following termination or separation of employment, solicit any TriNet current customers with which Employee actually did business and had personal contact during the 18 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.6.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Oklahoma.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Sub-section 4.1 does not apply if the state in which Employee last worked for TriNet was Oklahoma, in which case Employee will not, during employment with TriNet and for twelve (12) months following termination or separation of employment for any reason, directly solicit TriNet&#8217;s established customers or the business or patronage of such established customers either for Employee&#8217;s own purposes or on behalf of any other person, partnership, corporation, or other entity. This restriction on direct solicitation of established customers is further limited to (a) established customers that Employee serviced, solicited, or interacted with at any time during the 24 months immediately preceding Employee&#8217;s termination of employment with TriNet&#59; and (b) established customers serviced or solicited by other TriNet employees whom Employee supervised during the 24 months immediately preceding Employee&#8217;s termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.7.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">South Dakota</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. If the state in which Employee last worked for TriNet was South Dakota, enforcement of the restrictions in Section 4.1 will be limited to the geographic area or areas for which Employee was responsible at any time during the twelve (12) months immediately preceding Employee&#8217;s termination of employment with TriNet.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Employee Non-Solicitation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Employee will not, directly or indirectly, during employment with TriNet and for twelve (12) months following termination or separation of employment, solicit or recruit any TriNet employee(s), non-employee director(s) or consultant(s) of TriNet to accept a position with another company or entity, nor otherwise encourage or induce any TriNet employee, non-employee director or consultant to terminate their employment or affiliation with TriNet. This restriction applies only to (a) employees Employee supervised at any time during the 24 months immediately preceding termination of employment with TriNet, (b) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">employees with whom Employee worked in the same office at any time during the 24 months immediately preceding termination of employment with TriNet, and (c) employees with whom Employee otherwise had material contact at any time during the 24 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Alabama</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was Alabama, in which case Employee will not directly or indirectly, during employment with TriNet and for twelve (12) months following termination or separation of employment, hire or employ any agent, servant or employee of TriNet who holds a position uniquely essential to the management, organization, or service of the business of TriNet.  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">California</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee primarily resides or primarily works for TriNet is California, provided, however, that with respect to Non-Solicitation of employees, Employee nevertheless is bound by the terms of Section 1.2 above.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in Colorado while working for TriNet, in which case Employee will not solicit, directly or indirectly, any TriNet employee(s) to leave his&#47;her employment with TriNet. This restriction applies only to (a) employees Employee supervised at any time during the 24 months immediately preceding termination of employment with TriNet, (b) employees with whom Employee worked in the same office at any time during the 24 months immediately preceding termination of employment with TriNet, and (c) employees with whom Employee otherwise had material contact at any time during the 24 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  4.2.4.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Illinois</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was Illinois unless, as of the time of execution of the Restricted Stock Unit Award Agreement, Employee&#8217;s actual or expected annualized rate of earnings with TriNet exceeds forty-five thousand dollars ($45,000) per year (or such other amount established by existing statutory terms or subsequent statutory modifications).</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Nebraska</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was Nebraska, in which case Employee will not, during employment with TriNet and for twelve (12) months following termination or separation of employment, solicit any TriNet current employee with whom Employee had personal contact during the 18 months immediately preceding termination of employment with TriNet. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.6.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">North Dakota</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was North Dakota, in which case Employee will not, during employment with TriNet and for twelve (12) months following the end of Employee&#8217;s employment with TriNet, solicit an employee of TriNet to leave TriNet&#8217;s employment.  This restriction is limited to employees of TriNet with whom Employee had business-related contact or dealings.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Oklahoma</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was Oklahoma, in which case, during employment and for a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">period of twelve (12) months following the end of Employee&#8217;s employment with TriNet, Employee shall not, directly or indirectly, actively or inactively, solicit any employees or independent contractors of TriNet to become employees or independent contractors of another person or business.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. During Employee&#8217;s employment with TriNet, and for a period of twelve (12) months immediately following termination or separation of such employment for any reason, Employee will not, directly or indirectly, perform on behalf of a competitor the same or similar job duties that Employee performed in Employee&#8217;s last twelve (12) months of employment with TriNet. This restriction will only apply in the geographic territory for which Employee had responsibility in Employee&#8217;s last twelve (12) months of employment with TriNet. Additionally, this restriction will only apply to the performance of job duties competitive with a segment or business line of TriNet&#8217;s business in which Employee worked in his&#47;her last twelve (12) months of employment with TriNet. Employee has the right to consult with Employee&#8217;s counsel prior to accepting the Restricted Stock Unit Award Agreement containing this RCA.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Notwithstanding the foregoing, where applicable, this Section 5 will apply only to the extent permissible under (i) the ABA Model Rules of Professional Conduct&#8217;s provisions regarding restrictions on the right to practice law, and&#47;or (ii) any applicable state counterpart similarly addressing restrictions on the right to practice law. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">California, Oklahoma, Minnesota, Nebraska, North Dakota</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Section 5, above, does not apply if the state in which Employee last worked for TriNet was California, Oklahoma, Minnesota, Nebraska or North Dakota.  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in Colorado while working for TriNet, see Sub-section 6.1 below for important limitations and acknowledgments relating to the restrictions contained in the above Section 5.  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Illinois.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Section 5, above, does not apply if the state in which Employee last worked for TriNet was Illinois unless, as of the time of execution of the Restricted Stock Unit Award Agreement, Employee&#8217;s actual or expected annualized rate of earnings with TriNet exceeds seventy-five thousand dollars ($75,000) per year (or such other amount established by existing statutory terms or subsequent statutory modifications).</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Massachusetts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If Employee is, and has been for at least 30 days immediately preceding Employee&#8217;s cessation of employment, a resident of or employed in Massachusetts at the time of Employee&#8217;s termination of employment, then Employee hereby agrees that Employee&#8217;s acceptance of the Award identified in the Restricted Stock Unit Award Agreement, and Employee&#8217;s enjoyment of the financial opportunities flowing from such participation, provide Employee with a valuable investment opportunity which constitutes other mutually agreed consideration supporting Employee&#8217;s agreement to abide by the restrictions contained herein for purposes of compliance with Massachusetts law relating to non-competition agreements.    </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">The restrictions contained in this Section 5 will not apply in the event Employee is (i) laid off, or (ii) involuntarily terminated by TriNet without Cause. In the event of a termination for Cause (as defined below), however, this Section 5 shall be in full force and effect to the same extent as it would if Employee resigned voluntarily.  The definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:103%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8221; means any of the following&#58; (i) an unsatisfactory level of performance&#59; (ii) a violation of any legal or contractual obligation to TriNet&#59; (iii) non-compliance with TriNet policies or procedures&#59; (iv) substantiated violation of the TriNet Code of Business Conduct and Ethics&#59; (v) the conviction of a felony involving fraud or dishonesty directed against TriNet&#59; or (vi) any willful act or failure to act that adversely affects the business of TriNet in any material respect. For purposes of this definition, &#8220;unsatisfactory level of performance&#8221; means a serious or repeated performance failure, including, without limitation, serious conduct, behavior, or attendance failures that are subject to formal corrective action up to and including termination of employment. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Maine.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If Employee last worked for TriNet in Maine, then Employee acknowledges and agrees that Employee received a copy of this RCA at least three business days before Employee was required to sign the Restricted Stock Unit Award Agreement.  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Oregon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If Employee last worked for TriNet in Oregon and entered the Restricted Stock Unit Award Agreement after the commencement of employment, then Employee hereby agrees that Employee&#8217;s acceptance of the Award identified in the Restricted Stock Unit Award Agreement, and Employee&#8217;s enjoyment of the financial opportunities flowing from such participation, provide Employee with a valuable investment opportunity which constitutes a bona fide advancement of the Employee by TriNet supporting Employee&#8217;s agreement to abide by the restrictions contained herein for purposes of compliance with Oregon law relating to non-competition agreements. Section 5, above, does not apply if Employee last worked for TriNet in Oregon and the total amount of Employee&#8217;s annual gross salary and commissions, calculated on an annual basis, at the time of Employee&#8217;s termination does not exceed $116,427, adjusted annually for inflation pursuant to the Consumer Price Index for All Urban Consumers, West Region (All Items), as published by the Bureau of Labor Statistics of the United States Department of Labor immediately preceding the calendar year of Employee&#8217;s termination.</font><font style="background-color:#ffffff;color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Washington</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If Employee last worked for TriNet in Washington and entered the Restricted Stock Unit Award Agreement at the outset of Employee&#8217;s employment, then Employee hereby acknowledges and agrees that Employee received written notice of the terms in Section 5 prior to accepting the offer of employment with TriNet. If Employee last worked for TriNet in Washington and entered the Restricted Stock Unit Award Agreement after the commencement of employment, then Employee hereby agrees that Employee&#8217;s acceptance of the Award identified in the Restricted Stock Unit Award Agreement, and Employee&#8217;s enjoyment of the financial opportunities flowing from such participation, provide Employee with a valuable investment opportunity which constitutes independent consideration supporting Employee&#8217;s agreement to abide by the restrictions contained herein for purposes of compliance with Washington law relating to non-competition agreements. Section 5, above, does not apply if Employee last worked for TriNet in Washington and the total amount of Employee&#8217;s annualized Earnings does not exceed $123,394.17, adjusted annually for inflation by the Washington Department of Labor and Industries on September 30 of each year, calculated based on the federal Bureau of Labor Statistics&#8217; Consumer Price Index for Urban Wage Earners and Clerical Workers (CPI-W).  Earnings for purposes of this Section 5.3 means the compensation reflected on box 1 of Employee&#8217;s United States Internal Revenue Service Form W-2 that is paid to Employee over the prior year, or portion thereof for which Employee was employed, annualized </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">and calculated as of the earlier of the date enforcement of the noncompetition covenant is sought or the date of separation from employment. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Reasonableness of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Employee acknowledges and agrees that compliance with the non-disclosure, non-solicitation, and non-competition covenants above is both reasonable and necessary to protect TriNet&#8217;s legitimate business interests, including its confidential business information and trade secrets, its goodwill, its customer and employee relationships and investment therein, and its reputation, and that Employee&#8217;s violation of these covenants is inconsistent with TriNet&#8217;s provision of equity ownership incentive grants as contemplated by the Restricted Stock Unit Award Agreement. Employee further acknowledges and agrees that Employee&#8217;s post-employment competition, and&#47;or Employee&#8217;s solicitation of TriNet customers or personnel during this limited period of time, in violation of the non-competition and non-solicitation covenants above, would be contrary to the purpose, goal, and intent of TriNet&#8217;s agreement to provide Employee with the equity incentive award provided to Employee in the Restricted Stock Unit Award Agreement, and that but for Employee&#8217;s consent to such post-employment restrictions, the equity incentive award herein would not otherwise be awarded to Employee. Employee further acknowledges that Employee&#8217;s participation in equity ownership incentive grants is fully optional on the part of Employee, and that Employee opts to participate fully understanding that the foregoing covenants and restrictions would be conditions of such participation. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.1.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in Colorado while working for TriNet, then the restrictions contained in Sections 4 and 5, above, shall apply and be enforceable only if at the time this Agreement is entered into and at the time it is enforced, Employee earns (a) as to Section 5, an amount of Annualized Cash Compensation equivalent to or greater than the threshold amount to qualify as a Highly Compensated Worker, as the terms Annualized Cash Compensation, Highly Compensated Worker, and Threshold Amount for Highly Compensated Workers are defined in Colorado Revised Statutes Section 8-2-113 or any equivalent Colorado statutory provision that may be in effect at the time of Employee&#8217;s termination of employment with TriNet, or (b) as to Section 4, 60% of the amount set forth immediately above in Sub-section 6.1(a). Employee hereby agrees and acknowledges that&#58; (i) during the course of Employee&#8217;s employment with TriNet, Employee has had access to, gained knowledge of and&#47;or contributed to the development of  trade secret business information  of TriNet&#59; and (ii) the restrictions contained in Sections 1, 3, 4 and 5 are necessary to, and designed for, the protection of TriNet&#8217;s trade secrets by preventing such trade secrets from being disclosed to a competitor or used by a competitor in competition with TriNet.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Illinois</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If Employee last worked for TriNet in Illinois, then TriNet advises Employee to have this RCA reviewed by an attorney of Employee&#8217;s own choosing to receive legal advice about the RCA prior to Employee signing the Restricted Stock Unit Award Agreement.  Employee acknowledges and agrees that Employee received at least 14 days to review this RCA before Employee was required to sign the Restricted Stock Unit Award Agreement, although Employee may choose to sign in fewer than 14 days.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 7.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Irreparable Harm&#47;Injunctive Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Employee acknowledges and agrees that any breach of Employee&#8217;s obligations under the Non-Disclosure, Notice of Resignation, Non-Solicitation, and&#47;or Non-Competition covenants above, as applicable, will result in irreparable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">and continuing harm and injury to TriNet for which there is no adequate remedy at law. Employee further agrees that in the event Employee breaches or threatens to breach the non-disclosure, non-solicitation, and&#47;or non-competition covenants, in addition to any other rights, remedies or damages available to TriNet, TriNet shall be entitled to seek and obtain temporary, preliminary, and permanent injunctive relief to enforce the specific terms of these covenants. Employee further agrees and consents that in any action seeking temporary or preliminary injunctive relief to enforce any of the foregoing restrictions, TriNet and Employee shall be entitled to engage in expedited discovery in aid of proceedings seeking temporary and&#47;or preliminary injunctive relief, including expedited document production, interrogatories, and depositions limited at the expedited stage to those topics that are relevant to temporary and&#47;or preliminary injunctive relief.   </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 8.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Other Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If any provision of this RCA is found to be invalid or unenforceable, the parties hereto agree that a court may modify, alter or amend such provision to the extent necessary to make it enforceable. If a court declines to modify, alter or amend the provision to make it enforceable, then the remaining provisions of this RCA shall remain in full force and effect.  This RCA is assignable by TriNet and will be binding upon and inure to the benefit of TriNet&#8217;s successors, assigns and affiliated entities.  Employee agrees that, should TriNet, or any subsidiary or unit of TriNet in which Employee works, be acquired by, merge with, or otherwise combine with another business entity, TriNet&#8217;s rights under this RCA will be automatically assigned to the surviving entity, and such entity will have all rights to enforce this Agreement.  Employee hereby consents to any such actual or deemed automatic assignment. Notwithstanding the foregoing, Employee may not assign this RCA.  Nothing in this RCA shall be interpreted to limit any obligations owing by Employee to TriNet as a matter of common law, to the extent applicable. Nothing contained in this RCA shall be construed to reduce or limit TriNet&#8217;s right, title or interest in any Company Information or trade secrets so as to be less in any respect than TriNet would have had in the absence of this RCA. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 9.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Governing Law&#59; Venue&#59; Integration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The terms of this RCA and any disputes arising out of it shall be governed by, and construed in accordance with, the laws of the state or province in which Employee was last employed by TriNet, without giving effect to such state or province&#8217;s conflict of law principles.  Employee agrees and understands that such state or province&#8217;s laws will govern as set forth herein regardless of whether Employee moves Employee&#8217;s residence or place of employment to another state or location after termination of employment with TriNet. Notwithstanding any arbitration agreement that otherwise may exist between Employee and TriNet, Employee and TriNet agree that in the event of any dispute arising under this RCA, any such dispute is not subject to arbitration, and Employee and TriNet instead hereby mutually confer exclusive jurisdiction and venue for any dispute in any way related to this RCA on the state, provincial or federal court having original jurisdiction for the location in which Employee last worked for TriNet, and Employee and TriNet both agree not to bring any litigation in any way related to this RCA in any other court or forum. </font><font style="background-color:#ffffff;color:#232222;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">RCA </font><font style="background-color:#ffffff;color:#232222;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">replaces and supersedes any conflicting provision of any Restrictive Covenant Agreement contained in a prior </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement entered into by the parties under the TriNet Group, Inc. Amended and Restated 2019 Equity Incentive Plan</font><font style="background-color:#ffffff;color:#232222;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="background-color:#ffffff;color:#232222;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">         </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.1.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">California.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  If Employee primarily resides in or primarily works for TriNet in California, notwithstanding anything contained in Section 9 of this RCA, this RCA shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">governed, construed, and enforced in accordance with California law, and the state and&#47;or federal courts of California shall be the sole and exclusive jurisdiction and venue for resolution of any disputes arising under this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.2.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in Colorado while working for TriNet, then notwithstanding anything contained in Section 9 of this RCA, this RCA shall be governed, construed, and enforced in accordance with Colorado law, and the state and&#47;or federal courts of Colorado shall be the sole and exclusive jurisdiction and venue for resolution of any disputes arising under this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.3.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Massachusetts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. If Employee is, and has been for at least 30 days immediately preceding Employee&#8217;s cessation of employment, a resident of or employed in Massachusetts at the time of Employee&#8217;s termination of employment, then notwithstanding anything contained in Section 9 of this RCA&#58;  (1) this RCA shall be governed by and construed according to the laws of the Commonwealth of Massachusetts&#59; and (2) Employee consents to the personal jurisdiction of the court located in the county in which Employee resides as of the date of Employee&#8217;s termination of employment and the business litigation session of the Superior Court in Suffolk County, Massachusetts with respect to all matters arising out of or related to this RCA.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">***</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Employee understands and acknowledges that Employee has the right to consult and is encouraged to consult with Employee&#8217;s attorney to obtain legal counsel prior to making the choice to accept the Restricted Stock Unit Award Agreement and this RCA and the restrictions contained herein.  Employee acknowledges that Employee was given at least fourteen (14) days&#8217; notice together with the language of the covenants contained hereinabove, prior to the effective date of the covenants, in which to review the covenants.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">IN WITNESS WHEREOF, Employee accepts the obligations under this Restrictive Covenant Agreement and will be deemed to have accepted and signed this RCA upon Employee&#8217;s acceptance of the Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement to which it is attached.    </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>tnet-33125xexhibit103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i5851a91e20cb4401a0ea3caf0aedc5a9_37"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">TRINET GROUP, INC. RESTRICTED STOCK UNIT GRANT NOTICE (AMENDED AND RESTATED 2019 EQUITY INCENTIVE PLAN&#59; </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">PERFORMANCE AWARD)</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">TriNet Group, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), pursuant to its Amended and Restated 2019 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), hereby awards to Participant a performance-based Restricted Stock Unit Award in respect of the target and maximum number of restricted stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) for the number of shares of the Company&#8217;s Common Stock (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  The Award is subject to all of the terms and conditions as set forth herein, including the vesting criteria set forth on ATTACHMENT I hereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Vesting Criteria</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), and in the Plan, the Restricted Stock Unit Award Agreement and the Restrictive Covenant Agreement, all of which are attached hereto and incorporated herein in their entirety.  Capitalized terms not otherwise defined herein will have the meanings set forth in the Plan or the Restricted Stock Unit Award Agreement.  In the event of any conflict between the terms in the Award and the Plan, the terms of the Plan will control.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.474%"><tr><td style="width:1.0%"></td><td style="width:43.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top">Participant&#58;</td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Award Number&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Date of Grant&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Target Award&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Maximum Award&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">200% of Target Award</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Performance Period&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">See ATTACHMENT I</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Vesting Criteria</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#58;  The Award will be eligible for vesting, contingent upon attainment of both the performance and service conditions specified on the attached ATTACHMENT I.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Issuance Schedule&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The shares will be issued (to the extent any portion of the Award is earned and becomes vested in accordance with the Vesting Criteria) in accordance with the issuance schedule set forth in Section 6 of the Restricted Stock Unit Award Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Additional Terms&#47;Acknowledgements&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Participant acknowledges receipt of, and understands and agrees to, this Restricted Stock Unit Grant Notice, the Restricted Stock Unit Award Agreement (including any addenda attached thereto), the Restrictive Covenant Agreement and the Plan.  Participant further acknowledges that as of the Date of Grant, this Restricted Stock Unit Grant Notice, the Restricted Stock Unit Award Agreement, the Restrictive Covenant Agreement and the Plan set forth the entire understanding between Participant and the Company regarding this Award and supersede all prior oral and written agreements, promises and&#47;or representations on that subject with the exception of (i) equity awards previously granted and delivered to Participant, (ii) any compensation recovery policy that is adopted by the Company or is otherwise required by applicable law or listing standards applicable to the Company, and (iii) any written employment or severance arrangement that would provide for vesting acceleration of the Award upon the terms and conditions set forth therein.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">By accepting the Award, Participant acknowledges having received and read the Restricted Stock Unit Grant Notice, the Restricted Stock Unit Award Agreement, the Restrictive Covenant Agreement, applicable prospectus, and the Plan and agrees to all of the terms and conditions set </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">forth in these documents. Furthermore, by accepting the Award, Participant consents to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ATTACHMENT I</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">VESTING CRITERIA</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Performance Period</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">January 1, 2025 &#8211; December 31, 2025</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Performance Criteria</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The &#8220;Performance Criteria&#8221; for determining the Actual Award shall be based on the Company&#8217;s results in the following areas for the Performance Period as shown in the table below&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">50% shall be based on the Company&#8217;s Professional Service Revenue, as reported in the Company&#8217;s audited financial statements (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Professional Service Revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">50% shall be based on GAAP Earnings Per Share, as reported in the Company&#8217;s audited financial statements (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">GAAP EPS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">However, the forgoing will exclude any unanticipated Merger and&#47;or Acquisition activity after the Performance Criteria are established by the Company. </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Professional Service Revenue ($M)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">GAAP EPS $</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Max</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$784</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$3.65</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Target</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$713</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$2.90</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Threshold</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$642</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">$2.15</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Performance Multiplier</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; shall be determined as follows for each of the Performance Criteria, and then determining a total Performance Multiplier based on the weighting of the Performance Criteria set forth above&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:30.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.970%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Achievement Level</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Below Threshold</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Threshold</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Target</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Maximum</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Performance Multiplier (as a percentage of target)</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">0%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">50%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">100%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">200%</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If the GAAP EPS achievement level falls below threshold, then the Maximum Award shall be capped at the target achievement level for the Professional Service Revenue.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Performance Multiplier for any Achievement Level which falls between any of the amounts set forth in the table above shall be determined by linear interpolation.  For the avoidance of doubt, nothing greater than the Maximum Award can be earned under the Award.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Notwithstanding anything else, the total weighted Performance Multiplier may not exceed 125% of target unless there is at least 50% attainment of the corporate MBOs approved by the Compensation and Human Capital Management Committee of the Board of Directors of TriNet Group, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) for the Performance Period.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Certain Definitions</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Actual Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means the actual number of RSUs under the Award that are determined to be earned for the Performance Period, determined in accordance with, and subject further to the vesting requirements of, the rules under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Determination of Actual Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; below.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Determination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means the date on which the Committee certifies in writing the Performance Multiplier and determines the Actual Award for the Performance Period which shall in no event be later than the March 15 following the end of the Performance Period.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means January 1, 2025 through December 31, 2025.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-indent:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Determination and Vesting of Actual Award</font></div><div style="text-indent:2.25pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Committee shall determine the Actual Award based on the Performance Criteria set forth above for the Performance Period, which shall result in the Participant earning an Actual Award reflecting a number of RSUs equal to the total Performance Multiplier times the Target Award.  The Committee&#8217;s determination of the Actual Award shall be subject to its right to exercise negative discretion.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Actual Award will vest as follows&#58; 50% on December 31, 2026, and 50% on December 31, 2027, subject to Participant&#8217;s Continued Service through each such date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Vesting Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">For the avoidance of doubt, no amounts in excess of the Actual Award shall be eligible for vesting hereunder.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Example</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#58;  Assume that (i) Participant is granted a Target Award of 30,000 RSUs, and (ii) the Professional Service Revenue for the Performance Period is met at 100% of target, while the GAAP EPS exceeds the Maximum level.  This means that the total Performance Multiplier is (50% times 100%) + (50% times 200%), or a total 150% Performance Multiplier.  The Participant would earn (30,000 x 150%) or 45,000 RSUs as the Actual Award, which will be eligible for vesting subject to Participant&#8217;s Continued Service through the Vesting Schedule.  However, if (iii) the corporate MBOs are achieved at less than 50% of target, the total weighted Performance Multiplier would be capped at 125%, so that the Participant would earn (30,000 x 125%) or 37,500 RSUs as the Actual Award, which will be eligible for vesting subject to Participant&#8217;s Continued Service through the Vesting Schedule. Any amounts in excess of the Actual Award would be forfeited immediately.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Treatment on Change in Control</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">In the event of a Change in Control (as defined in the TriNet Group, Inc. Amended and Restated Executive Severance Benefit Plan or any amendment, restatement or successor to such plan and any similar plan or agreement then in effect and applicable to Participant (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Change in Control Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;)) prior to the Determination Date, the Committee will provide, effective upon such Change in Control, that the Actual Award shall be either (i) the Target Award or (ii) to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">extent the Performance Criteria are capable of measurement at such time, the Committee may determine actual performance for either the originally scheduled Performance Period or for a shortened Performance Period, as determined by the Committee in its sole discretion.  Such Actual Award shall remain subject to the Vesting Schedule&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">that, in the event of a Change in Control Termination (as defined in the applicable Change in Control Plan) within the applicable Change in Control Period (as defined in the applicable Change in Control Plan), the Actual Award shall be eligible for accelerated vesting in connection with or following such Change in Control to the same extent as provided for any time-based equity award under the applicable Change in Control Plan.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">TRINET GROUP, INC. AMENDED AND RESTATED 2019 EQUITY INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Participant has been granted an Award (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) of Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) pursuant to the TriNet Group, Inc. Amended and Restated 2019 Equity Incentive Plan (as it may be amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), the Notice of Restricted Stock Unit Award (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and this Restricted Stock Unit Award Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), dated as of the Date of Grant set forth in the Grant Notice for this Award (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). Except as otherwise indicated, any capitalized term used but not defined herein shall have the meaning ascribed to such term in the Plan. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:9pt;text-decoration:underline">Issuance of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Each RSU shall represent the right to receive one Share upon the vesting of such RSU, as determined in accordance with and subject to the terms of this Agreement, the Plan and the Notice. The number of RSUs is set forth in the Notice.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">    2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Vesting Dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Subject to Sections 3 and 4, the Award shall vest on the dates set forth in the Notice.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Except as otherwise provided for in any employment-related agreement between the Participant and the Company or any Subsidiary or Affiliate, upon a Termination of Service, the Committee, in its sole discretion, shall determine whether and to what extent any unvested RSUs may vest, settle, be paid or forfeited&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> that in the event of a Termination of Service for Cause, the Committee may determine whether and to what extent any vested RSUs may be forfeited.  Absent such exercise of discretion, in the event of the Participant&#8217;s Termination of Service for any reason, any RSUs that are not vested as of the date of such Termination of Service will be forfeited without payment of any consideration to Participant. For the avoidance of doubt and for purposes of this Award only, Termination of Service will be deemed to occur as of the date the Participant is no longer actively providing services as an Employee or Consultant (except, in certain circumstances at the sole discretion of the Company, to the extent the Participant is on a Company approved leave of absence) and will not be extended by any notice period or &#8220;garden leave&#8221; that may be required contractually or under applicable laws, unless otherwise determined by the Company in its sole discretion.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Notwithstanding the foregoing, on a Termination of Service in the event of death or Disability, the Award shall vest (i) if following the Determination Date, based on the Committee&#8217;s determination of an Actual Award, and (ii) if prior to the Determination Date, based on a deemed determination of a Target Award, and, in each case, prorated based on a ratio the numerator of which is the number of days in the Performance Period prior to the date of the Participant&#8217;s Termination of Service and the denominator of which is the total days in the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Performance Period, and be distributed as soon as practicable but in no event later than 60 days following the Participant&#8217;s Termination of Service.  For this purpose, Disability or Disabled shall mean that the Participant meets the initial eligibility requirements for receiving benefits under the Employer&#8217;s long term disability plan. In the event, the Participant is not eligible for or elects not to enroll in the Employer&#8217;s long term disability plan, the Participant is deemed Disabled by the Company if the Participant is</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months. An individual shall not be considered Disabled unless the individual furnishes proof of the existence thereof in such form and manner, and at such times, as the Company may require.  Further, the Company may retain a physician or other third party to assist in determining whether a Participant is Disabled.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. In the event of a Change in Control, the RSUs will be treated in accordance with Section 12(b) of the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. As a condition precedent to the grant of the Award, the Participant agrees to be subject to the restrictive covenants as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Restrictive Covenants Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Transfer of RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">     (a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">General Prohibition on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Except as may be permitted by the Committee, neither the Award nor any right under the Award shall be pledged, assignable, alienable, saleable or transferable by the Participant except as provided in this Section 6.  This provision shall not apply to any portion of the Award that has been fully settled and shall not preclude forfeiture of any portion of the Award in accordance with the terms herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   (b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Award may be transferable by will or pursuant to the laws of descent and distribution. In addition, upon receiving written permission from the Board or its duly authorized designee, the Participant may, by delivering written notice to the Company, in a form provided by or otherwise satisfactory to the Company and any broker designated by the Company to effect transactions under the Plan, designate a third party who, in the event of the Participant&#8217;s death, will thereafter be entitled to receive any distribution Shares or other consideration to which the Participant was entitled at the time of the Participant&#8217;s death pursuant to this Agreement. In the absence of such a designation, the Participant&#8217;s executor or administrator of the Participant&#8217;s estate will be entitled to receive, on behalf of the Participant&#8217;s estate, such Shares or other consideration.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  (c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Certain Trusts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Upon receiving written permission from the Board or its duly authorized designee, the Participant may transfer the Award to a trust if that Participant is considered to be the sole beneficial owner (determined under Section 671 of the U.S. Internal Revenue Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and applicable law) while the Award is held in the trust, provided that the Participant and the trustee enter into transfer and other agreements required by the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Participant shall have no voting rights or any other rights as a stockholder of the Company with respect to the RSUs unless and until the Participant becomes the record owner of the Shares underlying the RSUs.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Except as provided in the Notice, if a cash dividend is declared on Shares during the period commencing on the Grant Date and ending on the date on which the Shares underlying the RSUs are distributed to the Participant pursuant to this Agreement, the Committee shall determine, in its sole discretion, whether the Participant will be eligible to receive an amount in cash (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Dividend Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) equal to the dividend that the Participant would have received had the Shares underlying the RSUs been held by the Participant as of the time at which such dividend was declared. If applicable, each Dividend Equivalent will be paid to the Participant in cash as soon as reasonably practicable (and in no event later than 30 days) after the applicable Vesting Date of the corresponding RSUs. For clarity, no Dividend Equivalent will be paid with respect to any RSUs that are forfeited.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Distribution of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   (a) Subject to the provisions of this Agreement, upon the vesting of any of the RSUs, the Company shall deliver to the Participant, as soon as reasonably practicable (and in no event later than 30 days) after the applicable Vesting Date, one Share for each such RSU. Upon the delivery of Shares, such Shares shall be fully assignable, alienable, saleable and transferrable by the Participant&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> that any such assignment, alienation, sale, transfer or other alienation with respect to such Shares shall be in accordance with applicable securities laws and any applicable Company policy.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  (b) Notwithstanding the foregoing, in the event that (i) the Participant is subject to the Company&#8217;s policy permitting certain individuals to sell Shares only during certain &#8220;window&#8221; periods, in effect from time to time or the Participant is otherwise prohibited from selling Shares in the public market and any Shares covered by the Award are scheduled to be delivered on a day (the &#8220;Original Distribution Date&#8221;) that does not occur during an open &#8220;window period&#8221; applicable to the Participant, as determined by the Company in accordance with such policy, or does not occur on a date when the Participant is otherwise permitted to sell Shares on the open market, and (ii) the Company elects not to satisfy its obligations for Tax-Related Items (as defined in Section 10(a) below) by withholding Shares from the Participant&#8217;s distribution, then such Shares will not be delivered on such Original Distribution Date and will instead be delivered on the first business day of the next occurring open &#8220;window period&#8221; applicable to the Participant pursuant to such policy (regardless of whether the Participant is still providing continuous services at such time) or the next business day when the Participant is not prohibited from selling Shares in the open market, but in no event later than the fifteenth (15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">) day of the third calendar month of the calendar year following the calendar year in which the Shares originally became vested.  The form of such delivery (e.g., a stock certificate or electronic entry evidencing such Shares) will be determined by the Company.  In all cases, the delivery of Shares under this Award is intended to comply with Treasury Regulation Section 1.409A-1(b)(4) and will be construed and administered in such manner.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  10. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Responsibility for Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">     (a) The Participant acknowledges that, regardless of any action taken by the Company or the Participant&#8217;s employer (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Tax-Related Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) is and remains the Participant&#8217;s responsibility and may exceed the amount actually </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">withheld by the Company or the Employer. The Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including, but not limited to, the grant, vesting or settlement of the Award, the subsequent sale of Shares acquired upon settlement of the Award and the receipt of any dividends and&#47;or Dividend Equivalents&#59; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">     (b) As a condition to the grant, vesting and settlement of the Award, prior to any relevant taxable or tax withholding event, as applicable, the Participant agrees to make adequate arrangements satisfactory to the Company and&#47;or the Employer to satisfy (and will indemnify the Company and any Subsidiary or Affiliate) with respect to any and all Tax-Related Items which arise upon the grant, vesting or settlement of the Award, ownership or disposition of Shares, receipt of dividends, if any, or otherwise in connection with the Award or Shares. In this regard, the Participant authorizes the Company and&#47;or the Employer, or their respective agents, at their discretion, to satisfy any applicable withholding obligations with regard to all Tax-Related Items in the manner determined by the Company and&#47;or the Employer from time to time, which may include&#58; (i) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Company and&#47;or the Employer&#59; (ii) requiring the Participant to remit the aggregate amount of such Tax-Related Items to the Company in full, in cash or by check, bank draft or money order payable to the order of the Company or the Employer&#59; (iii) through a procedure whereby the Participant delivers irrevocable instructions to a broker reasonably acceptable to the Committee to sell Shares obtained upon settlement of the Award and to deliver promptly to the Company an amount of the proceeds of such sale equal to the amount of the Tax-Related Items&#59; (iv) by a &#8220;net settlement&#8221; under which the Company reduces the number of Shares issued on settlement of the Award by the number of Shares with an aggregate fair market value that equals the amount of the Tax-Related Items associated with such settlement&#59; or (v) any other method of withholding determined by the Company and permitted by applicable law. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">     (c) The Participant acknowledges and agrees that, absent an affirmative election otherwise, such Tax-Related Items shall be satisfied through &#8220;net settlement&#8221; as set forth in Section 10(b)(iv).  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">     (d) Depending on the withholding method, the Company or the Employer may withhold or account for Tax-Related Items by considering applicable statutory withholding rates or other applicable withholding rates, including maximum applicable rates, in which case the Participant will receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent number of Shares. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant is deemed to have been issued the full number of Shares subject to the settled Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">     (e) The Participant agrees to pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if the Participant fails to comply with the Participant&#8217;s obligations in connection with the Tax-Related Items. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">     (f) The Participant further acknowledges and agrees that the Participant is solely responsible for filing all relevant documentation that may be required in relation to the Award or any Tax-Related Items (other than filings or documentation that is the specific obligation of the Company or any Subsidiary or Affiliate pursuant to applicable laws), such as but not limited to personal income tax returns or reporting statements in relation to the grant, vesting or settlement of the Award, the holding of Shares or any bank or brokerage account, the subsequent sale of Shares, and the receipt of any dividends.  The Participant further acknowledges that the Company makes no representations or undertakings regarding the treatment of any Tax-Related Items and does not commit to and is under no obligation to structure the terms or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  The Participant also understands that applicable laws may require varying Share or Restricted Stock Unit valuation methods for purposes of calculating Tax-Related Items, and the Company assumes no responsibility or liability in relation to any such valuation or for any calculation or reporting of income or Tax-Related Items that may be required of the Participant under applicable laws.  Further, if the Participant has become subject to tax in more than one jurisdiction between the date of grant and the date of any relevant taxable event, the Participant acknowledges that the Company or any Subsidiary or Affiliate may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  11. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Not Salary, Pensionable Earnings or Base Pay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> The Participant acknowledges that the Award shall not be included in or deemed to be a part of (a) salary, normal salary or other ordinary compensation, (b) any definition of pensionable or other earnings (however defined) for the purpose of calculating any benefits payable to or on behalf of the Participant under any pension, retirement, termination or dismissal indemnity, severance benefit, retirement indemnity or other benefit arrangement of the Company or any Subsidiary or Affiliate (including the Employer) or (c) any calculation of base pay or regular pay for any purpose.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> 12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Cancellation&#47;Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Participant hereby acknowledges and agrees that the Participant and the Award are subject to the terms and conditions of Section 19 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Cancellation or &#8220;Clawback&#8221; of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">) of the Plan, subject to applicable law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  13. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Provisions of Plan Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Agreement is subject to all the terms, conditions and provisions of the Plan, including the amendment provisions thereof, and to such rules, regulations and interpretations relating to the Plan as may be adopted by the Committee and as may be in effect from time to time.  The Plan is incorporated herein by reference.  If and to the extent that this Agreement conflicts or is inconsistent with the Plan, the Plan shall control, and this Agreement shall be deemed to be modified accordingly.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  14. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Any notice required or permitted to be given under this Agreement shall be in writing and shall be deemed to have been given when delivered personally or by courier, or sent by certified or registered mail, postage prepaid, return receipt requested, duly addressed to the party concerned at the address indicated below or to such changed address as such party may subsequently by similar process give notice of&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If to the Company&#58;</font></div><div style="text-align:justify;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">TriNet Group, Inc.</font></div><div style="text-align:justify;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">One Park Place</font></div><div style="text-align:justify;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Suite 600</font></div><div style="text-align:justify;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Dublin, CA 94568</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Attention&#58; Chief Legal Officer</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If to the Participant, to the address of the Participant on file with the Company.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  15. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">No Right to Continued Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The grant of the Award shall not be construed as giving the Participant the right to be retained in the employ of, or to continue to provide services to, the Company or any Affiliate (including the Employer). Nothing in the Plan or in this Agreement shall interfere with or limit in any way the right of the Company or a Subsidiary or Affiliate thereof to terminate the Participant&#8217;s service at any time, subject to applicable laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  16. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">No Right to Future Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> In accepting the Award, the Participant acknowledges that the Plan is established voluntarily by the Company, is discretionary in nature, and may be modified, amended, suspended or terminated by the Company at any time. Any Award granted under the Plan shall be a one-time Award that does not constitute a promise of future grants. The Company, in its sole discretion, maintains the right to make available future grants under the Plan. The grant of RSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, other Awards or benefits in lieu of RSUs, even if RSUs have been granted repeatedly in the past, and all decisions with respect to future grants of RSUs or other Awards, if any, will be at the sole discretion of the Company.  In addition, the Participant&#8217;s participation in the Plan is voluntary, and the RSUs and the Shares subject to the RSUs are extraordinary items that do not constitute regular compensation for services rendered to the Company or any Subsidiary or Affiliate and are outside the scope of the Participant&#8217;s employment contract, if any.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  17. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Restrictive Legends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The shares issued under the Award will be endorsed with appropriate legends as determined by the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  18. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> This Agreement, the Plan, the Notice and any other agreements, schedules, addenda, appendices, exhibits and other documents referred to herein or therein constitute the entire agreement and understanding between the parties in respect of the subject matter hereof and supersede all prior and contemporaneous arrangements, agreements and understandings, both oral and written, whether in term sheets, presentations or otherwise, between the parties with respect to the subject matter hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  19. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> If any provision of this Agreement is or becomes or is deemed to be invalid, illegal or unenforceable in any jurisdiction, or would disqualify the Plan or this Agreement under any law deemed applicable by the Board, such provision shall be construed or deemed amended to conform to applicable laws, or if it cannot be so construed or deemed amended without, in the determination of the Board, materially altering the intent of this Agreement, such provision shall be stricken as to such jurisdiction, and the remainder of this Agreement shall remain in full force and effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  20. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Amendment&#59; Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> No amendment or modification of any provision of this Agreement that has a material adverse effect on the Participant shall be effective unless signed in writing by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">or on behalf of the Company and the Participant&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> that the Company may amend or modify this Agreement without the Participant&#8217;s consent in accordance with the provisions of the Plan or as otherwise set forth in this Agreement. No waiver of any breach or condition of this Agreement shall be deemed to be a waiver of any other or subsequent breach or condition, whether of like or different nature. Any amendment or modification of or to any provision of this Agreement, or any waiver of any provision of this Agreement, shall be effective only in the specific instance and for the specific purpose for which such amendment, modification or waiver is made or given.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  21. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Neither this Agreement nor any right, remedy, obligation or liability arising hereunder or by reason hereof shall be assignable by the Participant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  22.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Successors and Assigns&#59; No Third-Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Agreement shall inure to the benefit of and be binding upon the Company and the Participant and their respective heirs, successors, legal representatives and permitted assigns. Nothing in this Agreement, express or implied, is intended to confer on any Person other than the Company and the Participant, and their respective heirs, successors, legal representatives and permitted assigns, any rights, remedies, obligations or liabilities under or by reason of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  23. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">No Advice Regarding Grant&#59; Opportunity to Obtain Advice of Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant&#8217;s participation in the Plan, or the Participant&#8217;s acquisition or sale of the underlying Shares. The Participant is hereby advised to consult with the Participant&#8217;s own personal tax, financial and&#47;or legal advisors regarding the Tax-Related Items arising in connection with the Award.  By accepting the Award, the Participant acknowledges and agrees that he or she has done so or knowingly and voluntarily declined to do so.  The Participant acknowledges and agrees that he or she has reviewed the Agreement, the Notice and the Plan in their entirety, including any addenda or other documents referred to herein or therein, and have had the opportunity to obtain the advice of counsel prior to executing and accepting the Award, and fully understood the provisions of the Award.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  24. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Dispute Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">All controversies and claims arising out of or relating to this Agreement, or the breach hereof, shall be settled by the Company&#8217;s or the Employer&#8217;s mandatory dispute resolution procedures, if any, as may be in effect from time to time with respect to matters arising out of or relating to the Participant&#8217;s employment with the Company or the Employer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  25. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Governing Law&#59; Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">All matters arising out of or relating to this Agreement and the transactions contemplated hereby, including its validity, interpretation, construction, performance and enforcement, shall be governed by and construed in accordance with the internal laws of the State of Delaware, without giving effect to its principles of conflict of laws. Notwithstanding any arbitration agreement that otherwise may exist between the Participant and the Company, the Participant and the Company agree that, in the event of any dispute arising under this Agreement, any such dispute is not subject to arbitration, and the Participant and the Company instead hereby submit and consent to the exclusive jurisdiction of the State of Delaware and agree that any such litigation shall be conducted only in the courts of Delaware or the federal courts of the United States located in Delaware and no other courts.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  26. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Imposition of other Requirements and Participant Undertaking</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> The Company reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on the Award and on any Shares to be issued upon settlement of the Award, or take any other action, to the extent the Company determines it is necessary or advisable for legal or administrative reasons.  The Participant agrees to take whatever additional action and execute whatever additional documents the Company may deem necessary or advisable to accomplish the foregoing or to carry out or give effect to any of the obligations or restrictions imposed on either the Participant or the RSU pursuant to this Agreement. Furthermore, the Participant acknowledges that the applicable laws of the country in which the Participant is residing or working at the time of grant, vesting and settlement of the RSUs or the ownership or sale of Shares received pursuant to the RSUs (including any rules or regulations governing securities, foreign exchange, tax, labor, or other matters) may subject the Participant to additional procedural or regulatory requirements that the Participant is and will be solely responsible for and must fulfill.  Such requirements may be outlined in but are not limited to the Country-Specific Addendum (the &#8220;Addendum&#8221;) attached hereto, which forms part of this Agreement.  Notwithstanding any provision herein, the Participant&#8217;s participation in the Plan shall be subject to any applicable special terms and conditions or disclosures as set forth in the Addendum.  The Participant also understands and agrees that if the Participant works, resides, moves to, or otherwise is or becomes subject to applicable laws or company policies of another jurisdiction at any time, certain country-specific notices, disclaimers and&#47;or terms and conditions may apply to the Participant as from the date of grant, unless otherwise determined by the Company in its sole discretion.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  27. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">References</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">References herein to rights and obligations of the Participant shall apply, where appropriate, to the Participant&#8217;s legal representative or estate without regard to whether specific reference to such legal representative or estate is contained in a particular provision of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> 28. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant&#8217;s Personal Data (as described below) by and among, as applicable, the Company, any Subsidiary, Affiliate or third parties as may be selected by the Company for the exclusive purpose of implementing, administering and managing the Participant&#8217;s participation in the Plan.  The Participant understands that refusal or withdrawal of consent will affect the Participant&#8217;s ability to participate in the Plan&#59; without providing consent, the Participant will not be able to participate in the Plan or realize benefits (if any) from the RSUs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Participant understands that the Company and any Subsidiary, Affiliate or designated third parties may hold personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company or any Subsidiary or Affiliate, details of all RSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Participant&#8217;s favor (&#8220;Personal Data&#8221;).  The Participant understands that Personal Data may be transferred to any Subsidiary, Affiliate or third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the United States, the Participant&#8217;s country (if different than the United States), or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than the Participant&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">country.  In particular, the Company may transfer Personal Data to the broker or stock plan administrator assisting with the Plan, to its legal counsel and tax&#47;accounting advisor, and to the affiliate or entity that is the Participant&#8217;s employer and its payroll provider. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Participant should also refer to any data privacy policy implemented by the Company (which will be available to the Participant separately and may be updated from time to time) for more information regarding the collection, use, storage, and transfer of the Participant&#8217;s Personal Data.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  29. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Foreign Exchange Fluctuations and Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Participant understands and agrees that, if required by the Company or applicable laws, any cross-border funds transfers in connection with the RSUs (including proceeds from the sale of Shares or receipt of any dividends) must be made through a locally authorized financial institution or registered foreign exchange agency and may require the Participant to provide to such entity certain information regarding the transaction.  Moreover, the Participant understands and agrees that the future value of the underlying Shares is unknown and cannot be predicted with certainty and may decrease in value.  The Participant understands that neither the Company nor any Subsidiary or Affiliate is responsible for any foreign exchange fluctuation between local currency and the United States Dollar or the selection by the Company or any Subsidiary or Affiliate in its sole discretion of an applicable foreign currency exchange rate that may affect the value of the RSUs (or the calculation of income or Tax-Related Items thereunder).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  30. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Communications and Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Company may, in its sole discretion, decide to deliver any documents related to the Participant&#8217;s current or future participation in the Plan, shares, or any other Company-related documents by electronic means.  By accepting this Agreement, whether electronically or otherwise, the Participant hereby consents to receive such documents by electronic delivery and agree to participate in the Plan through an online or electronic system established and maintained by the Company or a third party designated by the Company, including but not limited to the use of electronic signatures or click-through electronic acceptance of terms and conditions.  To the extent the Participant has been provided with a copy of this Agreement, the Plan, or any other documents relating to the RSUs in a language other than English, the English language documents will prevail in case of any ambiguities or divergences as a result of translation.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Country-Specific Addendum</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Addendum includes additional country-specific notices, disclaimers, and&#47;or terms and conditions that apply to individuals who work or reside in the countries listed below and that may be material to the Participant&#8217;s participation in the Plan.  Such notices, disclaimers, and&#47;or terms and conditions may also apply, as from the date of grant, if the Participant moves to or otherwise is or becomes subject to the applicable laws or Company policies of the country listed.  However, because foreign exchange regulations and other local laws are subject to frequent change, the Participant is advised to seek advice from his or her own personal legal and tax advisor prior to accepting an RSU or holding or selling Shares acquired under the Plan.  The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant&#8217;s acceptance of the RSUs or participation in the Plan.  Unless otherwise noted below, capitalized terms shall have the same meaning assigned to them under the Plan and the Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement. This Addendum forms part of the Restricted Stock Unit Award Agreement and should be read in conjunction with the Restricted Stock Unit Award Agreement and the Plan. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Securities Law Notice&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Unless otherwise noted, neither the Company nor the Shares are registered with any local stock exchange or under the control of any local securities regulator outside the United States.  The Restricted Stock Unit Award Agreement (of which this Addendum is a part), the Plan, and any other communications or materials that you may receive regarding participation in the Plan do not constitute advertising or an offering of securities outside the United States, and the issuance of securities described in any Plan-related documents is not intended for public offering or circulation in the Participant&#8217;s jurisdiction.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:18.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.804%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Canada</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Securities Law Notice. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The security represented by the RSUs was issued pursuant to an exemption from the prospectus requirements of applicable securities legislation in Canada. The Participant acknowledges that, as long as the Company is not a reporting issuer in any jurisdiction in Canada, the RSUs and the underlying Shares will be subject to an indefinite hold period in Canada and subject to restrictions on their transfer in Canada. Subject to the terms and conditions of the Agreement and applicable securities laws, the Participant is permitted to sell Shares acquired through the designated broker appointed under the Plan, assuming the sale of such Shares takes place outside Canad</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Settlement in Shares Only. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Notwithstanding any discretion in the Plan to the contrary, settlement of the RSUs shall only be made in Shares issued by the Company from treasury and not, in whole or in part, in the form of cash (other than as explicitly consented to by you in Section 10 of the Agreement for tax withholding and payment purposes) or other consideration.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Employee Tax Treatment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">For Canadian federal income tax purposes, the RSUs are intended to be treated as an agreement by the Company to sell or issue Shares to the employee and, as such, is intended to be subject to the rules in section 7 of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Income Tax Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> (Canada). Under those rules, the employee will be considered to have received an employment benefit at the time of settlement of the vested RSUs equal to the full value of the Shares received, which amount will be taxed as employment income and will be subject to withholding at source</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Foreign Ownership Reporting. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If the Participant is a Canadian resident, his or her ownership of certain foreign property (including shares of foreign corporations) in excess of $100,000 may be subject to ongoing annual reporting obligations. The Participant should please refer to CRA</font><font style="color:#0563c1;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Form T113</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5 (Foreign Income Verification Statement) and consult their tax advisor for further details</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Quebec&#58; Consent to Receive Information in English. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The following applies if the Participant is a resident of Quebec&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The parties acknowledge that it is their express wish that this Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Les parties reconnaissent avoir exig&#233; la redaction en anglais de cette convention, ainsi que de tous documents ex&#233;cut&#233;s, avis donn&#233;s et procedures judiciaries intent&#233;es, directement ou indirectement, relativement &#224; la pr&#233;sente convention.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:18.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">India</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Exchange Control Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> The Participant understands that he or she must repatriate to India and convert to local currency any proceeds from the sale of Shares acquired under the Plan within 90 days of receipt and any dividends received in relation to the Shares within 60 days of receipt. The Participant will receive a foreign inward remittance certificate (&#8220;FIRC&#8221;) from the bank where the Participant deposits the foreign currency. The Participant should maintain the FIRC as evidence of the repatriation of funds in case the Reserve Bank of India, the Company, or any Subsidiary or Affiliate requests proof of repatriati</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Share Valuation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> The amount of the Award subject to tax, including for reporting and withholding, will partially depend upon a valuation that the Company will obtain from a Category I Merchant Banker in India. The Company has no responsibility or obligation to obtain the most favorable valuation possible nor obtain valuations more frequently than required under Indian tax law</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">APPENDIX A</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">RESTRICTIVE COVENANT AGREEMENT</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            As a material condition to the grant of the Award provided for under the Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement  by and between the grant recipient (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and TriNet Group, Inc. (collectively with its Subsidiaries and Affiliates, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">TriNet</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), Employee enters into and agrees to be bound by this Restrictive Covenant Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">RCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), made by and between Employee and TriNet effective as of the date Employee accepts the Award.  Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to them in the Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement or the TriNet Group, Inc. Amended and Restated 2019 Equity Incentive Plan.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 1.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">    1.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Non-Disclosure. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Employee agrees that during and after employment with TriNet, Employee will not (i) directly or indirectly disclose to any person or entity, or use, except for the sole benefit of TriNet, any of TriNet&#8217;s confidential or proprietary information or trade secrets (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Company Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) or (ii) publish or submit for publication, any article or book relating to TriNet, its development projects, or other aspects of TriNet business. By way of illustration and not limitation, Company Information shall include TriNet&#8217;s trade secrets&#59; research and development plans or projects&#59; data and reports&#59; computer materials such as software programs, instructions, source and object code, and printouts&#59; products prospective products, inventions, developments, and discoveries&#59; data compilations, development databases&#59; business improvements&#59; business plans (whether pursued or not)&#59; ideas&#59; budgets&#59; unpublished financial statements&#59; licenses&#59; pricing strategy and cost data&#59; information regarding the skills and compensation of any employees, non-employee directors or consultants of TriNet (other than Employee)&#59; the personally identifying and protected health information of any employee, non-employee director or consultant of TriNet (other than Employee), including worksite employees of TriNet customers&#59; lists of current and potential customers of TriNet&#59; information about customers&#8217; purchasing history, pricing, preferences and profitability&#59; strategies, forecasts and other marketing information and techniques&#59; employment and recruiting strategies and processes&#59; sales practices, strategies, methods, forecasts, compensation plans, and other sales information&#59; investor information&#59; and the identities of TriNet&#8217;s suppliers, vendors,  and contractors, and all information about those supplier, vendor and contractor relationships such as contact person(s), pricing and other terms.  The definition of Company Information shall include both &#8220;know-how&#8221; (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">i.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">., information about what works well) and &#8220;negative know-how&#8221; (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">i.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">., information about what does not work well).  Employee further acknowledges and agrees that all Company Information is confidential and proprietary and shall remain the exclusive property of TriNet.  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">1.1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">   Wisconsin.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If Employee last worked for TriNet in Wisconsin, the restrictions set forth in Section 1.1 shall apply during Employee&#8217;s employment with TriNet and for eighteen (18) months after Employee&#8217;s employment with TriNet ends.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">      1.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Improper Use of Trade Secret Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  In furtherance of Employee&#8217;s promises in this Section 1, Employee agrees that during Employee&#8217;s employment and for a period of one year following termination of employment with TriNet, Employee will not, for Employee&#8217;s own benefit or for the benefit of a competitor of TriNet, use TriNet&#8217;s trade secrets, or use Employee&#8217;s knowledge of TriNet&#8217;s trade secret customer information, directly or indirectly, to (i) identify TriNet customers for solicitation&#59; (ii) facilitate the solicitation of TriNet&#8217;s customers&#59; (iii) target any employee, non-employee director(s) or consultant(s) of TriNet for solicitation or recruitment to discontinue, in whole or in part, his&#47;her employment or other relationship with TriNet, or using trade secrets to facilitate any such solicitation or recruitment&#59; or (iv) otherwise compete unfairly with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Permitted Disclosures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Nothing in this RCA limits Employee&#8217;s ability to communicate directly with and provide information, including documents, not otherwise protected from disclosure by any applicable law or privilege, to the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) or any other federal, provincial, state or local governmental agency or commission or self-regulatory organization regarding possible legal violations, without disclosure to TriNet.  TriNet may not retaliate against Employee for any of these activities, and nothing in the RCA requires Employee to waive any monetary award or other payment to which Employee might become entitled from the SEC or any other government agency or self-regulatory organization as a result of such communication.  Nothing contained in this Agreement restricts or limits Employee&#8217;s right to discuss or disclose information about unlawful acts in the workplace, at work-related events, or between TriNet employees or TriNet and Employee, such as harassment, discrimination, retaliation, sexual assault, a wage and hour violation, or any other conduct that Employee has reason to believe is unlawful or that is otherwise recognized as against a clear mandate of public policy, nor does this Agreement prohibit Employee from discussing Employee&#8217;s employment or reporting possible violations of law or regulation with the Equal Employment Opportunity Commission, United States Department of Labor, the Occupational Safety and Health Administration, the National Labor Relations Board, the Securities and Exchange Commission, or other federal government agency or state or local government agency. This Agreement does not prohibit Employee from discussing the terms and conditions of Employee&#8217;s employment with others to the extent expressly permitted by Section 7 of the National Labor Relations Act or to the extent that such disclosure is protected under the applicable provisions of law or regulation, including but not limited to &#8220;whistleblower&#8221; statutes or other similar provisions that protect such disclosure.  Nor does this Agreement require Employee not to disclose or discuss conduct or the existence of a settlement involving conduct relating to a dispute&#58; (1) involving a nonconsensual sexual act or sexual contact, as such terms are defined in section 2246 of title 18, United States Code, or similar applicable tribal or state law&#59; or (2) relating to conduct that is alleged to constitute sexual harassment under applicable federal, tribal, or state law. Further, pursuant to the Defend Trade Secrets Act of 2016 or applicable law, Employee shall not have criminal or civil liability under any federal, provincial or state trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a federal, provincial, state, or local government official, either directly or indirectly, or to an attorney and (ii) solely for the purpose of reporting or investigating a suspected violation of law&#59; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  In addition and without limiting the preceding sentence, if Employee files a lawsuit for retaliation by TriNet for reporting a suspected violation of law, Employee may disclose the trade secret to Employee&#8217;s attorney and may use the trade secret information in the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">court proceeding, if Employee (X) files any document containing the trade secret under seal and (Y) does not disclose the trade secret, except pursuant to court order.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Notice of Resignation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> In the event Employee resigns Employee&#8217;s employment with TriNet and is immediately prior to such resignation employed (1) in any position in the Field Sales, Virtual Sales, and Channel and Partnership Sales departments, or (2) in any other part of TriNet with a job code of Executive Director or above, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">excluding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">any &#8220;officers&#8221; of the Company (as such term is defined by Section 16 of the Securities Exchange Act of 1934, as amended) to help effectuate and ensure an orderly transition </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Employee shall provide TriNet with thirty (30) days&#8217; notice of Employee&#8217;s resignation from TriNet</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> as more specifically set forth in Sub-sections 3.1 through 3.4, below.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            3.1.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Thirty (30) Days&#8217; Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Employee will provide thirty days&#8217; notice of Employee&#8217;s resignation in writing submitted to Employee&#8217;s direct manager and the Human Resources Department via email to MYHR&#64;trinet.com, and such written notice shall include a disclosure and identification of any new position, affiliation and&#47;or employment Employee has accepted, intends to accept or is considering accepting upon expiration of the Notice Period. (The first thirty (30) days following submission of a resignation in compliance with this RCA as outlined below shall be the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Notice Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.&#8221;) </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            3.2.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Duties and Cooperation During Notice Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. During the Notice Period Employee&#8217;s manager may ask Employee to take steps to help transition responsibility for ongoing projects and&#47;or other job duties.  Employee agrees to perform these duties and tasks, as Employee&#8217;s manager in the manager&#8217;s sole discretion may direct, including without limitation any or all of the following&#58;  (i) organize files and notes of any projects for transition&#59; (ii) meet with Employee&#8217;s managers or their designee to review files and other data to help ensure that TriNet personnel are aware of and understand any files, projects or other business related data&#59; (iii) meet with Employee&#8217;s manager or the manager&#8217;s designee to review the status of any projects, work, clients or personnel for which Employee was assigned responsibility, in order to help ensure that business needs may be seamlessly transitioned to and serviced by other TriNet personnel&#59; (iv) otherwise being available to TriNet, as requested by Employee&#8217;s managers, to provide reasonable assistance to effectuate an orderly transition of knowledge, files, projects, data, client service or personnel responsibilities, and any other job duties, prior to Employee&#8217;s last day of employment.  The foregoing list is neither intended to be an exhaustive list of the transition-related tasks Employee may be required to perform, nor is it a promise that TriNet will have Employee engage in any or all of the listed tasks.  There may be times during the Notice Period when TriNet is preparing for the transition in a way that does not involve Employee&#8217;s active engagement, and as such TriNet at its sole discretion may instruct Employee not to work or enter TriNet&#8217;s premises on some or all days of the Notice Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Conduct During Notice Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. During the Notice Period, Employee will be a TriNet employee, will remain on TriNet&#8217;s payroll, will receive the same base rate of pay, and will continue to be eligible for all employee benefits just as in the period prior to Employee&#8217;s giving Notice of Resignation to TriNet. Employee&#8217;s primary job duties during the Notice Period will involve assisting TriNet to effectuate an orderly transition of duties to other TriNet personnel as assigned by Employee&#8217;s manager. During the Notice Period, Employee shall&#58; (i) not discuss or communicate about Employee&#8217;s impending departure from TriNet with clients or others who are not employees of TriNet unless authorized in writing to do so by Employee&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">manager&#59; (ii) not take, remove or transfer any TriNet data, records or information off the premises of any TriNet office or facility&#59; (iii) access TriNet systems only with express permission of Employee&#8217;s manager (Employee understands that such accessibility may be terminated during the Notice Period)&#59; (iv) return to Employee&#8217;s TriNet manager, within one business day of tendering Employee&#8217;s notice of resignation, all files, data and information relating to TriNet clients or business which Employee may have had off premises during the course of Employee&#8217;s employment&#59; (v) not use any social networking system or function to update any clients about Employee&#8217;s employment status with TriNet and&#47;or any impending change of such status&#59; and (vi) if Employee has had remote access to TriNet computer systems or if Employee has ever used a non-TriNet issued computer or electronic device for work, Employee will, upon TriNet&#8217;s request, make such personal computer(s) or other electronic devices available to TriNet and&#47;or its computer forensic experts for imaging and searching to verify that all TriNet client data and any other non-public information has been removed. Employee understands and agrees that a core purpose of the Notice Period is to enable the orderly transition of knowledge, files, data and client responsibility to other TriNet employees, and accordingly Employee understands and agrees that TriNet is free to and may elect to engage in a variety of transition-related activities, including but not limited to notifying clients of Employee&#8217;s intent to leave TriNet, informing clients of the identity of other TriNet employees being assigned to service their accounts, introducing the clients to other TriNet personnel, and&#47;or holding meetings with clients that may or may not include Employee, as Employee&#8217;s manager may elect. Employee agrees and understands that during the Notice Period, Employee owes TriNet an unmitigated duty of loyalty, and that Employee shall do nothing during the Notice Period that Employee intends or reasonably expects to further Employee&#8217;s personal interests or the interests of Employee&#8217;s new employer to the actual or potential detriment of TriNet.   </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.4.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">At Will (United States Employees)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Employees in the United States are employed by TriNet on an at-will basis only. Employee understands and agrees that nothing in the Restricted Stock Unit Award Agreement or this RCA changes the Employee&#8217;s &#34;at will&#34; employment status, and that TriNet may end the employment relationship at any time, with or without notice, for any reason or no reason at all. Likewise, Employee is free to end the employment relationship at any time, subject only to Employee&#8217;s obligation to provide notice in the manner described herein. Without limitation of the foregoing, Employee understands that TriNet retains the right in its absolute and sole discretion to terminate Employee&#8217;s employment after receiving notice from Employee pursuant to this RCA, at which point Employee&#8217;s employment and the Notice Period will come to an end (including any associated obligation by TriNet to continue Employee&#8217;s salary and benefits during the Notice Period), but in no event shall TriNet terminate Employee&#8217;s employment or the Notice Period sooner than two (2) weeks after the date on which Employee gives notice of resignation pursuant to Section 3 (provided, however, that TriNet retains the right as set forth above to determine what duties, if any, will be performed  during such two-week period).</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.4.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Canada</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The foregoing paragraph 3.4 shall not apply to Canada employees,  and TriNet shall not terminate the Employee&#8217;s employment or the Notice Period sooner than the lesser of only&#58; (i) the minimum period of notice prescribed by applicable employment standards legislation, and (ii) two (2) weeks after the date on which Employee gives notice of resignation pursuant to section 3.  TriNet may provide payment in lieu of such notice at its discretion.  In no event will Employee receive less than the minimum requirements prescribed by applicable employment standards legislation and, should such legislation provide for any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">minimum benefit or entitlement in excess of the payment or benefits provided pursuant to this paragraph, Employee will receive such greater minimum entitlement and nothing more.   </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.4.2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">India</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This Section 3.4.2 shall apply to India employees in lieu of the first paragraph of Section 3.4. Subject to the Notice Period requirement above in Section 3.3, either party may terminate the employment without cause by giving prior written notice to the other party as specified in the Employee&#8217;s applicable offer letter from the Company or its Subsidiary or Affiliate that employs Employee (&#8220;TriNet&#8221;), or payment in lieu of such notice by TriNet.  Further, TriNet reserves the right to terminate Employee&#8217;s employment for cause without giving any prior notice or payment in lieu of notice in accordance with its internal policies and the offer letter.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 4.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Non-Solicitation. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Customer Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Employee will not, directly or indirectly, during employment with TriNet and for twelve (12) months following termination or separation of such employment, solicit or attempt to solicit any of TriNet&#8217;s customers or business or patronage of such customers, either for themselves or on behalf of any other person, partnership, corporation, or other entity for the purpose of (i) providing or selling services, goods or products that are the same as or similar to the kinds or types of services, goods or products being provided or sold by TriNet, or (ii) entering into or seeking to enter into any contract or other arrangement with any such entity for the performance or sale of services or goods and products of a nature being provided or sold by TriNet. Employee understands that Employee&#8217;s agreement &#8220;not to solicit&#8221; as set forth in this Section 4.1 means that Employee will not, directly or indirectly, initiate any contact or communication with any entity that, at the time, has a contractual relationship with TriNet for the purpose of soliciting, inviting, encouraging, recommending or requesting any such entity to do business with Employee and&#47;or any other person or entity.  This restriction is limited to (a) customers Employee serviced, solicited or interacted with at any time during the 24 months immediately preceding termination of employment with TriNet&#59; (b) customers serviced or solicited by other TriNet employees whom Employee directly supervised during the 24 months immediately preceding termination of employment with TriNet&#59; and (c) customers about whom Employee had access to Confidential Information during the 24 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.1.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Alabama.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Sub-section 4.1, above, does not apply if the state in which Employee last worked for TriNet was Alabama, in which case Employee will not directly or indirectly, during employment with TriNet and for twelve (12) months following termination or separation of such employment for any reason, solicit any of TriNet&#8217;s current customers, either for Employee&#8217;s own benefit or advantage or on behalf of any other person, partnership, corporation, or other entity, so long as TriNet carries on a like business. This restriction is limited to (a) current customers Employee serviced, solicited or interacted with at any time during the 24 months immediately preceding termination of employment with TriNet&#59; (b) current customers serviced or solicited by other TriNet employees whom Employee directly supervised during the 24 months immediately preceding termination of employment with TriNet&#59; and (c) current customers about whom Employee had access to Confidential Information during the 24 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">California &#38; North Dakota</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.1, above, does not apply if the state in which Employee primarily resides or primarily works for TriNet in California or North Dakota, provided, however, that with respect to Notice of Resignation and Non-Solicitation of customers Employee nevertheless is bound by the terms of Sections 3 and 1.2 above.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. If at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in Colorado while working for TriNet, see Sub-section 6.1 below for important limitations and acknowledgments relating to the restrictions contained in the above Sub-section 4.1.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.4.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Illinois</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Subsection 4.1, above, does not apply if the state in which Employee last worked for TriNet was Illinois unless, as of the time of execution of the Restricted Stock Unit Award Agreement, Employee&#8217;s actual or expected annualized rate of earnings with TriNet exceed Forty-five thousand dollars ($45,000) per year (or such other amount established by existing statutory terms or subsequent statutory modifications).    </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            4.1.5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Nebraska.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Sub-section 4.1 does not apply if the state in which Employee last worked for TriNet was Nebraska, in which case Employee will not, during employment with TriNet and for twelve (12) months following termination or separation of employment, solicit any TriNet current customers with which Employee actually did business and had personal contact during the 18 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.6.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Oklahoma.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Sub-section 4.1 does not apply if the state in which Employee last worked for TriNet was Oklahoma, in which case Employee will not, during employment with TriNet and for twelve (12) months following termination or separation of employment for any reason, directly solicit TriNet&#8217;s established customers or the business or patronage of such established customers either for Employee&#8217;s own purposes or on behalf of any other person, partnership, corporation, or other entity. This restriction on direct solicitation of established customers is further limited to (a) established customers that Employee serviced, solicited, or interacted with at any time during the 24 months immediately preceding Employee&#8217;s termination of employment with TriNet&#59; and (b) established customers serviced or solicited by other TriNet employees whom Employee supervised during the 24 months immediately preceding Employee&#8217;s termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.1.7.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">South Dakota</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. If the state in which Employee last worked for TriNet was South Dakota, enforcement of the restrictions in Section 4.1 will be limited to the geographic area or areas for which Employee was responsible at any time during the twelve (12) months immediately preceding Employee&#8217;s termination of employment with TriNet.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Employee Non-Solicitation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Employee will not, directly or indirectly, during employment with TriNet and for twelve (12) months following termination or separation of employment, solicit or recruit any TriNet employee(s), non-employee director(s) or consultant(s) of TriNet to accept a position with another company or entity, nor otherwise encourage or induce any TriNet employee, non-employee director or consultant to terminate their employment or affiliation with TriNet. This restriction applies only to (a) employees Employee supervised at any time during the 24 months immediately preceding termination of employment with TriNet, (b) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">employees with whom Employee worked in the same office at any time during the 24 months immediately preceding termination of employment with TriNet, and (c) employees with whom Employee otherwise had material contact at any time during the 24 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Alabama</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was Alabama, in which case Employee will not directly or indirectly, during employment with TriNet and for twelve (12) months following termination or separation of employment, hire or employ any agent, servant or employee of TriNet who holds a position uniquely essential to the management, organization, or service of the business of TriNet.  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">California</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee primarily resides or primarily works for TriNet is California, provided, however, that with respect to Non-Solicitation of employees, Employee nevertheless is bound by the terms of Section 1.2 above.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in Colorado while working for TriNet, in which case Employee will not solicit, directly or indirectly, any TriNet employee(s) to leave his&#47;her employment with TriNet. This restriction applies only to (a) employees Employee supervised at any time during the 24 months immediately preceding termination of employment with TriNet, (b) employees with whom Employee worked in the same office at any time during the 24 months immediately preceding termination of employment with TriNet, and (c) employees with whom Employee otherwise had material contact at any time during the 24 months immediately preceding termination of employment with TriNet.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  4.2.4.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Illinois</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was Illinois unless, as of the time of execution of the Restricted Stock Unit Award Agreement, Employee&#8217;s actual or expected annualized rate of earnings with TriNet exceeds forty-five thousand dollars ($45,000) per year (or such other amount established by existing statutory terms or subsequent statutory modifications).</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Nebraska</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was Nebraska, in which case Employee will not, during employment with TriNet and for twelve (12) months following termination or separation of employment, solicit any TriNet current employee with whom Employee had personal contact during the 18 months immediately preceding termination of employment with TriNet. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.6.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">North Dakota</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was North Dakota, in which case Employee will not, during employment with TriNet and for twelve (12) months following the end of Employee&#8217;s employment with TriNet, solicit an employee of TriNet to leave TriNet&#8217;s employment.  This restriction is limited to employees of TriNet with whom Employee had business-related contact or dealings.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.2.7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Oklahoma</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Sub-section 4.2, above, does not apply if the state in which Employee last worked for TriNet was Oklahoma, in which case, during employment and for a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">period of twelve (12) months following the end of Employee&#8217;s employment with TriNet, Employee shall not, directly or indirectly, actively or inactively, solicit any employees or independent contractors of TriNet to become employees or independent contractors of another person or business.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. During Employee&#8217;s employment with TriNet, and for a period of twelve (12) months immediately following termination or separation of such employment for any reason, Employee will not, directly or indirectly, perform on behalf of a competitor the same or similar job duties that Employee performed in Employee&#8217;s last twelve (12) months of employment with TriNet. This restriction will only apply in the geographic territory for which Employee had responsibility in Employee&#8217;s last twelve (12) months of employment with TriNet. Additionally, this restriction will only apply to the performance of job duties competitive with a segment or business line of TriNet&#8217;s business in which Employee worked in his&#47;her last twelve (12) months of employment with TriNet. Employee has the right to consult with Employee&#8217;s counsel prior to accepting the Restricted Stock Unit Award Agreement containing this RCA.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Notwithstanding the foregoing, where applicable, this Section 5 will apply only to the extent permissible under (i) the ABA Model Rules of Professional Conduct&#8217;s provisions regarding restrictions on the right to practice law, and&#47;or (ii) any applicable state counterpart similarly addressing restrictions on the right to practice law. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">California, Oklahoma, Minnesota, Nebraska, North Dakota</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Section 5, above, does not apply if the state in which Employee last worked for TriNet was California, Oklahoma, Minnesota, Nebraska or North Dakota.  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in Colorado while working for TriNet, see Sub-section 6.1 below for important limitations and acknowledgments relating to the restrictions contained in the above Section 5.  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Illinois.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Section 5, above, does not apply if the state in which Employee last worked for TriNet was Illinois unless, as of the time of execution of the Restricted Stock Unit Award Agreement, Employee&#8217;s actual or expected annualized rate of earnings with TriNet exceeds seventy-five thousand dollars ($75,000) per year (or such other amount established by existing statutory terms or subsequent statutory modifications). </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Massachusetts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If Employee is, and has been for at least 30 days immediately preceding Employee&#8217;s cessation of employment, a resident of or employed in Massachusetts at the time of Employee&#8217;s termination of employment, then Employee hereby agrees that Employee&#8217;s acceptance of the Award identified in the Restricted Stock Unit Award Agreement, and Employee&#8217;s enjoyment of the financial opportunities flowing from such participation, provide Employee with a valuable investment opportunity which constitutes other mutually agreed consideration supporting Employee&#8217;s agreement to abide by the restrictions contained herein for purposes of compliance with Massachusetts law relating to non-competition agreements.    </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">The restrictions contained in this Section 5 will not apply in the event Employee is (i) laid off, or (ii) involuntarily terminated by TriNet without Cause. In the event of a termination for Cause (as defined below), however, this Section 5 shall be in full force and effect to the same extent as it would if Employee resigned voluntarily.  The definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:103%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8221; means any of the following&#58; (i) an unsatisfactory level of performance&#59; (ii) a violation of any legal or contractual obligation to TriNet&#59; (iii) non-compliance with TriNet policies or procedures&#59; (iv) substantiated violation of the TriNet Code of Business Conduct and Ethics&#59; (v) the conviction of a felony involving fraud or dishonesty directed against TriNet&#59; or (vi) any willful act or failure to act that adversely affects the business of TriNet in any material respect. For purposes of this definition, &#8220;unsatisfactory level of performance&#8221; means a serious or repeated performance failure, including, without limitation, serious conduct, behavior, or attendance failures that are subject to formal corrective action up to and including termination of employment. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Maine.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If Employee last worked for TriNet in Maine, then Employee acknowledges and agrees that Employee received a copy of this RCA at least three business days before Employee was required to sign the Restricted Stock Unit Award Agreement.  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Oregon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If Employee last worked for TriNet in Oregon and entered the Restricted Stock Unit Award Agreement after the commencement of employment, then Employee hereby agrees that Employee&#8217;s acceptance of the Award identified in the Restricted Stock Unit Award Agreement, and Employee&#8217;s enjoyment of the financial opportunities flowing from such participation, provide Employee with a valuable investment opportunity which constitutes a bona fide advancement of the Employee by TriNet supporting Employee&#8217;s agreement to abide by the restrictions contained herein for purposes of compliance with Oregon law relating to non-competition agreements. Section 5, above, does not apply if Employee last worked for TriNet in Oregon and the total amount of Employee&#8217;s annual gross salary and commissions, calculated on an annual basis, at the time of Employee&#8217;s termination does not exceed $116,427, adjusted annually for inflation pursuant to the Consumer Price Index for All Urban Consumers, West Region (All Items), as published by the Bureau of Labor Statistics of the United States Department of Labor immediately preceding the calendar year of Employee&#8217;s termination.</font><font style="background-color:#ffffff;color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Washington</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If Employee last worked for TriNet in Washington and entered the Restricted Stock Unit Award Agreement at the outset of Employee&#8217;s employment, then Employee hereby acknowledges and agrees that Employee received written notice of the terms in Section 5 prior to accepting the offer of employment with TriNet. If Employee last worked for TriNet in Washington and entered the Restricted Stock Unit Award Agreement after the commencement of employment, then Employee hereby agrees that Employee&#8217;s acceptance of the Award identified in the Restricted Stock Unit Award Agreement, and Employee&#8217;s enjoyment of the financial opportunities flowing from such participation, provide Employee with a valuable investment opportunity which constitutes independent consideration supporting Employee&#8217;s agreement to abide by the restrictions contained herein for purposes of compliance with Washington law relating to non-competition agreements. Section 5, above, does not apply if Employee last worked for TriNet in Washington and the total amount of Employee&#8217;s annualized Earnings does not exceed $123,394.17, adjusted annually for inflation by the Washington Department of Labor and Industries on September 30 of each year, calculated based on the federal Bureau of Labor Statistics&#8217; Consumer Price Index for Urban Wage Earners and Clerical Workers (CPI-W).  Earnings for purposes of this Section 5.3 means the compensation reflected on box 1 of Employee&#8217;s United States Internal Revenue Service Form W-2 that is paid to Employee over the prior year, or portion thereof for which Employee was employed, annualized </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">and calculated as of the earlier of the date enforcement of the noncompetition covenant is sought or the date of separation from employment. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 6.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Reasonableness of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Employee acknowledges and agrees that compliance with the non-disclosure, non-solicitation, and non-competition covenants above is both reasonable and necessary to protect TriNet&#8217;s legitimate business interests, including its confidential business information and trade secrets, its goodwill, its customer and employee relationships and investment therein, and its reputation, and that Employee&#8217;s violation of these covenants is inconsistent with TriNet&#8217;s provision of equity ownership incentive grants as contemplated by the Restricted Stock Unit Award Agreement. Employee further acknowledges and agrees that Employee&#8217;s post-employment competition, and&#47;or Employee&#8217;s solicitation of TriNet customers or personnel during this limited period of time, in violation of the non-competition and non-solicitation covenants above, would be contrary to the purpose, goal, and intent of TriNet&#8217;s agreement to provide Employee with the equity incentive award provided to Employee in the Restricted Stock Unit Award Agreement, and that but for Employee&#8217;s consent to such post-employment restrictions, the equity incentive award herein would not otherwise be awarded to Employee. Employee further acknowledges that Employee&#8217;s participation in equity ownership incentive grants is fully optional on the part of Employee, and that Employee opts to participate fully understanding that the foregoing covenants and restrictions would be conditions of such participation. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.1.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in Colorado while working for TriNet, then the restrictions contained in Sections 4 and 5, above, shall apply and be enforceable only if at the time this Agreement is entered into and at the time it is enforced, Employee earns (a) as to Section 5, an amount of Annualized Cash Compensation equivalent to or greater than the threshold amount to qualify as a Highly Compensated Worker, as the terms Annualized Cash Compensation, Highly Compensated Worker, and Threshold Amount for Highly Compensated Workers are defined in Colorado Revised Statutes Section 8-2-113 or any equivalent Colorado statutory provision that may be in effect at the time of Employee&#8217;s termination of employment with TriNet, or (b) as to Section 4, 60% of the amount set forth immediately above in Sub-section 6.1(a). Employee hereby agrees and acknowledges that&#58; (i) during the course of Employee&#8217;s employment with TriNet, Employee has had access to, gained knowledge of and&#47;or contributed to the development of  trade secret business information  of TriNet&#59; and (ii) the restrictions contained in Sections 1, 3, 4 and 5 are necessary to, and designed for, the protection of TriNet&#8217;s trade secrets by preventing such trade secrets from being disclosed to a competitor or used by a competitor in competition with TriNet.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Illinois</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If Employee last worked for TriNet in Illinois, then TriNet advises Employee to have this RCA reviewed by an attorney of Employee&#8217;s own choosing to receive legal advice about the RCA prior to Employee signing the Restricted Stock Unit Award Agreement.  Employee acknowledges and agrees that Employee received at least 14 days to review this RCA before Employee was required to sign the Restricted Stock Unit Award Agreement, although Employee may choose to sign in fewer than 14 days.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 7.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Irreparable Harm&#47;Injunctive Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Employee acknowledges and agrees that any breach of Employee&#8217;s obligations under the Non-Disclosure, Notice of Resignation, Non-Solicitation, and&#47;or Non-Competition covenants above, as applicable, will result in irreparable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">and continuing harm and injury to TriNet for which there is no adequate remedy at law. Employee further agrees that in the event Employee breaches or threatens to breach the non-disclosure, non-solicitation, and&#47;or non-competition covenants, in addition to any other rights, remedies or damages available to TriNet, TriNet shall be entitled to seek and obtain temporary, preliminary, and permanent injunctive relief to enforce the specific terms of these covenants. Employee further agrees and consents that in any action seeking temporary or preliminary injunctive relief to enforce any of the foregoing restrictions, TriNet and Employee shall be entitled to engage in expedited discovery in aid of proceedings seeking temporary and&#47;or preliminary injunctive relief, including expedited document production, interrogatories, and depositions limited at the expedited stage to those topics that are relevant to temporary and&#47;or preliminary injunctive relief.   </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 8.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Other Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If any provision of this RCA is found to be invalid or unenforceable, the parties hereto agree that a court may modify, alter or amend such provision to the extent necessary to make it enforceable. If a court declines to modify, alter or amend the provision to make it enforceable, then the remaining provisions of this RCA shall remain in full force and effect.  This RCA is assignable by TriNet and will be binding upon and inure to the benefit of TriNet&#8217;s successors, assigns and affiliated entities.  Employee agrees that, should TriNet, or any subsidiary or unit of TriNet in which Employee works, be acquired by, merge with, or otherwise combine with another business entity, TriNet&#8217;s rights under this RCA will be automatically assigned to the surviving entity, and such entity will have all rights to enforce this Agreement.  Employee hereby consents to any such actual or deemed automatic assignment. Notwithstanding the foregoing, Employee may not assign this RCA.  Nothing in this RCA shall be interpreted to limit any obligations owing by Employee to TriNet as a matter of common law, to the extent applicable. Nothing contained in this RCA shall be construed to reduce or limit TriNet&#8217;s right, title or interest in any Company Information or trade secrets so as to be less in any respect than TriNet would have had in the absence of this RCA. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SECTION 9.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Governing Law&#59; Venue&#59; Integration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The terms of this RCA and any disputes arising out of it shall be governed by, and construed in accordance with, the laws of the state or province in which Employee was last employed by TriNet, without giving effect to such state or province&#8217;s conflict of law principles.  Employee agrees and understands that such state or province&#8217;s laws will govern as set forth herein regardless of whether Employee moves Employee&#8217;s residence or place of employment to another state or location after termination of employment with TriNet. Notwithstanding any arbitration agreement that otherwise may exist between Employee and TriNet, Employee and TriNet agree that in the event of any dispute arising under this RCA, any such dispute is not subject to arbitration, and Employee and TriNet instead hereby mutually confer exclusive jurisdiction and venue for any dispute in any way related to this RCA on the state, provincial or federal court having original jurisdiction for the location in which Employee last worked for TriNet, and Employee and TriNet both agree not to bring any litigation in any way related to this RCA in any other court or forum. </font><font style="background-color:#ffffff;color:#232222;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">RCA </font><font style="background-color:#ffffff;color:#232222;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">replaces and supersedes any conflicting provision of any Restrictive Covenant Agreement contained in a prior </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement entered into by the parties under the TriNet Group, Inc. Amended and Restated 2019 Equity Incentive Plan</font><font style="background-color:#ffffff;color:#232222;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="background-color:#ffffff;color:#232222;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">         </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.1.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">California.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  If Employee primarily resides in or primarily works for TriNet in California, notwithstanding anything contained in Section 9 of this RCA, this RCA shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">governed, construed, and enforced in accordance with California law, and the state and&#47;or federal courts of California shall be the sole and exclusive jurisdiction and venue for resolution of any disputes arising under this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.2.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Colorado</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If at the time of Employee&#8217;s termination of employment with TriNet, Employee had been primarily working for TriNet in Colorado or had been primarily residing in Colorado while working for TriNet, then notwithstanding anything contained in Section 9 of this RCA, this RCA shall be governed, construed, and enforced in accordance with Colorado law, and the state and&#47;or federal courts of Colorado shall be the sole and exclusive jurisdiction and venue for resolution of any disputes arising under this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.3.      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Massachusetts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. If Employee is, and has been for at least 30 days immediately preceding Employee&#8217;s cessation of employment, a resident of or employed in Massachusetts at the time of Employee&#8217;s termination of employment, then notwithstanding anything contained in Section 9 of this RCA&#58;  (1) this RCA shall be governed by and construed according to the laws of the Commonwealth of Massachusetts&#59; and (2) Employee consents to the personal jurisdiction of the court located in the county in which Employee resides as of the date of Employee&#8217;s termination of employment and the business litigation session of the Superior Court in Suffolk County, Massachusetts with respect to all matters arising out of or related to this RCA.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">***</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Employee understands and acknowledges that Employee has the right to consult and is encouraged to consult with Employee&#8217;s attorney to obtain legal counsel prior to making the choice to accept the Restricted Stock Unit Award Agreement and this RCA and the restrictions contained herein.  Employee acknowledges that Employee was given at least fourteen (14) days&#8217; notice together with the language of the covenants contained hereinabove, prior to the effective date of the covenants, in which to review the covenants.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">    IN WITNESS WHEREOF, Employee accepts the obligations under this Restrictive Covenant Agreement and will be deemed to have accepted and signed this RCA upon Employee&#8217;s acceptance of the Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement to which it is attached.    </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>tnet-033125xexhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="idff5a4a1985a4f528fe6ec2346255a68_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael Q. Simonds, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this quarterly report on Form&#160;10-Q of TriNet Group,&#160;Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer&#160;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) &#160;&#160;&#160;&#160;evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer&#160;and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 25, 2025</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael Q. Simonds</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Q. Simonds</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>tnet-033125xexhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i262b74acd46641919371b25859f90264_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kelly Tuminelli, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this quarterly report on Form&#160;10-Q of TriNet Group,&#160;Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer&#160;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) &#160;&#160;&#160;&#160;evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer&#160;and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 25, 2025</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kelly Tuminelli</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kelly Tuminelli</font></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>tnet-033125xexhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i8d51c1b2123e4fcfa4f2bd3bc6257dd4_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of TriNet Group,&#160;Inc., a Delaware corporation (the &#8220;Company&#8221;), on Form&#160;10-Q for the period ending March&#160;31, 2025 as filed with the U.S. Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned officers of the Company does hereby certify, pursuant to 18 U.S.C. &#167; 1350 (section 906 of the Sarbanes-Oxley Act of 2002), that&#58;</font></div><div style="margin-top:6pt;padding-left:33.75pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.28pt">The Report containing the financial statements fully complies with the requirements of section 13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d))&#59; and</font></div><div style="margin-top:6pt;padding-left:33.75pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.28pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification (i)&#160;is given to such officers&#8217; knowledge, based upon such officers&#8217; investigation as such officers reasonably deem appropriate&#59; and (ii)&#160;is being furnished solely pursuant to 18 U.S.C. &#167; 1350 (section 906 of the Sarbanes-Oxley Act of 2002) and is not being filed as part of the Report or as a separate disclosure document and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 25, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael Q. Simonds</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Q. Simonds</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 25, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kelly Tuminelli</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kelly Tuminelli</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-top:7pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>tnet-20250331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:104eff25-bde6-411e-ba54-56469600d7a1,g:ffef9025-6e41-425a-998c-b582f585f1c3-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:tnet="http://www.trinet.com/20250331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.trinet.com/20250331">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tnet-20250331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tnet-20250331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tnet-20250331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tnet-20250331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.trinet.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited" roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited">
        <link:definition>9952151 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited">
        <link:definition>9952152 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical">
        <link:definition>9952153 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited">
        <link:definition>9952154 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
        <link:definition>9952155 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>9952156 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED" roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED">
        <link:definition>9952157 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTS" roleURI="http://www.trinet.com/role/INVESTMENTS">
        <link:definition>9952158 - Disclosure - INVESTMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDWORKERSCOMPENSATIONCOSTS" roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTS">
        <link:definition>9952159 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.trinet.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>9952160 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>9952161 - Disclosure - STOCK BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITY">
        <link:definition>9952162 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.trinet.com/role/INCOMETAXES">
        <link:definition>9952163 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.trinet.com/role/EARNINGSPERSHARE">
        <link:definition>9952164 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURING" roleURI="http://www.trinet.com/role/RESTRUCTURING">
        <link:definition>9952165 - Disclosure - RESTRUCTURING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATION" roleURI="http://www.trinet.com/role/SEGMENTINFORMATION">
        <link:definition>9952166 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>9955511 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>9955512 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables" roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables">
        <link:definition>9955513 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSTables" roleURI="http://www.trinet.com/role/INVESTMENTSTables">
        <link:definition>9955514 - Disclosure - INVESTMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDWORKERSCOMPENSATIONCOSTSTables" roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSTables">
        <link:definition>9955515 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>9955516 - Disclosure - STOCK BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>9955517 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.trinet.com/role/EARNINGSPERSHARETables">
        <link:definition>9955518 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGTables" roleURI="http://www.trinet.com/role/RESTRUCTURINGTables">
        <link:definition>9955519 - Disclosure - RESTRUCTURING (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.trinet.com/role/SEGMENTINFORMATIONTables">
        <link:definition>9955520 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails">
        <link:definition>9955521 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails" roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails">
        <link:definition>9955522 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Assets and Liabilities of the Trust (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails" roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails">
        <link:definition>9955523 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Worksite Employee Changes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails" roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails">
        <link:definition>9955524 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails" roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails">
        <link:definition>9955525 - Disclosure - INVESTMENTS - Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails" roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails">
        <link:definition>9955526 - Disclosure - INVESTMENTS - Schedule of Fair value of Debt Investments by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails" roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails">
        <link:definition>9955527 - Disclosure - INVESTMENTS - Schedule of Available-for-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSAdditionalInformationDetails" roleURI="http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails">
        <link:definition>9955528 - Disclosure - INVESTMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails" roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails">
        <link:definition>9955529 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Loss Reserve Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails" roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails">
        <link:definition>9955530 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1" roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1">
        <link:definition>9955530 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails" roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails">
        <link:definition>9955531 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONAdditionalInformationDetails" roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails">
        <link:definition>9955532 - Disclosure - STOCK BASED COMPENSATION - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails" roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails">
        <link:definition>9955533 - Disclosure - STOCK BASED COMPENSATION - Schedule of RSU and RSA Activity under Equity-Based Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails" roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails">
        <link:definition>9955534 - Disclosure - STOCK BASED COMPENSATION - Schedule of stock option activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofStockOptionsDetails" roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofStockOptionsDetails">
        <link:definition>9955535 - Disclosure - STOCK BASED COMPENSATION - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofShareBasedPaymentArrangementActivityDetails" roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofShareBasedPaymentArrangementActivityDetails">
        <link:definition>9955536 - Disclosure - STOCK BASED COMPENSATION - Schedule of Share-Based Payment Arrangement, Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails">
        <link:definition>9955537 - Disclosure - STOCK BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofCommonStockDetails" roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails">
        <link:definition>9955538 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYAdditionalInformationDetails" roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails">
        <link:definition>9955539 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.trinet.com/role/INCOMETAXESDetails">
        <link:definition>9955540 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails" roleURI="http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails">
        <link:definition>9955541 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGNarrativeDetails" roleURI="http://www.trinet.com/role/RESTRUCTURINGNarrativeDetails">
        <link:definition>9955542 - Disclosure - RESTRUCTURING - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails" roleURI="http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails">
        <link:definition>9955543 - Disclosure - RESTRUCTURING - Schedule of Changes in Accrued Severance and Exit and Disposal Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONAdditionalInformationDetails" roleURI="http://www.trinet.com/role/SEGMENTINFORMATIONAdditionalInformationDetails">
        <link:definition>9955544 - Disclosure - SEGMENT INFORMATION - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" roleURI="http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails">
        <link:definition>9955545 - Disclosure - SEGMENT INFORMATION - Schedule of Segment Reporting Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="tnet_ProfessionalServicesMember" abstract="true" name="ProfessionalServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_InsuranceServicesMember" abstract="true" name="InsuranceServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" abstract="false" name="CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_InterestExpenseBankFeesAndOther" abstract="false" name="InterestExpenseBankFeesAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_OtherPayrollAssetsCurrent" abstract="false" name="OtherPayrollAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" abstract="false" name="CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" abstract="false" name="AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_InsurancePremiumsAndOtherPayables" abstract="false" name="InsurancePremiumsAndOtherPayables" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_IncreaseDecreaseInOtherPayrollAssets" abstract="false" name="IncreaseDecreaseInOtherPayrollAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet" abstract="false" name="ChangeInVariableInterestEntityAssetsAndLiabilitiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable" abstract="false" name="NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_CashCashEquivalentsAndInvestmentsTextBlock" abstract="false" name="CashCashEquivalentsAndInvestmentsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock" abstract="false" name="ScheduleOfWorksiteEmployeeChangesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="tnet_TriNetTrustMember" abstract="true" name="TriNetTrustMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified" abstract="false" name="NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified" abstract="false" name="NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_AvailableForSaleMarketableSecuritiesMember" abstract="true" name="AvailableForSaleMarketableSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_CollateralbyTypeAxis" abstract="true" name="CollateralbyTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="tnet_CollateralByTypeDomain" abstract="true" name="CollateralByTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="tnet_PayrollFundsCollectedMember" abstract="true" name="PayrollFundsCollectedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_HealthBenefitClaimsCollateralMember" abstract="true" name="HealthBenefitClaimsCollateralMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_WorkersCompensationClaimsCollateralMember" abstract="true" name="WorkersCompensationClaimsCollateralMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_TrustForOurHRISUsersCollateralMember" abstract="true" name="TrustForOurHRISUsersCollateralMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="tnet_InsuranceCarriersSecurityDepositsMember" abstract="true" name="InsuranceCarriersSecurityDepositsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember" abstract="true" name="RestrictedCashAndCashEquivalentsAndInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_A2029NotesPayableMember" abstract="true" name="A2029NotesPayableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_A2031NotesPayableMember" abstract="true" name="A2031NotesPayableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" abstract="false" name="CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" abstract="false" name="CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_CollateralHeldByInsuranceCarriers" abstract="false" name="CollateralHeldByInsuranceCarriers" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_TimeBasedRestrictedStockUnitsMember" abstract="true" name="TimeBasedRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" abstract="true" name="PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_PerformanceBasedRestrictedStockUnitsMember" abstract="true" name="PerformanceBasedRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="tnet_AggregateIntrinsicValueRollForward" abstract="true" name="AggregateIntrinsicValueRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_SystemsDevelopmentAndProgrammingCostsMember" abstract="true" name="SystemsDevelopmentAndProgrammingCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_IncomeTaxesDisclosureTable" abstract="true" name="IncomeTaxesDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="tnet_IncomeTaxesDisclosureLineItems" abstract="true" name="IncomeTaxesDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="tnet_AccruedSalariesCurrentMember" abstract="true" name="AccruedSalariesCurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="tnet_RestructuringChargesAdditions" abstract="false" name="RestructuringChargesAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_RestructuringChargesPayments" abstract="false" name="RestructuringChargesPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="tnet_WorkersCompensationCosts" abstract="false" name="WorkersCompensationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_HealthInsuranceCosts" abstract="false" name="HealthInsuranceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther" abstract="false" name="SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_ClientSupportCosts" abstract="false" name="ClientSupportCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_CorporateAdministrationExpenses" abstract="false" name="CorporateAdministrationExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_SystemSupportAndDevelopmentExpenses" abstract="false" name="SystemSupportAndDevelopmentExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>tnet-20250331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:104eff25-bde6-411e-ba54-56469600d7a1,g:ffef9025-6e41-425a-998c-b582f585f1c3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="tnet-20250331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c3c6f351-02de-45d9-af9b-d4259f5e1b49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f221d898-38ab-4d42-96e0-f1e94ab2b335" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c3c6f351-02de-45d9-af9b-d4259f5e1b49" xlink:to="loc_us-gaap_NetIncomeLoss_f221d898-38ab-4d42-96e0-f1e94ab2b335" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_068eb164-0f08-4cd5-92a0-3a5955fcc479" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c3c6f351-02de-45d9-af9b-d4259f5e1b49" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_068eb164-0f08-4cd5-92a0-3a5955fcc479" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_99e0b958-2670-47f7-bfd7-a9e1d7abf87c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_8b80644a-95d0-4715-adee-b9d703f9deda" xlink:href="tnet-20250331.xsd#tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_99e0b958-2670-47f7-bfd7-a9e1d7abf87c" xlink:to="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_8b80644a-95d0-4715-adee-b9d703f9deda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_23729654-22b7-47fc-9f4e-b229c3f9f98e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_99e0b958-2670-47f7-bfd7-a9e1d7abf87c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_23729654-22b7-47fc-9f4e-b229c3f9f98e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_c03c24b4-6aea-4f97-9590-1674474d0e02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_99e0b958-2670-47f7-bfd7-a9e1d7abf87c" xlink:to="loc_us-gaap_SellingAndMarketingExpense_c03c24b4-6aea-4f97-9590-1674474d0e02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_c43e1eed-39fb-4596-9e11-e6fd30043f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_99e0b958-2670-47f7-bfd7-a9e1d7abf87c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_c43e1eed-39fb-4596-9e11-e6fd30043f5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction_3c17ea58-8679-4182-a13e-a00e8dfa5ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingInsuranceAndClaimsCostsProduction"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_99e0b958-2670-47f7-bfd7-a9e1d7abf87c" xlink:to="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction_3c17ea58-8679-4182-a13e-a00e8dfa5ec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InterestExpenseBankFeesAndOther_a5100cd2-2f5e-4363-91ac-0b1187574d6d" xlink:href="tnet-20250331.xsd#tnet_InterestExpenseBankFeesAndOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_99e0b958-2670-47f7-bfd7-a9e1d7abf87c" xlink:to="loc_tnet_InterestExpenseBankFeesAndOther_a5100cd2-2f5e-4363-91ac-0b1187574d6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_7d0225f0-2eac-4500-ac5e-5e77e13958fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_99e0b958-2670-47f7-bfd7-a9e1d7abf87c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_7d0225f0-2eac-4500-ac5e-5e77e13958fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_783b27ff-f149-4c0e-837e-a60c63b1d02b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_dc55dc92-0e5d-45a2-9a1b-923dcffea066" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_783b27ff-f149-4c0e-837e-a60c63b1d02b" xlink:to="loc_us-gaap_CostsAndExpenses_dc55dc92-0e5d-45a2-9a1b-923dcffea066" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_537263b3-9e9c-4e9d-8cb2-77ee0606bb27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_783b27ff-f149-4c0e-837e-a60c63b1d02b" xlink:to="loc_us-gaap_Revenues_537263b3-9e9c-4e9d-8cb2-77ee0606bb27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e978b151-098f-4009-ae90-0f95f07b49d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b92418f8-0664-4fde-9ba8-ebb287a99a95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_e978b151-098f-4009-ae90-0f95f07b49d6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b92418f8-0664-4fde-9ba8-ebb287a99a95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_845da9fd-4d57-40ed-a1cc-765ca32bc748" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_e978b151-098f-4009-ae90-0f95f07b49d6" xlink:to="loc_us-gaap_InterestIncomeOperating_845da9fd-4d57-40ed-a1cc-765ca32bc748" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b118e5d3-73e6-4e52-b9f0-822dc5d4c348" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_409e9de0-33d7-4b0e-8a8c-96ee8ec604e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b118e5d3-73e6-4e52-b9f0-822dc5d4c348" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_409e9de0-33d7-4b0e-8a8c-96ee8ec604e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ac441243-1b60-4edb-93a1-c0fb0369c62a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b118e5d3-73e6-4e52-b9f0-822dc5d4c348" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ac441243-1b60-4edb-93a1-c0fb0369c62a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="tnet-20250331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a8ba4266-08a2-417d-a192-1e84cce7bcf4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_c4dd2235-0bff-46a2-996e-f27e200d3851" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a8ba4266-08a2-417d-a192-1e84cce7bcf4" xlink:to="loc_us-gaap_PreferredStockValue_c4dd2235-0bff-46a2-996e-f27e200d3851" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_f80ea9d0-bba7-498d-bb8d-e8fac2513c17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a8ba4266-08a2-417d-a192-1e84cce7bcf4" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_f80ea9d0-bba7-498d-bb8d-e8fac2513c17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8b3a1dce-d28c-463b-bd34-b3fcfac39ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a8ba4266-08a2-417d-a192-1e84cce7bcf4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8b3a1dce-d28c-463b-bd34-b3fcfac39ebe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f0bd649b-fd9c-42fc-b468-26cf6b560710" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a8ba4266-08a2-417d-a192-1e84cce7bcf4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f0bd649b-fd9c-42fc-b468-26cf6b560710" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7993079d-6dec-4051-a2d4-ae6bdf0c38dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a0dde806-3286-48b3-a517-c67ad4067ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7993079d-6dec-4051-a2d4-ae6bdf0c38dd" xlink:to="loc_us-gaap_LiabilitiesCurrent_a0dde806-3286-48b3-a517-c67ad4067ec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_125acd37-b931-4ecd-aa1b-1e4ed8fb76bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7993079d-6dec-4051-a2d4-ae6bdf0c38dd" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_125acd37-b931-4ecd-aa1b-1e4ed8fb76bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_b3b45d42-d817-4e9e-99fc-3f229f9324f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7993079d-6dec-4051-a2d4-ae6bdf0c38dd" xlink:to="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_b3b45d42-d817-4e9e-99fc-3f229f9324f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4d74581c-f055-420a-8bd4-a99bed6e8c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7993079d-6dec-4051-a2d4-ae6bdf0c38dd" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4d74581c-f055-420a-8bd4-a99bed6e8c2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ec2bb107-019e-4c87-bf13-89927d8d33c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7993079d-6dec-4051-a2d4-ae6bdf0c38dd" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ec2bb107-019e-4c87-bf13-89927d8d33c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7c43472d-bd94-4732-80b0-58e2b3bc4965" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7993079d-6dec-4051-a2d4-ae6bdf0c38dd" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7c43472d-bd94-4732-80b0-58e2b3bc4965" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_541a2bef-47b3-4f25-868a-165dfc19fd69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2adb7d39-758e-4d28-85d8-5cc10db45f24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_541a2bef-47b3-4f25-868a-165dfc19fd69" xlink:to="loc_us-gaap_AssetsCurrent_2adb7d39-758e-4d28-85d8-5cc10db45f24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_6771c5f9-a728-4aac-8369-dc899e140b33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_541a2bef-47b3-4f25-868a-165dfc19fd69" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_6771c5f9-a728-4aac-8369-dc899e140b33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2fee5918-da08-4f71-81eb-6bfc5b0f71d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_541a2bef-47b3-4f25-868a-165dfc19fd69" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2fee5918-da08-4f71-81eb-6bfc5b0f71d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_d847c8d0-a386-44fa-aae3-882b7efdba84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_541a2bef-47b3-4f25-868a-165dfc19fd69" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_d847c8d0-a386-44fa-aae3-882b7efdba84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_22b47df0-acbc-4e3b-b07f-e673c4267f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_541a2bef-47b3-4f25-868a-165dfc19fd69" xlink:to="loc_us-gaap_Goodwill_22b47df0-acbc-4e3b-b07f-e673c4267f5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_71f3c925-98dd-4b4b-80a9-25612469a0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_541a2bef-47b3-4f25-868a-165dfc19fd69" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_71f3c925-98dd-4b4b-80a9-25612469a0f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ce5479be-b0d2-49f9-bd29-6cd04bb6a51c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_541a2bef-47b3-4f25-868a-165dfc19fd69" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ce5479be-b0d2-49f9-bd29-6cd04bb6a51c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2fd6613d-b944-4c6d-a4e5-1520b7a48bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a02adc4b-131a-460b-8d14-2725d6654a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2fd6613d-b944-4c6d-a4e5-1520b7a48bc7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a02adc4b-131a-460b-8d14-2725d6654a4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_1ffcce80-13f7-4aa7-b8bc-3a748d7878d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2fd6613d-b944-4c6d-a4e5-1520b7a48bc7" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_1ffcce80-13f7-4aa7-b8bc-3a748d7878d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_616bbf65-c30c-447a-b445-35d41a454162" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2fd6613d-b944-4c6d-a4e5-1520b7a48bc7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_616bbf65-c30c-447a-b445-35d41a454162" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_5efec1eb-d383-4e45-988c-cc2a11bd4c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2fd6613d-b944-4c6d-a4e5-1520b7a48bc7" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_5efec1eb-d383-4e45-988c-cc2a11bd4c6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_c2afb2b7-00fe-40c3-9f69-2603d539a8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2fd6613d-b944-4c6d-a4e5-1520b7a48bc7" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_c2afb2b7-00fe-40c3-9f69-2603d539a8f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_OtherPayrollAssetsCurrent_8e23fae2-c305-43ed-ae0b-16dba1d6246f" xlink:href="tnet-20250331.xsd#tnet_OtherPayrollAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2fd6613d-b944-4c6d-a4e5-1520b7a48bc7" xlink:to="loc_tnet_OtherPayrollAssetsCurrent_8e23fae2-c305-43ed-ae0b-16dba1d6246f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_ff079d13-cbcf-40b1-8709-12ed36be437a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2fd6613d-b944-4c6d-a4e5-1520b7a48bc7" xlink:to="loc_us-gaap_OtherAssetsCurrent_ff079d13-cbcf-40b1-8709-12ed36be437a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_683a5e1a-1989-4ddf-b4a3-bac180f59de2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_93d2979a-433e-49ce-9fbf-a5d87ac70140" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_683a5e1a-1989-4ddf-b4a3-bac180f59de2" xlink:to="loc_us-gaap_Liabilities_93d2979a-433e-49ce-9fbf-a5d87ac70140" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1336c35b-0ef2-4203-84e5-0ba5d8b1037e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_683a5e1a-1989-4ddf-b4a3-bac180f59de2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1336c35b-0ef2-4203-84e5-0ba5d8b1037e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7f6d3d3a-7147-4aa6-b345-961479fa1894" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_683a5e1a-1989-4ddf-b4a3-bac180f59de2" xlink:to="loc_us-gaap_StockholdersEquity_7f6d3d3a-7147-4aa6-b345-961479fa1894" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e78329e0-a40a-4ed8-bde5-6a138fa425cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_71b21039-6a4b-41eb-b658-a7e370c630f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e78329e0-a40a-4ed8-bde5-6a138fa425cc" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_71b21039-6a4b-41eb-b658-a7e370c630f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0588ba87-11cc-41e8-a858-a97817d5cfce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e78329e0-a40a-4ed8-bde5-6a138fa425cc" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0588ba87-11cc-41e8-a858-a97817d5cfce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_0d271e18-c4fc-448d-8a39-a34b9fd8162d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e78329e0-a40a-4ed8-bde5-6a138fa425cc" xlink:to="loc_us-gaap_AccruedSalariesCurrent_0d271e18-c4fc-448d-8a39-a34b9fd8162d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent_891df658-d049-419e-bfea-e3d74461408d" xlink:href="tnet-20250331.xsd#tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e78329e0-a40a-4ed8-bde5-6a138fa425cc" xlink:to="loc_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent_891df658-d049-419e-bfea-e3d74461408d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_ea37d4b3-fb6c-46b1-9aec-438cda3e70e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e78329e0-a40a-4ed8-bde5-6a138fa425cc" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_ea37d4b3-fb6c-46b1-9aec-438cda3e70e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_04209c59-85fb-46b2-bd8d-43e246e88a74" xlink:href="tnet-20250331.xsd#tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e78329e0-a40a-4ed8-bde5-6a138fa425cc" xlink:to="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_04209c59-85fb-46b2-bd8d-43e246e88a74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4096232f-6c75-4a32-af95-ae6b29107195" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e78329e0-a40a-4ed8-bde5-6a138fa425cc" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4096232f-6c75-4a32-af95-ae6b29107195" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsurancePremiumsAndOtherPayables_b3c3c5f1-077f-4a81-a70f-60d05045ea12" xlink:href="tnet-20250331.xsd#tnet_InsurancePremiumsAndOtherPayables"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e78329e0-a40a-4ed8-bde5-6a138fa425cc" xlink:to="loc_tnet_InsurancePremiumsAndOtherPayables_b3c3c5f1-077f-4a81-a70f-60d05045ea12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_810e1d04-defc-4c87-b7b8-5ca79ae321de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e78329e0-a40a-4ed8-bde5-6a138fa425cc" xlink:to="loc_us-gaap_LinesOfCreditCurrent_810e1d04-defc-4c87-b7b8-5ca79ae321de" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="tnet-20250331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f06310f8-b86e-46b9-965d-31f646e06cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9b2d86b2-ce1d-4ce4-921e-64b8f1ca2d01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f06310f8-b86e-46b9-965d-31f646e06cf4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9b2d86b2-ce1d-4ce4-921e-64b8f1ca2d01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6f80716f-9296-4f0a-b1c0-976b18d46d61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f06310f8-b86e-46b9-965d-31f646e06cf4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6f80716f-9296-4f0a-b1c0-976b18d46d61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eeafedd6-fc1e-4c54-a609-ce629792bba5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f06310f8-b86e-46b9-965d-31f646e06cf4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eeafedd6-fc1e-4c54-a609-ce629792bba5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_64620ac1-2f43-4edb-b4cc-f1bc4dae05b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet_6b730d83-8a54-428b-81d9-a5907e9ebf15" xlink:href="tnet-20250331.xsd#tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_64620ac1-2f43-4edb-b4cc-f1bc4dae05b0" xlink:to="loc_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet_6b730d83-8a54-428b-81d9-a5907e9ebf15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_b591db1c-1ea7-4cd0-8588-ac52237f633f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_64620ac1-2f43-4edb-b4cc-f1bc4dae05b0" xlink:to="loc_us-gaap_PaymentsOfDividends_b591db1c-1ea7-4cd0-8588-ac52237f633f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6702f47f-a38e-43d4-be76-78f3341026f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_64620ac1-2f43-4edb-b4cc-f1bc4dae05b0" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6702f47f-a38e-43d4-be76-78f3341026f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_968322d7-b5a8-42d9-9bd7-ab59671a455a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_64620ac1-2f43-4edb-b4cc-f1bc4dae05b0" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_968322d7-b5a8-42d9-9bd7-ab59671a455a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0e108e73-a01e-4968-91ca-678ab8164cba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_ea6c4948-63db-4a90-983a-f4869f1c3756" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0e108e73-a01e-4968-91ca-678ab8164cba" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_ea6c4948-63db-4a90-983a-f4869f1c3756" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_4a6e7af2-e7e3-4d61-9f04-0b4153f16cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0e108e73-a01e-4968-91ca-678ab8164cba" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_4a6e7af2-e7e3-4d61-9f04-0b4153f16cd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_64beb2a1-3b85-4bb2-89b8-69a7cb2e16c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0e108e73-a01e-4968-91ca-678ab8164cba" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_64beb2a1-3b85-4bb2-89b8-69a7cb2e16c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_34fc9e02-f7bc-483d-afc8-f3114d3b3254" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0e108e73-a01e-4968-91ca-678ab8164cba" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_34fc9e02-f7bc-483d-afc8-f3114d3b3254" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_be8cbbac-c8a3-4636-9380-7ae843bca937" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_NetIncomeLoss_be8cbbac-c8a3-4636-9380-7ae843bca937" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_b4e75195-b29d-48ea-aeb2-9ead4d97624c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_b4e75195-b29d-48ea-aeb2-9ead4d97624c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_41e29226-ba8d-4f47-8577-02548027f00f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_41e29226-ba8d-4f47-8577-02548027f00f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_057de372-9b46-4490-83ea-dcc0006428b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_ShareBasedCompensation_057de372-9b46-4490-83ea-dcc0006428b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2c125c7b-3d32-494a-a9b3-e22ef3e96f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2c125c7b-3d32-494a-a9b3-e22ef3e96f3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_b71a04c2-7e0b-419c-a166-7d33b0a03d08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_b71a04c2-7e0b-419c-a166-7d33b0a03d08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_05d8d1ff-e386-4044-8c9f-3da0c5bb63f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_05d8d1ff-e386-4044-8c9f-3da0c5bb63f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncreaseDecreaseInOtherPayrollAssets_e8910837-7c22-4b31-888a-8754671b55c4" xlink:href="tnet-20250331.xsd#tnet_IncreaseDecreaseInOtherPayrollAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_tnet_IncreaseDecreaseInOtherPayrollAssets_e8910837-7c22-4b31-888a-8754671b55c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_3727531e-6262-40ae-91c3-fdc7381eda36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_3727531e-6262-40ae-91c3-fdc7381eda36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4c514e60-121a-45f8-9e82-a04a2cdb8933" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4c514e60-121a-45f8-9e82-a04a2cdb8933" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_861646f3-4b2f-4ec2-812c-15168e52af43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_861646f3-4b2f-4ec2-812c-15168e52af43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_fce15b6d-3db4-4160-a22b-aadc5df64799" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_fce15b6d-3db4-4160-a22b-aadc5df64799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_00cffd4e-7918-4378-8058-138a888d21ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_00cffd4e-7918-4378-8058-138a888d21ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_2880a45b-1a9f-40be-89ea-12f862f29fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_2880a45b-1a9f-40be-89ea-12f862f29fc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_189df63f-f96e-4268-bce0-1f37ee148db8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_189df63f-f96e-4268-bce0-1f37ee148db8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_03a998f4-2f25-4b61-8065-c1c7ab2da9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_03a998f4-2f25-4b61-8065-c1c7ab2da9c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_3538f6ae-3123-4b5a-acdb-bb6949ade395" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_3538f6ae-3123-4b5a-acdb-bb6949ade395" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_4db3f342-07c7-433d-8e1b-f4a32ecd8d30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_4db3f342-07c7-433d-8e1b-f4a32ecd8d30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_1c81a975-82e9-4050-934d-71dd23f0f411" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_GainLossOnInvestments_1c81a975-82e9-4050-934d-71dd23f0f411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_50f47e1b-1ae8-4dc2-96dc-4082dd2b069d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80b7355-2705-4d17-ad75-a8801e34415d" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_50f47e1b-1ae8-4dc2-96dc-4082dd2b069d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestments_3ae9efbe-313a-4a6d-be76-eca28349525f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_55f12e5f-30c2-4969-b38f-f35771f94e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestrictedCashAndInvestments_3ae9efbe-313a-4a6d-be76-eca28349525f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_55f12e5f-30c2-4969-b38f-f35771f94e1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_6e3666fa-0979-4b09-b318-ebc5426178c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestrictedCashAndInvestments_3ae9efbe-313a-4a6d-be76-eca28349525f" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_6e3666fa-0979-4b09-b318-ebc5426178c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_e965ee5d-6f89-4601-9c5a-75ce8a292949" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestrictedCashAndInvestments_3ae9efbe-313a-4a6d-be76-eca28349525f" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_e965ee5d-6f89-4601-9c5a-75ce8a292949" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d164ad5c-7bb7-4079-a620-a115ebce175d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0c0f03e9-ffe2-42ef-b9a8-7efbaacc27e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d164ad5c-7bb7-4079-a620-a115ebce175d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0c0f03e9-ffe2-42ef-b9a8-7efbaacc27e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_32ae8637-933f-45c4-ab9b-6393ec46ed8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d164ad5c-7bb7-4079-a620-a115ebce175d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_32ae8637-933f-45c4-ab9b-6393ec46ed8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d232138b-83d1-40bd-9d52-bd06efa691aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d164ad5c-7bb7-4079-a620-a115ebce175d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d232138b-83d1-40bd-9d52-bd06efa691aa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_d478f2e1-2fe3-423b-b085-20de60811461" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d001b4c5-a34d-45a8-bf7b-eb1b175e2160" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_d478f2e1-2fe3-423b-b085-20de60811461" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d001b4c5-a34d-45a8-bf7b-eb1b175e2160" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_6fcc6a7a-9c27-4289-b1e4-3e082077a67b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_d478f2e1-2fe3-423b-b085-20de60811461" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_6fcc6a7a-9c27-4289-b1e4-3e082077a67b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_a274fec7-df90-4aba-9ddd-91dc5f7e3b99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_d478f2e1-2fe3-423b-b085-20de60811461" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_a274fec7-df90-4aba-9ddd-91dc5f7e3b99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_3a2dbe2a-43c8-4d2f-9fa7-865d10be0eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_d478f2e1-2fe3-423b-b085-20de60811461" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_3a2dbe2a-43c8-4d2f-9fa7-865d10be0eb5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f91a713d-f1c8-44fb-9fa8-e87fbd3aa50d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_dfe1840a-f7fc-4ed6-80de-85fdc040d94c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f91a713d-f1c8-44fb-9fa8-e87fbd3aa50d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_dfe1840a-f7fc-4ed6-80de-85fdc040d94c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_07091d04-1576-4df5-bbc4-5396bafe954a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f91a713d-f1c8-44fb-9fa8-e87fbd3aa50d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_07091d04-1576-4df5-bbc4-5396bafe954a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_b7a64655-9fa8-4416-8f5a-6e060c539a97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_8257544a-ddbd-4e58-92a3-b923dd99c867" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_b7a64655-9fa8-4416-8f5a-6e060c539a97" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_8257544a-ddbd-4e58-92a3-b923dd99c867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_69d1fdab-84fb-4bc1-bc19-0f42140b5eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_b7a64655-9fa8-4416-8f5a-6e060c539a97" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_69d1fdab-84fb-4bc1-bc19-0f42140b5eb8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_fe701d22-6806-4e1b-8ea2-8d4e30ad3c39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_ced96af5-67fe-4646-a522-f11fed5c834d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_fe701d22-6806-4e1b-8ea2-8d4e30ad3c39" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_ced96af5-67fe-4646-a522-f11fed5c834d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_4f5709c6-4c6b-4a88-9e7c-760677b76ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_fe701d22-6806-4e1b-8ea2-8d4e30ad3c39" xlink:to="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_4f5709c6-4c6b-4a88-9e7c-760677b76ddc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1" xlink:type="simple" xlink:href="tnet-20250331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_533b1793-c1e4-455f-9abe-752148bbf7da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_3198aa11-3efa-4101-818c-94514495a3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_533b1793-c1e4-455f-9abe-752148bbf7da" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_3198aa11-3efa-4101-818c-94514495a3a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_dc668335-861a-4431-928e-cd6f617f62a0" xlink:href="tnet-20250331.xsd#tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_533b1793-c1e4-455f-9abe-752148bbf7da" xlink:to="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_dc668335-861a-4431-928e-cd6f617f62a0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8eb4923f-d2f8-4166-9616-ada73cc3dd44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_45c02931-c455-4b3f-8eb9-bb8c376a5f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8eb4923f-d2f8-4166-9616-ada73cc3dd44" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_45c02931-c455-4b3f-8eb9-bb8c376a5f6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_233c8520-9e67-4738-b71a-dd14063addb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8eb4923f-d2f8-4166-9616-ada73cc3dd44" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_233c8520-9e67-4738-b71a-dd14063addb8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_38d7864c-6c3d-4761-bacf-cbd2cacbf4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InterestExpenseBankFeesAndOther_34d6741a-3f15-4cec-8eeb-b6767426c1f6" xlink:href="tnet-20250331.xsd#tnet_InterestExpenseBankFeesAndOther"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_38d7864c-6c3d-4761-bacf-cbd2cacbf4e4" xlink:to="loc_tnet_InterestExpenseBankFeesAndOther_34d6741a-3f15-4cec-8eeb-b6767426c1f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CorporateAdministrationExpenses_c87de4f1-946a-4520-8e9c-1f50f0b52432" xlink:href="tnet-20250331.xsd#tnet_CorporateAdministrationExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_38d7864c-6c3d-4761-bacf-cbd2cacbf4e4" xlink:to="loc_tnet_CorporateAdministrationExpenses_c87de4f1-946a-4520-8e9c-1f50f0b52432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_SystemSupportAndDevelopmentExpenses_6ccb336d-b19a-46f9-8ef2-b845c969201e" xlink:href="tnet-20250331.xsd#tnet_SystemSupportAndDevelopmentExpenses"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_38d7864c-6c3d-4761-bacf-cbd2cacbf4e4" xlink:to="loc_tnet_SystemSupportAndDevelopmentExpenses_6ccb336d-b19a-46f9-8ef2-b845c969201e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_WorkersCompensationCosts_c6ea3a39-aa4e-46bd-800a-03db3f8ea880" xlink:href="tnet-20250331.xsd#tnet_WorkersCompensationCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_38d7864c-6c3d-4761-bacf-cbd2cacbf4e4" xlink:to="loc_tnet_WorkersCompensationCosts_c6ea3a39-aa4e-46bd-800a-03db3f8ea880" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_9ef41b87-623d-4b47-b669-12b00299e1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_38d7864c-6c3d-4761-bacf-cbd2cacbf4e4" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_9ef41b87-623d-4b47-b669-12b00299e1b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther_22c5cdc2-51a2-4edd-a588-ea26ab62af3e" xlink:href="tnet-20250331.xsd#tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_38d7864c-6c3d-4761-bacf-cbd2cacbf4e4" xlink:to="loc_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther_22c5cdc2-51a2-4edd-a588-ea26ab62af3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7f39b9d3-2144-4b39-a883-a0f5a383775a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_38d7864c-6c3d-4761-bacf-cbd2cacbf4e4" xlink:to="loc_us-gaap_Revenues_7f39b9d3-2144-4b39-a883-a0f5a383775a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_52022127-785f-4ff7-b07f-cad6478d2bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_38d7864c-6c3d-4761-bacf-cbd2cacbf4e4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_52022127-785f-4ff7-b07f-cad6478d2bc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7893a21a-4e88-4161-b0c9-e9359b06da23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_38d7864c-6c3d-4761-bacf-cbd2cacbf4e4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7893a21a-4e88-4161-b0c9-e9359b06da23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_HealthInsuranceCosts_3b6cd53e-8b98-454f-b2bf-4437e07f5dcc" xlink:href="tnet-20250331.xsd#tnet_HealthInsuranceCosts"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_38d7864c-6c3d-4761-bacf-cbd2cacbf4e4" xlink:to="loc_tnet_HealthInsuranceCosts_3b6cd53e-8b98-454f-b2bf-4437e07f5dcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_f750d4b6-b13c-4d58-b58b-affa3777f391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_38d7864c-6c3d-4761-bacf-cbd2cacbf4e4" xlink:to="loc_us-gaap_OtherExpenses_f750d4b6-b13c-4d58-b58b-affa3777f391" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ClientSupportCosts_43536571-fd0a-4afd-8373-0e57bcf6c3b5" xlink:href="tnet-20250331.xsd#tnet_ClientSupportCosts"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_38d7864c-6c3d-4761-bacf-cbd2cacbf4e4" xlink:to="loc_tnet_ClientSupportCosts_43536571-fd0a-4afd-8373-0e57bcf6c3b5" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>tnet-20250331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:104eff25-bde6-411e-ba54-56469600d7a1,g:ffef9025-6e41-425a-998c-b582f585f1c3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="tnet-20250331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a6468ab7-723d-4216-8c10-233e13aa0717" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_StatementTable_a6468ab7-723d-4216-8c10-233e13aa0717" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bc908600-389e-40c0-a8b2-e0d881d35149" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a6468ab7-723d-4216-8c10-233e13aa0717" xlink:to="loc_srt_ProductOrServiceAxis_bc908600-389e-40c0-a8b2-e0d881d35149" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bc908600-389e-40c0-a8b2-e0d881d35149_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_bc908600-389e-40c0-a8b2-e0d881d35149" xlink:to="loc_srt_ProductsAndServicesDomain_bc908600-389e-40c0-a8b2-e0d881d35149_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_14212c3f-4832-41e1-b789-b4277867c2b6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_bc908600-389e-40c0-a8b2-e0d881d35149" xlink:to="loc_srt_ProductsAndServicesDomain_14212c3f-4832-41e1-b789-b4277867c2b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ProfessionalServicesMember_4e36f5bd-92b4-45aa-8476-09b03d017883" xlink:href="tnet-20250331.xsd#tnet_ProfessionalServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_14212c3f-4832-41e1-b789-b4277867c2b6" xlink:to="loc_tnet_ProfessionalServicesMember_4e36f5bd-92b4-45aa-8476-09b03d017883" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsuranceServicesMember_e3e855d8-d86b-4288-b909-a565f0ea5e38" xlink:href="tnet-20250331.xsd#tnet_InsuranceServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_14212c3f-4832-41e1-b789-b4277867c2b6" xlink:to="loc_tnet_InsuranceServicesMember_e3e855d8-d86b-4288-b909-a565f0ea5e38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_15147a3d-cb63-430c-8c98-9f3278364c29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_15147a3d-cb63-430c-8c98-9f3278364c29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_06376dcb-1e0d-495e-9ffd-2d14124c0857" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_InterestIncomeOperating_06376dcb-1e0d-495e-9ffd-2d14124c0857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dc4b8570-99ed-4278-bc01-f74d7352572a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_Revenues_dc4b8570-99ed-4278-bc01-f74d7352572a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction_4bdc0e4e-8a16-48a2-ba7f-209781c73cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingInsuranceAndClaimsCostsProduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction_4bdc0e4e-8a16-48a2-ba7f-209781c73cb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_797802ce-3807-4d9c-ae20-fd4eff0bdf0d" xlink:href="tnet-20250331.xsd#tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_797802ce-3807-4d9c-ae20-fd4eff0bdf0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_9637aa3f-1c09-41c3-9363-3c6193db7f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_SellingAndMarketingExpense_9637aa3f-1c09-41c3-9363-3c6193db7f0c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_aeb02685-04ac-41e3-9580-d80678ef821b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_aeb02685-04ac-41e3-9580-d80678ef821b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d23263ad-4d88-40c4-aaa9-b391e8e746c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d23263ad-4d88-40c4-aaa9-b391e8e746c1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_afb85671-8392-4ddc-a632-6b0be00470c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_afb85671-8392-4ddc-a632-6b0be00470c6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InterestExpenseBankFeesAndOther_5a41cf3b-d726-4fbb-b985-f743f8e53993" xlink:href="tnet-20250331.xsd#tnet_InterestExpenseBankFeesAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_tnet_InterestExpenseBankFeesAndOther_5a41cf3b-d726-4fbb-b985-f743f8e53993" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f61d9473-a0f8-4ec0-a05e-d3948966d22c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_CostsAndExpenses_f61d9473-a0f8-4ec0-a05e-d3948966d22c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5dc3f5c9-7da9-41cd-93a6-45db8ba56a06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5dc3f5c9-7da9-41cd-93a6-45db8ba56a06" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3d9b47cc-ed9d-4406-9c46-5dfd8738dc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3d9b47cc-ed9d-4406-9c46-5dfd8738dc4e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7c68f0f5-973c-472d-86de-3003c08a217f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_NetIncomeLoss_7c68f0f5-973c-472d-86de-3003c08a217f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c2a98a26-827e-4583-9c9e-8c47e79ac592" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c2a98a26-827e-4583-9c9e-8c47e79ac592" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1eb46cc3-6652-48e4-937c-4f3e422e4c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_1eb46cc3-6652-48e4-937c-4f3e422e4c0f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_53d3284c-4246-408b-a613-6828e83f25a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_EarningsPerShareAbstract_53d3284c-4246-408b-a613-6828e83f25a4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4547c750-4d83-44a9-8b4c-15fb066010db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_53d3284c-4246-408b-a613-6828e83f25a4" xlink:to="loc_us-gaap_EarningsPerShareBasic_4547c750-4d83-44a9-8b4c-15fb066010db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7d15236b-2987-4d61-bb8d-9ad20957d4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_53d3284c-4246-408b-a613-6828e83f25a4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7d15236b-2987-4d61-bb8d-9ad20957d4ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_70f40f43-1ec9-4499-8ee8-29f523d13382" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_70f40f43-1ec9-4499-8ee8-29f523d13382" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6cf9464e-58bc-4027-a5b2-c67bfb973815" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_70f40f43-1ec9-4499-8ee8-29f523d13382" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6cf9464e-58bc-4027-a5b2-c67bfb973815" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d1c68757-7046-4489-8bff-3a973103328c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_70f40f43-1ec9-4499-8ee8-29f523d13382" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d1c68757-7046-4489-8bff-3a973103328c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="tnet-20250331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_23c865a8-f16d-4047-9283-b101ca3d010b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e409a4fc-d84c-4d97-9f7f-00d86cdf0081" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_23c865a8-f16d-4047-9283-b101ca3d010b" xlink:to="loc_us-gaap_StatementTable_e409a4fc-d84c-4d97-9f7f-00d86cdf0081" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_da1c47f7-ec7e-4a4c-b420-df6373f5057f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e409a4fc-d84c-4d97-9f7f-00d86cdf0081" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_da1c47f7-ec7e-4a4c-b420-df6373f5057f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_da1c47f7-ec7e-4a4c-b420-df6373f5057f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_da1c47f7-ec7e-4a4c-b420-df6373f5057f" xlink:to="loc_us-gaap_EquityComponentDomain_da1c47f7-ec7e-4a4c-b420-df6373f5057f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c0d92ff7-2be2-4bbc-aac6-3670976d6074" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_da1c47f7-ec7e-4a4c-b420-df6373f5057f" xlink:to="loc_us-gaap_EquityComponentDomain_c0d92ff7-2be2-4bbc-aac6-3670976d6074" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_583db9c4-fdca-402d-9e38-6dd02aedb9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c0d92ff7-2be2-4bbc-aac6-3670976d6074" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_583db9c4-fdca-402d-9e38-6dd02aedb9d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d59ca275-a896-40cf-84e0-cf883ecf657c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c0d92ff7-2be2-4bbc-aac6-3670976d6074" xlink:to="loc_us-gaap_RetainedEarningsMember_d59ca275-a896-40cf-84e0-cf883ecf657c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7a8816a5-2f67-4b23-a1a3-03904c405290" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c0d92ff7-2be2-4bbc-aac6-3670976d6074" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7a8816a5-2f67-4b23-a1a3-03904c405290" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_23c865a8-f16d-4047-9283-b101ca3d010b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1334c2cf-65e8-4782-abd3-1515e2e6825c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_StockholdersEquity_1334c2cf-65e8-4782-abd3-1515e2e6825c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b1233923-87d5-46ba-ab25-8ab6b20f512d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b1233923-87d5-46ba-ab25-8ab6b20f512d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f5c9e804-05c9-4875-86f9-09e72bd9b692" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_NetIncomeLoss_f5c9e804-05c9-4875-86f9-09e72bd9b692" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockStock_0e2fa0ce-51fc-46b7-b1e4-20f8160e2549" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCommonStockStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_DividendsCommonStockStock_0e2fa0ce-51fc-46b7-b1e4-20f8160e2549" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_bc0a0505-70f3-4276-9646-4fedc1b89319" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_bc0a0505-70f3-4276-9646-4fedc1b89319" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_cdb8c8cb-8931-481a-b5ab-e42961cb98e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_cdb8c8cb-8931-481a-b5ab-e42961cb98e2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fab00452-f2d1-4ac3-90eb-566b6b501a63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fab00452-f2d1-4ac3-90eb-566b6b501a63" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_13427d9e-a387-40bc-8dce-d76ca1fcae47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_71944ac7-f91a-4443-91ec-16cf0d72508a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_566e644a-d6ba-4da4-9341-7cfc3232cd97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_71944ac7-f91a-4443-91ec-16cf0d72508a" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_566e644a-d6ba-4da4-9341-7cfc3232cd97" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_19ace032-5f20-4cb9-aba0-0cb1ec2d0080" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_566e644a-d6ba-4da4-9341-7cfc3232cd97" xlink:to="loc_srt_StatementGeographicalAxis_19ace032-5f20-4cb9-aba0-0cb1ec2d0080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_19ace032-5f20-4cb9-aba0-0cb1ec2d0080_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_19ace032-5f20-4cb9-aba0-0cb1ec2d0080" xlink:to="loc_srt_SegmentGeographicalDomain_19ace032-5f20-4cb9-aba0-0cb1ec2d0080_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_494bdf66-d039-4eb8-b943-b02eef057d2e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_19ace032-5f20-4cb9-aba0-0cb1ec2d0080" xlink:to="loc_srt_SegmentGeographicalDomain_494bdf66-d039-4eb8-b943-b02eef057d2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_0501d540-1291-42ba-9908-a3ef315fd43f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_494bdf66-d039-4eb8-b943-b02eef057d2e" xlink:to="loc_us-gaap_NonUsMember_0501d540-1291-42ba-9908-a3ef315fd43f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d6a343c1-1ce3-446c-b614-4a9c13f0916b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_566e644a-d6ba-4da4-9341-7cfc3232cd97" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d6a343c1-1ce3-446c-b614-4a9c13f0916b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d6a343c1-1ce3-446c-b614-4a9c13f0916b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d6a343c1-1ce3-446c-b614-4a9c13f0916b" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d6a343c1-1ce3-446c-b614-4a9c13f0916b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6b0f871e-2f42-450b-9432-7c392f227f81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d6a343c1-1ce3-446c-b614-4a9c13f0916b" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6b0f871e-2f42-450b-9432-7c392f227f81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_2ea475c5-8927-4cfc-91ed-8d5337dbd42a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6b0f871e-2f42-450b-9432-7c392f227f81" xlink:to="loc_us-gaap_SalesRevenueNetMember_2ea475c5-8927-4cfc-91ed-8d5337dbd42a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_dc4f8437-c50e-4a74-b153-8dea79f10694" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_566e644a-d6ba-4da4-9341-7cfc3232cd97" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_dc4f8437-c50e-4a74-b153-8dea79f10694" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_dc4f8437-c50e-4a74-b153-8dea79f10694_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_dc4f8437-c50e-4a74-b153-8dea79f10694" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_dc4f8437-c50e-4a74-b153-8dea79f10694_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_28272d7d-2364-4453-9f34-da5f5a7dc3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_dc4f8437-c50e-4a74-b153-8dea79f10694" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_28272d7d-2364-4453-9f34-da5f5a7dc3d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_cc7fd23c-faf5-43c0-862b-fb966f7a6b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_28272d7d-2364-4453-9f34-da5f5a7dc3d6" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_cc7fd23c-faf5-43c0-862b-fb966f7a6b0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_4d4ac682-5c37-4a99-ac64-4c3738f95f99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_566e644a-d6ba-4da4-9341-7cfc3232cd97" xlink:to="loc_us-gaap_NatureOfExpenseAxis_4d4ac682-5c37-4a99-ac64-4c3738f95f99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_4d4ac682-5c37-4a99-ac64-4c3738f95f99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_4d4ac682-5c37-4a99-ac64-4c3738f95f99" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_4d4ac682-5c37-4a99-ac64-4c3738f95f99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_dc656f19-126d-4eaf-91bf-f71585b25c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_4d4ac682-5c37-4a99-ac64-4c3738f95f99" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_dc656f19-126d-4eaf-91bf-f71585b25c7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember_2fea7009-0f1d-439a-88f4-8ce4f35d36a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_dc656f19-126d-4eaf-91bf-f71585b25c7a" xlink:to="loc_us-gaap_HealthCareMember_2fea7009-0f1d-439a-88f4-8ce4f35d36a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_a763a6a0-5f02-4d57-8cab-f7dc96300096" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_71944ac7-f91a-4443-91ec-16cf0d72508a" xlink:to="loc_us-gaap_NumberOfReportableSegments_a763a6a0-5f02-4d57-8cab-f7dc96300096" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_68410deb-71c2-4455-a103-153e72dafe32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_71944ac7-f91a-4443-91ec-16cf0d72508a" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_68410deb-71c2-4455-a103-153e72dafe32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_afea2d46-63ee-4768-9d1e-1e4460253f02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_71944ac7-f91a-4443-91ec-16cf0d72508a" xlink:to="loc_us-gaap_PrepaidInsurance_afea2d46-63ee-4768-9d1e-1e4460253f02" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_4a8381bd-3f3b-46a1-9ab2-7882c86efe86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9024873e-4560-4121-9e94-67479f1f79b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4a8381bd-3f3b-46a1-9ab2-7882c86efe86" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9024873e-4560-4121-9e94-67479f1f79b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_18f31293-b4e5-42f2-9007-ca8ed7c95f16" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9024873e-4560-4121-9e94-67479f1f79b4" xlink:to="loc_srt_ConsolidatedEntitiesAxis_18f31293-b4e5-42f2-9007-ca8ed7c95f16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_18f31293-b4e5-42f2-9007-ca8ed7c95f16_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_18f31293-b4e5-42f2-9007-ca8ed7c95f16" xlink:to="loc_srt_ConsolidatedEntitiesDomain_18f31293-b4e5-42f2-9007-ca8ed7c95f16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f2e298f9-3d07-42f8-b6d2-de4fd29a428d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_18f31293-b4e5-42f2-9007-ca8ed7c95f16" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f2e298f9-3d07-42f8-b6d2-de4fd29a428d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TriNetTrustMember_1f59383e-6a9a-42ae-b8d1-8b4d99a05d9a" xlink:href="tnet-20250331.xsd#tnet_TriNetTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f2e298f9-3d07-42f8-b6d2-de4fd29a428d" xlink:to="loc_tnet_TriNetTrustMember_1f59383e-6a9a-42ae-b8d1-8b4d99a05d9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c4e34db8-1669-4f00-97c7-7e2a87771cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4a8381bd-3f3b-46a1-9ab2-7882c86efe86" xlink:to="loc_us-gaap_AssetsAbstract_c4e34db8-1669-4f00-97c7-7e2a87771cbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f864bb4b-6cb9-4d13-9b3a-640c12f1e22d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_c4e34db8-1669-4f00-97c7-7e2a87771cbb" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f864bb4b-6cb9-4d13-9b3a-640c12f1e22d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_01c5b5f9-9072-46d8-a4fa-29292d9d5fad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f864bb4b-6cb9-4d13-9b3a-640c12f1e22d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_01c5b5f9-9072-46d8-a4fa-29292d9d5fad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_60e04ad1-73a0-4584-9323-02176358b7fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f864bb4b-6cb9-4d13-9b3a-640c12f1e22d" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_60e04ad1-73a0-4584-9323-02176358b7fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_752f4227-a909-4ee4-925d-345936a985d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f864bb4b-6cb9-4d13-9b3a-640c12f1e22d" xlink:to="loc_us-gaap_AssetsCurrent_752f4227-a909-4ee4-925d-345936a985d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ccdbc149-872f-482f-95a7-f3db4e55ae68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f864bb4b-6cb9-4d13-9b3a-640c12f1e22d" xlink:to="loc_us-gaap_Assets_ccdbc149-872f-482f-95a7-f3db4e55ae68" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_bc3d29d0-c168-46dd-8a65-8476bca94320" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4a8381bd-3f3b-46a1-9ab2-7882c86efe86" xlink:to="loc_us-gaap_LiabilitiesAbstract_bc3d29d0-c168-46dd-8a65-8476bca94320" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_642cd544-30a2-44bf-9c59-6678202a97d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_bc3d29d0-c168-46dd-8a65-8476bca94320" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_642cd544-30a2-44bf-9c59-6678202a97d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_94f2b176-7f7c-4ee6-989d-e6f2aad59477" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_642cd544-30a2-44bf-9c59-6678202a97d1" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_94f2b176-7f7c-4ee6-989d-e6f2aad59477" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_7d853336-eeff-41db-b595-7a21c3f62cab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_642cd544-30a2-44bf-9c59-6678202a97d1" xlink:to="loc_us-gaap_AccruedSalariesCurrent_7d853336-eeff-41db-b595-7a21c3f62cab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_54b43c2d-45be-4c3a-856e-7733dcf34bc2" xlink:href="tnet-20250331.xsd#tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_642cd544-30a2-44bf-9c59-6678202a97d1" xlink:to="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_54b43c2d-45be-4c3a-856e-7733dcf34bc2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_38314140-cb43-4990-a5c4-3f90f2784fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_642cd544-30a2-44bf-9c59-6678202a97d1" xlink:to="loc_us-gaap_LiabilitiesCurrent_38314140-cb43-4990-a5c4-3f90f2784fa3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6f231169-ae2d-4924-860c-d2284301ca0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_642cd544-30a2-44bf-9c59-6678202a97d1" xlink:to="loc_us-gaap_Liabilities_6f231169-ae2d-4924-860c-d2284301ca0e" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementTable_2f6ae491-2077-4e25-9c64-6f39e9b3b0aa" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CondensedCashFlowStatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_srt_CondensedCashFlowStatementTable_2f6ae491-2077-4e25-9c64-6f39e9b3b0aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_e1bd85e3-75e7-46a2-90bd-66029889c338" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedCashFlowStatementTable_2f6ae491-2077-4e25-9c64-6f39e9b3b0aa" xlink:to="loc_srt_RestatementAxis_e1bd85e3-75e7-46a2-90bd-66029889c338" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_e1bd85e3-75e7-46a2-90bd-66029889c338_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_e1bd85e3-75e7-46a2-90bd-66029889c338" xlink:to="loc_srt_RestatementDomain_e1bd85e3-75e7-46a2-90bd-66029889c338_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_89ff7484-40ea-460d-83e4-8bab2873cc13" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_e1bd85e3-75e7-46a2-90bd-66029889c338" xlink:to="loc_srt_RestatementDomain_89ff7484-40ea-460d-83e4-8bab2873cc13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_03a7d6df-c82e-40a9-92e4-280a22c3118c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_89ff7484-40ea-460d-83e4-8bab2873cc13" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_03a7d6df-c82e-40a9-92e4-280a22c3118c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_854af3f8-3cbd-4be7-8cdb-73b30deeca80" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_89ff7484-40ea-460d-83e4-8bab2873cc13" xlink:to="loc_srt_RestatementAdjustmentMember_854af3f8-3cbd-4be7-8cdb-73b30deeca80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a7c88654-5824-411f-9d61-bdb6f9baf238" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a7c88654-5824-411f-9d61-bdb6f9baf238" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_d8643d29-cd17-4d9e-b71e-d3cc72785598" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_d8643d29-cd17-4d9e-b71e-d3cc72785598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_6b0defb1-fee5-4f26-bfe6-f5b20023a86e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_6b0defb1-fee5-4f26-bfe6-f5b20023a86e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncreaseDecreaseInOtherPayrollAssets_ef2826aa-f1e3-4df1-9113-2f06188f2f79" xlink:href="tnet-20250331.xsd#tnet_IncreaseDecreaseInOtherPayrollAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_tnet_IncreaseDecreaseInOtherPayrollAssets_ef2826aa-f1e3-4df1-9113-2f06188f2f79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_61109d3d-5e1b-4c36-acf6-3a141585b0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_61109d3d-5e1b-4c36-acf6-3a141585b0d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_02c21c24-7cd9-4003-961f-119942576c54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_02c21c24-7cd9-4003-961f-119942576c54" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_6db384d2-eb9e-4d59-886d-f3b74321643e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_6db384d2-eb9e-4d59-886d-f3b74321643e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_81d0f8b0-c14d-46a1-864a-481b2e53863a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_81d0f8b0-c14d-46a1-864a-481b2e53863a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_dd0c8d13-ecf1-4c7d-8ce2-44bc0012a01f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_dd0c8d13-ecf1-4c7d-8ce2-44bc0012a01f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_9dec5e3b-bb7c-4b3f-aa63-a8f6c3a76716" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_9dec5e3b-bb7c-4b3f-aa63-a8f6c3a76716" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified_23669668-22f5-4c6a-b64c-be34c2b7a34b" xlink:href="tnet-20250331.xsd#tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified_23669668-22f5-4c6a-b64c-be34c2b7a34b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet_d5b91957-11fc-40af-9f3d-2e9ff6f67b04" xlink:href="tnet-20250331.xsd#tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet_d5b91957-11fc-40af-9f3d-2e9ff6f67b04" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified_cd5edc48-bbea-425b-8c20-bb1e4ef531a7" xlink:href="tnet-20250331.xsd#tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified_cd5edc48-bbea-425b-8c20-bb1e4ef531a7" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_9161e060-119a-47cb-bbe2-000cd19913d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_0cac3ed6-07f3-46e9-ae0b-ff0553b59811" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_9161e060-119a-47cb-bbe2-000cd19913d4" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_0cac3ed6-07f3-46e9-ae0b-ff0553b59811" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9799cac6-ee64-4b34-80a4-03068e1b7b50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_0cac3ed6-07f3-46e9-ae0b-ff0553b59811" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9799cac6-ee64-4b34-80a4-03068e1b7b50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9799cac6-ee64-4b34-80a4-03068e1b7b50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9799cac6-ee64-4b34-80a4-03068e1b7b50" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9799cac6-ee64-4b34-80a4-03068e1b7b50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f4b04d7-d4bd-4e65-bd88-6610ab49b43f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9799cac6-ee64-4b34-80a4-03068e1b7b50" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f4b04d7-d4bd-4e65-bd88-6610ab49b43f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_287fad6c-4567-4f9f-86ce-8454a6bf9a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f4b04d7-d4bd-4e65-bd88-6610ab49b43f" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_287fad6c-4567-4f9f-86ce-8454a6bf9a5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AvailableForSaleMarketableSecuritiesMember_0b930851-bab0-4550-ae30-d4f6dd10e2d7" xlink:href="tnet-20250331.xsd#tnet_AvailableForSaleMarketableSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f4b04d7-d4bd-4e65-bd88-6610ab49b43f" xlink:to="loc_tnet_AvailableForSaleMarketableSecuritiesMember_0b930851-bab0-4550-ae30-d4f6dd10e2d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralbyTypeAxis_59f18ce5-da8d-41c7-a491-cc3599702247" xlink:href="tnet-20250331.xsd#tnet_CollateralbyTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_0cac3ed6-07f3-46e9-ae0b-ff0553b59811" xlink:to="loc_tnet_CollateralbyTypeAxis_59f18ce5-da8d-41c7-a491-cc3599702247" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralByTypeDomain_59f18ce5-da8d-41c7-a491-cc3599702247_default" xlink:href="tnet-20250331.xsd#tnet_CollateralByTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_tnet_CollateralbyTypeAxis_59f18ce5-da8d-41c7-a491-cc3599702247" xlink:to="loc_tnet_CollateralByTypeDomain_59f18ce5-da8d-41c7-a491-cc3599702247_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralByTypeDomain_6c8db68b-663e-4b56-90da-ca7c848fb67b" xlink:href="tnet-20250331.xsd#tnet_CollateralByTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_tnet_CollateralbyTypeAxis_59f18ce5-da8d-41c7-a491-cc3599702247" xlink:to="loc_tnet_CollateralByTypeDomain_6c8db68b-663e-4b56-90da-ca7c848fb67b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PayrollFundsCollectedMember_da4eb71a-3c3a-4ab1-be25-b20118d3812f" xlink:href="tnet-20250331.xsd#tnet_PayrollFundsCollectedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tnet_CollateralByTypeDomain_6c8db68b-663e-4b56-90da-ca7c848fb67b" xlink:to="loc_tnet_PayrollFundsCollectedMember_da4eb71a-3c3a-4ab1-be25-b20118d3812f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_HealthBenefitClaimsCollateralMember_a82356de-ab09-430b-b1b8-d207ca6acceb" xlink:href="tnet-20250331.xsd#tnet_HealthBenefitClaimsCollateralMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tnet_CollateralByTypeDomain_6c8db68b-663e-4b56-90da-ca7c848fb67b" xlink:to="loc_tnet_HealthBenefitClaimsCollateralMember_a82356de-ab09-430b-b1b8-d207ca6acceb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_WorkersCompensationClaimsCollateralMember_ccdb34b5-b282-4c75-872c-9e314182823e" xlink:href="tnet-20250331.xsd#tnet_WorkersCompensationClaimsCollateralMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tnet_CollateralByTypeDomain_6c8db68b-663e-4b56-90da-ca7c848fb67b" xlink:to="loc_tnet_WorkersCompensationClaimsCollateralMember_ccdb34b5-b282-4c75-872c-9e314182823e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TrustForOurHRISUsersCollateralMember_f65eeae4-fb99-422e-a4f8-5d3eb46c6b09" xlink:href="tnet-20250331.xsd#tnet_TrustForOurHRISUsersCollateralMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tnet_CollateralByTypeDomain_6c8db68b-663e-4b56-90da-ca7c848fb67b" xlink:to="loc_tnet_TrustForOurHRISUsersCollateralMember_f65eeae4-fb99-422e-a4f8-5d3eb46c6b09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsuranceCarriersSecurityDepositsMember_9f421bf5-6ecb-4290-b4c5-a8f97273a03d" xlink:href="tnet-20250331.xsd#tnet_InsuranceCarriersSecurityDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tnet_CollateralByTypeDomain_6c8db68b-663e-4b56-90da-ca7c848fb67b" xlink:to="loc_tnet_InsuranceCarriersSecurityDepositsMember_9f421bf5-6ecb-4290-b4c5-a8f97273a03d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c40d805c-949f-4cab-990c-153d37c94f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_9161e060-119a-47cb-bbe2-000cd19913d4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c40d805c-949f-4cab-990c-153d37c94f2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_eae1d66b-a5ea-4905-99bb-0dee8609cd06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_9161e060-119a-47cb-bbe2-000cd19913d4" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_eae1d66b-a5ea-4905-99bb-0dee8609cd06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_05426cb8-2d28-41b2-8fbc-6ae70c79e40e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_9161e060-119a-47cb-bbe2-000cd19913d4" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_05426cb8-2d28-41b2-8fbc-6ae70c79e40e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestments_39053678-e8b9-44f1-8817-8ac8960e3bde" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_9161e060-119a-47cb-bbe2-000cd19913d4" xlink:to="loc_us-gaap_RestrictedCashAndInvestments_39053678-e8b9-44f1-8817-8ac8960e3bde" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2cf7228-77ab-4f8d-a7a5-3c2db2f69e40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2cf7228-77ab-4f8d-a7a5-3c2db2f69e40" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_9a749d34-ad45-464e-84bb-01a43271c7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_9a749d34-ad45-464e-84bb-01a43271c7bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_9a749d34-ad45-464e-84bb-01a43271c7bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_9a749d34-ad45-464e-84bb-01a43271c7bd" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_9a749d34-ad45-464e-84bb-01a43271c7bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6859ed10-6841-4bab-b9c3-0afbe19a2349" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_9a749d34-ad45-464e-84bb-01a43271c7bd" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6859ed10-6841-4bab-b9c3-0afbe19a2349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_5a753614-97d7-40cb-9d9c-f4f7db3bd552" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6859ed10-6841-4bab-b9c3-0afbe19a2349" xlink:to="loc_us-gaap_MoneyMarketFundsMember_5a753614-97d7-40cb-9d9c-f4f7db3bd552" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_d4cf9f3c-946a-439b-8edf-b66129e871f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6859ed10-6841-4bab-b9c3-0afbe19a2349" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_d4cf9f3c-946a-439b-8edf-b66129e871f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_dfae378f-59ae-4a3e-936f-a55dbe25e032" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_dfae378f-59ae-4a3e-936f-a55dbe25e032" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dfae378f-59ae-4a3e-936f-a55dbe25e032_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_dfae378f-59ae-4a3e-936f-a55dbe25e032" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dfae378f-59ae-4a3e-936f-a55dbe25e032_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c54154ac-2ad8-4a15-adf6-5072ab2d649d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_dfae378f-59ae-4a3e-936f-a55dbe25e032" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c54154ac-2ad8-4a15-adf6-5072ab2d649d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_bfaa6721-ef49-4a87-bbad-bf6b7e43d906" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c54154ac-2ad8-4a15-adf6-5072ab2d649d" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_bfaa6721-ef49-4a87-bbad-bf6b7e43d906" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9d1e8750-bfad-4e2c-821b-84525449dbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c54154ac-2ad8-4a15-adf6-5072ab2d649d" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9d1e8750-bfad-4e2c-821b-84525449dbc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_35c5818f-30a6-4b2c-9aac-9853af5a9d12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c54154ac-2ad8-4a15-adf6-5072ab2d649d" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_35c5818f-30a6-4b2c-9aac-9853af5a9d12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_5277dac3-97b3-48c6-be7b-539b4fc39170" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c54154ac-2ad8-4a15-adf6-5072ab2d649d" xlink:to="loc_us-gaap_CertificatesOfDepositMember_5277dac3-97b3-48c6-be7b-539b4fc39170" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d28ef4b-7b9f-4a8f-b8da-86abaf46e964" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d28ef4b-7b9f-4a8f-b8da-86abaf46e964" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4d28ef4b-7b9f-4a8f-b8da-86abaf46e964_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d28ef4b-7b9f-4a8f-b8da-86abaf46e964" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4d28ef4b-7b9f-4a8f-b8da-86abaf46e964_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8f36d02f-04f4-4f52-bad4-d8ad6393da4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d28ef4b-7b9f-4a8f-b8da-86abaf46e964" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8f36d02f-04f4-4f52-bad4-d8ad6393da4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b33d3a3d-aa3b-452f-a554-2e5be350a340" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8f36d02f-04f4-4f52-bad4-d8ad6393da4f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b33d3a3d-aa3b-452f-a554-2e5be350a340" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22401419-51a5-43bb-b804-edd99768ef71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22401419-51a5-43bb-b804-edd99768ef71" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22401419-51a5-43bb-b804-edd99768ef71_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22401419-51a5-43bb-b804-edd99768ef71" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22401419-51a5-43bb-b804-edd99768ef71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a5d66f6-0f5c-4c1c-9cd7-c5ec0da74016" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22401419-51a5-43bb-b804-edd99768ef71" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a5d66f6-0f5c-4c1c-9cd7-c5ec0da74016" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_7bd5ccb5-3faa-4b54-b6df-b78278b44088" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a5d66f6-0f5c-4c1c-9cd7-c5ec0da74016" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_7bd5ccb5-3faa-4b54-b6df-b78278b44088" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ae854b85-7895-4b44-ba3e-93775adf6e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a5d66f6-0f5c-4c1c-9cd7-c5ec0da74016" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ae854b85-7895-4b44-ba3e-93775adf6e2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a1b00529-06ab-4cd7-87c2-83dca77e6b70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a1b00529-06ab-4cd7-87c2-83dca77e6b70" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a1b00529-06ab-4cd7-87c2-83dca77e6b70_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a1b00529-06ab-4cd7-87c2-83dca77e6b70" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a1b00529-06ab-4cd7-87c2-83dca77e6b70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3bd1ddb2-6e20-4108-87b8-162be0ee773d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a1b00529-06ab-4cd7-87c2-83dca77e6b70" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3bd1ddb2-6e20-4108-87b8-162be0ee773d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_92b43a86-ce5d-4d4f-8b28-16c1fc16a9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3bd1ddb2-6e20-4108-87b8-162be0ee773d" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_92b43a86-ce5d-4d4f-8b28-16c1fc16a9fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_c65095ac-93ab-421a-8ff1-6223505484de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3bd1ddb2-6e20-4108-87b8-162be0ee773d" xlink:to="loc_us-gaap_InvestmentsMember_c65095ac-93ab-421a-8ff1-6223505484de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember_4a502ed8-c4ad-4065-9dd8-7782066ade6e" xlink:href="tnet-20250331.xsd#tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3bd1ddb2-6e20-4108-87b8-162be0ee773d" xlink:to="loc_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember_4a502ed8-c4ad-4065-9dd8-7782066ade6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_af441310-95ee-46a7-8e24-e5ad74fbf60c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2cf7228-77ab-4f8d-a7a5-3c2db2f69e40" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_af441310-95ee-46a7-8e24-e5ad74fbf60c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_fb7d3492-4bd5-461d-99a9-3480e6a240cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_af441310-95ee-46a7-8e24-e5ad74fbf60c" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_fb7d3492-4bd5-461d-99a9-3480e6a240cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_31486a36-9287-48de-a413-206a3bd808ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_af441310-95ee-46a7-8e24-e5ad74fbf60c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_31486a36-9287-48de-a413-206a3bd808ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_99be5d53-723a-423d-98d7-18dc811f1d10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_af441310-95ee-46a7-8e24-e5ad74fbf60c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_99be5d53-723a-423d-98d7-18dc811f1d10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_dd8f6d18-1e5c-44fd-a9f2-34d8bce65c15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_af441310-95ee-46a7-8e24-e5ad74fbf60c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_dd8f6d18-1e5c-44fd-a9f2-34d8bce65c15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_46d0bca9-1f3e-49d7-94b2-393e30c2faf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_af441310-95ee-46a7-8e24-e5ad74fbf60c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_46d0bca9-1f3e-49d7-94b2-393e30c2faf5" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#INVESTMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d957883a-2aae-46b8-9321-3d8f722750c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ff5f2b81-e048-42a6-96bf-482a1c74ca27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d957883a-2aae-46b8-9321-3d8f722750c7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ff5f2b81-e048-42a6-96bf-482a1c74ca27" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2e55a148-0a0d-4bc6-8b20-30cf94631436" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ff5f2b81-e048-42a6-96bf-482a1c74ca27" xlink:to="loc_us-gaap_DebtInstrumentAxis_2e55a148-0a0d-4bc6-8b20-30cf94631436" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2e55a148-0a0d-4bc6-8b20-30cf94631436_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2e55a148-0a0d-4bc6-8b20-30cf94631436" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2e55a148-0a0d-4bc6-8b20-30cf94631436_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1558b50e-7bc5-4e81-ba94-0045c39d1b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2e55a148-0a0d-4bc6-8b20-30cf94631436" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1558b50e-7bc5-4e81-ba94-0045c39d1b3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_A2029NotesPayableMember_aded8f06-10a1-4f7b-9782-890a07b1b356" xlink:href="tnet-20250331.xsd#tnet_A2029NotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1558b50e-7bc5-4e81-ba94-0045c39d1b3e" xlink:to="loc_tnet_A2029NotesPayableMember_aded8f06-10a1-4f7b-9782-890a07b1b356" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_A2031NotesPayableMember_51b1e5b0-f9b7-41e4-8c95-ee1da145e479" xlink:href="tnet-20250331.xsd#tnet_A2031NotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1558b50e-7bc5-4e81-ba94-0045c39d1b3e" xlink:to="loc_tnet_A2031NotesPayableMember_51b1e5b0-f9b7-41e4-8c95-ee1da145e479" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_d129dc8c-b4a9-4c4d-a292-a36c59066afe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d957883a-2aae-46b8-9321-3d8f722750c7" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_d129dc8c-b4a9-4c4d-a292-a36c59066afe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKBASEDCOMPENSATIONAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57dba20e-04fe-4725-ac6b-4030d03fe780" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67fb91fe-7b09-40fc-8614-3ac9a6647b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57dba20e-04fe-4725-ac6b-4030d03fe780" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67fb91fe-7b09-40fc-8614-3ac9a6647b1c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e55ae08d-288a-4464-ace5-a176517e8078" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67fb91fe-7b09-40fc-8614-3ac9a6647b1c" xlink:to="loc_us-gaap_AwardTypeAxis_e55ae08d-288a-4464-ace5-a176517e8078" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e55ae08d-288a-4464-ace5-a176517e8078_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e55ae08d-288a-4464-ace5-a176517e8078" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e55ae08d-288a-4464-ace5-a176517e8078_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f772136-5aac-4115-90da-dda8eb35ec26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e55ae08d-288a-4464-ace5-a176517e8078" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f772136-5aac-4115-90da-dda8eb35ec26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TimeBasedRestrictedStockUnitsMember_09979ac7-645f-41bf-9fae-877f36522171" xlink:href="tnet-20250331.xsd#tnet_TimeBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f772136-5aac-4115-90da-dda8eb35ec26" xlink:to="loc_tnet_TimeBasedRestrictedStockUnitsMember_09979ac7-645f-41bf-9fae-877f36522171" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_2c22bd4d-4bd0-446b-99b7-152a262ed799" xlink:href="tnet-20250331.xsd#tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f772136-5aac-4115-90da-dda8eb35ec26" xlink:to="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_2c22bd4d-4bd0-446b-99b7-152a262ed799" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsMember_d82ed8b5-b0c3-4ebc-8d10-d5128414b017" xlink:href="tnet-20250331.xsd#tnet_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f772136-5aac-4115-90da-dda8eb35ec26" xlink:to="loc_tnet_PerformanceBasedRestrictedStockUnitsMember_d82ed8b5-b0c3-4ebc-8d10-d5128414b017" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1c1c6f4c-c605-480d-a4ab-c26fdbd3dcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f772136-5aac-4115-90da-dda8eb35ec26" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1c1c6f4c-c605-480d-a4ab-c26fdbd3dcaa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_48bde80f-53ff-48f7-b83b-c6562c1aac2d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67fb91fe-7b09-40fc-8614-3ac9a6647b1c" xlink:to="loc_srt_RangeAxis_48bde80f-53ff-48f7-b83b-c6562c1aac2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_48bde80f-53ff-48f7-b83b-c6562c1aac2d_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_48bde80f-53ff-48f7-b83b-c6562c1aac2d" xlink:to="loc_srt_RangeMember_48bde80f-53ff-48f7-b83b-c6562c1aac2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c26fdea7-c87d-4e15-b4f7-534f0fbd20eb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_48bde80f-53ff-48f7-b83b-c6562c1aac2d" xlink:to="loc_srt_RangeMember_c26fdea7-c87d-4e15-b4f7-534f0fbd20eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_aaccede2-8814-452d-9eea-3a4c61b6a4b6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c26fdea7-c87d-4e15-b4f7-534f0fbd20eb" xlink:to="loc_srt_MinimumMember_aaccede2-8814-452d-9eea-3a4c61b6a4b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f30f4867-2a27-47da-b71d-93e98e99e064" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c26fdea7-c87d-4e15-b4f7-534f0fbd20eb" xlink:to="loc_srt_MaximumMember_f30f4867-2a27-47da-b71d-93e98e99e064" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_7ffc7f55-276a-4edf-bb68-d916bcb8dfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67fb91fe-7b09-40fc-8614-3ac9a6647b1c" xlink:to="loc_us-gaap_VestingAxis_7ffc7f55-276a-4edf-bb68-d916bcb8dfe9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_7ffc7f55-276a-4edf-bb68-d916bcb8dfe9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_7ffc7f55-276a-4edf-bb68-d916bcb8dfe9" xlink:to="loc_us-gaap_VestingDomain_7ffc7f55-276a-4edf-bb68-d916bcb8dfe9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_23a0419f-7c10-4b97-b367-8e50cff6201b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_7ffc7f55-276a-4edf-bb68-d916bcb8dfe9" xlink:to="loc_us-gaap_VestingDomain_23a0419f-7c10-4b97-b367-8e50cff6201b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_fa75d73f-7397-41b0-ad68-83da7b2bb586" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_23a0419f-7c10-4b97-b367-8e50cff6201b" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_fa75d73f-7397-41b0-ad68-83da7b2bb586" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0e795d72-bca9-41df-a702-67c77c90ffa3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67fb91fe-7b09-40fc-8614-3ac9a6647b1c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0e795d72-bca9-41df-a702-67c77c90ffa3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0e795d72-bca9-41df-a702-67c77c90ffa3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0e795d72-bca9-41df-a702-67c77c90ffa3" xlink:to="loc_us-gaap_ClassOfStockDomain_0e795d72-bca9-41df-a702-67c77c90ffa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_06be79d5-5087-44cb-86c8-2bb0ddf3070e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0e795d72-bca9-41df-a702-67c77c90ffa3" xlink:to="loc_us-gaap_ClassOfStockDomain_06be79d5-5087-44cb-86c8-2bb0ddf3070e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_57b0a13d-4996-460b-bdff-bfda31da7086" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_06be79d5-5087-44cb-86c8-2bb0ddf3070e" xlink:to="loc_us-gaap_CommonClassAMember_57b0a13d-4996-460b-bdff-bfda31da7086" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_782a33a2-27de-49c9-ab36-64be022646d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57dba20e-04fe-4725-ac6b-4030d03fe780" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_782a33a2-27de-49c9-ab36-64be022646d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_b40762cc-2bab-4dc2-9798-9770276fbc31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57dba20e-04fe-4725-ac6b-4030d03fe780" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_b40762cc-2bab-4dc2-9798-9770276fbc31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_bd87929d-c0ab-4d8c-b01c-b95d6744beda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57dba20e-04fe-4725-ac6b-4030d03fe780" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_bd87929d-c0ab-4d8c-b01c-b95d6744beda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_de018eba-0981-4677-9eb9-eab5e986f300" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57dba20e-04fe-4725-ac6b-4030d03fe780" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_de018eba-0981-4677-9eb9-eab5e986f300" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5ee13f70-7260-4e73-bf3a-c2ae100436bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57dba20e-04fe-4725-ac6b-4030d03fe780" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5ee13f70-7260-4e73-bf3a-c2ae100436bc" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e13e18e8-7737-49a2-8d93-7dc992699c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a0978f5b-bc85-4ee8-861f-ee0404fce7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e13e18e8-7737-49a2-8d93-7dc992699c5c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a0978f5b-bc85-4ee8-861f-ee0404fce7f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_09de38ab-de10-42c3-818b-1d09b6b5bc39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a0978f5b-bc85-4ee8-861f-ee0404fce7f1" xlink:to="loc_us-gaap_AwardTypeAxis_09de38ab-de10-42c3-818b-1d09b6b5bc39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09de38ab-de10-42c3-818b-1d09b6b5bc39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_09de38ab-de10-42c3-818b-1d09b6b5bc39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09de38ab-de10-42c3-818b-1d09b6b5bc39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c516143b-2c01-4757-90a4-ae1e898f248e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_09de38ab-de10-42c3-818b-1d09b6b5bc39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c516143b-2c01-4757-90a4-ae1e898f248e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TimeBasedRestrictedStockUnitsMember_534e8f77-b6fd-4e69-b767-054c8bed23e2" xlink:href="tnet-20250331.xsd#tnet_TimeBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c516143b-2c01-4757-90a4-ae1e898f248e" xlink:to="loc_tnet_TimeBasedRestrictedStockUnitsMember_534e8f77-b6fd-4e69-b767-054c8bed23e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsMember_6967a8d1-522b-4b8a-9459-3bd257e7d252" xlink:href="tnet-20250331.xsd#tnet_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c516143b-2c01-4757-90a4-ae1e898f248e" xlink:to="loc_tnet_PerformanceBasedRestrictedStockUnitsMember_6967a8d1-522b-4b8a-9459-3bd257e7d252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f9a9bef5-0d98-49aa-ac46-fd836926f030" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e13e18e8-7737-49a2-8d93-7dc992699c5c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f9a9bef5-0d98-49aa-ac46-fd836926f030" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a987cf46-9bb2-4102-9bd7-84351fe73867" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f9a9bef5-0d98-49aa-ac46-fd836926f030" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a987cf46-9bb2-4102-9bd7-84351fe73867" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3ff5093c-0299-499e-9072-64986c156daa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f9a9bef5-0d98-49aa-ac46-fd836926f030" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3ff5093c-0299-499e-9072-64986c156daa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_aa2a8d70-07d7-4c81-acc6-c6967bf936e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f9a9bef5-0d98-49aa-ac46-fd836926f030" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_aa2a8d70-07d7-4c81-acc6-c6967bf936e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_97b70973-62fb-427a-9800-e5cf146d3c39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f9a9bef5-0d98-49aa-ac46-fd836926f030" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_97b70973-62fb-427a-9800-e5cf146d3c39" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2448c82f-2584-447a-b19d-da87cb828477" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2b058822-0290-4bb4-9321-567148dc5dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e13e18e8-7737-49a2-8d93-7dc992699c5c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2b058822-0290-4bb4-9321-567148dc5dd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8a71f7c6-0a1d-464d-be59-30beefa58736" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2b058822-0290-4bb4-9321-567148dc5dd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8a71f7c6-0a1d-464d-be59-30beefa58736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3ebd1a87-f905-4399-8fcf-a857c5f7a702" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2b058822-0290-4bb4-9321-567148dc5dd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3ebd1a87-f905-4399-8fcf-a857c5f7a702" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4d6a9055-cf90-4949-a021-3720485bee4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2b058822-0290-4bb4-9321-567148dc5dd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4d6a9055-cf90-4949-a021-3720485bee4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_bceb2f36-90f7-481c-9ff0-e4a804ebb362" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2b058822-0290-4bb4-9321-567148dc5dd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_bceb2f36-90f7-481c-9ff0-e4a804ebb362" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_03f1eb21-76cf-4463-9112-203f6f7e808a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c79b665-73cc-4bbb-9ba3-347c14cdc67d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa6b54b5-9784-46cd-9224-9cf4944f9c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c79b665-73cc-4bbb-9ba3-347c14cdc67d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa6b54b5-9784-46cd-9224-9cf4944f9c1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0d1a57b4-3152-42c5-a8ce-8efc7753ee24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa6b54b5-9784-46cd-9224-9cf4944f9c1f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0d1a57b4-3152-42c5-a8ce-8efc7753ee24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0d1a57b4-3152-42c5-a8ce-8efc7753ee24_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0d1a57b4-3152-42c5-a8ce-8efc7753ee24" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0d1a57b4-3152-42c5-a8ce-8efc7753ee24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8726257a-913a-4de7-bd99-531e67bde8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0d1a57b4-3152-42c5-a8ce-8efc7753ee24" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8726257a-913a-4de7-bd99-531e67bde8a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_fa940dde-1823-4fad-919d-19199fb8ac0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8726257a-913a-4de7-bd99-531e67bde8a7" xlink:to="loc_us-gaap_CostOfSalesMember_fa940dde-1823-4fad-919d-19199fb8ac0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_7e2b0d9d-dd08-478a-8066-238262405a41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8726257a-913a-4de7-bd99-531e67bde8a7" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_7e2b0d9d-dd08-478a-8066-238262405a41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_8647b33d-20c4-455d-9e37-9a20fb556c77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8726257a-913a-4de7-bd99-531e67bde8a7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_8647b33d-20c4-455d-9e37-9a20fb556c77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_SystemsDevelopmentAndProgrammingCostsMember_9a6e809a-555b-41b1-b782-4619dbf4cc4c" xlink:href="tnet-20250331.xsd#tnet_SystemsDevelopmentAndProgrammingCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8726257a-913a-4de7-bd99-531e67bde8a7" xlink:to="loc_tnet_SystemsDevelopmentAndProgrammingCostsMember_9a6e809a-555b-41b1-b782-4619dbf4cc4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2cf116d6-7037-420f-b34d-564bce8419a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c79b665-73cc-4bbb-9ba3-347c14cdc67d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2cf116d6-7037-420f-b34d-564bce8419a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_ae705d63-855e-4ece-8517-f94b857bb8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c79b665-73cc-4bbb-9ba3-347c14cdc67d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_ae705d63-855e-4ece-8517-f94b857bb8f0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKHOLDERSEQUITYScheduleofCommonStockDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9126705c-72af-4ebe-bcd1-2b6d2903339c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2229b46-0f8e-45c6-a9a1-d2e31876a035" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9126705c-72af-4ebe-bcd1-2b6d2903339c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2229b46-0f8e-45c6-a9a1-d2e31876a035" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_028a350d-ea33-4350-993b-633a52edbe02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2229b46-0f8e-45c6-a9a1-d2e31876a035" xlink:to="loc_us-gaap_AwardTypeAxis_028a350d-ea33-4350-993b-633a52edbe02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_028a350d-ea33-4350-993b-633a52edbe02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_028a350d-ea33-4350-993b-633a52edbe02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_028a350d-ea33-4350-993b-633a52edbe02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2479ad72-3e1a-45bb-9fa4-e901b524adad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_028a350d-ea33-4350-993b-633a52edbe02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2479ad72-3e1a-45bb-9fa4-e901b524adad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_ffc0af4d-c5dc-4698-b7a4-72a936f593d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2479ad72-3e1a-45bb-9fa4-e901b524adad" xlink:to="loc_us-gaap_RestrictedStockMember_ffc0af4d-c5dc-4698-b7a4-72a936f593d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_894eec1e-3b77-4f36-b88e-d3c70bdb5d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2479ad72-3e1a-45bb-9fa4-e901b524adad" xlink:to="loc_us-gaap_StockOptionMember_894eec1e-3b77-4f36-b88e-d3c70bdb5d6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9126705c-72af-4ebe-bcd1-2b6d2903339c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_83cb43e1-ce09-4ab7-8ab3-09a439855f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:to="loc_us-gaap_CommonStockSharesIssued_83cb43e1-ce09-4ab7-8ab3-09a439855f2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d85b1c23-3ce7-4c9d-9ede-02a1bb22ecc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d85b1c23-3ce7-4c9d-9ede-02a1bb22ecc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c8318dd2-88ea-4c5a-9a71-aeb2f3736e00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c8318dd2-88ea-4c5a-9a71-aeb2f3736e00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_31698e5e-3cef-4d10-ac5d-dbc125e92691" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_31698e5e-3cef-4d10-ac5d-dbc125e92691" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_73588794-84ae-4d3c-b87f-fe2d63f83676" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_73588794-84ae-4d3c-b87f-fe2d63f83676" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_87aa1b8b-9315-4ab8-a7a8-4c6aa71fbb03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_87aa1b8b-9315-4ab8-a7a8-4c6aa71fbb03" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e660f043-b5d9-49c9-bc1b-a099be3e68b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ddf20800-6aa5-42e1-8513-ebfd680828e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#INCOMETAXESDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncomeTaxesDisclosureLineItems_3cd8a507-eca4-49a7-9a87-3b9ca7088f15" xlink:href="tnet-20250331.xsd#tnet_IncomeTaxesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncomeTaxesDisclosureTable_3f6c2025-822e-426f-8507-8b3bb981f6d7" xlink:href="tnet-20250331.xsd#tnet_IncomeTaxesDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_tnet_IncomeTaxesDisclosureLineItems_3cd8a507-eca4-49a7-9a87-3b9ca7088f15" xlink:to="loc_tnet_IncomeTaxesDisclosureTable_3f6c2025-822e-426f-8507-8b3bb981f6d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_40cf8a04-895c-4f25-b678-2b299983d0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_tnet_IncomeTaxesDisclosureTable_3f6c2025-822e-426f-8507-8b3bb981f6d7" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_40cf8a04-895c-4f25-b678-2b299983d0a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_40cf8a04-895c-4f25-b678-2b299983d0a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_40cf8a04-895c-4f25-b678-2b299983d0a9" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_40cf8a04-895c-4f25-b678-2b299983d0a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_d1c98dce-589f-426f-84c6-3b4f5b858412" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_40cf8a04-895c-4f25-b678-2b299983d0a9" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_d1c98dce-589f-426f-84c6-3b4f5b858412" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember_2b56e409-5804-488a-a709-514e72f9e4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_d1c98dce-589f-426f-84c6-3b4f5b858412" xlink:to="loc_us-gaap_CapitalLossCarryforwardMember_2b56e409-5804-488a-a709-514e72f9e4ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_92b855ea-bbff-49fe-9410-25f56dceeaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tnet_IncomeTaxesDisclosureLineItems_3cd8a507-eca4-49a7-9a87-3b9ca7088f15" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_92b855ea-bbff-49fe-9410-25f56dceeaa9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_1d6ebc3a-a198-40bb-a380-239f5b068247" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tnet_IncomeTaxesDisclosureLineItems_3cd8a507-eca4-49a7-9a87-3b9ca7088f15" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_1d6ebc3a-a198-40bb-a380-239f5b068247" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_0330dbc4-7fe7-433d-a1ce-8200d0c7d26f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tnet_IncomeTaxesDisclosureLineItems_3cd8a507-eca4-49a7-9a87-3b9ca7088f15" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_0330dbc4-7fe7-433d-a1ce-8200d0c7d26f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_12753096-59dc-49cf-9d96-df4f66b04839" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tnet_IncomeTaxesDisclosureLineItems_3cd8a507-eca4-49a7-9a87-3b9ca7088f15" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_12753096-59dc-49cf-9d96-df4f66b04839" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_550bbad7-d8b8-437c-95c0-bf069911bdce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_96bf3388-759e-44db-8d78-da16c93f7bff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_550bbad7-d8b8-437c-95c0-bf069911bdce" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_96bf3388-759e-44db-8d78-da16c93f7bff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis_83b358c8-816f-4134-8f4a-c0a8273de4df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_96bf3388-759e-44db-8d78-da16c93f7bff" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis_83b358c8-816f-4134-8f4a-c0a8273de4df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain_83b358c8-816f-4134-8f4a-c0a8273de4df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis_83b358c8-816f-4134-8f4a-c0a8273de4df" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain_83b358c8-816f-4134-8f4a-c0a8273de4df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain_595b434b-9981-484e-b2e9-5e651243dda2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis_83b358c8-816f-4134-8f4a-c0a8273de4df" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain_595b434b-9981-484e-b2e9-5e651243dda2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_6c55ca7f-fe9a-42a9-93fa-2d1ec45bcae9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain_595b434b-9981-484e-b2e9-5e651243dda2" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_6c55ca7f-fe9a-42a9-93fa-2d1ec45bcae9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedSalariesCurrentMember_cb105517-e171-4ce2-b8aa-a3dbe1ced499" xlink:href="tnet-20250331.xsd#tnet_AccruedSalariesCurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain_595b434b-9981-484e-b2e9-5e651243dda2" xlink:to="loc_tnet_AccruedSalariesCurrentMember_cb105517-e171-4ce2-b8aa-a3dbe1ced499" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9ef6fd0b-5e88-4e58-9b6a-2686cc4c2300" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_550bbad7-d8b8-437c-95c0-bf069911bdce" xlink:to="loc_us-gaap_RestructuringCharges_9ef6fd0b-5e88-4e58-9b6a-2686cc4c2300" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_RestructuringChargesAdditions_c46562e7-f1c9-4793-9dc1-6f3e88d70b31" xlink:href="tnet-20250331.xsd#tnet_RestructuringChargesAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_550bbad7-d8b8-437c-95c0-bf069911bdce" xlink:to="loc_tnet_RestructuringChargesAdditions_c46562e7-f1c9-4793-9dc1-6f3e88d70b31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_RestructuringChargesPayments_3ae2270a-47e2-43e0-9637-f7af94f09a03" xlink:href="tnet-20250331.xsd#tnet_RestructuringChargesPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_550bbad7-d8b8-437c-95c0-bf069911bdce" xlink:to="loc_tnet_RestructuringChargesPayments_3ae2270a-47e2-43e0-9637-f7af94f09a03" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55867d68-199f-4e0a-ba11-4dfcd192c75b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55867d68-199f-4e0a-ba11-4dfcd192c75b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_eacd7010-5f11-4a45-af75-0b91973ce2e2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55867d68-199f-4e0a-ba11-4dfcd192c75b" xlink:to="loc_srt_ProductOrServiceAxis_eacd7010-5f11-4a45-af75-0b91973ce2e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_eacd7010-5f11-4a45-af75-0b91973ce2e2_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_eacd7010-5f11-4a45-af75-0b91973ce2e2" xlink:to="loc_srt_ProductsAndServicesDomain_eacd7010-5f11-4a45-af75-0b91973ce2e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_45fc8abb-659d-45d4-bd22-e7d876e554fd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_eacd7010-5f11-4a45-af75-0b91973ce2e2" xlink:to="loc_srt_ProductsAndServicesDomain_45fc8abb-659d-45d4-bd22-e7d876e554fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ProfessionalServicesMember_7a7398c4-7df0-40e7-9de3-44ba7ad7043c" xlink:href="tnet-20250331.xsd#tnet_ProfessionalServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_45fc8abb-659d-45d4-bd22-e7d876e554fd" xlink:to="loc_tnet_ProfessionalServicesMember_7a7398c4-7df0-40e7-9de3-44ba7ad7043c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsuranceServicesMember_0c688bbb-b988-4f36-9d9b-a3dac069172f" xlink:href="tnet-20250331.xsd#tnet_InsuranceServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_45fc8abb-659d-45d4-bd22-e7d876e554fd" xlink:to="loc_tnet_InsuranceServicesMember_0c688bbb-b988-4f36-9d9b-a3dac069172f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_15d1d958-0d79-4af0-b7cf-bb3753b123fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55867d68-199f-4e0a-ba11-4dfcd192c75b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_15d1d958-0d79-4af0-b7cf-bb3753b123fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_15d1d958-0d79-4af0-b7cf-bb3753b123fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_15d1d958-0d79-4af0-b7cf-bb3753b123fa" xlink:to="loc_us-gaap_SegmentDomain_15d1d958-0d79-4af0-b7cf-bb3753b123fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c3df25d8-7f1e-471c-a660-3d8336865440" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_15d1d958-0d79-4af0-b7cf-bb3753b123fa" xlink:to="loc_us-gaap_SegmentDomain_c3df25d8-7f1e-471c-a660-3d8336865440" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ReportableSegmentMember_7d5a6752-533f-4aed-b238-d31ec9d2b1a6" xlink:href="tnet-20250331.xsd#tnet_ReportableSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c3df25d8-7f1e-471c-a660-3d8336865440" xlink:to="loc_tnet_ReportableSegmentMember_7d5a6752-533f-4aed-b238-d31ec9d2b1a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6be302c0-94cd-4734-b83d-9b90bdfdfcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6be302c0-94cd-4734-b83d-9b90bdfdfcd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_e90d0153-6c09-4ad0-b888-d704687e2ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_InterestIncomeOperating_e90d0153-6c09-4ad0-b888-d704687e2ff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_936dbe85-d61d-4dbf-a176-393bbb049bef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_Revenues_936dbe85-d61d-4dbf-a176-393bbb049bef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_WorkersCompensationCosts_08d42efe-5aea-4140-8af1-411cf044f01f" xlink:href="tnet-20250331.xsd#tnet_WorkersCompensationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_tnet_WorkersCompensationCosts_08d42efe-5aea-4140-8af1-411cf044f01f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_HealthInsuranceCosts_64864f9c-f271-48f4-99fc-898e1be65f50" xlink:href="tnet-20250331.xsd#tnet_HealthInsuranceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_tnet_HealthInsuranceCosts_64864f9c-f271-48f4-99fc-898e1be65f50" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther_755de801-1cd1-4c0b-ac9e-f42c2d55dd8d" xlink:href="tnet-20250331.xsd#tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther_755de801-1cd1-4c0b-ac9e-f42c2d55dd8d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ClientSupportCosts_fa5a5f82-7cd2-4513-96a0-7208ab540bbe" xlink:href="tnet-20250331.xsd#tnet_ClientSupportCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_tnet_ClientSupportCosts_fa5a5f82-7cd2-4513-96a0-7208ab540bbe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CorporateAdministrationExpenses_f72d846a-f990-43d3-94e1-ed4999d23240" xlink:href="tnet-20250331.xsd#tnet_CorporateAdministrationExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_tnet_CorporateAdministrationExpenses_f72d846a-f990-43d3-94e1-ed4999d23240" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_SystemSupportAndDevelopmentExpenses_26558fbe-da08-4c06-aa8c-5c1d416cad4e" xlink:href="tnet-20250331.xsd#tnet_SystemSupportAndDevelopmentExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_tnet_SystemSupportAndDevelopmentExpenses_26558fbe-da08-4c06-aa8c-5c1d416cad4e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_7e6a18e7-0b84-4354-b548-442eed2acf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_7e6a18e7-0b84-4354-b548-442eed2acf6a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1daa2ac5-2afd-4c6d-b417-d021b4d659e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1daa2ac5-2afd-4c6d-b417-d021b4d659e6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_dc68a803-b2ed-4019-bd31-1c7e1b6f6730" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_OtherExpenses_dc68a803-b2ed-4019-bd31-1c7e1b6f6730" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InterestExpenseBankFeesAndOther_e4c04d2d-56eb-46e7-b724-8a6efdde3341" xlink:href="tnet-20250331.xsd#tnet_InterestExpenseBankFeesAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_tnet_InterestExpenseBankFeesAndOther_e4c04d2d-56eb-46e7-b724-8a6efdde3341" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b245b64d-3157-4596-8eb1-df8ba06a9933" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b245b64d-3157-4596-8eb1-df8ba06a9933" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d730f0e2-86e2-422e-8a68-c7d56f6121e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_NetIncomeLoss_d730f0e2-86e2-422e-8a68-c7d56f6121e6" xlink:type="arc" order="14"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>tnet-20250331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:104eff25-bde6-411e-ba54-56469600d7a1,g:ffef9025-6e41-425a-998c-b582f585f1c3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_tnet_TimeBasedRestrictedStockUnitsMember_0369d29b-f4c8-40ec-8bf7-fa0cd4a424dc_terseLabel_en-US" xlink:label="lab_tnet_TimeBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Time-Based Restricted Stock Units</link:label>
    <link:label id="lab_tnet_TimeBasedRestrictedStockUnitsMember_label_en-US" xlink:label="lab_tnet_TimeBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Time-Based Restricted Stock Units [Member]</link:label>
    <link:label id="lab_tnet_TimeBasedRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_tnet_TimeBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Time-Based Restricted Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TimeBasedRestrictedStockUnitsMember" xlink:href="tnet-20250331.xsd#tnet_TimeBasedRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_TimeBasedRestrictedStockUnitsMember" xlink:to="lab_tnet_TimeBasedRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c61b0682-e759-470a-8589-34cc3d19eca1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_4e9f9fe4-5d7a-4acf-b6d2-6b5f6b930ce1_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9be9fce6-e7b2-4817-bde1-bb0d7d615796_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Remaining Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_db9e3255-8577-4413-a77f-0ddce3937adc_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_c512d90b-5e6b-40bb-8206-6f89948b6819_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_8b18ed3e-618d-43ee-9b4a-5ef911c803b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_fcf07fd0-0e58-48de-bb2e-a506a5440de2_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll funds receivable</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_8aa69434-756a-4b53-9d97-e5837835b665_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash, Cash Equivalents and Investments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_580268ff-e385-4751-8465-875ce83ab039_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d77a95b1-e35a-49be-b03e-23b1a59b6857_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net change in cash and cash equivalents, unrestricted and restricted</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_43030784-5cc7-4010-b560-cfd9356edfd6_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_9160275e-83d0-43c5-a01d-b1eabbd996c6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_585b8d83-db25-4170-ae5a-9bd2129393da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7f6031bd-54c2-4fb2-8121-4dd99ff69cd7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_97c2735a-af74-4e46-af8a-298d1c96932d_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_InsuranceCarriersSecurityDepositsMember_855d4f85-2369-4878-8f5d-148c9ab7a19a_terseLabel_en-US" xlink:label="lab_tnet_InsuranceCarriersSecurityDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other security deposits</link:label>
    <link:label id="lab_tnet_InsuranceCarriersSecurityDepositsMember_label_en-US" xlink:label="lab_tnet_InsuranceCarriersSecurityDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Carriers Security Deposits [Member]</link:label>
    <link:label id="lab_tnet_InsuranceCarriersSecurityDepositsMember_documentation_en-US" xlink:label="lab_tnet_InsuranceCarriersSecurityDepositsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Insurance Carriers Security Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsuranceCarriersSecurityDepositsMember" xlink:href="tnet-20250331.xsd#tnet_InsuranceCarriersSecurityDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_InsuranceCarriersSecurityDepositsMember" xlink:to="lab_tnet_InsuranceCarriersSecurityDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_4bfa47ca-5e18-4ee5-9e5a-d1dedb138f4d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes paid, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_e25d28a5-5bea-40b9-85a3-c508affb7cd4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Class A</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_f30974b2-a814-46ef-8f2f-91cc556ffcb9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_7854455d-d16a-4e14-9bfc-6fc6eaea491f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_InsurancePremiumsAndOtherPayables_4b4fd541-1738-44a6-913b-d8f5f0e484ce_terseLabel_en-US" xlink:label="lab_tnet_InsurancePremiumsAndOtherPayables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance premiums and other payables</link:label>
    <link:label id="lab_tnet_InsurancePremiumsAndOtherPayables_label_en-US" xlink:label="lab_tnet_InsurancePremiumsAndOtherPayables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Premiums And Other Payables</link:label>
    <link:label id="lab_tnet_InsurancePremiumsAndOtherPayables_documentation_en-US" xlink:label="lab_tnet_InsurancePremiumsAndOtherPayables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Insurance Premiums and Other Payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsurancePremiumsAndOtherPayables" xlink:href="tnet-20250331.xsd#tnet_InsurancePremiumsAndOtherPayables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_InsurancePremiumsAndOtherPayables" xlink:to="lab_tnet_InsurancePremiumsAndOtherPayables" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_4a80e47a-5abc-4210-9f85-ffc459d11f90_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock and additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_SystemsDevelopmentAndProgrammingCostsMember_e7d2e22c-be3e-4c12-b928-8c2360cdad47_verboseLabel_en-US" xlink:label="lab_tnet_SystemsDevelopmentAndProgrammingCostsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Systems development and programming costs</link:label>
    <link:label id="lab_tnet_SystemsDevelopmentAndProgrammingCostsMember_label_en-US" xlink:label="lab_tnet_SystemsDevelopmentAndProgrammingCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Systems Development And Programming Costs [Member]</link:label>
    <link:label id="lab_tnet_SystemsDevelopmentAndProgrammingCostsMember_documentation_en-US" xlink:label="lab_tnet_SystemsDevelopmentAndProgrammingCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Primary financial statement caption encompassing systems development and programming costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_SystemsDevelopmentAndProgrammingCostsMember" xlink:href="tnet-20250331.xsd#tnet_SystemsDevelopmentAndProgrammingCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_SystemsDevelopmentAndProgrammingCostsMember" xlink:to="lab_tnet_SystemsDevelopmentAndProgrammingCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_cf4bf0ff-14cc-42c0-a819-5e666b8fc29f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6273d328-597e-4728-b3a8-c3c60b728553_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Shares issued and outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_7e000f78-b14a-4a4f-b433-089e6a34d1d7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Shares issued and outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_883b3dff-4cf0-467d-8fef-140062f564c1_terseLabel_en-US" xlink:label="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll tax liabilities and other payroll withholdings</link:label>
    <link:label id="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_624a1ac4-bdd8-4978-8dd9-decc8b1fbf16_verboseLabel_en-US" xlink:label="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Payroll tax liabilities and other payroll withholdings</link:label>
    <link:label id="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_label_en-US" xlink:label="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Payroll Tax Liabilities And Other Payroll Withholdings</link:label>
    <link:label id="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_documentation_en-US" xlink:label="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Payroll Tax Liabilities And Other Payroll Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" xlink:href="tnet-20250331.xsd#tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" xlink:to="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_c4429e3e-babf-427c-96b8-804e24dd49d8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale and maturity of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_7f27012f-480d-459d-a82b-ed72784459ad_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_d23d82e0-2192-4220-9b36-a0df29e473a6_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_6b1f76cd-5c1a-485f-bdd8-3cdc55734cec_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_3a752818-0048-452b-9305-384cb055cc80_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross realized losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_6c2941b7-1c01-4905-b7d2-50ad7d25d630_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Client deposits and other client liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_ac9af2b9-aecd-4a28-9cdc-bcbfd6a09511_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_5c9eb6be-7bcc-485a-bcaf-53cbc3e184a5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_HealthBenefitClaimsCollateralMember_2b2b8b09-fc04-41d1-8567-b2164ec5b02a_terseLabel_en-US" xlink:label="lab_tnet_HealthBenefitClaimsCollateralMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collateral for health benefits claims</link:label>
    <link:label id="lab_tnet_HealthBenefitClaimsCollateralMember_label_en-US" xlink:label="lab_tnet_HealthBenefitClaimsCollateralMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Health Benefit Claims Collateral [Member]</link:label>
    <link:label id="lab_tnet_HealthBenefitClaimsCollateralMember_documentation_en-US" xlink:label="lab_tnet_HealthBenefitClaimsCollateralMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Health Benefit Claims Collateral [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_HealthBenefitClaimsCollateralMember" xlink:href="tnet-20250331.xsd#tnet_HealthBenefitClaimsCollateralMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_HealthBenefitClaimsCollateralMember" xlink:to="lab_tnet_HealthBenefitClaimsCollateralMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_44b0819d-154d-4b28-8358-7e580f1feb07_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market mutual funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_f0694dd0-d190-42e7-921c-1c8bb999e095_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_792e2cd7-42c2-43ca-96ea-5654990b1e28_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. treasuries</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_6a6c1a76-9eb1-4e70-bfe3-5b86bed852d8_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses, net</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_111095b2-2440-47ee-a3d4-be619611d530_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_15697770-9d07-47c7-9f13-a74f95901d19_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c4de4345-c7b6-46e2-8253-6f7bedac957d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_83f33154-bd29-4f96-a85e-faa3a410db40_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_1f92c312-249b-406f-9270-b1a0512c351d_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_afccde92-ba61-416e-bd0d-00b916a73d5d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock and additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stocks, Including Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:to="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_31a1d4a2-e587-49af-89f9-c9ece8018a1e_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassified amounts</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_76369005-610b-4660-bafc-06a2632937de_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_0ccf489e-68c0-4503-a0e4-d384cf11f3db_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total stock based compensation capitalized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Amount Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_9d5b1a59-fcd2-4d89-9f75-6f511a0a6f8d_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_73d0c4e8-a537-4dec-9edf-cf71add05606_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total costs and operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_154cd3c5-f379-485c-856c-2de51dcf0fe6_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1b771a8f-6760-415b-99af-7481f2a87fe2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_0ae5ec86-fd81-43df-a1de-ab1a0863c395_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_7ecc28cb-5b55-4744-941d-5414e691c332_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Capital Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_f5ccd5ae-1e2e-4aed-93f2-47bba36bedc1_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_8f257526-9e42-47f4-8549-cd3b5ec73ec4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross proceeds from maturities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_8095f12d-6162-43be-ab6e-09a3f0bab8ea_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50b2019f-6c99-4310-96ce-c40bac1ce663_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_03931c03-50d0-4ad6-86ca-65bf39899034_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_884e996d-6fd1-4131-995c-5ba52cf31528_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_66cce4d2-6d8e-4763-8c58-4a803e04e697_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_db295184-5ea3-4e96-b84c-6829248ec03d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_bfc396a0-b700-4f4b-ab36-907ea46aaad5_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_AccruedSalariesCurrentMember_81fc55d1-9d16-4a5b-92e7-94620d981dec_terseLabel_en-US" xlink:label="lab_tnet_AccruedSalariesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued wages</link:label>
    <link:label id="lab_tnet_AccruedSalariesCurrentMember_label_en-US" xlink:label="lab_tnet_AccruedSalariesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Salaries, Current [Member]</link:label>
    <link:label id="lab_tnet_AccruedSalariesCurrentMember_documentation_en-US" xlink:label="lab_tnet_AccruedSalariesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedSalariesCurrentMember" xlink:href="tnet-20250331.xsd#tnet_AccruedSalariesCurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_AccruedSalariesCurrentMember" xlink:to="lab_tnet_AccruedSalariesCurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified_562ddd5d-5ab8-422b-894e-4db61ecf27c0_verboseLabel_en-US" xlink:label="lab_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified_label_en-US" xlink:label="lab_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Amounts Reclassified</link:label>
    <link:label id="lab_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified_documentation_en-US" xlink:label="lab_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Amounts Reclassified</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified" xlink:href="tnet-20250331.xsd#tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified" xlink:to="lab_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6f323daf-42d7-409d-b059-b13b97c4345b_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4c1a3f4c-f1b2-4052-92fb-91c32f4ff2da_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_6a6d1703-8a75-4e49-b4fd-c08f6c9fe219_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_eb45cf1d-ae61-43ba-9648-a89a1bcfe9e7_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_4bfcb0b3-f3df-41ac-b071-3acd16d3b1d9_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified_9b86ffff-39a9-4648-9956-aa9ab1bb9b84_verboseLabel_en-US" xlink:label="lab_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified_label_en-US" xlink:label="lab_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Amounts Reclassified</link:label>
    <link:label id="lab_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified_documentation_en-US" xlink:label="lab_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Amounts Reclassified</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified" xlink:href="tnet-20250331.xsd#tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified" xlink:to="lab_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b1bcaba1-f56a-4dc1-aeef-d79ff74d5011_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Awards effectively repurchased for required employee withholding taxes</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_78981f63-c1d1-4ee9-b6fa-484d6fb6a73d_terseLabel_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_HealthInsuranceCosts_0b404882-8e33-43a4-9dc9-49f5028e8f2f_terseLabel_en-US" xlink:label="lab_tnet_HealthInsuranceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Health insurance costs</link:label>
    <link:label id="lab_tnet_HealthInsuranceCosts_label_en-US" xlink:label="lab_tnet_HealthInsuranceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Health Insurance Costs</link:label>
    <link:label id="lab_tnet_HealthInsuranceCosts_documentation_en-US" xlink:label="lab_tnet_HealthInsuranceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Health Insurance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_HealthInsuranceCosts" xlink:href="tnet-20250331.xsd#tnet_HealthInsuranceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_HealthInsuranceCosts" xlink:to="lab_tnet_HealthInsuranceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_697b1151-a156-406e-9e7e-8cff1235feb0_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_7c8b5735-1218-4173-8951-d60cca5de260_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_48ffc5f0-c5bb-49bb-83b4-da685c3d2cef_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8b3d75ce-ffa4-431c-9206-cc87206013f2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_1c3b420e-29f1-4d8e-b216-f2a55faf7d64_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpenses_9bfd066a-9352-4c7e-ac6a-2767a03eb56c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherExpenses_label_en-US" xlink:label="lab_us-gaap_OtherExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenses" xlink:to="lab_us-gaap_OtherExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_PayrollFundsCollectedMember_9264f14d-f120-4b7a-880a-214c6e472ec6_terseLabel_en-US" xlink:label="lab_tnet_PayrollFundsCollectedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll funds collected</link:label>
    <link:label id="lab_tnet_PayrollFundsCollectedMember_label_en-US" xlink:label="lab_tnet_PayrollFundsCollectedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payroll Funds Collected [Member]</link:label>
    <link:label id="lab_tnet_PayrollFundsCollectedMember_documentation_en-US" xlink:label="lab_tnet_PayrollFundsCollectedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payroll Funds Collected [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PayrollFundsCollectedMember" xlink:href="tnet-20250331.xsd#tnet_PayrollFundsCollectedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_PayrollFundsCollectedMember" xlink:to="lab_tnet_PayrollFundsCollectedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_834f49ec-0074-44df-80da-11b77634dac5_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_ea9bad97-5b48-4d17-b559-2ae48c3aff1e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CashCashEquivalentsAndInvestmentsTextBlock_e676f712-4d18-4a8a-a7e0-5190b2dd05e4_terseLabel_en-US" xlink:label="lab_tnet_CashCashEquivalentsAndInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED</link:label>
    <link:label id="lab_tnet_CashCashEquivalentsAndInvestmentsTextBlock_label_en-US" xlink:label="lab_tnet_CashCashEquivalentsAndInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents And Investments [Text Block]</link:label>
    <link:label id="lab_tnet_CashCashEquivalentsAndInvestmentsTextBlock_documentation_en-US" xlink:label="lab_tnet_CashCashEquivalentsAndInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents and Investments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CashCashEquivalentsAndInvestmentsTextBlock" xlink:href="tnet-20250331.xsd#tnet_CashCashEquivalentsAndInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CashCashEquivalentsAndInvestmentsTextBlock" xlink:to="lab_tnet_CashCashEquivalentsAndInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f9a74d41-8064-44c8-bd34-32e94b433bcc_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_20031f01-6121-49a5-826e-b439b79fc91e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair value of Debt Investments by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_f309fed1-44d0-4b82-aac4-c0f61851b583_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_0a482534-596c-4e53-8315-9a2f0097026e_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_3e93184c-c0ff-4427-b27b-77fed763b704_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_ea3a4c25-ee72-4125-ad60-15ecfe022997_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_22941f31-b661-4312-a258-8253adbf2c3b_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_7d6f557a-19b3-4915-8701-5e56f386efa6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends paid (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_aa89a900-c835-4cb7-b33b-2699a66affd1_verboseLabel_en-US" xlink:label="lab_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Performance-based RSUs and RSAs</link:label>
    <link:label id="lab_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_label_en-US" xlink:label="lab_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance-Based Restricted Stock Units and Restricted Stock Awards [Member]</link:label>
    <link:label id="lab_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_documentation_en-US" xlink:label="lab_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance-Based Restricted Stock Units and Restricted Stock Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" xlink:href="tnet-20250331.xsd#tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" xlink:to="lab_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_15a6970e-f311-4d27-8eac-4205f9169ca1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_7fa5c9d3-8041-42c3-a4e7-2b06fc5fd074_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Available-for-Sale Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_e1f53c24-8040-4d3f-9260-21e73bd1e1d2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Systems development and programming</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e44b4c1f-9e6c-4dd5-ac2a-f8f07d2d5acb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_79442c2f-676b-4d3d-b578-ca0c1313b204_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_2cac9b01-db5d-4599-99b4-87053b7422f6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c5d1f77e-8ff7-4b03-8845-880a34fedda3_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Shares issued and outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_dbfa0d23-980c-4f03-80e6-313ca2533631_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Shares issued and outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_e90d6b2f-9205-4f6d-b425-c26258cf8736_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_f6c2a57c-f55a-499b-ba3a-1e982b7fc0bb_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent of concentration risk (less than)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingInsuranceAndClaimsCostsProduction_fb580629-310b-4180-969c-5dff4a50bdba_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingInsuranceAndClaimsCostsProduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance costs</link:label>
    <link:label id="lab_us-gaap_OperatingInsuranceAndClaimsCostsProduction_label_en-US" xlink:label="lab_us-gaap_OperatingInsuranceAndClaimsCostsProduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Insurance and Claims Costs, Production</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingInsuranceAndClaimsCostsProduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction" xlink:to="lab_us-gaap_OperatingInsuranceAndClaimsCostsProduction" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidInsurance_9696046f-3b0d-4905-84bd-0629672704ba_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepayments offsetting accrued health insurance costs</link:label>
    <link:label id="lab_us-gaap_PrepaidInsurance_label_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7a410565-e5e4-434e-a0bb-3a97b2a703e6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock from exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_ProfessionalServicesMember_b6d00146-958d-450d-ade7-31701c8c1d20_terseLabel_en-US" xlink:label="lab_tnet_ProfessionalServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Professional service revenues</link:label>
    <link:label id="lab_tnet_ProfessionalServicesMember_label_en-US" xlink:label="lab_tnet_ProfessionalServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Professional Services [Member]</link:label>
    <link:label id="lab_tnet_ProfessionalServicesMember_documentation_en-US" xlink:label="lab_tnet_ProfessionalServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Professional Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ProfessionalServicesMember" xlink:href="tnet-20250331.xsd#tnet_ProfessionalServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_ProfessionalServicesMember" xlink:to="lab_tnet_ProfessionalServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_553fb9ee-0dbe-4a05-a345-0e1144be85a1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_534b877f-76ec-4b63-ba29-1f79221fc286_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a3a8e7f4-e115-4561-b7c1-2e15dd77ebf8_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Basis of Consolidation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_4068ecb7-6400-4051-a930-2703ba3c7728_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2939f36b-2849-4c94-8c81-eaca4d80ad99_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9d34241c-7bc1-4cb7-bdf6-23b02feb21b0_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares of common stock outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_890357ed-386b-4958-ada6-0c86fed3221a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis_dbd5d25c-cacf-44e8-8c6c-d8955d9e75ae_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Activity, Accrual [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Activity, Accrual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis" xlink:to="lab_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_2374825a-7b7d-473e-95e3-bc0cb984657a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_943e3c76-b4d2-4c1a-9ab9-28fa5e76407c_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_e131e17d-19aa-43c3-9da3-ceada7b63bf9_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_RestructuringChargesAdditions_c2eb04f4-f59f-4f8d-a8bb-485af7a0782f_terseLabel_en-US" xlink:label="lab_tnet_RestructuringChargesAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(+) Additions</link:label>
    <link:label id="lab_tnet_RestructuringChargesAdditions_label_en-US" xlink:label="lab_tnet_RestructuringChargesAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges, Additions</link:label>
    <link:label id="lab_tnet_RestructuringChargesAdditions_documentation_en-US" xlink:label="lab_tnet_RestructuringChargesAdditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring Charges, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_RestructuringChargesAdditions" xlink:href="tnet-20250331.xsd#tnet_RestructuringChargesAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_RestructuringChargesAdditions" xlink:to="lab_tnet_RestructuringChargesAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_b5e32de2-971a-445b-b7e1-4a8aa639343d_totalLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued costs, net of carrier collateral offset</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_7fb33a03-b27e-4cc8-afe3-c183bdd04502_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total accrued costs, net of carrier collateral offset</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Workers' Compensation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a5758f00-3a21-4eba-bcb3-3930990ff170_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">One year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent_d9879918-cf84-433e-98b9-b1b5f4e1d840_terseLabel_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued health insurance costs, net</link:label>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent_label_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collateral Paid To Insurance Carriers, Net Of Health Benefit Loss Reserves, Current</link:label>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent_documentation_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collateral Paid To Insurance Carriers, Net Of Health Benefit Loss Reserves, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" xlink:href="tnet-20250331.xsd#tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" xlink:to="lab_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_TrustForOurHRISUsersCollateralMember_678e21f7-3cb4-4602-adfe-16c4a5bb245e_terseLabel_en-US" xlink:label="lab_tnet_TrustForOurHRISUsersCollateralMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trust for our HRIS Users</link:label>
    <link:label id="lab_tnet_TrustForOurHRISUsersCollateralMember_label_en-US" xlink:label="lab_tnet_TrustForOurHRISUsersCollateralMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trust For our HRIS Users Collateral [Member]</link:label>
    <link:label id="lab_tnet_TrustForOurHRISUsersCollateralMember_documentation_en-US" xlink:label="lab_tnet_TrustForOurHRISUsersCollateralMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trust For our HRIS Users Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TrustForOurHRISUsersCollateralMember" xlink:href="tnet-20250331.xsd#tnet_TrustForOurHRISUsersCollateralMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_TrustForOurHRISUsersCollateralMember" xlink:to="lab_tnet_TrustForOurHRISUsersCollateralMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_281e8d40-0197-4c9d-a9d0-e005b2be0ac9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_3241e3f6-2dab-4372-a07f-4d198db7652a_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_d3aaa10a-eab9-4cb5-a3dd-1680beca95b9_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued wages</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_a94e8918-42e6-4908-835b-627773cd42e9_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued wages</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_fcc74f42-11b6-491a-9c59-449fc4c16f1b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_64a7043d-0d77-4333-bffe-bfc56e219759_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_58d731b5-30dc-4b69-bb59-7bc38aac88ee_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_e7bb6afd-2376-403f-ae03-e06c4488e88a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable_e84d88b3-46c8-4036-9bdc-4eb2aa81c716_terseLabel_en-US" xlink:label="lab_tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable from sale of business</link:label>
    <link:label id="lab_tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable_label_en-US" xlink:label="lab_tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash or Part Noncash Divestiture, Amount of Consideration Receivable</link:label>
    <link:label id="lab_tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable_documentation_en-US" xlink:label="lab_tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Noncash or Part Noncash Divestiture, Amount of Consideration Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable" xlink:href="tnet-20250331.xsd#tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable" xlink:to="lab_tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_bf406a21-e039-451f-b228-3df232b6515e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_d44ce26d-fc48-4583-a02b-e82ab3d575a7_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost of providing services</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a7280bb6-b6f3-4d52-8eb1-ca67973d29c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_IncreaseDecreaseInOtherPayrollAssets_1823d8e3-e0eb-4ed8-a2ed-6764262eeb05_negatedTerseLabel_en-US" xlink:label="lab_tnet_IncreaseDecreaseInOtherPayrollAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other payroll assets</link:label>
    <link:label id="lab_tnet_IncreaseDecreaseInOtherPayrollAssets_label_en-US" xlink:label="lab_tnet_IncreaseDecreaseInOtherPayrollAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease In Other Payroll Assets</link:label>
    <link:label id="lab_tnet_IncreaseDecreaseInOtherPayrollAssets_documentation_en-US" xlink:label="lab_tnet_IncreaseDecreaseInOtherPayrollAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase Decrease In Other Payroll Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncreaseDecreaseInOtherPayrollAssets" xlink:href="tnet-20250331.xsd#tnet_IncreaseDecreaseInOtherPayrollAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_IncreaseDecreaseInOtherPayrollAssets" xlink:to="lab_tnet_IncreaseDecreaseInOtherPayrollAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_e13d9d41-4114-435f-8768-d87829278d49_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_84ce83bd-517b-46b5-8444-2a379c71563d_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilutive effect of stock options and restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_bba0cf56-37d3-420e-b419-9157a14b4598_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_6a3ff8ae-d625-4f50-9eac-a5cd25ad1412_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Changes in Accrued Severance and Exit and Disposal Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c48238d9-9288-44d3-a93d-c71be45e8f6d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_f93f8a94-ebb6-482b-a363-45041dc917e8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_36adb4f9-0d54-4a5a-be3d-148048eb8f2e_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5f719298-3b91-4f94-aaaa-0ae4812408da_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected Dividend Yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_626bc7aa-fd46-4d52-9601-eaa9ca032566_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_646c701a-de54-4fea-b6be-624e6fb75e1e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_12087bc0-e100-4a9e-9712-cdf7b15b182b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0005957e-5ac5-4cd5-aae1-47d45202c997_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d83fa04c-12df-4ffc-8829-7d0a0300a299_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock from vested restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8d2c4c26-f12b-4066-9070-fb6b6e99689e_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ac67d551-a499-45cc-afe9-2942dfb74565_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-Free Interest Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_0d011365-930f-47ef-83e1-80ad17cae07d_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends payable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_f033ec8b-34f2-4b5c-992e-eab29723f7e7_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_4f68a985-37ad-4084-9432-02c5a3b9d27e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_0b6257f6-f0fd-4cf4-8aeb-8a1c13c5095a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_9e8f3248-a18d-427c-b77d-ba36c808f19c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Activities in Liability for Unpaid Claims and Claims Adjustment Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_7543c66a-f172-4a72-8568-4a837c48cfeb_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-US</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_1e7d039a-56e9-4378-baad-b80d73d8d61b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ad98cd7f-b159-4550-96df-13cc1e98f132_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3c85c1e2-972c-488c-9781-a8c9b1d9b17f_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_dfa0a54f-de44-42ca-9592-094b2cd54739_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_32ace6ef-9380-4d68-bbf0-1ddcbde3c374_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cf9b3fee-b134-4fe8-be40-c61e5aaaee64_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_7217397f-7184-47dd-bcc3-fafc2d4513c9_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_85b4eaff-09d1-46a7-ac2c-66b247f3afd5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_ClientSupportCosts_a11b4b7f-ed86-4bcd-8bb5-aec8f28b73db_terseLabel_en-US" xlink:label="lab_tnet_ClientSupportCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Client support costs</link:label>
    <link:label id="lab_tnet_ClientSupportCosts_label_en-US" xlink:label="lab_tnet_ClientSupportCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Client Support Costs</link:label>
    <link:label id="lab_tnet_ClientSupportCosts_documentation_en-US" xlink:label="lab_tnet_ClientSupportCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Client Support Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ClientSupportCosts" xlink:href="tnet-20250331.xsd#tnet_ClientSupportCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_ClientSupportCosts" xlink:to="lab_tnet_ClientSupportCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_c02218c7-6dd8-46db-8d72-98469956c3a7_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_86872477-e019-4f1a-b380-c7cf03f30bf5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Paid</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_A2031NotesPayableMember_c718d078-a402-48db-9772-41f046d0e946_terseLabel_en-US" xlink:label="lab_tnet_A2031NotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2031 Notes</link:label>
    <link:label id="lab_tnet_A2031NotesPayableMember_label_en-US" xlink:label="lab_tnet_A2031NotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2031 Notes Payable [Member]</link:label>
    <link:label id="lab_tnet_A2031NotesPayableMember_documentation_en-US" xlink:label="lab_tnet_A2031NotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2031 Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_A2031NotesPayableMember" xlink:href="tnet-20250331.xsd#tnet_A2031NotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_A2031NotesPayableMember" xlink:to="lab_tnet_A2031NotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_553f3121-59c1-4310-9340-2018843eb7f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payroll funds receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f2ec455c-cd8f-41d5-a377-cd6d56cc1076_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_82b61974-1c03-4b9e-b02e-a72e84595caf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_7481c5d3-46cf-4c2b-bd1f-f2a1feba1c51_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_a4d7fb68-7418-490d-b98a-1f580e25a102_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted EPS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_9a31646a-9bb6-4c59-9618-74a40838a16f_terseLabel_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_label_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_f7083c43-8ab2-4e34-826c-6af481df8403_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of ROU asset, lease modification, impairment, and abandonment</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e1bf2df9-a6d6-4b4b-b8f8-bff8f7c0d12a_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_c6095cb4-9fc2-4d89-9eb3-fd29f0a3b4a7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ACCRUED WORKERS' COMPENSATION COSTS</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2d1cbe5a-433c-46a2-8af8-fc337f1274c1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Client deposits and other client liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1102319e-dcbc-4e38-be70-11effb334f2b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross proceeds from sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_9593cf56-22af-4ac9-8998-66d2281cb8fc_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of shares that are expected to vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_585ea5f6-8c09-46c1-8d24-7a6089f180f4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_f33cc782-fcc8-45be-afab-52dae11bf61e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_c483ff06-2967-44df-88c7-aa61d1a41fb7_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RESTRUCTURING</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_6a41f652-e9cb-495e-bbab-ec89c08e2201_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_1d341a49-7915-4e86-9fef-f08182723555_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Arrangement, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityReserveEstimatePolicy_83cec5e6-de7e-4bf2-9c3a-c244cd21beb2_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityReserveEstimatePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Health Insurance Costs</link:label>
    <link:label id="lab_us-gaap_LiabilityReserveEstimatePolicy_label_en-US" xlink:label="lab_us-gaap_LiabilityReserveEstimatePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Reserve Estimate, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityReserveEstimatePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityReserveEstimatePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityReserveEstimatePolicy" xlink:to="lab_us-gaap_LiabilityReserveEstimatePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_a670732c-2617-48f7-84a5-13b611f580f8_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_60363be9-a659-45e8-933a-e36edce034ce_terseLabel_en-US" xlink:label="lab_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted, Weighted Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_label_en-US" xlink:label="lab_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Granted, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_documentation_en-US" xlink:label="lab_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Granted, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:href="tnet-20250331.xsd#tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:to="lab_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3bcc5bca-5fd1-4b3c-aadb-0ecfa863416d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_IncomeTaxesDisclosureTable_278a7827-1060-4920-8aaf-5109c9ec928e_terseLabel_en-US" xlink:label="lab_tnet_IncomeTaxesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes Disclosure [Table]</link:label>
    <link:label id="lab_tnet_IncomeTaxesDisclosureTable_label_en-US" xlink:label="lab_tnet_IncomeTaxesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Disclosure [Table]</link:label>
    <link:label id="lab_tnet_IncomeTaxesDisclosureTable_documentation_en-US" xlink:label="lab_tnet_IncomeTaxesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Taxes Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncomeTaxesDisclosureTable" xlink:href="tnet-20250331.xsd#tnet_IncomeTaxesDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_IncomeTaxesDisclosureTable" xlink:to="lab_tnet_IncomeTaxesDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_95a0e850-ac55-4dc2-a57f-b09bc7c79950_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosures of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_9bf4f710-2eca-4b80-bc5f-204245575514_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_670160b9-f23f-4f41-a6b4-8129df1330c8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_92fd82de-d172-439b-9d45-222c6cdadff6_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_3439ad08-f056-43a9-85ea-6a43bf6996dd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_3bf6ad07-85cb-41b9-a7e2-043d7dc21614_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_583fd596-1e11-414c-93ae-6a82289a4c43_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec201acf-d8c9-4036-84cb-c483fd6b6ffe_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_f71ee2f2-40d6-4d10-88f8-28ab134dca09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_e3d70b9e-df9b-49b2-8bfd-cc2aa9cc13fe_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_9350da56-d93e-4e1b-951a-cdcfc766f646_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities &amp; stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_708fdc63-5ec1-482e-9dc1-888679d0181e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_291a3753-056f-4864-ae81-70c594aec3b5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring balance</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_74347c74-2f8c-4f0f-b2b8-c6b271037561_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f7c472ea-823b-4e7b-9a27-ceedcc59a2cd_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_131ea21c-2246-41d8-8393-79cc9098b727_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_WorkersCompensationCosts_f4894bed-2efd-41be-8cb5-39c948c5ea7e_terseLabel_en-US" xlink:label="lab_tnet_WorkersCompensationCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Workers' compensation costs</link:label>
    <link:label id="lab_tnet_WorkersCompensationCosts_label_en-US" xlink:label="lab_tnet_WorkersCompensationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Workers' Compensation Costs</link:label>
    <link:label id="lab_tnet_WorkersCompensationCosts_documentation_en-US" xlink:label="lab_tnet_WorkersCompensationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Workers' Compensation Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_WorkersCompensationCosts" xlink:href="tnet-20250331.xsd#tnet_WorkersCompensationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_WorkersCompensationCosts" xlink:to="lab_tnet_WorkersCompensationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CorporateAdministrationExpenses_9bcb5f66-8d0e-4f7e-a816-826962995e35_terseLabel_en-US" xlink:label="lab_tnet_CorporateAdministrationExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate administration</link:label>
    <link:label id="lab_tnet_CorporateAdministrationExpenses_label_en-US" xlink:label="lab_tnet_CorporateAdministrationExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Administration Expenses</link:label>
    <link:label id="lab_tnet_CorporateAdministrationExpenses_documentation_en-US" xlink:label="lab_tnet_CorporateAdministrationExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Corporate Administration Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CorporateAdministrationExpenses" xlink:href="tnet-20250331.xsd#tnet_CorporateAdministrationExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CorporateAdministrationExpenses" xlink:to="lab_tnet_CorporateAdministrationExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_82aa7ca2-9c47-4a52-a76a-ab704a3f7392_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_4b331d19-f76f-48f8-ada8-4e58c5da7c46_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Awards effectively repurchased for required employee withholding taxes</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d9df6548-2a13-41b8-b652-a3f3f06212d5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockStock_189a47cb-809c-46bb-a4cb-c6f19e1a15fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Common stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Common Stock, Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCommonStockStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockStock" xlink:to="lab_us-gaap_DividendsCommonStockStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c7c82b16-b5a2-4fdb-b7d9-def5c3a866af_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected Term (in Years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cae42458-dd5f-4fc2-8ad1-709d9a61dd9a_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_f262446f-4068-46b6-9349-33ba04dd02a6_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6261184a-63ac-4471-a681-1e423a53dba1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_3cac1ab1-35a1-4871-9d26-c8171683a624_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d742b483-f766-4cce-acd0-22f57a656a8b_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_ea76d66e-cfae-4861-90d3-122d846fe19e_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f243d26e-aa01-426a-a33c-7ed4bef0ab78_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6e4aa017-2391-4073-a88f-9d1780cd6220_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d80edd90-89f9-4250-890f-d90aa7fc1baf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedCashFlowStatementTable_bbad78cf-c460-4a73-9b29-ec9e36187685_terseLabel_en-US" xlink:label="lab_srt_CondensedCashFlowStatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Condensed Cash Flow Statement [Table]</link:label>
    <link:label id="lab_srt_CondensedCashFlowStatementTable_label_en-US" xlink:label="lab_srt_CondensedCashFlowStatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Condensed Cash Flow Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementTable" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CondensedCashFlowStatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedCashFlowStatementTable" xlink:to="lab_srt_CondensedCashFlowStatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_a2feb323-6681-456f-9010-f2b1ffa5f8bc_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableFairValueDisclosure_ffe443fc-52ea-4bdf-80dc-20953ba44f60_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableFairValueDisclosure" xlink:to="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_70c4bfb1-cfc0-47c4-89ac-d23fdb1f63eb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_119798ef-f00b-4022-8be2-e3a8911a70d6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_91ff8915-4e6e-4b43-a239-872c33f044a9_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_e6e918c6-ba89-4238-b689-b1d93c3ed5cf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_26874b7a-7ee2-4815-940f-2143bb8785f8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a54abe1c-346e-41ee-a275-8b5133348b9a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_748901a4-31a5-4ffb-bda4-66426fffe07a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_23dd9902-04c3-457c-8725-1e85f61114f1_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving credit agreement borrowings</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_e5ea51e2-c58b-4574-b967-e5ab95420408_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_5de57ad5-af56-4c55-a7eb-15c036b563b7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_b5d65039-6199-403b-9e1a-ecf7a34376f7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_969b3b9d-c5dd-4b74-9061-51fdea41707b_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2c0f35c3-1d5e-438d-8008-a974696d21cb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_186adc2e-4ca3-45a1-ab8c-5ce97ae955ff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Losses on investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_60f0f2cf-17cc-44d4-947e-0276087a6449_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_a18b4947-c5fe-4776-a4aa-447da8108c91_negatedTerseLabel_en-US" xlink:label="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Collateral paid to carriers and offset against accrued costs</link:label>
    <link:label id="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_292998fa-43f8-4007-a9cf-8a197e0795f6_terseLabel_en-US" xlink:label="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collateral paid to carriers and offset against loss reserves</link:label>
    <link:label id="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_label_en-US" xlink:label="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Collateral</link:label>
    <link:label id="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_documentation_en-US" xlink:label="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" xlink:href="tnet-20250331.xsd#tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" xlink:to="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_472089ed-c8ff-40fa-ad32-513325e68631_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_InsuranceServicesMember_87b7cdfb-a5ba-434e-8636-975308bc6ffd_terseLabel_en-US" xlink:label="lab_tnet_InsuranceServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance service revenues</link:label>
    <link:label id="lab_tnet_InsuranceServicesMember_label_en-US" xlink:label="lab_tnet_InsuranceServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Services [Member]</link:label>
    <link:label id="lab_tnet_InsuranceServicesMember_documentation_en-US" xlink:label="lab_tnet_InsuranceServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Insurance Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsuranceServicesMember" xlink:href="tnet-20250331.xsd#tnet_InsuranceServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_InsuranceServicesMember" xlink:to="lab_tnet_InsuranceServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_52f18154-a882-47c3-b9fd-6ba481f35c72_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_SystemSupportAndDevelopmentExpenses_afe2e5bd-5793-493b-b3a2-d3f11eec6375_terseLabel_en-US" xlink:label="lab_tnet_SystemSupportAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">System support &amp; development</link:label>
    <link:label id="lab_tnet_SystemSupportAndDevelopmentExpenses_label_en-US" xlink:label="lab_tnet_SystemSupportAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">System Support And Development Expenses</link:label>
    <link:label id="lab_tnet_SystemSupportAndDevelopmentExpenses_documentation_en-US" xlink:label="lab_tnet_SystemSupportAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">System Support And Development Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_SystemSupportAndDevelopmentExpenses" xlink:href="tnet-20250331.xsd#tnet_SystemSupportAndDevelopmentExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_SystemSupportAndDevelopmentExpenses" xlink:to="lab_tnet_SystemSupportAndDevelopmentExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_073624b9-2088-4716-9cc6-66e1c21e31da_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_c9fb2f4c-9525-4f51-ae62-f55539492344_terseLabel_en-US" xlink:label="lab_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of providing services</link:label>
    <link:label id="lab_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_label_en-US" xlink:label="lab_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost Of Goods And Service, Excluding Depreciation, Depletion, And Amortization, And Operating Insurance And Claims Costs, Production</link:label>
    <link:label id="lab_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_documentation_en-US" xlink:label="lab_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cost Of Goods And Service, Excluding Depreciation, Depletion, And Amortization, And Operating Insurance And Claims Costs, Production</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" xlink:href="tnet-20250331.xsd#tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" xlink:to="lab_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_0bf03928-55a7-47eb-b053-fe669025cf64_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_804835e5-f146-4ac7-a763-f56e02fd44a4_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Software and other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a259ebe0-e5af-4866-836e-576f0d6c170f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedSalaries_5c04ce76-4135-4576-ad03-ecbd5782a456_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued wages</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedSalaries_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Salaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_32db3c26-a32f-46f5-9019-98b20220eab5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Incurred</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_AggregateIntrinsicValueRollForward_eda8c745-dbb6-42bd-b713-62484e75a722_terseLabel_en-US" xlink:label="lab_tnet_AggregateIntrinsicValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_tnet_AggregateIntrinsicValueRollForward_label_en-US" xlink:label="lab_tnet_AggregateIntrinsicValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value [Roll Forward]</link:label>
    <link:label id="lab_tnet_AggregateIntrinsicValueRollForward_documentation_en-US" xlink:label="lab_tnet_AggregateIntrinsicValueRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AggregateIntrinsicValueRollForward" xlink:href="tnet-20250331.xsd#tnet_AggregateIntrinsicValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_AggregateIntrinsicValueRollForward" xlink:to="lab_tnet_AggregateIntrinsicValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_8c55a9cc-775f-428f-a940-5177feec18a2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_20a7f4b3-7a95-470c-a162-5a9edd0c1970_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost, Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_853ce6cc-b0fb-4e67-a98b-f4b9ab3da4ff_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_ReportableSegmentMember_9cb7fa1b-1b78-4441-9e3f-b7686f1e991c_terseLabel_en-US" xlink:label="lab_tnet_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:label id="lab_tnet_ReportableSegmentMember_label_en-US" xlink:label="lab_tnet_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment [Member]</link:label>
    <link:label id="lab_tnet_ReportableSegmentMember_documentation_en-US" xlink:label="lab_tnet_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ReportableSegmentMember" xlink:href="tnet-20250331.xsd#tnet_ReportableSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_ReportableSegmentMember" xlink:to="lab_tnet_ReportableSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_InterestExpenseBankFeesAndOther_d2dfbeac-a29f-4818-b6e5-d4e34d0101f8_negatedTerseLabel_en-US" xlink:label="lab_tnet_InterestExpenseBankFeesAndOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense, bank fees and other</link:label>
    <link:label id="lab_tnet_InterestExpenseBankFeesAndOther_e1839793-58f3-4c9e-95ff-11366d588106_terseLabel_en-US" xlink:label="lab_tnet_InterestExpenseBankFeesAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense, bank fees and other</link:label>
    <link:label id="lab_tnet_InterestExpenseBankFeesAndOther_label_en-US" xlink:label="lab_tnet_InterestExpenseBankFeesAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Bank Fees and Other</link:label>
    <link:label id="lab_tnet_InterestExpenseBankFeesAndOther_documentation_en-US" xlink:label="lab_tnet_InterestExpenseBankFeesAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Expense, Bank Fees and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InterestExpenseBankFeesAndOther" xlink:href="tnet-20250331.xsd#tnet_InterestExpenseBankFeesAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_InterestExpenseBankFeesAndOther" xlink:to="lab_tnet_InterestExpenseBankFeesAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_e43ff51c-2ca1-4859-9d19-8a5934b5cca8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5caf90ed-f6e8-412d-8789-14a8a8b7b64b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected Volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_cb5b5846-baa7-43a3-8978-fa48c2211172_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of RSU Activity under Equity-Based Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_78ee9434-fbc9-4667-8857-b926bf516587_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_6b2c4c31-23fb-4c7a-baf7-3f83c1222ca1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_b139d48f-baab-4263-b75a-1456bcb6b9e6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance period for 2025 and 2024 awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_eb9741c3-3169-4bdd-ba0d-37162663ba71_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_190b0521-e6c2-4720-a33f-283de27965f8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1007c488-e15e-4002-bea0-c96beeff7c2d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent of share value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_1f6e13b5-400d-4a65-9eb0-9bfd188fe8e9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9bfbec85-1d54-453b-999e-662a0d700559_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_c80628c2-4170-4b06-be0b-a7b37a80e390_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther_cb0458b4-f4bd-40bd-8d9d-037b3815a22f_terseLabel_en-US" xlink:label="lab_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales &amp; marketing</link:label>
    <link:label id="lab_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther_label_en-US" xlink:label="lab_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling And Marketing Expense, Excluding Stock Based Compensation And Other</link:label>
    <link:label id="lab_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther_documentation_en-US" xlink:label="lab_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Selling And Marketing Expense, Excluding Stock Based Compensation And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther" xlink:href="tnet-20250331.xsd#tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther" xlink:to="lab_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5a5801b1-a7b7-495a-876b-3058436f099b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_33c3d6b3-a970-41f1-aa34-e08ad6da65a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Awards effectively repurchased for required employee withholding taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_555965d2-c829-4ebb-8c91-cfc062d8b121_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, cash equivalents and investments</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_8101c349-5ebc-41a1-a986-3c6babfa969f_netLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, cash equivalents and investments</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_9271e03f-131d-4808-9095-bff09ce29b80_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total restricted cash, cash equivalents and investments</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Investments, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:to="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_85871403-bcaa-437f-82b2-c8aeb1d917a8_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain_7315d655-62f9-40f4-bb30-3528455a63a0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Activity, Accrual [Domain]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Activity, Accrual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain" xlink:to="lab_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_126472b3-6acd-4f3d-bf8f-202bd61d9dd0_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_837f3db9-08bd-449a-860b-104e990d36c5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_f8d9bc03-4d91-4a8b-b803-0747b7f258bd_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total incurred</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_4c4eea81-1c8a-49fa-98fc-aba1dd161879_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalents Items [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalents Items [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8ced7b5a-3c0a-4327-b3ef-d0b4003f7867_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_6af65efa-3165-40a2-8433-ee7b8ba2a408_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_d03bb220-9478-48c0-9240-e97df55132d3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_464dd889-e638-4c84-ae61-28a9f419a096_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_26b02ae2-918a-4775-b934-afaa45d01e4a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_6ff442a5-00f1-4fdb-bdbd-db57e9c07400_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, unrestricted and restricted:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_d5e498ef-cd00-4346-ae6d-d74717fa340a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued health insurance costs, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Health Care Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember_d0a480a3-b9b4-4b69-b59f-f85c76c7b37e_terseLabel_en-US" xlink:label="lab_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Cash, Cash Equivalents and Investments</link:label>
    <link:label id="lab_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember_label_en-US" xlink:label="lab_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, and Cash Equivalents and Investments [Member]</link:label>
    <link:label id="lab_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember_documentation_en-US" xlink:label="lab_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restricted Cash, and Cash Equivalents and Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember" xlink:href="tnet-20250331.xsd#tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember" xlink:to="lab_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock_10b54080-694d-41b2-89d1-711a73ae7e49_terseLabel_en-US" xlink:label="lab_tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Worksite Employee Changes</link:label>
    <link:label id="lab_tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock_label_en-US" xlink:label="lab_tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Worksite Employee Changes [Table Text Block]</link:label>
    <link:label id="lab_tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock_documentation_en-US" xlink:label="lab_tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Worksite Employee Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock" xlink:href="tnet-20250331.xsd#tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock" xlink:to="lab_tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f4555058-3d0e-4ea2-a1be-3625442e1ff4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_5261ffe4-c8ed-4100-a915-b00e7442057c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock from vested restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_58e9867b-4740-456a-a473-1102fbc8b532_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8c89b28f-dd9b-4d36-bc7b-1ada1d3b90ba_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_499c45c4-55fe-4405-ae71-82acc59a509a_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_50ae8ea8-994f-435d-a86d-a5896c64225f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_7ec14054-9432-4df1-88c7-8cfcbe80016c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_0ace825e-0bdf-4be3-83b5-7412e38a4096_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Sales</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_4f1b3509-f4be-43a9-b46e-514ff4e61af3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assets and Liabilities in our Consolidated Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a46df6f2-4dde-4182-8ae3-001a17112a47_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_9989e677-3f85-4b1a-b4a1-6cab11497def_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_8e853645-badd-4d1a-a90c-ead7e5331e07_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsMember_e8c3e65a-32e7-4434-bfaa-94ec22c0c139_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsMember_label_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsMember" xlink:to="lab_us-gaap_InvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_395a3858-07ed-4a45-a762-efccb59e0dbf_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_fe4aa6b7-9873-413d-9189-01904f93e5a9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CollateralbyTypeAxis_ecc4732b-152f-4281-88b5-1fafe8f16b8f_terseLabel_en-US" xlink:label="lab_tnet_CollateralbyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collateral, by Type [Axis]</link:label>
    <link:label id="lab_tnet_CollateralbyTypeAxis_label_en-US" xlink:label="lab_tnet_CollateralbyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collateral, by Type [Axis]</link:label>
    <link:label id="lab_tnet_CollateralbyTypeAxis_documentation_en-US" xlink:label="lab_tnet_CollateralbyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collateral, by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralbyTypeAxis" xlink:href="tnet-20250331.xsd#tnet_CollateralbyTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CollateralbyTypeAxis" xlink:to="lab_tnet_CollateralbyTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_5e41dfe7-ad15-4854-97c0-d12ec16acded_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_9b041957-4ea6-4afb-9422-4f5992fbac77_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock and Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock Including Additional Paid in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_c2b36ad6-0dee-410e-9adb-411be25ef8a8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss from disposition of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_2ac0e07f-c539-4566-b156-aea6a426a83f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_6c52c845-38a5-42c7-8d84-c24669b26d8b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_bbaba1e6-daa8-4e8f-881c-ea0eda7a10d7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_bf5c9255-94d4-4056-9404-6df556a64c34_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental schedule of noncash investing and financing activities</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_b56b90f3-89d6-4be4-a15e-8e7eeb540b5d_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_7dfbb8df-1dbd-43e1-b159-0ea5329b2cfe_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_60086a08-30a4-4032-8e6b-cbbf23115329_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, noncurrent</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_782de704-3cfe-44b3-a995-1f956b015d12_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued workers' compensation costs, noncurrent, net</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_1de9ee2b-9c0a-4bb0-b38a-3a600dad1e3e_verboseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Payable in more than 1 year (net of collateral paid to carriers)</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Workers' Compensation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8675029b-fd1f-4c0b-aad1-8e462359e9e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_WorkersCompensationClaimsCollateralMember_15932ddf-751a-4383-8cd2-725e6a8dba53_terseLabel_en-US" xlink:label="lab_tnet_WorkersCompensationClaimsCollateralMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collateral for workers' compensation claims</link:label>
    <link:label id="lab_tnet_WorkersCompensationClaimsCollateralMember_label_en-US" xlink:label="lab_tnet_WorkersCompensationClaimsCollateralMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Workers' Compensation Claims Collateral [Member]</link:label>
    <link:label id="lab_tnet_WorkersCompensationClaimsCollateralMember_documentation_en-US" xlink:label="lab_tnet_WorkersCompensationClaimsCollateralMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Workers' Compensation Claims Collateral [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_WorkersCompensationClaimsCollateralMember" xlink:href="tnet-20250331.xsd#tnet_WorkersCompensationClaimsCollateralMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_WorkersCompensationClaimsCollateralMember" xlink:to="lab_tnet_WorkersCompensationClaimsCollateralMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b2e980db-8cb8-42d3-8aa1-55ccb0809f07_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average grant date fair value of stock options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cadb98a6-a8a6-4ade-b446-42a87d938669_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_2a0eb674-2afb-481b-8982-4bcca3939fd7_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_eb42a8f0-1ec0-49b7-b356-ca5f9acba00c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_446feb30-d98d-4567-bac9-2f343413135d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_da7a8f35-b7ae-41b7-8e56-29f9558f295f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_1ce92689-a470-4e76-95b4-f86d8f2860c2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_c25aada5-596a-4c59-87fe-ff5c676eb734_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_2f56ce56-0c6c-465a-be8f-0feb453284a4_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_85a42784-584d-4fd5-9825-d205064014f9_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_17818f02-c422-4f40-82df-30fd9b306231_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_217b6347-330c-4e3b-9700-6eb1c0291590_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_42f66c4f-a0d6-415d-bee3-ebb6b98543fd_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7e27741b-d675-4ae9-a1b7-1aa2e64dd9b0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INVESTMENTS</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_PerformanceBasedRestrictedStockUnitsMember_637c6155-2cfc-42e1-bb75-3cd43343c8ff_terseLabel_en-US" xlink:label="lab_tnet_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance-Based Restricted Stock Units</link:label>
    <link:label id="lab_tnet_PerformanceBasedRestrictedStockUnitsMember_label_en-US" xlink:label="lab_tnet_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance-Based Restricted Stock Units [Member]</link:label>
    <link:label id="lab_tnet_PerformanceBasedRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_tnet_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance-Based Restricted Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsMember" xlink:href="tnet-20250331.xsd#tnet_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_PerformanceBasedRestrictedStockUnitsMember" xlink:to="lab_tnet_PerformanceBasedRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_e39a4d2f-12f5-4d97-8c52-90d30e57916a_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued workers' compensation costs, net</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_2613e638-97d7-4410-8a8e-2bbbba676f81_verboseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Payable in less than 1 year (net of collateral paid to carriers)</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Workers' Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_af467c49-55b5-4835-9f13-30dee4319e4b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_3462fab4-5b39-4918-9bd0-6e06c0fe019c_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash dividend declared, but not yet paid</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_163b7797-4783-4623-96ca-aa2457b33b40_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_0c13878b-0e0d-47c5-9229-12dfb7b8c95c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_29b0003a-6ba6-47db-89dc-59b8e3bd2260_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_b6b11d03-a7d1-45d0-a1b3-bdcf62048427_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_78671462-aab1-4dea-aaea-8cad453022c4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_2a80d061-1d7a-4cb4-bf82-7545065e2c9e_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedCashFlowStatementsCaptionsLineItems_46540270-5b0b-4ee7-8091-89ebdb172de3_terseLabel_en-US" xlink:label="lab_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Condensed Cash Flow Statements</link:label>
    <link:label id="lab_srt_CondensedCashFlowStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Condensed Cash Flow Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3df2d6eb-156c-46fc-b679-989461ee9589_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_fded5a02-49cf-4a7d-a889-a0a262a07382_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_8d4aca21-35a6-416d-9d94-6f2585a8311d_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_38fa71f2-c0b8-41b9-95d3-561ae87e4b1a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_RestructuringChargesPayments_292c906d-9b28-435b-a5ac-3a65c641b5d6_terseLabel_en-US" xlink:label="lab_tnet_RestructuringChargesPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(-) Payments</link:label>
    <link:label id="lab_tnet_RestructuringChargesPayments_label_en-US" xlink:label="lab_tnet_RestructuringChargesPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges, Payments</link:label>
    <link:label id="lab_tnet_RestructuringChargesPayments_documentation_en-US" xlink:label="lab_tnet_RestructuringChargesPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring Charges, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_RestructuringChargesPayments" xlink:href="tnet-20250331.xsd#tnet_RestructuringChargesPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_RestructuringChargesPayments" xlink:to="lab_tnet_RestructuringChargesPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_abe74a0c-e4f4-4595-ba3e-fc970672c081_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_211c543e-1ff4-4aa8-864b-740f0b51e83a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_63b8ab26-6baf-4516-8db9-af5fa5115ca7_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent_cb9ca6a0-c9a7-43e7-88a8-fd577dc93f23_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, cash equivalents and investments, noncurrent</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent_6d964445-179e-42e8-a1af-552d2cd2abf7_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Collateral for workers' compensation claims</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Investments, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestments_c0a33c9d-87c2-454d-8776-58ceb28f71b0_totalLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestments_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndInvestments" xlink:to="lab_us-gaap_RestrictedCashAndInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7e8661b2-9b1a-4874-8fe1-5bd1c2cca162_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_499f484c-8540-4c88-b7fa-4fffc0c146fd_netLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_aac009c9-704c-4008-bed2-efa2d8b6e5db_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_249112d2-1cf6-4df8-a5ab-4e524c246361_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_16346773-e936-425d-b9c3-1e5a0a6629b2_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Certificate of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_06e5a40f-a67f-45bf-8f67-e04afec97cc8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_202c3967-5523-4cea-805b-57dbc1c91eee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Issued and Outstanding Common Stock</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Common Stock Outstanding Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent_c160c367-3260-4ff4-a4a9-5494f4e35c45_terseLabel_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collateral paid, noncurrent</link:label>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent_label_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collateral Paid To Insurance Carriers, Net Of Workers' Compensation Loss Reserves, Noncurrent</link:label>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent_documentation_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collateral Paid To Insurance Carriers, Net Of Workers' Compensation Loss Reserves, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" xlink:href="tnet-20250331.xsd#tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" xlink:to="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_2df8c9e5-0cbd-4f11-92eb-8ab0b6434464_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e89adce5-9e3d-4da9-acfd-0e00045056d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_404db5f2-a0cc-4900-a315-333028482b54_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_e1f67bc4-437c-41ef-8249-25ae808ecafa_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8eb3ff00-3554-4262-b8bc-637d30f61b89_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic EPS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_338b03ff-ec97-44e8-ae29-3691e94b0969_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_09ec0972-9170-4a79-94e2-a12108876a19_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_9207f6e2-9b79-4bfb-8f1b-1202d671a7e2_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_b9c53824-5bd0-43ab-827b-bf2a3e4ed809_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based payment award, expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_870e9af1-3fe6-4c44-ad19-a2265d9781ee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operation, Product Information, Concentration of Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_IncomeTaxesDisclosureLineItems_15d5f3b0-4742-4013-8ae1-3ed7d989891f_terseLabel_en-US" xlink:label="lab_tnet_IncomeTaxesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes Disclosure [Line Items]</link:label>
    <link:label id="lab_tnet_IncomeTaxesDisclosureLineItems_label_en-US" xlink:label="lab_tnet_IncomeTaxesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Disclosure [Line Items]</link:label>
    <link:label id="lab_tnet_IncomeTaxesDisclosureLineItems_documentation_en-US" xlink:label="lab_tnet_IncomeTaxesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Taxes Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncomeTaxesDisclosureLineItems" xlink:href="tnet-20250331.xsd#tnet_IncomeTaxesDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_IncomeTaxesDisclosureLineItems" xlink:to="lab_tnet_IncomeTaxesDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d4035456-c9df-4ea5-a88d-1c245f06e0e5_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payable for purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0342901e-9c6f-41f4-887b-2c9a49aa27af_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_c0d71bb8-6178-4166-9a17-08b4cece0c39_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_fcedf7cd-b816-4aa0-a7fe-e6264314eec7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_efa38289-8f4e-441e-8cd7-78a1741c3c79_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_b26c0349-3143-4696-8204-80c0850425b9_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">As previously reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_8d5344a9-e88f-4c2a-abae-32777c863fc4_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ff1a5343-0f00-44a8-9f08-b1adc09c5a21_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_a3d6af41-c1f7-42f6-9065-eea755038483_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_a09e761a-6b4f-429f-b1e6-1c0beed9a9d3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4f02353c-97c9-4a1d-9f55-2e2b43b665c8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Acquisitions of property and equipment and software</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_96864f8d-6bab-4399-a50d-b2e251d5494e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_fabc21e6-5b3d-409a-9676-8e55b90f012f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_0a1b8fd3-3a79-4858-a993-0fac423baa96_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_7eebf920-bf8b-4fec-b456-816696678225_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of deferred costs</link:label>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Other Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:to="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_0ab5c931-da5a-461c-ae24-e42e49a32717_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_960add46-7020-47c0-83f4-c7a278fc2242_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_351cc1f3-b2e8-456f-b81d-64497af81165_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">STOCK BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_bf0b6be9-65df-484c-a992-ac2c256548d7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_21ad8771-31d8-4389-b8fc-28cded802d0a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_d09988cd-9e77-4109-af67-a8b72935a7fc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_810d4304-c5ec-4d55-a9f4-f5179c016632_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of stock option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CollateralHeldByInsuranceCarriers_3984379a-32a6-4086-bbce-3f51a0deb836_terseLabel_en-US" xlink:label="lab_tnet_CollateralHeldByInsuranceCarriers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collateral held by insurance carriers</link:label>
    <link:label id="lab_tnet_CollateralHeldByInsuranceCarriers_label_en-US" xlink:label="lab_tnet_CollateralHeldByInsuranceCarriers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collateral Held By Insurance Carriers</link:label>
    <link:label id="lab_tnet_CollateralHeldByInsuranceCarriers_documentation_en-US" xlink:label="lab_tnet_CollateralHeldByInsuranceCarriers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collateral Held by Insurance Carriers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralHeldByInsuranceCarriers" xlink:href="tnet-20250331.xsd#tnet_CollateralHeldByInsuranceCarriers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CollateralHeldByInsuranceCarriers" xlink:to="lab_tnet_CollateralHeldByInsuranceCarriers" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CollateralByTypeDomain_073a9259-b1d1-474d-9706-176a62be59f6_terseLabel_en-US" xlink:label="lab_tnet_CollateralByTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collateral, by Type [Domain]</link:label>
    <link:label id="lab_tnet_CollateralByTypeDomain_label_en-US" xlink:label="lab_tnet_CollateralByTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collateral, by Type [Domain]</link:label>
    <link:label id="lab_tnet_CollateralByTypeDomain_documentation_en-US" xlink:label="lab_tnet_CollateralByTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collateral, by Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralByTypeDomain" xlink:href="tnet-20250331.xsd#tnet_CollateralByTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CollateralByTypeDomain" xlink:to="lab_tnet_CollateralByTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_TriNetTrustMember_8775caca-cc16-48db-a88f-a0fbec480690_terseLabel_en-US" xlink:label="lab_tnet_TriNetTrustMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">TriNet Trust</link:label>
    <link:label id="lab_tnet_TriNetTrustMember_label_en-US" xlink:label="lab_tnet_TriNetTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">TriNet Trust [Member]</link:label>
    <link:label id="lab_tnet_TriNetTrustMember_documentation_en-US" xlink:label="lab_tnet_TriNetTrustMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">TriNet Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TriNetTrustMember" xlink:href="tnet-20250331.xsd#tnet_TriNetTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_TriNetTrustMember" xlink:to="lab_tnet_TriNetTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_d2d86583-be21-4209-a51c-d23aeb866634_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total stock based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_89443c5f-be92-4191-8994-d21cd358d84d_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_a22a46cf-e9e0-49c0-9f4c-b0e9525579fb_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_022935f1-2d2a-462b-959a-e4a1ce43df80_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_aa6ae694-e3fd-47af-a9d3-04c7e53dfb0d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6746c548-2e65-400f-9b9e-3b9809a6c65f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_4a730dd8-d48a-43cd-a84e-6cb46dbe1a97_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued workers' compensation costs, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Workers' Compensation Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bb675df1-f0d0-4d43-8729-d823938775d0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c641e7ec-08cb-4507-b455-c822e5351819_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_bd0ea1fd-d62b-4387-abfd-02890d019d8b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll taxes liabilities and other payroll withholdings</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Employee-Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_8c158060-8847-4b89-b656-a27798f0dcb7_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_4a39cf5c-fda1-4b82-a661-070c84055bf6_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_bf9f863e-fb0b-4972-97ef-27d4620aac98_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_c3633849-7863-45c6-a9b9-180cb2778d31_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_9b9ed8b4-62f8-4031-a728-03f4c95b2713_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_a3aeb2a9-a4b6-4a8b-8b76-449ced1d46e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_3718f108-9c31-4d2b-b9f8-96eb77e1bd35_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLossCarryforwardMember_47a33516-2cd3-4d9e-b06c-794cf8ee48d9_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLossCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital Loss Carryforward</link:label>
    <link:label id="lab_us-gaap_CapitalLossCarryforwardMember_label_en-US" xlink:label="lab_us-gaap_CapitalLossCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Loss Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLossCarryforwardMember" xlink:to="lab_us-gaap_CapitalLossCarryforwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_922a8ca1-0151-4284-817e-2856b0bf52d4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_db1bfcf0-5f9f-4634-bfdd-ed612901f7a6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_1d6408fe-4c26-4d3d-a173-df2cc6da2f39_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_4383f55d-fd09-41f1-bd09-b8e8df93506d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_913c4a42-1c27-4bcd-9390-851395586340_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64154c3a-82b6-4773-b8eb-e9c7dbbb09a0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent_152ee552-2468-492b-ab87-5d7b75fadfef_terseLabel_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collateral paid, current</link:label>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent_label_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collateral Paid To Insurance Carriers, Net Of Workers' Compensation Loss Reserves, Current</link:label>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent_documentation_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collateral Paid to Insurance Carriers, Net of Workers' Compensation Loss Reserves, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" xlink:href="tnet-20250331.xsd#tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" xlink:to="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_OtherPayrollAssetsCurrent_2a50fe7c-c43b-4e36-a742-58e6dff9bf45_terseLabel_en-US" xlink:label="lab_tnet_OtherPayrollAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other payroll assets</link:label>
    <link:label id="lab_tnet_OtherPayrollAssetsCurrent_label_en-US" xlink:label="lab_tnet_OtherPayrollAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Payroll Assets Current</link:label>
    <link:label id="lab_tnet_OtherPayrollAssetsCurrent_documentation_en-US" xlink:label="lab_tnet_OtherPayrollAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Payroll Assets Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_OtherPayrollAssetsCurrent" xlink:href="tnet-20250331.xsd#tnet_OtherPayrollAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_OtherPayrollAssetsCurrent" xlink:to="lab_tnet_OtherPayrollAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOperating_486d28b9-92bf-42de-a59d-2f617e7a5c03_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperating_3df0b74c-3e0a-4728-9a6b-26c04d944fab_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOperating" xlink:to="lab_us-gaap_InterestIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_A2029NotesPayableMember_bc173c3f-e68c-4bcf-97e5-d5bed7b5cc90_terseLabel_en-US" xlink:label="lab_tnet_A2029NotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029 Notes</link:label>
    <link:label id="lab_tnet_A2029NotesPayableMember_label_en-US" xlink:label="lab_tnet_A2029NotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2029 Notes Payable [Member]</link:label>
    <link:label id="lab_tnet_A2029NotesPayableMember_documentation_en-US" xlink:label="lab_tnet_A2029NotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2029 Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_A2029NotesPayableMember" xlink:href="tnet-20250331.xsd#tnet_A2029NotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_A2029NotesPayableMember" xlink:to="lab_tnet_A2029NotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareMember_64ed444b-a5fa-46f5-aa67-d06543627dbd_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Health Care</link:label>
    <link:label id="lab_us-gaap_HealthCareMember_label_en-US" xlink:label="lab_us-gaap_HealthCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Health Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareMember" xlink:to="lab_us-gaap_HealthCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_bcd32f0f-4ca2-4c18-a222-6cc126a39e0e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_88ec6cdd-e424-480e-81ef-396786df9a1b_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_6d08fb85-4a1a-448f-a0e3-c89a04e30c84_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_9953f17b-9d82-465a-9c2b-34b8faf29de8_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Total accrued costs, beginning of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_81677226-b45e-4d04-bc81-4ea0dc624f56_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Total accrued costs, end of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_8c285c5e-d14b-4bea-8177-003249955019_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total accrued costs, end of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f78b9cf9-fb41-4332-a721-241425a9bd9d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_1df58106-f4da-4d3c-ad49-94a62fc9cce9_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_57f90288-76f6-4f44-a984-f339565086a2_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_AvailableForSaleMarketableSecuritiesMember_bd25597a-7bd0-4255-835d-95422e2acbbc_terseLabel_en-US" xlink:label="lab_tnet_AvailableForSaleMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available-for-sale marketable securities</link:label>
    <link:label id="lab_tnet_AvailableForSaleMarketableSecuritiesMember_label_en-US" xlink:label="lab_tnet_AvailableForSaleMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-Sale Marketable Securities [Member]</link:label>
    <link:label id="lab_tnet_AvailableForSaleMarketableSecuritiesMember_documentation_en-US" xlink:label="lab_tnet_AvailableForSaleMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Available-for-Sale Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AvailableForSaleMarketableSecuritiesMember" xlink:href="tnet-20250331.xsd#tnet_AvailableForSaleMarketableSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_AvailableForSaleMarketableSecuritiesMember" xlink:to="lab_tnet_AvailableForSaleMarketableSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet_725165de-b6fe-4c4a-bb87-6c0a8e044bc1_negatedTerseLabel_en-US" xlink:label="lab_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in WSE and TriNet Trust related assets and liabilities, net</link:label>
    <link:label id="lab_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet_533dbd16-0453-4fa1-99c5-781ec3fedaf4_verboseLabel_en-US" xlink:label="lab_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Change in WSE and TriNet Trust related assets and liabilities, net</link:label>
    <link:label id="lab_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet_label_en-US" xlink:label="lab_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change In Variable Interest Entity Assets And Liabilities, Net</link:label>
    <link:label id="lab_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet_documentation_en-US" xlink:label="lab_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Change In Variable Interest Entity Assets And Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet" xlink:href="tnet-20250331.xsd#tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet" xlink:to="lab_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c52a7aa8-1436-47d5-95cd-60cefa085ef2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f151062c-e12a-4e87-bfe6-091135dac188_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares of common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_58d23daf-3440-449c-a63b-7d06b754f9c9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AFS securities, gross realized gain (loss)</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_9e8a959b-2912-42be-87ca-3cb011665431_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_label_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfExpenseAxis" xlink:to="lab_us-gaap_NatureOfExpenseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_30379f06-3f09-4051-acd8-658cc26dbcb3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_94e44c25-1335-4dc2-aab8-7b0b0b8dfce2_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_5e6268f0-b715-4fad-a8b9-8d0a6c702ad1_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9481bbf4-335b-49c7-9ff8-9d05b26141ff_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total fair value of options granted</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_4771400f-89ec-48a7-9ad5-abe4af6db9a2_terseLabel_en-US" xlink:label="lab_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_label_en-US" xlink:label="lab_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants In Period, Intrinsic Value</link:label>
    <link:label id="lab_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_documentation_en-US" xlink:label="lab_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants In Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:href="tnet-20250331.xsd#tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:to="lab_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_ca9d55ae-b748-445f-abb2-00ea856e46aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>tnet-20250331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:104eff25-bde6-411e-ba54-56469600d7a1,g:ffef9025-6e41-425a-998c-b582f585f1c3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.trinet.com/role/Cover" xlink:type="simple" xlink:href="tnet-20250331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5fabe74f-4ce4-4405-81a9-7ce8fef389da" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_DocumentType_5fabe74f-4ce4-4405-81a9-7ce8fef389da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_e47a52e1-8a8a-41e9-ade2-1feb5c0f578a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_DocumentQuarterlyReport_e47a52e1-8a8a-41e9-ade2-1feb5c0f578a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ec209e43-7f82-41f1-9e39-f2a1cf1c0e2c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_DocumentPeriodEndDate_ec209e43-7f82-41f1-9e39-f2a1cf1c0e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_4e9bd1d3-e94d-4959-abd3-8493771c1403" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_DocumentTransitionReport_4e9bd1d3-e94d-4959-abd3-8493771c1403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_03ef9d8b-6bd7-49b7-9ba8-82d77e23c434" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityFileNumber_03ef9d8b-6bd7-49b7-9ba8-82d77e23c434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_33eb9046-7f2f-46b1-8f6f-61ff6676097c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityRegistrantName_33eb9046-7f2f-46b1-8f6f-61ff6676097c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6175ccfb-a0b6-40e2-9b0f-ab73b898043b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6175ccfb-a0b6-40e2-9b0f-ab73b898043b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_41272f48-91ef-45d3-9207-c17552e583cf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityTaxIdentificationNumber_41272f48-91ef-45d3-9207-c17552e583cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_1fc8e4c4-ca11-41c0-b951-62569bb667bc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityAddressAddressLine1_1fc8e4c4-ca11-41c0-b951-62569bb667bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_d9161f0c-41bc-47a9-8e66-22ad7b7d5f30" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityAddressAddressLine2_d9161f0c-41bc-47a9-8e66-22ad7b7d5f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_acff65c6-0c5f-4c49-a095-f47810cce2dc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityAddressCityOrTown_acff65c6-0c5f-4c49-a095-f47810cce2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_8bfb7dd2-c665-4a75-be0d-d0d7ac86068a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityAddressStateOrProvince_8bfb7dd2-c665-4a75-be0d-d0d7ac86068a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f7202e75-fa55-44eb-9ac3-da1fc011e737" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityAddressPostalZipCode_f7202e75-fa55-44eb-9ac3-da1fc011e737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_7befc7ce-4793-42d3-89e4-4d0c3f87ac94" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_CityAreaCode_7befc7ce-4793-42d3-89e4-4d0c3f87ac94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_37b37937-d5fb-47f0-ae84-1c23ab43b2bb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_LocalPhoneNumber_37b37937-d5fb-47f0-ae84-1c23ab43b2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7e7103ed-2a41-474d-a89d-e1b1aaf5ac9f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_Security12bTitle_7e7103ed-2a41-474d-a89d-e1b1aaf5ac9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_f38d6d75-2527-4b87-81e8-b556a153af09" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_TradingSymbol_f38d6d75-2527-4b87-81e8-b556a153af09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_342880c9-55b3-4669-b471-06fe48e5d599" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_SecurityExchangeName_342880c9-55b3-4669-b471-06fe48e5d599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_33123be2-9e1a-4fe7-aeba-6f5c46023da3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityCurrentReportingStatus_33123be2-9e1a-4fe7-aeba-6f5c46023da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_30578387-a8fb-4f2e-8a8c-4b4f3f6473bc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityInteractiveDataCurrent_30578387-a8fb-4f2e-8a8c-4b4f3f6473bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_bec06d00-a4f6-43a5-8a1b-f30eb5be9ff4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityFilerCategory_bec06d00-a4f6-43a5-8a1b-f30eb5be9ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_4261ce1a-a7cb-44e7-a326-6675a34447b4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntitySmallBusiness_4261ce1a-a7cb-44e7-a326-6675a34447b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ec8ee5b6-5b19-4213-8abd-797999b2abeb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityEmergingGrowthCompany_ec8ee5b6-5b19-4213-8abd-797999b2abeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_cecf44d3-9669-4295-901b-748977d64db7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityShellCompany_cecf44d3-9669-4295-901b-748977d64db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_1333d84f-df8d-4381-8f9b-d9974e440f04" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_1333d84f-df8d-4381-8f9b-d9974e440f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_049f88ba-c17b-4db5-a99f-e7df839d69be" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_EntityCentralIndexKey_049f88ba-c17b-4db5-a99f-e7df839d69be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_0794b30c-ce79-4d3b-a585-ede95bddf18f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_CurrentFiscalYearEndDate_0794b30c-ce79-4d3b-a585-ede95bddf18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_764466b3-5674-4478-a462-b7449efd26da" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_DocumentFiscalYearFocus_764466b3-5674-4478-a462-b7449efd26da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_1f42c1ce-772a-407f-b9c4-cda6d785e473" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_DocumentFiscalPeriodFocus_1f42c1ce-772a-407f-b9c4-cda6d785e473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c54d7e41-5cd5-4604-9f5f-24040526f09d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ca6f9b03-7738-41a3-ba9d-7134a3c4ef4a" xlink:to="loc_dei_AmendmentFlag_c54d7e41-5cd5-4604-9f5f-24040526f09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="tnet-20250331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_b889d8f9-254b-484a-bcd8-8a68f5046b55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a6468ab7-723d-4216-8c10-233e13aa0717" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b889d8f9-254b-484a-bcd8-8a68f5046b55" xlink:to="loc_us-gaap_StatementTable_a6468ab7-723d-4216-8c10-233e13aa0717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bc908600-389e-40c0-a8b2-e0d881d35149" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a6468ab7-723d-4216-8c10-233e13aa0717" xlink:to="loc_srt_ProductOrServiceAxis_bc908600-389e-40c0-a8b2-e0d881d35149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_14212c3f-4832-41e1-b789-b4277867c2b6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_bc908600-389e-40c0-a8b2-e0d881d35149" xlink:to="loc_srt_ProductsAndServicesDomain_14212c3f-4832-41e1-b789-b4277867c2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ProfessionalServicesMember_4e36f5bd-92b4-45aa-8476-09b03d017883" xlink:href="tnet-20250331.xsd#tnet_ProfessionalServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_14212c3f-4832-41e1-b789-b4277867c2b6" xlink:to="loc_tnet_ProfessionalServicesMember_4e36f5bd-92b4-45aa-8476-09b03d017883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsuranceServicesMember_e3e855d8-d86b-4288-b909-a565f0ea5e38" xlink:href="tnet-20250331.xsd#tnet_InsuranceServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_14212c3f-4832-41e1-b789-b4277867c2b6" xlink:to="loc_tnet_InsuranceServicesMember_e3e855d8-d86b-4288-b909-a565f0ea5e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a6468ab7-723d-4216-8c10-233e13aa0717" xlink:to="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_15147a3d-cb63-430c-8c98-9f3278364c29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_15147a3d-cb63-430c-8c98-9f3278364c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_06376dcb-1e0d-495e-9ffd-2d14124c0857" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_InterestIncomeOperating_06376dcb-1e0d-495e-9ffd-2d14124c0857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dc4b8570-99ed-4278-bc01-f74d7352572a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_Revenues_dc4b8570-99ed-4278-bc01-f74d7352572a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction_4bdc0e4e-8a16-48a2-ba7f-209781c73cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingInsuranceAndClaimsCostsProduction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction_4bdc0e4e-8a16-48a2-ba7f-209781c73cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_797802ce-3807-4d9c-ae20-fd4eff0bdf0d" xlink:href="tnet-20250331.xsd#tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_797802ce-3807-4d9c-ae20-fd4eff0bdf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_9637aa3f-1c09-41c3-9363-3c6193db7f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_SellingAndMarketingExpense_9637aa3f-1c09-41c3-9363-3c6193db7f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_aeb02685-04ac-41e3-9580-d80678ef821b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_aeb02685-04ac-41e3-9580-d80678ef821b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d23263ad-4d88-40c4-aaa9-b391e8e746c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d23263ad-4d88-40c4-aaa9-b391e8e746c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_afb85671-8392-4ddc-a632-6b0be00470c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_afb85671-8392-4ddc-a632-6b0be00470c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InterestExpenseBankFeesAndOther_5a41cf3b-d726-4fbb-b985-f743f8e53993" xlink:href="tnet-20250331.xsd#tnet_InterestExpenseBankFeesAndOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_tnet_InterestExpenseBankFeesAndOther_5a41cf3b-d726-4fbb-b985-f743f8e53993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f61d9473-a0f8-4ec0-a05e-d3948966d22c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_CostsAndExpenses_f61d9473-a0f8-4ec0-a05e-d3948966d22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5dc3f5c9-7da9-41cd-93a6-45db8ba56a06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5dc3f5c9-7da9-41cd-93a6-45db8ba56a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3d9b47cc-ed9d-4406-9c46-5dfd8738dc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3d9b47cc-ed9d-4406-9c46-5dfd8738dc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7c68f0f5-973c-472d-86de-3003c08a217f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_NetIncomeLoss_7c68f0f5-973c-472d-86de-3003c08a217f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c2a98a26-827e-4583-9c9e-8c47e79ac592" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c2a98a26-827e-4583-9c9e-8c47e79ac592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1eb46cc3-6652-48e4-937c-4f3e422e4c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_1eb46cc3-6652-48e4-937c-4f3e422e4c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_53d3284c-4246-408b-a613-6828e83f25a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_EarningsPerShareAbstract_53d3284c-4246-408b-a613-6828e83f25a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4547c750-4d83-44a9-8b4c-15fb066010db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_53d3284c-4246-408b-a613-6828e83f25a4" xlink:to="loc_us-gaap_EarningsPerShareBasic_4547c750-4d83-44a9-8b4c-15fb066010db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7d15236b-2987-4d61-bb8d-9ad20957d4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_53d3284c-4246-408b-a613-6828e83f25a4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7d15236b-2987-4d61-bb8d-9ad20957d4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_70f40f43-1ec9-4499-8ee8-29f523d13382" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_80f714ad-695f-4f11-932c-b3e0f3c1c963" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_70f40f43-1ec9-4499-8ee8-29f523d13382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6cf9464e-58bc-4027-a5b2-c67bfb973815" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_70f40f43-1ec9-4499-8ee8-29f523d13382" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6cf9464e-58bc-4027-a5b2-c67bfb973815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d1c68757-7046-4489-8bff-3a973103328c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_70f40f43-1ec9-4499-8ee8-29f523d13382" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d1c68757-7046-4489-8bff-3a973103328c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="tnet-20250331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4e20b947-571b-4ea0-8ed0-0030f6fb49b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c910f094-f53c-48c8-9ea3-f6e8584bfed7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4e20b947-571b-4ea0-8ed0-0030f6fb49b8" xlink:to="loc_us-gaap_AssetsAbstract_c910f094-f53c-48c8-9ea3-f6e8584bfed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_66854bb0-446e-4654-b4d9-88a3290fafbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c910f094-f53c-48c8-9ea3-f6e8584bfed7" xlink:to="loc_us-gaap_AssetsCurrentAbstract_66854bb0-446e-4654-b4d9-88a3290fafbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5e229ead-f502-491c-88a0-8bafcb593bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_66854bb0-446e-4654-b4d9-88a3290fafbf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5e229ead-f502-491c-88a0-8bafcb593bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_82d2573d-8ec4-4079-81ad-f29e6ed20183" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_66854bb0-446e-4654-b4d9-88a3290fafbf" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_82d2573d-8ec4-4079-81ad-f29e6ed20183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ad205aaa-df01-48c1-ae1c-97348d544faf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_66854bb0-446e-4654-b4d9-88a3290fafbf" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ad205aaa-df01-48c1-ae1c-97348d544faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_cb77d349-236c-4adb-9fc3-b819f8110d02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_66854bb0-446e-4654-b4d9-88a3290fafbf" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_cb77d349-236c-4adb-9fc3-b819f8110d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_2217326b-b95f-4e1f-b4a1-367eb63ba915" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_66854bb0-446e-4654-b4d9-88a3290fafbf" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_2217326b-b95f-4e1f-b4a1-367eb63ba915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_OtherPayrollAssetsCurrent_23a75a88-b2bf-486b-87e8-1c8d5cb3fdb0" xlink:href="tnet-20250331.xsd#tnet_OtherPayrollAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_66854bb0-446e-4654-b4d9-88a3290fafbf" xlink:to="loc_tnet_OtherPayrollAssetsCurrent_23a75a88-b2bf-486b-87e8-1c8d5cb3fdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_045b991a-8e20-47a8-8ec0-64b2e5ea5b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_66854bb0-446e-4654-b4d9-88a3290fafbf" xlink:to="loc_us-gaap_OtherAssetsCurrent_045b991a-8e20-47a8-8ec0-64b2e5ea5b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_17943fb8-f0a5-42da-9ed1-2d10c06d47db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_66854bb0-446e-4654-b4d9-88a3290fafbf" xlink:to="loc_us-gaap_AssetsCurrent_17943fb8-f0a5-42da-9ed1-2d10c06d47db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_9d8a8ec9-03f8-420f-b63b-1857e16d82e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c910f094-f53c-48c8-9ea3-f6e8584bfed7" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_9d8a8ec9-03f8-420f-b63b-1857e16d82e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_58053a3f-bb64-4883-8f93-04fd5cd9f9a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c910f094-f53c-48c8-9ea3-f6e8584bfed7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_58053a3f-bb64-4883-8f93-04fd5cd9f9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_cf1882b7-4665-4723-8ab7-3abeb8d45557" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c910f094-f53c-48c8-9ea3-f6e8584bfed7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_cf1882b7-4665-4723-8ab7-3abeb8d45557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b8ea5132-b17b-47f0-a543-74d9159c0c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c910f094-f53c-48c8-9ea3-f6e8584bfed7" xlink:to="loc_us-gaap_Goodwill_b8ea5132-b17b-47f0-a543-74d9159c0c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_55615550-3501-49c0-816d-4d20e3d56b17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c910f094-f53c-48c8-9ea3-f6e8584bfed7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_55615550-3501-49c0-816d-4d20e3d56b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f48afe33-0ab1-4130-98c1-f7a7390782be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c910f094-f53c-48c8-9ea3-f6e8584bfed7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f48afe33-0ab1-4130-98c1-f7a7390782be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b119f75e-9c31-4cfa-ade3-c574dbe4d1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c910f094-f53c-48c8-9ea3-f6e8584bfed7" xlink:to="loc_us-gaap_Assets_b119f75e-9c31-4cfa-ade3-c574dbe4d1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2b946621-c695-427e-bc40-e607e71d444c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4e20b947-571b-4ea0-8ed0-0030f6fb49b8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2b946621-c695-427e-bc40-e607e71d444c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_bdcba4f1-fcf8-45fa-9fa6-634bf3660602" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2b946621-c695-427e-bc40-e607e71d444c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_bdcba4f1-fcf8-45fa-9fa6-634bf3660602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_d1d1d356-5872-4afa-8565-32ee3407bae7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bdcba4f1-fcf8-45fa-9fa6-634bf3660602" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_d1d1d356-5872-4afa-8565-32ee3407bae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_70712eaf-4719-42d7-96ed-dcb194888769" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bdcba4f1-fcf8-45fa-9fa6-634bf3660602" xlink:to="loc_us-gaap_LinesOfCreditCurrent_70712eaf-4719-42d7-96ed-dcb194888769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_da1bc208-e4dc-4a70-b092-b71ecb4e0da6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bdcba4f1-fcf8-45fa-9fa6-634bf3660602" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_da1bc208-e4dc-4a70-b092-b71ecb4e0da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_c81bc257-5408-4801-94cf-b29a262cc3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bdcba4f1-fcf8-45fa-9fa6-634bf3660602" xlink:to="loc_us-gaap_AccruedSalariesCurrent_c81bc257-5408-4801-94cf-b29a262cc3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent_2a725534-be3f-4fe8-b749-0972b21d8d47" xlink:href="tnet-20250331.xsd#tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bdcba4f1-fcf8-45fa-9fa6-634bf3660602" xlink:to="loc_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent_2a725534-be3f-4fe8-b749-0972b21d8d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_43345b7e-72d2-4809-b07e-64624a17fbc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bdcba4f1-fcf8-45fa-9fa6-634bf3660602" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_43345b7e-72d2-4809-b07e-64624a17fbc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_b44ddf11-2276-4722-93d7-e4101b97afbf" xlink:href="tnet-20250331.xsd#tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bdcba4f1-fcf8-45fa-9fa6-634bf3660602" xlink:to="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_b44ddf11-2276-4722-93d7-e4101b97afbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_496952a0-06b8-4a9e-9dd5-f2bcc9d6a030" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bdcba4f1-fcf8-45fa-9fa6-634bf3660602" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_496952a0-06b8-4a9e-9dd5-f2bcc9d6a030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsurancePremiumsAndOtherPayables_76cc1ef8-be3a-4718-9326-b4bff2bad124" xlink:href="tnet-20250331.xsd#tnet_InsurancePremiumsAndOtherPayables"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bdcba4f1-fcf8-45fa-9fa6-634bf3660602" xlink:to="loc_tnet_InsurancePremiumsAndOtherPayables_76cc1ef8-be3a-4718-9326-b4bff2bad124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0c052934-795d-460d-ac85-60d45a4eff3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bdcba4f1-fcf8-45fa-9fa6-634bf3660602" xlink:to="loc_us-gaap_LiabilitiesCurrent_0c052934-795d-460d-ac85-60d45a4eff3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4423c728-2bcc-4c11-8f6c-d938107587cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2b946621-c695-427e-bc40-e607e71d444c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4423c728-2bcc-4c11-8f6c-d938107587cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_14c2fea2-6579-49bd-8a2b-7cc2ebedc33c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2b946621-c695-427e-bc40-e607e71d444c" xlink:to="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_14c2fea2-6579-49bd-8a2b-7cc2ebedc33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e596b038-5bd5-431f-8b30-f6c7dd97423c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2b946621-c695-427e-bc40-e607e71d444c" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e596b038-5bd5-431f-8b30-f6c7dd97423c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1d44f301-b380-4d68-858b-02ae2fa34279" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2b946621-c695-427e-bc40-e607e71d444c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1d44f301-b380-4d68-858b-02ae2fa34279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_481c60d7-579a-4601-b32e-b92f6ca4f84a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2b946621-c695-427e-bc40-e607e71d444c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_481c60d7-579a-4601-b32e-b92f6ca4f84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8ed3dced-5795-4902-b6fd-eec7a3c1814e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2b946621-c695-427e-bc40-e607e71d444c" xlink:to="loc_us-gaap_Liabilities_8ed3dced-5795-4902-b6fd-eec7a3c1814e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_499dd3ec-7f9e-4a42-9bd2-2654b6f0f8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2b946621-c695-427e-bc40-e607e71d444c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_499dd3ec-7f9e-4a42-9bd2-2654b6f0f8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6447c274-09e0-43dd-8fdc-9a518cb31eed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2b946621-c695-427e-bc40-e607e71d444c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_6447c274-09e0-43dd-8fdc-9a518cb31eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2ab1da74-f090-4df3-9fdf-66c186703248" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6447c274-09e0-43dd-8fdc-9a518cb31eed" xlink:to="loc_us-gaap_PreferredStockValue_2ab1da74-f090-4df3-9fdf-66c186703248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_ccd8b564-4ce6-44d1-99ce-3d0c98db9996" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6447c274-09e0-43dd-8fdc-9a518cb31eed" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_ccd8b564-4ce6-44d1-99ce-3d0c98db9996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_10c74aef-d6a2-4f4a-b9ef-dd49f22631dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6447c274-09e0-43dd-8fdc-9a518cb31eed" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_10c74aef-d6a2-4f4a-b9ef-dd49f22631dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6a5bf66d-1400-4dd8-bd74-d50cb7717456" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6447c274-09e0-43dd-8fdc-9a518cb31eed" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6a5bf66d-1400-4dd8-bd74-d50cb7717456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e02740f4-5f3e-4b9b-94dd-9fa5c972a822" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6447c274-09e0-43dd-8fdc-9a518cb31eed" xlink:to="loc_us-gaap_StockholdersEquity_e02740f4-5f3e-4b9b-94dd-9fa5c972a822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b422f766-f89e-45f6-8901-a055c13de2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2b946621-c695-427e-bc40-e607e71d444c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_b422f766-f89e-45f6-8901-a055c13de2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="simple" xlink:href="tnet-20250331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e673914a-0dbb-4470-9374-a7c54c32c16e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6886102a-2b92-4713-8679-d60814b13098" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e673914a-0dbb-4470-9374-a7c54c32c16e" xlink:to="loc_us-gaap_StockholdersEquityAbstract_6886102a-2b92-4713-8679-d60814b13098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_a9ac7f41-764b-4821-aa84-df9bb61514de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6886102a-2b92-4713-8679-d60814b13098" xlink:to="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_a9ac7f41-764b-4821-aa84-df9bb61514de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f577ddf2-3f64-41a0-95d9-1f75b1a44ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_a9ac7f41-764b-4821-aa84-df9bb61514de" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f577ddf2-3f64-41a0-95d9-1f75b1a44ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4da84917-00f3-491d-8e13-936bc12e2dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_a9ac7f41-764b-4821-aa84-df9bb61514de" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_4da84917-00f3-491d-8e13-936bc12e2dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_6bedfceb-425c-422f-8347-d6329f381f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_a9ac7f41-764b-4821-aa84-df9bb61514de" xlink:to="loc_us-gaap_PreferredStockSharesIssued_6bedfceb-425c-422f-8347-d6329f381f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_3bdd54cd-2013-4dac-a594-f8caac65089c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_a9ac7f41-764b-4821-aa84-df9bb61514de" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_3bdd54cd-2013-4dac-a594-f8caac65089c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_c7391734-af69-4c2c-bf70-2fb2acfec786" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6886102a-2b92-4713-8679-d60814b13098" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_c7391734-af69-4c2c-bf70-2fb2acfec786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f4f593ee-8ac6-4937-929a-956f65bbe5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_c7391734-af69-4c2c-bf70-2fb2acfec786" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f4f593ee-8ac6-4937-929a-956f65bbe5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ab4a6b8d-1af6-40d5-84c3-1bbed13c5f13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_c7391734-af69-4c2c-bf70-2fb2acfec786" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ab4a6b8d-1af6-40d5-84c3-1bbed13c5f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_9f5fce45-b997-4ba9-934a-7fe2ceacc6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_c7391734-af69-4c2c-bf70-2fb2acfec786" xlink:to="loc_us-gaap_CommonStockSharesIssued_9f5fce45-b997-4ba9-934a-7fe2ceacc6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c7c333e9-2789-4c42-bc57-99ddfe5ec822" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_c7391734-af69-4c2c-bf70-2fb2acfec786" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c7c333e9-2789-4c42-bc57-99ddfe5ec822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="tnet-20250331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_8ad0b4dd-8321-4409-a190-cabbdb26b25d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e409a4fc-d84c-4d97-9f7f-00d86cdf0081" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_8ad0b4dd-8321-4409-a190-cabbdb26b25d" xlink:to="loc_us-gaap_StatementTable_e409a4fc-d84c-4d97-9f7f-00d86cdf0081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_da1c47f7-ec7e-4a4c-b420-df6373f5057f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e409a4fc-d84c-4d97-9f7f-00d86cdf0081" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_da1c47f7-ec7e-4a4c-b420-df6373f5057f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c0d92ff7-2be2-4bbc-aac6-3670976d6074" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_da1c47f7-ec7e-4a4c-b420-df6373f5057f" xlink:to="loc_us-gaap_EquityComponentDomain_c0d92ff7-2be2-4bbc-aac6-3670976d6074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_583db9c4-fdca-402d-9e38-6dd02aedb9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c0d92ff7-2be2-4bbc-aac6-3670976d6074" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_583db9c4-fdca-402d-9e38-6dd02aedb9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d59ca275-a896-40cf-84e0-cf883ecf657c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c0d92ff7-2be2-4bbc-aac6-3670976d6074" xlink:to="loc_us-gaap_RetainedEarningsMember_d59ca275-a896-40cf-84e0-cf883ecf657c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7a8816a5-2f67-4b23-a1a3-03904c405290" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c0d92ff7-2be2-4bbc-aac6-3670976d6074" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7a8816a5-2f67-4b23-a1a3-03904c405290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_23c865a8-f16d-4047-9283-b101ca3d010b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e409a4fc-d84c-4d97-9f7f-00d86cdf0081" xlink:to="loc_us-gaap_StatementLineItems_23c865a8-f16d-4047-9283-b101ca3d010b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_23c865a8-f16d-4047-9283-b101ca3d010b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1334c2cf-65e8-4782-abd3-1515e2e6825c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_StockholdersEquity_1334c2cf-65e8-4782-abd3-1515e2e6825c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b1233923-87d5-46ba-ab25-8ab6b20f512d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b1233923-87d5-46ba-ab25-8ab6b20f512d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f5c9e804-05c9-4875-86f9-09e72bd9b692" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_NetIncomeLoss_f5c9e804-05c9-4875-86f9-09e72bd9b692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockStock_0e2fa0ce-51fc-46b7-b1e4-20f8160e2549" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCommonStockStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_DividendsCommonStockStock_0e2fa0ce-51fc-46b7-b1e4-20f8160e2549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_bc0a0505-70f3-4276-9646-4fedc1b89319" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_bc0a0505-70f3-4276-9646-4fedc1b89319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_cdb8c8cb-8931-481a-b5ab-e42961cb98e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_cdb8c8cb-8931-481a-b5ab-e42961cb98e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fab00452-f2d1-4ac3-90eb-566b6b501a63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fab00452-f2d1-4ac3-90eb-566b6b501a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_13427d9e-a387-40bc-8dce-d76ca1fcae47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d4ecd6da-59f3-4cf2-ae73-0c3b1d16870b" xlink:to="loc_us-gaap_StockholdersEquity_13427d9e-a387-40bc-8dce-d76ca1fcae47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="tnet-20250331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_68d2f09f-f5c1-4766-9ea6-264629ff0bce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_a8b9c3eb-2477-4a31-ad9f-69604f89eba4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68d2f09f-f5c1-4766-9ea6-264629ff0bce" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_a8b9c3eb-2477-4a31-ad9f-69604f89eba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_75c711da-f452-40bf-b063-d2d1c94e27c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_a8b9c3eb-2477-4a31-ad9f-69604f89eba4" xlink:to="loc_us-gaap_NetIncomeLoss_75c711da-f452-40bf-b063-d2d1c94e27c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_af9a80dc-63ba-468c-9abc-b3bf0a1f0ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_a8b9c3eb-2477-4a31-ad9f-69604f89eba4" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_af9a80dc-63ba-468c-9abc-b3bf0a1f0ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_7932bea5-ed77-47f9-b5d3-d335faa90a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_af9a80dc-63ba-468c-9abc-b3bf0a1f0ba8" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_7932bea5-ed77-47f9-b5d3-d335faa90a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_7e9bc622-d6ad-4ad6-bab9-427879e41697" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_af9a80dc-63ba-468c-9abc-b3bf0a1f0ba8" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_7e9bc622-d6ad-4ad6-bab9-427879e41697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_56a9875d-b853-4294-8bb5-245e41f4cb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_af9a80dc-63ba-468c-9abc-b3bf0a1f0ba8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_56a9875d-b853-4294-8bb5-245e41f4cb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_c7dc010f-5a67-446d-949a-cae89cf0204d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_af9a80dc-63ba-468c-9abc-b3bf0a1f0ba8" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_c7dc010f-5a67-446d-949a-cae89cf0204d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ac330904-5d2e-4a59-a2f3-dcb36237e75e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_af9a80dc-63ba-468c-9abc-b3bf0a1f0ba8" xlink:to="loc_us-gaap_ShareBasedCompensation_ac330904-5d2e-4a59-a2f3-dcb36237e75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_7aa58ae5-d509-46dd-b91f-c5a0cad9cf92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_af9a80dc-63ba-468c-9abc-b3bf0a1f0ba8" xlink:to="loc_us-gaap_GainLossOnInvestments_7aa58ae5-d509-46dd-b91f-c5a0cad9cf92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_d1cc7013-684b-4713-a034-152950875189" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_af9a80dc-63ba-468c-9abc-b3bf0a1f0ba8" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_d1cc7013-684b-4713-a034-152950875189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_9895dd4b-7389-4dce-a92b-0550a467158e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_af9a80dc-63ba-468c-9abc-b3bf0a1f0ba8" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_9895dd4b-7389-4dce-a92b-0550a467158e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc2f8eb3-6b59-4bc7-a5b3-53b3d16dd261" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_af9a80dc-63ba-468c-9abc-b3bf0a1f0ba8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc2f8eb3-6b59-4bc7-a5b3-53b3d16dd261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dfb4d266-0e12-4503-902e-e65c8e8630f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc2f8eb3-6b59-4bc7-a5b3-53b3d16dd261" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dfb4d266-0e12-4503-902e-e65c8e8630f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_6be25080-08c6-46a4-9869-bb0d66c47342" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc2f8eb3-6b59-4bc7-a5b3-53b3d16dd261" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_6be25080-08c6-46a4-9869-bb0d66c47342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9bf22e59-b27b-4f6a-8159-79f8c94905e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc2f8eb3-6b59-4bc7-a5b3-53b3d16dd261" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9bf22e59-b27b-4f6a-8159-79f8c94905e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncreaseDecreaseInOtherPayrollAssets_a683ec4a-2327-4604-bc8e-a0abe182b5a6" xlink:href="tnet-20250331.xsd#tnet_IncreaseDecreaseInOtherPayrollAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc2f8eb3-6b59-4bc7-a5b3-53b3d16dd261" xlink:to="loc_tnet_IncreaseDecreaseInOtherPayrollAssets_a683ec4a-2327-4604-bc8e-a0abe182b5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_6be2b51c-de73-458e-836c-a52080bab725" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc2f8eb3-6b59-4bc7-a5b3-53b3d16dd261" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_6be2b51c-de73-458e-836c-a52080bab725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1d6846ce-886b-4e86-b007-fc0270af3122" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc2f8eb3-6b59-4bc7-a5b3-53b3d16dd261" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1d6846ce-886b-4e86-b007-fc0270af3122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_09dff1a8-83ff-444f-a314-5c823fc76f96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc2f8eb3-6b59-4bc7-a5b3-53b3d16dd261" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_09dff1a8-83ff-444f-a314-5c823fc76f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_efc7d38f-8ad6-4393-b431-1d622139398d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc2f8eb3-6b59-4bc7-a5b3-53b3d16dd261" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_efc7d38f-8ad6-4393-b431-1d622139398d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_c98a0933-98ec-441c-a784-c53ba7fa34dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc2f8eb3-6b59-4bc7-a5b3-53b3d16dd261" xlink:to="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_c98a0933-98ec-441c-a784-c53ba7fa34dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_0845fa3a-1ca1-4191-8591-f563ce9ef225" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc2f8eb3-6b59-4bc7-a5b3-53b3d16dd261" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_0845fa3a-1ca1-4191-8591-f563ce9ef225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_3e21247b-373e-42e6-afa2-df55f90b7aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc2f8eb3-6b59-4bc7-a5b3-53b3d16dd261" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_3e21247b-373e-42e6-afa2-df55f90b7aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089d6ad5-6684-4718-ae4d-d873c2e8af76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_a8b9c3eb-2477-4a31-ad9f-69604f89eba4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089d6ad5-6684-4718-ae4d-d873c2e8af76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_dd2a3bf0-6082-46a4-b65c-a5f85228cb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68d2f09f-f5c1-4766-9ea6-264629ff0bce" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_dd2a3bf0-6082-46a4-b65c-a5f85228cb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a21bddf4-d7ee-4942-94ad-6a795a02af10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_dd2a3bf0-6082-46a4-b65c-a5f85228cb2c" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a21bddf4-d7ee-4942-94ad-6a795a02af10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_3c84920a-3f07-4b15-b1bc-e2a0c4d1303d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_dd2a3bf0-6082-46a4-b65c-a5f85228cb2c" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_3c84920a-3f07-4b15-b1bc-e2a0c4d1303d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_eb48d0f1-e7db-4fa7-9e66-0c7e74d5e0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_dd2a3bf0-6082-46a4-b65c-a5f85228cb2c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_eb48d0f1-e7db-4fa7-9e66-0c7e74d5e0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_192a5ab9-6f24-4ec5-af25-c17a462b6550" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_dd2a3bf0-6082-46a4-b65c-a5f85228cb2c" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_192a5ab9-6f24-4ec5-af25-c17a462b6550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6141a39e-4918-4db3-8ff9-bd386484ba51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_dd2a3bf0-6082-46a4-b65c-a5f85228cb2c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6141a39e-4918-4db3-8ff9-bd386484ba51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_c6e1aaba-1e67-465c-9fdf-e471eaf4a4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68d2f09f-f5c1-4766-9ea6-264629ff0bce" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_c6e1aaba-1e67-465c-9fdf-e471eaf4a4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet_a49da765-6944-48ff-b147-e1b738fc51b5" xlink:href="tnet-20250331.xsd#tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_c6e1aaba-1e67-465c-9fdf-e471eaf4a4f5" xlink:to="loc_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet_a49da765-6944-48ff-b147-e1b738fc51b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_29a941d9-8aa1-4d48-81ec-33a15877a506" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_c6e1aaba-1e67-465c-9fdf-e471eaf4a4f5" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_29a941d9-8aa1-4d48-81ec-33a15877a506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7bc3cb9d-9725-4b33-9aa8-fc5dde674c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_c6e1aaba-1e67-465c-9fdf-e471eaf4a4f5" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7bc3cb9d-9725-4b33-9aa8-fc5dde674c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_8307f4a1-02e9-4cb9-a806-739abaea8318" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_c6e1aaba-1e67-465c-9fdf-e471eaf4a4f5" xlink:to="loc_us-gaap_PaymentsOfDividends_8307f4a1-02e9-4cb9-a806-739abaea8318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6cedc90-38c6-4174-945e-6853417393c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_c6e1aaba-1e67-465c-9fdf-e471eaf4a4f5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6cedc90-38c6-4174-945e-6853417393c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_18f552c5-7b7f-4c6f-8014-69ddb9436e87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68d2f09f-f5c1-4766-9ea6-264629ff0bce" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_18f552c5-7b7f-4c6f-8014-69ddb9436e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_4ed3793e-8464-4aa1-9ea2-3cd02bd7dd07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68d2f09f-f5c1-4766-9ea6-264629ff0bce" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_4ed3793e-8464-4aa1-9ea2-3cd02bd7dd07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c0192640-c562-4302-b425-3e834949238f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_4ed3793e-8464-4aa1-9ea2-3cd02bd7dd07" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c0192640-c562-4302-b425-3e834949238f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4fb6a90b-6deb-45e1-a370-74c459ea553a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_4ed3793e-8464-4aa1-9ea2-3cd02bd7dd07" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4fb6a90b-6deb-45e1-a370-74c459ea553a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_0851c1a1-315e-44b0-8112-de47111e55fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68d2f09f-f5c1-4766-9ea6-264629ff0bce" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_0851c1a1-315e-44b0-8112-de47111e55fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_42d3fdc2-4c1a-4d2f-92a9-811383af718b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0851c1a1-315e-44b0-8112-de47111e55fe" xlink:to="loc_us-gaap_InterestPaidNet_42d3fdc2-4c1a-4d2f-92a9-811383af718b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_8382887f-d39a-4816-b454-eb020e740b37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0851c1a1-315e-44b0-8112-de47111e55fe" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_8382887f-d39a-4816-b454-eb020e740b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ee3e457e-de17-4024-a99a-5d07a5c5089f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_68d2f09f-f5c1-4766-9ea6-264629ff0bce" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ee3e457e-de17-4024-a99a-5d07a5c5089f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_4e1cf170-5da7-4dee-ae77-89c8f36f97e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ee3e457e-de17-4024-a99a-5d07a5c5089f" xlink:to="loc_us-gaap_DividendsCommonStockCash_4e1cf170-5da7-4dee-ae77-89c8f36f97e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_76f842ec-475b-4758-a809-f1e42e4c81eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ee3e457e-de17-4024-a99a-5d07a5c5089f" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_76f842ec-475b-4758-a809-f1e42e4c81eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable_400a1a9c-9054-431e-a395-8910b97bfa09" xlink:href="tnet-20250331.xsd#tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ee3e457e-de17-4024-a99a-5d07a5c5089f" xlink:to="loc_tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable_400a1a9c-9054-431e-a395-8910b97bfa09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="tnet-20250331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8d85c059-f85a-4f9c-8b7a-6023f9f21bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_8454b302-f17f-4e15-9986-776af81d900f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8d85c059-f85a-4f9c-8b7a-6023f9f21bf1" xlink:to="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_8454b302-f17f-4e15-9986-776af81d900f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED" xlink:type="simple" xlink:href="tnet-20250331.xsd#CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_433ec865-ab81-4cc0-b3e5-3d8762553bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CashCashEquivalentsAndInvestmentsTextBlock_6ee4cdb6-c3ea-42b8-9f0e-e44930fba2d4" xlink:href="tnet-20250331.xsd#tnet_CashCashEquivalentsAndInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_433ec865-ab81-4cc0-b3e5-3d8762553bf6" xlink:to="loc_tnet_CashCashEquivalentsAndInvestmentsTextBlock_6ee4cdb6-c3ea-42b8-9f0e-e44930fba2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTS" xlink:type="simple" xlink:href="tnet-20250331.xsd#INVESTMENTS"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INVESTMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_77383793-daad-4628-86ab-b1c8a007f22b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_545d42f4-3276-4acd-ae5e-f503739cfae7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_77383793-daad-4628-86ab-b1c8a007f22b" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_545d42f4-3276-4acd-ae5e-f503739cfae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTS" xlink:type="simple" xlink:href="tnet-20250331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTS"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_6916f96f-571b-44aa-b321-733cdc791eff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_9ab5f01f-5da4-4e05-b026-248ce41a5526" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_6916f96f-571b-44aa-b321-733cdc791eff" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_9ab5f01f-5da4-4e05-b026-248ce41a5526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="tnet-20250331.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a95610f3-12fa-4965-89e0-9f1277052c42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ed8ca78a-6df3-473d-a84c-df4021901974" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a95610f3-12fa-4965-89e0-9f1277052c42" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ed8ca78a-6df3-473d-a84c-df4021901974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0fe6a3e8-1e96-4fe1-9900-b66f33e83f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9f43a18c-bff1-4932-a9e7-eef7fdbaf048" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0fe6a3e8-1e96-4fe1-9900-b66f33e83f5d" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9f43a18c-bff1-4932-a9e7-eef7fdbaf048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8e5a279f-eb60-42d1-b2dd-622d4b4bb74f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_64aec332-71f4-42a7-92d1-24acd140c910" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8e5a279f-eb60-42d1-b2dd-622d4b4bb74f" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_64aec332-71f4-42a7-92d1-24acd140c910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INCOMETAXES" xlink:type="simple" xlink:href="tnet-20250331.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_70728787-1666-481b-9cac-e6914b1c12cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_ce2eb669-d53b-403c-80c9-a42a3ec16b94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_70728787-1666-481b-9cac-e6914b1c12cf" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_ce2eb669-d53b-403c-80c9-a42a3ec16b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="tnet-20250331.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_615a1899-fcaa-417a-9a6a-ab9f8cba0aae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_4437ddbb-ae1d-43fb-ab06-ab98e6f3cc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_615a1899-fcaa-417a-9a6a-ab9f8cba0aae" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_4437ddbb-ae1d-43fb-ab06-ab98e6f3cc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/RESTRUCTURING" xlink:type="simple" xlink:href="tnet-20250331.xsd#RESTRUCTURING"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/RESTRUCTURING" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b92c9198-ca4a-4511-9096-1e5e53361327" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_e56670e9-8fb1-4769-b9e4-92a218e54eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b92c9198-ca4a-4511-9096-1e5e53361327" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_e56670e9-8fb1-4769-b9e4-92a218e54eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/SEGMENTINFORMATION" xlink:type="simple" xlink:href="tnet-20250331.xsd#SEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/SEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4b48f946-96fc-4e49-a5ba-cfa1c92da25e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_65d7107a-3394-4534-bda8-a0087729178f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4b48f946-96fc-4e49-a5ba-cfa1c92da25e" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_65d7107a-3394-4534-bda8-a0087729178f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="tnet-20250331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6a3aa86-030a-416b-8796-c5fddda9eaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_49252e23-8d4d-44b6-a6ab-23870921a20e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6a3aa86-030a-416b-8796-c5fddda9eaf3" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_49252e23-8d4d-44b6-a6ab-23870921a20e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ea5e8572-fdf6-419c-abbb-70dc13c884f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6a3aa86-030a-416b-8796-c5fddda9eaf3" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ea5e8572-fdf6-419c-abbb-70dc13c884f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_7d4e673d-c3d3-447a-a6fc-d49f93c8637d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6a3aa86-030a-416b-8796-c5fddda9eaf3" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_7d4e673d-c3d3-447a-a6fc-d49f93c8637d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_1117f8af-dfe2-4c83-9379-0887b6349f82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6a3aa86-030a-416b-8796-c5fddda9eaf3" xlink:to="loc_us-gaap_UseOfEstimates_1117f8af-dfe2-4c83-9379-0887b6349f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityReserveEstimatePolicy_435d372f-0236-47fc-b106-ba9da7f39ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityReserveEstimatePolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6a3aa86-030a-416b-8796-c5fddda9eaf3" xlink:to="loc_us-gaap_LiabilityReserveEstimatePolicy_435d372f-0236-47fc-b106-ba9da7f39ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1355ce79-329a-4945-93d5-6ef7dac6c60f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6a3aa86-030a-416b-8796-c5fddda9eaf3" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1355ce79-329a-4945-93d5-6ef7dac6c60f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="tnet-20250331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_37574dea-7a25-46fd-a3d5-6ddf1b7dd82b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_3d9c971e-ade5-4525-b542-ad8d33d5f62e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_37574dea-7a25-46fd-a3d5-6ddf1b7dd82b" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_3d9c971e-ade5-4525-b542-ad8d33d5f62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock_123054c5-041f-47e2-ab5f-c9c43c003fff" xlink:href="tnet-20250331.xsd#tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_37574dea-7a25-46fd-a3d5-6ddf1b7dd82b" xlink:to="loc_tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock_123054c5-041f-47e2-ab5f-c9c43c003fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables" xlink:type="simple" xlink:href="tnet-20250331.xsd#CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_d5dcb825-26f2-46f6-bf8a-1177b79b980e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_cfd9a42d-5a44-4199-9993-19a52e5dcb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_d5dcb825-26f2-46f6-bf8a-1177b79b980e" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_cfd9a42d-5a44-4199-9993-19a52e5dcb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSTables" xlink:type="simple" xlink:href="tnet-20250331.xsd#INVESTMENTSTables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INVESTMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1b10b7a2-9f3d-4972-94fc-969707ca255f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_65463096-904a-45fc-8114-0f61e9016af3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1b10b7a2-9f3d-4972-94fc-969707ca255f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_65463096-904a-45fc-8114-0f61e9016af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_317ba23e-5fc7-4871-9b6a-1a0a992e50d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1b10b7a2-9f3d-4972-94fc-969707ca255f" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_317ba23e-5fc7-4871-9b6a-1a0a992e50d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_4acdcb76-c955-456d-bd9e-943dc97231eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1b10b7a2-9f3d-4972-94fc-969707ca255f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_4acdcb76-c955-456d-bd9e-943dc97231eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSTables" xlink:type="simple" xlink:href="tnet-20250331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTSTables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_e184e001-102b-4662-beed-abba3b3d0c03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_bf84205b-776a-4d19-98f5-6631e5b660d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e184e001-102b-4662-beed-abba3b3d0c03" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_bf84205b-776a-4d19-98f5-6631e5b660d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be250274-652b-4a2e-98b2-438dac781d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_a3e6927f-a5ae-45c9-bd63-cff3ce6078e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be250274-652b-4a2e-98b2-438dac781d0c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_a3e6927f-a5ae-45c9-bd63-cff3ce6078e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0195e616-66a3-4531-aba9-685d4efe47b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be250274-652b-4a2e-98b2-438dac781d0c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0195e616-66a3-4531-aba9-685d4efe47b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_7487615d-c155-4303-b9cf-0ad24bc896f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be250274-652b-4a2e-98b2-438dac781d0c" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_7487615d-c155-4303-b9cf-0ad24bc896f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_06edf84c-333b-423a-bf1a-df15a0163609" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be250274-652b-4a2e-98b2-438dac781d0c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_06edf84c-333b-423a-bf1a-df15a0163609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_fb29a492-31bb-4b4c-964d-6125fe86a37f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be250274-652b-4a2e-98b2-438dac781d0c" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_fb29a492-31bb-4b4c-964d-6125fe86a37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5cbf0e1c-17b0-45e0-93d6-b450a790f47f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_73a14ec4-d4cd-488d-901c-c5bd219229a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5cbf0e1c-17b0-45e0-93d6-b450a790f47f" xlink:to="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_73a14ec4-d4cd-488d-901c-c5bd219229a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="tnet-20250331.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0ba70752-90a7-4930-8d5d-e4801b461aac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d1c4ec6e-3c61-44f2-9bb9-2ffcc70e7a57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0ba70752-90a7-4930-8d5d-e4801b461aac" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d1c4ec6e-3c61-44f2-9bb9-2ffcc70e7a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/RESTRUCTURINGTables" xlink:type="simple" xlink:href="tnet-20250331.xsd#RESTRUCTURINGTables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/RESTRUCTURINGTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c393df0b-a58a-4472-ade1-d1155f777ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_11a1d9a5-00d4-4f06-ad23-b513b8606556" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c393df0b-a58a-4472-ade1-d1155f777ccb" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_11a1d9a5-00d4-4f06-ad23-b513b8606556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="tnet-20250331.xsd#SEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/SEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a63f00b1-9bbd-425f-9560-3f375f4ac7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_d644da10-4ff8-4eb1-b111-dcd3de615f25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a63f00b1-9bbd-425f-9560-3f375f4ac7a4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_d644da10-4ff8-4eb1-b111-dcd3de615f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_490c4030-91f4-4dfc-8a42-ff33d3eb1584" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_566e644a-d6ba-4da4-9341-7cfc3232cd97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_490c4030-91f4-4dfc-8a42-ff33d3eb1584" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_566e644a-d6ba-4da4-9341-7cfc3232cd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_19ace032-5f20-4cb9-aba0-0cb1ec2d0080" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_566e644a-d6ba-4da4-9341-7cfc3232cd97" xlink:to="loc_srt_StatementGeographicalAxis_19ace032-5f20-4cb9-aba0-0cb1ec2d0080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_494bdf66-d039-4eb8-b943-b02eef057d2e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_19ace032-5f20-4cb9-aba0-0cb1ec2d0080" xlink:to="loc_srt_SegmentGeographicalDomain_494bdf66-d039-4eb8-b943-b02eef057d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_0501d540-1291-42ba-9908-a3ef315fd43f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_494bdf66-d039-4eb8-b943-b02eef057d2e" xlink:to="loc_us-gaap_NonUsMember_0501d540-1291-42ba-9908-a3ef315fd43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d6a343c1-1ce3-446c-b614-4a9c13f0916b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_566e644a-d6ba-4da4-9341-7cfc3232cd97" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d6a343c1-1ce3-446c-b614-4a9c13f0916b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6b0f871e-2f42-450b-9432-7c392f227f81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d6a343c1-1ce3-446c-b614-4a9c13f0916b" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6b0f871e-2f42-450b-9432-7c392f227f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_2ea475c5-8927-4cfc-91ed-8d5337dbd42a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6b0f871e-2f42-450b-9432-7c392f227f81" xlink:to="loc_us-gaap_SalesRevenueNetMember_2ea475c5-8927-4cfc-91ed-8d5337dbd42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_dc4f8437-c50e-4a74-b153-8dea79f10694" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_566e644a-d6ba-4da4-9341-7cfc3232cd97" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_dc4f8437-c50e-4a74-b153-8dea79f10694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_28272d7d-2364-4453-9f34-da5f5a7dc3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_dc4f8437-c50e-4a74-b153-8dea79f10694" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_28272d7d-2364-4453-9f34-da5f5a7dc3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_cc7fd23c-faf5-43c0-862b-fb966f7a6b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_28272d7d-2364-4453-9f34-da5f5a7dc3d6" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_cc7fd23c-faf5-43c0-862b-fb966f7a6b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_4d4ac682-5c37-4a99-ac64-4c3738f95f99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_566e644a-d6ba-4da4-9341-7cfc3232cd97" xlink:to="loc_us-gaap_NatureOfExpenseAxis_4d4ac682-5c37-4a99-ac64-4c3738f95f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_dc656f19-126d-4eaf-91bf-f71585b25c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_4d4ac682-5c37-4a99-ac64-4c3738f95f99" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_dc656f19-126d-4eaf-91bf-f71585b25c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember_2fea7009-0f1d-439a-88f4-8ce4f35d36a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_dc656f19-126d-4eaf-91bf-f71585b25c7a" xlink:to="loc_us-gaap_HealthCareMember_2fea7009-0f1d-439a-88f4-8ce4f35d36a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_71944ac7-f91a-4443-91ec-16cf0d72508a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_566e644a-d6ba-4da4-9341-7cfc3232cd97" xlink:to="loc_us-gaap_ProductInformationLineItems_71944ac7-f91a-4443-91ec-16cf0d72508a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_a763a6a0-5f02-4d57-8cab-f7dc96300096" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_71944ac7-f91a-4443-91ec-16cf0d72508a" xlink:to="loc_us-gaap_NumberOfReportableSegments_a763a6a0-5f02-4d57-8cab-f7dc96300096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_68410deb-71c2-4455-a103-153e72dafe32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_71944ac7-f91a-4443-91ec-16cf0d72508a" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_68410deb-71c2-4455-a103-153e72dafe32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_afea2d46-63ee-4768-9d1e-1e4460253f02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_71944ac7-f91a-4443-91ec-16cf0d72508a" xlink:to="loc_us-gaap_PrepaidInsurance_afea2d46-63ee-4768-9d1e-1e4460253f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5cbff7e3-2ace-4351-b571-beef13be7060" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9024873e-4560-4121-9e94-67479f1f79b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5cbff7e3-2ace-4351-b571-beef13be7060" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9024873e-4560-4121-9e94-67479f1f79b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_18f31293-b4e5-42f2-9007-ca8ed7c95f16" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9024873e-4560-4121-9e94-67479f1f79b4" xlink:to="loc_srt_ConsolidatedEntitiesAxis_18f31293-b4e5-42f2-9007-ca8ed7c95f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f2e298f9-3d07-42f8-b6d2-de4fd29a428d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_18f31293-b4e5-42f2-9007-ca8ed7c95f16" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f2e298f9-3d07-42f8-b6d2-de4fd29a428d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TriNetTrustMember_1f59383e-6a9a-42ae-b8d1-8b4d99a05d9a" xlink:href="tnet-20250331.xsd#tnet_TriNetTrustMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f2e298f9-3d07-42f8-b6d2-de4fd29a428d" xlink:to="loc_tnet_TriNetTrustMember_1f59383e-6a9a-42ae-b8d1-8b4d99a05d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_4a8381bd-3f3b-46a1-9ab2-7882c86efe86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9024873e-4560-4121-9e94-67479f1f79b4" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_4a8381bd-3f3b-46a1-9ab2-7882c86efe86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c4e34db8-1669-4f00-97c7-7e2a87771cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4a8381bd-3f3b-46a1-9ab2-7882c86efe86" xlink:to="loc_us-gaap_AssetsAbstract_c4e34db8-1669-4f00-97c7-7e2a87771cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f864bb4b-6cb9-4d13-9b3a-640c12f1e22d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c4e34db8-1669-4f00-97c7-7e2a87771cbb" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f864bb4b-6cb9-4d13-9b3a-640c12f1e22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_01c5b5f9-9072-46d8-a4fa-29292d9d5fad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f864bb4b-6cb9-4d13-9b3a-640c12f1e22d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_01c5b5f9-9072-46d8-a4fa-29292d9d5fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_60e04ad1-73a0-4584-9323-02176358b7fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f864bb4b-6cb9-4d13-9b3a-640c12f1e22d" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_60e04ad1-73a0-4584-9323-02176358b7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_752f4227-a909-4ee4-925d-345936a985d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f864bb4b-6cb9-4d13-9b3a-640c12f1e22d" xlink:to="loc_us-gaap_AssetsCurrent_752f4227-a909-4ee4-925d-345936a985d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ccdbc149-872f-482f-95a7-f3db4e55ae68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f864bb4b-6cb9-4d13-9b3a-640c12f1e22d" xlink:to="loc_us-gaap_Assets_ccdbc149-872f-482f-95a7-f3db4e55ae68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_bc3d29d0-c168-46dd-8a65-8476bca94320" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4a8381bd-3f3b-46a1-9ab2-7882c86efe86" xlink:to="loc_us-gaap_LiabilitiesAbstract_bc3d29d0-c168-46dd-8a65-8476bca94320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_642cd544-30a2-44bf-9c59-6678202a97d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bc3d29d0-c168-46dd-8a65-8476bca94320" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_642cd544-30a2-44bf-9c59-6678202a97d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_94f2b176-7f7c-4ee6-989d-e6f2aad59477" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_642cd544-30a2-44bf-9c59-6678202a97d1" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_94f2b176-7f7c-4ee6-989d-e6f2aad59477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_7d853336-eeff-41db-b595-7a21c3f62cab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_642cd544-30a2-44bf-9c59-6678202a97d1" xlink:to="loc_us-gaap_AccruedSalariesCurrent_7d853336-eeff-41db-b595-7a21c3f62cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_54b43c2d-45be-4c3a-856e-7733dcf34bc2" xlink:href="tnet-20250331.xsd#tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_642cd544-30a2-44bf-9c59-6678202a97d1" xlink:to="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_54b43c2d-45be-4c3a-856e-7733dcf34bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_38314140-cb43-4990-a5c4-3f90f2784fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_642cd544-30a2-44bf-9c59-6678202a97d1" xlink:to="loc_us-gaap_LiabilitiesCurrent_38314140-cb43-4990-a5c4-3f90f2784fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6f231169-ae2d-4924-860c-d2284301ca0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_642cd544-30a2-44bf-9c59-6678202a97d1" xlink:to="loc_us-gaap_Liabilities_6f231169-ae2d-4924-860c-d2284301ca0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_47243bcd-e959-4fa4-beac-59b694dde37d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementTable_2f6ae491-2077-4e25-9c64-6f39e9b3b0aa" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CondensedCashFlowStatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_47243bcd-e959-4fa4-beac-59b694dde37d" xlink:to="loc_srt_CondensedCashFlowStatementTable_2f6ae491-2077-4e25-9c64-6f39e9b3b0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_e1bd85e3-75e7-46a2-90bd-66029889c338" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementTable_2f6ae491-2077-4e25-9c64-6f39e9b3b0aa" xlink:to="loc_srt_RestatementAxis_e1bd85e3-75e7-46a2-90bd-66029889c338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_89ff7484-40ea-460d-83e4-8bab2873cc13" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_e1bd85e3-75e7-46a2-90bd-66029889c338" xlink:to="loc_srt_RestatementDomain_89ff7484-40ea-460d-83e4-8bab2873cc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_03a7d6df-c82e-40a9-92e4-280a22c3118c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_89ff7484-40ea-460d-83e4-8bab2873cc13" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_03a7d6df-c82e-40a9-92e4-280a22c3118c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_854af3f8-3cbd-4be7-8cdb-73b30deeca80" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_89ff7484-40ea-460d-83e4-8bab2873cc13" xlink:to="loc_srt_RestatementAdjustmentMember_854af3f8-3cbd-4be7-8cdb-73b30deeca80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementTable_2f6ae491-2077-4e25-9c64-6f39e9b3b0aa" xlink:to="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a7c88654-5824-411f-9d61-bdb6f9baf238" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a7c88654-5824-411f-9d61-bdb6f9baf238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_d8643d29-cd17-4d9e-b71e-d3cc72785598" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_d8643d29-cd17-4d9e-b71e-d3cc72785598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_6b0defb1-fee5-4f26-bfe6-f5b20023a86e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_6b0defb1-fee5-4f26-bfe6-f5b20023a86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncreaseDecreaseInOtherPayrollAssets_ef2826aa-f1e3-4df1-9113-2f06188f2f79" xlink:href="tnet-20250331.xsd#tnet_IncreaseDecreaseInOtherPayrollAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_tnet_IncreaseDecreaseInOtherPayrollAssets_ef2826aa-f1e3-4df1-9113-2f06188f2f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_61109d3d-5e1b-4c36-acf6-3a141585b0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_61109d3d-5e1b-4c36-acf6-3a141585b0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_02c21c24-7cd9-4003-961f-119942576c54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_02c21c24-7cd9-4003-961f-119942576c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_6db384d2-eb9e-4d59-886d-f3b74321643e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_6db384d2-eb9e-4d59-886d-f3b74321643e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_81d0f8b0-c14d-46a1-864a-481b2e53863a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_81d0f8b0-c14d-46a1-864a-481b2e53863a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_dd0c8d13-ecf1-4c7d-8ce2-44bc0012a01f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_dd0c8d13-ecf1-4c7d-8ce2-44bc0012a01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_9dec5e3b-bb7c-4b3f-aa63-a8f6c3a76716" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_9dec5e3b-bb7c-4b3f-aa63-a8f6c3a76716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified_23669668-22f5-4c6a-b64c-be34c2b7a34b" xlink:href="tnet-20250331.xsd#tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified_23669668-22f5-4c6a-b64c-be34c2b7a34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet_d5b91957-11fc-40af-9f3d-2e9ff6f67b04" xlink:href="tnet-20250331.xsd#tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet_d5b91957-11fc-40af-9f3d-2e9ff6f67b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified_cd5edc48-bbea-425b-8c20-bb1e4ef531a7" xlink:href="tnet-20250331.xsd#tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedCashFlowStatementsCaptionsLineItems_13a7cedd-a151-44a0-b4d0-a0ff1dbe6891" xlink:to="loc_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified_cd5edc48-bbea-425b-8c20-bb1e4ef531a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_26a0455c-7ed9-4139-bd38-57d5c88370be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_0cac3ed6-07f3-46e9-ae0b-ff0553b59811" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_26a0455c-7ed9-4139-bd38-57d5c88370be" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_0cac3ed6-07f3-46e9-ae0b-ff0553b59811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9799cac6-ee64-4b34-80a4-03068e1b7b50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_0cac3ed6-07f3-46e9-ae0b-ff0553b59811" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9799cac6-ee64-4b34-80a4-03068e1b7b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f4b04d7-d4bd-4e65-bd88-6610ab49b43f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9799cac6-ee64-4b34-80a4-03068e1b7b50" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f4b04d7-d4bd-4e65-bd88-6610ab49b43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_287fad6c-4567-4f9f-86ce-8454a6bf9a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f4b04d7-d4bd-4e65-bd88-6610ab49b43f" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_287fad6c-4567-4f9f-86ce-8454a6bf9a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AvailableForSaleMarketableSecuritiesMember_0b930851-bab0-4550-ae30-d4f6dd10e2d7" xlink:href="tnet-20250331.xsd#tnet_AvailableForSaleMarketableSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f4b04d7-d4bd-4e65-bd88-6610ab49b43f" xlink:to="loc_tnet_AvailableForSaleMarketableSecuritiesMember_0b930851-bab0-4550-ae30-d4f6dd10e2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralbyTypeAxis_59f18ce5-da8d-41c7-a491-cc3599702247" xlink:href="tnet-20250331.xsd#tnet_CollateralbyTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_0cac3ed6-07f3-46e9-ae0b-ff0553b59811" xlink:to="loc_tnet_CollateralbyTypeAxis_59f18ce5-da8d-41c7-a491-cc3599702247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralByTypeDomain_6c8db68b-663e-4b56-90da-ca7c848fb67b" xlink:href="tnet-20250331.xsd#tnet_CollateralByTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_CollateralbyTypeAxis_59f18ce5-da8d-41c7-a491-cc3599702247" xlink:to="loc_tnet_CollateralByTypeDomain_6c8db68b-663e-4b56-90da-ca7c848fb67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PayrollFundsCollectedMember_da4eb71a-3c3a-4ab1-be25-b20118d3812f" xlink:href="tnet-20250331.xsd#tnet_PayrollFundsCollectedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_CollateralByTypeDomain_6c8db68b-663e-4b56-90da-ca7c848fb67b" xlink:to="loc_tnet_PayrollFundsCollectedMember_da4eb71a-3c3a-4ab1-be25-b20118d3812f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_HealthBenefitClaimsCollateralMember_a82356de-ab09-430b-b1b8-d207ca6acceb" xlink:href="tnet-20250331.xsd#tnet_HealthBenefitClaimsCollateralMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_CollateralByTypeDomain_6c8db68b-663e-4b56-90da-ca7c848fb67b" xlink:to="loc_tnet_HealthBenefitClaimsCollateralMember_a82356de-ab09-430b-b1b8-d207ca6acceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_WorkersCompensationClaimsCollateralMember_ccdb34b5-b282-4c75-872c-9e314182823e" xlink:href="tnet-20250331.xsd#tnet_WorkersCompensationClaimsCollateralMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_CollateralByTypeDomain_6c8db68b-663e-4b56-90da-ca7c848fb67b" xlink:to="loc_tnet_WorkersCompensationClaimsCollateralMember_ccdb34b5-b282-4c75-872c-9e314182823e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TrustForOurHRISUsersCollateralMember_f65eeae4-fb99-422e-a4f8-5d3eb46c6b09" xlink:href="tnet-20250331.xsd#tnet_TrustForOurHRISUsersCollateralMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_CollateralByTypeDomain_6c8db68b-663e-4b56-90da-ca7c848fb67b" xlink:to="loc_tnet_TrustForOurHRISUsersCollateralMember_f65eeae4-fb99-422e-a4f8-5d3eb46c6b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsuranceCarriersSecurityDepositsMember_9f421bf5-6ecb-4290-b4c5-a8f97273a03d" xlink:href="tnet-20250331.xsd#tnet_InsuranceCarriersSecurityDepositsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_CollateralByTypeDomain_6c8db68b-663e-4b56-90da-ca7c848fb67b" xlink:to="loc_tnet_InsuranceCarriersSecurityDepositsMember_9f421bf5-6ecb-4290-b4c5-a8f97273a03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_9161e060-119a-47cb-bbe2-000cd19913d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_0cac3ed6-07f3-46e9-ae0b-ff0553b59811" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_9161e060-119a-47cb-bbe2-000cd19913d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c40d805c-949f-4cab-990c-153d37c94f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_9161e060-119a-47cb-bbe2-000cd19913d4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c40d805c-949f-4cab-990c-153d37c94f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_eae1d66b-a5ea-4905-99bb-0dee8609cd06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_9161e060-119a-47cb-bbe2-000cd19913d4" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_eae1d66b-a5ea-4905-99bb-0dee8609cd06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_05426cb8-2d28-41b2-8fbc-6ae70c79e40e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_9161e060-119a-47cb-bbe2-000cd19913d4" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_05426cb8-2d28-41b2-8fbc-6ae70c79e40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestments_39053678-e8b9-44f1-8817-8ac8960e3bde" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_9161e060-119a-47cb-bbe2-000cd19913d4" xlink:to="loc_us-gaap_RestrictedCashAndInvestments_39053678-e8b9-44f1-8817-8ac8960e3bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0168e08a-108e-47a9-9fc4-a6e77523d877" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0168e08a-108e-47a9-9fc4-a6e77523d877" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_9a749d34-ad45-464e-84bb-01a43271c7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_9a749d34-ad45-464e-84bb-01a43271c7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6859ed10-6841-4bab-b9c3-0afbe19a2349" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_9a749d34-ad45-464e-84bb-01a43271c7bd" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6859ed10-6841-4bab-b9c3-0afbe19a2349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_5a753614-97d7-40cb-9d9c-f4f7db3bd552" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6859ed10-6841-4bab-b9c3-0afbe19a2349" xlink:to="loc_us-gaap_MoneyMarketFundsMember_5a753614-97d7-40cb-9d9c-f4f7db3bd552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_d4cf9f3c-946a-439b-8edf-b66129e871f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6859ed10-6841-4bab-b9c3-0afbe19a2349" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_d4cf9f3c-946a-439b-8edf-b66129e871f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_dfae378f-59ae-4a3e-936f-a55dbe25e032" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_dfae378f-59ae-4a3e-936f-a55dbe25e032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c54154ac-2ad8-4a15-adf6-5072ab2d649d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_dfae378f-59ae-4a3e-936f-a55dbe25e032" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c54154ac-2ad8-4a15-adf6-5072ab2d649d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_bfaa6721-ef49-4a87-bbad-bf6b7e43d906" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c54154ac-2ad8-4a15-adf6-5072ab2d649d" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_bfaa6721-ef49-4a87-bbad-bf6b7e43d906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9d1e8750-bfad-4e2c-821b-84525449dbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c54154ac-2ad8-4a15-adf6-5072ab2d649d" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9d1e8750-bfad-4e2c-821b-84525449dbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_35c5818f-30a6-4b2c-9aac-9853af5a9d12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c54154ac-2ad8-4a15-adf6-5072ab2d649d" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_35c5818f-30a6-4b2c-9aac-9853af5a9d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_5277dac3-97b3-48c6-be7b-539b4fc39170" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c54154ac-2ad8-4a15-adf6-5072ab2d649d" xlink:to="loc_us-gaap_CertificatesOfDepositMember_5277dac3-97b3-48c6-be7b-539b4fc39170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d28ef4b-7b9f-4a8f-b8da-86abaf46e964" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d28ef4b-7b9f-4a8f-b8da-86abaf46e964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8f36d02f-04f4-4f52-bad4-d8ad6393da4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d28ef4b-7b9f-4a8f-b8da-86abaf46e964" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8f36d02f-04f4-4f52-bad4-d8ad6393da4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b33d3a3d-aa3b-452f-a554-2e5be350a340" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8f36d02f-04f4-4f52-bad4-d8ad6393da4f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b33d3a3d-aa3b-452f-a554-2e5be350a340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22401419-51a5-43bb-b804-edd99768ef71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22401419-51a5-43bb-b804-edd99768ef71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a5d66f6-0f5c-4c1c-9cd7-c5ec0da74016" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22401419-51a5-43bb-b804-edd99768ef71" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a5d66f6-0f5c-4c1c-9cd7-c5ec0da74016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_7bd5ccb5-3faa-4b54-b6df-b78278b44088" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a5d66f6-0f5c-4c1c-9cd7-c5ec0da74016" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_7bd5ccb5-3faa-4b54-b6df-b78278b44088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ae854b85-7895-4b44-ba3e-93775adf6e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a5d66f6-0f5c-4c1c-9cd7-c5ec0da74016" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ae854b85-7895-4b44-ba3e-93775adf6e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a1b00529-06ab-4cd7-87c2-83dca77e6b70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a1b00529-06ab-4cd7-87c2-83dca77e6b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3bd1ddb2-6e20-4108-87b8-162be0ee773d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a1b00529-06ab-4cd7-87c2-83dca77e6b70" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3bd1ddb2-6e20-4108-87b8-162be0ee773d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_92b43a86-ce5d-4d4f-8b28-16c1fc16a9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3bd1ddb2-6e20-4108-87b8-162be0ee773d" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_92b43a86-ce5d-4d4f-8b28-16c1fc16a9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_c65095ac-93ab-421a-8ff1-6223505484de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3bd1ddb2-6e20-4108-87b8-162be0ee773d" xlink:to="loc_us-gaap_InvestmentsMember_c65095ac-93ab-421a-8ff1-6223505484de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember_4a502ed8-c4ad-4065-9dd8-7782066ade6e" xlink:href="tnet-20250331.xsd#tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3bd1ddb2-6e20-4108-87b8-162be0ee773d" xlink:to="loc_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember_4a502ed8-c4ad-4065-9dd8-7782066ade6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2cf7228-77ab-4f8d-a7a5-3c2db2f69e40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_03be532d-f52e-45e7-b6af-f948bd0ac0a6" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2cf7228-77ab-4f8d-a7a5-3c2db2f69e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_af441310-95ee-46a7-8e24-e5ad74fbf60c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2cf7228-77ab-4f8d-a7a5-3c2db2f69e40" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_af441310-95ee-46a7-8e24-e5ad74fbf60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_fb7d3492-4bd5-461d-99a9-3480e6a240cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_af441310-95ee-46a7-8e24-e5ad74fbf60c" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_fb7d3492-4bd5-461d-99a9-3480e6a240cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_31486a36-9287-48de-a413-206a3bd808ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_af441310-95ee-46a7-8e24-e5ad74fbf60c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_31486a36-9287-48de-a413-206a3bd808ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_99be5d53-723a-423d-98d7-18dc811f1d10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_af441310-95ee-46a7-8e24-e5ad74fbf60c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_99be5d53-723a-423d-98d7-18dc811f1d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_dd8f6d18-1e5c-44fd-a9f2-34d8bce65c15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_af441310-95ee-46a7-8e24-e5ad74fbf60c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_dd8f6d18-1e5c-44fd-a9f2-34d8bce65c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_46d0bca9-1f3e-49d7-94b2-393e30c2faf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_af441310-95ee-46a7-8e24-e5ad74fbf60c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_46d0bca9-1f3e-49d7-94b2-393e30c2faf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_22a0ef53-0cf8-4ec0-9db8-78d998424542" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_6377a2ee-3f10-4d00-b4b9-e5dbf870132b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_22a0ef53-0cf8-4ec0-9db8-78d998424542" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_6377a2ee-3f10-4d00-b4b9-e5dbf870132b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_389b82a1-9be6-40a6-9b62-02da35f461d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_22a0ef53-0cf8-4ec0-9db8-78d998424542" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_389b82a1-9be6-40a6-9b62-02da35f461d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_50599408-b36e-4a9c-85ae-3d9706215e70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_22a0ef53-0cf8-4ec0-9db8-78d998424542" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_50599408-b36e-4a9c-85ae-3d9706215e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_98d8fbc2-ca5f-42ee-9010-8e02d9fde6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_22a0ef53-0cf8-4ec0-9db8-78d998424542" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_98d8fbc2-ca5f-42ee-9010-8e02d9fde6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_8fdc387c-3b9c-4ffb-8df3-ab98ba395255" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_22a0ef53-0cf8-4ec0-9db8-78d998424542" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_8fdc387c-3b9c-4ffb-8df3-ab98ba395255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_05703358-e874-4825-af66-8b760677342a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_d812abbf-3c93-42ff-b63a-cd1d7f2a00ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_05703358-e874-4825-af66-8b760677342a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_d812abbf-3c93-42ff-b63a-cd1d7f2a00ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_306498ff-795c-4f2c-9c69-a4a6ba2e92d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_05703358-e874-4825-af66-8b760677342a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_306498ff-795c-4f2c-9c69-a4a6ba2e92d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_75a82e25-db03-436f-a3d1-3b3f3ab8d965" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_05703358-e874-4825-af66-8b760677342a" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_75a82e25-db03-436f-a3d1-3b3f3ab8d965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_6ae07149-a876-44f6-85d6-6f319677ed8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_05703358-e874-4825-af66-8b760677342a" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_6ae07149-a876-44f6-85d6-6f319677ed8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#INVESTMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_fc8c5387-dafb-4131-92c8-64c7e4376e97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ff5f2b81-e048-42a6-96bf-482a1c74ca27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_fc8c5387-dafb-4131-92c8-64c7e4376e97" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ff5f2b81-e048-42a6-96bf-482a1c74ca27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2e55a148-0a0d-4bc6-8b20-30cf94631436" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ff5f2b81-e048-42a6-96bf-482a1c74ca27" xlink:to="loc_us-gaap_DebtInstrumentAxis_2e55a148-0a0d-4bc6-8b20-30cf94631436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1558b50e-7bc5-4e81-ba94-0045c39d1b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2e55a148-0a0d-4bc6-8b20-30cf94631436" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1558b50e-7bc5-4e81-ba94-0045c39d1b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_A2029NotesPayableMember_aded8f06-10a1-4f7b-9782-890a07b1b356" xlink:href="tnet-20250331.xsd#tnet_A2029NotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1558b50e-7bc5-4e81-ba94-0045c39d1b3e" xlink:to="loc_tnet_A2029NotesPayableMember_aded8f06-10a1-4f7b-9782-890a07b1b356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_A2031NotesPayableMember_51b1e5b0-f9b7-41e4-8c95-ee1da145e479" xlink:href="tnet-20250331.xsd#tnet_A2031NotesPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1558b50e-7bc5-4e81-ba94-0045c39d1b3e" xlink:to="loc_tnet_A2031NotesPayableMember_51b1e5b0-f9b7-41e4-8c95-ee1da145e479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d957883a-2aae-46b8-9321-3d8f722750c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ff5f2b81-e048-42a6-96bf-482a1c74ca27" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d957883a-2aae-46b8-9321-3d8f722750c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_d129dc8c-b4a9-4c4d-a292-a36c59066afe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d957883a-2aae-46b8-9321-3d8f722750c7" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_d129dc8c-b4a9-4c4d-a292-a36c59066afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_8207e5ae-cec1-4dfc-b568-d8f26290ae24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_2a28ecc3-bb23-47da-9501-ad600001dc89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_8207e5ae-cec1-4dfc-b568-d8f26290ae24" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_2a28ecc3-bb23-47da-9501-ad600001dc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_40b76c4b-9a6e-452f-9e88-9e388e9d8fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_2a28ecc3-bb23-47da-9501-ad600001dc89" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_40b76c4b-9a6e-452f-9e88-9e388e9d8fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_74901bee-d795-4b6d-bf15-de96e92a3802" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_2a28ecc3-bb23-47da-9501-ad600001dc89" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_74901bee-d795-4b6d-bf15-de96e92a3802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_028c2dd7-e86f-41a5-86bd-6701ae53a614" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_74901bee-d795-4b6d-bf15-de96e92a3802" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_028c2dd7-e86f-41a5-86bd-6701ae53a614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_bb332180-eaba-48a8-9a14-7345c2ed922f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_74901bee-d795-4b6d-bf15-de96e92a3802" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_bb332180-eaba-48a8-9a14-7345c2ed922f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_b0f307c5-3ee8-4780-a84c-1b59360cd974" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_74901bee-d795-4b6d-bf15-de96e92a3802" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_b0f307c5-3ee8-4780-a84c-1b59360cd974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_3fdacc34-02a0-471d-8a75-c240d070513d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_2a28ecc3-bb23-47da-9501-ad600001dc89" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_3fdacc34-02a0-471d-8a75-c240d070513d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_39d7c6e4-ed7a-490a-8ae5-718a01540020" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_3fdacc34-02a0-471d-8a75-c240d070513d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_39d7c6e4-ed7a-490a-8ae5-718a01540020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_7100b6ab-20ea-4586-a2f4-9e95e99b9090" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_3fdacc34-02a0-471d-8a75-c240d070513d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_7100b6ab-20ea-4586-a2f4-9e95e99b9090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_eb5f57f6-8c0c-49b1-bf4e-0d579051ab5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_3fdacc34-02a0-471d-8a75-c240d070513d" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_eb5f57f6-8c0c-49b1-bf4e-0d579051ab5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_448aade1-f140-488d-9b02-985d953ee373" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_2a28ecc3-bb23-47da-9501-ad600001dc89" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_448aade1-f140-488d-9b02-985d953ee373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_8980d348-675c-41e4-91be-5076776983e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_6340fcc4-32a7-4c90-b9e4-a082e3968e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_8980d348-675c-41e4-91be-5076776983e2" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_6340fcc4-32a7-4c90-b9e4-a082e3968e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_6fa84ee2-fe40-4028-b92b-c937d45259f7" xlink:href="tnet-20250331.xsd#tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_8980d348-675c-41e4-91be-5076776983e2" xlink:to="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_6fa84ee2-fe40-4028-b92b-c937d45259f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_c6253859-30a9-4b94-8c25-3af45b47fbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_8980d348-675c-41e4-91be-5076776983e2" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_c6253859-30a9-4b94-8c25-3af45b47fbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_c30157c8-989d-4dca-aa2a-d82178e2b41f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_8980d348-675c-41e4-91be-5076776983e2" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_c30157c8-989d-4dca-aa2a-d82178e2b41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_70261368-8254-4f35-b349-24e350ca2be6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_8980d348-675c-41e4-91be-5076776983e2" xlink:to="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_70261368-8254-4f35-b349-24e350ca2be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_e5f2c239-4eb6-4f2f-b621-d2ea5f3d6693" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_8980d348-675c-41e4-91be-5076776983e2" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_e5f2c239-4eb6-4f2f-b621-d2ea5f3d6693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent_391edfc4-cca4-46c2-86e3-8b50d692ae60" xlink:href="tnet-20250331.xsd#tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_8980d348-675c-41e4-91be-5076776983e2" xlink:to="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent_391edfc4-cca4-46c2-86e3-8b50d692ae60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent_49f04a0d-968d-483e-803e-b07355ead6bc" xlink:href="tnet-20250331.xsd#tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_8980d348-675c-41e4-91be-5076776983e2" xlink:to="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent_49f04a0d-968d-483e-803e-b07355ead6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_5cc4041a-8e2a-4c62-b628-d96d12d43ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralHeldByInsuranceCarriers_516914f3-a09a-4707-870e-3f38b550b01b" xlink:href="tnet-20250331.xsd#tnet_CollateralHeldByInsuranceCarriers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_5cc4041a-8e2a-4c62-b628-d96d12d43ee3" xlink:to="loc_tnet_CollateralHeldByInsuranceCarriers_516914f3-a09a-4707-870e-3f38b550b01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_ecc1bc52-caae-4d01-ab09-23413611b7dc" xlink:href="tnet-20250331.xsd#tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_5cc4041a-8e2a-4c62-b628-d96d12d43ee3" xlink:to="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_ecc1bc52-caae-4d01-ab09-23413611b7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKBASEDCOMPENSATIONAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3a3b653d-5204-4c70-97b6-65e7a9eace03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67fb91fe-7b09-40fc-8614-3ac9a6647b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3a3b653d-5204-4c70-97b6-65e7a9eace03" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67fb91fe-7b09-40fc-8614-3ac9a6647b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e55ae08d-288a-4464-ace5-a176517e8078" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67fb91fe-7b09-40fc-8614-3ac9a6647b1c" xlink:to="loc_us-gaap_AwardTypeAxis_e55ae08d-288a-4464-ace5-a176517e8078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f772136-5aac-4115-90da-dda8eb35ec26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e55ae08d-288a-4464-ace5-a176517e8078" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f772136-5aac-4115-90da-dda8eb35ec26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TimeBasedRestrictedStockUnitsMember_09979ac7-645f-41bf-9fae-877f36522171" xlink:href="tnet-20250331.xsd#tnet_TimeBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f772136-5aac-4115-90da-dda8eb35ec26" xlink:to="loc_tnet_TimeBasedRestrictedStockUnitsMember_09979ac7-645f-41bf-9fae-877f36522171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_2c22bd4d-4bd0-446b-99b7-152a262ed799" xlink:href="tnet-20250331.xsd#tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f772136-5aac-4115-90da-dda8eb35ec26" xlink:to="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_2c22bd4d-4bd0-446b-99b7-152a262ed799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsMember_d82ed8b5-b0c3-4ebc-8d10-d5128414b017" xlink:href="tnet-20250331.xsd#tnet_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f772136-5aac-4115-90da-dda8eb35ec26" xlink:to="loc_tnet_PerformanceBasedRestrictedStockUnitsMember_d82ed8b5-b0c3-4ebc-8d10-d5128414b017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1c1c6f4c-c605-480d-a4ab-c26fdbd3dcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f772136-5aac-4115-90da-dda8eb35ec26" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1c1c6f4c-c605-480d-a4ab-c26fdbd3dcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_48bde80f-53ff-48f7-b83b-c6562c1aac2d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67fb91fe-7b09-40fc-8614-3ac9a6647b1c" xlink:to="loc_srt_RangeAxis_48bde80f-53ff-48f7-b83b-c6562c1aac2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c26fdea7-c87d-4e15-b4f7-534f0fbd20eb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_48bde80f-53ff-48f7-b83b-c6562c1aac2d" xlink:to="loc_srt_RangeMember_c26fdea7-c87d-4e15-b4f7-534f0fbd20eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_aaccede2-8814-452d-9eea-3a4c61b6a4b6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c26fdea7-c87d-4e15-b4f7-534f0fbd20eb" xlink:to="loc_srt_MinimumMember_aaccede2-8814-452d-9eea-3a4c61b6a4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f30f4867-2a27-47da-b71d-93e98e99e064" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c26fdea7-c87d-4e15-b4f7-534f0fbd20eb" xlink:to="loc_srt_MaximumMember_f30f4867-2a27-47da-b71d-93e98e99e064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_7ffc7f55-276a-4edf-bb68-d916bcb8dfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67fb91fe-7b09-40fc-8614-3ac9a6647b1c" xlink:to="loc_us-gaap_VestingAxis_7ffc7f55-276a-4edf-bb68-d916bcb8dfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_23a0419f-7c10-4b97-b367-8e50cff6201b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_7ffc7f55-276a-4edf-bb68-d916bcb8dfe9" xlink:to="loc_us-gaap_VestingDomain_23a0419f-7c10-4b97-b367-8e50cff6201b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_fa75d73f-7397-41b0-ad68-83da7b2bb586" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_23a0419f-7c10-4b97-b367-8e50cff6201b" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_fa75d73f-7397-41b0-ad68-83da7b2bb586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0e795d72-bca9-41df-a702-67c77c90ffa3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67fb91fe-7b09-40fc-8614-3ac9a6647b1c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0e795d72-bca9-41df-a702-67c77c90ffa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_06be79d5-5087-44cb-86c8-2bb0ddf3070e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0e795d72-bca9-41df-a702-67c77c90ffa3" xlink:to="loc_us-gaap_ClassOfStockDomain_06be79d5-5087-44cb-86c8-2bb0ddf3070e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_57b0a13d-4996-460b-bdff-bfda31da7086" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_06be79d5-5087-44cb-86c8-2bb0ddf3070e" xlink:to="loc_us-gaap_CommonClassAMember_57b0a13d-4996-460b-bdff-bfda31da7086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57dba20e-04fe-4725-ac6b-4030d03fe780" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67fb91fe-7b09-40fc-8614-3ac9a6647b1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57dba20e-04fe-4725-ac6b-4030d03fe780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_782a33a2-27de-49c9-ab36-64be022646d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57dba20e-04fe-4725-ac6b-4030d03fe780" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_782a33a2-27de-49c9-ab36-64be022646d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_b40762cc-2bab-4dc2-9798-9770276fbc31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57dba20e-04fe-4725-ac6b-4030d03fe780" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_b40762cc-2bab-4dc2-9798-9770276fbc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_bd87929d-c0ab-4d8c-b01c-b95d6744beda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57dba20e-04fe-4725-ac6b-4030d03fe780" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_bd87929d-c0ab-4d8c-b01c-b95d6744beda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_de018eba-0981-4677-9eb9-eab5e986f300" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57dba20e-04fe-4725-ac6b-4030d03fe780" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_de018eba-0981-4677-9eb9-eab5e986f300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5ee13f70-7260-4e73-bf3a-c2ae100436bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_57dba20e-04fe-4725-ac6b-4030d03fe780" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5ee13f70-7260-4e73-bf3a-c2ae100436bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_448dcbe7-a013-4413-a3eb-abd415c6377e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a0978f5b-bc85-4ee8-861f-ee0404fce7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_448dcbe7-a013-4413-a3eb-abd415c6377e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a0978f5b-bc85-4ee8-861f-ee0404fce7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_09de38ab-de10-42c3-818b-1d09b6b5bc39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a0978f5b-bc85-4ee8-861f-ee0404fce7f1" xlink:to="loc_us-gaap_AwardTypeAxis_09de38ab-de10-42c3-818b-1d09b6b5bc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c516143b-2c01-4757-90a4-ae1e898f248e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_09de38ab-de10-42c3-818b-1d09b6b5bc39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c516143b-2c01-4757-90a4-ae1e898f248e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TimeBasedRestrictedStockUnitsMember_534e8f77-b6fd-4e69-b767-054c8bed23e2" xlink:href="tnet-20250331.xsd#tnet_TimeBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c516143b-2c01-4757-90a4-ae1e898f248e" xlink:to="loc_tnet_TimeBasedRestrictedStockUnitsMember_534e8f77-b6fd-4e69-b767-054c8bed23e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsMember_6967a8d1-522b-4b8a-9459-3bd257e7d252" xlink:href="tnet-20250331.xsd#tnet_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c516143b-2c01-4757-90a4-ae1e898f248e" xlink:to="loc_tnet_PerformanceBasedRestrictedStockUnitsMember_6967a8d1-522b-4b8a-9459-3bd257e7d252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e13e18e8-7737-49a2-8d93-7dc992699c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a0978f5b-bc85-4ee8-861f-ee0404fce7f1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e13e18e8-7737-49a2-8d93-7dc992699c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f9a9bef5-0d98-49aa-ac46-fd836926f030" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e13e18e8-7737-49a2-8d93-7dc992699c5c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f9a9bef5-0d98-49aa-ac46-fd836926f030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a987cf46-9bb2-4102-9bd7-84351fe73867" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f9a9bef5-0d98-49aa-ac46-fd836926f030" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a987cf46-9bb2-4102-9bd7-84351fe73867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3ff5093c-0299-499e-9072-64986c156daa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f9a9bef5-0d98-49aa-ac46-fd836926f030" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3ff5093c-0299-499e-9072-64986c156daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_aa2a8d70-07d7-4c81-acc6-c6967bf936e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f9a9bef5-0d98-49aa-ac46-fd836926f030" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_aa2a8d70-07d7-4c81-acc6-c6967bf936e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_97b70973-62fb-427a-9800-e5cf146d3c39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f9a9bef5-0d98-49aa-ac46-fd836926f030" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_97b70973-62fb-427a-9800-e5cf146d3c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2448c82f-2584-447a-b19d-da87cb828477" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f9a9bef5-0d98-49aa-ac46-fd836926f030" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2448c82f-2584-447a-b19d-da87cb828477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2b058822-0290-4bb4-9321-567148dc5dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e13e18e8-7737-49a2-8d93-7dc992699c5c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2b058822-0290-4bb4-9321-567148dc5dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8a71f7c6-0a1d-464d-be59-30beefa58736" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2b058822-0290-4bb4-9321-567148dc5dd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8a71f7c6-0a1d-464d-be59-30beefa58736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3ebd1a87-f905-4399-8fcf-a857c5f7a702" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2b058822-0290-4bb4-9321-567148dc5dd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3ebd1a87-f905-4399-8fcf-a857c5f7a702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4d6a9055-cf90-4949-a021-3720485bee4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2b058822-0290-4bb4-9321-567148dc5dd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4d6a9055-cf90-4949-a021-3720485bee4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_bceb2f36-90f7-481c-9ff0-e4a804ebb362" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2b058822-0290-4bb4-9321-567148dc5dd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_bceb2f36-90f7-481c-9ff0-e4a804ebb362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_03f1eb21-76cf-4463-9112-203f6f7e808a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2b058822-0290-4bb4-9321-567148dc5dd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_03f1eb21-76cf-4463-9112-203f6f7e808a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_395c6817-b36d-4e35-9f2a-44105e3c2131" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84c5234d-fbfd-4ebb-87f3-6eaa56459bab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_395c6817-b36d-4e35-9f2a-44105e3c2131" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84c5234d-fbfd-4ebb-87f3-6eaa56459bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a2db74f9-8977-4827-bfb8-fad37ab7c6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84c5234d-fbfd-4ebb-87f3-6eaa56459bab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a2db74f9-8977-4827-bfb8-fad37ab7c6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_361458ca-9745-4179-b5b7-d2091a43e0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84c5234d-fbfd-4ebb-87f3-6eaa56459bab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_361458ca-9745-4179-b5b7-d2091a43e0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9665c9ac-8430-4f9f-b43c-e4d657e81c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84c5234d-fbfd-4ebb-87f3-6eaa56459bab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9665c9ac-8430-4f9f-b43c-e4d657e81c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_73ff6a66-66bf-4288-921e-00272de40015" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_395c6817-b36d-4e35-9f2a-44105e3c2131" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_73ff6a66-66bf-4288-921e-00272de40015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8b3dd55d-b6df-4f7e-bf22-ce0cb091abf6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_73ff6a66-66bf-4288-921e-00272de40015" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8b3dd55d-b6df-4f7e-bf22-ce0cb091abf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1657c738-7a10-4fdf-bb9a-8927d8a6a46a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_73ff6a66-66bf-4288-921e-00272de40015" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1657c738-7a10-4fdf-bb9a-8927d8a6a46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_515244fd-42c3-4187-9f8f-ad2dbc7cc535" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_73ff6a66-66bf-4288-921e-00272de40015" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_515244fd-42c3-4187-9f8f-ad2dbc7cc535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3b2cf624-2913-471e-a47d-5c50111886d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_395c6817-b36d-4e35-9f2a-44105e3c2131" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3b2cf624-2913-471e-a47d-5c50111886d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_ec9755cd-6869-4254-ad84-0e5da7ac537f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3b2cf624-2913-471e-a47d-5c50111886d6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_ec9755cd-6869-4254-ad84-0e5da7ac537f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_95287dbf-ce1f-4c56-b771-16d87f8aa077" xlink:href="tnet-20250331.xsd#tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3b2cf624-2913-471e-a47d-5c50111886d6" xlink:to="loc_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_95287dbf-ce1f-4c56-b771-16d87f8aa077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AggregateIntrinsicValueRollForward_c4ee1e1d-ad93-40ce-a75c-f0cd0f2397a0" xlink:href="tnet-20250331.xsd#tnet_AggregateIntrinsicValueRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_395c6817-b36d-4e35-9f2a-44105e3c2131" xlink:to="loc_tnet_AggregateIntrinsicValueRollForward_c4ee1e1d-ad93-40ce-a75c-f0cd0f2397a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_28871506-f677-4031-a17a-b22a7400fb94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_AggregateIntrinsicValueRollForward_c4ee1e1d-ad93-40ce-a75c-f0cd0f2397a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_28871506-f677-4031-a17a-b22a7400fb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_eaa707a9-8180-4a58-aa2d-3dfb9f46341e" xlink:href="tnet-20250331.xsd#tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_AggregateIntrinsicValueRollForward_c4ee1e1d-ad93-40ce-a75c-f0cd0f2397a0" xlink:to="loc_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_eaa707a9-8180-4a58-aa2d-3dfb9f46341e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_97823f0e-a815-42a7-b866-058360d21ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_AggregateIntrinsicValueRollForward_c4ee1e1d-ad93-40ce-a75c-f0cd0f2397a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_97823f0e-a815-42a7-b866-058360d21ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofStockOptionsDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f4f19290-731c-4d39-9eb7-aeea643cd5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f816c41e-fba3-418c-9544-86f8fb62a7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f4f19290-731c-4d39-9eb7-aeea643cd5f3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f816c41e-fba3-418c-9544-86f8fb62a7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_62994388-7238-4e85-98f3-5fbe3e8c47f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f4f19290-731c-4d39-9eb7-aeea643cd5f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_62994388-7238-4e85-98f3-5fbe3e8c47f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4414abf9-f668-4f3f-aca0-205cc5a1ab8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f4f19290-731c-4d39-9eb7-aeea643cd5f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4414abf9-f668-4f3f-aca0-205cc5a1ab8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5368935b-d276-4d8e-8b0a-a66ee3fc7466" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f4f19290-731c-4d39-9eb7-aeea643cd5f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5368935b-d276-4d8e-8b0a-a66ee3fc7466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofShareBasedPaymentArrangementActivityDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKBASEDCOMPENSATIONScheduleofShareBasedPaymentArrangementActivityDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofShareBasedPaymentArrangementActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a7f32dd6-d08b-4aec-ab23-9eeda885e524" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_eaaec6a2-a51c-47c5-b02e-cd06d375cc3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a7f32dd6-d08b-4aec-ab23-9eeda885e524" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_eaaec6a2-a51c-47c5-b02e-cd06d375cc3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_e268fa9d-da89-470f-88e2-a9b21167693b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a7f32dd6-d08b-4aec-ab23-9eeda885e524" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_e268fa9d-da89-470f-88e2-a9b21167693b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0fd317d8-be0c-46e3-bfb2-4f70f51319fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa6b54b5-9784-46cd-9224-9cf4944f9c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0fd317d8-be0c-46e3-bfb2-4f70f51319fc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa6b54b5-9784-46cd-9224-9cf4944f9c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0d1a57b4-3152-42c5-a8ce-8efc7753ee24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa6b54b5-9784-46cd-9224-9cf4944f9c1f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0d1a57b4-3152-42c5-a8ce-8efc7753ee24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8726257a-913a-4de7-bd99-531e67bde8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0d1a57b4-3152-42c5-a8ce-8efc7753ee24" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8726257a-913a-4de7-bd99-531e67bde8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_fa940dde-1823-4fad-919d-19199fb8ac0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8726257a-913a-4de7-bd99-531e67bde8a7" xlink:to="loc_us-gaap_CostOfSalesMember_fa940dde-1823-4fad-919d-19199fb8ac0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_7e2b0d9d-dd08-478a-8066-238262405a41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8726257a-913a-4de7-bd99-531e67bde8a7" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_7e2b0d9d-dd08-478a-8066-238262405a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_8647b33d-20c4-455d-9e37-9a20fb556c77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8726257a-913a-4de7-bd99-531e67bde8a7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_8647b33d-20c4-455d-9e37-9a20fb556c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_SystemsDevelopmentAndProgrammingCostsMember_9a6e809a-555b-41b1-b782-4619dbf4cc4c" xlink:href="tnet-20250331.xsd#tnet_SystemsDevelopmentAndProgrammingCostsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8726257a-913a-4de7-bd99-531e67bde8a7" xlink:to="loc_tnet_SystemsDevelopmentAndProgrammingCostsMember_9a6e809a-555b-41b1-b782-4619dbf4cc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c79b665-73cc-4bbb-9ba3-347c14cdc67d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fa6b54b5-9784-46cd-9224-9cf4944f9c1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c79b665-73cc-4bbb-9ba3-347c14cdc67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2cf116d6-7037-420f-b34d-564bce8419a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c79b665-73cc-4bbb-9ba3-347c14cdc67d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2cf116d6-7037-420f-b34d-564bce8419a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_ae705d63-855e-4ece-8517-f94b857bb8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c79b665-73cc-4bbb-9ba3-347c14cdc67d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_ae705d63-855e-4ece-8517-f94b857bb8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKHOLDERSEQUITYScheduleofCommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_88ceaad0-05a4-4c24-ad69-aeccdee9c8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2229b46-0f8e-45c6-a9a1-d2e31876a035" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_88ceaad0-05a4-4c24-ad69-aeccdee9c8f0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2229b46-0f8e-45c6-a9a1-d2e31876a035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_028a350d-ea33-4350-993b-633a52edbe02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2229b46-0f8e-45c6-a9a1-d2e31876a035" xlink:to="loc_us-gaap_AwardTypeAxis_028a350d-ea33-4350-993b-633a52edbe02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2479ad72-3e1a-45bb-9fa4-e901b524adad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_028a350d-ea33-4350-993b-633a52edbe02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2479ad72-3e1a-45bb-9fa4-e901b524adad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_ffc0af4d-c5dc-4698-b7a4-72a936f593d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2479ad72-3e1a-45bb-9fa4-e901b524adad" xlink:to="loc_us-gaap_RestrictedStockMember_ffc0af4d-c5dc-4698-b7a4-72a936f593d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_894eec1e-3b77-4f36-b88e-d3c70bdb5d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2479ad72-3e1a-45bb-9fa4-e901b524adad" xlink:to="loc_us-gaap_StockOptionMember_894eec1e-3b77-4f36-b88e-d3c70bdb5d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9126705c-72af-4ebe-bcd1-2b6d2903339c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2229b46-0f8e-45c6-a9a1-d2e31876a035" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9126705c-72af-4ebe-bcd1-2b6d2903339c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9126705c-72af-4ebe-bcd1-2b6d2903339c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_83cb43e1-ce09-4ab7-8ab3-09a439855f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:to="loc_us-gaap_CommonStockSharesIssued_83cb43e1-ce09-4ab7-8ab3-09a439855f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d85b1c23-3ce7-4c9d-9ede-02a1bb22ecc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d85b1c23-3ce7-4c9d-9ede-02a1bb22ecc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c8318dd2-88ea-4c5a-9a71-aeb2f3736e00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c8318dd2-88ea-4c5a-9a71-aeb2f3736e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_31698e5e-3cef-4d10-ac5d-dbc125e92691" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_31698e5e-3cef-4d10-ac5d-dbc125e92691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_73588794-84ae-4d3c-b87f-fe2d63f83676" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_73588794-84ae-4d3c-b87f-fe2d63f83676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_87aa1b8b-9315-4ab8-a7a8-4c6aa71fbb03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_87aa1b8b-9315-4ab8-a7a8-4c6aa71fbb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e660f043-b5d9-49c9-bc1b-a099be3e68b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:to="loc_us-gaap_CommonStockSharesIssued_e660f043-b5d9-49c9-bc1b-a099be3e68b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ddf20800-6aa5-42e1-8513-ebfd680828e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e6ad6263-25a0-4c0d-a686-9c02515d6939" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ddf20800-6aa5-42e1-8513-ebfd680828e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#STOCKHOLDERSEQUITYAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0ce60081-3d78-4f69-9334-b0bce7fe23ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_bb32fcdb-f25b-46e0-8f2c-40ca0ff9c545" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ce60081-3d78-4f69-9334-b0bce7fe23ea" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_bb32fcdb-f25b-46e0-8f2c-40ca0ff9c545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_d9c3693a-a881-4ee8-a0f0-349188c3ddae" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ce60081-3d78-4f69-9334-b0bce7fe23ea" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_d9c3693a-a881-4ee8-a0f0-349188c3ddae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_f8ea3800-fb45-4935-9333-d9faf70517be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ce60081-3d78-4f69-9334-b0bce7fe23ea" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_f8ea3800-fb45-4935-9333-d9faf70517be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_c4625c04-296d-431c-b5a9-0f5f9be2dd99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ce60081-3d78-4f69-9334-b0bce7fe23ea" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_c4625c04-296d-431c-b5a9-0f5f9be2dd99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_41b45997-8194-407a-961a-78fdfb30f9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncomeTaxesDisclosureTable_3f6c2025-822e-426f-8507-8b3bb981f6d7" xlink:href="tnet-20250331.xsd#tnet_IncomeTaxesDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_41b45997-8194-407a-961a-78fdfb30f9c6" xlink:to="loc_tnet_IncomeTaxesDisclosureTable_3f6c2025-822e-426f-8507-8b3bb981f6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_40cf8a04-895c-4f25-b678-2b299983d0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_IncomeTaxesDisclosureTable_3f6c2025-822e-426f-8507-8b3bb981f6d7" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_40cf8a04-895c-4f25-b678-2b299983d0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_d1c98dce-589f-426f-84c6-3b4f5b858412" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_40cf8a04-895c-4f25-b678-2b299983d0a9" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_d1c98dce-589f-426f-84c6-3b4f5b858412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember_2b56e409-5804-488a-a709-514e72f9e4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_d1c98dce-589f-426f-84c6-3b4f5b858412" xlink:to="loc_us-gaap_CapitalLossCarryforwardMember_2b56e409-5804-488a-a709-514e72f9e4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncomeTaxesDisclosureLineItems_3cd8a507-eca4-49a7-9a87-3b9ca7088f15" xlink:href="tnet-20250331.xsd#tnet_IncomeTaxesDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_IncomeTaxesDisclosureTable_3f6c2025-822e-426f-8507-8b3bb981f6d7" xlink:to="loc_tnet_IncomeTaxesDisclosureLineItems_3cd8a507-eca4-49a7-9a87-3b9ca7088f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_92b855ea-bbff-49fe-9410-25f56dceeaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_IncomeTaxesDisclosureLineItems_3cd8a507-eca4-49a7-9a87-3b9ca7088f15" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_92b855ea-bbff-49fe-9410-25f56dceeaa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_1d6ebc3a-a198-40bb-a380-239f5b068247" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_IncomeTaxesDisclosureLineItems_3cd8a507-eca4-49a7-9a87-3b9ca7088f15" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_1d6ebc3a-a198-40bb-a380-239f5b068247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_0330dbc4-7fe7-433d-a1ce-8200d0c7d26f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_IncomeTaxesDisclosureLineItems_3cd8a507-eca4-49a7-9a87-3b9ca7088f15" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_0330dbc4-7fe7-433d-a1ce-8200d0c7d26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_12753096-59dc-49cf-9d96-df4f66b04839" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_IncomeTaxesDisclosureLineItems_3cd8a507-eca4-49a7-9a87-3b9ca7088f15" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_12753096-59dc-49cf-9d96-df4f66b04839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_06736408-17db-4bec-89c4-b05eddc9f293" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5def8a7d-fbff-48d0-afb9-8c3d386bfede" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_06736408-17db-4bec-89c4-b05eddc9f293" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5def8a7d-fbff-48d0-afb9-8c3d386bfede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4ffc81d0-aa01-4ee8-8895-11fcdf0bb5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_06736408-17db-4bec-89c4-b05eddc9f293" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4ffc81d0-aa01-4ee8-8895-11fcdf0bb5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_10ff4235-e872-47d5-a0bd-36a8519a1773" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_06736408-17db-4bec-89c4-b05eddc9f293" xlink:to="loc_us-gaap_EarningsPerShareBasic_10ff4235-e872-47d5-a0bd-36a8519a1773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_64320a3e-602b-4886-8f8d-f5d1d933dc3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_06736408-17db-4bec-89c4-b05eddc9f293" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_64320a3e-602b-4886-8f8d-f5d1d933dc3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cc308c04-b18d-407f-9150-73542f672e18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1f67a073-9f45-4209-93f2-8fa884d9ed58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_06736408-17db-4bec-89c4-b05eddc9f293" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1f67a073-9f45-4209-93f2-8fa884d9ed58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cc3ef49a-689d-45d4-82e7-7ed97eb53d85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_06736408-17db-4bec-89c4-b05eddc9f293" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cc3ef49a-689d-45d4-82e7-7ed97eb53d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_23b2041a-ab3b-4668-ac2c-764f19b62f73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_06736408-17db-4bec-89c4-b05eddc9f293" xlink:to="loc_us-gaap_EarningsPerShareDiluted_23b2041a-ab3b-4668-ac2c-764f19b62f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e67f42c5-0a74-4e7d-9110-3fd3760f4998" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_06736408-17db-4bec-89c4-b05eddc9f293" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e67f42c5-0a74-4e7d-9110-3fd3760f4998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/RESTRUCTURINGNarrativeDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#RESTRUCTURINGNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/RESTRUCTURINGNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e2d6c322-74e7-40c5-89aa-f3179b61ef43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_ae3aa517-f4a5-46d9-bfe5-687f9290c359" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e2d6c322-74e7-40c5-89aa-f3179b61ef43" xlink:to="loc_us-gaap_RestructuringCosts_ae3aa517-f4a5-46d9-bfe5-687f9290c359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0b6d94c5-2a8a-427b-8444-3381197be8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_96bf3388-759e-44db-8d78-da16c93f7bff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0b6d94c5-2a8a-427b-8444-3381197be8b9" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_96bf3388-759e-44db-8d78-da16c93f7bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis_83b358c8-816f-4134-8f4a-c0a8273de4df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_96bf3388-759e-44db-8d78-da16c93f7bff" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis_83b358c8-816f-4134-8f4a-c0a8273de4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain_595b434b-9981-484e-b2e9-5e651243dda2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis_83b358c8-816f-4134-8f4a-c0a8273de4df" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain_595b434b-9981-484e-b2e9-5e651243dda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_6c55ca7f-fe9a-42a9-93fa-2d1ec45bcae9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain_595b434b-9981-484e-b2e9-5e651243dda2" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_6c55ca7f-fe9a-42a9-93fa-2d1ec45bcae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedSalariesCurrentMember_cb105517-e171-4ce2-b8aa-a3dbe1ced499" xlink:href="tnet-20250331.xsd#tnet_AccruedSalariesCurrentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain_595b434b-9981-484e-b2e9-5e651243dda2" xlink:to="loc_tnet_AccruedSalariesCurrentMember_cb105517-e171-4ce2-b8aa-a3dbe1ced499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_550bbad7-d8b8-437c-95c0-bf069911bdce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_96bf3388-759e-44db-8d78-da16c93f7bff" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_550bbad7-d8b8-437c-95c0-bf069911bdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9ef6fd0b-5e88-4e58-9b6a-2686cc4c2300" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_550bbad7-d8b8-437c-95c0-bf069911bdce" xlink:to="loc_us-gaap_RestructuringCharges_9ef6fd0b-5e88-4e58-9b6a-2686cc4c2300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_RestructuringChargesAdditions_c46562e7-f1c9-4793-9dc1-6f3e88d70b31" xlink:href="tnet-20250331.xsd#tnet_RestructuringChargesAdditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_550bbad7-d8b8-437c-95c0-bf069911bdce" xlink:to="loc_tnet_RestructuringChargesAdditions_c46562e7-f1c9-4793-9dc1-6f3e88d70b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_RestructuringChargesPayments_3ae2270a-47e2-43e0-9637-f7af94f09a03" xlink:href="tnet-20250331.xsd#tnet_RestructuringChargesPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_550bbad7-d8b8-437c-95c0-bf069911bdce" xlink:to="loc_tnet_RestructuringChargesPayments_3ae2270a-47e2-43e0-9637-f7af94f09a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/SEGMENTINFORMATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#SEGMENTINFORMATIONAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/SEGMENTINFORMATIONAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_48d0f7c5-a744-422f-991c-1e2c3989cc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b7526b2c-8a26-4915-b9cf-ee0fecea682f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_48d0f7c5-a744-422f-991c-1e2c3989cc7d" xlink:to="loc_us-gaap_NumberOfReportableSegments_b7526b2c-8a26-4915-b9cf-ee0fecea682f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" xlink:type="simple" xlink:href="tnet-20250331.xsd#SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7140a686-800c-40d9-a623-ba885c9325e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55867d68-199f-4e0a-ba11-4dfcd192c75b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7140a686-800c-40d9-a623-ba885c9325e0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55867d68-199f-4e0a-ba11-4dfcd192c75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_eacd7010-5f11-4a45-af75-0b91973ce2e2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55867d68-199f-4e0a-ba11-4dfcd192c75b" xlink:to="loc_srt_ProductOrServiceAxis_eacd7010-5f11-4a45-af75-0b91973ce2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_45fc8abb-659d-45d4-bd22-e7d876e554fd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_eacd7010-5f11-4a45-af75-0b91973ce2e2" xlink:to="loc_srt_ProductsAndServicesDomain_45fc8abb-659d-45d4-bd22-e7d876e554fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ProfessionalServicesMember_7a7398c4-7df0-40e7-9de3-44ba7ad7043c" xlink:href="tnet-20250331.xsd#tnet_ProfessionalServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_45fc8abb-659d-45d4-bd22-e7d876e554fd" xlink:to="loc_tnet_ProfessionalServicesMember_7a7398c4-7df0-40e7-9de3-44ba7ad7043c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsuranceServicesMember_0c688bbb-b988-4f36-9d9b-a3dac069172f" xlink:href="tnet-20250331.xsd#tnet_InsuranceServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_45fc8abb-659d-45d4-bd22-e7d876e554fd" xlink:to="loc_tnet_InsuranceServicesMember_0c688bbb-b988-4f36-9d9b-a3dac069172f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_15d1d958-0d79-4af0-b7cf-bb3753b123fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55867d68-199f-4e0a-ba11-4dfcd192c75b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_15d1d958-0d79-4af0-b7cf-bb3753b123fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c3df25d8-7f1e-471c-a660-3d8336865440" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_15d1d958-0d79-4af0-b7cf-bb3753b123fa" xlink:to="loc_us-gaap_SegmentDomain_c3df25d8-7f1e-471c-a660-3d8336865440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ReportableSegmentMember_7d5a6752-533f-4aed-b238-d31ec9d2b1a6" xlink:href="tnet-20250331.xsd#tnet_ReportableSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c3df25d8-7f1e-471c-a660-3d8336865440" xlink:to="loc_tnet_ReportableSegmentMember_7d5a6752-533f-4aed-b238-d31ec9d2b1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_55867d68-199f-4e0a-ba11-4dfcd192c75b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6be302c0-94cd-4734-b83d-9b90bdfdfcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6be302c0-94cd-4734-b83d-9b90bdfdfcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_e90d0153-6c09-4ad0-b888-d704687e2ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_InterestIncomeOperating_e90d0153-6c09-4ad0-b888-d704687e2ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_936dbe85-d61d-4dbf-a176-393bbb049bef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_Revenues_936dbe85-d61d-4dbf-a176-393bbb049bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_WorkersCompensationCosts_08d42efe-5aea-4140-8af1-411cf044f01f" xlink:href="tnet-20250331.xsd#tnet_WorkersCompensationCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_tnet_WorkersCompensationCosts_08d42efe-5aea-4140-8af1-411cf044f01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_HealthInsuranceCosts_64864f9c-f271-48f4-99fc-898e1be65f50" xlink:href="tnet-20250331.xsd#tnet_HealthInsuranceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_tnet_HealthInsuranceCosts_64864f9c-f271-48f4-99fc-898e1be65f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther_755de801-1cd1-4c0b-ac9e-f42c2d55dd8d" xlink:href="tnet-20250331.xsd#tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther_755de801-1cd1-4c0b-ac9e-f42c2d55dd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ClientSupportCosts_fa5a5f82-7cd2-4513-96a0-7208ab540bbe" xlink:href="tnet-20250331.xsd#tnet_ClientSupportCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_tnet_ClientSupportCosts_fa5a5f82-7cd2-4513-96a0-7208ab540bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CorporateAdministrationExpenses_f72d846a-f990-43d3-94e1-ed4999d23240" xlink:href="tnet-20250331.xsd#tnet_CorporateAdministrationExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_tnet_CorporateAdministrationExpenses_f72d846a-f990-43d3-94e1-ed4999d23240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_SystemSupportAndDevelopmentExpenses_26558fbe-da08-4c06-aa8c-5c1d416cad4e" xlink:href="tnet-20250331.xsd#tnet_SystemSupportAndDevelopmentExpenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_tnet_SystemSupportAndDevelopmentExpenses_26558fbe-da08-4c06-aa8c-5c1d416cad4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_7e6a18e7-0b84-4354-b548-442eed2acf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_7e6a18e7-0b84-4354-b548-442eed2acf6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1daa2ac5-2afd-4c6d-b417-d021b4d659e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1daa2ac5-2afd-4c6d-b417-d021b4d659e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_dc68a803-b2ed-4019-bd31-1c7e1b6f6730" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_OtherExpenses_dc68a803-b2ed-4019-bd31-1c7e1b6f6730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InterestExpenseBankFeesAndOther_e4c04d2d-56eb-46e7-b724-8a6efdde3341" xlink:href="tnet-20250331.xsd#tnet_InterestExpenseBankFeesAndOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_tnet_InterestExpenseBankFeesAndOther_e4c04d2d-56eb-46e7-b724-8a6efdde3341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b245b64d-3157-4596-8eb1-df8ba06a9933" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b245b64d-3157-4596-8eb1-df8ba06a9933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d730f0e2-86e2-422e-8a68-c7d56f6121e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_29667f1d-9585-4f55-8169-69f8c54e493d" xlink:to="loc_us-gaap_NetIncomeLoss_d730f0e2-86e2-422e-8a68-c7d56f6121e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tnet-20250331_g1.jpg
<TEXT>
begin 644 tnet-20250331_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#H17AI9@  34T *@    @ ! $[  (
M   *   (2H=I  0    !   (5)R=  $    4   0S.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%N;F$@3&EA
M;P  !9 #  (    4   0HI $  (    4   0MI*1  (    #.3(  )*2  (
M   #.3(  .H<  <   @,   (E@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M%1%E!+$G  K'VU/^9?>;?5ZR^P_N9J4445J8A1110!\H?M2?\E0T[_L#1?\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tnet-20250331_g10.jpg
<TEXT>
begin 644 tnet-20250331_g10.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^:2>B5E)V2M>3T7WGW%17R7HG[9_C7XN_P#!/_Q;\7-,O!H_C#PVJVEY=6*
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M:3L[.ST>^E]#TKQC^US\./AW^SKHW[17C:VNK6SUW3K6?3]*AVR7$TL\7F+
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M\NGS845\+>#OBE^V1\</VJ?B3\ _A[\9?[(TVQUO4 =4N[1)6TJR@O'C5(%
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MJWI\J21Y-RPVX>*,D)^[D8X'USP*_0/PYI^H:3X>L-*U?5I+^[MK***ZOI5
M:YD5 &D(  !8@L<#'-=W#G$<.)*#Q%&A.%/I*7+:3NTTK-O1K5['!Q+PS/AF
MNL/6Q$)U>L8<S<59--W26J>BW+M%?'?Q3^-/[1/[2G[6^I_LN? 'XB#P=I'A
MN"1]8UF&+=/*T>Q97R/FP))%C5%9<\LQZ!>Z_9GT#]N#X9_&+4/A[\9M5_X3
M'P1Y!-EXMGN($EBEV!U(4MYS G*,I#!6P0V,[L<-Q53QF/=&AAJDJ:FZ?M4D
MX<ZWND^913T<^7EOUMJ;XGA*K@\O5:OB:4:KIJK[)MJ?(]K-KE<FM5#FYK=+
MZ'T517Q%X>^+'[57[>WQ=\2Z9\$/BS_P@W@KPU,$AN[6(^;.&9UB9BN'=W$;
M,5W*B* .3RW4?LP_M#_'GX>?M.7?[''[2WB"'7KIX6?0M?1 '<B$SJ&8!=Z/
M&&.6&Y77;D@\<V&XVP.)KT[49JC5G[.%5I<DIW:LM>9)M-)M6;[:G5BN!L?A
M</5O6INO2A[2=%-\\863N_=Y6TFG))W2[GUK17G%_P#M??LQ:7JLVAZC\</#
MT-Y;7#03V\E\ R2*Q5D(]0017H]?58?&X/%N2H5(SY=^5IV];/38^2Q.!QN#
M477I2AS;<T6K^EUKN@HHHKI.4**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "JVL*SZ1=(BDDVS@ #DG::LT4I+F30XOEDF?G7^SU\
M"/&7BK]@7XL>%-7\&:G:ZE%J<.IZ7;76GR1RRM;QI(?+5E!8LJN@P#G=CK4G
M[)OP1\=6/[*7QK\<^)?">K)JVJ:"=*TRVN[&5;B18X2[A58;F!+Q 8'_ "SQ
MVK]$**_.L/X=8&A/#S=9MTJ4Z>RUYN>TGKO'G=OEJ?I.(\2L?7AB(>Q25:K"
MK\3TY>2\5IM+V:O\]#XF^'G[-GCGXQ_\$P[;X96FBW%GXBL]7N=0T[3]1B,#
M2R1W,A\LA\;2\;.%)P,E<D#)K-\'_MQ?%SX?? 2W_9RU#]FKQ0WCC3-%&BZ:
MPL)!$R+'Y,4K1[-Y94V_* 0Y7.X!N/NNBNS_ %,JX:-*6!Q<J4XTHT9/EC+G
MC'9V?PR[--G%_KM1Q,JT<?@XU:<JTJT8\\HN$I;JZ^*+ZII>I\3^$_V7?'OP
M4_X)N>.M!\1Z+._B7Q,([V72;6,RRP()(%CA*IG+A59F Z;L?PFO1_V7O#GB
M#3/^"::^&]2T&\M]1_X1;7T^P3VKI-N>>\*KL(W9(88&.<CUKZ1HKLP/"&#R
M[$PJ4)M1C0=!)J^CES.3?>_2UM3CQ_&6-S+#3IXB"<IXA5VT[:J/(H)=DNM[
MZ'Q9^QK\,_'EU_P3K^)7@.7PGJ%OJ^HW6K+8:?=V;Q2SLVGVX0*K@$[F!4=L
MU6_X)_?%'6(_@7XE_9HU/X8Z]9ZAIVAZO?/J-Q9LL+,P4+;X*[A(=[<'^Y[\
M?;E%<V%X->"J82='$->QIND_=3YXMW[^Z[]5<ZL5QJL=3Q<*^&3]O555>\UR
M32MV]Y6Z.Q\K_P#!)7POXE\*? ?Q!8^*/#M]IL\GBZ22.&_M'A=D^RVXW .
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M;#_8.^(7AOQK\2/C<_CSPSKMTT>J6D]OL52NTR1HASY3;6+(R$ E2&7'!O\
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M&KUC*?+-6VTNG>Q[S\/_ /@I-\/?'_[12? *S\$7D GUJYTZVUU[Y&BE:+S
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MP">>PKC/VYM:\9^&_P#@HMX)\0_#WPZVKZQ8Z)8W%GI2/M:\V3W3-$#V+(&
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MLH@8>@#5F?\ !+;P?K7BFV\:_M4>-HPVK>,M;EBMY=N (E<R3%/1&E<+CMY
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M\%+/%%O\6;FUG\10:3=P:I<V4>R*X>-;=!,J\8#JJOC ^]T'0;ND_%K]J?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.;X=Z=^U%!XDA\3+%J#6=KXSE9]9MM';4+EM+AOV<EOM*6!M5<-\X(P_SAJ
M/IVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /P3_X?2?\
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M$Y; P  /GO\ X>6_]45_\N/_ .YJ/^'EO_5%?_+C_P#N:@#ZFHKY9_X>6_\
M5%?_ "X__N:C_AY;_P!45_\ +C_^YJ /J:BOEG_AY;_U17_RX_\ [FH_X>6_
M]45_\N/_ .YJ /J:BOEG_AY;_P!45_\ +C_^YJ/^'EO_ %17_P N/_[FH ^I
MJ*^6?^'EO_5%?_+C_P#N:C_AY;_U17_RX_\ [FH ^IJ*^6?^'EO_ %17_P N
M/_[FKZFH **** "BBB@ HHHH **** "BBB@ HHHH _EOHHHK_00_S["BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH _J0HHHK_/L_T$"BBB@ HHHH
M *_+.OU,K\LZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_4R
MORSK]3* "BBB@ HHHH **** "BBB@ HHHH **** /Y;Z***_T$/\^PHHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /ZD****_S[/]! HHHH ****
M"ORSK]3*_+.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OU,K
M\LZ_4R@ HHHH **** "BBB@ HHHH **** "BBB@#^6^BBBO]!#_/L**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#^I"BBBO\^S_00**** "BBB@
MK\LZ_4RORSH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K]3*_
M+.OU,H **** "BBB@ HHHH **** "BBB@ HHHH _EOHHHK_00_S["BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH _J0HHHK_/L_T$"BBB@ HHHH *
M_+.OU,K\LZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_4ROR
MSK]3* "BBB@ HHHH **** "BBB@ HHHH **** /Y;Z***_T$/\^PHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /ZD****_S[/]! HHHH **** "O
MRSK]3*_+.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OU,K\L
MZ_4R@ HHHH **** "BBB@ HHHH **** "BBB@#^6^BBBO]!#_/L**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#^I"BBBO\^S_00**** "BBB@ K\
MLZ_4RORSH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K]3*_+.
MOU,H **** "BBB@ HHHH **** "BBB@ HHHH _EOHHHK_00_S["BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH _J0HHHK_/L_T$"BBB@ HHHH *_+
M.OU,K\LZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_4RORSK
M]3* "BBB@ HHHH **** "BBB@ HHHH **** /Y;Z***_T$/\^PHHHH ****
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M (7#?_&J/^')'[)__11?BG_X7#?_ !JOL.B@#X\_X<D?LG_]%%^*?_A<-_\
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M?Q$\->(_"5Y\-=3&E^-?!NKV4;ZK9Z@_E_9[:)(9'CN#<&:(0O&Y23S%Y'.
M#QGQI_P2)^+'C7XE-^T!XM_;4NO$GC6TUC3=7L['5O!-M;>'M3O; ;;>74["
MTE3[5(J (LJNC1@# (&VOIS]J[]GBS_:N_9L\4?LZ^(O%,NDQ>*=,6TNM5LK
M4.T)$B2%DC9L'E,8+=#UKF?@U^V;-X\^+=O\"OB_\ /%GPQ\4ZMH<NL^&;'Q
M3/8SQ:S9Q,BS>3-9SRHL\7F1F2!RKJKAL$9(X:[_ ."I?A>+PA<_'BP_9K^(
M%Y\&[+4WM+GXL6R6)LS&DY@>^2S^T_;)+-9 <SB+[H+!2!0!]3*NU0H/08I:
M\(^/W[<*?"#XN:/\$?AY^S[XR^)?B#5O"LGB)K;P8UF5M=/6X6W69VN9XAAI
M&PNTG.#7I7P2^)'B7XK^ +?QEXM^$.O^!KV:>6-_#WB9K<W<01BH=OL\DB88
M<C#$X/.* .MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHKR'X^_M:VOP@^(^A? WP%\(_$7Q"\>^(=-GU.T\,>&Y;6 VNGPNL<EY<W%W
M-%#!%YCK&I+$NYV@&@"Y^U#^RCX,_:>TK0[J_P#$^L^&/%/A'4FU'P9XU\-7
M"Q:AHUTR;'*%U9)(I$^26%U*2+P1D CYM\:?\$B?BQXU^)3?M >+?VU+KQ)X
MUM-8TW5[.QU;P3;6WA[4[VP&VWEU.PM)4^U2*@"+*KHT8 P"!MKV;1/^"BGP
M9_X4=XY^,?Q$\->(_"5Y\-=3&E^-?!NKV4;ZK9Z@_E_9[:)(9'CN#<&:(0O&
MY23S%Y'.-#X-?MFS>//BW;_ KXO_   \6?#'Q3JVARZSX9L?%,]C/%K-G$R+
M-Y,UG/*BSQ>9&9('*NJN&P1D@ Z;]J[]GBS_ &KOV;/%'[.OB+Q3+I,7BG3%
MM+K5;*U#M"1(DA9(V;!Y3&"W0]:]'5=JA0>@Q7RS=_\ !4OPO%X0N?CQ8?LU
M_$"\^#=EJ;VES\6+9+$V9C2<P/?)9_:?MDEFL@.9Q%]T%@I KVK]HC]H_P"&
M'[,GP-UC]H#XCZO_ ,232;(31+:$/+?RO@06\ SB225V5$&<9;)( ) !WM%<
MM\#?BKI?QU^"OA'XV:'IEQ967C#PS8:U:6=V5,L$5U;I.L;E2064. <<9%=3
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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G **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tnet-20250331_g11.jpg
<TEXT>
begin 644 tnet-20250331_g11.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC_P4:\!>&O&G[)WB;4-;L8GNM$@COM+NG0;[>59$!VGMN4LA'<-["O//V6/
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M\YY?0C4=-4U.K&OSN+DE=RI):*4KQ3YO,]MHHHK]./RL**** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7S=_P %.?VMOB+^RS\(O"FB?!!M A\??%'X@6'@WPCJGBK)TS19
M)XI[FZU6[160O!:V=K<S%=R@LJ G!(/TC7PG_P %XOV=8_C!\*/@S\7]?^$V
MI>._"7PB^.NC^*/B1X2TG3'OI[WPWY5Q;7S+:1@O=K&)XY)( K>9"LP((R*
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MC>I-J/AN^^&_A>UAU&('YH7EMM/2:-6Z;HV5AV(H ^5?V$_^"CWQXO\ Q/\
M"7XG_M)?M2Z1XM\)?%_X"^*/B1XZT5=!L+.'X6G2I[!MD<MK&LYM EY/:N+Q
MI93-9EA(/FC'V-^P3XT^/GQ9^ D?QV_:"N+BTO/B!JUSXA\,>$[FP@@D\+Z!
M<%?[-TZ0QHK23BV6.>=I2SK/<3("$1%7PO\ :9_9X_9_^*'[5FC?L._ _P"!
MG@[PZOC:6'Q_^TQKGAKPQ:65SJWA^TNRUEIU]-#&KSOJ6HIM;S&):VL[\'[W
M/A'[#W[0_P 9_%/[;7PST2[_ &B_'.N_%/7/B+\0[/\ :3^$^I^(+FXTOPAH
M-HVH?V/*FFOF'2HU>+24M[B)4-VMTY+R[B4 /U4HHHH **** "BBB@ HHHH
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M_AN7_A-KW_A3O_"I_P#A'/W?]G?\)-_:?V[_ %:^9YGD?N_]9OV[?X=N><T
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M_P"S-_T/_P 4_P#PX][_ (T?\.A_V9O^A_\ BG_X<>]_QK\N/U$=_P %I/\
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M,W_0_P#Q3_\ #CWO^-'_  Z'_9F_Z'_XI_\ AQ[W_&@#ZFHKY9_X=#_LS?\
M0_\ Q3_\./>_XT?\.A_V9O\ H?\ XI_^''O?\: /J:BOEG_AT/\ LS?]#_\
M%/\ \./>_P"-'_#H?]F;_H?_ (I_^''O?\: /J:BOEG_ (=#_LS?]#_\4_\
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M)XOOIM5M4M[A/$GBB?4$55;<"BRG"'/4CM7KM !1110 4444 %%%% 'X)_\
M!:3_ )27_$K_ +@W_IFL:^6Z^I/^"TG_ "DO^)7_ '!O_3-8U\MU_<G"7_)*
M8#_KQ2_]-Q/X;XM_Y*O'_P#7^K_Z<D%%%%?0'SX4444 %%%% !7[V?\ !%O_
M )1H?#7_ +C/_IYOJ_!.OWL_X(M_\HT/AK_W&?\ T\WU?CWC;_R2E'_K_'_T
MW4/V'P2_Y*NM_P!>)?\ IRF?4E%%%?RX?U&?+?\ P6D_Y1H?$K_N#?\ IYL:
M_!.OWL_X+2?\HT/B5_W!O_3S8U^"=?U'X)?\DI6_Z_R_]-TS^7/&W_DJZ/\
MUXC_ .G*@4445^PGX\%%%% !1110 5]2?\$6_P#E)?\ #7_N,_\ IFOJ^6Z^
MI/\ @BW_ ,I+_AK_ -QG_P!,U]7S_%O_ "2F/_Z\5?\ TW(^@X2_Y*O ?]?Z
M7_IR)^]E%%%?PV?W(%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X)_\
M!:3_ )27_$K_ +@W_IFL:^6Z^I/^"TG_ "DO^)7_ '!O_3-8U\MU_<G"7_)*
M8#_KQ2_]-Q/X;XM_Y*O'_P#7^K_Z<D%%%%?0'SX4444 %%%% !7[V?\ !%O_
M )1H?#7_ +C/_IYOJ_!.OWL_X(M_\HT/AK_W&?\ T\WU?CWC;_R2E'_K_'_T
MW4/V'P2_Y*NM_P!>)?\ IRF?4E%%%?RX?U&?+?\ P6D_Y1H?$K_N#?\ IYL:
M_!.OWL_X+2?\HT/B5_W!O_3S8U^"=?U'X)?\DI6_Z_R_]-TS^7/&W_DJZ/\
MUXC_ .G*@4445^PGX\%%%% !1110 5]2?\$6_P#E)?\ #7_N,_\ IFOJ^6Z^
MI/\ @BW_ ,I+_AK_ -QG_P!,U]7S_%O_ "2F/_Z\5?\ TW(^@X2_Y*O ?]?Z
M7_IR)^]E%%%?PV?W(%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU(HH_P"(I\>?]!G_ )3I?_(!_P 0LX#_ .@/_P J5?\ Y,_+?_B&L_ZO1_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'S]^UK^S+XX\:_'[X-?M=_!&&T?QC\+_ !#<6.K:?>7(@36?"^JHEOJ=KOQC
MS8BEO>P[CM,EGY>5\TL'?'?_ ()8_P#!/G]IGXHW'QH^./[+/AS7O$M_%!%J
M^HR^?"-62''E+?10R)'?!  H%PL@"@+T %>_T4 ?//[9?[*7B/\ :?O?A/\
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M?_ G_A*2?_%4 >Z45X7_ ,(#_P %!/\ HO\ X$_\)23_ .*H_P"$!_X*"?\
M1?\ P)_X2DG_ ,50![I17A?_  @/_!03_HO_ ($_\)23_P"*H_X0'_@H)_T7
M_P "?^$I)_\ %4 >Z45X7_P@/_!03_HO_@3_ ,)23_XJC_A ?^"@G_1?_ G_
M (2DG_Q5 'NE%>%_\(#_ ,%!/^B_^!/_  E)/_BJ/^$!_P""@G_1?_ G_A*2
M?_%4 >Z45X7_ ,(#_P %!/\ HO\ X$_\)23_ .*H_P"$!_X*"?\ 1?\ P)_X
M2DG_ ,50![I17A?_  @/_!03_HO_ ($_\)23_P"*H_X0'_@H)_T7_P "?^$I
M)_\ %4 >Z45X7_P@/_!03_HO_@3_ ,)23_XJC_A ?^"@G_1?_ G_ (2DG_Q5
M 'NE%>%_\(#_ ,%!/^B_^!/_  E)/_BJ/^$!_P""@G_1?_ G_A*2?_%4 >Z4
M5X7_ ,(#_P %!/\ HO\ X$_\)23_ .*H_P"$!_X*"?\ 1?\ P)_X2DG_ ,50
M![I17A?_  @/_!03_HO_ ($_\)23_P"*H_X0'_@H)_T7_P "?^$I)_\ %4 >
MZ45X7_P@/_!03_HO_@3_ ,)23_XJC_A ?^"@G_1?_ G_ (2DG_Q5 'NE%>%_
M\(#_ ,%!/^B_^!/_  E)/_BJ/^$!_P""@G_1?_ G_A*2?_%4 >Z45X7_ ,(#
M_P %!/\ HO\ X$_\)23_ .*H_P"$!_X*"?\ 1?\ P)_X2DG_ ,50![I17A?_
M  @/_!03_HO_ ($_\)23_P"*H_X0'_@H)_T7_P "?^$I)_\ %4 >Z45X7_P@
M/_!03_HO_@3_ ,)23_XJC_A ?^"@G_1?_ G_ (2DG_Q5 'NE%>%_\(#_ ,%!
M/^B_^!/_  E)/_BJ/^$!_P""@G_1?_ G_A*2?_%4 >Z45X7_ ,(#_P %!/\
MHO\ X$_\)23_ .*H_P"$!_X*"?\ 1?\ P)_X2DG_ ,50![I17A?_  @/_!03
M_HO_ ($_\)23_P"*H_X0'_@H)_T7_P "?^$I)_\ %4 >Z45Y]\&?#G[26B:G
M>R_''XC^'M<M'@46,6BZ.ULT4F[EF))W#'&*]!H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /E__@L1\ ?B)\>_V"_%<_P0O;FV^(OP_GM?
M'7PXN+1F$G]LZ1*+R*)0I&XS)'+;[3P?/YKRC]OW]LVZ_:<_X):?#VV_9;UU
M[+Q3^UZVA^$/!$UO+NETN/6(O,U.X?;AE^QV"7Q=A@H\8Z'%?>]?GK^PS_P2
M_P#CO\!OV\[[7OB:-*;X(_!VY\3W/[-=C:WZO+;R>)KJ.[O@\(YB%D@N;.+=
M]Z.Z8KQF@#H?!/[9_P"TY,?%_P %_P#@FK^P_H/CKX<_L[WH\"ZAJ_C'XG/H
MUYKNIZ9;1)<Z9I42V-P)'@&R)I[F2&-Y=RC[I:N3\,_M<^"?VT?^"C'[$O[2
M?P@N]3M_#/CGX-_$>^73+_,<MO-&=)BEM[B-25\V"9)HFP2 R-M)!R>@\!_"
M7_@I#^P!X]^-'@3]EO\ 9D\)?%CPC\4OB;K'CSP7XCU/XA1Z*WAG4=6*R7=I
MJ5O)"SSVT=R&E1[8L[1L5(4XVY_[)/\ P2M^,O[)/Q<_9%MH=;L/$>B_!OX;
M>/+#X@>(X[A8?-UG7;JTO28(6P[PM<?:PIP"J*FX G% '71_\%=]1?\ X(NV
M'_!6S_A0D N+W1+._/@/_A)3L0SZO'IVS[9]GR<!_,SY/.-N!]ZKGQ3_ ."A
MW[7NK?MI_$W]B']D#]C'P_XRUKX;>&]$UR^\2^*_B,VCZ<\%_#-(MN0EE/(+
MEFB*1*!Y;!9'DDCV*K_)OB']@3_@K3#_ ,$F+K_@CCX:_9N\#/IOAN5+6Q^+
M<GQ(B\KQ!I=OK2:C;I;Z>81+;W,@5(Y//=8T5)&4NS(M?=7[/G[-/Q6^'O\
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MP+^&OP4T9/B$^@>(HSJ/B;Q=;:7%96]I$8B3%:64@>Z\QN)IDB&PJFX_6/[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tnet-20250331_g12.jpg
<TEXT>
begin 644 tnet-20250331_g12.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQD\4>#[K1K#3(; DKI]J]TB/+<3;F&P*,,L3895D:/\ 7NBB@ HHHH ****
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M% !1110 4444 %%%% !1110 4444 >??M;?\FJ?$W_LGNM?^D,U?S85_2?\
MM;?\FJ?$W_LGNM?^D,U?S85_2'@;_P BW&?XX_DS^</'+_D8X/\ P2_-!111
M7[H?A04444 %%%% !1110 4444 ?TG_LD_\ )JGPR_[)[HO_ *0PUZ#7GW[)
M/_)JGPR_[)[HO_I##7H-?P1F7_(QK?XY?FS^]\M_Y%U'_!'\D%%%%<1VA111
M0 4444 <]\7/^24^)_\ L7KW_P!$/7YJ5^E?Q<_Y)3XG_P"Q>O?_ $0]?FI0
M 4444 %%%% !1110 4444 %%%% 'Z5_"/_DE/AC_ +%ZR_\ 1"5T-<]\(_\
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M?P1F7_(QK?XY?FS^]\M_Y%U'_!'\D%%%%<1VA1110 4444 <]\7/^24^)_\
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M110 4444 <]\7/\ DE/B?_L7KW_T0]?FI7Z5_%S_ ))3XG_[%Z]_]$/7YJ4
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M% !1110 4444 %%%% !1110 4444 >??M;?\FJ?$W_LGNM?^D,U?S85_2?\
MM;?\FJ?$W_LGNM?^D,U?S85_2'@;_P BW&?XX_DS^</'+_D8X/\ P2_-!111
M7[H?A04444 %%%% !1110 4444 ?TG_LD_\ )JGPR_[)[HO_ *0PUZ#7GW[)
M/_)JGPR_[)[HO_I##7H-?P1F7_(QK?XY?FS^]\M_Y%U'_!'\D%%%%<1VA111
M0 4444 <]\7/^24^)_\ L7KW_P!$/7YJ5^E?Q<_Y)3XG_P"Q>O?_ $0]?FI0
M 4444 %%%% !1110 4444 %%%% 'Z5_"/_DE/AC_ +%ZR_\ 1"5T-<]\(_\
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M?P1F7_(QK?XY?FS^]\M_Y%U'_!'\D%%%%<1VA1110 4444 <]\7/^24^)_\
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MS;_T;WX'_P#"3L__ (W1_P 1MXJ_Y\T/_ :G_P L#_B"7"O_ #^K_P#@5/\
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M9/V;?^C>_ __ (2=G_\ &Z/^&9/V;?\ HWOP/_X2=G_\;H _+/\ X:5^ ?\
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MNK;2>6R/]2^.E_8Y \8?\%G_ -JOQCK(WW?A[0O#&BZ47Y,%I+:+)(B^BM)
MKD>IK*_9!_X*&?L??!+P_P"%_P!F+]G_ /87^/'A;2)]2M[&WFO?AJ(XO/GD
M2,W=W.;@LQ)(9Y6R0J^B@"7XRZSXA_X)U_\ !2WQ3^V'XJ^&_B+6OA/\8O"=
MA9>)];\,:3)?/X>UBQ1(HI+B&(%Q"\*?> Y:5L9*D, :'[7+MX/_ ."UG[+?
MBK1OW=SXC\,^)]&U<IP;BTBM))HT;U5992X'J*^CM+\!_LK_ +#/@[QY\8+>
MWT[P7H^MZU<^)O'.M7^I3R+<7LN/,G8S.Y#,<!8H\ LV%3<V#\P_!#5?$/\
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MT*STZU,TDQMK"U2&/S)',DC[4 &YG9F8]2S$GDU<HHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
8B@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tnet-20250331_g13.jpg
<TEXT>
begin 644 tnet-20250331_g13.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_"FTTGS):=+_ &%7!_'7]H_X6_L[Z987WQ%U:5)]6G,&DZ?:P&2>\D!4,%'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+R7QI9>'].T5K^-I;.R6>Y5VN+N6%#+Y:HL:HR%I%W8'IG[%/[7G@/\ ;@^
M-A\=_ ?A[5]$,FHWNE:[X;\00K'?Z)JME</;7EC.J,R[XYHV&5)#+M8=<4 >
ML4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445\_\ [<W_
M  4U_9-_X)ZZ79-\?/%&KW.N:K93WFC>#O"6@7&JZO?6\+*)9U@@4^5"A89F
MF:.//R[BW% 'T!17C_@+]OS]CKXD?LR7_P"V/X;^/FB1_#?2/M"ZWXEU=Y-/
M32I8'\N:WNXKI8Y;:=7*H89463<Z *=RY=^S#^WM^R)^V5=:EIO[-_QMT[Q%
M?Z/;Q7&I:2UK<65]!;R_ZJX-K=QQ3&!_X9@AC;LQH ]>HKP*Q_X*D?\ !/[4
MOV@!^R_9?M0^'9/&AU]M"2P G%M)JR_>TY;TQ_97O ?E-L)3+N^79NXK!_:%
M_P""RO\ P3%_91^+^K_ +]H?]L#PWX6\8:#]G_M?0;^WNFFM?/MX[F+<8X67
MYH9HW&">''?B@#Z;HKSO]F']K']G;]L[X8CXS?LO_%.P\8^%SJ$UB-8TV.58
MC<1!3)'B5%;*[ESQCFO1* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;X71?!7]F/X76'@_PM#>S7D6C::\C1+/*09'S(S-EB!GGM0!Z#1110 4444
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M_P# J?\ \K#_ (C;Q5_SYH?^ U/_ )8?O9_P^D_X)H?]'*?^6=K/_P AT?\
M#Z3_ ()H?]'*?^6=K/\ \AU^"=%'_$$N%?\ G]7_ / J?_RL/^(V\5?\^:'_
M (#4_P#EA^]G_#Z3_@FA_P!'*?\ EG:S_P#(='_#Z3_@FA_T<I_Y9VL__(=?
M@G11_P 02X5_Y_5__ J?_P K#_B-O%7_ #YH?^ U/_EA_4A1117\N']1A111
M0 4444 %%%?EG0!^IE%?EG10!^IE%?EG10!^IE%?EG10!^IE%?EG10!^IE%?
MEG10!^IE%?EG10!^IE%?EG10!^IE%?EG10!^IE%?EG7ZF4 %%%% !1110 44
M44 %%%% !1110 4444 ?RWT445_H(?Y]A1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 ?U(4445_GV?Z"!1110 4444 %?EG7ZF5^6= !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %?J97Y9U^IE !1110 4444 %%%
M% !1110 4444 %%%% '\M]%%%?Z"'^?84444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% ']2%%%%?Y]G^@@4444 %%%% !7Y9U^IE?EG0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7ZF5^6=?J90 4444 %%%% !111
M0 4444 %%%% !1110!_+?1117^@A_GV%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!_4A1117^?9_H(%%%% !1110 5^6=?J97Y9T %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5^IE?EG7ZF4 %%%% !1110 4444
M %%%% !1110 4444 ?RWT445_H(?Y]A1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 ?U(4445_GV?Z"!1110 4444 %?EG7ZF5^6= !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %?J97Y9U^IE !1110 4444 %%%%
M!1110 4444 %%%% '\M]%%%?Z"'^?84444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% ']2%%%%?Y]G^@@4444 %%%% !7Y9U^IE?EG0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7ZF5^6=?J90 4444 %%%% !1110
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MWO\ !/\ Z&WQW_X65S_C7NE% 'A?_#O?X)_]#;X[_P#"RN?\:/\ AWO\$_\
MH;?'?_A97/\ C7NE% 'A?_#O?X)_]#;X[_\ "RN?\:/^'>_P3_Z&WQW_ .%E
M<_XU[I10!X7_ ,.]_@G_ -#;X[_\+*Y_QH_X=[_!/_H;?'?_ (65S_C7NE%
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M?P*CE5D;[+-+%M<#<N')P>0#Q0!WM%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%> ?M4_MZV/[/_ ,8/#'[,WPM^ ?B[XL_%+Q9HUUK5
MAX*\'SV-L;+2;>1(I=1O;N_N(+>U@\V18D+.6DD.U5)H T/VVOV$_AW^VMH?
MAF]U3QKXA\%>-_ .LMJ_PZ^)'@VZ2'5?#MZR>7(8S(CQRP31_NYK>16CE3@C
M(5E^.OB+_P $!_CM\1_C(W[5GCS_ (*/7WC#XCV'B#1]?T_3->^&UG9>$]9U
M+2UV6DVLZ58S1_;I4C"QI.KQO$H&T,!L/T7X;_X*Z?L[?\,S_$S]H;XN>#/&
M'@/4/@WK2Z)\1_AYK^FQ2:YIVJR>3]ELX4MY9(KLW9N(!;212&.7SE.Y<-MU
M?V=_^"BEQ\4/CW:?LP_M ?LJ>//@MXWU[PU/XA\&:9XWN=-N8/$6G0-&MS]G
MN-/NIXUN8/-B,MK(5E19%;!&2 #L_P!NK]DC3_VZ_P!CGQM^R+XN\;S:#!XX
MT5+"]US3K$2O;$2QRETB=\')CQ@MP#U.*]@C01HJ _= %?#U]_P6_P#!,'@"
M]_:BTO\ 8X^*VH?L\:=K,EA=_'>SCTQM/,4=T;634XM/-Y_:$NG)*#FY6#[J
MLP0@5](?M<?M@_!7]B[]F7Q#^U9\7]?QX:T+35N8$L"LL^JS286VM+5<XEFG
MD9$C&<$N"2%!8 'J5%</^S+\<M$_:=_9P\ ?M)>&M%NM-T[X@>"]+\1V&GWS
M*9[6&^M([E(I"A*EU64*<$C(.*[B@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#YU_;E_;)^'7[(>J^'[/P?\'Y/B
M'\<O'T$VC_#'P#H$$2ZKK00B67S;EA_H>FPL5EGN)#Y<8YPS8!^)?VP?V-_B
M%^RM^QEIO[0O[47CJP\0^/O'_P"U[\//'/Q^US2XFBTFQM(]8LK6+3[97^86
M-G&+>%'D^=R"[8W!5^U?VK?^"2W[!'[;?Q@L?CY^TI\'M5UOQ=IN@)HECK.G
M_$+7M):&P6:280!-/OH(\>9*[$[=S$C).U<:/P=_X)??L-_ KX/^-/@%X$^"
M\]QX/^(< A\8:#XI\6ZMKL.H1A&0+G4[JX:( .?]64YPWWE! !Y+^W?MU?\
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+ 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>tnet-20250331_g14.jpg
<TEXT>
begin 644 tnet-20250331_g14.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M12.K!=QC)&>Q&0#Q2_LR?M :;^TO\+(OBCI7AR?2H9;V:V%I<3K(P,9 )W
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MB/;PIJ,UB/;K5M?PU34+::<JM>Z?H?"GB3]N'XN>-?@%-^S?8_LU>*!XYO\
M0_[#OF-A)Y:HT?DR3"/9O#,N[Y2 %)SN(7!O_$C]F;QO\&/^"9-Q\,[C1Y[[
MQ%?:W;:EJ=AIT1G:*62>/]V-@.[9&B!B,C(;!(P:^W**T_U,JXF%5X[%RJSE
M2E1B^6,>2,MW9?%)]6VC/_7:EAITE@,'&E"-:-:<>>4N>4=E=_#%:V23/FZ;
MPYX@/_!+X>&1H5Y_:7_"NEB_L_[*_G^9L'R>7C=N]L9KSWX>_#+Q]K7_  2:
MU?P%:>$=1&M/]IFCTN2S=;AQ'J*S$",C<240D #)XQG-?:=%=M;A.A6J*4JK
MLL.\/MTE;WO738X:/%]>A2<8TE=XF.)O=[QO[NVVNY\1?LX?%+5O&G[!WC+]
MG^/X9:[:ZEX:\"ZFANIK-O+O9)7G98XAMR7&\ KUSTKTO_@G-X<\0^'OV-I-
M'\0:%>V-V;[43]EO+5XI,'H=K 'GM7TE14Y7PM/ 8C#UJN(=25&DZ*]U1O%M
M6>C>J22\]RLUXLAF&&Q%"EAU3C6K*L_><K22=UJEHVV_+9'PS^P?X(\9Z%^Q
MK\8]'UOPCJEG=WFG7PM+6ZL)(Y)R=.=0$5E!;)XX[\5Z9_P2]\&:IIO[*VH^
M&/''ABZM?M?B.]6>QU*T>(R0O! IRK@$J1D?G7TU7)?'#1OB_KWPVOM-^!/B
MVPT3Q.SQ'3[_ %.%7@4"13(K@Q2=4W '8><=.M<^ X5I9%##UXSE5^K4IP45
M%7GS/FTN[7Z)7L^YTYAQ;6S^>(P\H1I?6:M.;DY.T.5<NME>W5NUUV9^;=I\
M&_'LO[1:_L#R7LK:!%\0C?R1\[C!Y()N/8_8QN^IZU^IMI:6MA:16-E D4,,
M:QPQ1KA44#  '8 #%?.W[(O[%GC;X1?$W7/CW\=O'MIXC\8ZQ&\8FL@[10!V
M!D?<Z(2QVJH 10B@@9!P/HVL> L@K9/A*U:O!PE5F^6,FG*-.-_9Q=KJZNWI
MW-O$'B&CG6,H4*$U.-*"YI1349U9)>TDKV=G9+5=#Y*_X*X^%/%'BSX4>%;7
MPMX;O]3EB\0N\L>GV;S,B^0XR0@) SWKE_\ @HIX+\8^(?"_P0BT'PGJ=\UE
M!*+U;.PDE,'R6'W]H.W[K=<=#Z5]NT5U9MP=1S6KC9RK./UE4D]+\OLI)JVN
MM[?(Y<HXTK932P4(T5+ZLZK6MN;VL7%WTTM?SN?,'_!67PSXD\5?LY:-IWA?
MP_?:E<)XUMI'@L+1YG5!:7@+%4!(&2!GW'K53]I#Q!\4_!_P'^'EJ/V<=)\>
M>$!H>GCQ38WVF2SWMBZ0QABBJP,1*%E$NT[&!W<$ _55%=..X8^MXS%8F%=P
ME6A".D4[<C;VE=23O9IK;J<N XI^IX+"X:=!3C0G.>LI*_.DMXV<7&UTT]^A
M^8FO_#+P3\9?BWX83]AGX)>._"]]#J EU6_UE76VL&#H5E5S)(8PA#DDN,\*
MJDXKVS_@HMX;\?\ @C]I+X<_M.:'X)OM:T?P^MLE^MA"SF-X+MIMKE0?+#K(
M0K$8RI^E?9]%>/2X H4\!B**K<LZLH3O"$8QBZ>L>6FG;OS:Z^5CVJOB)B*F
M88>LZ'-"E"<+3G*<YQJ:2YJC5^W+IIYW/SQ_;+^(OQ,_:LU[P#XV\*_ 3Q9I
MGAO2M0EBLKG4]-;S[J61X&E?RX]VV)1&@#YPQ+>A ]*_;8\'^*M<_;M^#6MZ
M3X7U"[L;._TPW=Y;64DD4 74]Q+NH(7 Y.3TYK[$HK>?!,J_UB6(Q3G.M.E.
M3Y4M:6R23M9[>2[O4PAQTL/]6CA\*H0H0K0C'F;TJ[MMJ]T]?-O9+0^?/^"F
M7ASXL^*/V99].^%%K?W++JT,FNVFFJS33V 23>NU?F=1(8F91V4D\ U\F^/[
M3P'X^_9@M/"?[/O['7B"UUC3$M)?%WBFZT7>Z.N(W2*;+22F25@Q4!<*"=F
M=OZ:T5>?<%PSO'U,2Z_+[2G[-IPC)I*^L&_AO?WK;]T]5GP_QQ/(LOI894.;
MV=3VB:G*";=M)QC\=K>[?;LUH_@[]LCPOXM\5_L(?!K2_#_@_5KJ[L;2RAO+
M.#396F@>*P\I]Z!=RX=2.17L'_!0KPYX@U_]BE=%T'0KR]O//TS_ $2TM7DE
M^4KGY5!/'?CBOI&BMWPA2E3Q<76?^T4H4GIMR1<;K76][VZ'.N,JL:N#FJ*_
MV>K.JO>^+GDI<KTTM:U^O8^(_P!HG]FCXC_%C]A'X6ZGX,\.W=QKO@_1('N-
M&$#"Y>&2!!*%0_,9%:-#LQDC=C) !FU[_@H+^T?\5=%T;X?? ;X":YIWC62Z
MB76;B]TX2VT> 0Z@.OR*S$$N^W8 1SG(^UJ*QJ<'UZ==U,%C)T>>%.%3EBFY
M>S7+%Q;UA*VEU<WI<9X>I0C3QV"A6]G.I.GS2:4?:/FE&26DXWUL['Q!^WE\
M!/B/9_$GP-^T=KGP]7QU9Z=I%I9>.=*TZV<I+)$S-(X1<LD4@D< X(0H-W49
MH?#";X7_ !L^-^A:+\!/V#[*T\.0R1R:[KWB?3YH'LF5\LR-'*8\J!\JG+.W
M90#7W=145N!\//-)XFG5M"<HRE%TX3DVK7M.2;BI6]Y6>M[-&E'CS$0RJ&%J
M4;SIQE"$E4G"*3O:\(M*3C?W7=:6NG8****^Z/@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *\9_:D_;=^%G[+CVVA:U:W6L^(;
MV(26NA::5#A"2 \KGB-200.&8D<*0"1[-7PI^S-96?Q9_P""I/Q#\1^-8%NY
M_#LFJ/I:W"[O+>VNH;*%@#_=B)QZ'!'(S7RG%.:X[ K#83!-1JXBHH*35U%6
MO*5NK2V3T/KN%,IR_'O%8O')RI8>FYN*=G-W2C&_1-[M:G:>&/\ @JYX?MO$
M]KH7QM^ VO>"[6](\G4)IVN JDX\QD:&)M@SR4#'T!KZRL+ZRU2QAU/3;N.>
MWN(EEMYX7#)(C#*LI'!!!!!]ZY3XS_ ?X7_M ^&[?PG\5?#8U&RM;U;J%%G>
M)T< CAT(9002" 1D5Y'^VM^T ?V+?@?H'@KX-Z3%;ZEJ'_$N\.1S;ITL;>%%
M#. Y)D90T:J&R,N"<@;3E3Q.;\-X;$8G.,1&M0@DXR45&I?9Q<8KE=VTHNZ=
MWKY:U,+D_$V)PV%R7#2HXB;:E!R<J=MU)2D^962;DK-66GG]&45\0?$;PA_P
M42_9T^&@_:)U7]HT:S-8B*XU_P -7,?FQ01NR@J 1L< L VP(0,E2<9K=_:9
M_;H^(#_L@>"_C!\(X_[%NO&%Z]IJ>H"$3'37B#K+&FX$99T?:Q&=BD@ D$92
MXWP>&I5GC:%2C.G!5.22C>4&U%.-I-?$TFFU9O7K;:/ N,Q56@L#B*=:%6;I
M\\7)*,TN9J5XI_"FTTG=+3I?["K@_CQ^T?\ "W]G31;/5OB/JTL<NIS&'2M/
MM8#)/>2#;N"#@ #<N68@#(YR0#\L?"_7/CSJ?BS0M6_9\_X* Z'\09KFX!U3
MPYXN9K$E."56&4R2E3R,QJK+P1G-8G_!6SPU\08/B9X/UW4/&22Z1J32Q:'I
M2Q_\@^=!;B:3=CYMY9#_ , KS\UXUQ5/ANOC\+AVI0<4FW"</>:7,I0FU*U[
M63NI-75KGH93P-A:G$V'R_%XE.$U-M)3A/W$WRN,X*46[7NU9Q3L[V/OZBOC
MG]K;XN?M-_LI? /PAX-U/XIB_P!=US6+N+6?&\5@&:W@5E9(T4K@,4D/.-V(
MFQ@G(S?@_J_QZO?'VA:A\!/V]M!^)%K<S;M:T'Q7*UE+Y0P658)/-FP1NPR*
MI4@9!!->A5XTH4LR^I?5YNHE!R5Z?-'G2:2BY\T[7][D4DNYYU+@?$5<M^O?
M68*FW-0=JG++D;3;DH<L+V]U3<6^Q]L445\=_MF_'K]I#P3^V;X2^%'P1\6B
M!=;T*U6#2[N-3:O=3W%U")I/E+84!&/./W?0\@^YGF=8?(<''$5H2DG*,;12
M;O)V6C:/"R'(\1Q!C98:C.,6HRG>3:5HJ[U2?^1]B45\,?&'QO\ MD_L(^./
M#OQ ^(7QP;QYX<UN\,6JV4]MY:!AAGC1#GRCM)*,A RAW+C@]=^V%^U)\2M6
M^.GAW]E_X'?$&Q\*C5+2*ZUGQ5>.B>2DB-*JAWXC B7?D89F=5!7G/ARXWP-
M"C6^L49TZM.4(>S?+S-U/@Y6I.+3L]>;2SOTO[L.!,?7K4?JU>G4HU8SG[1<
MW+%4_CYDXJ2<;K3EUNK=;?7-%?%GPX^/OQB_9S_:=\-_!'XA_'ZP^)GACQ<8
MH+75HI$>:SN)',29969E/F; 59F!5PPP<BJ7QH^,W[67B']O7Q#^S7\&/B8=
M/M[^"W@L4NXU\G3D.GP7$TZD(6#8$F#SR_&#@B9\=8&G@U5=&?M/:JBZ:Y7)
M3E%RCJI<K3MHT^OJ7#@+'U,8Z2KT_9^R=95'S*+A&2C+1QYDXMZIKIZ'W!17
M!_LX> _BM\.?A?!X:^,_Q&;Q1KJWD[RZF7+ 1%\1H&958X4 G=DAF89( KR#
M]O?]ICXJ> /%GA+]GGX$7<5EXG\93QJ=3E16-M'),((E3<"%+/ORY!VA..3D
M>YCL\HY9DZQ^*IRCI'W-'/FDTE'1VO=VWL>#@,AK9IG3R_"5(RUE[^JARQ3;
MGJKJ-E?:_D?3=%?)FD_#'_@HK\"?B5X?O]'^)\OQ/T.^E_XJ*QOIHH!;("N\
M!KB0%3AB49&Y*'<F."G[4_[1/QW\<?M,V'[&_P"S3KT.AWS0H^N:[(@+QEH?
M/*AB&V(D.UB5&]F8*",?-YE3BVGA<'*KBL+5IS4XTXP:3<Y3UBH23Y)>?O:6
M=^E_4I\'U,5C(TL)BZ52FX2J2FI-*$(:2<XM<\;=+Q]ZZMUM]:45\0^*OBK^
MU;^P)\4O#</QJ^+/_">>"O$4QCN+BZB/G0;2@E92V71T#JP&XJXR, \K]4>.
M_P!I'X#_  QUX^&/B!\5M&TC4!"LIM+V["/L;[K8]#@UUY=Q-@<8JL<0G0J4
MFE.-1Q5G)7CJFXM25[6?1G'F7"V/P3HRPS6(IUDY0E34G=1=I:-*2<79--=4
M=M17R/\ MD?MG>([CQ%X,^#?[-/Q!TNRD\91I<3^+VF3R;>W>=X%VNP*H-T<
MI=L;@$&WDURUG\=OC7^R1\</"7AOQK^TKI_Q/\)>*[D6]],LL<DU@^]$9\AW
M9-OF*PRQ5U#C:" 1YV*XXRO#8V5)0E*G!QC.HN7DBYVM]KFDM5=Q32N>GA>
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MXN?M7?M*_MFQZ9\)/V>?@WXC\,$ZC'/J.L+=RH\;(3M#3JB+!&I.XDG<Q50
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M;Q.ZAO8M*T[>XVGTIO[3G[(G[6/[2OCNX\.ZU\<M$M/AP=42ZLM,6W/VN !
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M=?'[_A;L<7A;]K?PY\4_ C6N_4VOKX+J-N2& *Q#S)$=6V_?8(RL>AP5QO\
M@I)>O\*?CU\'_C_I!\NZLM3DM;V1>#);QRQ/Y9/H4EN%/LYK3'\38E9)'-*4
M'3C3J14XOEDI0;49<LHN2:7,I*47O&STWSR[A;#//9935G&I*K2DZ<H\\7&:
M3G'FC)1:;Y7%QDMI76NWV+1117W)\$%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!X[^W=X\\4>!OV:M>B\#Z+?WVL:Y&-*LH].M'FDC$P(EDP@)
M4+$),-V8KZU\]?L__P#!*+P!X[^#VA>-/BKXH\4:9KFJ6?VFZT^R>"-+='8F
M-2LD+,&\O86!/#$C Q7W/17RN9<)9=G6;K&8_P#>1C#DC!KW8N]W+1ZM[>A]
M;E?&&9Y'D[P67OV4I3YY5$_>DK64;-:);^I\!:7\#/$_[!7[;GAG4/A_IWB'
M6_!^K6L<%_?FR,[1P3,8IEE:% O[MU28<#@+UYKT;_@IE\*_'=CK'@W]ISX.
M:7>3>(O#E\MI<?V?:M-*8LM)"Y50255_,4^OG"OK>BN&/ ^#IY7BLOI5'&E5
MFIP26M*2L_==^Z3Z=5U.Z7'F-JYMA<QJTE*K2@Z<VWI5B[KWE:R=FT][Z/H?
M.W_!.?X 3?##]FCS?%VF36^K^,99+W58KA"DT<+ QPQMGD?)E\'D&5J^7? 7
M@/P3^R+XR\2?#W]JW]EG4_%]O)=!O#>O:?IYE691N VDLJE'!0\'<AR"I)P/
MTKHIXO@C!U<%@Z-":C+#)J+E",XM224N:$M&VU>]]'L&$X[QM+'XVO7@YQQ3
M3DHSE"47%MQY9QU22?+:VJT9\H?LJ^$M:U'X'^/_ !Y>_LPZ/X ?5-!NK71X
M=-M[A+J_A\F0_/'*Q(&=@4X&\[B !C-S_@DOX7\1^%/V>]<L?%'AZ^TVXD\9
M3ND-_:/"[)]DM0& < D9##/J#7U'179@.%:6!Q>%KJJVZ$9Q^&*YG-IMVC9*
MW1)>KOJ<68<65L?A,7AW225><)?%*7*H)I*\KMWOJV]]E;0_/'QY:VG@;]N3
MQ=XG_:\^"7B;QII-]/./"26-DUS%Y1D#6P1"RI(HA!0KN.ULY4G)'2_L4^&_
M%FA_MZ>)/$6O?!#4/!>F:YX>N1I6EMI9B@M(W:VFBBRBB-6\I"2O&&RI ((K
M[IHKRL/P)"AF$,3]8NHU752Y(\S;O=2G\4M]'I;L]+>MB./YXC+9X5X>SG15
M%OGERI*UG&'PQV]Y:W[K6_P+\%;GX[?\$[?BOXL\ 2_ '7_&'A_7KE&T>]T6
MWD;S?+9_)972-QN*2;7C.&4@$<?>=^R7JOC_ ,1_\%,O$6N_%#P\FE:W>:1<
MSWNEI*)!9J\,!CA+#J5C**3Z@]*]*U?]CS]L3X:?$[5O&'[,G[2%G!I6K32N
M-(\52S2I:J[[_+56BG1MIX5P%;'![YZO]DW]CGQE\(?B1KWQY^-OQ"M_$GC/
M7X6AFFLHBL$*,RLY!*KN8[$ PB!57 &#Q\S@,@SI9AA,)&E5A1H5G-*7LW3C
M'WG[LU[\VV_=32LF[]U]3F'$.1RR[&8R56E.OB*"IN4/:*I.7NKWH2]R"27O
M--\S2MV?RWX7^&7@K]CWXH^)_!G[3O[,>I^,="NIPWA?7;"P,P**S[=I+*AW
MJR;ANW(R=#FOH_\ X)^>'KS4I-<^)US^R]HOP\M+D&UT2:UAGBN[VV:3>0Z2
ML?E 6/YP%#MDJ !7TQ17UN3\$T,FQL*E.JG3@Y.,?9PYES=)5+<TE&_N[/S:
MT/C\ZXZQ&=X&=*K2:JU%%2E[2?*^6VL:=^6+E;WMUV2>H5^7^L_LH^.KK]N*
MY^%4?@W5O^$8O/'BSRW L9?LOV$R&8$OC82L#LH.>I([U^H%%>AQ-PKA.)U0
M5:3C[*?-HKW76/DGIK^!YO"W%F+X5EB'0@I>UARZNUG]F7FXZZ>>Y\J_\%6/
MA3XE\8?"[PU\0O NDWMUJ_AG7L1KIL#O-'#,O+J$!;Y9(H?IG-:7_!,;X.ZK
MX%_9>NI?$6G7NEZCXFU:ZGE$L;07,$2@6Z<$!E(,;NI_V\^E?3%%$>%<)'BF
M6=\SYI0Y>6VE[)<U^_*K6M\QRXMQCX3CD?*N6,^;FOK:[?+;MS/FO?Y'PAX"
M_:&_:G_8>\;>(/!/[0W@KQ5XZTB[N_,TW7Y;V>?[N5#PRR!U*.NTF(E2A'8Y
M!K^!-)^*G[;?[;/AW]H.W^#UWX1\-^')+26>^NH67[0+:1I4!D*J)I78A"%!
MVH!D_+D_>]%>5'@FO+V>'K8V<\-3FIQIN,>:Z=TG4^)I-^MM+['K2XZP\?:X
MBC@80Q52#A*HI2Y;-)-JG\*;2[VOK;>_P)^T%KGCSX/?\%+KGXZZ7\(=>\16
M&F6\.V+3K*7;/YFE"W.V41LORF3)X/W2*]&_X>;^.O\ HRSQG_W\E_\ D:OK
M6BMZ/"V;8'$8B>"S!TXUJDJCC[*$K2E:^LKO9)&%?BS)\?AL/3QV7*I*C3C2
M4O:SC>,-M(V6[;^90\*ZU+XD\+Z;XBGTV2S>_L(;E[.;[\!= QC;@<KG!X'2
MODK]K2SD\ _\%&OA!\4+T%+#5HX=,$K?=$PFEB;GL MU%7V)7DW[8_[-L_[2
MOPL3P]X?U.WT[Q%I.H1W_AW4KEF5(9U.&5V168*RD] <,%.#MQ7H\49=BL?D
MMJ'O5:4H5(K;FE3DI6]9)-+S:/-X4S/"9?GEZ[Y:-6,Z<GORQJ1<;][1;3?6
MR9R7[<7B[]JWX6ZCX:^*?P)-UJGAW3IQ_P )3X;M+".5I@KA@Y(C:4(R[D8J
M<)A6QR37RAX&T7QW^V!!X=^%'@KX3WUI;V/CW4=9UCQ9<Q$1V,%Q.':$2;0-
MRJ"2N<LZK@#!-?I-X7'B0>&M/7QC]D_M8640U/[ [- ;C8/,\LLJDINSC*@X
MQP*H_#[X;>#OA=H]QH/@G2VM+6ZU&>^GC:X>3=/,^^1LN21ECG X'85X^;\'
MULZS-5YXF:P\U[]-ZV^!VA>_*I<JYK;-:;Z>SDW&E#(\J="&%@\1!^Y46E_C
M5YVMSN/,^5O=/7;7Y*_;!\(?$O\ 9_\ VR=!_;/\(^!;SQ#HGD)%K$-C&S-
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MHK]+/R\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC@CNBCK&R%< N& !^MR.DB"2-PRL,JP.01ZTM?&W[ GA3X3Z'^P5XJ7_ ()
M?M%Z/XRT/6/%&I7GPYB\=75S<:/X+FF>(R:.((TCO+>VM\O*EI+B4--@LJ."
M.,_X(F^%/BWX!^-'[7?@7XY?'34OB1XHTOXWV4>K^,-3M$MFOIG\/Z=*WEVZ
M$I;0J7V10J2(XT103C- 'WY17QK_ ,%B/$WBWQ#IOP'_ &1?#OB[5M"TSXX?
M'33?#7C>_P!#U"2SNYO#\-I=W][9Q7$162 W M8X6=&#>7)(N?FKP_XFWN@?
M\$=/VR_%7A+]EK3[S3OASXI_95\8>.5^']QJ]S>:?8^(_#GES)>6Z7$CF 3V
M\YBE2,JLABC8C<,D _3JBOQ_\??L[:3^QA_P2P^%'_!7GP;XT\4W/QZTYO _
MB_XB^-KWQ5>S2^,8M:O]/BU33+V)Y3#):&/4'6*,(/*\B(Q[3DGT3_@OI^T#
M\6?C=^SE\;_V6OV7_&EWHFC?"OX:W7B7XY>-=,D*O%)]G,VF^&;>0<BXN2%N
M;DC_ %=HBH3FZ  !^GE%<K\"Y'E^"7@Z65RS-X5T\LS'))^S1\FNJH ****
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M_(='_#Z3_@I?_P!'*?\ EG:-_P#(=?+=%'^J7"O_ $ 4/_!5/_Y$/];>*O\
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MF_Z*7_Y1KW_XS1_PVK^S-_T4O_RC7O\ \9H ]3HKRS_AM7]F;_HI?_E&O?\
MXS7J= !1110 4444 %%%% !1110 4444 %%%% '\M]%%%?Z"'^?84444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% ']2%%%%?Y]G^@@4444 %%%% !7
MY9U^IE?EG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7ZF5^6
M=?J90 4444 %%%% !1110 4444 %%%% !1110!_+?1117^@A_GV%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!_4A1117^?9_H(%%%% !1110 5^
M6=?J97Y9T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^IE?EG
M7ZF4 %%%% !1110 4444 %%%% !1110 4444 ?RWT445_H(?Y]A1110 4444
M %%%% !1110 4444 %%%% !1110 4444 ?U(4445_GV?Z"!1110 4444 %?E
MG7ZF5^6= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?J97Y9U
M^IE !1110 4444 %%%% !1110 4444 %%%% '\M]%%%?Z"'^?84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% ']2%%%%?Y]G^@@4444 %%%% !7Y9
MU^IE?EG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7ZF5^6=?
MJ90 4444 %%%% !1110 4444 %%%% !1110!_+?1117^@A_GV%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!_4A1117^?9_H(%%%% !1110 5^6=
M?J97Y9T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^IE?EG7Z
MF4 %%%% !1110 4444 %%%% !1110 4444 ?RWT445_H(?Y]A1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ?U(4445_GV?Z"!1110 4444 %?EG7
MZF5^6= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?J97Y9U^I
ME !1110 4444 %%%% !1110 4444 %%%% '\M]%%%?Z"'^?84444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% ']2%%%%?Y]G^@@4444 %%%% !7Y9U^
MIE?EG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7ZF5^6=?J9
M0 4444 %%%% !1110 4444 <9\9O@9X0^.>F66D^+]4UJUCL9VFA;1=6DM&9
MBNTABGWACL:\^_X=[_!/_H;?'?\ X65S_C7NE% 'A?\ P[W^"?\ T-OCO_PL
MKG_&C_AWO\$_^AM\=_\ A97/^->Z44 >%_\ #O?X)_\ 0V^._P#PLKG_ !H_
MX=[_  3_ .AM\=_^%E<_XU[I10!X7_P[W^"?_0V^._\ PLKG_&C_ (=[_!/_
M *&WQW_X65S_ (U[I10!X7_P[W^"?_0V^.__  LKG_&C_AWO\$_^AM\=_P#A
M97/^->Z44 >%_P##O?X)_P#0V^.__"RN?\:/^'>_P3_Z&WQW_P"%E<_XU[I1
M0!X7_P .]_@G_P!#;X[_ /"RN?\ &C_AWO\ !/\ Z&WQW_X65S_C7NE% 'A?
M_#O?X)_]#;X[_P#"RN?\:/\ AWO\$_\ H;?'?_A97/\ C7NE% 'A?_#O?X)_
M]#;X[_\ "RN?\:/^'>_P3_Z&WQW_ .%E<_XU[I10!X7_ ,.]_@G_ -#;X[_\
M+*Y_QH_X=[_!/_H;?'?_ (65S_C7NE% 'A?_  [W^"?_ $-OCO\ \+*Y_P :
M/^'>_P $_P#H;?'?_A97/^->Z44 >%_\.]_@G_T-OCO_ ,+*Y_QH_P"'>_P3
M_P"AM\=_^%E<_P"->Z44 >%_\.]_@G_T-OCO_P +*Y_QH_X=[_!/_H;?'?\
MX65S_C7NE% 'A?\ P[W^"?\ T-OCO_PLKG_&C_AWO\$_^AM\=_\ A97/^->Z
M44 >%_\ #O?X)_\ 0V^._P#PLKG_ !H_X=[_  3_ .AM\=_^%E<_XU[I10!X
M7_P[W^"?_0V^._\ PLKG_&C_ (=[_!/_ *&WQW_X65S_ (U[I10!X7_P[W^"
M?_0V^.__  LKG_&C_AWO\$_^AM\=_P#A97/^->Z44 >%_P##O?X)_P#0V^._
M_"RN?\:/^'>_P3_Z&WQW_P"%E<_XU[I10!X7_P .]_@G_P!#;X[_ /"RN?\
M&C_AWO\ !/\ Z&WQW_X65S_C7NE% 'A?_#O?X)_]#;X[_P#"RN?\:/\ AWO\
M$_\ H;?'?_A97/\ C7NE% 'A?_#O?X)_]#;X[_\ "RN?\:/^'>_P3_Z&WQW_
M .%E<_XU[I10!X7_ ,.]_@G_ -#;X[_\+*Y_QH_X=[_!/_H;?'?_ (65S_C7
MNE% 'A?_  [W^"?_ $-OCO\ \+*Y_P :/^'>_P $_P#H;?'?_A97/^->Z44
M>%_\.]_@G_T-OCO_ ,+*Y_QH_P"'>_P3_P"AM\=_^%E<_P"->Z44 >%_\.]_
M@G_T-OCO_P +*Y_QH_X=[_!/_H;?'?\ X65S_C7NE% 'GWP9_9K\!? S4[W5
MO"&L^(;J2_@6*9=:UR6[55#9!4.?E.>XKT&BB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *XOX_P#[17P,_97^&%_\:/VB_BIHW@[POII5;O6=<O!#
M$';A(TS\TDC'A8T#.QX4$UVE?!O[7&DZ3\6O^"ZO[-'PB^,%C#>>$?#?PO\
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MXN:R^'3Z<5L=)6Z2U6XE>\N85(>5P%VDYP3V->Q_LV?&'QE\=?A3:_$3Q[\
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MI/Q/HOCOXB_#W6;3Q'H/A]=!L?$WA/QQJ^AZG)I0.?L,]UI]U#+=09R=DS.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
6444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>tnet-20250331_g15.jpg
<TEXT>
begin 644 tnet-20250331_g15.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC_P4:\!>&O&G[)WB;4-;L8GNM$@COM+NG0;[>59$!VGMN4LA'<-["O//V6/
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M\YY?0C4=-4U.K&OSN+DE=RI):*4KQ3YO,]MHHHK]./RL**** "BBB@ HHHH
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M /!47Q/JOAS]D?5+;2YGC_M75+2RN70X/E%S(PSZ'RPI]02.]=)^P)X+\/\
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M44 %%%% 'QC_ ,$YO!WB[P[^TS\5]2\0>%M2L;>ZN)3:W%Y8R1)-_ILA^5F
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%?*G[9/_!7+]FS]D?]HCX:_LDQS_\
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MTG03LW7>LWDLS+'Y5G"?-$1.Z:9H(5!\PD?(7_!&K_AA&+]K/]L3]C?]G?\
M:?\ #OB?2O&5GX6CT#5M/\86]_J/BC/A=4UC5DD5V-U,;V>XEGE7*K/*P.WI
M7ZK>*O /@3QW'#%XW\%:3K*VQ8VZZKIL5P(BV-Q7S%.W.!G'7 KR#]GK]@CX
M5?LZ?M2?&#]J#PBED;SXL7FBS#2H="@MX]"73],CL#';NG)6;9YK\+\Q[]:
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MU=R)?M]\+F0:B88&>WA*0VV%<EQ(V& !]@T444 %%%% !1110 4444 %%%%
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M'_T&?^4ZO_R!^I%,2"".5YXX45Y,>8X4 MCID]\5^77_ !$I_P#5EW_F1O\
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M !&WA7_GS7_\!I__ "P_ ?\ B"7%7_/ZA_X%4_\ E9^"=%?O9_PY;_X)H?\
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M **** "BBB@#Z7_X)M_\C3XI_P"P?;?^AO7UK7R5_P $V_\ D:?%/_8/MO\
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M_(U:G_V$)O\ T,UGUH>+?^1JU/\ ["$W_H9K/H **** "BBB@ HHHH ^E_\
M@FW_ ,C3XI_[!]M_Z&]?6M?)7_!-O_D:?%/_ &#[;_T-Z^M: "BBB@ HHHH
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M0F_]#-9]:'BW_D:M3_["$W_H9K/H **** "BBB@ HHHH ^E_^";?_(T^*?\
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MQ6_U7SRIEWU/VG(HOF]IRWYHJ6W)+:]MS^I"BOY;Z*^D_P"($_\ 4Q_\H_\
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MU?;W_!%#]E7X<_M2^/?'FD?$37?$UC%I&D6<ULWAKQ!-I[NSRR*0YB/SC"C
M/3FOA/$S_DAL9Z1_]+B?=^&?_)<X/UE_Z1(_;*BOEG_AT/\ LS?]#_\ %/\
M\./>_P"-'_#H?]F;_H?_ (I_^''O?\:_C8_LD^IJ*^6?^'0_[,W_ $/_ ,4_
M_#CWO^-'_#H?]F;_ *'_ .*?_AQ[W_&@#ZFHKY9_X=#_ +,W_0__ !3_ /#C
MWO\ C1_PZ'_9F_Z'_P"*?_AQ[W_&@#ZFHKY9_P"'0_[,W_0__%/_ ,./>_XT
M?\.A_P!F;_H?_BG_ .''O?\ &@#ZFHKY9_X=#_LS?]#_ /%/_P ./>_XT?\
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M^!UM_P#(]'_#NGX)?]#1XJ_\#K;_ .1Z /B^BOM#_AW3\$O^AH\5?^!UM_\
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MXE_[#]Y_Z/>OZ<:_F.^*W_)4?$O_ &'[S_T>]?OG@7_O./\ 2G^<S\#\=/\
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M%?S'?%;_ )*CXE_[#]Y_Z/>OZ<:_F.^*W_)4?$O_ &'[S_T>]?OG@7_O./\
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M]?OG@7_O./\ 2G^<S\#\=/\ =\!ZU/R@8%%%%?T0?SN%%%% !1110 5^E/\
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M?$O_ &'[S_T>]?OG@7_O./\ 2G^<S\#\=/\ =\!ZU/R@8%%%%?T0?SN%%%%
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M'P'^J7%7_0!7_P#!53_Y$^6Z*^I/^'+?_!2__HVO_P O'1O_ ),H_P"'+?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\2>)+O7]8L=/>002ZC<L&N)UC9BD1=@&98PJDY.,DT =G1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
&*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>tnet-20250331_g16.jpg
<TEXT>
begin 644 tnet-20250331_g16.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPK^UEXHTCQ3X8\32;$U:PA1#:X9%D966*(DQET9E=2"K?*0>FY^W!^UU\6O
MOQPT+]G;X2^+M&\(OJ-I#/J/BO7D0Q0^:[JHW2*Z1Q@)RY4DE@!MVDGGGQOE
M5'!5:]:$X3IRC"5.44IJ4]8_:Y;26J?-:R.B' F;UL=2H4*E.<*L93C4C)NF
MXPTD[\O->+T:Y;W>Q]:UX_\ M'_M9P_ _P 7Z!\+?"'PXO?&'B_Q(K2:=H5G
M>+; 1 D;WE96VY*OCY2,1L25 Y\L^'&K?\%&/ OQ+T-;_P 2Z'\5O!VI.IO]
M0TB6SC2VB+ .RRE8CYB@[@N75@,#!Z7OVM/ OQ/\#?M<^ _VM/!GPTU;Q=I>
MBZ4^FZKI>@P&:ZBR+E0ZQC+$%;HD$# ,?)7(-8YAQ%CL3D\JV%I5*,HU(1FY
M03<82DN:<$N>,[1?3FMNT;Y=PW@<+G,:.+K4JT94ZDH*-1I2G&+Y83;Y)PO)
M6UY;[)GJ?[+O[4>@?M+Z'JSP^&+O0=<\/7_V/7]"O91(]K(=P!#@#<I*.O*J
M048$="6_#O\ :9_X6C^T-XJ^"_A#P5Y^D^#X575_%1U+Y/MC''V981'R0PD!
M8N.8GXZ9^;OAGK_Q#_95^%7Q?_:K^(?A*X\/:S\0=>"^$/#VHIMN%N));F16
M>,C("F<MM8 E8&X^9<^W_LF>$/ ?[*/P6TGPS\4/'.CZ5XI\1N=5UO\ MC58
MH9Y[J;'R?O&!?8-J'&<L&/\ %7-DV>YKCEA:->?)**E.M)I1O#FE&E%IJT74
MMSNR3M'2UT=6=9!E&7_6Z^'ASQDXTZ,5)RM/EC.M)-.\E2OR*[:O+6]CW:BD
M1TD4.C!E89!!R"*6OT$_.0HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *^!/VU?#WC/\ 95_;6T?]KO1- DO-#U"[AFF>,$(LP@^S
MW%LS?P-)$"RD\$NV,[2*^^ZJZYH6B>)M)GT'Q)H]KJ%C=)LN;.]MUEBE7T9&
M!##V(KY[B7(?[?P$:4*GLZE.4:D)6ORSCL[=5J_SZ'TG"_$'^KV82JSI^TI5
M(2IU(7MS0END^CT7Y=3XR^,__!5&TT7Q+X?\7_!+5=(UKP_+:A-=\+ZG97-O
MJ*3%B2WF>7Y2 *%4%7D&2V5(P1RO_!-RRO?CK^UQXK_:1\4:C90W4 N;F+35
MNE,WG73%?D3.XQ1QETW8ZLH]:^JX_P!AW]DF+5/[77X#:"90^[8T#&+/_7(M
MLQ[;<50T;]A+]GSPQ\=;#X]^$?#LFE7]B9'72K%U2P:9D*"418^1@&. I"YP
M=N1FOC)<,\8XG.L/C<?6IU:=.HI>SBY12TMSJZ;]WXN6]F[VM=GVL>*."L-D
M>)P.74:E&I4IN'M)*,F];\CY9)>]K'GM=*U[V1J_MK?\FG^/O^Q;G_D*\V_X
M)-_\FHC_ +&6\_\ 08J^B_$OAK0?&.@W?A?Q1I,-]IU]"8KRSN$W),AZJP[B
MJ?@+X<^!?A=H/_"+_#SPM9Z/I_G--]CL8MB>8V-S8]3@?E7V5;)J]3BFEFBD
MN2-*4+:WNY7OVL?%T<[H4N$ZN4N+YYU8U+Z6LHVMWN;5?G)^W[^U[/\ &CXL
M2? '2?%CZ+X'TC51:ZWJ$,32F\FC?$LK(G,D<; A(QPS+N)Y7;^C=>9W7[&O
M[+%[<R7MY\"?#LDLTA>61[$$NQ.22>Y)KCXQR;.,^R^.$P-6-.+?O\W-[T?Y
M?=UL_M:J^U]SLX+SO)>'\REC,?2E4DE^[Y>7W9?S>]I=?9T=GK:]CRK]C_\
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M7_ ^$SC&T\RS:OBX1Y8U)RDEV4FW;\0HHHKT#S@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:_V1O^"4^M?%>+X/>(K;1_$7B.V^,6B:*C33VRW$9$.H"-N5+?=+@;>2,@4
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MA+*,\(F]2[(#FO)_V7?^"S/P-^/W@#Q;K'Q*^#GQ!^%'C#P3JT=CKOPW\?\
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M9-^,D?@+Q/KVC^ _VI=#\0>)D\)^'+G5+FUT^WM;MI9O)MD=R ,#IR2!U(H
MYC]M7_@AY^R_^R=^S/XU_:N_X)G3>+?@I\6_AOX:O/$OA[7/#OC[5[FVU(V,
M+W+6%Y:WMU-#/!,D;QD%1RXW;E!1J?\ P5'_ &K?&'[3/_!NYX>_;&T?Q58>
M&H?%6@^%_$/CSP\/$XT=M=T]I(9-4T*TNF=7#S8EC1%/F2HAC 8OM.A^V/\
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M)\ ?^":OQ.^(T<'B+XJW;^%=*?#+:/%NOYE_ZYGB'ZO\P_N5]D_!O]FSX0_
MG2?[+\!>&MKLX>:]OI3/-(X&-V6X4X ^X%''2OP;QBHY%Q=E$,!2J_OZ<U*,
MDKI+:2;NKW6ME?5*]C]Y\+^$.)\'BY8RO3]E0G&S4M)/K%J.^G]ZVC=KGC6A
M?"_Q_P")%672?"UTT;?=EE41(1ZAGP#^%=3IW[,7CFY ?4-4TZV!ZKYCNP_
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ML?\ ";_V@KV#V4FWRY4D7._>6555<LSL$ +$"N _90_X*C_L2_MI^/+SX5_
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MIS78TD<:11K%$@55 "JHP !VI:DH**** "BBB@ HHHH **** "BBB@ HHHH
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M*)[&4HO'6OS._;)_X+M?'SXWP7?@C]GC3I/A[X=F!CDU&.<2:Q=(?^FR_+;
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M*_##]S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K\\/VD)+2V_X.4OV=)?B8ZKH\O[/WBB/X<FZ.(SXA^TD
MWHBSQYO]G[<XYVXK]#Z\/_;L_P""?WP'_P""@GP[TKP9\7I=<T;6/#&KIJ_@
M?QUX/U4Z?KGAC4D^[=65RH/EMP,JP9&VJ2NY$90#S/\ X*4_'[]O+X.^'_%E
MS\)/V#?AQ\5?A)8?#^[O_&-UXR^(BV+W$*0W#7MFU@]G,L\1MT'#'$GF,I7
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MU/6I-.N-7UB1@#@M")M.MB#QF-O3)_:>@ HHHH **** "BBB@ HHHH ****
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MU\<^(%LH[-=;\6>#+*_NA;H6*1>;-&S;%+L0N<#<?6O7Z* /*O@)^PO^Q?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
# ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>tnet-20250331_g17.jpg
<TEXT>
begin 644 tnet-20250331_g17.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@!
MP '0 P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MURVDM4^:UD=$.!,WK8ZE0H5*<X58RG&I&3=-QAI)WY>:\7HURWN]CZUKQ_\
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M) 4*A]JLA  .:]SH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _-_X ^"O&5G_P %1/\
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M[F"ZW9QR"6W@GN;>&.-5D5ECFN<A!\BCP7_@FA^QS_P3V7]J#]M#X<?\%!O
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M@ K\Z?\ @M/HW_#&/Q[^"/\ P6@\$126A^&_BBU\&_&F2V7B_P#!&K3B!WF
M_P!9]ENI8Y(EX^><$GY5Q^BU>/?\%!/V<K3]KK]A[XK_ +-5S8K<2^,? >I:
M?IRN,[+YH&:TD'NEPL3CW04 >OPS17$2W%O*KQNH9'1LA@>001U%.KY7_P""
M(W[1-Y^U-_P2B^!OQ>U>]:XU)_ \&D:Q/(<R27NFN^G3N_HS26K.?][TKZHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^B]!^ K\[Q_B+E.';CAH2J/O\,?O=W_Y*<E7-:$-(*_X'D7_  0PU>P_9W\
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M2_$34?\ @F)_P3?\6*/B#+'Y7Q;^*-BY>V^']@W$EO#(A&[4Y!E0JD&'GE9
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M&8@$H^2 K$?27_!1+_@I)\&?^">OP)MOBKXAMQXM\1:_J=EIO@'X>Z#J,?\
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MC#QT?B?^S3^QWX0\->) K"#7A;RWEY:A@580373R/;Y!(/EE<@D'@UYW9?\
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MJ,<79:YA58YRK*(E=1MQ'E?OG(!XA\1OB%XJ^*WCC4_B)XVU'[5J>JW)FNI
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M:&:-D=&*NC#!4CJ".QK]2J^+/V\/@TG@?Q_'\1=$M=FG>(F9KA47Y8KP<O\
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MK)8C4?$.5PQO[@"256]2F5B!_NQ+7M%%%?H9^;A1110 4444 %%%% !1110
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M?PA,;>WDEEBFM5N8KF/]Q<!7_P!7)AP<\5]R?L_?\$_OV'/V4O$,_B[]FO\
M9(^'?@?6+F$PSZQX:\)6MK=O$<9C\]$$FPX!*;MI(SB@#U^BBB@ KSO]K7]I
M;X>?L<?LT>-_VHOBK=>7H7@?P[<:I>() KW+(O[JWC)X\R64I$@[O(H[UZ)7
MYU?MC74/_!67_@H1X<_X)R>#'&H_!KX':S9^,/VD-3A^>TU35HF+Z3X6+#AS
MO!N+F/D!4"DK)'B@#T7_ ((8_LS_ !#^#O[']S^T)^T):$?%K]H'Q+=?$;XC
M/*A#VTU^?,M+$!OFC2"U,2^4?]6[RJ *Z/\ X+ V[R_LSZ+,BDB+QO;%CZ V
MEX/YD5]6@ # %?.O_!4O0VU;]D'5KY8RW]F:M8W)('W09A#G_P B_K7R_&M)
MUN$\;%?\^Y/[E?\ 0^JX'JJCQ?@9/_GY%?>[?J?ES1117\=G]I!7W#_P1>OH
MH]3^(FFEOGE@TN51[(UV#_Z&*^'J^L/^"07BI=)_:&UGPO,X":OX8E,8SUEB
MFB8#_O@R'\*^S\/:\</QE@YOK)K_ ,"C*/ZGQ/B/AY8G@G&0CTBI?^ SC)_@
MC](****_KD_CD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y5_X
M*572->>#K(-\R17[L/9C;@?^@FOEVO?O^"B.O+?_ !?TW0HG!73]#0N/[LDD
MCL1_WR$/XUX#0 4444 ?:'_!.N Q_!34YB/]9XFFQ]!;VX_QKWRO'/V$=*;3
MOV=["[9,?;M0NIP?7$ACS_Y#KV.@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BL+XI>'_ !KXM^&7B/PK\-OB"WA+Q%J>A7EIH'BM-+BOCHM[
M)"Z07HMIOW=P89"LGE/\C[-K<$U^5'[>^C?\%L/V0F^'_P ,OAK_ ,%Q;_Q_
M\5OBUXMCT'X=^ Q^S?X4L5N]N)+V_N;@)*;>SM+?,LLHC<C*#;\Q90#]=**^
M OC[XC_:Z\<_MD^#?V KG]NK7OAZGA3]F"7QWXE^)/A;0M*M[KQ7XAAO8M.:
M::*ZMIH8;.)E>ZEMH50'[4JEE55QD?#S]OK]I7]L7]B?]E?X<>!M<;PQ\9_V
MB-(M-7\6Z]H]JBMX=\-Z>T<FLZU'&ZLL1N!Y-M;A@5\W4D*Y\LT ?HI12*H5
M0HSP,<G-+0 4444 %%%% ''?M!?"O6OC?\%_$?PE\/?%?Q%X&O-?TYK2'Q=X
M2N5AU/2]Q&9;:1@1'+@$!L'&<]JYO]C7]C'X"?L'_!"S^ O[/7AJ:STJ&ZEO
M=3U'4;DW.H:UJ$I!GO[VX8;KBXD(!9SP %50J*JCU6B@ KSS]K3P>WCS]F?Q
MQX8B@,LLOANYEMXP,EY8D,L8'N71:]#ILL4<T;0S1AT=2KJPR"#U!KFQF&AC
M,)4P\]IQ<7Z-6.G!8J>"QE/$0WA)27K%I_H?AC174_&_X?3_  I^,'B7X<SQ
M,@T?6KBV@W]6A#GRW^C)M8>QKEJ_B&O1J8:O*C45I1;3]4[,_NW#UZ>*H0K4
MW>,DFO1JZ"O2_P!CKXD1_"C]IKP=XSNKD0VJ:PEM?2,<*L$X,$C'V59"W_ :
M\THZ=*UP6+J8#&4\33^*$E)>L7=?D9X["4LPP57"U/AJ1E%^DDT_S/W0HKR_
M]CCXT1?'G]G?P]XXFN1)J$=J++61NR1=P@(Y/IO 60#TD%>H5_;&!QE',,'3
MQ5%WC.*DO1JY_#&/P5?+L;4PM96G3DXOU3L%%%%=1R!1110 4444 %%%% !1
M110 4444 %%%% !117C?[>_[4.D?L@_LO>(_C'?Q>?>1QI8Z)9+/Y;W-Y.=B
M*K8.-HWR'@_+$W!KIP>$Q.88NGAL/'FG-J,5W;=E_P .]%U.;&8S#9?A)XG$
M2Y803E)]DE=_TM3Y._:/\9IX^^-_B/Q'#+OA;46@MF!X:*$")2/8A ?QKB*\
MJ^'/[9?P/^(6RUN?$)T.];K;:V!$I..2)LF/&>!N96/]VO5(Y$EC66)PR.H9
M&4Y# ]"#W%=>:9)FV2UO98ZA*F_[RT?H]GZILY,KSO*<ZH^UP->-1?W7JO5;
MKYI"T45N_#'P?-X_^(>B^"XE)_M+4HH9"O58RPWM^"[C^%>6>H??W[/OAM_"
M7P2\+Z%+'LDCT>&29,?=DD7S&'_?3FNQI(XXXHUBB0*J@!5 P !VI: "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_/[]CJT7]KS_@MA^T9^UC
MXF_TO2/@-INF_"?X:QR?,EK=21"^UNX5>B3><\<.\?,8B5) XK] :YSX?_!_
MX4_"BZU^^^&/PWT/P]-XJUZ;6_$TNC:9%;-JNI3!1+>7!C4&:=PBAI&RQVC)
MXH X3]K3]CC]C3]J?0;/6_VOO@SX9\2V/A*&ZNK74M?3R_[.MVC_ -)!F5E9
M8'1!YL;-Y;A!O4[1C\[KWQO\7+CP-X1_;9^%>L2?#*3]JOXW>%?A/\+]9L-'
MMEN/ 'PJB6\:P-C!<1/!;7%^UN]P R,B'4K8!=T* ?JA\4_AAX%^-?PWUSX1
M?$_0%U7PYXDTR;3M<TN2>2-+RTE4I+"S1LK;74E6 (R"0>":R/BO^S?\!OCE
M\')OV>_BU\)M#UWP5-:P6Y\-7UBIM8XX"I@\M1CRC&40HR;60JI4@@4 >"?\
M$QOC%\:/$7C;X_?LS?%WXKZA\0X?@M\5(_#_ (;^(&L6MM%?:E8SZ79WPMKL
MVD44,MS;/<-"\B1IN&PLH;)/UC7%_ /]G3X'?LM_#R+X4?L^?#+2_"GA^*[E
MNCI^E0[1-<2MNEGE=B7FE<XW2.S.V!DG KM* "BBB@ HHHH **** "BBB@#\
MB?\ @H#^T%\$_C#^W9\1_AU\,8-7B\0?#IM,TOQZFHZ88(GO)K7SH)8&)S)&
MT ";BJY,#%=R%6/DM?1/_!P-^PMXTT&:Q_X*R_LL^&9;WQ=\/]*^Q_%SPQ8)
MAO%7A1#O>; ^]<V?,BMU,08$D1(C?+OP]\?>$_BGX(TOXB^!=7CO](UBS2ZL
M+J/HZ,.A'\+ Y!4\@@@\BOY@\4>':N59]+&PC^ZKN]^T_M)^;?O+O=]F?U3X
M4\24LWX?C@9R_>X=<MN\/LM>27NOM9=T;-%%%?F1^IGU1_P2Q_:/B^%_Q9F^
M$7B?41%HWBYT2T:1L+!J*\1GV\P?NSZMY?I7Z45^&,,TUM,EQ;S-')&P:.1&
M(96!R"".AK]5/V!_VM;/]I;X8KI?B.]C7Q=H,20ZS"2 UTG1+M1W#=&Q]U\]
M RY_?/";BJ$Z+R7$R]Y7=._5;RCZKXEY7['\]>+_  E.%99YAH^Z[*K;H]HR
M]'I%^:7<]ZHHHK]P/P@**** "BBB@ HHHH **** "BBB@ HHHH *_%__ (+M
M_MDP?&_X^6W[._@G5/-\._#V61-1>*3*76KN,3'CKY*_NAW#F;L17WI_P5=_
MX* :9^Q9\$)-#\'ZG$WQ!\56\EOX;ME8%K&,@K)?NO8)T3/WI,<$*^/P?NKJ
MYOKF2]O;B2:::0O--*Y9G8G)8D\DD\DFOWOP=X1G.N\]Q4?=C=4K]7M*?HE>
M*\V^Q^">,7%T(4%D6%E[TK.JUT6\8>K=I/R2[D==5\//C=\5/A7(/^$'\:7E
MG#N):R9A+;L3U)B<%,G^]C/H:Y6BOZ"Q.%PV,HNCB(*<'NI)-/U3T/Y]PV*Q
M.#K*MAYN$ULXMIKT:U/JCX<?\%$K.;98_%?P6T+'@ZCHAW+UP-T,C9 [DAS[
M+VK] _\ @EO/X%^-OC'4?B_X.UV#4]/T"V\B*2-65H[J8%0&1P&4B,2=0/O
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M3(84)K]]/WJC_O/[/I%:>MWU"BBBOB3[8**** "BBB@ HHHH **** "BBB@
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MQ%X4\-9Y.5:@GAZKZP2Y6_.&W_@+CYG\M<.>*W$N1P5&NUB*:Z3;YDO*>_\
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MHU+,[$X  '))/:C8-PMK:XO+B.TM('EEE<)%%&I9G8G   Y))[5^UW_!'O\
MX)J#]E'P./CG\9-$4?$3Q%9[8K.=03H-D^#Y ])WX,AZJ,1C&'+<-_P2._X)
M'M\(&T[]J']I_P /C_A*R%G\+>%KN/(T8$96YN%/_+SW5#_JNI_>8$?Z,5_-
MWB?XAPS!2R?+)WI?\O)K[5OLQ?\ *NK^T]%[OQ?TEX8>'D\OY<XS.%JCUIP?
MV4_M27\SZ+[.[][8HHHK\,/W(**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\Y/VZ?"V@_M<_P#!=O\
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M*>-S^,L%ER=+#O1O[<UYV^&+[+5]79V/Z3X(\+,%D$HXW,6JN(6J7V(/RO\
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M8ZE&NEU^"7WI./\ Y*?E.;^"_#V,DYX&K*@^WQQ^YM2_\F/Y<J*_HO\ B/\
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M?[8?PK\,?M$:M\</#FE>!?%.G1:AI%SH<G]I7EU;MSC:NV*%L@J0SLZ,K*R
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M&>QT/X9Z-X(\=?$[5HK866O^)9IS=W5K:0VJBVA@M;6*TMVMXLB,XWEG=F8
M[3]BS]H?]HOX1?M-?!WP1\:?VS=5^*_A?XT?LUWOQ)\6W?BBSTN"/PK?VIT^
M5KRTDLK> 0:;*E[)$(I?,"F!6$GW@?HG_@FS\3OC/^TKX#\4_MC_ !)U[4(?
M#'Q/\1M??"/PC=P")='\)P)Y%A<LNT/Y]\%>_?<S86YA08V8KYX_:A_8C_9,
M\%_$KP]_P3:_8G^ ^@>!]9^/:27GQHUGPS;F*XTOX=6$ZR7]NKY)M8KVXECT
M^*&,+%_I4[A08B1YI!^US^UOX86\_:^\.?M%:C8Z3H'[9\7P5TW]GNUT734T
M-?#<>KQZ.MLJBV^UKJ1C/VU9A/M  01&+B@#]8Z*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#(\?
M> / WQ5\%:I\-_B9X0TW7_#^MV3V>L:)K%FEQ:WMNXP\4L3@K(C#@J00:\'_
M .'/'_!*#_I&Y\#_ /PV.F?_ !FOH^B@#R_XT?L3?LA?M%?#+1O@S\<_V:O!
M7BKPKX<BBC\.Z'K/AZ":WTI(XUC1;52O^C@1JJ#R]ORC;TXKJOA!\%_A%^S]
MX!L?A7\#/ACH/@_PUIH(L="\-Z5%96D.XY8K'$JKN8Y+-C+$DDDG-=-10!R^
MC?!;X7>'_BWKGQWTGP=;1^+_ !)I-EI>LZ^S.\\]E:-*UO;@LQ$<:-/,VQ H
M+2%FR>:X:3_@G[^Q9+^T@/VNY/V;/"S?$<70N_\ A*38?OOM8B\D7>S/E_:1
M'\@N-OFA>-^*]AHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
C **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>tnet-20250331_g18.jpg
<TEXT>
begin 644 tnet-20250331_g18.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"'*HM/:.[;6K;MV2$N/Y4LUPV,HX=I492ERRJSGS.2<=Y:))/1*-^[9\W?\
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MT>I^U%_P4C7X<^+-0^&?P1\#W.OZMHFH0P:WJ;PLUK;MYJH\ "Y9G+'RMQP
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M&3QZ5TU?)OC+]LWQM\'OV"/!WQ2N;U=5\8^)[=;:TN[Y 0)"9&>X=1@-M50
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MKB*,82*%50J<AI,EF7!V$9QBO7K*RM--LH=.T^V2&"WB6."&-<*B*,!0.P
M%>M@<JK0XEEB6FJ=*C&C!O5RN^:4OE:*OU=SR,?FU&?"\<*FG4K5IUII:*-E
MR1C\[R=NBL2T445]8?(!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 45F>,O&W@SX=>&KKQG\0?%VF:%H
M]B@>]U;6;^.UMK=20 7EE9509(&21R16DCI(@DC<,K#*L#D$>M "T444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117YT?&O_
M (++_M9#XZZQH7['_P"P?8_$#P#X,\>>)/"6O:AJ7C0V6L^)-3T.PDN=3@TF
MT2"15\AHV56F9OM3KY:+&3O !^B]%?+7Q>_X*5:II/B'X8_"+]FW]EGQ3\0/
MB;\4O [>,;+P-J]]%X=;P]H:" 276KS7:LUFPFN([?RA')(90ZX&WG(T?_@K
M=X/T[]F3X]_&/XR_ S7/!/C;]G"TG;XD?#34M4M[B99C8B\L?LUY#F*>"\C>
M/RIL*<L=R# R ?7E%?,?[+O[8'[=WQL^(^DZ#\:?^"5/B;X6^$]2LI+B;QIJ
MOQ7\/:DEKB$R1(UG9SM<$R-M3[GR%LM@ U1\??\ !7+]FS0/^"A7P[_X)O\
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MDS.)-+GN;9[6=XP& )>"1XSN!X8XP>: .JHHHH **** "BBB@ HHHH ****
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M=3_[!\W_ * :/:>R]^U[:_<'L_;?N[VOI]Y_+_17V!179_Q/#_U3_P#Y=_\
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M3H>*/_0'@_\ P77_ /F@/^)*?"O_ *#,;_X,H?\ S,?-_P#PH3XL_P#0J?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<I.#@D9'!H LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?%'[6?[2WQ!^)7Q.\4_\$WO^"8OA?3(OB1J:^?\7/B>M@J:-\-H;V/Y
MKRY,>W[;K,L7S06@.XD++,RQH<^?_"W]FKX=_L0?\%:OV8_V=?"1N$\(Z'^R
M7XH\+^!9]2D#27FI6NJ:5<7;YP 9W@+3.% &&; "C ]5\7_\$%/^"67CGXB>
M)OBOXA^ /B'^W_&.OW6M^);ZQ^+_ (JM!?7]Q(9)IVC@U-(U+,QX50JC 4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
&4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>tnet-20250331_g19.jpg
<TEXT>
begin 644 tnet-20250331_g19.jpg
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MVM:W4],HJ#5-4TS0].GUC6M1@L[2UB:6YNKJ98XXD R69F("@#DD\5X[>?\
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M%9^:,;@1R4 _&O?_  9_P2)_9[\/:Y!JWB7Q7XBUR&"0/_9\\T4,,N/X7\M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH **** "BBB@#^='_@H5_P GT?%S_LH6J_\ I2]>.U[%_P %"O\ D^CXN?\
M90M5_P#2EZ\=K^\<D_Y$N&_Z]P_])1_!V=_\CK$_]?)_^E,****],\P****
M"BBB@ K]J_\ @WT_Y,7U'_LH6H?^DUG7XJ5^U?\ P;Z?\F+ZC_V4+4/_ $FL
MZ_*_&+_DC7_U\A^I^J>#G_)9+_KW/]#BOVA_^2[>+_\ L8;K_P!&M7&UV7[0
M_P#R7;Q?_P!C#=?^C6KC:_D\_K **** "BBB@ HHHH *^V/^">W_ "0FX_[&
M&X_]%0U\3U]L?\$]O^2$W'_8PW'_ **AH ]THHHH **** "BBB@ HHHH _G1
M_P""A7_)]'Q<_P"RA:K_ .E+UX[7L7_!0K_D^CXN?]E"U7_TI>O':_O')/\
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MG7XJ5^U?_!OI_P F+ZC_ -E"U#_TFLZ_*_&+_DC7_P!?(?J?JG@Y_P EDO\
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M?JG@Y_R62_Z]S_0XK]H?_DNWB_\ [&&Z_P#1K5QM=E^T/_R7;Q?_ -C#=?\
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M<_T.*_:'_P"2[>+_ /L8;K_T:U<;79?M#_\ )=O%_P#V,-U_Z-:N-K^3S^L
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MOQB_Y(U_]?(?J?JG@Y_R62_Z]S_0XK]H?_DNWB__ +&&Z_\ 1K5QM=E^T/\
M\EV\7_\ 8PW7_HUJXVOY//ZP"BBB@ HHHH **** "OMC_@GM_P D)N/^QAN/
M_14-?$]?;'_!/;_DA-Q_V,-Q_P"BH: /=**** "BBB@ HHHH **** /YT?\
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MO_I2]>.U[%_P4*_Y/H^+G_90M5_]*7KQVO[QR3_D2X;_ *]P_P#24?P=G?\
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M0 5%?6%CJEI)I^IV45Q;RKME@GC#HX]"IX(J6B@#"_X5=\,_^B=Z%_X*(?\
MXFC_ (5=\,_^B=Z%_P""B'_XFMVB@#"_X5=\,_\ HG>A?^"B'_XFC_A5WPS_
M .B=Z%_X*(?_ (FMVB@#"_X5=\,_^B=Z%_X*(?\ XFC_ (5=\,_^B=Z%_P""
MB'_XFMVB@#"_X5=\,_\ HG>A?^"B'_XFC_A5WPS_ .B=Z%_X*(?_ (FMVB@#
M"_X5=\,_^B=Z%_X*(?\ XFC_ (5=\,_^B=Z%_P""B'_XFMVB@#"_X5=\,_\
MHG>A?^"B'_XFC_A5WPS_ .B=Z%_X*(?_ (FMVB@#"_X5=\,_^B=Z%_X*(?\
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M&O@OP-<Z#?\ AC5+33Y+[?"LE]="_L=L;1N[B*1"T;G@E" ?<%%?"G_!2/\
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4H **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>tnet-20250331_g2.jpg
<TEXT>
begin 644 tnet-20250331_g2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *:!>,# 2(  A$! Q$!_\0
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MP !BN@_X4WXN_P"B[?$#_P  ?#W_ ,JJ /5:*\J_X4WXN_Z+M\0/_ 'P]_\
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MC_A3?B[_ *+M\0/_  !\/?\ RJH ]5HKRK_A3?B[_HNWQ _\ ?#W_P JJ/\
MA3?B[_HNWQ _\ ?#W_RJH ]5HKRK_A3?B[_HNWQ _P# 'P]_\JJ/^%-^+O\
MHNWQ _\  'P]_P#*J@#U6BO*O^%-^+O^B[?$#_P!\/?_ "JH_P"%-^+O^B[?
M$#_P!\/?_*J@#U6BO*O^%-^+O^B[?$#_ , ?#W_RJH_X4WXN_P"B[?$#_P
M?#W_ ,JJ /5:*\J_X4WXN_Z+M\0/_ 'P]_\ *JC_ (4WXN_Z+M\0/_ 'P]_\
MJJ /5:*\J_X4WXN_Z+M\0/\ P!\/?_*JC_A3?B[_ *+M\0/_  !\/?\ RJH
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MP]_\JJ /5:*\J_X4WXN_Z+M\0/\ P!\/?_*JC_A3?B[_ *+M\0/_  !\/?\
MRJH ]5HKRK_A3?B[_HNWQ _\ ?#W_P JJ/\ A3?B[_HNWQ _\ ?#W_RJH ]5
MHKRK_A3?B[_HNWQ _P# 'P]_\JJ/^%-^+O\ HNWQ _\  'P]_P#*J@#U6BO*
MO^%-^+O^B[?$#_P!\/?_ "JH_P"%-^+O^B[?$#_P!\/?_*J@#U6BO*O^%-^+
MO^B[?$#_ , ?#W_RJH_X4WXN_P"B[?$#_P  ?#W_ ,JJ /5:*\J_X4WXN_Z+
MM\0/_ 'P]_\ *JC_ (4WXN_Z+M\0/_ 'P]_\JJ /5:*\J_X4WXN_Z+M\0/\
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M?\,T^$?^@O\ $#_PX_B'_P"3J/\ AFGPC_T%_B!_X<?Q#_\ )U 'JM%>5?\
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M/_#C^(?_ ).H_P"&:?"/_07^('_AQ_$/_P G4 >JT5Y5_P ,T^$?^@O\0/\
MPX_B'_Y.H_X9I\(_]!?X@?\ AQ_$/_R=0!ZK17E7_#-/A'_H+_$#_P ./XA_
M^3J/^&:?"/\ T%_B!_X<?Q#_ /)U 'JM%>5?\,T^$?\ H+_$#_PX_B'_ .3J
M/^&:?"/_ $%_B!_X<?Q#_P#)U 'JM%>5?\,T^$?^@O\ $#_PX_B'_P"3J/\
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M_)U 'JM%>5?\,T^$?^@O\0/_  X_B'_Y.H_X9I\(_P#07^('_AQ_$/\ \G4
M>JT5Y5_PS3X1_P"@O\0/_#C^(?\ Y.H_X9I\(_\ 07^('_AQ_$/_ ,G4 >JT
M5Y5_PS3X1_Z"_P 0/_#C^(?_ ).H_P"&:?"/_07^('_AQ_$/_P G4 >JT5Y5
M_P ,T^$?^@O\0/\ PX_B'_Y.H_X9I\(_]!?X@?\ AQ_$/_R=0!ZK17E7_#-/
MA'_H+_$#_P ./XA_^3J/^&:?"/\ T%_B!_X<?Q#_ /)U 'JM%>5?\,T^$?\
MH+_$#_PX_B'_ .3J/^&:?"/_ $%_B!_X<?Q#_P#)U 'JM%>5?\,T^$?^@O\
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MFFW*7$+XZX="0?SH U**** "BBB@ HHHH **** "BO&O&7[57A'P/^T;X/\
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M^3IOAY_V)GB;_P!+M!KU6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW_VH:G9E]HN5'EIY?#P-M^;_ %R\\4 ?0-%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5Y5X<_Y.F^(?_8F>&?\ TNUZO5:\J\.?\G3?$/\ [$SPS_Z7:]0!ZK11
M10!Y5\&_^2B_';_L<[;_ -1[1J]5KRKX-_\ )1?CM_V.=M_ZCVC5ZK0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB)J,M]97MB9$MXFDGDG0O.D;K&$:=T99-F=H(8#DU_V9?@M\?O#/@G]L,_\
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MP ?9_P"TE^WM\0/AC^TAHGPU^'W@?3_':^(?#MO?Z/;JLJW4UY.\FQF<2!1
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MOAY_V)GB;_TNT&O5:\J\1_\ )TWP\_[$SQ-_Z7:#7JM !1110 4444 %%%%
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MU#X]^,_CQ\98=#T'Q7K6D2:=:^']#*%5=XDBWR,C.HPD8 ^=R2Q)8;0#X?\
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M\;Z'I_P1\4_ VYM;SQG\+["#34MM1E6$ZA'$=ZON8A,F1I=R,5!68X(Q@@'
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MYF9IHA>%]RAR[DX7!W'Y>:^XJK:EJ5IH]C/>W]U#8V<"[Y;BYD$<<:CJ68D
M#W- '+?!_P"$WAWX&?#;0O WA6WDMM"T>$Q0"9]\CEF9WD=L#+.[,QP ,L<
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M;EDCC$:NRH7^6)69BJY9FXKM*** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KRKPY_P G3?$/_L3/#/\ Z7:]7JM>5>'/^3IOB'_V)GAG_P!+
MM>H ]5HHHH \J^#?_)1?CM_V.=M_ZCVC5ZK7E7P;_P"2B_';_L<[;_U'M&KU
M6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRK]K'_ )-9^,G_ &)FL_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%>5>'/\ DZ;XA_\ 8F>&?_2[7J]5KRKPY_R=-\0_^Q,\,_\ I=KU 'JM%%%
M'E7P;_Y*+\=O^QSMO_4>T:O5:\J^#?\ R47X[?\ 8YVW_J/:-7JM !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MY5^UC_R:S\9/^Q,UG_TAFKU6O*OVL?\ DUGXR?\ 8F:S_P"D,U !XC_Y.F^'
MG_8F>)O_ $NT&O5:\J\1_P#)TWP\_P"Q,\3?^EV@UZK0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7E7AS_DZ;XA_]B9X9_\
M2[7J]5KRKPY_R=-\0_\ L3/#/_I=KU 'JM%%% 'E7P;_ .2B_';_ +'.V_\
M4>T:O5:\J^#?_)1?CM_V.=M_ZCVC5ZK0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%?./Q4_:G\8?#5==U8_!K6+KP=HUX
MUI<:[=:G%:EP)/+$L<!1G:-FQM?@$%3QFM'XF?M5KX3\&_#;7/#'A67Q9-X[
MN(;;3K&:^6P97E5=BLS(ZAMSA><+U.[% 'OM%><?"_QWX]\33:G_ ,)Q\-U^
M'UK;1J\%PVOV^HB<Y.X$1 ;-H .3US[5YOH_[5WB;X@75[??#SX2ZEXP\'VE
MV;1M?;58;/S2#AGA@=2TBCKP<^H!XH ^CZ*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "O*OVL?^36?C)_V)FL_P#I#-7JM>5?
MM8_\FL_&3_L3-9_](9J #Q'_ ,G3?#S_ +$SQ-_Z7:#7JM>5>(_^3IOAY_V)
MGB;_ -+M!KU6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6O*O@W_R47X[?]CG;?\ J/:-7JM !1110 4444 %%%% !1110 4444 %%%%
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M$N$\WCM2O_V]'_,Z(\691+>K;_MV7^1]PT5\60?\%)+5B/.\"31#_IGJ8?\
MG$*U[/\ X*.>%F ^U>$]8B/?R98G_F17/+AG-X[T']\?\SHCQ-E$MJZ^Z7^1
M]>45\KP_\%%/AZW^MT+Q,A_V;>W8?^CQ5ZW_ ."@GPTFQOM==MQ_TTM$/_H,
MAK!\/YI'?#R-UQ!E<ML1$^FJ*^?K7]NGX2W 'F:M?6I_Z:Z?*?\ T$&M*']M
M3X.2_P#,VE#Z/IMV/U\K%<\LGS*.^'G_ . O_(Z(YQELML1#_P "7^9[?17D
M%M^UQ\)+K&SQG:+_ -=(I4_F@K8M?VCOA?> %/'FA+G_ )ZWB1_^A$5SRR[&
MP^*C)?\ ;K_R-XYC@I_#6B_^WE_F>CT5S/AWXG>#_%U[]CT/Q5HNL7FPR&VL
M=0BFDV@@%MJL3C)'..XKIJXYTYTWRS33\SMA4A47-!IKR"BBBLS0**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRK]K'_DU
MGXR?]B9K/_I#-7JM>5?M8_\ )K/QD_[$S6?_ $AFH /$?_)TWP\_[$SQ-_Z7
M:#7JM>5>(_\ DZ;X>?\ 8F>)O_2[0:]5H **** "BBB@ HHHH ***^9_VMM)
M^"MIJFE:Q\8=5U@I=64EKINCV\UU]F=HFW/*J0# E_?(-TC!2%08X- 'TQ17
MP#\#=&\5^(OV#?B396\MUKRWDLRZ)I]M,+NZ2'$>Z/9&6922&/E]?O' W<S_
M +.*_ [P7XV^'^DZW\.O%'@;XIBWMXX]0\1175M#=7QB$<C1HTY&'<L%W1J/
MF  !X !][T5\<?MN_!/P#HOPW\6^/]9O]5F\7S3QMI-U=:G(WD3%U"P01 A
MFT,<;20 3D8KW#]E1O$4G[//@=_%4MQ-K;V.^22[+&4QF1S#O+<D^48\YYH
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MOQ;\6K_3_$>M^,+3^S[RPT7SH+..WW1L55_E<G]Q$ >" IR3DFOINB@#X_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /I7X&?MM>)OAR;?2_%'G>*/#ZX4.[YO+=?\ 8=C\X _A
M<YZ , ,5][?#OXI>&?BIH:ZIX:U6'4(.!)&IQ)"Q&=KH>5/!ZCG&1D<U^.E;
M?@_QKKO@'6X=7\/:I<:3J,7W9K=L9&<[6!X9>!\K @XZ5\/F_"N%Q]ZN'_=U
M/P?JOU7W,^XRCBK%8"U+$?O*?XKT?7T?WH_9NBODGX%_MW:/XF%MH_CU(=!U
M/B-=53(M)CTR^3F(GCKE>IRO KZRM[B*Z@CFAD66*10Z.AR&4C((/H0:_',=
MEV*RVI[/$PMV?1^C/V/ YCA<RI^TPT[]UU7JB2BBBO-/2"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *\J_:Q_Y-9^,G_8F:S_Z0S5ZK7E7[6/_
M ":S\9/^Q,UG_P!(9J #Q'_R=-\//^Q,\3?^EV@UZK7E7B/_ ).F^'G_ &)G
MB;_TNT&O5: "BBB@ HKBO"OQ0@\3>(SH=QH.L^']0>P&IV\>K11(;BWWA"X$
M<CE""RY20(XW#*]<9_AOXUV.O^#[GQ9<:#K&A^&(;%[]=4U$VI26->H5(IY)
M-QP< H,XQU(! /1:*X_P?\28/%FL7>D7&BZMX<U>WMHKW[#K"1+))!(2%D4Q
M22*0&4J02&4\$#(KL* /'_VGOC5J7P)\$:/X@TVPM=2,^L0V5Q;W18;H6BE=
MMC*?E?\ =@!B& R?E-?,NJ_\%&_%$S'^SO">E68["YGDG_ELKU;_ (*)?\D4
MT3_L88/_ $FN:_.VOU[AG)L!C<!&OB*2E*[5]?\ ,_(>)LYQ^"Q\J&'JN,;+
M33_(^E=2_P""@'Q/OD*PPZ#I^?XK:R<D?]]R-7+7O[9OQ@O-P_X2TVZ'^&&P
MMEQ^/EY_6O$Z*^VIY+EM/X</'_P%/\SXFIG695/BQ$O_  )K\CT+4?VA?B9J
MCL\WCK7D9NOV>^>'_P! (KFM4\>>)=<S_:/B'5;_ #U^U7LLG_H3&L*BO0AA
M:%/X*:7HD>?/%5ZGQU&_5L4DL22<FDHHKI.8**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHH **** "BBB@ KRKPY_R=-\0_\ L3/#/_I=KU>JUY5X<_Y.F^(?_8F>&?\
MTNUZ@#U6BBB@#RKX-_\ )1?CM_V.=M_ZCVC5ZK7E7P;_ .2B_';_ +'.V_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M '$?_;6OB2OZ"X5_Y$]#_M[_ -*D?S[Q5_R.*_\ V[_Z3$****^K/E HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *V/"
M?C#6O NM0ZOH&I7&E:C#PL]N^TD=U8=&4XY4@@]Q6/14RC&<7&2NF5&4H24H
MNS1]\_ K]O'3/$'V?1_B"D6C:@<(FKQ BUE/0>8.3&3QSRO4DJ.*^M[2\@OK
M:*XMIH[B"50Z21L&5E(R"".H((K\3Z]9^"O[3'C#X)W,<.GW7]I:%NS)H]XQ
M,/)Y,9ZQMR>1QDY(:OS7-^#Z=:];+_=E_*]GZ/I^7H?I64<85*-J.8>]'^9;
MKU77\_4_5VBO)_@M^TIX/^-EJL>FW?V#6U3=-I%X0LRX'S,O9UZ\KT&,@$XK
MUBOR?$8>MA:CI5XN,ET9^L8?$T<5356A)2B^J/'OB1I'QR7Q/>W'@#7O![Z'
M=1*L=EXDM9UELG"@,T;P@[\D;OGR!G&,"N,^$_[$OACP]\+=0\+^/&'C&YU7
M4QJ]^\4LMK$)U5E01^6RM@!WZ]2QXX 'TI17,=)\CO\ L ^%=-^/GAOQ%HFD
MZ?9^ +"SW76DR:C>-=/?*TC1RJ23\H)AX\P#Y#\ISS9_:;^ ?QC^.?BC3/L%
MYX&M/#FA:@+[2OM,MXEVYVKD3XC=#\RG[F..]?5]% '/^ O^$J_X1.Q_X37^
MQ_\ A)OWGVO^P?-^Q?ZQMGE^;\_W-F<_Q;L<8KH*** "BBB@ KRK]K'_ )-9
M^,G_ &)FL_\ I#-7JM>5?M8_\FL_&3_L3-9_](9J #Q'_P G3?#S_L3/$W_I
M=H->JUY5XC_Y.F^'G_8F>)O_ $NT&O5: "BBB@ HHHH **** /EO_@HE_P D
M4T3_ +&&#_TFN:_.VOT2_P""B7_)%-$_[&&#_P!)KFOSMK]WX/\ ^16O\3/P
MCC#_ )&LO\*"BBBOMCXD**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?_R*U_B9^$<8?\C67^%!1117VQ\2%%%% !1110 4444 %%%% !1110 4444
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M '$?_;6OB2OZ"X5_Y$]#_M[_ -*D?S[Q5_R.*_\ V[_Z3$****^K/E HHHH
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MO\*"BBBOMCXD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@W_R47X[?]CG;?\ J/:-7JM>5?!O_DHOQV_['.V_]1[1J]5H **** "BBB@
MHHHH ^)/^"E/_-.?^XC_ .VM?$E?;?\ P4I_YIS_ -Q'_P!M:^)*_H+A7_D3
MT/\ M[_TJ1_/O%7_ ".*_P#V[_Z3$****^K/E HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHK[8^)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** .W^!O_ "6OX?\ _8PZ?_Z4QU^O]?D!\#?^2U_#_P#[
M&'3_ /TICK]?Z_'N.?\ >*/^%_F?L/ _^[5O\2_(****_,S],"BBB@ KRKPY
M_P G3?$/_L3/#/\ Z7:]7JM>5>'/^3IOB'_V)GAG_P!+M>H ]5HHHH \J^#?
M_)1?CM_V.=M_ZCVC5ZK7E7P;_P"2B_';_L<[;_U'M&KU6@ HHHH **** "BB
MB@#XD_X*4_\ -.?^XC_[:U\25]M_\%*?^:<_]Q'_ -M:^)*_H+A7_D3T/^WO
M_2I'\^\5?\CBO_V[_P"DQ"BBBOJSY0**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZD_X)V_
M\EKUO_L7I_\ TIMJ_1*OSM_X)V_\EKUO_L7I_P#TIMJ_1*OPCC#_ )&LO\*/
MW?@__D5K_$PHHHKXD^V"BBB@ KRK]K'_ )-9^,G_ &)FL_\ I#-7JM>5?M8_
M\FL_&3_L3-9_](9J #Q'_P G3?#S_L3/$W_I=H->JUY5XC_Y.F^'G_8F>)O_
M $NT&O5: "BBB@ HHHH **** /EO_@HE_P D4T3_ +&&#_TFN:_.VOT2_P""
MB7_)%-$_[&&#_P!)KFOSMK]WX/\ ^16O\3/PCC#_ )&LO\*"BBBOMCXD****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P""E/\ S3G_ +B/_MK7Q)7VW_P4I_YIS_W$?_;6OB2OZ"X5_P"1/0_[>_\
M2I'\^\5?\CBO_P!N_P#I,0HHHKZL^4"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#M_@;_R6OX?_P#8PZ?_ .E,=?K_ %^0'P-_Y+7\/_\ L8=/_P#2F.OU
M_K\>XY_WBC_A?YG[#P/_ +M6_P 2_(****_,S],"BBB@ KRKPY_R=-\0_P#L
M3/#/_I=KU>JUY5X<_P"3IOB'_P!B9X9_]+M>H ]5HHHH \J^#?\ R47X[?\
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M_=^#_P#D5K_$PHHHKXD^V"BBB@ KRK]K'_DUGXR?]B9K/_I#-7JM>5?M8_\
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M_P"EVO5ZK7E7AS_DZ;XA_P#8F>&?_2[7J /5:*** /*O@W_R47X[?]CG;?\
MJ/:-7JM>5?!O_DHOQV_['.V_]1[1J]5H **** "BBB@ HHHH ^)/^"E/_-.?
M^XC_ .VM?$E?;?\ P4I_YIS_ -Q'_P!M:^)*_H+A7_D3T/\ M[_TJ1_/O%7_
M ".*_P#V[_Z3$****^K/E HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /J3_ ()V_P#):];_
M .Q>G_\ 2FVK]$J_.W_@G;_R6O6_^Q>G_P#2FVK]$J_".,/^1K+_  H_=^#_
M /D5K_$PHHHKXD^V"BBB@ KRK]K'_DUGXR?]B9K/_I#-7JM>5?M8_P#)K/QD
M_P"Q,UG_ -(9J #Q'_R=-\//^Q,\3?\ I=H->JUY5XC_ .3IOAY_V)GB;_TN
MT&O5: "BBB@ HHHH **** /EO_@HE_R131/^QA@_])KFOSMK]$O^"B7_ "13
M1/\ L88/_2:YK\[:_=^#_P#D5K_$S\(XP_Y&LO\ "@HHHK[8^)"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* .W^!O_ "6OX?\ _8PZ?_Z4QU^O]?D!\#?^2U_#_P#[&'3_ /TICK]?Z_'N
M.?\ >*/^%_F?L/ _^[5O\2_(****_,S],"BBB@ KRKPY_P G3?$/_L3/#/\
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M ^)/^"E/_-.?^XC_ .VM?$E?;?\ P4I_YIS_ -Q'_P!M:^)*_H+A7_D3T/\
MM[_TJ1_/O%7_ ".*_P#V[_Z3$****^K/E HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /J3_
M ()V_P#):];_ .Q>G_\ 2FVK]$J_.W_@G;_R6O6_^Q>G_P#2FVK]$J_".,/^
M1K+_  H_=^#_ /D5K_$PHHHKXD^V"BBB@ KRK]K'_DUGXR?]B9K/_I#-7JM>
M5?M8_P#)K/QD_P"Q,UG_ -(9J #Q'_R=-\//^Q,\3?\ I=H->JUY5XC_ .3I
MOAY_V)GB;_TNT&O5: "BBB@ HKE/"?Q0\-^-M0>QTF\N)+I;9;U([FQN+;SK
M=CM6:(RHHEC)_C3<O(YY&:>G_&?PAJ4.HS1:E/''8:>VK2M<Z?<P"2S4$FXA
MWQCSH^/O1;ARO]X9 .WHK!\)^-=-\:VLEQIB:B($"L)+_2[JR#A@2I3SXTWC
M ZKD#(]16]0!\M_\%$O^2*:)_P!C#!_Z37-?G;7Z)?\ !1+_ )(IHG_8PP?^
MDUS7YVU^[\'_ /(K7^)GX1QA_P C67^%!1117VQ\2%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 =O\#?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^I/^"=O_ "6O
M6_\ L7I__2FVK]$J_.W_ ()V_P#):];_ .Q>G_\ 2FVK]$J_".,/^1K+_"C]
MWX/_ .16O\3"BBBOB3[8**** "O*OVL?^36?C)_V)FL_^D,U>JUY5^UC_P F
ML_&3_L3-9_\ 2&:@ \1_\G3?#S_L3/$W_I=H->JUY5XC_P"3IOAY_P!B9XF_
M]+M!KU6@ HHHH **** "BBB@#Y;_ ."B7_)%-$_[&&#_ -)KFOSMK]$O^"B7
M_)%-$_[&&#_TFN:_.VOW?@__ )%:_P 3/PCC#_D:R_PH****^V/B0HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#M_@;_R6OX?_ /8PZ?\ ^E,=?K_7Y ? W_DM?P__ .QAT_\ ]*8Z_7^O
MQ[CG_>*/^%_F?L/ _P#NU;_$OR"BBBOS,_3 HHHH *\J\.?\G3?$/_L3/#/_
M *7:]7JM>5>'/^3IOB'_ -B9X9_]+M>H ]5HHHH \J^#?_)1?CM_V.=M_P"H
M]HU>JUY5\&_^2B_';_L<[;_U'M&KU6@ HHHH **** "BBB@#XD_X*4_\TY_[
MB/\ [:U\25]M_P#!2G_FG/\ W$?_ &UKXDK^@N%?^1/0_P"WO_2I'\^\5?\
M(XK_ /;O_I,0HHHKZL^4"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^I/\ @G;_ ,EKUO\
M[%Z?_P!*;:OT2K\[?^"=O_):];_[%Z?_ -*;:OT2K\(XP_Y&LO\ "C]WX/\
M^16O\3"BBBOB3[8**** "O*OVL?^36?C)_V)FL_^D,U>JUY5^UC_ ,FL_&3_
M +$S6?\ TAFH /$?_)TWP\_[$SQ-_P"EV@UZK7E7B/\ Y.F^'G_8F>)O_2[0
M:]5H **** "BBB@ HHHH ^6_^"B7_)%-$_[&&#_TFN:_.VOT2_X*)?\ )%-$
M_P"QA@_])KFOSMK]WX/_ .16O\3/PCC#_D:R_P *"BBBOMCXD**** "BBB@
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M[8**** "O*OVL?\ DUGXR?\ 8F:S_P"D,U>JUY5^UC_R:S\9/^Q,UG_TAFH
M/$?_ "=-\//^Q,\3?^EV@UZK7E7B/_DZ;X>?]B9XF_\ 2[0:]5H **** "BB
MB@ HHHH ^6_^"B7_ "131/\ L88/_2:YK\[:_1+_ (*)?\D4T3_L88/_ $FN
M:_.VOW?@_P#Y%:_Q,_".,/\ D:R_PH****^V/B0HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZD_X)V_\EKUO_L7I_P#TIMJ_
M1*OSM_X)V_\ ):];_P"Q>G_]*;:OT2K\(XP_Y&LO\*/W?@__ )%:_P 3"BBB
MOB3[8**** "O*OVL?^36?C)_V)FL_P#I#-7JM>5?M8_\FL_&3_L3-9_](9J
M#Q'_ ,G3?#S_ +$SQ-_Z7:#7JM>5>(_^3IOAY_V)GB;_ -+M!KU6@ HHHH *
M*** "BBB@#Y;_P""B7_)%-$_[&&#_P!)KFOSMK]$O^"B7_)%-$_[&&#_ -)K
MFOSMK]WX/_Y%:_Q,_".,/^1K+_"@HHHK[8^)"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M /8PZ?\ ^E,=?K_7Y ? W_DM?P__ .QAT_\ ]*8Z_7^OQ[CG_>*/^%_F?L/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ^I/\ @G;_ ,EKUO\ [%Z?_P!*;:OT2K\[
M?^"=O_):];_[%Z?_ -*;:OT2K\(XP_Y&LO\ "C]WX/\ ^16O\3"BBBOB3[8*
M*** "O*OVL?^36?C)_V)FL_^D,U>JUY5^UC_ ,FL_&3_ +$S6?\ TAFH /$?
M_)TWP\_[$SQ-_P"EV@UZK7E7B/\ Y.F^'G_8F>)O_2[0:]5H **** "BBB@
MHHHH ^6_^"B7_)%-$_[&&#_TFN:_.VOT2_X*)?\ )%-$_P"QA@_])KFOSMK]
MWX/_ .16O\3/PCC#_D:R_P *"BBBOMCXD**** "BBB@ HHHH **** "BBB@
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MQ>G_ /2FVK]$J_".,/\ D:R_PH_=^#_^16O\3"BBBOB3[8**** "O*OVL?\
MDUGXR?\ 8F:S_P"D,U>JUY5^UC_R:S\9/^Q,UG_TAFH /$?_ "=-\//^Q,\3
M?^EV@UZK7E7B/_DZ;X>?]B9XF_\ 2[0:]5H **** "BBB@ HHHH ^6_^"B7_
M "131/\ L88/_2:YK\[:_1+_ (*)?\D4T3_L88/_ $FN:_.VOW?@_P#Y%:_Q
M,_".,/\ D:R_PH****^V/B0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#M_@;_ ,EK^'__ &,.G_\ I3'7
MZ_U^0'P-_P"2U_#_ /[&'3__ $ICK]?Z_'N.?]XH_P"%_F?L/ _^[5O\2_(*
M***_,S],"BBB@ KRKPY_R=-\0_\ L3/#/_I=KU>JUY5X<_Y.F^(?_8F>&?\
MTNUZ@#U6BBB@#RKX-_\ )1?CM_V.=M_ZCVC5ZK7E7P;_ .2B_';_ +'.V_\
M4>T:O5: "BBB@ HHHH **** /B3_ (*4_P#-.?\ N(_^VM?$E?;?_!2G_FG/
M_<1_]M:^)*_H+A7_ )$]#_M[_P!*D?S[Q5_R.*__ &[_ .DQ"BBBOJSY0***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .W^!O_):_A__ -C#I_\ Z4QU^O\
M7Y ? W_DM?P__P"QAT__ -*8Z_7^OQ[CG_>*/^%_F?L/ _\ NU;_ !+\@HHH
MK\S/TP**** "O*O#G_)TWQ#_ .Q,\,_^EVO5ZK7E7AS_ ).F^(?_ &)GAG_T
MNUZ@#U6BBB@#RKX-_P#)1?CM_P!CG;?^H]HU>JUY5\&_^2B_';_L<[;_ -1[
M1J]5H **** "BBB@ HHHH ^)/^"E/_-.?^XC_P"VM?$E?;?_  4I_P":<_\
M<1_]M:^)*_H+A7_D3T/^WO\ TJ1_/O%7_(XK_P#;O_I,0HHHKZL^4"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ]5HHHH \J^#?_)1?CM_V.=M_P"H]HU>JUY5\&_^2B_';_L<[;_U'M&KU6@
MHHJ&\O(-/M9KJZFCMK:!&EEFF<(D:*,LS,>   22: )J*Q]$\8:#XFTN;4]'
MUO3=5TV%F66\L;N.:&,J S!G4D @$$Y/ (JM8?$3PKJNB7FLV7B;1[S2+,XN
M=0M[^)[> X!P\@;:O!'4]Q0!T-%9^A^(-+\4:;'J.C:E9ZMI\A(2ZL9TFB8@
MX(#J2#@@CKVK0H ^)/\ @I3_ ,TY_P"XC_[:U\25]M_\%*?^:<_]Q'_VUKXD
MK^@N%?\ D3T/^WO_ $J1_/O%7_(XK_\ ;O\ Z3$****^K/E HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO_D>OJ2BC_6#-?\ G_(/]7\J_P"?$3Y;_P"'=OPX_P"@WXI_\"[;_P"1Z/\
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MO_D>OJ2BC_6#-?\ G_(/]7\J_P"?$3Y;_P"'=OPX_P"@WXI_\"[;_P"1Z/\
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MC_6#-?\ G_(/]7\J_P"?$3Y;_P"'=OPX_P"@WXI_\"[;_P"1Z/\ AW;\./\
MH-^*?_ NV_\ D>OJ2BC_ %@S7_G_ "#_ %?RK_GQ$\+^#'[)VB? SXAW7B/0
M=;U"[L[C2VT]['441Y [3)(9!*@08Q&HV;,Y).[M7NE%%>3BL77QM3VN(ES2
MVN>IA<)0P5/V6'CRQWL%%%%<AV!1110 5Y5^UC_R:S\9/^Q,UG_TAFKU6O*O
MVL?^36?C)_V)FL_^D,U !XC_ .3IOAY_V)GB;_TNT&O5:\J\1_\ )TWP\_[$
MSQ-_Z7:#7JM !3)7,<3NL;2LH)$:XRWL,D#/U-/HH \$T.RU3QCXZU2[LO\
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M/EO_ (=V_#C_ *#?BG_P+MO_ )'H_P"'=OPX_P"@WXI_\"[;_P"1Z^I**/\
M6#-?^?\ (/\ 5_*O^?$3Y;_X=V_#C_H-^*?_  +MO_D>C_AW;\./^@WXI_\
M NV_^1Z^I**/]8,U_P"?\@_U?RK_ )\1/EO_ (=V_#C_ *#?BG_P+MO_ )'H
M_P"'=OPX_P"@WXI_\"[;_P"1Z^I**/\ 6#-?^?\ (/\ 5_*O^?$3Y;_X=V_#
MC_H-^*?_  +MO_D>C_AW;\./^@WXI_\  NV_^1Z^I**/]8,U_P"?\@_U?RK_
M )\1/EO_ (=V_#C_ *#?BG_P+MO_ )'H_P"'=OPX_P"@WXI_\"[;_P"1Z^I*
M*/\ 6#-?^?\ (/\ 5_*O^?$3Y;_X=V_#C_H-^*?_  +MO_D>C_AW;\./^@WX
MI_\  NV_^1Z^I**/]8,U_P"?\@_U?RK_ )\1/EO_ (=V_#C_ *#?BG_P+MO_
M )'H_P"'=OPX_P"@WXI_\"[;_P"1Z^I**/\ 6#-?^?\ (/\ 5_*O^?$3Y;_X
M=V_#C_H-^*?_  +MO_D>C_AW;\./^@WXI_\  NV_^1Z^I**/]8,U_P"?\@_U
M?RK_ )\1/EO_ (=V_#C_ *#?BG_P+MO_ )'H_P"'=OPX_P"@WXI_\"[;_P"1
MZ^I**/\ 6#-?^?\ (/\ 5_*O^?$3Y;_X=V_#C_H-^*?_  +MO_D>C_AW;\./
M^@WXI_\  NV_^1Z^I**/]8,U_P"?\@_U?RK_ )\1/EO_ (=V_#C_ *#?BG_P
M+MO_ )'H_P"'=OPX_P"@WXI_\"[;_P"1Z^I**/\ 6#-?^?\ (/\ 5_*O^?$3
MY;_X=V_#C_H-^*?_  +MO_D>C_AW;\./^@WXI_\  NV_^1Z^I**/]8,U_P"?
M\@_U?RK_ )\1/EO_ (=V_#C_ *#?BG_P+MO_ )'H_P"'=OPX_P"@WXI_\"[;
M_P"1Z^I**/\ 6#-?^?\ (/\ 5_*O^?$3Y;_X=V_#C_H-^*?_  +MO_D>C_AW
M;\./^@WXI_\  NV_^1Z^I**/]8,U_P"?\@_U?RK_ )\1/EO_ (=V_#C_ *#?
MBG_P+MO_ )'H_P"'=OPX_P"@WXI_\"[;_P"1Z^I**/\ 6#-?^?\ (/\ 5_*O
M^?$3Y;_X=V_#C_H-^*?_  +MO_D>C_AW;\./^@WXI_\  NV_^1Z^I**/]8,U
M_P"?\@_U?RK_ )\1/EO_ (=V_#C_ *#?BG_P+MO_ )'H_P"'=OPX_P"@WXI_
M\"[;_P"1Z^I**/\ 6#-?^?\ (/\ 5_*O^?$3Y;_X=V_#C_H-^*?_  +MO_D>
MC_AW;\./^@WXI_\  NV_^1Z^I**/]8,U_P"?\@_U?RK_ )\1/EO_ (=V_#C_
M *#?BG_P+MO_ )'H_P"'=OPX_P"@WXI_\"[;_P"1Z^I**/\ 6#-?^?\ (/\
M5_*O^?$3Y;_X=V_#C_H-^*?_  +MO_D>C_AW;\./^@WXI_\  NV_^1Z^I**/
M]8,U_P"?\@_U?RK_ )\1/EO_ (=V_#C_ *#?BG_P+MO_ )'H_P"'=OPX_P"@
MWXI_\"[;_P"1Z^I**/\ 6#-?^?\ (/\ 5_*O^?$3Y;_X=V_#C_H-^*?_  +M
MO_D>C_AW;\./^@WXI_\  NV_^1Z^I**/]8,U_P"?\@_U?RK_ )\1/EO_ (=V
M_#C_ *#?BG_P+MO_ )'H_P"'=OPX_P"@WXI_\"[;_P"1Z^I**/\ 6#-?^?\
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M'XY?M,?L[? +XEWUXV@R^"D\1>*["RN9+;^U+\03HZ2,C [1);$\'I(^.<$
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M!(96X8K@C!H ]_KRKPY_R=-\0_\ L3/#/_I=KU>JUY5X<_Y.F^(?_8F>&?\
MTNUZ@#U6BBB@#RKX-_\ )1?CM_V.=M_ZCVC5ZK7E7P;_ .2B_';_ +'.V_\
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M_$.VMKFQNO!UA]MFM[J)?]5.@(\M=S2#>>VP@-\P'WY10!^:7A/0_CE^R/\
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M@W23Z:EA):QF-?+M6B7^*%<1EC\S%<D FO6** "BBB@ HHHH **** "BBB@
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M#\-_'/\ 8W_81.D>%?!.M:S\5?'6NW>H7RZ'927TF@K-$BF0K"K8D\N% O\
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MQM<:U:>(M0G=Y_#U[JD5Y8Z8J32[#:K$62,RJX>3#MN8#.",5]8T44 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>5>
M'/\ DZ;XA_\ 8F>&?_2[7J]5KRKPY_R=-\0_^Q,\,_\ I=KU 'JM%%% 'SKX
M0^-WPZ^&OQ:^..F>+O'WA?PKJ4WBVUN8[/6]9MK.9XCX?TA1($D=25+(XW8Q
ME2.QKM?^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\
M':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^
M&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@
MA_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T6
M3X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_
M /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A4
M6/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\
M\=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU
M6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#
MRK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_A
MK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(
M?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D
M^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__
M (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%
MC_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\
M':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^
M&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@
MA_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T6
M3X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_
M /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A4
M6/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\
M\=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU
M6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#
MRK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_A
MK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(
M?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D
M^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__
M (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%
MC_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\
M':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^
M&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@
MA_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T6
M3X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_
M /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A4
M6/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\
M\=KU6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU
M6B@#RK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#
MRK_AK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_A
MK'X(?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(
M?]%D^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D
M^'__ (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__
M (5%C_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%
MC_\ ':/^&L?@A_T63X?_ /A46/\ \=KU6B@#RK_AK'X(?]%D^'__ (5%C_\
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M_P#^%18__':/^&L?@A_T63X?_P#A46/_ ,=KU6B@#RK_ (:Q^"'_ $63X?\
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M_P#A46/_ ,=KU6B@#RK_ (:Q^"'_ $63X?\ _A46/_QVC_AK'X(?]%D^'_\
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M_P"&L?@A_P!%D^'_ /X5%C_\=H_X:Q^"'_19/A__ .%18_\ QVO5:* /*O\
MAK'X(?\ 19/A_P#^%18__':/^&L?@A_T63X?_P#A46/_ ,=KU6B@#RK_ (:Q
M^"'_ $63X?\ _A46/_QVC_AK'X(?]%D^'_\ X5%C_P#':]5HH \J_P"&L?@A
M_P!%D^'_ /X5%C_\=H_X:Q^"'_19/A__ .%18_\ QVO5:* /*O\ AK'X(?\
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M_P#':]5HH \J_P"&L?@A_P!%D^'_ /X5%C_\=H_X:Q^"'_19/A__ .%18_\
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@2_BO(4E%YKC&,O&S ,%=#MSG# ]Q7NM% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>tnet-20250331_g20.jpg
<TEXT>
begin 644 tnet-20250331_g20.jpg
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MEZ5H#:E=;#PRR1M=R_@;>"+G_;KIO^"-7_)-/&?_ &';?_T2:,-Q1FN+X_\
MJ-.:^JWG%*RUE"FI2UM?24EU#%<*91@_#SZ_4@_K=H3;N](U*CC'W;VUC%]#
M[+HHHK]//RH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KSW]J;
M6OB]X:^!>N^)O@84/B/3H%N;:)K19S+$C@RJJ,#N;R]Y P22 !R:]"HKGQ="
M6*PM2C&;@Y)KFCHXW5KI]UNCIP>(CA,73K2@IJ,DW&2NI6=[-=GLSXZ_9Z_X
M*0_ SQ_\)E\-?M;:Q;)KEN\@O6OO#[7%KJ"%B4=4AB=5(4A"I49*Y&<\>1?
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M/_D(6]C;!%N/E*_-Z\$C\34OPZ^$7PR^$=E<Z=\,_!&GZ)!>2B2ZBT^ ()7
MP&/J<<5?#_!.+R?$8&M.K&3H^V<WK>4JFS5UT25[D<1<=X3.L-CZ,*4HJM[%
M4UI:,:6Z=GU;;5NYT=%%%?I!^9!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 ?#G[6'_  5)_;<_9&\/^.OBGX^_
MX)&:^WPY\#S7DLWCR;XY>%;:"\T^*4I%=I;O<^>IF&PI 4,Q:58PI<A:Z77O
M^"G_ ,3I++X3?#/X<_L.^)=9^-7Q4\#S>+Y/A5J7B>TTT>%=&B:)'NM4OI5*
MP9DGAB6-8GD,C,A52N#S7[<EH?VPO^"GWP*_X)]ZG^^\%>"M$N?C-\3M,?\
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MGH7_ &,.J?\ I0:_)/&C_DD8?]?8_P#I,S];\%_^2NG_ ->I?^E0/.OVKO\
MDXCQ5_V$1_Z+2O/*]#_:N_Y.(\5?]A$?^BTKSROY6/ZI"BBB@ HHHH ****
M"BBB@#Z6_P"";?\ R-?BC_L'6_\ Z,:OK:ODG_@FW_R-?BC_ +!UO_Z,:OK:
M@ HHHH **** .?\ BU_R2KQ-_P!B]>_^B'K^8^OZ</BU_P DJ\3?]B]>_P#H
MAZ_F/K^B? O_ ';'^M/\IG\[>.G^\X#TJ?G ****_>S\$"BBB@ HHHH ****
M "OW,_X(3_\ *//0O^QAU3_TH-?AG7[F?\$)_P#E'GH7_8PZI_Z4&OR3QH_Y
M)&'_ %]C_P"DS/UOP7_Y*Z?_ %ZE_P"E0/.OVKO^3B/%7_81'_HM*\\KT/\
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MVH **** "BBB@#G_ (M?\DJ\3?\ 8O7O_HAZ_F/K^G#XM?\ )*O$W_8O7O\
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MXZ?[S@/2I^< HHHK][/P0**** "BBB@ HHHH *_<S_@A/_RCST+_ +&'5/\
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M]A$?^BTKSROY6/ZI"BBB@ HHHH **** "BBB@#Z6_P"";?\ R-?BC_L'6_\
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M10 4444 %%%0:KJNF:'IESK>MZC!9V5G \]W=W4RQQ01(I9W=V("JH!)).
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MQA\1[#Q!H^OZ?IFO?#:SLO">LZEI:[+2;6=*L9H_MTJ1A8TG5XWB4#:& V$
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M#?0V^'UWX=;1[KPN;&..PCTX1>7Y*Q@!8T1 -N -FT$8(!KX3_X),_ 32_\
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M&]:71/B/\/-?TV*37-.U63R?LMG"EO+)%=F[-Q +:2*0QR^<IW+AMNK^SO\
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MW?%S3;1+>UU);>=9+GPUX>1 %FD=U\NYO /)A4NJ^8S 'H_B#^P9\$?VF_\
M@HQX]\1^$_\ @H'\1O!GBCPI\*O#GA?5/A[\*-570[W0]-\V[NK.5[TQO++%
M(TDK"./:@9!YF_"@ 'UA^S9\8?&7QU^%-K\1/'OP \5?#+4KBYGBD\)^,VM3
M?P*CE5D;[+-+%M<#<N')P>0#Q7>U\B_\$;/CK\:_C#\!_B+X'^.7Q(E\<WWP
ME^./B7X?Z-\0;FWCCG\4:;ILD0@OIO* C>8>:T#N@PSV[$Y8LQ^NJ "BBB@
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MW.)I'$6Z.VA7RX]D8V9"@EB>THH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>tnet-20250331_g21.jpg
<TEXT>
begin 644 tnet-20250331_g21.jpg
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MXC+LS@I-N,J3A&$5&2O>Z5KW6E]]SKJ***^\/S\**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HKYF_X*<?\%/\ X0_\$R?ACH/C#QUX;O/$NO>*O$%MIGAW
MPII=P(YIT>XABGO)'*L(;>#SX]TA4@R301\-*IK4_;&_;IUS]G7XJ> ?V;/@
MI^S]J7Q1^*7Q'@U*]T#PM:Z];Z3:6NG6"1M=WMY?3AE@C4S1(H5'>1GPJ\4
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M4?ZI<*_] %#_ ,%4_P#Y$/\ 6WBK_H/K_P#@VI_\D?4G_#Z3_@I?_P!'*?\
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MBB@#Z6_X)M_\C7XH_P"P=;_^C&KZVKY)_P"";?\ R-?BC_L'6_\ Z,:OK:@
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M_P"P=;_^C&KZVH **** "BBB@#G_ (M?\DJ\3?\ 8O7O_HAZ_F/K^G#XM?\
M)*O$W_8O7O\ Z(>OYCZ_HGP+_P!VQ_K3_*9_.WCI_O. ]*GYP"BBBOWL_! H
MHHH **** "BBB@ K]S/^"$__ "CST+_L8=4_]*#7X9U^YG_!"?\ Y1YZ%_V,
M.J?^E!K\D\:/^21A_P!?8_\ I,S];\%_^2NG_P!>I?\ I4#SK]J[_DXCQ5_V
M$1_Z+2O/*]#_ &KO^3B/%7_81'_HM*\\K^5C^J0HHHH **** "BBB@ HHHH
M^EO^";?_ "-?BC_L'6__ *,:OK:ODG_@FW_R-?BC_L'6_P#Z,:OK:@ HHHH
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MODG_ ()M_P#(U^*/^P=;_P#HQJ^MJ "BBB@ HHHH Y_XM?\ )*O$W_8O7O\
MZ(>OYCZ_IP^+7_)*O$W_ &+U[_Z(>OYCZ_HGP+_W;'^M/\IG\[>.G^\X#TJ?
MG ****_>S\$"BBB@ HHHH **** "OW,_X(3_ /*//0O^QAU3_P!*#7X9U^YG
M_!"?_E'GH7_8PZI_Z4&OR3QH_P"21A_U]C_Z3,_6_!?_ )*Z?_7J7_I4#SK]
MJ[_DXCQ5_P!A$?\ HM*\\KT/]J[_ ).(\5?]A$?^BTKSROY6/ZI"BBB@ HHH
MH **** "BBB@#Z6_X)M_\C7XH_[!UO\ ^C&KZVKY)_X)M_\ (U^*/^P=;_\
MHQJ^MJ "BBB@ HHHH Y_XM?\DJ\3?]B]>_\ HAZ_F/K^G#XM?\DJ\3?]B]>_
M^B'K^8^OZ)\"_P#=L?ZT_P IG\[>.G^\X#TJ?G ****_>S\$/2OB-^SI=_"[
M]G[P)\9_%'B<1ZC\0+B^FTCPVMC\T6F6S)$+R24OQYLI=4CV<K&7W\@5Z/\
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M:3^\_-*M.5&K*G+=-K[@K]S/^"$__*//0O\ L8=4_P#2@U^&=?N9_P $)_\
ME'GH7_8PZI_Z4&ORCQH_Y)&'_7V/_I,S]7\%_P#DKI_]>I?^E0/.OVKO^3B/
M%7_81'_HM*\\KT/]J[_DXCQ5_P!A$?\ HM*\\K^5C^J0HHHH **** "BBB@
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MM7R3_P $V_\ D:_%'_8.M_\ T8U?6U !1110 4444 <_\6O^25>)O^Q>O?\
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M?0V^'UWX=;1[KPN;&..PCTX1>7Y*Q@!8T1 -N -FT$8(!KX3_P""3/P$TO\
MX*%_\$,/@K\+_P!ICQUXQOO#5I>:C:W$6C^(Y].;Q5H>GZIJ5A8V-])#MEEL
MGM4MRT2NGF""++;258^-W_! WXP?M#Z=X>^'_P 5_P#@K1\6=0\)>#;&_L/"
M4L/A[3+?Q/9V%W ()K.;7(466[AD1(UF62,F98U#G@$?9O[$_P #/&O[,O[+
MO@[]GSQUKOAC4KGP9I8T>QO?"'AR32;*6QMV,=HWV9YYC'*8%C,N'*F4N5P"
M* /GG_@W?TK3="_X)+^ =$T:QBMK.S\6>-H+6VA3:D4:>+M8544#H   ![5]
MLUY!^PE^R/HO[#/[,NC_ +-/A_QG=>(+72-8UJ_35;RT6"21M1U:[U)D**2
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>tnet-20250331_g22.jpg
<TEXT>
begin 644 tnet-20250331_g22.jpg
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MCC2=#\4ZYK6H?#S3?%+S*@M]KR6[/&)76(OM262*./< QQQUQS^J?C']CO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4?ZI<*_] %#_ ,%4_P#Y$/\ 6WBK_H/K_P#@VI_\D?4G_#Z3_@I?_P!'*?\
MEG:-_P#(='_#Z3_@I?\ ]'*?^6=HW_R'7RW11_JEPK_T 4/_  53_P#D0_UM
MXJ_Z#Z__ (-J?_)'U)_P^D_X*7_]'*?^6=HW_P AU^K/_!)WX_?%O]I?]C;2
M?BM\;?%G]MZ_<ZQ?P3W_ -@M[;='',50;+>-$&!QD+D]\U^ 5?N9_P $)_\
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M9M_:E_X:$U;5-+_X07^R/[-MXY=_]I_:/,W,1C'E)C&/>O6Z "BBB@ HHHH
MY_XM?\DJ\3?]B]>_^B'K^8^OZ</BU_R2KQ-_V+U[_P"B'K^8^OZ)\"_]VQ_K
M3_*9_.WCI_O. ]*GYP"BBBOWL_! HHHH **** "BBB@ K]S/^"$__*//0O\
ML8=4_P#2@U^&=?N9_P $)_\ E'GH7_8PZI_Z4&OR3QH_Y)&'_7V/_I,S];\%
M_P#DKI_]>I?^E0/.OVKO^3B/%7_81'_HM*\\KT/]J[_DXCQ5_P!A$?\ HM*\
M\K^5C^J0HHHH **** "BBB@ HHHH ^EO^";?_(U^*/\ L'6__HQJ^MJ^2?\
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M?N9_P0G_ .4>>A?]C#JG_I0:_#.OW,_X(3_\H\]"_P"QAU3_ -*#7Y)XT?\
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MX[_\+*Y_QH_X=[_!/_H;?'?_ (65S_C7WW_$=O\ J7?^5O\ [D? _P#$"?\
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M=>(+72-8UJ_35;RT6"21M1U:[U)D**2 $:[:,'/(0'@G%>OT %%%% !1110
M4444 %%%% !1110 5X!^U3^WK8_L_P#Q@\,?LS?"WX!^+OBS\4O%FC76M6'@
MKP?/8VQLM)MY$BEU&]N[^X@M[6#S9%B0LY:20[54FO?Z^=?VY?VR?AU^R'JO
MA^S\'_!^3XA_'+Q]!-H_PQ\ Z!!$NJZT$(EE\VY8?Z'IL+%99[B0^7&.<,V
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M@+F1+T/LMA:Q;69[II'"1+&-Y=P%ZU\A^%OV>/VK?VRO$?C;_@H_^TCX!O/
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M92>(O!RZ=8:7#_9NB6J:1*5D(@OD5 YM0,+$58-VH _2:BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
;"BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>tnet-20250331_g23.jpg
<TEXT>
begin 644 tnet-20250331_g23.jpg
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU_R2KQ-_V+U[_P"B'K^8^OZ)\"_]VQ_K3_*9_.WCI_O. ]*GYP"BBBOWL_!
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M]?S'U_3A\6O^25>)O^Q>O?\ T0]?S'U_1/@7_NV/]:?Y3/YV\=/]YP'I4_.
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MU#]GC3M9DL+OX[V<>F-IYBCNC:R:G%IYO/[0ETY)0<W*P?=5F"$"O0OVJ_\
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MIXCT'P^N@V/B;PGXXU?0]3DTH'/V&>ZT^ZAENH,Y.R9G +,1@LQ/O]% ')_
M[X&?"+]FKX5:-\$/@1\/].\+^%/#]L8-(T32XBL4"EB['))9W9V9V=B7=F9F
M)8DGK*** "BBB@ HHHH \D_;&_88_9>_;\^'>F?"C]K#X=W/B;0-'U^'6].L
M;;Q-J.EF&_BCECBG\RPN()&*K-)@,Q4%LXR 1Q'[-G_!)#]@O]D;XK6OQL^
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BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>tnet-20250331_g24.jpg
<TEXT>
begin 644 tnet-20250331_g24.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@"
M4@#< P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M \0_92_;9T']JCQ/KWAG2/ =YI#Z%"DDDMS>I*)=SLF %48^[FO*M9_X*]>$
M=)U^^T"/X&ZQ</8W<D#O%JD?S;'*[L;. <5QO_!(+_DJWQ#_ .O&#_T?)7E?
M[,G[5'A_]E'X]^-O%OB'PI>:M'J;W-I'#9S(C(PNM^XENV%Q7X=+C/.WDF75
MZV+5'VTZJG4]G&22@[1]VWRTMYG[Q'@G(EGN98>C@W6]C"BZ=/VDHMN:O+WK
M_/6_D?0'_#X3PS_T;YKW_@R3_P"-U]E5\D>"/^"MOP[\;^--(\%VOPCUJ"75
M]4M[*.>2^A*QM+(L88@<D MFOK>OT#A',99C"M/^T%BTG%:4O9\N]_6^GI;S
M/SOC'+8Y94HP_LYX1M2>M5U.=:6_P\NOK?R"BBBOL3XL**** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 4/_  53_P#D3\Y_^'#OA3_H%>!/^_\ KO\ \G4?\.'?"G_0*\"?]_\ 7?\
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M^"E/_!/[2/CN/V8]3_;)^'$'C[^TAIS>%I?%EL+I;TG:+1AOPMP6^40DB0G
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M3>+,--U6!(WFLY2IPLR++&63JNX \\4 =11110 4444 %%%% !1110 4444
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L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>tnet-20250331_g25.jpg
<TEXT>
begin 644 tnet-20250331_g25.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<6I)V::U3VM;>]]+$]%>:>$_VQ/V8O'/BN/P3X6^,^C76IS2^5;V_FL@F?.
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M>/=-\265SHILVNQJEO<+) 8%!9I ZD@J #D^QKSO_AN7]DC_ *+QH7_?U_\
MXFGB,SRW"*+KUH0YM5S22NNZN]?D+#Y7F>+<E0H3GRNSY8R=GV=EH_4]7HIL
M,L<\2SPN&1U#*P[@]#3J[=SAV"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/TKE_P!@;3=1TC]D3P7IVK6$UK<165P)8+B(HZ'[5,>58 C@BK_[8?QG\5?
MSX'7_BSP'H%QJ.O74R6.CQ06C3"*:0,?-95!R$17;D8+!0>#7WF$E@Z7!-)X
MU-TE0CSK6[7LU=:6=WM8_/L9'&UN.:RP,DJKQ$^1Z63]H[/6ZLM[_,^4_P!N
M_P"$_P "/ ?ASP%^S5\#/!MA-\1AJ-JINM*M$2]DB\IDW7,B<EY9"C@,25"E
MOE7&>H_:)TG_ (6G_P %#_A5\$?B-LU72M,T".:\M+@;HKJX$=Q-*S*>"'\B
M($'J%P>M>6_LK?'2#X#:QJ'Q*\>_LV^-/%GCG5;B5[GQ%=(^8D<\B,-&2&;^
M)R<G.T8&<^Q_M=:3XV^'W[1_PX_;?T'P!J>J:+::5#!X@L=/A,D]H&$N2P[9
MCN&4$X7=& 2NX9_,:4\%F& JXZE%1BZN'=2E&,K0H4Y:<WNI3D]YVNDEV/U6
MK#'9=F%' 59.4E2Q*IUI3C>=>I%-\OO-PBMH7LVWW*GPOTC1O@C_ ,%5=7^'
M7P]TV'3-#\0^'RTFE6<8CMXF^RI<?*@X7#Q,0 ./,8# .*Z/Q=^RY^RW^RG\
M+O&_Q*^.$UOXNNM>>62*\\1643W;W,BN1#;'&5E=V9BZX(ZD@+D8W[,=GXF_
M:#_;3\1_MD7W@C5="\*6.D?9M$.KVWERSOY"0\ 9#?()6;:6"EE7)ZUX;X^^
M-_BGXV_M&#XH_'GX'^+=>\*:5)(/#OA&VM)888T##9YN4.[<!ND[NV!G8 M=
M%3'9;E^52JRH*3JXBO\ 5^:,N2%.5DZCBD_=W:7+=WTMJSEIX',\QS>-&%=Q
M5+#T/K'+*//.I&[5-2;7O[)OF25O>OHCU#X$6GQ"^&G_  2J\::GJUE>,VO-
M=?V#:+&S2"SNA!:[E4#(4L9I!VP=W0YKSSX4ZK\!_A7X \*+^TG^PQJR:7J
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,]?"Y#CL;0]K1<6O9SJ-<RNHT_BYENGU2>ZU1[I17A?P)_:B\;_%+]J+XA?
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MIGB\7?C;38II=UUJLUN]H+5P)9FD-LDS.BG#NNUW7[3_ ."D'[(/@+_@H?\
ML]6?C#Q1\>?%P^%VG>"=1UZ?P)X7U'[#I_C.1[6.XL9-0E0">6VB"%Q;JR*[
M2*S'Y #X/\6/A#_P6Z_; _9!7_@FG\=O@?\ #SPS%KFF6_AWXD?M%P?$8:C'
MJNDQF-;FZL](%NEP+VYB0@B9DC5G<Y4,/+^]=>^#]EH?[,E[\ OAM:[+>S\"
M2>'] @N)ONHED;:!6?Z!03^- 'S_ /\ !!#_ )0X_L]?]D[MO_1DE?7=?/W_
M  2K_9T^)7[)'_!.WX1_LV?&*ULX?$_@[PC#IVM1:?=B>%9U=R0D@ #C!'-?
M0- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%8OC#XC_#[X?3Z3;>._&^DZ-)KVJ)INB1ZIJ$<!O[QU9DMX0Y'F2E
M48A%R2%/'%;5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !17.?%_7M6\+?"KQ)XET*[\B]L-$NKBTF\M6\N1(F96
MPP(."!P017Q3_P -J_M,_P#12_\ RC67_P 9H ^^:*^!O^&U?VF?^BE_^4:R
M_P#C-'_#:O[3/_12_P#RC67_ ,9H ^^:*^!O^&U?VF?^BE_^4:R_^,T?\-J_
MM,_]%+_\HUE_\9H ^^:*^!O^&U?VF?\ HI?_ )1K+_XS1_PVK^TS_P!%+_\
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M=E97?RL:4JV+G42G2Y5WYD_P/9:***^;.P**** "BBB@ HHHH ***Y/XW_\
M"]/^%:W_ /PS=_PB?_"8[X?[+_X3C[5_9FWS4\WS?LO[W/E;]NW^/;GC-:T:
M?MJT:?,E=I7;LE?JWT2ZF=:I[*E*=F[)NRU;MT2[]CK**^6/^-VG_5K'_ER4
M?\;M/^K6/_+DKW?]7O\ J+H?^#/^ >)_;W_4+6_\ _X)]3T5\L?\;M/^K6/_
M "Y*/^-VG_5K'_ER4?ZO?]1=#_P9_P  /[>_ZA:W_@'_  3ZGHKY8_XW:?\
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ML[.UU#3Y:['U/17RQ_QNT_ZM8_\ +DH_XW:?]6L?^7)5_P"KW_470_\ !G_
M(_M[_J%K?^ ?\$^IZ*^6/^-VG_5K'_ER4?\ &[3_ *M8_P#+DH_U>_ZBZ'_@
MS_@!_;W_ %"UO_ /^"?4]%?+'_&[3_JUC_RY*/\ C=I_U:Q_Y<E'^KW_ %%T
M/_!G_ #^WO\ J%K?^ ?\$^IZ*^6/^-VG_5K'_ER4?\;M/^K6/_+DH_U>_P"H
MNA_X,_X ?V]_U"UO_ /^"?4]%>??LY?\-5_\(?>?\-<_\*^_M_\ M)O[/_X5
MQ]N^Q_8_+3;YGVWY_-\SS,X^7;L[YKT&O$Q-'ZO7E3YE*W6+NGZ,]G#UOK%&
M-3E<;])*S7J@HHHK V"BBB@ HHHH **** "BO/OVC?V@/^&=/!]GXO\ ^%)?
M$'QW]LU);/\ LOX<>&_[4O(,QN_G21^8FV(;-I?/WG08YKQG_AZ1_P!8Z?VI
M_P#PT7_W37KX/(<VS"@JV'I\T7UO%;>K3/*Q>=Y7@:WLJ]2TNUI/\DSZGHKY
M8_X>D?\ 6.G]J?\ \-%_]TT?\/2/^L=/[4__ (:+_P"Z:Z_]5,__ .?/_DT/
M_DCE_P!9\C_Y_?\ DLO_ )$^IZ*^6/\ AZ1_UCI_:G_\-%_]TT?\/2/^L=/[
M4_\ X:+_ .Z:/]5,_P#^?/\ Y-#_ .2#_6?(_P#G]_Y++_Y$^IZ*^6/^'I'_
M %CI_:G_ /#1?_=-'_#TC_K'3^U/_P"&B_\ NFC_ %4S_P#Y\_\ DT/_ )(/
M]9\C_P"?W_DLO_D3ZGHKY8_X>D?]8Z?VI_\ PT7_ -TT?\/2/^L=/[4__AHO
M_NFC_53/_P#GS_Y-#_Y(/]9\C_Y_?^2R_P#D3ZGHKYU^&?\ P4/_ .%E^/\
M2? /_##/[17A_P#M:]2V_MKQ-\,OLFGV>[_EI/-]H;RXQW;!Q7T57EX[+<;E
MM10Q,>5M76J>GR;/2P688/,:;GAY<R3L]&OS2"BBBN$[0HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *_,'Q9_P;??\ "4>*=3\2_P##9?D?VCJ$UUY'_"N]WE^8Y?;G
M^T!G&<9P,^E?I]17T&0\4Y[PS*I++:WLW.W-[L97M>WQ1E;=['A9WPUDG$<8
M1S&E[10OR^]*-KVO\+5]EN?EC_Q#1?\ 5ZO_ )CC_P"^-'_$-%_U>K_YCC_[
MXU^IU%?1_P#$5N/O^@S_ ,ITO_D#Y_\ XACP/_T"?^5*O_R9^6/_ !#1?]7J
M_P#F./\ [XT?\0T7_5ZO_F./_OC7ZG44?\16X^_Z#/\ RG2_^0#_ (ACP/\
M] G_ )4J_P#R9^6/_$-%_P!7J_\ F./_ +XT?\0T7_5ZO_F./_OC7ZG44?\
M$5N/O^@S_P ITO\ Y /^(8\#_P#0)_Y4J_\ R9^6/_$-%_U>K_YCC_[XT?\
M$-%_U>K_ .8X_P#OC7ZG44?\16X^_P"@S_RG2_\ D _XACP/_P! G_E2K_\
M)GY8_P#$-%_U>K_YCC_[XU]Z_L0_LO?\,;?LU:#^SQ_PG/\ PD?]B2WC_P!L
M?V9]C\[S[J6XQY7FR;=OF[?OG.W/&<#UFBO&SSC;B?B/"+"YCB/:04E)+DA'
M5)I.\8I[-];'K9-P;PWP_BGB<OH<DVG%OFG+1M.UI2:W2Z7"BBBOE3Z<****
M "BBB@ HHHH *^4_^"EG_!3C_AW??>#K+_A2/_"8?\)9%?ON_P"$E_L_[+]F
M-N,?\>TV_=Y_^SC;WSQ]65\I_P#!2S_@F/\ \/$+[P=>_P#"[O\ A#_^$3BO
MTV_\(U_:'VK[2;<Y_P"/F'9M\C_:SN[8Y^CX3_U?_MZE_;?^[>]S_'_*^7X/
M>^*VWSTN?/\ %']N_P!AU?[&_P!Y]WE^'^9<WQ^[\-]_EK8^7?\ B)=_ZLJ_
M\R/_ />ZC_B)=_ZLJ_\ ,C__ 'NH_P"(:+_J]7_S''_WQH_XAHO^KU?_ #''
M_P!\:_8_^-!_U]:/R7_C>/\ 7U8/^(EW_JRK_P R/_\ >ZC_ (B7?^K*O_,C
M_P#WNH_XAHO^KU?_ #''_P!\:/\ B&B_ZO5_\QQ_]\:/^-!_U]:#_C>/]?5@
M_P"(EW_JRK_S(_\ ][J/^(EW_JRK_P R/_\ >ZC_ (AHO^KU?_,<?_?&C_B&
MB_ZO5_\ ,<?_ 'QH_P"-!_U]:#_C>/\ 7U8/^(EW_JRK_P R/_\ >ZC_ (B7
M?^K*O_,C_P#WNH_XAHO^KU?_ #''_P!\:/\ B&B_ZO5_\QQ_]\:/^-!_U]:#
M_C>/]?5@_P"(EW_JRK_S(_\ ][J]C_80_P""U7_#;'[1.G_ /_AFK_A&?MVG
MW5U_:W_"9?;=GDQ%]OE?8XLYQC.X8]#7CG_$-%_U>K_YCC_[XU['^PA_P15_
MX8G_ &B=/^/G_#2O_"3?8=/NK7^R?^$-^Q;_ #HBF[S?MDN,9SC:<^HKR\[_
M .(+?V/B/[._C\DN3_>?CM[OQ>[OWT[GI9/_ ,1@_M6A]?\ X'/'G_W?X;^]
M\/O;=M>Q]UT445^&G[0%%%% !1110 4444 %%%4O$FL?\(]X=O\ 7_L_G?8;
M*6X\K?MW[$+;<X.,XQG!H NT5\L_\/+?^J*_^7'_ /<U'_#RW_JBO_EQ_P#W
M-0!]#^.?A?X#^)5QH-WXX\.QZA)X8U^+6]":25U^R7\4<D<<XVL,D)-(,-E?
MFZ=*WZ^6?^'EO_5%?_+C_P#N:C_AY;_U17_RX_\ [FH ^IJ*^6?^'EO_ %17
M_P N/_[FH_X>6_\ 5%?_ "X__N:@#ZFHKY9_X>6_]45_\N/_ .YJ/^'EO_5%
M?_+C_P#N:@#ZFHKY9_X>6_\ 5%?_ "X__N:C_AY;_P!45_\ +C_^YJ /J:BL
MCX?^*O\ A.O VC^-/L'V7^U=-AN_LWF[_*\Q VW=@;L9QG SZ5KT %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!R/Q__P"2&^+_ /L6KW_T2]?G
M#7Z/?'__ )(;XO\ ^Q:O?_1+U^<- !1110 4444 %%%% !1110 5^F7PW_Y)
MWH'_ &!;7_T2M?F;7Z9?#?\ Y)WH'_8%M?\ T2M &U1110 4444 %%%% !11
M10 4444 %%%% 'PC_P '$.K7MW^PAX>^#!N'ATKXI?&_P9X/\2R(Q7_B6W.J
MQR3J2.BN( C>JNP/!-?77QH_9U^!7[1?A/3_  %\=OA1H?BS0M+U>VU.ST37
M;!;BS6ZM]WDR-"WR2;-QPK KG!QP*\A_X*W?LB^*_P!MC]@CQO\ !KX97"6_
MC>UCM?$'P_NF8+Y>N:;<1WMFNX\*))(?)+'A5F8]J](_8]_:2\-_M=_LT>#_
M -H?PU9R60\1Z0LFIZ1<(RS:3J,9,-[I\RL R36]S'- ZD9#Q-0!\L?\$,X(
M+77_ -L^VMH4CCC_ &XO&BQQHH"JHM-+   Z "E6_G^&_P#P<DOH7AJ0QV/Q
M-_9(6]\3V47"S7VEZ^T5I=OZL(+B6$$]C7T1^QS^Q?X8_8ZU#XN:AX:\:W^L
MM\7/C)J_Q"U%;ZW2,6%S?QVT;VL>S[T:"V4AF^8[CFO#/V(_#$_[4G_!3'XV
M_P#!2HQE_">C:%;_  ?^$M_@[=3LM/NWNM:OH^SPMJA,$<BDAQ9.<D;: /MN
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^&?V!-?G_ &EO^"J/
M[67[2WB1C/'\.-4TGX2>!8Y/^8;9VEN+_5 O;-Q>W$;L>NV")>=HK[FKX5_8
M&T:X_9H_X*O_ +67[,GB1#!#\2[[2?BYX#E<'_B8VEU +#5<=LP7L,2D==L\
M9.-PH \%_P""R'["^A>"_P!I?]GC]MGX@?&?QEXV\8:S^VO\/])\,66MZD$T
MGPCHLM^\KV&GV<06-2[V\+2SR;Y9#$O*C(/V=_P6&^$+?&3_ ()I_%_3M+NY
M+/7O#?@^Y\6>$-4MFVSZ?K6CC^TK&>)^L;B>UC&X?PLPY!(-'_@J7^R=\7OV
MLM%^ UC\(+.PFD^'W[3O@[QQXC^WWP@":3IL\SW+1Y!WR .NU!RU6?\ @LA\
M8G^#'_!-#XNW^DV4E[K_ (H\)S^$?!^E6R[I]0UG6!_9EE!$@Y=S-=(VT?PH
MQZ F@#TO]B3X^3?M4?L=?"S]I.[M8X+GQW\/M(UV]MXAA8;BYLXI98Q[+(SK
M^%>H5YA^Q1\ Y/V5_P!CWX6_LV7%TEQ/X$^'^D:%=W,1RL\]K9Q0RR#V:16;
M\:]/H **** "BBB@ HHHH **** "BBB@ HHHH **** "OC+_ (+T_%_QK\-_
M^"=^K_#OX::W-I?B+XO>+-$^'&E:I V'M!K%ZEM<R*>H;[*;E5(P59E/:OLV
MOC'_ (+W_"#QO\2O^"=&M_$'X8Z+)J?B3X1>*=%^(VD:9""6N_['O$N;B,8Y
M+?91<E0.2RJ!UH ];^(7_!/3]F3Q_J7P1OO$>@W46C_L]77VOX?^&HKE%TJ.
M2.Q%G;R7$#H1*;:,!H6!4QN-V3R*^5/A1XM\/_\ !17_ (+=Z%^UQ^RII4<W
MPQ^ '@36_"7B[XKV<6VT\;:S?% ND6LH_P"/VWLL&<S*3&LCD#AXW?;_ ."N
M?@O]N7_@H3^S=\+?#/\ P3PTC2?$?PG\?)#KOQ-8^/?^$?NO$6@R1036NEQ7
M2QR/#;W22R&=D&\JBH#AW![_ /81U;_@HO\ #W6_"G[/_P 0?^";'PF^$?PC
MT739;6*X\#_%4:@VEI'"[0I%9BSB$F^;:&8N#\[.2QSD YWX3:]<?L\_\%\O
MB5^S[HC>7X8^.?P.T_XD268XB@\1:;>C1[IXT'"M/:?97D;^-K=2>>3]S5\+
M?![19_VB_P#@OE\4/VA=%0R>&?@5\$].^&9O "8KCQ#J-X-8NTC<<,T%J;:.
M1?X6G //3[IH **** "BBB@ HHHH **** "BBB@ HHHH **** "J?B/Q!HWA
M+P]?^*O$5^EKI^F64MW?74GW888T+NY]@H)_"KE<3^TK\/\ 5_BS^SGX_P#A
M7X?E"7_B;P3JNE6+EMH6:XLY84.>WS..: /AW]B?P?\ M3?ME?\ !./XK?MP
M_!?Q]8^#?CC^U%->7WA#Q'KWF&/PGX?AN)++1K*,Q*Y406*RW"LBG_2;V20@
MEC7D/_!1+]B/X'_\$NOAK\'OB1^Q+X_\=6O[3FL_%#P_HOA:\N/B!JFHWOQ'
MFENHEU.+4[6XN)(I[9X&EEE<1JL3&, H& /J_P"P?^W/IO[*O_!N/\/?VH-,
M^&.L^*M4\ ?#J/08_!6CV4CWMWK=G=MI7V1TC5GB'VJ/,C;24C#OM.,'P+_@
MG_\ MV_L8^'/BLG[=/[?7BOXK?$']I#Q-8BU2\'P)\1KHW@&RF_Y@VB0M9E8
M(EWE)+DDR3'>2V'?> ?8G[;'BJ3]BG_@HQ\!OVL-"D-MX<^-OB*'X/?%*SC.
M([R[N(Y[CP[?%1@>=!<I=6YD.28;S;GY4%?;%?!W_!<RSG^(MW^RC^SOX94S
M>(/%G[6GA6_M;>(9DBT_2UN;Z_NP.N(84!)_VQTK[QH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "N/\9_ 3X2_$#XJ>#_C;XK\(K<>*_ 37W_"*:W%
M>3P36:7D/DW,3>4ZB:&1 I:*4/'OCC?;OC1E["B@ KC_ (E_ 3X2_&+Q3X.\
M9?$SPBNKWW@#7SK?A,7-Y.(+'4?(DMUNC KB*:5(YI!&TJ.8BY9-K?-7844
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4V6**>)H9HU='4JZ,
M,A@>H([BG44 <C\"_@3\*?V:?AAI_P &/@CX5_L/POI,EPVE:.E[//'9K-/)
M.\<1G=VCB#R-LB4B.)=J1JB*JCKJ** ./^"?P$^$O[.OA:]\&_!WPBNDV.IZ
M_?ZWJA>\GN9[[4;V=KBZNIY[AWEFEDD<DL[L0 JC"JJCL*** "BBB@ HHHH
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M_ #_ )(;X0_[%JR_]$I774 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!R/Q_\ ^2&^+_\ L6KW_P!$O7YPU^CWQ_\ ^2&^+_\ L6KW_P!$O7YP
MT %%%% !1110 4444 %%%% !7Z9?#?\ Y)WH'_8%M?\ T2M?F;7Z9?#?_DG>
M@?\ 8%M?_1*T ;5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5B_$C_DG>O_ /8%NO\ T2U;58OQ(_Y)WK__ &!;K_T2U 'YFT444 %%%% !
M1110 4444 %%%% 'Z/? #_DAOA#_ +%JR_\ 1*5UU<C\ /\ DAOA#_L6K+_T
M2E==0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '(_'_P#Y(;XO
M_P"Q:O?_ $2]?G#7Z/?'_P#Y(;XO_P"Q:O?_ $2]?G#0 4444 %%%% !1110
M 4444 %?IE\-_P#DG>@?]@6U_P#1*U^9M?IE\-_^2=Z!_P!@6U_]$K0!M444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6+\2/^2=Z_\ ]@6Z
M_P#1+5M5B_$C_DG>O_\ 8%NO_1+4 ?F;1110 4444 %%%% !1110 4444 ?H
M]\ /^2&^$/\ L6K+_P!$I775R/P _P"2&^$/^Q:LO_1*5UU !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 <C\?_ /DAOB__ +%J]_\ 1+U^<-?H
M]\?_ /DAOB__ +%J]_\ 1+U^<- !1110 4444 %%%% !1110 5^F7PW_ .2=
MZ!_V!;7_ -$K7YFU^F7PW_Y)WH'_ &!;7_T2M &U1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %8OQ(_Y)WK_P#V!;K_ -$M6U6+\2/^2=Z_
M_P!@6Z_]$M0!^9M%%% !1110 4444 %%%% !1110!^CWP _Y(;X0_P"Q:LO_
M $2E==7(_ #_ )(;X0_[%JR_]$I774 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!R/Q_\ ^2&^+_\ L6KW_P!$O7YPU^CWQ_\ ^2&^+_\ L6KW
M_P!$O7YPT %%%% !1110 4444 %%%% !7Z9?#?\ Y)WH'_8%M?\ T2M?F;7Z
M9?#?_DG>@?\ 8%M?_1*T ;5%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5B_$C_DG>O_ /8%NO\ T2U;58OQ(_Y)WK__ &!;K_T2U 'YFT44
M4 %%%% !1110 4444 %%%% 'Z/? #_DAOA#_ +%JR_\ 1*5UU<C\ /\ DAOA
M#_L6K+_T2E==0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '(_'
M_P#Y(;XO_P"Q:O?_ $2]?G#7Z/?'_P#Y(;XO_P"Q:O?_ $2]?G#0 4444 %%
M%% !1110 4444 %?IE\-_P#DG>@?]@6U_P#1*U^9M?IE\-_^2=Z!_P!@6U_]
M$K0!M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6+\2/^2=
MZ_\ ]@6Z_P#1+5M5B_$C_DG>O_\ 8%NO_1+4 ?F;1110 4444 %%%% !1110
M 4444 ?H]\ /^2&^$/\ L6K+_P!$I775R/P _P"2&^$/^Q:LO_1*5UU !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 <C\?_ /DAOB__ +%J]_\
M1+U^<-?H]\?_ /DAOB__ +%J]_\ 1+U^<- !1110 4444 %%%% !1110 5^F
M7PW_ .2=Z!_V!;7_ -$K7YFU^F7PW_Y)WH'_ &!;7_T2M &U1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %8OQ(_Y)WK_P#V!;K_ -$M6U6+
M\2/^2=Z__P!@6Z_]$M0!^9M%%% !1110 4444 %%%% !1110!^CWP _Y(;X0
M_P"Q:LO_ $2E==7(_ #_ )(;X0_[%JR_]$I774 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!R/Q_\ ^2&^+_\ L6KW_P!$O7YPU^CWQ_\ ^2&^
M+_\ L6KW_P!$O7YPT %%%% !1110 4444 %%%% !7Z9?#?\ Y)WH'_8%M?\
MT2M?F;7Z9?#?_DG>@?\ 8%M?_1*T ;5%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5B_$C_DG>O_ /8%NO\ T2U;58OQ(_Y)WK__ &!;K_T2
MU 'YFT444 %%%% !1110 4444 %%%% 'Z/? #_DAOA#_ +%JR_\ 1*5UU<C\
M /\ DAOA#_L6K+_T2E==0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% '(_'_P#Y(;XO_P"Q:O?_ $2]?G#7Z/?'_P#Y(;XO_P"Q:O?_ $2]?G#0
M 4444 %%%% !1110 4444 %?IE\-_P#DG>@?]@6U_P#1*U^9M?IE\-_^2=Z!
M_P!@6U_]$K0!M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M6+\2/^2=Z_\ ]@6Z_P#1+5M5B_$C_DG>O_\ 8%NO_1+4 ?F;1110 4444 %%
M%% !1110 4444 ?H]\ /^2&^$/\ L6K+_P!$I775R/P _P"2&^$/^Q:LO_1*
M5UU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <C\?_ /DAOB__
M +%J]_\ 1+U^<-?H]\?_ /DAOB__ +%J]_\ 1+U^<- !1110 4444 %%%% !
M1110 5^F7PW_ .2=Z!_V!;7_ -$K7YFU^F7PW_Y)WH'_ &!;7_T2M &U1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8OQ(_Y)WK_P#V!;K_
M -$M6U6+\2/^2=Z__P!@6Z_]$M0!^9M%%% !1110 4444 %%%% !1110!^CW
MP _Y(;X0_P"Q:LO_ $2E==7(_ #_ )(;X0_[%JR_]$I774 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!R/Q_\ ^2&^+_\ L6KW_P!$O7YPU^CW
MQ_\ ^2&^+_\ L6KW_P!$O7YPT %%%% !1110 4444 %%%% !7Z9?#?\ Y)WH
M'_8%M?\ T2M?F;7Z9?#?_DG>@?\ 8%M?_1*T ;5%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5B_$C_DG>O_ /8%NO\ T2U;58OQ(_Y)WK__
M &!;K_T2U 'YFT444 %%%% !1110 4444 %%%% 'Z/? #_DAOA#_ +%JR_\
M1*5UU<C\ /\ DAOA#_L6K+_T2E==0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% '(_'_P#Y(;XO_P"Q:O?_ $2]?G#7Z/?'_P#Y(;XO_P"Q:O?_
M $2]?G#0 4444 %%%% !1110 4444 %?IE\-_P#DG>@?]@6U_P#1*U^9M?IE
M\-_^2=Z!_P!@6U_]$K0!M4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !6+\2/^2=Z_\ ]@6Z_P#1+5M5B_$C_DG>O_\ 8%NO_1+4 ?F;1110
M 4444 %%%% !1110 4444 ?H]\ /^2&^$/\ L6K+_P!$I775R/P _P"2&^$/
M^Q:LO_1*5UU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <C\?_
M /DAOB__ +%J]_\ 1+U^<-?H]\?_ /DAOB__ +%J]_\ 1+U^<- !1110 444
M4 %%%% !1110 5^F7PW_ .2=Z!_V!;7_ -$K7YFU^F7PW_Y)WH'_ &!;7_T2
MM &U1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8OQ(_Y)WK
M_P#V!;K_ -$M6U6+\2/^2=Z__P!@6Z_]$M0!^9M%%% !1110 4444 %%%% !
M1110!^CWP _Y(;X0_P"Q:LO_ $2E==7(_ #_ )(;X0_[%JR_]$I774 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!R/Q_\ ^2&^+_\ L6KW_P!$
MO7YPU^CWQ_\ ^2&^+_\ L6KW_P!$O7YPT %%%% !1110 4444 %%%% !7Z9?
M#?\ Y)WH'_8%M?\ T2M?F;7Z9?#?_DG>@?\ 8%M?_1*T ;5%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5B_$C_DG>O_ /8%NO\ T2U;58OQ
M(_Y)WK__ &!;K_T2U 'YFT444 %%%% !1110 4444 %%%% 'Z/? #_DAOA#_
M +%JR_\ 1*5UU<C\ /\ DAOA#_L6K+_T2E==0 4444 %%%% !1110 4444 %
M%%% !116?XK\5^'/ WAR[\6^+=7AL--L(3+>7DYPD2=-QQVYH T**\H_X;G_
M &1_^B]:#_W^?_XFC_AN?]D?_HO6@_\ ?Y__ (F@#U>BO*/^&Y_V1_\ HO6@
M_P#?Y_\ XFC_ (;G_9'_ .B]:#_W^?\ ^)H ZGX__P#)#?%__8M7O_HEZ_.&
MOM+XO_MD_LN>*?A5XD\-:%\;]!GO;_1+JWM(?M)7S)'B957+  9)')(%?%/]
MI:!_T-^@_P#@_M?_ (Y0!)14?]I:!_T-^@_^#^U_^.4?VEH'_0WZ#_X/[7_X
MY0!)14?]I:!_T-^@_P#@_M?_ (Y1_:6@?]#?H/\ X/[7_P".4 245'_:6@?]
M#?H/_@_M?_CE']I:!_T-^@_^#^U_^.4 245'_:6@?]#?H/\ X/[7_P".4?VE
MH'_0WZ#_ .#^U_\ CE $E?IE\-_^2=Z!_P!@6U_]$K7YD_VEH'_0WZ#_ .#^
MU_\ CE?<O@G]M;]E/2/!FD:3J/QTT&.XM=+MX9X_M#':ZQJK#(!!P0>G% 'M
M=%>4?\-S_LC_ /1>M!_[_/\ _$T?\-S_ +(__1>M!_[_ #__ !- 'J]%>4?\
M-S_LC_\ 1>M!_P"_S_\ Q-'_  W/^R/_ -%ZT'_O\_\ \30!ZO17E'_#<_[(
M_P#T7K0?^_S_ /Q-'_#<_P"R/_T7K0?^_P __P 30!ZO17E'_#<_[(__ $7K
M0?\ O\__ ,31_P -S_LC_P#1>M!_[_/_ /$T >KT5Y1_PW/^R/\ ]%ZT'_O\
M_P#\31_PW/\ LC_]%ZT'_O\ /_\ $T >KT5Y1_PW/^R/_P!%ZT'_ +_/_P#$
MT?\ #<_[(_\ T7K0?^_S_P#Q- 'J]%>4?\-S_LC_ /1>M!_[_/\ _$T?\-S_
M +(__1>M!_[_ #__ !- 'J]%>4?\-S_LC_\ 1>M!_P"_S_\ Q-'_  W/^R/_
M -%ZT'_O\_\ \30!ZO17E'_#<_[(_P#T7K0?^_S_ /Q-'_#<_P"R/_T7K0?^
M_P __P 30!ZO17E'_#<_[(__ $7K0?\ O\__ ,31_P -S_LC_P#1>M!_[_/_
M /$T >KT5Y1_PW/^R/\ ]%ZT'_O\_P#\31_PW/\ LC_]%ZT'_O\ /_\ $T >
MKT5Y1_PW/^R/_P!%ZT'_ +_/_P#$T?\ #<_[(_\ T7K0?^_S_P#Q- 'J]%>4
M?\-S_LC_ /1>M!_[_/\ _$T?\-S_ +(__1>M!_[_ #__ !- 'J]%>4?\-S_L
MC_\ 1>M!_P"_S_\ Q-'_  W/^R/_ -%ZT'_O\_\ \30!ZO17E'_#<_[(_P#T
M7K0?^_S_ /Q-'_#<_P"R/_T7K0?^_P __P 30!ZO17E'_#<_[(__ $7K0?\
MO\__ ,31_P -S_LC_P#1>M!_[_/_ /$T >KT5Y1_PW/^R/\ ]%ZT'_O\_P#\
M31_PW/\ LC_]%ZT'_O\ /_\ $T >KT5Y1_PW/^R/_P!%ZT'_ +_/_P#$T?\
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M_LC_ /1>M!_[_/\ _$T?\-S_ +(__1>M!_[_ #__ !- 'J]%>4?\-S_LC_\
M1>M!_P"_S_\ Q-'_  W/^R/_ -%ZT'_O\_\ \30!ZO17E'_#<_[(_P#T7K0?
M^_S_ /Q-'_#<_P"R/_T7K0?^_P __P 30!ZO17E'_#<_[(__ $7K0?\ O\__
M ,31_P -S_LC_P#1>M!_[_/_ /$T >KT5Y1_PW/^R/\ ]%ZT'_O\_P#\31_P
MW/\ LC_]%ZT'_O\ /_\ $T >KT5Y1_PW/^R/_P!%ZT'_ +_/_P#$T?\ #<_[
M(_\ T7K0?^_S_P#Q- 'J]%>4?\-S_LC_ /1>M!_[_/\ _$T?\-S_ +(__1>M
M!_[_ #__ !- 'J]%>4?\-S_LC_\ 1>M!_P"_S_\ Q-'_  W/^R/_ -%ZT'_O
M\_\ \30!ZO17E'_#<_[(_P#T7K0?^_S_ /Q-'_#<_P"R/_T7K0?^_P __P 3
M0!ZO17E'_#<_[(__ $7K0?\ O\__ ,31_P -S_LC_P#1>M!_[_/_ /$T >KT
M5Y1_PW/^R/\ ]%ZT'_O\_P#\31_PW/\ LC_]%ZT'_O\ /_\ $T >KT5Y1_PW
M/^R/_P!%ZT'_ +_/_P#$T?\ #<_[(_\ T7K0?^_S_P#Q- 'J]%>4?\-S_LC_
M /1>M!_[_/\ _$T?\-S_ +(__1>M!_[_ #__ !- 'J]%>4?\-S_LC_\ 1>M!
M_P"_S_\ Q-'_  W/^R/_ -%ZT'_O\_\ \30!ZO17E'_#<_[(_P#T7K0?^_S_
M /Q-'_#<_P"R/_T7K0?^_P __P 30!ZO17E'_#<_[(__ $7K0?\ O\__ ,31
M_P -S_LC_P#1>M!_[_/_ /$T >KT5Y1_PW/^R/\ ]%ZT'_O\_P#\31_PW/\
MLC_]%ZT'_O\ /_\ $T >KT5Y1_PW/^R/_P!%ZT'_ +_/_P#$T?\ #<_[(_\
MT7K0?^_S_P#Q- 'J]%>4?\-S_LC_ /1>M!_[_/\ _$T?\-S_ +(__1>M!_[_
M #__ !- 'J]%>4?\-S_LC_\ 1>M!_P"_S_\ Q-'_  W/^R/_ -%ZT'_O\_\
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M_/\ _$T?\-S_ +(__1>M!_[_ #__ !- 'J]%>4?\-S_LC_\ 1>M!_P"_S_\
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M^.4?VEH'_0WZ#_X/[7_XY0!)14?]I:!_T-^@_P#@_M?_ (Y1_:6@?]#?H/\
MX/[7_P".4 245'_:6@?]#?H/_@_M?_CE']I:!_T-^@_^#^U_^.4 245'_:6@
M?]#?H/\ X/[7_P".4?VEH'_0WZ#_ .#^U_\ CE 'Z1? #_DAOA#_ +%JR_\
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M  J[X9_]$[T+_P %$/\ \36[10!A?\*N^&?_ $3O0O\ P40__$T?\*N^&?\
MT3O0O_!1#_\ $UNT4 87_"KOAG_T3O0O_!1#_P#$T?\ "KOAG_T3O0O_  40
M_P#Q-;M% &%_PJ[X9_\ 1.]"_P#!1#_\31_PJ[X9_P#1.]"_\%$/_P 36[10
M!A?\*N^&?_1.]"_\%$/_ ,31_P *N^&?_1.]"_\ !1#_ /$UNT4 87_"KOAG
M_P!$[T+_ ,%$/_Q-'_"KOAG_ -$[T+_P40__ !-;M% &%_PJ[X9_]$[T+_P4
M0_\ Q-'_  J[X9_]$[T+_P %$/\ \36[10!A?\*N^&?_ $3O0O\ P40__$T?
M\*N^&?\ T3O0O_!1#_\ $UNT4 87_"KOAG_T3O0O_!1#_P#$T?\ "KOAG_T3
MO0O_  40_P#Q-;M% &%_PJ[X9_\ 1.]"_P#!1#_\31_PJ[X9_P#1.]"_\%$/
M_P 36[10!A?\*N^&?_1.]"_\%$/_ ,31_P *N^&?_1.]"_\ !1#_ /$UNT4
M87_"KOAG_P!$[T+_ ,%$/_Q-'_"KOAG_ -$[T+_P40__ !-;M% &%_PJ[X9_
M]$[T+_P40_\ Q-'_  J[X9_]$[T+_P %$/\ \36[10!A?\*N^&?_ $3O0O\
MP40__$T?\*N^&?\ T3O0O_!1#_\ $UNT4 87_"KOAG_T3O0O_!1#_P#$T?\
M"KOAG_T3O0O_  40_P#Q-;M% &%_PJ[X9_\ 1.]"_P#!1#_\31_PJ[X9_P#1
M.]"_\%$/_P 36[10!A?\*N^&?_1.]"_\%$/_ ,31_P *N^&?_1.]"_\ !1#_
M /$UNT4 87_"KOAG_P!$[T+_ ,%$/_Q-'_"KOAG_ -$[T+_P40__ !-;M% &
M%_PJ[X9_]$[T+_P40_\ Q-'_  J[X9_]$[T+_P %$/\ \36[10!A?\*N^&?_
M $3O0O\ P40__$T?\*N^&?\ T3O0O_!1#_\ $UNT4 87_"KOAG_T3O0O_!1#
M_P#$T?\ "KOAG_T3O0O_  40_P#Q-;M% &%_PJ[X9_\ 1.]"_P#!1#_\31_P
MJ[X9_P#1.]"_\%$/_P 36[10!A?\*N^&?_1.]"_\%$/_ ,31_P *N^&?_1.]
M"_\ !1#_ /$UNT4 87_"KOAG_P!$[T+_ ,%$/_Q-'_"KOAG_ -$[T+_P40__
M !-;M% &%_PJ[X9_]$[T+_P40_\ Q-'_  J[X9_]$[T+_P %$/\ \36[10!A
M?\*N^&?_ $3O0O\ P40__$T?\*N^&?\ T3O0O_!1#_\ $UNT4 87_"KOAG_T
M3O0O_!1#_P#$T?\ "KOAG_T3O0O_  40_P#Q-;M% &%_PJ[X9_\ 1.]"_P#!
M1#_\31_PJ[X9_P#1.]"_\%$/_P 36[10!A?\*N^&?_1.]"_\%$/_ ,31_P *
MN^&?_1.]"_\ !1#_ /$UNT4 87_"KOAG_P!$[T+_ ,%$/_Q-'_"KOAG_ -$[
MT+_P40__ !-;M% &%_PJ[X9_]$[T+_P40_\ Q-'_  J[X9_]$[T+_P %$/\
M\36[10!A?\*N^&?_ $3O0O\ P40__$T?\*N^&?\ T3O0O_!1#_\ $UNT4 87
M_"KOAG_T3O0O_!1#_P#$T?\ "KOAG_T3O0O_  40_P#Q-;M% &%_PJ[X9_\
M1.]"_P#!1#_\31_PJ[X9_P#1.]"_\%$/_P 36[10!A?\*N^&?_1.]"_\%$/_
M ,31_P *N^&?_1.]"_\ !1#_ /$UNT4 87_"KOAG_P!$[T+_ ,%$/_Q-'_"K
MOAG_ -$[T+_P40__ !-;M% &%_PJ[X9_]$[T+_P40_\ Q-'_  J[X9_]$[T+
M_P %$/\ \36[10!A?\*N^&?_ $3O0O\ P40__$T?\*N^&?\ T3O0O_!1#_\
M$UNT4 87_"KOAG_T3O0O_!1#_P#$T?\ "KOAG_T3O0O_  40_P#Q-;M% &%_
MPJ[X9_\ 1.]"_P#!1#_\31_PJ[X9_P#1.]"_\%$/_P 36[10!A?\*N^&?_1.
M]"_\%$/_ ,31_P *N^&?_1.]"_\ !1#_ /$UNT4 87_"KOAG_P!$[T+_ ,%$
M/_Q-'_"KOAG_ -$[T+_P40__ !-;M% &%_PJ[X9_]$[T+_P40_\ Q-'_  J[
MX9_]$[T+_P %$/\ \36[10!A?\*N^&?_ $3O0O\ P40__$T?\*N^&?\ T3O0
MO_!1#_\ $UNT4 87_"KOAG_T3O0O_!1#_P#$T?\ "KOAG_T3O0O_  40_P#Q
M-;M% &%_PJ[X9_\ 1.]"_P#!1#_\31_PJ[X9_P#1.]"_\%$/_P 36[10!A?\
M*N^&?_1.]"_\%$/_ ,31_P *N^&?_1.]"_\ !1#_ /$UNT4 87_"KOAG_P!$
M[T+_ ,%$/_Q-'_"KOAG_ -$[T+_P40__ !-;M% &%_PJ[X9_]$[T+_P40_\
MQ-'_  J[X9_]$[T+_P %$/\ \36[10!A?\*N^&?_ $3O0O\ P40__$T?\*N^
M&?\ T3O0O_!1#_\ $UNT4 87_"KOAG_T3O0O_!1#_P#$T?\ "KOAG_T3O0O_
M  40_P#Q-;M% &%_PJ[X9_\ 1.]"_P#!1#_\31_PJ[X9_P#1.]"_\%$/_P 3
M6[10!A?\*N^&?_1.]"_\%$/_ ,31_P *N^&?_1.]"_\ !1#_ /$UNT4 87_"
MKOAG_P!$[T+_ ,%$/_Q-'_"KOAG_ -$[T+_P40__ !-;M% &%_PJ[X9_]$[T
M+_P40_\ Q-'_  J[X9_]$[T+_P %$/\ \36[10!A?\*N^&?_ $3O0O\ P40_
M_$T?\*N^&?\ T3O0O_!1#_\ $UNT4 87_"KOAG_T3O0O_!1#_P#$T?\ "KOA
MG_T3O0O_  40_P#Q-;M% &%_PJ[X9_\ 1.]"_P#!1#_\31_PJ[X9_P#1.]"_
M\%$/_P 36[10!A?\*N^&?_1.]"_\%$/_ ,31_P *N^&?_1.]"_\ !1#_ /$U
MNT4 87_"KOAG_P!$[T+_ ,%$/_Q-'_"KOAG_ -$[T+_P40__ !-;M% &%_PJ
M[X9_]$[T+_P40_\ Q-'_  J[X9_]$[T+_P %$/\ \36[10!A?\*N^&?_ $3O
M0O\ P40__$T?\*N^&?\ T3O0O_!1#_\ $UNT4 87_"KOAG_T3O0O_!1#_P#$
MT?\ "KOAG_T3O0O_  40_P#Q-;M% &%_PJ[X9_\ 1.]"_P#!1#_\31_PJ[X9
M_P#1.]"_\%$/_P 36[10!A?\*N^&?_1.]"_\%$/_ ,31_P *N^&?_1.]"_\
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MYB^&'PQ\1_$J?3FO$\/:#>:F]HDFPSB"!Y2@8@[2VS&<'&>E?%?P5_X*D?\
M!1?]H'X$^'?VDOA5_P $:]0U;PIXIT"'6M%FM_CSHB75U9RQB1"L$L2-YA4\
M(VTYX.*^LOVLO^36/B7_ -D_UG_TAFK\FO@=\$?^"O\ X)_X(@_"KX__ +*'
M_!0_Q#J6C:=\*]*U.[^$>A_#?0;74SH0MT:XM-+U22UGE%Y'!O,3R1N\C* "
M'*Y /U/_ &,/VP?A9^W'^RYX9_:O^%L.H:?H7B.TG=['78%@N]-N+>>2WNK:
MX4,0DD4\,J,02IV9!((->G:3K&DZ]81ZKH>J6U[:R@^5<VDZR1O@X.&4D'FO
MQI_:&L/@[K_[(?[!'[,/_!/C1]'\6?L_?$SQ=J<M]H?Q+\9W.EV/BG48K*>^
MM]-UN]MH)W,TVHM=O+:^4R375N(MJJ!MD\2^%/VKOV%->_:HU'X+^$O@C\&[
MI_V2]4\0M\%O@=XYOM0>QUB"8QVOB>&RDTRTAL&%N;F-O*QYC6\#%&()H _8
M^TU_0K_4[C1;'6K2:\LP#=VD5RK2P9Z;U!RN>V133XD\.BX-H=>LO-%N9S%]
MJ3<(@VTR8SG:&^7/3/%?G_\ !O\ 8F_X)-?LY> OV6?VBO!]]#X&\7ZKK.BV
MW@OX@>#BQU7XAZCJ5@[/9:I<1PS2:C;W0,DTK3$",QAA+"H.?CGX:?L3_L[6
MG_!O#\=?VTQ\,;:_^*.JZ!\2+3_A+KMY)KNST^/Q!J%M]D@W,5A@"6^\H@ W
M22MU=B0#]SY+JUA,8EN8U,K;8@S@;SC.!ZG%?/OQ$_;[@^ O@M/&'[1_P2U;
MPM_:WQVMOAQX0M+36K+4'U>.[U*.RLM88HZBVMY _G/$^98E4@J6(!\ _;X\
M:^$M0^)'_!/72+#Q'937.K?&W3M2TR&*X5FNK2/PU?J\Z 'YHP;B %AQ^]7U
M%?'GQ3^#7P@^*W[._B&;XJ?#30?$"P_\%=-0TT/K>EQ7 2QOO%=O%>V^9%.(
MIXU5)4^ZZJ P(% '['^$/BCXXUSXO>-O!'B7X4-HOA?PW9Z3-X=\;2^(+::'
MQ"UU%,]RBVZ'S;7[.T<:EI>)?.!3A377VNN:)?:C<Z/9:Q:S7=GM^UVL5PK2
M0;AE=Z@Y7(Z9ZU^-'_!1'P]H7@G2?^"I7A7P=HUKI>F:1\$?A/::5I]A L4-
MI!%9Z@D44:* $1%5550    *]N^,W[%7[-G[#G[:?[%'Q&_9B^&MIX6\3>)/
MB-J/ASQIXDL'?[=XIL[GP]?7$_\ :DS,7OY'G@2;S)R[B0;@0: /THN/$&@V
MFI+HUWK=I%>/ TR6DERJRM$.KA2<E1@Y.,<5:CDCFC66)PRL 593D$'H0:_%
M31OV<?V.OV@?^"*7[17[<O[7NAZ/+\?1>?$*?QI\0-4NMFO^&/$-E>W]MIVD
MV]P6\VSB6%+"!+)&6.6.8(4(EQ7ZG_\ !/O_ ),+^"/_ &2'PU_Z:[:@#UVB
MBB@ HHHH **** "OAW0O^"I7[97Q?^*'Q6\&?LK_ /!+J[^(&B_"CXF:CX)U
M3Q ?C-I6DM>7]FD,CE+>[B5E!CN(F&6*_-C=P:^XJ^&_^",<\%KXP_;2NKJ9
M(XH_VTO%;222, JJ--T@DDGH .] 'M_[#/[>'@;]MOP_XILK?X>^(? GCKX?
M:]_8GQ&^''B^*--2\/WQC$D>XQ,T<\$L9\R&XC8I*F2,$$#VK3M?T+5[JZL=
M)UJTNI[*3R[V&WN5=K=^?E<*24/!X..E?BY^V?\ '?XB7EW_ ,%+OVT/V*/&
M$JZ+9^$O '@>/QOX=NF\FZU&VD$.LW%O<0AOGL;*^=&F3+1G#+G:#77^"_V1
M?B?^S)^T7^S!\1_AA\ OV5_V?TN?'UCI2>(/AW\7-3OM1^(VA7%M(;O398CH
M\*ZO))#MNDN+B1BDL$;>8N_- 'ZY3>(_#UM=V^GW&O64<]W*\5K ]T@>9U^\
MJ G+$=P.13]3US1-%B>?6-8M;1(U#.]S<+&%!8*"2Q& 6( ]R!7X_?LT_L5_
M\$^?C-^R)^VO\>OV@/"^@:MXJT'X[_%+[1XTU>56U'P*+/4;JYM3IT['?II5
MG%WF$H9))COWC"@^ _[/GA?_ (*2_MP?LVV?_!0[P0WC"2\_X)Z:=XD\1Z%K
M<TJ1:EJK:O;1+=7<:LOF/MNII=K<+*X8 ,BX /V U#7]"TF[M;#5=:M+6>]D
M\NRAN+E4>X?CY4!(+GD<#/6I-2U+3M'L9=4U?4(+6V@3=-<7,H2.-?5F8@ ?
M6OQ4\ _LX_%']L7XX_M:^*/B1^Q5^SS\41X4^,>M^#[?5OC%\3+_ $G4O _A
MK3XHUTR'3H8M*N4TJV^R@727<$D;R/+*Q/R5V/[.WA.__:P^+W[%7[+W_!0O
MXE^&?C!X*_X4!XG\0Z7-#J4^H>'_ !]XCL=1M;6UEG%U%%_:<EOI;&;$\1_>
M-+)@Y+$ _4CXM_%'QOX-LO"&H_"SX4-XXA\1>,=/TO5I;+Q!;6::1IEP7\[5
M=TQQ<I"%4^3'F23?\O0UU>I^)O#>B7EMIVL^(+&TN+U]EG!=7:1O.WHBL06/
M(X&>M?E5^U#\*/V,/V>_%7PZ^ /[&?C._%GH/_!0KX=77BOX?PLYT;P9J5W;
M2S-9Z:#"L<,<B;;B2WCDD6*65AB+/EC@_P!H_P"'OP?_ &L=%_:T^/7PZ_X)
M\> ?B!HND>)O$NE>+/C_ /M'?$>..\T2ZTFU\FXM="M;?3I[BSM+5D_T?]];
ML['+-A@5 /U+^*?[77PQ^$G[3?PO_92\16]\_B3XKVNN76A3PB/[-:PZ5!!+
M<&=F<,K.;F%(U56W$ODC;SO?!7XD^/\ XA:%K^K_ !.^$4O@B72?%FIZ;I]M
M<Z];7W]H:?;3LD&I!X#MA6>,"00O\\8.U^17Y5_ [X2_"3]H'X\?\$L/BG\<
MOAOH'BWQ)XA_9W\07&MZ]XBTJ&[N]2N=-T;1;BPEFEE4M+);S2SS1LQ+(\LC
M@@LQ/)>%K;3?B#I'@S]FGXO:E-;?"#XE_P#!2/XF:9\2K?[8]O;:RT,^HW.F
MZ3=.I&^"YO(D#0DXD,:CF@#]K-*U[0M<TT:SHFM6EY9G.+JUN5DC..OS*2..
M])#XB\/W&J#1(-<LWO6MQ<+:)=(93$>!)L!SM_VL8K\MOVCO@]\'/V-/V^O&
M7P+_ &*?!NE>#O#/CS]CGQMK7Q6^'OA*W6UTFVFLQ'#I>K&SBQ%;W$AEN+?S
M%5?,4'()&:\L7]BW]F_]G_\ X)1?L6_ML?"OX;VNF?%Z?QA\)-2O?B5'(YUF
M\_M26PAN[6:Z+&26U,%PT MF)B6)415"J!0!^U%?"?P2_P""U.H?%_XC_#C5
M;G]DN]TKX.?&'XC:IX'^&OQ,'C6WN;Z]U6R:[3-WHZPB2S@E>PN@LGG2,NQ3
M(D8<&OI']O3]I#6OV/\ ]B_XG_M1>&_!9\0ZAX#\%7^LV6C$L$N98(691(5^
M81 @,Y'(16(Z5^-'Q'T7Q)_P0]3P5_P6"UO5/!OQTM/C-X>U*^M=,^T0Z7IW
M@[QQK5JUY'J&@V@E6)=/N4"6UU(@^T^5%YADQ(8P ?OE16-\.==U/Q1\/=!\
M3:U-I<EYJ.C6MU=R:)=_:+)I9(E=C;R_\M(22=C_ ,2X/>MF@ HHHH *^8?V
M[?VU?VN?V0[+Q)\0?AS_ ,$_)/B-\/\ PEX.N/$&O>,(OBIIVDM!';12S7,8
MLYXGE<QQ1;@5SOW8 R*^GJ\._P""G?\ RC6_:&_[(;XM_P#3-=4 <?\ L-_M
MM_M9?M7Z7X?^)7Q1_8"/PT^'7BCP9#XBT7QK<_%?3=4\V&>&*>W1K2&-)8]\
M4NXLV-FW##)KZ3T[Q/X:UC2SKFD>(;&ZLE)!O+:[1X@1U&]21^M?F+\8M;^%
M/B;_ ()H?L)?LT>-_@AK_P 5=?\ B!X8\*R>$?A3:>+(-%T7Q+/I_AF.ZF76
M[F>.17L(8_WQ@VN994B'EOMP.8_8=^#?@[PI_P %7_CW^RO\8OV;/@S\+O W
MBO\ 9=T_4OB%\(?AAXC>]\.PEM3N8#-?![2RBANS9R?/Y4*((7B<,2[&@#]:
MI;VS@6-IKN)!,X2$M(!O8] /4GT%<Y\</B]X1_9]^"WB_P"/7C\W(T'P1X7U
M#7];-E!YLWV2SMI+B;RTR-[[(VPN1DX%?D3_ ,$<-3T7XQ?MM>#O '[2'Q&\
M4>(_ /PQ\+ZO-^P?)XQTH6\'BO0X=1N;2YUIG+DW>H6EJEM;P!TC9;(K<K&#
M(7'WK_P6,_:F\:_LI?L:2:U\/].\/?VEXX\8Z-X'77/&%E]IT;P_%JUTMI+J
M5_"2!+;Q1NV48A&9D#94E2 8G[&7_!4OQ]^T7\<_"?P1^-W[),GPXE^)?PL/
MQ!^&&IV7CRWUZ+5=&62W5ENUA@B-C<A;J!]@,T9#,!*67!^H_BYX_A^%'PI\
M3_%*XTQKV/PUX>O=5>S2789Q;P/,8PQ!VEMF,X.,]#7XQ_#G2]=_X-T_VW?"
M7[)>DV_AOXI/^T!=>']$^&'Q1\=^(8[34?"^FI?01:KI-S%YH%MIZO,UU:I;
MJD;2OY;"9URGZ[_MB?\ )H_Q3_[)QKG_ *03T ,_8[_:*LOVNOV5?AY^U#IW
MA670X/'_ (0L->AT>>[$[V2W,*RB)I JARN[&X*,XZ"M7X8?$3XA^-/&?C?P
M[XS^#T_AK3O#>OQV/AO6)=<M[M?$5JUM%*UXL41WVH61WB\N7YR8MP^5A7C'
M_!%S_E$I^SC_ -D;T#_TBBK\^OVH/$VLZ.G[7WA2;Q1?:%X/\9?MQ_#[PS\4
MM=T^^>TDL?"]]8Z)#J#&X0AH$="L+N"/DF92<,: /V5TC7]"\0123Z!K=I?)
M#*8IGL[E90D@ZH2I.&'<'FBUU_0K[5+C1++6K2:]M INK.*Y5I80>A= <KGM
MD5^;G[>7P+_8N_X)H^%O'_Q%_8$LQ\*OCA?_ +-GBUO#7@3X;V'V:PUNRT^"
M*5]7O+:"!H_M5DS!X+F1XW=I)$S-RJ_-O@C]E#XK_"7X+_LW_M(?"KX,_LM?
M"35)/&/A6YT+XZZ3\9-6N/$'CAKYXVN+&\;^Q4?59-2B>97@EE90SDKM"< '
M[9W_ (E\.:4$.J:_96PDN1;1FXND3=,1D1C)Y<_W>M/UC6]%\/6#:KK^KVMC
M:H0'N;RX6*-23@99B ,FORP^ G_!/G]D3]KOXN?MY^-?VE_@QI?C2]LOC7J^
MF:'_ &^K3IHJGP]ILKW%DC';:W+LT>ZXC"RD6\(W8C4#S/P'\*?B5^V9^S)^
MQ)XMM+SX1?&OQKX?_9[N;^^_9]^/U]/]E\2V;&TMCK5L_E31-?0>6L.^XCD&
MR9VRK9:@#]HHKFWGMUNX9T>)T#I*K JRD9!!Z$8[U!H^NZ)XBLO[2\/ZQ:WU
MN7*">SN%E3<."-RDC(]*_#OXN_$T:G^PUX._8U^!/[.5W\,=)/[;*^!/C)\)
M?&WQ1D?P]:S36LFHCP_#K%C%(8=&N)WMUV1Q#:Q:(JHDRWL_PO\ @!\3/V6_
MVU?$&FWUK^SY^RQX?\3?L\>)9/''@WX+^/;^[D>VMT46OBE-..EV<$$MD_F*
M;D$-(LC+EBM 'ZMV/B+P_JFH7.DZ9KMG<7=DP6\M8+I'D@)Z!U!RI^N*N5^+
MO[)_P@\._L'_ !%_99\6?';]B'X9M8:YXKTKPS\._P!JC]G#QF8)_%]WJMG)
M%:G7K&XACNKZ.\4F>:0R2HCJ6&!@']HJ "BBB@ HHHH **** "BBB@ HHHH
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MM+_2[R8%\ -<26RR2L0 6Q(0, @ 'JVE_P#!7GX5^&/V;?B_\9_VC?A'XD\
M^*O@3JMOI7Q'^&K30:C?QWMV(#IJ64L+".\COOM,"V\O[L,SD,$"DU-\.?\
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M+_X);VUY8V%]^TY):2:E?PV-C]M\"Z[ LUS*P2.)6DL0-S,< 9YH ]#\1_\
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M2^%OA]\6M9T*XUNTL)].A\/PP/"D6DW/GC-S>QM($+P@K*TJ+&">*W_V>_\
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MB5I9IGQ.!N9W9C@ 9->D^(O^"<'[#_BO]G'P[^R3X@_9ST*X^'WA&X6X\*:
M6F4Z-.KNZS6MPL@GMY 9)/G20-AV&<$BO;:* /"[K_@F=^PA>?LOS_L83?LT
MZ /AC>:DNHZAX3C,R17MX)5F^TW$BR"6XF,B(QDD=F)1<D[1CC?@G_P1._X)
M7_LY_%31?C=\$OV,O#/A[Q7X=N_M.B:U97%V9;27:R;U#S,N=K,.0>M?4U%
M'SQXQ_X)._\ !.;X@?&BY_:!\8_LD>%;_P 47VL1ZMJ5Q+#*+2_U!#E;NXLE
M<6MQ/N^;S9(F<M\Q)/-?0]%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M?FGXL\%_M)_\%$?^"OWC?XJ?LS?M':3\/M"_96T"/P-H>M:MX"3Q%!?>(M6B
M%UK301O=6ZPRPVZV-J[98C+*!AB:^>_BMIGQ4_8$^&'[>7_!.#X_?$^Q\4K\
M3_@9XE^,OP\\1V'AT:1:WES=6T]OKMI%:B:9866X6&80I(0%:23"A\#]L**
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
(B@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>tnet-20250331_g3.jpg
<TEXT>
begin 644 tnet-20250331_g3.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@!
MX &X P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!QQUKXD^$WQ:\3:#X-_9W_X)Y6\FH7$NWQ$_B>PF2WLLX'RRQ285%Y)>0 D
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MBBON#X,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#/QPT'XU:)^UI\%/#8UTZ3H<EAJNFK"97A0I.C2",$,ZM'.X^3)4J&]QE?\
M!/C]J#]G[Q/%X3^#GBOX>VVG^-M*TS[#HWB"\L(93=JIDD$<<^WS(B0[D(?E
M.3AB6P?CJN?9S2XW6$Q&(5&GS6A"4/<J1]RUI_SRO*VMHM*-G=H^SH\/Y)5X
M%>,PV'=>IRWG.,_?IS]^]X?R1M&^EY)N5U9,^TZ*^*/$_P 8/VK_ !K^WIXK
M_9T^%OQ872M/FA\N"6]LTFCTJ$6\$LDT28RTGWD4$D9E/3AEYWPU\1_VX/!?
M[4.K?L8:=\=(M9OM1*)#XEUBR\TV$9MUNFN(E8DAO*++Y;%EW=,<-7LU./,)
M"K986JX^UE1YDH6=17M%+FN^:VCLDKZO>WBT_#_%U*7,\524O8QK\K<[JD[7
MDWR-+EOJKMNSLMK_ 'S7DWAC]JBV\2_M.ZO^S6OP\U&"32K=Y3KTDP,$VV.-
M\!=O_33'7^$UX5\"OB?^T;\%OVZH_P!EGXJ_%VX\9Z7JUH[I>7L6&1OLCW*2
M)DEHSE"A3<5P<^F.E^&OQQ^*^L_\%*?%?P<U/QK=3>&;'3Y9+32&5/+C806[
M @A=W5V/7O1+BQ8Q8=TU.C+ZS["<7&,GS)-N+?-9+9\T6WV0+A%X*6)51PK1
M^K>WA-2G%<KDDI)<MVUJN65EW9Z3\'/VN]%^,'Q]\7_ 6Q\%W5E<^$7N5GU&
M6[5TN?)N%@.U0 5R3GDFF?LW_M@:)^T9XG\8^&=+\$W6F/X0F6.:6>[607)9
MYDRH"C;_ *DGG/WJ\._8E_Y2*_&G_KMJG_IS2HO^"7SM'\6/C5(C89;^$@^A
M\^]KR\KXESC$XO PJ5+JK5Q,9>ZM8TTW!;:6MTWZGK9KPQDV%P>/J4Z=G2HX
M:<?>EI*HTIO?6]]GHNA]!?LJ?M1VW[4.A:MK=M\/M0\/C2KN. PZA*',VY2V
MX85>!C%>KU\>?L(_M8>/]4_9_P#B-\7?C?XNO->7PLRS0"8(KE1 S>4NU0,L
MP !/<US_ ,(K3]OG]LWPW??''1?V@X_!^GM>2Q:!H]G&R0RE#@J=@SY8;Y=[
M^8Q*MQ@#/=EG&//E>$485,37K1E*T8PC+EC)IRDN;EBNBLW=^9Y^:<%\F:XM
MRG3PV'HRC"\I3G'FE%-1B^7FD^KNE9>2/N.BOEG]D#]K?XE_%+P+X]^&WQ:*
M1>-? UC<E]0AB1#.$$B$LJC:)(Y$P2H"D,O&02?-/V5==_;B_;"^&>KQ6'[1
MY\/V>DZDR_VN;$/>7L[1(1!O3;Y42 !MR\YE/#8 ':N-L%7CAUA*-2K*NIN,
M4HIIP=I1ES2233\[::7NK\+X%QU"6)^MUZ=*-"4%*3<FFJBO&4>6+<DU;I?7
M6UG;[QHKY#_84_:H^-/BSX7?$W3?B3._B+6OA_9M<Z<\BCSKMO+N#]G8H 7^
M>W #8W'S.O KQ[X:_'?XL?'?1]0\6Z]_P4'7P=XK%Q*=.\*WMG]CL) !F,>?
MN6%58_+RKD8RV<YKGGQ_EOU3#5J5*4G74FHMP@UR/EDFYR2<KZ**;;.F'AYF
M?US$T:M6,50<$Y)3FGSKFBTH1DU&VKE))(^\/CM\1]:^$/PEUSXFZ#X._MZ;
M1+,W<NE_;OLQDA4@RL'\M\;4W/C;SMQQ4_P=^*GAKXV?#/1_BAX2D)LM7M!*
ML;,"T+@E9(FQ_$CAE/NM8GP%L_BIX@^"=MI?[0U_H6KZI=V\D-U>Z'/YL%]:
MNN%=L(JABI(8)E3@$'G \"_X)/Z_J.CV/Q%^!]]<M)%X7\1K):ES_P ]#+%(
M!Z#-LIQZN?4UZ,LYQ,,\P4'=4L3"5HR23C."4]>NL6TU=J\5;K?S8Y)AIY#C
M9Q:=;"U(7E%MQG";<-.FDDFG9.TG?I;Z^HHHKZL^1"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "OCN"S?X<?\%>99]1'EP>,_#N^Q=N W^AJ#S[R6CCZD
M"OL2O&/VKOV;/%'Q@UGP?\3OA7JFFZ?XP\%ZU'=6$^JR2);W-ON#/!(T:.V,
MJI'RD8+C^+-?,\4X#$8O"4:V'CS3H5855%;R47:27GRMV\SZGA3,,-@\77H8
MB7+"O2J4G)[1<E>+?ES15_)L\]_;5^)/[5GP/^*%IX\\+6M[XA^&MYI;P:IH
MMG81D6DK1O&Y>1(S(HY6168[=P*G P#XM^RUX+\>?M(?$?X0:MHOPSN](T'X
M9V,1U3Q3=0E%U!XIVF6-&P XW80*"2 SL< XK]#+RRAU/3I=.U"(&.XA:.>-
M7."K## '@]SSQ6;X!\">%_ACX.T_P#X+T\VFE:7!Y-E;M,\AC3).-SDL>2>I
M->3C>#:^.SQ8FKB9.A?F<'JU+FA)1BW=J#<$VE:UK+23MZ^!XVH9?D+PM+"Q
M6(2Y%46B<7&<7*4592FE-I-WO>[UBK_*?PN\(>++;_@JWXO\4W/AC48],FTV
M41:C)92"!S]FMA@2$;3R".#V-%IX0\6#_@KQ=>+3X8U'^RCIH U,V4GV<G^R
M$7'F8V_>XZ]>*^Q**ZH\'T8TXP]L_=Q/UG;K=ODWVUW_  .27&=:52<_8KWL
M+]6WZ62Y]M]-OQ/CSQ?X1\63?\%;?#WBN+PQJ+:7'IN)-26RD-NI_LVX7!DQ
MM') Z]2!1\*O"/BRU_X*L>,?%-SX8U&/3)M-E6'49+*00.?L]L,"0C:>01P>
MQK[#HH7!])5_:>V?^\O$[=7'EY=]O/\  'QG6>']E[%?[JL-OT4N;GVW\OQ/
MCS]C;PCXLT?]O_XPZ]JWAC4;6QNYM2^R7MS92)%/G448;'8 -D<C!Z<U#_P3
M:\'^+?#GQ.^,=SXA\+ZC81WEY$;22]L9(EG'GWARA8#=P1T]1ZU]DT48+@^C
M@Z^&J*LW[&=6:TW]JFFM].6_S'C>-*V-H8FDZ*7MJ=&#UV]BTT]M>:WR/A;_
M ()_? GQ5XU_9=^*OPI\3Z)?:+<>(&2"RDU.RDA D\AMCX9064.%SCM57]GK
M]J/XJ_L3^ +G]GSXM?LX^([R_P!.O9WT&6QB(BN/,8N4W[2'3>6(DCWY#8V\
M<_>=%<F'X)GE^'PWU+%.G6HPE#GY(R4H2DY6<6[:/5._K<Z\3QU#,<1BOKV$
M52C7G&IR<\HN,XQ4;J25]5HTUZ6/CS]BO]G[XJ:'X8^)W[0OQ:\/3:9K7CC3
M[UK+1Y(6295D\V:1VC/S)OD90J'YL(21R*V?^"2GA?Q-X4^!?B&R\4^';[39
MY/%CO'#J%H\+LGV6W&X!P"1D$9]C7U517?EO"&%RO$X2K2J-^PC46NKFZCO*
M3?37I;R.#,^,L7FN&Q=&K32]O*F]'905)6C%+JK=;^9\4_\ !//PM\5?"/B?
MXVZEI7@R:WU2>6*308]<M)8+>[F66]*J6(&5)*@D'@,#7FWC3Q-\%/%FGZQI
M?[27[$GB'0/B&T\XLY? VF26EO.Q'R,R/*5+;N2X20,/F'7%?H_17FRX%7]E
M4<##$7C3Y])TXSB^>3E?E>TE>RDG\CTH<??\*U;'SP[4JG)K"K.$ER14;<RW
MC*UW%Q^9\V_\$R/AK\4?A/\ L]7<?Q8M;K3([W5I+S2],U'*26EMY:!F96YB
M#,K-L.,?>Q\U<?\ \$IM-N/$.I?%+XSF%A:^(/$J16;,,9*M-.X_*XCKZ3^/
MGACX@^-?@[X@\&_"V_T^UUO5M.>SM;K5)Y(X85D^21]T:.P81E]N%^]CI57]
MG#X)Z1^SU\&]%^%FE2I,]A;[K^[5<?:;ISNEDYYP6) !Z*%':NC"\.SP>9Y?
MAZ=W1PE.;YI?:E-<B7R7,^R7*CGQ?$D,;E68XBI95L94@N6/V80?.W\WRKNV
MI,[FBBBON#X,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_GV?Z"!1110 4444 %?RWU_4A7\M]?T%X$_\S'_N#_[E/Y]\=O\ F7?]QO\
MW$%%%%?T$?SZ%%%% !1110 4444 %%%% !1110 4444 %%%% !7]2%?RWU_4
MA7\^^.W_ #+O^XW_ +B/Z"\"?^9C_P!P?_<H4445_/I_004444 %%%% !111
M0 4444 %%%% '\M]%%%?Z"'^?84444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% ']2%%%%?Y]G^@@4444 %%%% !7\M]?U(5_+?7]!>!/\ S,?^X/\
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M/_0J?^3T'_QRC_A0GQ9_Z%3_ ,GH/_CE?2%%'_$Z'BC_ - >#_\ !=?_ .:
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MS?17TA_PH3X3?]"I_P"3T_\ \<H_X4)\)O\ H5/_ ">G_P#CE'_$Z'A=_P!
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M ?NA1117]V'\!A1110 4444 %?A?7[H5^%]?A/C7_P P'_<7_P!QG[]X&_\
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M_P!Q?_<9^_>!O_,P_P"X7_N4****_"3]^"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K]T*_"^OW0K]V\%/^8_\ [A?^Y#\!\<O^9?\ ]Q?_ '$%%%%?
MNQ^ A1110 4444 %%%% !1110 4444 ?A?1117\)G]^!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 ?NA1117]V'\!A1110 4444 %?A?7[H5^%]
M?A/C7_S ?]Q?_<9^_>!O_,P_[A?^Y0HHHK\)/WX**** "BBB@ HHHH ****
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M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^Z%%%%?W8?P&%%%%
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M_P"X7_N0_ ?'+_F7_P#<7_W$%%%%?NQ^ A1110 4444 %%%% !1110 4444
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MY2>%K>=[=R"T;E25.1D'%,HHKY<^K6P4444 %%%% !7[H5^%]?NA7[MX*?\
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M XSXS? SPA\<],LM)\7ZIK5K'8SM-"VBZM):,S%=I#%/O#'8UY]_P[W^"?\
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MW_X65S_C1_P[W^"?_0V^._\ PLKG_&O=** /"_\ AWO\$_\ H;?'?_A97/\
MC1_P[W^"?_0V^.__  LKG_&O=** /"_^'>_P3_Z&WQW_ .%E<_XT?\.]_@G_
M -#;X[_\+*Y_QKW2B@#PO_AWO\$_^AM\=_\ A97/^-'_  [W^"?_ $-OCO\
M\+*Y_P :]THH \+_ .'>_P $_P#H;?'?_A97/^-'_#O?X)_]#;X[_P#"RN?\
M:]THH \+_P"'>_P3_P"AM\=_^%E<_P"-'_#O?X)_]#;X[_\ "RN?\:]THH \
M+_X=[_!/_H;?'?\ X65S_C1_P[W^"?\ T-OCO_PLKG_&O=** /"_^'>_P3_Z
M&WQW_P"%E<_XT?\ #O?X)_\ 0V^._P#PLKG_ !KW2B@#PO\ X=[_  3_ .AM
M\=_^%E<_XT?\.]_@G_T-OCO_ ,+*Y_QKW2B@#PO_ (=[_!/_ *&WQW_X65S_
M (T?\.]_@G_T-OCO_P +*Y_QKW2B@#PO_AWO\$_^AM\=_P#A97/^-'_#O?X)
M_P#0V^.__"RN?\:]THH \+_X=[_!/_H;?'?_ (65S_C1_P .]_@G_P!#;X[_
M /"RN?\ &O=** /"_P#AWO\ !/\ Z&WQW_X65S_C1_P[W^"?_0V^._\ PLKG
M_&O=** /"_\ AWO\$_\ H;?'?_A97/\ C1_P[W^"?_0V^.__  LKG_&O=**
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M[P?D< CB/^#D_P#8]^%OQ:_X)V?%#]JOXGW7B+4M;\#_  ZBC\)^&9_$$O\
M8>D7S7JB34DLDVQRWK1W#0>?+OVQHH14.6(!^DZL'4,IR",BEIEO_P >\?\
MN#^5/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU_L<^-OV1?%WC>;08/'&BI87NN:=8B5[8B6.4ND3O@Y,>,%N >IQ7&?L[_\
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M4>%/A5X<\+ZI\/?A1JJZ'>Z'IOFW=U9RO>F-Y98I&DE81Q[4#(/,WX4#L_\
M@C9\=?C7\8?@/\1? _QR^)$OCF^^$OQQ\2_#_1OB#<V\<<_BC3=-DB$%]-Y0
M$;S#S6@=T&&>W8G+%F/=_'W_ ()A_L9_M)^)]%\=_$7X>ZS:>(]!\/KH-CXF
M\)^.-7T/4Y-*!S]AGNM/NH9;J#.3LF9P"S$8+,3ZG\#O@9\(OV:OA5HWP0^!
M'P_T[POX4\/VQ@TC1-+B*Q0*6+L<DEG=G9G9V)=V9F8EB20#K**** "BBB@
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>tnet-20250331_g4.jpg
<TEXT>
begin 644 tnet-20250331_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOH$'Q!:_ECYW& 0C-Q[$V8W#W;K7ZFVMK;6-K'96<"10PQA(HHUPJ*!@ #L
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$?VG]9_8MT_XZ1:O>WS*L?B;6++S6T^(VZW37$08DAO))7RV++N(Q@_-75_
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M12:6MC]1RW@SAFOF,<3B(-86K1H."4I:5:TN1*][NSC)M-Z7['Z"_M7?M/\
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MJFOFWX8_MQ?M5>'/AMX>\/:)^PIXGU*RL-#M+:TU&&SOBEU$D**DJE;4@A@
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M_: _95U#1?$VB?MSZ?X_U&:ZQK'AR&X6YBM\*&*N-[C8>5R!&XR" ,\>K?\
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M63FN:3M?EC=V(PW =7%T)XBGBZ;I1ER*:51Q<N52=VH/DBKVYI65SZY_:?\
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MO&GA5;6&W\3Z-;PM(R^674E@N2%:-UVMC >/YL9&:/P9?X;?&GX^Z+:? O\
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MG@OP5X/^''A'3? 'P^\+:?HFAZ-91V>D:/I-FEO;65O&H5(HHD 5$50 %
M%:= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9GC+QMX,^'7AJ
MZ\9_$'Q=IFA:/8H'O=6UF_CM;:W4D %Y9654&2!DD<D5I(Z2()(W#*PRK Y!
M'K7Y(_\ !PS\,M3?XS#XV?M(_ #Q5\1/@A8_!&?3/#$NB:9+JFG^#?&+:J))
MM4U"RB)94EL#'!'=%'6-D*X!<,/J;]@3PI\)]#_8*\5+_P $@/VB]'\9:'K'
MBC4KSX<Q>.KJYN-'\%S3/$9-'$$:1WEO;6^7E2TEQ*&FP65'! !]DT5\!_\
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M7'D@,YN8R5GD&-LD@)W2*YR<T >\T444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!\M_\/I/^":'_ $<I_P"6=K/_ ,AT?\/I/^":'_1RG_EG
M:S_\AU^"=%?U'_Q!+A7_ )_5_P#P*G_\K/Y<_P"(V\5?\^:'_@-3_P"6'[V?
M\/I/^":'_1RG_EG:S_\ (='_  ^D_P"":'_1RG_EG:S_ /(=?@G11_Q!+A7_
M )_5_P#P*G_\K#_B-O%7_/FA_P" U/\ Y8?O9_P^D_X)H?\ 1RG_ )9VL_\
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M@@4444 %%%% !7P-_P -J_M,_P#12_\ RC67_P 9K[YK\LZ /4_^&U?VF?\
MHI?_ )1K+_XS1_PVK^TS_P!%+_\ *-9?_&:\LHH ]3_X;5_:9_Z*7_Y1K+_X
MS1_PVK^TS_T4O_RC67_QFO+** /4_P#AM7]IG_HI?_E&LO\ XS1_PVK^TS_T
M4O\ \HUE_P#&:\LHH ]3_P"&U?VF?^BE_P#E&LO_ (S1_P -J_M,_P#12_\
MRC67_P 9KRRB@#U/_AM7]IG_ **7_P"4:R_^,T?\-J_M,_\ 12__ "C67_QF
MO+** /4_^&U?VF?^BE_^4:R_^,T?\-J_M,_]%+_\HUE_\9KRRB@#U/\ X;5_
M:9_Z*7_Y1K+_ .,T?\-J_M,_]%+_ /*-9?\ QFO+** /4_\ AM7]IG_HI?\
MY1K+_P",T?\ #:O[3/\ T4O_ ,HUE_\ &:\LHH ]3_X;5_:9_P"BE_\ E&LO
M_C-??-?EG7ZF4 %%%% !1110 4444 %%%% !1110 4444 ?RWT445_H(?Y]A
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?U(4445_GV?Z"!1110
M 4444 %?EG7ZF5^6= !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %?J97Y9U^IE !1110 4444 %%%% !1110 4444 %%%% '\M]%%%?Z"'^?84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% ']2%%%%?Y]G^@@4444
M%%%% !7Y9U^IE?EG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7ZF5^6=?J90 4444 %%%% !1110 4444 %%%% !1110!_+?1117^@A_GV%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!_4A1117^?9_H(%%%% !
M1110 5^6=?J97Y9T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5^IE?EG7ZF4 %%%% !1110 4444 %%%% !1110 4444 ?RWT445_H(?Y]A11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 ?U(4445_GV?Z"!1110 4
M444 %?EG7ZF5^6= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M?J97Y9U^IE !1110 4444 %%%% !1110 4444 %%%% '\M]%%%?Z"'^?8444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% ']2%%%%?Y]G^@@4444 %%
M%% !7Y9U^IE?EG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
MZF5^6=?J90 4444 %%%% !1110 4444 %%%% !1110!_+?1117^@A_GV%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!_4A1117^?9_H(%%%% !11
M10 5^6=?J97Y9T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^
MIE?EG7ZF4 %%%% !1110 4444 %%%% !1110 4444 ?RWT445_H(?Y]A1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 ?U(4445_GV?Z"!1110 444
M4 %?EG7ZF5^6= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?J
M97Y9U^IE !1110 4444 %%%% !1110 4444 %%%% '\M]%%%?Z"'^?84444
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M_P#Z*+\4_P#PN&_^-5]AT4 ?'G_#DC]D_P#Z*+\4_P#PN&_^-4?\.2/V3_\
MHHOQ3_\ "X;_ .-5]AT4 ?'G_#DC]D__ **+\4__  N&_P#C5'_#DC]D_P#Z
M*+\4_P#PN&_^-5]AT4 ?'G_#DC]D_P#Z*+\4_P#PN&_^-4?\.2/V3_\ HHOQ
M3_\ "X;_ .-5]AT4 ?'G_#DC]D__ **+\4__  N&_P#C5'_#DC]D_P#Z*+\4
M_P#PN&_^-5]AT4 ?'G_#DC]D_P#Z*+\4_P#PN&_^-4?\.2/V3_\ HHOQ3_\
M"X;_ .-5]AT4 >'_ +*_[ 7P9_9"\3ZGXL^&?BCQC?W.K6"VES'XD\0M>1*@
M</E%*J%;('/ID=Z]PHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N
M9^+WQF^%7P"\"7?Q-^,_C[3/#>@V6!<:GJMR(XPS?=1>[NQX5%!9CP :Z:OD
MO]HC3]/^(?\ P5;^!_P[^(]K'<^'=%\":_XE\.6%VH:"YUZ.6WA$A0_+))!
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L !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>tnet-20250331_g5.jpg
<TEXT>
begin 644 tnet-20250331_g5.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@!
MX &X P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>_MB>)?$_P ?KO4+#XAZPDRZ;I%[I$L1:67,LY(Q^Z*QH JL -C'G@5]$_\
M!2O0M;\1_LEZUI7A[1KN_NGU"Q*6UE;M+(P%PA)"J"3@<U[3<>#_  G=>)K?
MQI<^&;"36+6!H+;57M$-Q%$WWD63&X*>XSBM*JRSA2>#X<Q&4U:RDJO/[Z3Y
MFIK>5V[RNWJK)I(C-.+J>-XFPV<4J+BZ7L_<<ERITWM&T5:+26CNTV_(\W_8
M_P!.U#2/V7_ NF:K8S6MS!X<MTFM[B(H\;!>0RG!!]C6I^T-\2M:^$7P:U[Q
M_P"&O#L^K:G96@&F:?;6[RM+<.RQQY5/F*AF#-C^%37:45]'3P52AE:PE*IR
MRC!04K:IJ-E*WEO8^:J8ZG7S9XRM3YHRGSN%]&G*[C?SVN?EU\!_B3\1?AI\
M6-1^.?Q8_98\4^/O%-W<>=9ZAJ!GMUM)#G=($^RR OT"G@(!A0."/J#XR6?C
M_P#;U_8EO]2L_A5=^&_$-GK'VK3?#U]<,\DS6YVD!GCBY>.20*-N-V!GG(^I
M:*^1RO@BK@,#6P-;%NI0JQDI1Y(1;E+[;GK)R72[?3LC[+-N.Z.88^CCZ&#5
M.O2E!QE[2<DHPV@H.T5%]>5+KU;9^</C?XO?&C]H?]G[PA^Q?X>^ OB"W\1:
M3-9VFJW5U:ND?E6T9BC+!E!B_A9V? 78>N<CV#]MOQ'\5?@-^SEX0_9F^"FA
MZQ>3W&AQV6L:QI&GRR-':P1)&RAD4[&F;<2>H56'\61]?44Z?!>(CA*\9XV3
MJU81I^TY4G&G'[*2>[UYI7]+$U..,-+%X>4,#%4:4YU73YFU*I/[3;6T79QC
M:RV=S\[/V6OVE-?_ &6?!'_".^&/V%/$=]JMT VLZ_->SI->N.@Q]A;RXQ_#
M&"0.I)))/T+^UY\8?VK/@SXG\+_$WX8^&9-9\$-#$?$VBV>G++<QN&+.&DV%
MXT9& #@85D.[[P!^CJ*Z,!PKF.!RF6!CCY)+E]FXPA#DY7=_#\:E]I2O?O=W
M.?,.+<MQ^<1Q\LOBV^;VBE.<^?F22^*_(X_9<;6TTLDCX/\ $^I>//\ @HS^
MTAX)U3PQ\*M9\/\ A'PC*LVI:KK$.PD>:DDJAA\I9A&B(JECDEC@9Q]X445Z
MV29&\IG7K5:KJUJTE*<FE&]E:*45HDEYM^9X^>YZLWA0H4:2I4:,7&$$W*UW
MS2;D]6V_)+R"BBBO?/G@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *\-_:7_ &SKO]G?QY:^";?X&^(/$RW.DQWIO]*SY:%I94\L
MX1OF'EYZ]&%>Y45P9CA\;B<-R86M[*=U[W*I:=K/34]#+<1@<+BO:8NA[:%G
M[O,X:]'>.NA\>:9_P5OTW6KN:PT;]FOQ+=SVY_TB&VO%D>+G'S!8R5YXYKZ2
M^ WQ8E^-WPOT_P")$W@Z^T%KYYE.EZC_ *Z+RY7CRW Z[=PXZ$5\H_\ !-+_
M ).N^+__ %\S_P#I=)7K7_!03]JOQ9^SKX.T;PW\,8(V\4^*KJ2'3IY81(+6
M--@>0(>&<M(BJ&!'+$@XP?@N'L^S*CD53.\VQ7/2CSQY%3BG=3Y8M-6;;M9+
M:[WT/T'B/(,KK9_3R/)\)R59<DN=U)-6<.:2:=TDKW;WM'1:V/H6N3^-'QM^
M'/P \$R>/_B=K9LK!9A!"$A:22XG9698HU7JQ",>P 4DD $U\E_%+PY_P4(_
M95\ 1?M!ZO\ M%IXC2SEA;Q#X?N8S+! LCJF &&'3<RJ2GEL,Y7C)&%_P42\
M;^)?CI^S)\/_ -H+1O$?V;PMJ]S##<>&67<8]3V7>Z7?CD)Y<L7;.<XKJS/C
M>MA<NQ+CAIT\12@IJ$U'6+=N?W9:I/XE=-/0Y<JX$HXO,L+S8J%3#59NFYTW
M+2:7-R>]&Z<E\+LTUK?8^[O"GB*S\7^%M-\6:?#)';ZII\-W!', '5)$#J&P
M2,X89P35^OFWX7>$OVOO!G['GV?PAX^TWQ%XIU.VM)_#ESJ&V&/2K![:+$8W
MKM=T .-WRY8$Y P?G[XR?$']I']G/P[IGCW_ (;UL?$7B:6ZB&J>#;6[BNA:
M$J68%0[HRJ1M.43.<CI77C>,GE>"IU\3A:EG!2D_<2C?2RO-<TNO+&[LT<>!
MX*6;8ZKA\-BZ=U-P@O?;E;6[M!N,>G-*R;3/KG]K;]K#1OV3O#.D^)=9\'7.
MLIJM^]JD5K=+$8RJ;]Q+ Y]*]4T^[6_L(+Y4*B>%9 I/3(!Q^M?#_P#P4^\7
MS_$']EOX5^/;JV2&76VAU"2&/.U&FL5D*C/8%L5]M>'/^1>L/^O*+_T 5V91
MF^)Q_$>-P[E>E"-&4%9*W/%MZ[N^F^QQ9QD^&R_AO XE1M6G.M&;NW?DE%+3
M96N]MSQ3]JW]N71?V6O&>C^"K_X;ZAKMQK%C]H@:RNUC(/F&,)M*DL21V]:\
MZO?^"L>FZ&$N?%/[-'BS3K4L!)<32JNW/IO103[9%<3_ ,%1/$#>$_VJ/AEX
MJ339;PZ9:V]V+.#[\_EWQ?RUX/+8P..IJQ\9?^"D=[\:O!FL?L^^&/V;]5CU
MWQ/9/ID%MJ5V"T;3+@,(O+!9P#N7D8(!SQ7P^;<5YAA\XQU!YA['V4DJ</8J
M?.W%.UTKW;TU?4^\RCA'+<1DN Q$<N]O[6+=6?MG3Y$IVO9NUDM=%T/L'X,_
M&+P/\>/A[8_$OX?7TDVGWP8;)TV2P2*</%(N3M=3UY(/!!(()ZFOD[X2V7C#
M_@G?^P3J_B?QOI\,OB*74'OH=):4.D%S<>3!%$[*<,%""1PI_O 'O7E=OXZ_
M:W?X*M^U/_PVKI0U;R3J \#-/;X-N'^[Y6=@?;\WE^7G'\6ZOIGQG/ 82A#&
M8>4L0Z2JU(QY5R1V;?-):MWM!7ENCY9<$T\PQE>>"Q$8X9572IRES/GENDN2
M,M$K7F[1V9^@M%?&GQ^_:6^.'C?]C;P?^UA\'?%5QH-Q:WAM_%NFV2*\))D\
MDN0X8A1-&H49SMN!DG%=)^V'^V9JFB?LJ>$O&OP?U=[+7_'[6[:8UJH>6V10
MKW 4$$%E<I"1@\R'O7=4XURFE3KU)*7+3IPJIZ>_"?P\FN_-:+O;WF<%+@?.
M*M6A3BX\U2K.BUK^[G#XE/3;EO)-7O%'U/17Q_\ M2_M$_'/X$>!/AS^SUH/
MC:(>/?%%I#_;WBG4VC M6DD6,X)78@,K.OF$?(D61R<CE-9^.7QS_8T^(GA;
M4/%?[4>F_$_PKKMT8=<MUFCDELL%=[*0[NN%<LAW!6V$,HX-88OCG+\'B94Z
ME*?+3Y/:2]VU-SM9-<W-*UUS<J:B=&$X"S'&X:-6G6AS5.?V4?>O44+W:?+R
MQO9\O,TY'W717Q_^VG\>_P!HCP%^V-X)^%_P6\6K!'KFB6JQZ7>(IM9;J>ZN
M81++QNVC"$X/1.GKRGQ=\<?M??L8?'#P5>^./VA9O&6E>*KS%[9SV0BA*I+$
ML\2Q\B/"S*5="O/5<#!,9QOA,%6K1EAZCA1FH5)KEY8N5DG\5VFWT5UUW5S!
M<"8S&T*$HXBFIUX.=.#YN:2C=M:1:3275V?39V^ZZ*^5OVL?CC\5_ G[;'PJ
M^&_A'QK=6.AZY/IZZMIT2H4N1)?M&^XE2>4&W@BD_P""FWQQ^+'P8_X0'_A5
M_C6ZT?\ M6_O$U#[,J'SE3[/M!W*>F]NGK77C.+L#@L-C:TX2:PLHQE:VKER
MVY==O>6]CCP?!V/QN*P-"%2*>*C*4;WT4>:_-IO[KM:Y]545\I?MR_M.?$_1
MOC#X:_9=^#/C"S\,WVMQ1SZSXFO'11:QR.RJH=QB,!49V8?,<H%(YSR7A;X]
M?&?]ES]HGPK\-O'G[16G_$[PGXOFCMGODEC>:QF>18]V5=V3:SH2"S*R%L ,
M,C#%<:Y=A<QGAW3DX0G&$ZBY>6,Y6LK.7,TKI2:BTF;X3@;,\7EL,3&I%3J0
ME4A3?-S2A&]W=1Y4W9N*<DVC[:KQ_P#:D_;3^%?[+,%MIWB2*YU77;^+S++0
MM.*^88\D"21FXC0D$ \DD'"G!Q[!7PI\%K*S^+G_  5=\8ZMXV@6Z;PZ]\^F
M0W"[E1K9HK6$A3Q\JL7'HPW=>:Z.*<VQV7T\/AL$U&KB*BIJ35U%.[<K=6DM
M%L<_">48#,:F)Q..3E1P]-U'&+LYM62C?HFWJ]T=EX?_ ."K^BV/B.TTKXT_
ML_>(/!]E>M^XU&2X:XPF0/,,;PQ,5&>=FX^@/2O9/VF?VK/#'[.7PETOXOC0
MW\0Z?J^I06MG_9]XJ!TE@EF24.00RE8^W7<#74?&7X'_  T^/OA1/!?Q2\/#
M4+".[2YC02M&Z2+W5T(9<@E3@C()%?-O_!4[P=X;^'O['?ACP3X/TW['I>F>
M,+2"QM1,\GE1BTO,+N<ECCW)KR,RJ\69!DV-KUL3&JH0YJ<^11FI7U3BER-=
MGOY'L992X1XASO T*&%E1<Y\M2'.Y0<;:-2;YU+NMO,^K/!?B6+QGX.TGQA!
M:M FJZ9!>) [9,8EC5PI(ZD;L9K3KX+^(^G?MN?#;]E_0_VFH_VB_P"SK33]
M)TPV_A+3+$)%:V<@BB@W,V1-)\\9<.IY9OFP *]ZN_BC^T;\8OV,=!^(OP+M
MM*M_%VMZ?$U]=7<R11VJJ&6>6(2 IN+)\H?A0Q.25&?0P'%D:[G1K8>I&K"D
MJJ5HMSB]+Q49/5O2SLUUMK;SLPX0EAU"O1Q-*5*=5TG*\DJ<EK:3E%:):\RN
MGTOI?WJBOSJ^,OQ4_:'_ &7HM'\8:9^W=8>-=:FO$35_"T%RETEK\A9@R[W!
MCRI0G$;?,I&,Y'K7_!0S]I?XM?"_PW\+O%_PL\1W&EG7UGN;^RA"LMR EJZ1
M-N!./WC#C!^8URKCW 0PF*K5Z,X2P_(Y1O"3M.7*K.,FKI[IM->IUOP^S"IC
M,)1H5X3CB.=1E:<5>G'F=U**=FMFDT_0^NZ*^%/VI]2_;L_9@T31/C]XC_:0
M2_DU'5DMK[P[9V 2RLY7C>5850Y66/;&ZEB%;@'))W#T+]MG]L'XB>!_AAX"
MT?X.JMEXD^(MK%/%<A%=K.)DA.Q XV[W>95#$' 5NA((Z)<;8+#T\4\71J4I
M4%%N+47*2F[0Y>635V]+-JU]>MN>/ V.Q-3"K!UZ=6-=SBI1<E&+@KSYN:*=
MDM;I.Z6G2_U317PS^T9!^W;^R)\&5\5WW[2S>([;4[N&WOY6L_\ 2-*N#\X,
M,DFXR1ML:,Y 'S+A 3D=+^T+^V1\3_AE^R[\*[+PAK$;>,_'WA^TEGUR\5#]
MG'D0^9+AAL#N\HPQ&U0'.,X(B?&^#PWMUC:%2E*C",Y)\K;YI<L5'EDTVW;L
MN]K.U0X$QN*]A+!8BG6C6G*$7%R27+'FDY<T4TDK]&]+J]U?[!HKX,\:?&']
MHO\ 8UU3P[\0-7_:LTKXGZ-J-ZMOXAT..ZCE:$E=S",[F8# ?;(-@W* RD'%
M?=NGWUKJEA!J=C*)(+B%989!T9& (/Y&O6R3B"AG-2K1]G*G5I<O-&7*])*\
M6G%R33L^MTU9GD9YP[7R2G2K>TC4I5>;EE%26L7:2:DHR35UTLT[IDU%%%?0
M'SH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\8_\ !.KP
M=XN\/?M0?%C4]?\ "VI6-M=7$YM;B\L9(DFS>R$;&8 -QSQVKK?^"F'[/7Q'
M^*?A[PS\4OA+I,NHZQX.O)9)--MTWS30N8W#QIU=D>)?D')#G&<8KZAHKY"E
MP?A(\-3R:I4;C)M\RT:;GSIK?9V];'V57C+&2XGAG5*FHSBHQY7JFE#D:>WQ
M*_I<^$_CE^V!\5_VM/A2W[.WPZ_9K\26OB'7)((=<>>!O)M@DB2,$)4;5+(,
MO)M"KG.>HV_VOOV:/&'@'_@G=X1^$_AS39]8O/"NM6][JXTZ%I<%TNS.ZJ!N
M*++<]<?=Y..<?:-%<M3@R>-IXB6/Q4JM6K3]DI\L8\L+\VD5HVY:MMZ]+'53
MXVA@JF&CE^$C2HT:OM7#FE+FG;EUD]4E'1)+3=W/A7XO_$CXL_M%_L!6FF_"
MSX>^(]._X1N]T_3_ !'9^2WF:A:169#R1A1F2(2^66 R<+DC ->:?$NT\!_$
M+]F>Q\,?L[_L=>(;+4M+-I-XL\47>B[Y%=1Y;1139:27?*X8@;<*N=F =OZ:
MT5QXW@*IF#<JV+O*5-4Y-TXMZ7LX7;Y-_>2W[IZKNP/B#3RY*-#"6C&JZD4J
MDDM;74[)<^WNM[=FE9_!_P"VSX7\6^+OV)O@Q8>'?!^K7=U9Z?:17EG!ILKR
MV[QV"QN'0+E<.I'([5]R^'T>/0;&.12K+9Q!E(P0=HJW17TN59!#*\PK8M5.
M9U(4XM6M;V<7&^[WO?R/E\VX@GFN74<(Z?*J4ZLD[WO[62E;9;6M?KY'QC^W
M]X.\7:]^V+\)=8T/PKJ5[:6D]B;JZM+&22.'&H!CO900N!SSVYKT3_@H?^R>
M/C[\-?\ A./!6G?\5AX9B::P:!<27UN/F>VR.2W\<?\ M @8WDU]%45QU>$L
M#B5CXXB7-'%--JUN5QC9-/NGJGW.VEQCC\,\OEAX\LL(FD[WYU*5VFNS6C78
M^-/#\WQ7_;3_ &$M;^$?B[P[JEIX[\/"W:W;5[.2W_M41.'B<-( &=T5XV.>
M'PS$!J\=\*>*_A?X4^%5M\,=9_8'O]4^*-EMM<W^B3M!=$/CS9%1UEWE>-JK
M@MSNP<5^EM%>7BN!IXITJLL3>K&G[*4Y4XSYHIW3M*]IJ_Q7=^J/5PG'L,(J
MM*.%M1E4]K&$:LX<LFDI*\;<T':_)96Z,\G^&WP1L-<_97/PD\:?#?2O"AU_
M29UU30M&9GAL9)MQ!4L2?,7*,>2 XX) !KXY_8[_ &=_C%XL_:4\.>!/BYX<
MU&'P_P#"^:\N(!=V4B6[2I<LX6-V&U]UPROQD,B'ZU^CU%>CF/!N S'$8.I*
M37U>RLDO?BG&2C*UE;FBG9*V^AYV6\:YAEN'QM*,4_K%VFV[TY-2BY1O=W<9
M.-V[[:]_C[_@IK\ _&7B3Q9X0^/_ (4\!2>*K/P^4M_$.@PQ-(TMLD_G+E$!
M9HVW2(Y RH(/3)'!^'+_ .$OQN^)6@^#?V>_^"?]H+&5\>)M0\5Z=-$EF"R@
MLKQ2E55 '/S99R0 H(Y^_:*Y<=P30Q>:U,7"JHQJN+G%TX3=XV7NRDFXJ27O
M*SN=6 XZQ&#RBE@YTG*5)2C"2J3@DI:^]&+2FXM^Z[JQ\=_M5^#_ !5J7_!2
M'X4:_I/A?4+C3K.PTU;F^M[*1X8=M]=$AG VK@$'D]"*/^"IWA#Q9XH\:_":
M;PUX8U'44M-2OS=/8V4DPA!DL<%R@.W.UNOH?2OL2BM\9P?1Q>#QN'=5I8FI
M&;=OAY7%V6NM^7RW.?!<9UL'C<#B%13>%IRII7?O<RDKO32W-Y['QE_P4C\*
M^/\ PI\>OAO^TIX=\%WVM:5X:FMS?I8PL_EO;W8N KE0=@<,5#$8R#WQGSO]
MMSXE_$O]K)/!?B[P=\ O%FF^'-*O9H[>YU+33Y]W/+Y1<B./=B)!$H#YP2Y'
M48K]$:*Y,UX(EF-3%J.*E"EB'&4H<L7[T;6?,];:)M=^MM#LRGCN.6T\&YX2
M,ZN&4HPFY27NRO=<JTNKM)ZZ=+ZGQ3_P4,^!GB+3/V@/#?[3$7PLF\:>&(;:
M&V\3Z+!"TC 1L^2P4$A6C<8;!"M'\V,C.9\(9/AI\:OCSHFG? C]A2RL/"]K
M)%-K'B+Q-I\T$MFZ/N9XVCE:/<  $3YF9N3M ./NFBM*W!-"IFT\7"JE"I-3
ME%TX2?,MU&<DW&,K:JS\FC.AQUB*>3T\'4I.4Z<'",E4G%*+V<H1:4I1OH[K
MI=,*^+/VF?@_\:_V:_VJ1^V3\#/!DWB/2]0RVOZ1:1L[QLT8CF5E0%MC@"02
M '8^=PP &^TZ*][/<DHYYA8TY3<)PDIPG'>,EL]=&NZ>Z/G\@SVMD.*G4C!5
M(5(N$X2O:4);K35/LUJF?!GQ@_:^_:._;"TRR^#O[/GP1\2>'9Y[^*74M52Z
MD62,HP95,RHBP(' 8N6R=H''0]M_P40^&7Q"M/V*_!W@1[G5O%NMZ=XBL1J=
M_%#)<S7,@L[L22G +;=[8!/8J"<U]>T5X<^#Z^*PN*CC<9*K4KQ4.;E48QBG
M=<L$[7ON[_K?WH\9X?"8O"2P."C2I4)N?+S.4I2:L^:;5[6V5OOTM\V_M5>'
M/$.J?\$USX<TS0KVYU'_ (1K0$^P06KO-N6>S+#8!NR #D8XP?2O&OCAX#^.
M%Y_P37^'6B>$- U?R+*1V\4Z5;6T@N/*WR^69(P-QC5N2,8!*,1@9'WO16N9
M\'4<SJU)RK2CST%0T6R4N;FWZ[-=5U,<JXSK971IPC0C+DQ#KZO=N')RVMTW
M4NCMH?F7\>;+P+\4/@5I.E_LQ?L<>(=&@TJ]@F\0>(;K1=T[R>4\8MTE!>2=
M2SEF.1C:A*C/'IW_  4 \,^*_&OPQ^!=WX8\(ZK>^38,]U%;:=*[VV8;'B10
MN4/###8.5/I7W-17F/P_A/"XFE/$?QXTXOEIQBE[.2DN6,7;6UFN^M^AZB\1
M)T\7A:T,/_ E4DN:I*;E[2/*^:4E=VW3TTTMU/F/_@K!X:\1^*OV;]+T[PQH
M%[J5POC&VD:"PM7F<(+:Z!8J@)QD@9]Q7%_MA_L\_%3QE\"?A-\6OA?X=NKW
M6_!&A6?VW28K=GN-ODV[JZQ_>8QR189 -V'Z?*:^T*\B_:\_9L\3?M#^%=-3
MP'\3+WPMKVBW$DEA>V\\J1RK(%#QR>6P8 E$(89QM/!S77Q'PNL9#&XJ"E4G
M5A"*@FHM.G+F3C)W5^MFM;6OJ<G#/%3P53 X6;C3A1G4DYR3DFJD>5J459VZ
M73NKWMH?*/[9_P"TY\:/V@_V=XX-1_9ZU7PAH=CJEL^MZGJ[.HN+G#*D$"O&
MA9<EG)YQM4''\6Y^TO\ L]^.OB/^R5\%/BKX"\*2:[+X6\)6*ZIHT,+223VT
MEO;N&"+\SJ#&0P7)Q)GHI-=5XK_8K_;E^.NEZ9\//VA?VC?#L_A:PN8Y9%TF
MV9[F4H"H9LVT6]]I(RSD9.2":^M_#'AW2O!_AK3O"6A0&*QTNQAM+.(G.R*-
M B#/?"J*^>P'#&8\08C&3S3VBC4ITX*4U",^:,N:ZC!M*,6EO\5WWT^CS#BK
M+N'</@X95[-RI5*DW&FZDH<LH\MG.:4G*2;V^&R[*_P+:^(OA/\ %SQ1H/@W
M]G;_ ()YV\E]/+M\1/XHT^:.WLLX'RRQ285%^8EW )P $R<5^@.F6%KI6FV^
MEV4"10VT"10Q1C"HJ@  >P J>BON<@R!Y*ZDYU%.4[?#3A3226R45UW=V]=D
MCX/B'B%9W[*$*;A&%_BJ3J-MO=N3Z;*R6F[84445]$?-!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO$=Z' D++A@I !U%%?,'_#&W[>O_ $F ^('_ (:CP?\ _*RC_AC;]O7_ *3
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MZFHKY9_X5/\ \%<O^CM/A9_X0<O_ ,71_P *G_X*Y?\ 1VGPL_\ "#E_^+H
M^IJ*^6?^%3_\%<O^CM/A9_X0<O\ \71_PJ?_ (*Y?]':?"S_ ,(.7_XN@#ZF
MHKY9_P"%3_\ !7+_ *.T^%G_ (0<O_Q='_"I_P#@KE_T=I\+/_"#E_\ BZ /
MJ:BOEG_A4_\ P5R_Z.T^%G_A!R__ !='_"I_^"N7_1VGPL_\(.7_ .+H ^IJ
M*^6?^%3_ /!7+_H[3X6?^$'+_P#%T?\ "I_^"N7_ $=I\+/_  @Y?_BZ /J:
MBOEG_A4__!7+_H[3X6?^$'+_ /%T?\*G_P""N7_1VGPL_P#"#E_^+H ^IJ*^
M6?\ A4__  5R_P"CM/A9_P"$'+_\71_PJ?\ X*Y?]':?"S_P@Y?_ (N@#ZFH
MKY9_X5/_ ,%<O^CM/A9_X0<O_P 71_PJ?_@KE_T=I\+/_"#E_P#BZ /J:BOE
MG_A4_P#P5R_Z.T^%G_A!R_\ Q='_  J?_@KE_P!':?"S_P (.7_XN@#ZFHKY
M9_X5/_P5R_Z.T^%G_A!R_P#Q='_"I_\ @KE_T=I\+/\ P@Y?_BZ /J:BOEG_
M (5/_P %<O\ H[3X6?\ A!R__%T?\*G_ ."N7_1VGPL_\(.7_P"+H ^IJ*^6
M?^%3_P#!7+_H[3X6?^$'+_\ %T?\*G_X*Y?]':?"S_P@Y?\ XN@#ZFKYD_X*
M3_\ (#\)?]?=Y_Z#%53_ (5/_P %<O\ H[3X6?\ A!R__%UF>)?V3OV^/BHD
M-O\ '3XY_#_7XK(EM-33=%GT\PLV Y8A9-^0%P.,8[YH ^;**]]_X=T_&W_H
M:/"O_@=<_P#R/1_P[I^-O_0T>%?_  .N?_D>@#P*BO??^'=/QM_Z&CPK_P"!
MUS_\CT?\.Z?C;_T-'A7_ ,#KG_Y'H \"K[O_ &&O^3<=(_Z^[O\ ]'O7AO\
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M7Q?_ .R9ZY_Z0S5ZQ7D_[>?_ "9%\7_^R9ZY_P"D,U>ED_\ R-\/_P!?(?\
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M,/5?F?TW4445_ )_?H4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M>3_MY_\ )D7Q?_[)GKG_ *0S5ZQ7D_[>?_)D7Q?_ .R9ZY_Z0S5Z63_\C?#_
M /7R'_I2/-SC_D48C_KW/_TEG\X]%%%?WD?P:%%%% !7W[_P;K?\GB^+?^R9
MW7_IPL*^ J^_?^#=;_D\7Q;_ -DSNO\ TX6%?&^(7_)%XW_!^J/LO#W_ )+3
M!?X_T9^R=%%%?Q:?VD?SX_\ !53_ )2%?%/_ +&(?^B(J^?:^@O^"JG_ "D*
M^*?_ &,0_P#1$5?/M?W5PW_R3N#_ .O5/_TA'\*<1_\ )0XS_K[4_P#2V%%%
M%>T>,%=%\(?^2L^%_P#L8K+_ -'I7.UT7PA_Y*SX7_[&*R_]'I6.)_W:?H_R
M-\+_ +S#U7YG]-U%%%?P"?WZ%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %>3_MY_\ )D7Q?_[)GKG_ *0S5ZQ7D_[>
M?_)D7Q?_ .R9ZY_Z0S5Z63_\C?#_ /7R'_I2/-SC_D48C_KW/_TEG\X]%%%?
MWD?P:%%%% !7W[_P;K?\GB^+?^R9W7_IPL*^ J^_?^#=;_D\7Q;_ -DSNO\
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M3E*WLKVYFW:_M%>U][(_EOHK^I"BNW_B.W_4N_\ *W_W(XO^($_]3'_RC_\
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MP/@KH?B+QA,FNW7[/5M\,-(NM:ATPW+2KIWVD:HDPG>S56+>1YD?F%BC!<D
M_5VBOG5_VB_B)\)_^"CI_9>^)^N?VGX7^*?@2?Q'\)I&M(89+#4-*\F'5M'#
M1HIF5HI[6]C>4EU+W2%BBQ*ORQ^PG_P4<_:%\0>,O@W\4?VA_P!IG2O$?A?X
MT_"?QCXU\<>%'T/3[.'X6+H\UJRB.:VC6X-LBSRVDWVUI7,T.Y77YHP ?IC1
M7B/[ GC_ ..OQJ^!LG[0WQRN[BU7XAZU<:_X)\)W.G0V\GAOPW*$73+24HBO
M)/);HEU,92SI-=R1 A(T4>W4 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% 'P-_P3UL]<\,1_MZ?!V\^&
MUMXK\76O[1/B?74\%:A?"T37K+5M$L+G3+>2=D<117$2^1YA1@JJ3M;!%?-O
M[1?Q4_9)_;3_ &&_AI^Q;^PQ^R1?> ?V@H/&7AB?P]X L?AS>6%W\(]1L]2M
M9]2O;J\>TA2"&"&*YC-QN!N?-0JI+G;^GMK^S!X8T7]KBZ_:[\)Z]=:9JNN^
M"X_#GC'1X8D-KKL=O<&;3[J7HRW%MYMW&KC.Z.Z9&!V1E?3J /BW]MJ"X\6_
M\%?/V*O"OAA?-U#PZ?B!XFUQHAN:STD:$NG[W_NI)=7MO&">"PXY6JO[6'[/
M7P!^)_[3NC_L0?!+X&^#O#][\367QI^TIXB\.>&;6SO-2\*V=T#%8WL\,:R3
MOJ>H!;<[V):V@U#TKZ0\&?LR>&?#/[4'C+]K/6=>NM7\3^*-#T_0-,^U1JL6
M@Z+:;I?L5N!SB6ZEGN99"<NS1+PL*5Z2MO DS7*PH)'4*\@4;F S@$]\9/YT
M ?E;^R'^T)\9=>_;A^'VA2?M$^.-7^+>K_&;Q_IGQ]^#NH:_<S:/X5\(VG]J
M#2+A-,?,&FQ*(=%-O=QJC79NW!DFW$+^JM%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <9\9O@9X0^.>F66D
M^+]4UJUCL9VFA;1=6DM&9BNTABGWACL:\^_X=[_!/_H;?'?_ (65S_C7NE%
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M_P"AM\=_^%E<_P"->Z44 >%_\.]_@G_T-OCO_P +*Y_QH_X=[_!/_H;?'?\
MX65S_C7NE% 'A?\ P[W^"?\ T-OCO_PLKG_&C_AWO\$_^AM\=_\ A97/^->Z
M44 >%_\ #O?X)_\ 0V^._P#PLKG_ !H_X=[_  3_ .AM\=_^%E<_XU[I10!X
M7_P[W^"?_0V^._\ PLKG_&C_ (=[_!/_ *&WQW_X65S_ (U[I10!X7_P[W^"
M?_0V^.__  LKG_&C_AWO\$_^AM\=_P#A97/^->Z44 >%_P##O?X)_P#0V^._
M_"RN?\:/^'>_P3_Z&WQW_P"%E<_XU[I10!X7_P .]_@G_P!#;X[_ /"RN?\
M&C_AWO\ !/\ Z&WQW_X65S_C7NE% 'A?_#O?X)_]#;X[_P#"RN?\:/\ AWO\
M$_\ H;?'?_A97/\ C7NE% 'A?_#O?X)_]#;X[_\ "RN?\:/^'>_P3_Z&WQW_
M .%E<_XU[I10!X7_ ,.]_@G_ -#;X[_\+*Y_QH_X=[_!/_H;?'?_ (65S_C7
MNE% 'GWP9_9K\!? S4[W5O"&L^(;J2_@6*9=:UR6[55#9!4.?E.>XKT&BB@
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MW[7?Q(;X/?L^_M,:-K?BL6+WD7AVYL[O3[VX@3[\D,5Y#$TRK@EO+#;0"3@
MU\R?\%+/'7QU^'?_  69_9;\2_LZ_ 6U^)/B9/AAX]CA\,7GB^+0TDA;^S1)
M+]JEBE52@YV[<MTR*Y/X9_$K]HK_ (*8?\%:/ ?AK]I+X#^%_P!G[7OV4;J]
M\37/@RZ\8-K7B7Q1!J5D;.&XLKB*TAMO[))<B9XY)6,B)&ZQDC !^I%8NI?$
M?P!H_CG3/AAJGC32[?Q)K5E<7FD:#+?(+R\M[<H)YHX<[VCC,L89P-JF1 2"
MPS^4G[9W[<OQ@T*3X\^,/!/_  5(^(%S\0?AYJ.MS>"OAU\ ?@S_ ,)!X4T"
MUL86DAM=>OIM&F5KC$9^V.U[$D!9]J@)BNKT ?%7]IK_ (*S?L>?M):C\?\
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MS;^%O&?[.]I\';GP18P"*"ST2![S#139+!C%=M$ 1\H13DFOI:B@#X/\.?\
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M &A_@K\6?$VJ^(/#_P"T-\2+CQCJZ0*MG<Z'=O%9K";252W[R"6RBGCD8??
MRI (/!:[_P $BOVF/C/X2@^ G[7G_!6#XC?$OX/B: :MX%D\%:/I=]KUK#(C
MQVFH:M;1_:;B%B@$NWRWE!.Y\G-?=-% #+:VM[.WCL[2!(HHD"111J%5% P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
J444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>tnet-20250331_g6.jpg
<TEXT>
begin 644 tnet-20250331_g6.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;?*B0 -N7G,IX;  [5QM@J\<.L)1J595U-QBE%-.#M*,N:22:?G;32]U?A?
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MSX;^ WP>BNA+)X)L=0AQ->ZA,/EDU6ZV0K(J?NX(T$>7?)3YR\:>-O!.L_\
M!H7I?A_2GAFO;_X/Z5X.L])3'GS>(OMT.GFR6/[QN!>*P*8W JQ(X)H ^U/C
M)_P45^)=G^U%XE_9)_8]_8ZUCXP^)?A]HUCJ/Q*O4\766A:?H1O8VFL[)9[H
M-]IO)85,HB"JBHR%I5R=OKO[(W[4_P ./VS/@-I'Q]^&-IJ5E9:C-<VE_HVN
M6H@U#2-0M9Y+:[L;J(,PCGAGBDC8 E3MW*65E8_(-C\+?VH?A!_P4'^,/BG]
M@;XY_!C7M<\5>&/"ES\<O 7Q7N-4M;CPWJ%OIIM+'5K2:RA?[1#/;0?/ ^P%
MX,B9"Q V?^#>+P[XFT_]B3QAXTU[QJ?$]KXQ^/GC;7-#\5"R%LFNV<FJR0C4
M(X0S"*.>2"695#, )!AF&"0#[OHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ K\Q?\ @M5^UY^T5X>_:(E_9"^'7[6%S\$-"C^!DWC6QU[1
MH;:/5O&6K?VL++^Q[.ZN580?9X5%S((!Y[K*!PFXC].J_-#_ (+X_'WX2Z-X
M3\2?LY_MF?LM:=??#S6?AQ_:GPY^*VHZ!)J=O:^)DO1'/IC.D#_V9<&UV2QS
M;U\U2Z!LC:0#W&=?^"O_ ,)?V0]6^'<-YX,^)?Q:F^)4>@^#OB));PVT$'A>
MXN8E'B#5[%3;1FZMH6G+VMH2)#'$5#9=:P?AO\:?VROV7_\ @H[\.OV)/V@?
MVF-+^->B_%CP+KVM0:B/!%KHFK>%+G2S;L9)4LF\J2QN//:*/>GF"2/'F-@[
MOF/X _MNZS_P3(_8!^-GQW^$WPQ\=:_\)=1^-/\ 8W[)7A?Q?9ZK+)]AGLH_
M,G(E22]BT5)XKR>(,OF&.)E4;I5)]4_X)&_M!_L'^)OCS?Z]>?M/^)_B[^T[
M\4-/;_A*_&NM?"3Q)HUG#9VR-<?V1IGV[3X;?3].@"L4B+AYG&]R[E54 [*\
M_P""A?[8OBG_ (*U_"']FK_A0&J?#OX-^*5\:VL=_P"+K>W75O&-UH]I&S74
M5N"\EE8+)+$T+L5DN0Q<JJ8#=W_P5Z_;X\>?L9_L[:KH7[-FB6VN?&/7?"VL
MZGX2TRX4/!I.G:;9O=:CKEV#D"WM8@ H88EN)K>$ ^8<9_[8NB:U>_\ !8;]
MB_6[+2+J:RL="^)XO;N*W9HK<R:7I@0.X&$W$$#)&<''2O"_V_/V&?\ @I!X
M:M?VL?VJ/ _[0'PHUO3/B!\,-7TY--\0_#W4[S7--\,6VF7.S1-/GAOXX8=Q
M>:4D0MYEQ-YCA]J*H!]Y?L;?$;Q7\8?V0?A5\6_'E\EUKGBGX;:%J^LW,<"Q
M++=W.GP33.$0!4!=V.T  9P.*])KYT_X)+Z%\>/#G_!.SX1:3^T)K>@7NKQ^
M -&_LU?#^BW%BMKIW]G6PMK>XCGFE9KE$&V5P55F&0B=*^BZ "BBB@ HHHH
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M  ^D_P"":'_1RG_EG:S_ /(='^J7%7_0!7_\%5/_ )$/];>%?^@^A_X-I_\
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MHK_Y<?\ ]S4?\/+?^J*_^7'_ /<U 'U-17RS_P /+?\ JBO_ )<?_P!S4?\
M#RW_ *HK_P"7'_\ <U 'U-17RS_P\M_ZHK_Y<?\ ]S5]34 %%%% !1110 44
M44 %%%% !1110 4444 ?RWT445_H(?Y]A1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 ?U(4445_GV?Z"!1110 4444 %?EG7ZF5^6= !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %?J97Y9U^IE !1110 4444 %%%
M% !1110 4444 %%%% '\M]%%%?Z"'^?84444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% ']2%%%%?Y]G^@@4444 %%%% !7Y9U^IE?EG0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7ZF5^6=?J90 4444 %%%% !111
M0 4444 %%%% !1110!_+?1117^@A_GV%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!_4A1117^?9_H(%%%% !1110 5^6=?J97Y9T %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5^IE?EG7ZF4 %%%% !1110 4444
M %%%% !1110 4444 ?RWT445_H(?Y]A1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 ?U(4445_GV?Z"!1110 4444 %?EG7ZF5^6= !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %?J97Y9U^IE !1110 4444 %%%%
M!1110 4444 %%%% '\M]%%%?Z"'^?84444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% ']2%%%%?Y]G^@@4444 %%%% !7Y9U^IE?EG0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7ZF5^6=?J90 4444 %%%% !1110
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MX;_XU7V'10!\>?\ #DC]D_\ Z*+\4_\ PN&_^-4?\.2/V3_^BB_%/_PN&_\
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MP1Q138?]4O\ NBG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ [VBN6^!OQ5TOXZ_!7PC\;-#TRXLK+QAX9L-:M+.[*F6"*ZMTG6-RI(+*'
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M;<6C7$F7M6B,3(9-V_)0D;MV[OG/- 'B?_!+'Q__ ,)]^P%\*F_X0KQ!HO\
M8W@31M*QX@TW[,;[R=-MA]KM_F/FVTF<QR<;@#P,5]!5C_#OP!X2^%'@#0_A
M?X TG[!H7AS2+;3-&L?/DE^SVD$2Q11[Y&9WVHBC<S%CC))/-;% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
K!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>tnet-20250331_g7.jpg
<TEXT>
begin 644 tnet-20250331_g7.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR^)^):W$M>E.<.54X\JO)SDU=N\INSD]>RL%%%%?2'S 4444 %%%% !1110
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MG97O:Q]=T5\A_L _M:?$+Q5X:^(NF_&+Q@OB.V\"VGVZUUN.,>9/;J)S)\P
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _
M-?\ X+9?LQ_'G2_%7BW]NW]F;Q7X*U6^7X&#P/\ $3P!XNN98+B715U?[?;W
MNG7$*N8;C[0[HRRIY4B <AD%>D?LU7O[%?[>7PD^(>A?'S]D&T^$GB'X9?&N
M+Q-\:O FJ:M#%;V_BJS2"_BU:ZO+-XX-3MI(E@E\Z8>7*L7SH5135G_@I_\
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M17\L=%'_ ! ;_J8_^4?_ +J'_$;_ /J7_P#E7_[F?U.45_+'11_Q ;_J8_\
ME'_[J'_$;_\ J7_^5?\ [F?U.45_+'11_P 0&_ZF/_E'_P"ZA_Q&_P#ZE_\
MY5_^YG]3E%?RQT4?\0&_ZF/_ )1_^ZA_Q&__ *E__E7_ .YG]3E%?RQT4?\
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MCY\/K2?5]/MY8O#OBVW1H]2T<2E?-$,T;(^QPH#1EMC<$J2!75?\-J_LS?\
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M]%+_ /*->_\ QFC_ (;5_9F_Z*7_ .4:]_\ C- 'J=%>6?\ #:O[,W_12_\
MRC7O_P 9H_X;5_9F_P"BE_\ E&O?_C- 'J=%>6?\-J_LS?\ 12__ "C7O_QF
MO4Z "BBB@ HHHH **** "BBB@ HHHH **** /Y8Z***_T,/X+"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _J<HHHK_ #S/[T"BBB@ HHHH *_+
M.OU,K\LZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_4RORSK
M]3* "BBB@ HHHH **** "BBB@ HHHH **** /Y8Z***_T,/X+"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _J<HHHK_ #S/[T"BBB@ HHHH *_+
M.OU,K\LZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_4RORSK
M]3* "BBB@ HHHH **** "BBB@ HHHH **** /Y8Z***_T,/X+"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _J<HHHK_ #S/[T"BBB@ HHHH *_+
M.OU,K\LZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_4RORSK
M]3* "BBB@ HHHH **** "BBB@ HHHH **** /Y8Z***_T,/X+"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _J<HHHK_ #S/[T"BBB@ HHHH *_+
M.OU,K\LZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_4RORSK
M]3* "BBB@ HHHH **** "BBB@ HHHH **** /Y8Z***_T,/X+"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _J<HHHK_ #S/[T"BBB@ HHHH *_+
M.OU,K\LZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_4RORSK
M]3* "BBB@ HHHH **** "BBB@ HHHH **** /Y8Z***_T,/X+"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _J<HHHK_ #S/[T"BBB@ HHHH *_+
M.OU,K\LZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_4RORSK
M]3* "BBB@ HHHH **** "BBB@ HHHH **** /Y8Z***_T,/X+"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _J<HHHK_ #S/[T"BBB@ HHHH *_+
M.OU,K\LZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_4RORSK
M]3* "BBB@ HHHH **** "BBB@ HHHH **** /Y8Z***_T,/X+"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _J<HHHK_ #S/[T"BBB@ HHHH *_+
M.OU,K\LZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_4RORSK
M]3* "BBB@ HHHH **** "BBB@ HHHH **** /Y8Z***_T,/X+"BBB@ HHHH
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ML.B@#X\_X<D?LG_]%%^*?_A<-_\ &J/^')'[)_\ T47XI_\ A<-_\:K[#HH
M^//^')'[)_\ T47XI_\ A<-_\:H_X<D?LG_]%%^*?_A<-_\ &J^PZ* /CS_A
MR1^R?_T47XI_^%PW_P :H_X<D?LG_P#11?BG_P"%PW_QJOL.B@#X\_X<D?LG
M_P#11?BG_P"%PW_QJC_AR1^R?_T47XI_^%PW_P :K[#HH ^//^')'[)__11?
MBG_X7#?_ !JC_AR1^R?_ -%%^*?_ (7#?_&J^PZ* /CS_AR1^R?_ -%%^*?_
M (7#?_&J/^')'[)__11?BG_X7#?_ !JOL.B@#X\_X<D?LG_]%%^*?_A<-_\
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M@%X$N_B;\9_'VF>&]!LL"XU/5;D1QAF^ZB]W=CPJ*"S'@ UTU?)?[1&GZ?\
M$/\ X*M_ _X=_$>UCN?#NB^!-?\ $OARPNU#07.O1RV\(D*'Y9)((':1"02A
M8L,'F@#TWX+?\%"?V/?V@O',?PS^&/QDBF\0W%N9[/1=9T6^TFYO(P,E[>.^
M@A:X  +$QAN 3T!->@_&'XQ_#'X ?#C5/BY\8_&5IH'AS1H1+J.J7I8I&"0J
M@*H+.S,0JHH+,2  2<5\Y?\ !:C2=(LOV%-;^+]DJ6_B[P#KFD:SX#U>)!]I
MLM5&I6T<8A(^;,@<QE1]X-[#'+_\%MOV;_ 7Q#_8S\=_'[QW/K-[JGA7P9&G
MA[0Y=8D_LK3KMKI0]\MLN$>Z*3-%YK[MJ*NT*<D@'VV"& 8'@CBBFP_ZI?\
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M0<$)$RC*J>2H(\YTG_@C+_P3HT&PCTK0O@IK=E:Q9\JVM/B=XCCC3)).%74
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H@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>tnet-20250331_g8.jpg
<TEXT>
begin 644 tnet-20250331_g8.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC_P4:\!>&O&G[)WB;4-;L8GNM$@COM+NG0;[>59$!VGMN4LA'<-["O//V6/
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M\YY?0C4=-4U.K&OSN+DE=RI):*4KQ3YO,]MHHHK]./RL**** "BBB@ HHHH
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MKQSAG!QUQ7M7[+?[6WPW_:L\-W>J^#H;FQU#361=4T>^V^;!OSM=64X=&VL
MPP<J<@<9^2OAO\6?VVO^"?\ X??X;>+/@*NM>%[*ZEFBO8K61HU#,68I=P;D
M"L<MB12PST&,5[7^P)\2OV3OBAX@U_Q+\&_AD_A+Q?<0F7Q!ITU]+-YL3R[C
M)$2Y0QB0@'"(5) V@$9?#7$>;XK-J.'QF+7M)7]I1J4O923MI[*27O6?\SNU
MKOLN)^&LFPN3U\1@L&_9QY?9UZ57VL9*^OM8N7NW7\L;*6FV^+??\%6=+3Q3
MJGA;0_V=_$6J2Z5>RV\[V%XLGW'9-Q"QDJ"5[UI?#W_@JC\+O$7CJS\"_$/X
M;:]X2DOYTAAO-0*O%&S':IEX5D4GC=@@=\#)'SA^S)^TX?V9/C=\2M>;X::I
MXCCU"_F25=,?;]E5+F5B[G:V <^W2N@^*7B[Q]_P5-^('AS1/AC\)6T32_#D
MDB:MKEW>I(8$G:,LSG:O"B(E47<6)/3MX&&XSSZMA8U*.-]IB7-I8?V/Q)3M
M\:2M[OO-WT/H<5P3P_0Q<J=; ^SPJ@F\1[?X6X7^!MW][W4K:[GZ*5P/[0W[
M2/PS_9F\&+XQ^(U_+_I$ABT[3;- ]Q>R 9*HI(& ,$L2%&1DY(![R*,0Q+"K
M$A% !8Y)QZU\+_M?V]O\4_\ @I5X ^&'BY!/HMI'8*;*7F.4-))-("#UWX5#
MZA0*_4>*\XQ6396IX9+VM2<*<;[*4W:[\DKOU/RGA')L+G6;.GBFU2IPG4G;
M=Q@KV7FW9>ATD/\ P5L%FUOK?BK]F#Q#I_AVZE"P:TNH;_,4]U5X$1CCG D_
M&O?O$?[3O@&Q_9QN_P!I?P@6UW1;>P%U'% _E22?O!&T9W#Y'5B001P5-=?X
M[^'_ (3^)/@C4/AWXOTB.YTG4[-K:YML8 0C@J1]UE."I'*D CI7B7[3'P9^
M'/P)_82\<^!OA?H!T[3/L/GM UW+,6E:6$,Y:5F/.T< X]!7GSI\5Y1AL36K
MXJ-:G&E.2;@H3C-)M644XRC_ (M?7KZ,*G"&<XK"T</A)4*DJT(N*FYPE3DT
MG=R:E&7^'3?;2WJ'[._QHL/VA?@_I/Q=TS0IM-@U4W 2RGF$CQ^5/)"<L  <
MF,GIWKMJ_/KX ^ ?VNO$O[%</CSX??'E?"F@^&+/4KC1=%T^T(EU(13333/+
M.#E27,B*N"N$&0,DGW;]C[]H'XX_'S]C_5/%NG1Z?J7C?2[VYTNQN+\B&&ZF
M6.)XY90@P"%F&0  Q3MNS6>0<73QE+#T,71FJDZ*J*5HVJ62Y^51;:NW>*:5
MUT6E].(>#88*MB:^#KTW2A7=-QO*]/FD^3F<DD[)6DTW9[MV=OH^BOSY^+6L
M_M3?"+P!<?$WQU^WO80^,K>8,_@*RU"&5SF4+@)&Q3(4[BOE;<#&:],^,/[4
M?Q;U#_@G-X>^/N@>(VTGQ)J%Y!#=WMC$HW%9Y89"%8$#>8]V .,\8ITN.L&_
MK$:]"=.5*FZO*W!MP3M]F3Y97M[LK-=15N <8OJ\J&(A4C6JJBI)324VK_:B
MN:-KVE&Z?0^NJ*^%/'5Q^W5J7[+]E^UI<?M''38[32;6Z@\-:9:>7YEJ2D8G
MDDZ22OD2LK*5^8@$<*/0/$/[<?C3PY_P3WT+]H::WMG\5:Y*=*MI&A'E"[66
M>-IR@X^Y;O(%^[N(&,<5M1XVP#E46)HSI*-+VR<E'WJ=[75I.SNTE%V?>QC6
MX%S!1I/#5J=5RJ^P:BY>[4M>S<HJZLFW)76FESZKHKXB&B?M^?#_ /9QN_VG
M+C]H\ZE+?>'6O[SPS>V8?[+:S196:)_NI-&KK+L554%",L!M;4\$?MI?$;P!
M_P $\U^./BO6#KGBF^UZ?2]*N=01=OG,[%6<* "$C1V [E0#UJ*7&^$C-QQ>
M'J4;4G6][E?N*VW+)ZN_P[IZ/I>ZO F,E34\'B*=:]54?=<E:;OOS16BM\6J
M:U5];?9-%?G[J_C[]K3X<?!ZQ_:@'[:&D:SJ4D=M>ZAX'EG@D"03,N$\L-@L
M Z[T1$*C=ALJ*^U_@9\4;/XU?"'P_P#%.RM/LZZUIJ3RVX;(AEY61 >X5U8
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M.K!4ZE)MN,HJ*CJ[;Z73MIJNK,_PGXEL/&7ABP\5Z7%<1V^HVD=Q%%=P&*5
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MXERG)<OC_9CI.K]859*FZDDTHN[FYI6YF[<D=(K9WU/@O2/&GPK_ .%>:/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOJ:B@#Y9_P"%3_\ !7+_ *.T^%G_ (0<O_Q='_"I_P#@KE_T=I\+/_"#E_\
MBZ^IJ* /EG_A4_\ P5R_Z.T^%G_A!R__ !='_"I_^"N7_1VGPL_\(.7_ .+K
MZFHH ^6?^%3_ /!7+_H[3X6?^$'+_P#%T?\ "I_^"N7_ $=I\+/_  @Y?_BZ
M^IJ* /EG_A4__!7+_H[3X6?^$'+_ /%T?\*G_P""N7_1VGPL_P#"#E_^+KZF
MHH ^6?\ A4__  5R_P"CM/A9_P"$'+_\71_PJ?\ X*Y?]':?"S_P@Y?_ (NO
MJ:B@#Y9_X5/_ ,%<O^CM/A9_X0<O_P 71_PJ?_@KE_T=I\+/_"#E_P#BZ^IJ
M* /EG_A4_P#P5R_Z.T^%G_A!R_\ Q='_  J?_@KE_P!':?"S_P (.7_XNOJ:
MB@#Y9_X5/_P5R_Z.T^%G_A!R_P#Q='_"I_\ @KE_T=I\+/\ P@Y?_BZ^IJ*
M/EG_ (5/_P %<O\ H[3X6?\ A!R__%T?\*G_ ."N7_1VGPL_\(.7_P"+KZFH
MH ^6?^%3_P#!7+_H[3X6?^$'+_\ %T?\*G_X*Y?]':?"S_P@Y?\ XNOJ:B@#
MY9_X5/\ \%<O^CM/A9_X0<O_ ,71_P *G_X*Y?\ 1VGPL_\ "#E_^+KZFHH
M^6?^%3_\%<O^CM/A9_X0<O\ \71_PJ?_ (*Y?]':?"S_ ,(.7_XNOJ:B@#Y9
M_P"%3_\ !7+_ *.T^%G_ (0<O_Q='_"I_P#@KE_T=I\+/_"#E_\ BZ^IJ* /
MEG_A4_\ P5R_Z.T^%G_A!R__ !='_"I_^"N7_1VGPL_\(.7_ .+KZFHH ^$O
M$'[5?[6_@;7+SP9XI^+-G=:GI-R]IJ%SI^@VJ02S1L4=HU>(LJ%@2 22!U-4
M_P#AM7]IG_HI?_E&LO\ XS7-?'[_ )+CXP_[&6]_]'O7(T >I_\ #:O[3/\
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M3O/["4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;W_T>]<C0 4444 %%%% '2_!C_DL/A/_ +&6P_\ 2A*_2>OS8^#'_)8?"?\
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M@ HHHH Z7X,?\EA\)_\ 8RV'_I0E?I/7YL?!C_DL/A/_ +&6P_\ 2A*_2>@
MHHHH **** "BBB@ HHHH _G*_;Y_Y/@^+W_92=:_]+9:\DKUO]OG_D^#XO?]
ME)UK_P!+9:\DK^\LF_Y$^'_Z]P_])1_!N<_\CC$?]?)_^E,****](\T****
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M_.5^WS_R?!\7O^RDZU_Z6RUY)7K?[?/_ "?!\7O^RDZU_P"ELM>25_>63?\
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M_P#/ZO\ ^!4__E9^"?\ PY;_ ."E_P#T;7_Y>.C?_)E'_#EO_@I?_P!&U_\
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MUY)7]Y9-_P B?#_]>X?^DH_@W.?^1QB/^OD__2F%%%%>D>:%%%% 'I/[&?\
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MOOA,UO#>20R6_AW1=+@MUMXI8F62#?/?ZA.2C*P>X+ @X( /5_AY_P %:O\
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M.M?^ELM>25_>63?\B?#_ /7N'_I*/X-SG_D<8C_KY/\ ]*84445Z1YH4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!_.5^WS_R?!\7O^RDZU_Z6RUY)7K?[?/_ "?!\7O^RDZU
M_P"ELM>25_>63?\ (GP__7N'_I*/X-SG_D<8C_KY/_TIA1117I'FA1110!Z3
M^QG_ ,G@?"G_ +*5H7_IP@K^D>OYN/V,_P#D\#X4_P#92M"_].$%?TCU_-_C
ME_R,\'_@E_Z4C^D/ W_D68S_ !Q_])84445^%G[H?SE?M\_\GP?%[_LI.M?^
MELM>25ZW^WS_ ,GP?%[_ +*3K7_I;+7DE?WEDW_(GP__ %[A_P"DH_@W.?\
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M7_I2/Z0\#?\ D68S_''_ -)84445^%G[H%%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K O\
MX6_#W5/B7IOQCOO"5F_BG2-(NM+T[70FVXBLKF2&2:VW#&Z)G@A<HV0&C5A@
M\UOT4 %8/ACX7_#[P;XM\1^/?#'A.TL]:\77=O<^)=4C0F?4)(+=+>'S'))*
MQQ(JJHPJ_,0 68G>HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#_W^?_XFNZ_X5=\,_P#HG>A?^"B'_P")H_X5=\,_^B=Z%_X*(?\ XF@#A?\
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M &1_^B]:#_W^?_XFNZ_X5=\,_P#HG>A?^"B'_P")H_X5=\,_^B=Z%_X*(?\
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M!]5\1S:1#<B![U;*TDN#"LA5@A<1[=Q4XSG!Z4 >@45\7_%K_@JQ\6-%\;_
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M;W4X=/U<7S10ZTMI+IMI!IZW%L9(9$BQYAMX7*G.X?2^C?\ !*S_ ()XZ!\
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MP7I[6FCZ%IL-AI5H]S),8+:%!'''OE9G;:J@99B>.M &K1110 4444 ?#O\
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0H **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>tnet-20250331_g9.jpg
<TEXT>
begin 644 tnet-20250331_g9.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M='>?'+]J#XKW7_!/#PU\>_#/B%]'\1:E=6L5Y>6,:C<P>6.0A6! #&/=CMG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKP[8Z1H^DV45GI>E:9:)!;6=O&H2.&*- %C15 4*H    %7Z "BBB@ HHHH
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MRBORSHH _4RBORSHH _4RBORSHH _4RBORSHH _4RBORSHH _4RBORSK]3*
M"BBB@ HHHH **** "BBB@ HHHH **** /Y;Z***_T$/\^PHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** /ZD****_S[/]! HHHH **** "ORSK]3*
M_+.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OU,K\LZ_4R@
MHHHH **** "BBB@ HHHH **** "BBB@#^6^BBBO]!#_/L**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#^I"BBBO\^S_00**** "BBB@ K\LZ_4RO
MRSH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K]3*_+.OU,H *
M*** "BBB@ HHHH **** "BBB@ HHHH _EOHHHK_00_S["BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH _J0HHHK_/L_T$"BBB@ HHHH *_+.OU,K\
MLZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_4RORSK]3* "B
MBB@ HHHH **** "BBB@ HHHH **** /Y;Z***_T$/\^PHHHH **** "BBB@
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MLG_]%%^*?_A<-_\ &J/^')'[)_\ T47XI_\ A<-_\:K[#HH ^//^')'[)_\
MT47XI_\ A<-_\:H_X<D?LG_]%%^*?_A<-_\ &J^PZ* /CS_AR1^R?_T47XI_
M^%PW_P :H_X<D?LG_P#11?BG_P"%PW_QJOL.B@#X\_X<D?LG_P#11?BG_P"%
MPW_QJC_AR1^R?_T47XI_^%PW_P :K[#HH ^//^')'[)__11?BG_X7#?_ !JC
M_AR1^R?_ -%%^*?_ (7#?_&J^PZ* /CS_AR1^R?_ -%%^*?_ (7#?_&J/^')
M'[)__11?BG_X7#?_ !JOL.B@#X\_X<D?LG_]%%^*?_A<-_\ &J/^')'[)_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7\=?@KX1^-FAZ9<65EXP\,V&M6EG=E3+!%=6Z3K&Y4D%E#@''&174T %%%%
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M3_8R_9FTF'1?@QI6I?V=\4?B)96ZPV]\L,H>;0]&50!([,-DUR!Y<:E@-[,
M?;O@Q^PW^S9\ ]6U+Q'\//"&I?VKJFCC2)M8UGQ3J.I7L.G Y6S@GNYY)+:$
M'!"1,HRJGDJ"/.=)_P"",O\ P3HT&PCTK0O@IK=E:Q9\JVM/B=XCCC3)).%7
M4 !DDGZDT 4?&'[)?PN^.?[:'B[6O#W[8'C3PUKOA_P!HN@W_@[X?Z@-*N=*
MLO,N+BVD>ZV.\D;L\C!$VJ"HW[OE Z;_ ()J?%?XG_$CX3>,_"OQ4\:R>*KK
MX>?%36_!^F^,)X4277K*R>,174OE@(TG[QHF91AFA).223UGQ=_85_9H^-NN
MZ9XL\9^#M3M]:TG1QI-KKGA[Q5J.E7SZ>/\ ETFN+.>*2>+J=LC-@EB,$DGO
MOA7\*?AU\$? &F_"WX3>$+/0?#^D0&+3M+L(]L<2EBS'G)9F8LS.Q+,S%F))
M)H Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O&?VJOV
ME?!G[.E_H]MX;^&[^,OBKXNBDTWP+X1TB*-;_5 A$C^9.P_T:RB)$DLSG8@Y
MP6P#[-7BO[0/_!//]DC]J+XCVOQ<^-WPWU#5/$5EI"Z7::E9^,=6T\Q6BR/(
M(@EG=1)C?([$[<G(R3@8 /F']H_]FOQC\ OV9[+XQ_'CQ79ZSXN\7_M&>#?%
M7Q>U6P1DT^UMTU*VMX[. /R+2V3R8U9_F;!9L9 'M'[6074?^"B?[*VE:80]
M]:WWC&^O%3DQ6 T0PNSCLC2RP*,\%B/2O0_AM^PC^RM\*/AQXG^$?A/X92S>
M&_&,0B\2:3KWB'4-6CO$"LH7-]<3&,88_<*\X/4 A?@Q^PW^S9\ ]6U+Q'\/
M/"&I?VKJFCC2)M8UGQ3J.I7L.G Y6S@GNYY)+:$'!"1,HRJGDJ" #Q'XKZE>
M_P#!0QM3_8R_9FTF'1?@QI6I?V=\4?B)96ZPV]\L,H>;0]&50!([,-DUR!Y<
M:E@-[, >!_;3^(WBO4_B[XVT[XD_LH_%:^\"?#/P5>V7PR3P]X,:ZTF?4Y].
MDCFUJXF,BJ%MXW\B 8?RP9Y>&90OLVD_\$9?^"=&@V$>E:%\%-;LK6+/E6UI
M\3O$<<:9))PJZ@ ,DD_4FOHS4_!'AC6? UQ\-]4TYIM&N])?3;BT:XDR]JT1
MB9#)NWY*$C=NW=\YYH \3_X)8^/_ /A/OV OA4W_  A7B#1?[&\":-I6/$&F
M_9C?>3IML/M=O\Q\VVDSF.3C< >!BOH*L?X=^ /"7PH\ :'\+_ &D_8-"\.:
M1;:9HUCY\DOV>T@B6**/?(S.^U$4;F8L<9))YK8H **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Apr. 18, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TRINET GROUP, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-3359658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Park Place,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">352-5000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock par value $0.000025 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TNET<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,399,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000937098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,292<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingInsuranceAndClaimsCostsProduction', window );">Insurance costs</a></td>
<td class="nump">942<span></span>
</td>
<td class="nump">907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction', window );">Cost of providing services</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Systems development and programming</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_InterestExpenseBankFeesAndOther', window );">Interest expense, bank fees and other</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and operating expenses</a></td>
<td class="nump">1,177<span></span>
</td>
<td class="nump">1,158<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before tax</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of income taxes</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.72<span></span>
</td>
<td class="nump">$ 1.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.71<span></span>
</td>
<td class="nump">$ 1.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=tnet_ProfessionalServicesMember', window );">Professional service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service revenues</a></td>
<td class="nump">$ 209<span></span>
</td>
<td class="nump">$ 214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=tnet_InsuranceServicesMember', window );">Insurance service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service revenues</a></td>
<td class="nump">$ 1,065<span></span>
</td>
<td class="nump">$ 1,050<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost Of Goods And Service, Excluding Depreciation, Depletion, And Amortization, And Operating Insurance And Claims Costs, Production</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_InterestExpenseBankFeesAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense, Bank Fees and Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_InterestExpenseBankFeesAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477346/946-830-45-39<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingInsuranceAndClaimsCostsProduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Insurance and claims costs directly related to goods produced and sold, or services rendered, during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingInsuranceAndClaimsCostsProduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=tnet_ProfessionalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=tnet_ProfessionalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=tnet_InsuranceServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=tnet_InsuranceServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">$ 360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Restricted cash, cash equivalents and investments</a></td>
<td class="nump">1,024<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Payroll funds receivable</a></td>
<td class="nump">478<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses, net</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_OtherPayrollAssetsCurrent', window );">Other payroll assets</a></td>
<td class="nump">881<span></span>
</td>
<td class="nump">916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,857<span></span>
</td>
<td class="nump">3,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Restricted cash, cash equivalents and investments, noncurrent</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">461<span></span>
</td>
<td class="nump">461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Software and other intangible assets, net</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">3,775<span></span>
</td>
<td class="nump">4,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other current liabilities</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Revolving credit agreement borrowings</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Client deposits and other client liabilities</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued wages</a></td>
<td class="nump">544<span></span>
</td>
<td class="nump">580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent', window );">Accrued health insurance costs, net</a></td>
<td class="nump">189<span></span>
</td>
<td class="nump">189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrent', window );">Accrued workers' compensation costs, net</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings', window );">Payroll tax liabilities and other payroll withholdings</a></td>
<td class="nump">1,645<span></span>
</td>
<td class="nump">1,906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_InsurancePremiumsAndOtherPayables', window );">Insurance premiums and other payables</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,646<span></span>
</td>
<td class="nump">2,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, noncurrent</a></td>
<td class="nump">909<span></span>
</td>
<td class="nump">908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityNoncurrent', window );">Accrued workers' compensation costs, noncurrent, net</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred taxes</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, noncurrent</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">3,712<span></span>
</td>
<td class="nump">4,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital', window );">Common stock and additional paid-in capital</a></td>
<td class="nump">1,070<span></span>
</td>
<td class="nump">1,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,006)<span></span>
</td>
<td class="num">(984)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities &amp; stockholders' equity</a></td>
<td class="nump">$ 3,775<span></span>
</td>
<td class="nump">$ 4,119<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Payroll Tax Liabilities And Other Payroll Withholdings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collateral Paid To Insurance Carriers, Net Of Health Benefit Loss Reserves, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_InsurancePremiumsAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Insurance Premiums and Other Payables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_InsurancePremiumsAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_OtherPayrollAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Payroll Assets Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_OtherPayrollAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of par value plus amounts in excess of par value or issuance value for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStocksIncludingAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478600/954-210-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478600/954-210-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the noncurrent portion of the liabilities (due beyond one year; or beyond one operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.000025<span></span>
</td>
<td class="nump">$ 0.000025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common stock and additional paid-in capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.000025<span></span>
</td>
<td class="nump">$ 0.000025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">48,397,519<span></span>
</td>
<td class="nump">49,527,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">48,397,519<span></span>
</td>
<td class="nump">49,527,506<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock and Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings (Accumulated Deficit)</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 976<span></span>
</td>
<td class="num">$ (896)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockStock', window );">Common stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Awards effectively repurchased for required employee withholding taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2024</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">996<span></span>
</td>
<td class="num">(848)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">1,056<span></span>
</td>
<td class="num">(984)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockStock', window );">Common stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Awards effectively repurchased for required employee withholding taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2025</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 1,070<span></span>
</td>
<td class="num">$ (1,006)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAmortizationOfDeferredCharges', window );">Amortization of deferred costs</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of ROU asset, lease modification, impairment, and abandonment</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Losses on investments</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss from disposition of assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses, net</a></td>
<td class="nump">7<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_IncreaseDecreaseInOtherPayrollAssets', window );">Other payroll assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities', window );">Accounts payable and other liabilities</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Client deposits and other client liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedSalaries', window );">Accrued wages</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities', window );">Accrued health insurance costs, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities', window );">Accrued workers' compensation costs, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities', window );">Payroll taxes liabilities and other payroll withholdings</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale and maturity of marketable securities</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Acquisitions of property and equipment and software</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of business</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet', window );">Change in WSE and TriNet Trust related assets and liabilities, net</a></td>
<td class="num">(388)<span></span>
</td>
<td class="num">(213)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Awards effectively repurchased for required employee withholding taxes</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(494)<span></span>
</td>
<td class="num">(243)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents, unrestricted and restricted</a></td>
<td class="num">(407)<span></span>
</td>
<td class="num">(199)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents, unrestricted and restricted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of period</a></td>
<td class="nump">1,691<span></span>
</td>
<td class="nump">1,466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of period</a></td>
<td class="nump">1,284<span></span>
</td>
<td class="nump">1,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental schedule of noncash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividend declared, but not yet paid</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Payable for purchase of property and equipment</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable', window );">Receivable from sale of business</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Variable Interest Entity Assets And Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_IncreaseDecreaseInOtherPayrollAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Other Payroll Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_IncreaseDecreaseInOtherPayrollAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash or Part Noncash Divestiture, Amount of Consideration Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in accrued salaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in health care insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in employer-related costs classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due for insurance (or actual expenses) to cover the medical expenses and lost income for employees that are injured during the course of doing work-related activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of other deferred costs recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TriNet Group, Inc. (TriNet, or the Company, we, our and us) provides comprehensive HCM solutions for small and medium-size businesses under both a PEO model and an HRIS services model. These HCM solutions include multi-state payroll processing and tax administration, employee benefits programs, including health insurance and retirement plans, workers' compensation insurance and claims management, employment and benefit law compliance, and other HR-related services. Through our PEO service model, we are the employer of record for certain employment-related administrative and regulatory purposes for WSEs, including:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compensation through wages and salaries,</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain employer payroll-related tax payments, </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employee payroll-related tax withholdings and payments,</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employee benefit programs, including health and life insurance, and </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">workers' compensation coverage. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our PEO clients are responsible for the day-to-day job responsibilities of the WSEs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our HRIS and ASO services models, we provide cloud-based HCM services to SMBs that allows them to manage hiring, onboarding, employee information, payroll processing, payroll tax administration, health insurance, and other benefits, from a single cloud-based software platform. We are not the co-employer or employer of record for such employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in one reportable segment. All of our service revenues are generated from external clients. Less than 1% of our revenue is generated outside of the U.S. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Basis of Presentation and Basis of Consolidation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Rules and Regulations of the Securities and Exchange Commission. The unaudited condensed consolidated financial statements include the accounts of the Company and an entity consolidated under the variable interest model. Intercompany balances and transactions have been eliminated. Certain information and note disclosures included in our annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, that are normal and recurring in nature, necessary for fair financial statement presentation. The results of operations for the three months ended March&#160;31, 2025 are not necessarily indicative of the operating results anticipated for the full year. These financial statements should be read in conjunction with the audited Consolidated Financial Statements included in Part II, Item 8. Financial Statements and Supplementary Data of our Annual Report on Form 10-K for the year ended December&#160;31, 2024. Certain prior year amounts have been reclassified to conform to current period presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When entering into contractual arrangements with other entities, we assess whether we have a variable interest. If we determine that we have a variable interest, we then determine whether the arrangement is with a variable interest entity ("VIE"). If the arrangement is with a VIE, we assess whether we are the primary beneficiary of the VIE by identifying the most significant activities and determining who has the power over those activities and who has the obligation to absorb the majority of the losses or benefits of the VIE. We consolidate a VIE when we have the power to direct activities that most significantly affect the economic performance of the VIE and have the obligation to absorb the majority of their losses or benefits, making us the primary beneficiary. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, we assess whether any changes in our interest or relationship with the entity affect our determination of whether the entity is a VIE and, if so, whether we are the primary beneficiary.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, we created a trust ("TriNet Trust") for the purpose of holding ASO clients' payroll funds for the remittance to ASO Users, tax authorities and other recipients. TriNet Trust's assets are restricted and can only be used for payments on behalf of ASO clients, repayments of any advances from TriNet, or payments to TriNet of interest income earned on the balances of TriNet Trust. In the event of any losses, creditors to the Trust have </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recourse to TriNet Trust's property and not that of TriNet overall. The risks associated with the Trust are similar to those that currently exist for the Company such as banking losses in excess of FDIC insurance levels, interest rate and market conditions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that TriNet Trust meets the definition of a variable interest entity and as the primary beneficiary we have both the power to direct TriNet Trust&#8217;s activities that most significantly affect its performance and we have the right to receive benefits from TriNet Trust, in the form of interest income. As a result, TriNet Trust is consolidated into our financial statements.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024, TriNet Trust assumed ownership and responsibility of certain bank accounts that hold HRIS client funds and assumed related liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the assets and liabilities of TriNet Trust which are included in our consolidated balance sheet. These amounts on any particular date can vary due to timing of cash receipts and remittances.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TriNet Trust</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">103</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">103</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued wages</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll tax liabilities and other payroll withholdings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">87</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">103</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">103</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Statement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts on the Condensed Consolidated Statement of Income have been reclassified to conform to current period presentation. Specifically, interest income previously included in the former Other income (expense) category is now classified as a component of Total revenue. Similarly, Interest expense, bank fees and other has been reclassified as part of total expenses. These reclassifications eliminate the profitability measure of Operating Income on our Condensed Consolidated Statement of Income, which is not a key measure of profitability used by management.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Statement of Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts on the Condensed Consolidated Statement of Cash Flows have also been reclassified to conform to current period presentation, with no impact on the Condensed Consolidated Statements of Income and Comprehensive Income, Condensed Consolidated Statement of Balance Sheets and Condensed Consolidated Statements of Stockholders' Equity. In particular, changes in WSE related assets and liabilities were previously reported within operating activities and are now reclassified into financing activities to better reflect operating activities excluding the impact of client cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.683%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.943%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As previously reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reclassified<br/>amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As revised</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll funds receivable</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payroll assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(410)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Client deposits and other client liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued wages</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(51)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued health insurance costs, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued workers' compensation costs, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll taxes payable and other payroll withholdings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(180)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(240)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in WSE and TriNet Trust related assets and liabilities, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(213)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(213)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in financing activities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(213)</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(213)</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect certain reported amounts and related disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates are based on historical experience and on various other assumptions that we believe to be reasonable from the facts available to us. Some of the assumptions are highly uncertain at the time of estimation. To the extent actual experience differs from the assumptions used, our condensed consolidated financial statements could be materially affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Accrued Health Insurance Costs </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sponsor and administer a number of employee benefit plans for our PEO WSEs, including group health, dental, and vision as an employer plan sponsor under section 3(5) of the ERISA. In the three months ended March&#160;31, 2025, the majority of our group health insurance costs were related to risk-based plans. Our remaining group health insurance costs were for guaranteed-cost policies. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued health insurance costs are established to provide for the estimated unpaid costs of reimbursing the carriers for paying claims within the deductible layer in accordance with risk-based health insurance policies. These accrued costs include estimates for claims incurred but not paid. We assess accrued health insurance costs regularly based upon actuarial studies that include other relevant factors such as current and historical claims payment patterns, plan enrollment and medical trend rates. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain carrier contracts we are required to prepay our obligations for the expected claims activity for subsequent periods. These prepaid balances by agreement permit net settlement of obligations and offset the accrued health insurance costs. As of March&#160;31, 2025 and December&#160;31, 2024, prepayments and miscellaneous receivables offsetting accrued health insurance costs were $59 million and $60 million, respectively. When the prepaid amount is in excess of our recorded liability, the net asset position is included in prepaid expenses. As of March&#160;31, 2025 and December&#160;31, 2024, accrued health insurance costs offsetting prepaid expenses were $89 million and $90 million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently issued accounting guidance</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2024-03, Disaggregation of Income Statement Expenses, is to enhance the transparency and decision-usefulness of financial reporting by requiring public business entities to provide more detailed disclosures about the components of certain expense captions in their income statements. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2027. The Company is currently evaluating the provisions of this ASU.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div>In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances income tax disclosure requirements. The ASU mandates additional details in the income tax rate reconciliation, including quantitative thresholds for reconciling items, and requires disaggregation of income taxes paid by federal, state, and foreign jurisdictions, with further breakdowns for significant individual jurisdictions. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2024. The Company is currently evaluating the provisions of this ASU.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CashCashEquivalentsAndInvestmentsTextBlock', window );">CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED</a></td>
<td class="text">CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreements with certain of our workers' compensation and health benefit insurance carriers, we are required to maintain collateral in trust accounts for the benefit of specified insurance carriers and to reimburse the carriers&#8217; claim payments within our deductible layer. We invest a portion of the collateral amounts in marketable securities. We report the current and noncurrent portions of these trust accounts as restricted cash, cash equivalents and investments on the condensed consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We require our clients to prefund their payroll and related taxes and other withholding liabilities before payroll is processed or due for payment. This prefund, for PEO customers, as well as amounts held by our statutory trust for our HRIS Users, is included in restricted cash, cash equivalents and investments as payroll funds collected, which is designated to pay pending payrolls, payroll tax liabilities and other payroll withholdings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also invest available corporate funds, primarily in fixed income securities which meet the requirements of our corporate investment policy and are classified as AFS.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total cash, cash equivalents and investments are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Available-for-sale marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Available-for-sale marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">349</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">349</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll funds collected</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">726</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">726</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,131&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,131&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for health benefits claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for workers' compensation claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trust for our HRIS Users</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other security deposits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total restricted cash, cash equivalents and investments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">911</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,303&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments, noncurrent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for workers' compensation claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">134</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,284</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,507</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,691&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CashCashEquivalentsAndInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents and Investments [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CashCashEquivalentsAndInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">INVESTMENTS</a></td>
<td class="text">INVESTMENTS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our financial instruments by significant categories and fair value measurement on a recurring basis as of March&#160;31, 2025 and December&#160;31, 2024 and the amortized cost, gross unrealized gains, gross unrealized losses, fair value of our AFS investments: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Level</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Cash, Cash Equivalents and Investments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">226</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">226</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">116</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">226</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">226</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">116</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AFS Investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">176</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">176</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AFS Investments</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">222</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:20.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Level</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Cash, Cash Equivalents and Investments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">571</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AFS Investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AFS Investments</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use an independent pricing source to determine the fair value of our securities. The independent pricing source utilizes various pricing models for each asset class, including the market approach. The inputs and assumptions for the pricing models are market observable inputs including trades of comparable securities, dealer quotes, credit spreads, yield curves and other market-related data.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not adjusted the prices obtained from the independent pricing service and we believe the prices received from the independent pricing service are representative of the prices that would be received to sell the assets at the measurement date (exit price).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company's cash equivalents and restricted cash equivalents approximate their fair values due to their short-term maturities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have any Level 3 financial instruments recognized in our condensed consolidated balance sheets as of March&#160;31, 2025 and December&#160;31, 2024. There were no transfers between levels as of March&#160;31, 2025 and December&#160;31, 2024. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Sales and Maturities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of debt investments by contractual maturity are shown below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.436%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One year or less</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over one year through five years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">199</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over five years through ten years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over ten years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross proceeds from sales and maturities of AFS securities and gross realized losses for the three months ended March&#160;31, 2025 and 2024 are presented below. We had immaterial gross realized gains from sales of investments for the three months ended March&#160;31, 2025 and 2024.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross realized losses</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross proceeds from sales</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross proceeds from maturities</span></td><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Fair Value of Long-Term Debt</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our 2029 Notes and 2031 Notes was obtained from a third-party pricing service and is based on observable market inputs. As such, the fair value of the Senior Notes is considered Level 2 in the hierarchy for fair value measurement. As of March&#160;31, 2025, our 2029 Notes and 2031 Notes were carried at their cost, net of issuance costs, and had a fair value of $454 million and $407 million, respectively. As of December&#160;31, 2024, our 2029 Notes and 2031 Notes were carried at their cost, net of issuance costs, and had a fair value of $453 million and $408 million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2021 Revolver is a floating rate debt. At March&#160;31, 2025 and December&#160;31, 2024, the fair value of our 2021 Revolver approximated its carrying value (exclusive of issuance costs). The fair value of our floating rate debt is estimated based on a discounted cash flow, which incorporates credit spreads, market interest rates and contractual maturities to estimate the fair value and is considered Level 3 in the hierarchy for fair value measurement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/940-320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph b<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED WORKERS' COMPENSATION COSTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock', window );">ACCRUED WORKERS' COMPENSATION COSTS</a></td>
<td class="text">ACCRUED WORKERS' COMPENSATION COSTS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the accrued workers&#8217; compensation cost activity for the three months ended March&#160;31, 2025 and 2024:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accrued costs, beginning of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">158</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incurred</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(11)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes workers' compensation liabilities on the condensed consolidated balance sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, end of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral paid to carriers and offset against accrued costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, net of carrier collateral offset</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">156</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payable in less than 1 year<br/>(net of collateral paid to carriers of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> at March&#160;31, 2025 and December&#160;31, 2024)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payable in more than 1 year <br/>(net of collateral paid to carriers of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> at March&#160;31, 2025 and December&#160;31, 2024)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">111</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, net of carrier collateral offset</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">156</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incurred claims related to prior years represent changes in estimates for ultimate losses on workers' compensation claims. For the three months ended March&#160;31, 2025, the favorable development is due to lower than expected reported claim frequency and severity for the more recent years. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025 and December&#160;31, 2024, we had $25 million and $26&#160;million of collateral held by insurance carriers, respectively, of which $4 million was offset against accrued workers' compensation costs as the agreements permit and are net settled of insurance obligations against collateral held.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/944-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Contingencies </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are and, from time to time, have been and may in the future become involved in various litigation matters, legal proceedings, regulatory investigations and claims arising in the ordinary course of our business, including disputes with our clients or various class action, collective action, representative action, and other proceedings arising from the nature of our co-employment relationship with our clients and WSEs in which we are named as a defendant. In addition, due to the nature of our co-employment relationship with our clients and WSEs, we could be subject to liability for federal and state law violations, even if we do not participate in such violations. While our agreements with our clients contain indemnification provisions related to the conduct of our clients, we may not be able to avail ourselves of such provisions in every instance. We have accrued our current best estimates of probable losses with respect to these matters, which are individually and in aggregate immaterial to our condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the outcome of the matters described above cannot be predicted with certainty, management currently does not believe that any such claims or proceedings will have a materially adverse effect on our condensed consolidated financial position, results of operations, or cash flows. However, the unfavorable resolution of any particular matter or our reassessment of our exposure for any of the above matters based on additional information obtained in the future could have a material impact on our condensed consolidated financial position, results of operations, or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK BASED COMPENSATION</a></td>
<td class="text">STOCK BASED COMPENSATION<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Restricted Stock Units (RSUs)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Time-based RSUs generally vest over a four-year term. Performance-based RSUs are subject to vesting requirements and are earned, in part, based on certain financial performance metrics as defined in the grant notice. Actual number of shares earned under performance-based RSUs may range from 0% to 200% of the target award. Performance-based awards granted in 2025 and 2024 are earned based on a single-year performance period subject to subsequent multi-year time-based vesting with 50% of the shares earned vesting in one year after the performance period and the remaining shares in the year after. RSUs are generally forfeited if the participant terminates service prior to vesting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize RSU activity for the three months ended March&#160;31, 2025:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Time-based RSUs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.030%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">of Shares</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100,001&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.21&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">696,745&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(127,243)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,243)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at March&#160;31, 2025</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,572,260&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.48&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance-based RSUs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.128%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.056%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179,907&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,840&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,728)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124.31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at March&#160;31, 2025</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232,019&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.37&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options are granted to eligible employees at exercise prices equal to the fair market value of our common stock on the dates of grant. Stock options generally have a maximum contractual term of 10 years. Stock options vest after 3 years, and are generally forfeited if the employee terminates service prior to vesting.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity for the three months ended March&#160;31, 2025:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number<br/>of Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in&#160;millions)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,144&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.98</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at March&#160;31, 2025</span></div></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,144&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">76.69</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.98</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimated the fair value of stock options using the Black-Scholes option-pricing model. Because we do not have significant exercise history for our stock options, we estimate the expected term using the simplified method.  We estimate expected volatility using the daily historical trading data of our common shares. The table below summarizes the assumptions used.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our RSUs and PSUs is equal to the fair value of our common stock on the grant date. The fair value of stock options is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Option Assumptions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected Term (in Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected Volatility</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Risk-Free Interest Rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected Dividend Yield</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2025</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.09&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.43&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;padding-left:24.75pt;text-indent:-22.5pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:83.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Disclosures for Stock Options (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of stock options</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.65&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total fair value of options granted </span></td><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the beginning and ending balances of our issued and outstanding common stock for the three months ended March&#160;31, 2025 and 2024:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.597%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares issued and outstanding, beginning balance</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">49,527,506</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,664,471&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from vested restricted stock units</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">127,243</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from exercise of stock options</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,708&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1,210,403)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(197,872)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awards effectively repurchased for required employee withholding taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(46,827)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,249)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares issued and outstanding, ending balance</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">48,397,519</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,573,176&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Repurchases </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, there was $162 million remaining in the total authorization of $2,715&#160;million of our ongoing stock repurchase program.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We paid a common stock dividend of $0.25 per share in January 2025. We also declared common stock dividends of $0.275 per share to be paid in the second quarter of 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our ETR was 26% and 27% for the first quarter of 2025 and 2024, respectively. The decrease in the rate was primarily attributable to an increase in tax benefits related to excludable income for state tax purposes and a decrease in the state tax rate, offset by a decrease in tax benefits for stock-based compensation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have capital loss carryforwards of $3&#160;million. As a result of the sale of Clarus this quarter, we generated approximately $9&#160;million of capital loss carryforwards totaling $12&#160;million which will begin to expire in 2027.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have recorded an increase in the valuation allowance of $9&#160;million this quarter to reflect the estimated amount of deferred tax assets that may not be realized related to these capital loss carryforwards. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are subject to tax in U.S. federal and various state and local jurisdictions, as well as Canada and India. We are open to federal and significant state income tax examinations for tax years 2019 and subsequent years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic EPS is computed based on the weighted average shares of common stock outstanding during the period. Diluted EPS is computed based on those shares used in the basic EPS computation, plus potentially dilutive shares issuable under our equity-based compensation plans using the treasury stock method. Shares that are potentially anti-dilutive are excluded.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of our basic and diluted EPS attributable to our common stock:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.158%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">49</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic EPS</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.72</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.80&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">49</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of stock options and restricted stock units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">49</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.71</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.78&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">RESTRUCTURING</a></td>
<td class="text">RESTRUCTURING<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2024, we completed a detailed review of our strategy and made several decisions that will narrow and intensify our focus on our U.S. PEO business. This will include winding down the software-only HRIS product as well as other immaterial products not directly related to our U.S. PEO business.  In place of our software-only HRIS product, we will focus our ASO services to include both the software component, but also a significant service component similar to the types of services we provide to PEO clients. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with this adjustment to our product offerings, we have implemented changes to our operating expense structure, including our staffing and office footprint.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the restructuring initiatives, the Company incurred $1 million of restructuring costs for the three months ended March&#160;31, 2025. These expenses are classified in G&amp;A in our Condensed consolidated statement of income and comprehensive income.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Severance costs include payments to colleagues, estimated reimbursements for COBRA payments and outplacement services. The following table is a summary of accrued severance and exit and disposal costs included within accounts payable and other current liabilities and accrued wages:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.223%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accounts payable and other current liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued wages</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(+) Additions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(-) Payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at March&#160;31, 2025</span></div></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to make payments for these liabilities during 2025. We expect the restructuring efforts to continue through 2026 and may recognize additional expenses as they are incurred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/420/tableOfContent<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">SEGMENT INFORMATION<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in one reportable segment. Our chief operating decision maker for segment reporting purposes is our CEO, who uses the profitability and significant expense detail to allocate resources and assess performance based on key functions such as customer acquisition, customer service, and indirect costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary measure of profit or loss that the CEO uses is net income. The significant expenses used in these profit or loss reports align with the primary functions of the corresponding teams, with the exception of non-cash expenses such as depreciation, amortization and stock-based compensation as these expenses are not necessarily indicative of our ongoing operations. In this expense reporting methodology, overhead-type expenses, such as facilities and technology support for colleagues, are classified consistent with the primary function of the corresponding teams and not allocated to other significant expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides the primary measure of profitability and detail regarding the significant expenses reviewed by our CEO.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.414%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.644%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional service revenues</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">209</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance service revenues</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,065</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenues</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,292</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Workers' compensation costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health insurance costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">919</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales &amp; marketing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">60</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Client support costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">43</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate administration</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">System support &amp; development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, bank fees and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income Taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other includes certain costs that are considered non-recurring such as restructuring costs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text">We operate in one reportable segment. All of our service revenues are generated from external clients. Less than 1% of our revenue is generated outside of the U.S.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Basis of Consolidation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Rules and Regulations of the Securities and Exchange Commission. The unaudited condensed consolidated financial statements include the accounts of the Company and an entity consolidated under the variable interest model. Intercompany balances and transactions have been eliminated. Certain information and note disclosures included in our annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, that are normal and recurring in nature, necessary for fair financial statement presentation. The results of operations for the three months ended March&#160;31, 2025 are not necessarily indicative of the operating results anticipated for the full year. These financial statements should be read in conjunction with the audited Consolidated Financial Statements included in Part II, Item 8. Financial Statements and Supplementary Data of our Annual Report on Form 10-K for the year ended December&#160;31, 2024. Certain prior year amounts have been reclassified to conform to current period presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When entering into contractual arrangements with other entities, we assess whether we have a variable interest. If we determine that we have a variable interest, we then determine whether the arrangement is with a variable interest entity ("VIE"). If the arrangement is with a VIE, we assess whether we are the primary beneficiary of the VIE by identifying the most significant activities and determining who has the power over those activities and who has the obligation to absorb the majority of the losses or benefits of the VIE. We consolidate a VIE when we have the power to direct activities that most significantly affect the economic performance of the VIE and have the obligation to absorb the majority of their losses or benefits, making us the primary beneficiary. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, we assess whether any changes in our interest or relationship with the entity affect our determination of whether the entity is a VIE and, if so, whether we are the primary beneficiary.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, we created a trust ("TriNet Trust") for the purpose of holding ASO clients' payroll funds for the remittance to ASO Users, tax authorities and other recipients. TriNet Trust's assets are restricted and can only be used for payments on behalf of ASO clients, repayments of any advances from TriNet, or payments to TriNet of interest income earned on the balances of TriNet Trust. In the event of any losses, creditors to the Trust have </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recourse to TriNet Trust's property and not that of TriNet overall. The risks associated with the Trust are similar to those that currently exist for the Company such as banking losses in excess of FDIC insurance levels, interest rate and market conditions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that TriNet Trust meets the definition of a variable interest entity and as the primary beneficiary we have both the power to direct TriNet Trust&#8217;s activities that most significantly affect its performance and we have the right to receive benefits from TriNet Trust, in the form of interest income. As a result, TriNet Trust is consolidated into our financial statements.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024, TriNet Trust assumed ownership and responsibility of certain bank accounts that hold HRIS client funds and assumed related liabilities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Rules and Regulations of the Securities and Exchange Commission. The unaudited condensed consolidated financial statements include the accounts of the Company and an entity consolidated under the variable interest model. Intercompany balances and transactions have been eliminated. Certain information and note disclosures included in our annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, that are normal and recurring in nature, necessary for fair financial statement presentation. The results of operations for the three months ended March&#160;31, 2025 are not necessarily indicative of the operating results anticipated for the full year. These financial statements should be read in conjunction with the audited Consolidated Financial Statements included in Part II, Item 8. Financial Statements and Supplementary Data of our Annual Report on Form 10-K for the year ended December&#160;31, 2024. Certain prior year amounts have been reclassified to conform to current period presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When entering into contractual arrangements with other entities, we assess whether we have a variable interest. If we determine that we have a variable interest, we then determine whether the arrangement is with a variable interest entity ("VIE"). If the arrangement is with a VIE, we assess whether we are the primary beneficiary of the VIE by identifying the most significant activities and determining who has the power over those activities and who has the obligation to absorb the majority of the losses or benefits of the VIE. We consolidate a VIE when we have the power to direct activities that most significantly affect the economic performance of the VIE and have the obligation to absorb the majority of their losses or benefits, making us the primary beneficiary. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, we assess whether any changes in our interest or relationship with the entity affect our determination of whether the entity is a VIE and, if so, whether we are the primary beneficiary.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, we created a trust ("TriNet Trust") for the purpose of holding ASO clients' payroll funds for the remittance to ASO Users, tax authorities and other recipients. TriNet Trust's assets are restricted and can only be used for payments on behalf of ASO clients, repayments of any advances from TriNet, or payments to TriNet of interest income earned on the balances of TriNet Trust. In the event of any losses, creditors to the Trust have </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recourse to TriNet Trust's property and not that of TriNet overall. The risks associated with the Trust are similar to those that currently exist for the Company such as banking losses in excess of FDIC insurance levels, interest rate and market conditions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that TriNet Trust meets the definition of a variable interest entity and as the primary beneficiary we have both the power to direct TriNet Trust&#8217;s activities that most significantly affect its performance and we have the right to receive benefits from TriNet Trust, in the form of interest income. As a result, TriNet Trust is consolidated into our financial statements.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024, TriNet Trust assumed ownership and responsibility of certain bank accounts that hold HRIS client funds and assumed related liabilities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect certain reported amounts and related disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates are based on historical experience and on various other assumptions that we believe to be reasonable from the facts available to us. Some of the assumptions are highly uncertain at the time of estimation. To the extent actual experience differs from the assumptions used, our condensed consolidated financial statements could be materially affected.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityReserveEstimatePolicy', window );">Accrued Health Insurance Costs</a></td>
<td class="text">In the three months ended March&#160;31, 2025, the majority of our group health insurance costs were related to risk-based plans. Our remaining group health insurance costs were for guaranteed-cost policies. <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued health insurance costs are established to provide for the estimated unpaid costs of reimbursing the carriers for paying claims within the deductible layer in accordance with risk-based health insurance policies. These accrued costs include estimates for claims incurred but not paid. We assess accrued health insurance costs regularly based upon actuarial studies that include other relevant factors such as current and historical claims payment patterns, plan enrollment and medical trend rates. </span></div>In certain carrier contracts we are required to prepay our obligations for the expected claims activity for subsequent periods. These prepaid balances by agreement permit net settlement of obligations and offset the accrued health insurance costs.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently issued accounting guidance</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2024-03, Disaggregation of Income Statement Expenses, is to enhance the transparency and decision-usefulness of financial reporting by requiring public business entities to provide more detailed disclosures about the components of certain expense captions in their income statements. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2027. The Company is currently evaluating the provisions of this ASU.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div>In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances income tax disclosure requirements. The ASU mandates additional details in the income tax rate reconciliation, including quantitative thresholds for reconciling items, and requires disaggregation of income taxes paid by federal, state, and foreign jurisdictions, with further breakdowns for significant individual jurisdictions. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2024. The Company is currently evaluating the provisions of this ASU.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityReserveEstimatePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for estimating its liability as of the balance sheet date for the ultimate cost of settling reported and unreported claims incurred and claims adjustment expenses (including effects of inflation and other societal and economic factors).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/944-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityReserveEstimatePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Assets and Liabilities in our Consolidated Balance Sheet</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TriNet Trust</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">103</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">103</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued wages</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll tax liabilities and other payroll withholdings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">87</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">103</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">103</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock', window );">Schedule of Worksite Employee Changes</a></td>
<td class="text">In particular, changes in WSE related assets and liabilities were previously reported within operating activities and are now reclassified into financing activities to better reflect operating activities excluding the impact of client cash flows.<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.683%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.943%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As previously reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reclassified<br/>amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As revised</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll funds receivable</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payroll assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(410)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Client deposits and other client liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued wages</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(51)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued health insurance costs, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued workers' compensation costs, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll taxes payable and other payroll withholdings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(180)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(240)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in WSE and TriNet Trust related assets and liabilities, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(213)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(213)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in financing activities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(213)</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(213)</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Worksite Employee Changes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Schedule of Cash, Cash Equivalents and Investments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total cash, cash equivalents and investments are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Available-for-sale marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Available-for-sale marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">349</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">349</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll funds collected</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">726</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">726</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,131&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,131&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for health benefits claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for workers' compensation claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trust for our HRIS Users</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other security deposits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total restricted cash, cash equivalents and investments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">911</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,303&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments, noncurrent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for workers' compensation claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">134</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,284</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,507</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,691&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our financial instruments by significant categories and fair value measurement on a recurring basis as of March&#160;31, 2025 and December&#160;31, 2024 and the amortized cost, gross unrealized gains, gross unrealized losses, fair value of our AFS investments: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Level</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Cash, Cash Equivalents and Investments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">226</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">226</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">116</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">226</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">226</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">116</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AFS Investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">176</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">176</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AFS Investments</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">222</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:20.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Level</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Cash, Cash Equivalents and Investments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">571</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AFS Investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AFS Investments</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Fair value of Debt Investments by Contractual Maturity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of debt investments by contractual maturity are shown below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.436%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One year or less</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over one year through five years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">199</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over five years through ten years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over ten years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available-for-Sale Securities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross proceeds from sales and maturities of AFS securities and gross realized losses for the three months ended March&#160;31, 2025 and 2024 are presented below. We had immaterial gross realized gains from sales of investments for the three months ended March&#160;31, 2025 and 2024.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross realized losses</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross proceeds from sales</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross proceeds from maturities</span></td><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED WORKERS' COMPENSATION COSTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Activities in Liability for Unpaid Claims and Claims Adjustment Expenses</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the accrued workers&#8217; compensation cost activity for the three months ended March&#160;31, 2025 and 2024:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accrued costs, beginning of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">158</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incurred</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(11)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes workers' compensation liabilities on the condensed consolidated balance sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, end of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral paid to carriers and offset against accrued costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, net of carrier collateral offset</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">156</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payable in less than 1 year<br/>(net of collateral paid to carriers of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> at March&#160;31, 2025 and December&#160;31, 2024)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payable in more than 1 year <br/>(net of collateral paid to carriers of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> at March&#160;31, 2025 and December&#160;31, 2024)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">111</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, net of carrier collateral offset</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">156</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of RSU Activity under Equity-Based Plans</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize RSU activity for the three months ended March&#160;31, 2025:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Time-based RSUs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.030%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">of Shares</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100,001&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.21&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">696,745&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(127,243)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,243)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at March&#160;31, 2025</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,572,260&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.48&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance-based RSUs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.128%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.056%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179,907&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,840&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,728)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124.31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at March&#160;31, 2025</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232,019&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.37&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option activity</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity for the three months ended March&#160;31, 2025:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number<br/>of Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in&#160;millions)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,144&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.98</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at March&#160;31, 2025</span></div></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,144&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">76.69</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.98</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our RSUs and PSUs is equal to the fair value of our common stock on the grant date. The fair value of stock options is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Option Assumptions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected Term (in Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected Volatility</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Risk-Free Interest Rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected Dividend Yield</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2025</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.09&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.43&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Share-Based Payment Arrangement, Activity</a></td>
<td class="text"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:83.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Disclosures for Stock Options (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of stock options</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.65&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total fair value of options granted </span></td><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock based compensation expense for stock-based awards made to our employees pursuant to our equity plans were as follows:&#160;&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.696%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of providing services</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Systems development and programming costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stock based compensation expense</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stock based compensation capitalized</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock', window );">Schedule of Issued and Outstanding Common Stock</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the beginning and ending balances of our issued and outstanding common stock for the three months ended March&#160;31, 2025 and 2024:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.597%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares issued and outstanding, beginning balance</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">49,527,506</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,664,471&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from vested restricted stock units</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">127,243</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from exercise of stock options</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,708&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1,210,403)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(197,872)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awards effectively repurchased for required employee withholding taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(46,827)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,249)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares issued and outstanding, ending balance</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">48,397,519</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,573,176&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of our basic and diluted EPS attributable to our common stock:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.158%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">49</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic EPS</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.72</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.80&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">49</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of stock options and restricted stock units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">49</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.71</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.78&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Changes in Accrued Severance and Exit and Disposal Costs</a></td>
<td class="text">The following table is a summary of accrued severance and exit and disposal costs included within accounts payable and other current liabilities and accrued wages:<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.223%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accounts payable and other current liabilities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued wages</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(+) Additions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(-) Payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at March&#160;31, 2025</span></div></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides the primary measure of profitability and detail regarding the significant expenses reviewed by our CEO.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.414%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.644%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional service revenues</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">209</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance service revenues</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,065</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenues</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,292</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Workers' compensation costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health insurance costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">919</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales &amp; marketing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">60</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Client support costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">43</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate administration</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">System support &amp; development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, bank fees and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income Taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other includes certain costs that are considered non-recurring such as restructuring costs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepayments offsetting accrued health insurance costs</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=us-gaap_HealthCareMember', window );">Health Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepayments offsetting accrued health insurance costs</a></td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US | Revenue | Foreign Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percent of concentration risk (less than)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=us-gaap_HealthCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=us-gaap_HealthCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Assets and Liabilities of the Trust (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">$ 360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Restricted cash, cash equivalents and investments</a></td>
<td class="nump">1,024<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,857<span></span>
</td>
<td class="nump">3,180<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">3,775<span></span>
</td>
<td class="nump">4,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other current liabilities</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued wages</a></td>
<td class="nump">544<span></span>
</td>
<td class="nump">580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings', window );">Payroll tax liabilities and other payroll withholdings</a></td>
<td class="nump">1,645<span></span>
</td>
<td class="nump">1,906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,646<span></span>
</td>
<td class="nump">2,981<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">3,712<span></span>
</td>
<td class="nump">$ 4,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=tnet_TriNetTrustMember', window );">TriNet Trust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Restricted cash, cash equivalents and investments</a></td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other current liabilities</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued wages</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings', window );">Payroll tax liabilities and other payroll withholdings</a></td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">$ 103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Payroll Tax Liabilities And Other Payroll Withholdings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478600/954-210-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=tnet_TriNetTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=tnet_TriNetTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Worksite Employee Changes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Payroll funds receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses, net</a></td>
<td class="nump">7<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_IncreaseDecreaseInOtherPayrollAssets', window );">Other payroll assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities', window );">Accounts payable and other liabilities</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Client deposits and other client liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedSalaries', window );">Accrued wages</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities', window );">Accrued health insurance costs, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities', window );">Accrued workers' compensation costs, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities', window );">Payroll taxes liabilities and other payroll withholdings</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet', window );">Change in WSE and TriNet Trust related assets and liabilities, net</a></td>
<td class="nump">$ 388<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified', window );">Net cash used in financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(213)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As previously reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Payroll funds receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_IncreaseDecreaseInOtherPayrollAssets', window );">Other payroll assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(410)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities', window );">Accounts payable and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Client deposits and other client liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedSalaries', window );">Accrued wages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities', window );">Accrued health insurance costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities', window );">Accrued workers' compensation costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities', window );">Payroll taxes liabilities and other payroll withholdings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(240)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet', window );">Change in WSE and TriNet Trust related assets and liabilities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified', window );">Net cash used in financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Reclassified amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Payroll funds receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_IncreaseDecreaseInOtherPayrollAssets', window );">Other payroll assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities', window );">Accounts payable and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Client deposits and other client liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedSalaries', window );">Accrued wages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities', window );">Accrued health insurance costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities', window );">Accrued workers' compensation costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities', window );">Payroll taxes liabilities and other payroll withholdings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(180)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet', window );">Change in WSE and TriNet Trust related assets and liabilities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified', window );">Net cash used in financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (213)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedCashFlowStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedCashFlowStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Variable Interest Entity Assets And Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_IncreaseDecreaseInOtherPayrollAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Other Payroll Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_IncreaseDecreaseInOtherPayrollAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Cash Provided by (Used in) Financing Activities, Amounts Reclassified</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Cash Provided by (Used in) Operating Activities, Amounts Reclassified</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in accrued salaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in health care insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in employer-related costs classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due for insurance (or actual expenses) to cover the medical expenses and lost income for employees that are injured during the course of doing work-related activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">$ 360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">1,024<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Collateral for workers' compensation claims</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestments', window );">Total</a></td>
<td class="nump">1,507<span></span>
</td>
<td class="nump">1,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralbyTypeAxis=tnet_PayrollFundsCollectedMember', window );">Payroll funds collected</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">726<span></span>
</td>
<td class="nump">1,131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralbyTypeAxis=tnet_HealthBenefitClaimsCollateralMember', window );">Collateral for health benefits claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralbyTypeAxis=tnet_WorkersCompensationClaimsCollateralMember', window );">Collateral for workers' compensation claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Collateral for workers' compensation claims</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralbyTypeAxis=tnet_TrustForOurHRISUsersCollateralMember', window );">Trust for our HRIS Users</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralbyTypeAxis=tnet_InsuranceCarriersSecurityDepositsMember', window );">Other security deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">911<span></span>
</td>
<td class="nump">1,303<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestments', window );">Total</a></td>
<td class="nump">1,284<span></span>
</td>
<td class="nump">1,691<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Payroll funds collected</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">726<span></span>
</td>
<td class="nump">1,131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Collateral for health benefits claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Collateral for workers' compensation claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Collateral for workers' compensation claims</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Trust for our HRIS Users</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Other security deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember', window );">Available-for-sale marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestments', window );">Total</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember', window );">Available-for-sale marketable securities | Payroll funds collected</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember', window );">Available-for-sale marketable securities | Collateral for health benefits claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember', window );">Available-for-sale marketable securities | Collateral for workers' compensation claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Collateral for workers' compensation claims</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember', window );">Available-for-sale marketable securities | Trust for our HRIS Users</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember', window );">Available-for-sale marketable securities | Other security deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and investments whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements. For use in an unclassified balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478600/954-210-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478600/954-210-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478600/954-210-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralbyTypeAxis=tnet_PayrollFundsCollectedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralbyTypeAxis=tnet_PayrollFundsCollectedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralbyTypeAxis=tnet_HealthBenefitClaimsCollateralMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralbyTypeAxis=tnet_HealthBenefitClaimsCollateralMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralbyTypeAxis=tnet_WorkersCompensationClaimsCollateralMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralbyTypeAxis=tnet_WorkersCompensationClaimsCollateralMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralbyTypeAxis=tnet_TrustForOurHRISUsersCollateralMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralbyTypeAxis=tnet_TrustForOurHRISUsersCollateralMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralbyTypeAxis=tnet_InsuranceCarriersSecurityDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralbyTypeAxis=tnet_InsuranceCarriersSecurityDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis (Details) - Fair Value Measurement on a Recurring Basis - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">$ 226<span></span>
</td>
<td class="nump">$ 571<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">222<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds | Level 2 | Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency securities | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency securities | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency securities | Level 2 | Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2 | Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificate of deposit | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificate of deposit | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificate of deposit | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificate of deposit | Level 2 | Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market mutual funds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">226<span></span>
</td>
<td class="nump">570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market mutual funds | Level 1 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market mutual funds | Level 1 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market mutual funds | Level 1 | Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2 | Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_InvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_InvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Fair value of Debt Investments by Contractual Maturity (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">One year or less</a></td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Over one year through five years</a></td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Over five years through ten years</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Over ten years</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total fair value</a></td>
<td class="nump">$ 223<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Available-for-Sale Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss', window );">AFS securities, gross realized gain (loss)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Gross realized losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Gross proceeds from sales</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Gross proceeds from maturities</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tnet_A2029NotesPayableMember', window );">2029 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Fair value of notes payable</a></td>
<td class="nump">$ 454<span></span>
</td>
<td class="nump">$ 453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tnet_A2031NotesPayableMember', window );">2031 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Fair value of notes payable</a></td>
<td class="nump">$ 407<span></span>
</td>
<td class="nump">$ 408<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tnet_A2029NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tnet_A2029NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tnet_A2031NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tnet_A2031NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Loss Reserve Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments', window );">Total accrued costs, beginning of period</a></td>
<td class="nump">$ 158<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Incurred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total paid</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments', window );">Total accrued costs, end of period</a></td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of adjustments to the estimated reserve for unpaid claims and claims adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments', window );">Total accrued costs, end of period</a></td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">$ 158<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral', window );">Collateral paid to carriers and offset against accrued costs</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent', window );">Total accrued costs, net of carrier collateral offset</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrent', window );">Payable in less than 1 year (net of collateral paid to carriers)</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityNoncurrent', window );">Payable in more than 1 year (net of collateral paid to carriers)</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent', window );">Total accrued costs, net of carrier collateral offset</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent', window );">Collateral paid, current</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent', window );">Collateral paid, noncurrent</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collateral Paid to Insurance Carriers, Net of Workers' Compensation Loss Reserves, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collateral Paid To Insurance Carriers, Net Of Workers' Compensation Loss Reserves, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability for Unpaid Claims and Claims Adjustment Expense, Collateral</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of adjustments to the estimated reserve for unpaid claims and claims adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the noncurrent portion of the liabilities (due beyond one year; or beyond one operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED WORKERS' COMPENSATION COSTS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralHeldByInsuranceCarriers', window );">Collateral held by insurance carriers</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral', window );">Collateral paid to carriers and offset against loss reserves</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralHeldByInsuranceCarriers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collateral Held by Insurance Carriers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralHeldByInsuranceCarriers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability for Unpaid Claims and Claims Adjustment Expense, Collateral</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember', window );">Time-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember', window );">Time-Based Restricted Stock Units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percent of share value</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember', window );">Time-Based Restricted Stock Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percent of share value</a></td>
<td class="nump">200.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember', window );">Performance-based RSUs and RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Performance period for 2025 and 2024 awards</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsMember', window );">Performance-Based Restricted Stock Units | Share-based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Amount of shares that are expected to vesting percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Maximum | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION - Schedule of RSU and RSA Activity under Equity-Based Plans (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember', window );">Time-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Total Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance (in shares) | shares</a></td>
<td class="nump">1,100,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">696,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(127,243)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(97,243)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance (in shares) | shares</a></td>
<td class="nump">1,572,260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 97.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">76.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">90.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">65.83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 89.48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsMember', window );">Performance-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Total Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance (in shares) | shares</a></td>
<td class="nump">179,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">74,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(22,728)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance (in shares) | shares</a></td>
<td class="nump">232,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 106.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">76.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">124.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 83.37<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION - Schedule of stock option activity (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">270,144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">270,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">76.69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 76.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">9 years 11 months 23 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm', window );">Granted, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">9 years 11 months 23 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_AggregateIntrinsicValueRollForward', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Beginning balance, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue', window );">Granted, Aggregate Intrinsic Value | $</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Ending balance, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_AggregateIntrinsicValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_AggregateIntrinsicValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Granted, Weighted Average Remaining Contractual Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants In Period, Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Term (in Years)</a></td>
<td class="text">6 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected Volatility</a></td>
<td class="nump">42.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-Free Interest Rate</a></td>
<td class="nump">4.09%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected Dividend Yield</a></td>
<td class="nump">1.43%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION - Schedule of Share-Based Payment Arrangement, Activity (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value of stock options | $ / shares</a></td>
<td class="nump">$ 31.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value of options granted | $</a></td>
<td class="nump">$ 9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock based compensation expense</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Total stock based compensation capitalized</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of providing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock based compensation expense</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock based compensation expense</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock based compensation expense</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=tnet_SystemsDevelopmentAndProgrammingCostsMember', window );">Systems development and programming costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock based compensation expense</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=tnet_SystemsDevelopmentAndProgrammingCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=tnet_SystemsDevelopmentAndProgrammingCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Schedule of Common Stock (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued and outstanding, beginning balance (in shares)</a></td>
<td class="nump">49,527,506<span></span>
</td>
<td class="nump">50,664,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares issued and outstanding, beginning balance (in shares)</a></td>
<td class="nump">49,527,506<span></span>
</td>
<td class="nump">50,664,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="num">(1,210,403)<span></span>
</td>
<td class="num">(197,872)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Awards effectively repurchased for required employee withholding taxes (in shares)</a></td>
<td class="num">(46,827)<span></span>
</td>
<td class="num">(59,249)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued and outstanding, ending balance (in shares)</a></td>
<td class="nump">48,397,519<span></span>
</td>
<td class="nump">50,573,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares issued and outstanding, ending balance (in shares)</a></td>
<td class="nump">48,397,519<span></span>
</td>
<td class="nump">50,573,176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Issuance of common stock from vested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Issuance of common stock from vested restricted stock units (in shares)</a></td>
<td class="nump">127,243<span></span>
</td>
<td class="nump">160,118<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Issuance of common stock from exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from exercise of stock options (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,708<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Additional Information (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount | $</a></td>
<td class="nump">$ 162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount | $</a></td>
<td class="nump">$ 2,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends paid (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends payable (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.275<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Capital loss carryforwards</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember', window );">Capital Loss Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Capital loss carryforwards</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_IncomeTaxesDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_IncomeTaxesDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income</a></td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding (in shares)</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic EPS (in dollars per share)</a></td>
<td class="nump">$ 1.72<span></span>
</td>
<td class="nump">$ 1.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income</a></td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of stock options and restricted stock units (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares of common stock outstanding - diluted (in shares)</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted EPS (in dollars per share)</a></td>
<td class="nump">$ 1.71<span></span>
</td>
<td class="nump">$ 1.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect (in shares)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring Costs</a></td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING - Schedule of Changes in Accrued Severance and Exit and Disposal Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts payable and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring balance</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_RestructuringChargesAdditions', window );">(+) Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_RestructuringChargesPayments', window );">(-) Payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis=tnet_AccruedSalariesCurrentMember', window );">Accrued wages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring balance</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_RestructuringChargesAdditions', window );">(+) Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_RestructuringChargesPayments', window );">(-) Payments</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_RestructuringChargesAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges, Additions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_RestructuringChargesAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_RestructuringChargesPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges, Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_RestructuringChargesPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis=tnet_AccruedSalariesCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis=tnet_AccruedSalariesCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Schedule of Segment Reporting Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,292<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_InterestExpenseBankFeesAndOther', window );">Interest expense, bank fees and other</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=tnet_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,292<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_WorkersCompensationCosts', window );">Workers' compensation costs</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_HealthInsuranceCosts', window );">Health insurance costs</a></td>
<td class="nump">919<span></span>
</td>
<td class="nump">886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther', window );">Sales &amp; marketing</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_ClientSupportCosts', window );">Client support costs</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CorporateAdministrationExpenses', window );">Corporate administration</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_SystemSupportAndDevelopmentExpenses', window );">System support &amp; development</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_InterestExpenseBankFeesAndOther', window );">Interest expense, bank fees and other</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=tnet_ProfessionalServicesMember', window );">Professional service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service revenues</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=tnet_ProfessionalServicesMember', window );">Professional service revenues | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service revenues</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=tnet_InsuranceServicesMember', window );">Insurance service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service revenues</a></td>
<td class="nump">1,065<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=tnet_InsuranceServicesMember', window );">Insurance service revenues | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service revenues</a></td>
<td class="nump">$ 1,065<span></span>
</td>
<td class="nump">$ 1,050<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_ClientSupportCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Client Support Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_ClientSupportCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CorporateAdministrationExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Administration Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CorporateAdministrationExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_HealthInsuranceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Health Insurance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_HealthInsuranceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_InterestExpenseBankFeesAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense, Bank Fees and Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_InterestExpenseBankFeesAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Selling And Marketing Expense, Excluding Stock Based Compensation And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_SystemSupportAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>System Support And Development Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_SystemSupportAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_WorkersCompensationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Workers' Compensation Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_WorkersCompensationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477346/946-830-45-39<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=tnet_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=tnet_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=tnet_ProfessionalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=tnet_ProfessionalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=tnet_InsuranceServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=tnet_InsuranceServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>95
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( #E"F5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( #E"F5K(.'WO\P   "L"   1
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M9<:K;<E%>2>6]^^CZR^_B[#KC-W9ZS*NBA_&9T%9PY^[D%]02P,$%     @
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M3@H\W/[O#;#"Q([A[8N_ 5!+ P04    "  Y0IE:+AF%\>P%  "\'P  &
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M,B=D ZAK^R,4XX$T:6A(PC1\WNIH]GA8I@<U_+R*WPN]7LMDX9U^ /6&;A)
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MJ:OR/71YH>6F>)5[+[66:?'1[!V-9!M@?E]*J9\O[-OA^G\#3/\'4$L#!!0
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MG'>10^9-73[1(LWZHGNAL<O*AA$VPB!- -Y?"*&?)J;5*EOKT3]02P,$%
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MENY>@^T6G*WR]SQ/C',6YY=+2F *%@;P_P5C_&TA7AT5+R/'_P!02P,$%
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M<&@ OB^,:>(#;9"N[+__7U!+ P04    "  Y0IE:9H(@-CT%  !]#0  &
M 'AL+W=O<FMS:&5E=',O<VAE970X+GAM;+U7;6_;-A#^*P>WZ%; B2W9<9PW
M T[BH@'6-(N3]L.P#[1TMHA2HDM2<;Q?O^-1DIW5"99AVX?(/(KWW'.O8DY7
MVGRS&:*#QUP5]JR5.;<\[G1LDF$N[+Y>8D%OYMKDPI%H%AV[-"A25LI5)^YV
M!YU<R*(U.N6]&S,ZU:53LL ; [;,<V'6YZCTZJP5M>J-6[G(G-_HC$Z78H%3
M=/?+&T-2IT%)98Z%E;H @_.SUC@Z/N_[\WS@B\25W5J#]V2F]3<O7*5GK:XG
MA H3YQ$$_3S@!2KE@8C&]PJSU9CTBMOK&OT#^TZ^S(3%"ZV^RM1E9ZUA"U*<
MBU*Y6[WZB)4_!QXOT<KR$U;A[."H!4EIG<XK96*0RR+\BL<J#EL*P^XS"G&E
M$#/O8(A97@HG1J=&K\#XTX3F%^PJ:Q,Y6?BD3)VAMY+TW.AB//W8!O^$R:_W
M5U_&OTRN[Z8POKZ$J^LOD^G=)Y;WX/[ZEJ3;JXN[R26_WHBG'4=,/%XGJ:R>
M!ZOQ,U9[\$D7+K,P*5),G^IWR(/&C;AVXSQ^$?"3,/O0B]H0=^.#%_!Z35AZ
MC-=[+BS"9B"*%'@Q^5[*!Z&P<!9^&\^L,U1,O^]R.Z#V=Z/Z!CNV2Y'@68LZ
MR*)YP-;HW9MHT#UY@7._X=Q_"?T_2^6+5G?[]&]0@7NJ#0,N0W!H<@MZSH)8
M&,2<<[&2+H,$C:/AXU_KTO 00&-_@D3G-+FL",U/J<Q0*#H_PP+GTH$L;&E$
MD2 DPAA).FU8$;Q!&C:4<(,I. U^L#$^=9H2Q$0H4@5GJ#=IIB2Z]$QH.C*Y
M&IS(V"4F<BX)Y4=+S(? #<I\5AJ+K%R_??=F&$>')Y H(7-8BO7&6^\G.4E-
M4](XFRD$)=9(M?\5R<P#>DZPU(:=K@*V15SD@2[!T C^ADYX"(M)::23:!G'
MH <(JJ4Q9)OI%KJHQ<I G1)/_VDXA"44:A.9./(_H1YJ\Q-PJY,\:. <_"/&
M@2[EO;!>CTQH)5/A069"<0AYU-5$.4T<D41)!J&@4AG.2Q_?#*7QX3,4 +9F
M4#&6$X\8[&LZ9#BRF5:I+!:@I)A)Q=&@;%)>L8&0EK!U@M:3HX2G)7+BJPSM
MPUW&1]A\FU_=3#Y74YSKB^*R0D_&-JG(4)%S:W;".N%*I\VZBJ='\/L?;Z^F
M<&\90OKL):I,N;#^09C)=NV0YVFY/M C4/UG,LF\B12M7!0A6-J?!^HECD^E
M2TQJ%(KFDZAMXEJ?V(IOR)Q05C?U^B"DXCI,M*'*(J.!&%DPDLI4JK7W="X?
MV67JZ^V2K3CG_@+CRZ<JBJJDPDS8 &\"046L9+)FMK[GJ=FL#?U*$1I_F.[#
M9U)UVE'?_-W0$DZXW<@_?,GZ*\\QT+>)"-8?)[C$!/,91:?:Z<//OAVE4KZE
MWD/SZ?G!W+B.U!X5QIZEW=U=#'=,^G\ >@N]_A$]>6+%)XW<&W2?[I)\^]I*
M/8:;W74*A_&@ ??KJ!WUHNIYL9EVOGV>#GT;9JJ%7@^BB/[Z V),RRXM^W_5
MW?TIJ1 .N@T%6I+7M43+NV>Z%Z)NU)SSZ^%A(]+R,S=-%?XU]>!26\]Y2P?B
M9AU7V7G]!#B*HN!]VU=?U.YU>R$$[3[MOCI/[>U/PVM"&%>1IPS$0UH>4A(.
M*J_>$IMXV*??..ZQ=- ]Y-_!4<2[03J*AK#K[M39NA+3[%WPQ=_7$ W=<#MN
M=IO_+<;A2KTY'OXQH?Y=T"<<%,Y)M;M_>- "$R[[07!ZR1?LF78TZ'E)94>7
M%W^ WL^U=K7@#33_<8W^!%!+ P04    "  Y0IE:(AENOID'  !J%@  &
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M"1.^;(8;IY?^:^)4.Z=3?[E K,@P 9[/-!!>W+""ZO/RU;]02P,$%     @
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M8N?]B%$4T:_]/_C8E'LB&"\,7:G")YQ"7FZ5J49_F%$U)T1Y0?5"+J"QG*Y
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M-EG4EB,$@[S 2:D J.0B .$I>FMT%J9&4^%6P+F<NZSTI']NNS[E;@=47HY
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M#5X9[3+%.SI7)(#[<RG-YH$,5+?^LW\ 4$L#!!0    ( #E"F5I=[9FES@,
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M'Y>;FUGL")=/XZS#6 6,]!F,$7S6M2LMW-0YYM_+Q\2G)Y4>2:W2LX"?A1G
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M3V4O!EB7*=*_2(+]S7?^+U!+ P04    "  Y0IE:9^<A"B,%  !:"P  &0
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M ?M5M2.@W1A9NR[:2(,]Z98E3DU0-@"_;Z4TQXU-T,_A[!=02P,$%     @
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M 3.9:2EXS$HA93&L%&K,3+D@M_# ,Y9%G D(:1%)M4;#WY.--HIT]T];A4H
MHW8 =A9O=<XBO._D-I=ZQL[XPSOOX^#3&7JCFM[H7/1Q2+,=%P(M](G62& M
MJT?.-EQPPU$#)UZ%:E#'&*9,$$N$T,JMC=/9K.V<J'-14K<.NI0WY4)0774/
MUHHO:&-:*QH$F(3A?!W"K%"*R@O,X;Z%&=.)0Q_9!_RWX,],N/J_!Q^>D%K
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M.SB,;6KH1.4LPK,.%8E"^8"=R9M7WM!]UV)YT%@>M*%/YE23<9$@B!7<SK_
MU'":ZT<H*-02+K\7-*D]2UBF#CG0JN*P XL-PDHD5,$\6X.VS*CJF/^#UA16
MFT*- C3)ZXU$A+2D AHJ "4RVC29/($%E??QTEI+$ H60K,$KHIT2<Z0BS91
M"K[:TL+X>/J DCH%?*!<:2"^([QG7,(=2PJ$*Y$]H"(Y8+2($5J82EL 7M=S
MW:[K>O :QJ'C>R4,B0_'PVX8#" <.F$?[DJ,MYX?=OV@?P1CUQF,@7K "KE=
M&5<+PX$SZN^KW?>0= Y"O^L/7=(Y&CO!"&Y0VDZ:1?^CY^&X.W9#LL%SA\[
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M7Z2) W)8Q\-!B]:NP(W0M%"M6-(7#*4Q('TAA-X?3(#QF[C\#U!+ P04
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MK)2E4>27.<U^U,Z![&NE[&[C$K1?D^0?4$L#!!0    ( #E"F5IGGO,DS@,
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M1:O\@UE_PXT_?>8KC')AA74GV\LB*%KG3;T!DP6UU-V_>-[$80\P3-X!9!M
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M)<FI>N+;S[@SU#%\$:>R^ O;7:QC091+Q;,=6"O(4E;^DF^[A3@ M,\!W!W
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M+!FO3S.:V^!6KDF$0TL?=XEB@Y;W^V^MKO/G*=L-D1V9OZ[,7]>Q>],\6Z
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M09ZE@ZB,S\K@?5T;5I&8SUD<1NE,/TY<S3C9'<&Z0EV#"A7*'#B6C:4/#_(
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MM3ND/"\@?Y\R)EX?\A=L+BT._@502P,$%     @ .4*96I(T!6XN!P  ##X
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M7K)?*W.2%0+L^T6:TJ>;XH7@^@7P\?]02P,$%     @ .4*96MIL#6"L"0
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MNU(BUJ8;E4!DFZFB_ZA6BX[W7'>\NFW;6X=.>&+Z/_<9IFBCH;N 2TTB1E8
MZ9T,((6BZ$R+B>*Y:>Z67$&K:(8;Z.:)T ;P?L6Y>IKH#:K_!^'_4$L#!!0
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M7"$-D>L)ZOF",;GOZ 7*N[7!?U!+ P04    "  Y0IE:@W3JOCH$   2$@
M&0   'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6RUF']OFS@<QM^*Q9U.FW0%
M;'Z%7A(I:;N[:6H;-6WWMPM.@@HXLYUDD^[%SP8*Z0 K2=?\$3#@KS_^VGX>
MS'!'V3-?$2+ ]RS-^<A8";$^MRP>K4B&N4G7))=W%I1E6,@B6UI\S0B.BTI9
M:B';]JT,)[DQ'A;79FP\I!N1)CF9,< W68;9CRE)Z6YD0./EPEVR7 EUP1H/
MUWA)YD0\K&=,EJPZ2IQD).<)S0$CBY$Q@>=3Y*L*Q1./"=GQO7.@NO)$Z;,J
M?(Y'AJV(2$HBH4)@>=B2"Y*F*I+D^%8%->HV5<7]\Y?HGXK.R\X\84XN:/HU
MB<5J9 P,$),%WJ3BCN[^(U6'/!4OHBDO_L&N>M8V0+3A@F9594F0)7EYQ-^K
M1.Q5<%!/!5150 5WV5!!>8D%'@\9W0&FGI;1U$G1U:*VA$MR-2ISP>3=1-83
MX_G][<47,)W,KR[!Q>WU[.IF/KG_?'L#SL!<SH!XDQ) %^!N_@!P'LOC!$Q4
M(A/Q VSRF#!P]6TC"V=3F9H8S%*<<_#AD@B<I/SCT!*24;5D117/M.1!/3P.
MN*:Y6'%P)8/'K^M;LF]U!]%+!Z=(&_ :,Q,X\&^ ;.2!/X$%^ HSPJN#I@6G
M3J%3M.#VM' O9VG5_3O"!4LB(4_G@D;/X"%/!._*@C:D6HKG?(TC,C+D6N.$
M;8DQ_NL/Z-O_:(#=&M@MHCM]P%3@%-QLLB<Y?')PYQV9*"G==Z#T:DI/F]8I
MEG,I(N!#DE=C]1'\WSEJ)6L9S2NB*2W:CB&TY0\.K6T'AE]C^%J,?QG.U7@>
MBN&W,/S0#UROFR*H*0(MQ:.<6$= !"V(,X@"Y#K=%(.:8J"ED#JX(,DQ((,V
M2-C/$=8<X6^=&F%[:G@!0K[=C0'M1CQM[4KZ6H@^B<\F6\*DB8%BM@"IQ 1\
MP@D#CSC=D$X5M-]A:<$]U8<'9S"F:8H9!VNI!D4.53(;H>RD+Z,'>QD- Q/9
MX=ZO)[>H040'+[Q3$,OH*L\U8^";0<_4@XW:0[W<[RW%4["<-E9HFUY?NAI-
MAUHQ_F5MGD+FMLE\SQST):S1<7BXD)_"Y;7FVB TW4$/5J/K4"_L,\**EUJ)
M=K1[ZT.?NGH;,X#!;S)PJ+654T$;OX!ZPSA6J&';+V 0AG;0,]B-84"]8QSK
MXK!M&8$[<'L, S6&@;2Z?H*#5@%?62B27MXS_U%C >AP"S@(!+9 D(-LV*-<
MJ!%ZA-[)1)'604Z<W:AQ J1W@C<*6Q5]7]B@[9L];XJH<0*D=X(W&B?J\ %I
MG'[?.#<^@/0^\&:'JN*_(H/(-9V>5WS4> '2>\%;1])O6Y1C.K^JEK6W3<\(
M6Q8?(SB(Z"87Y8Z]OEI_\)B4V_SF\?)KB=S5+A.YTT[)0E:US4"FAI4?(,J"
MH.MBT_]$A:!9<;HB6.[7U0/R_H)2\5)0#=2?@<8_ 5!+ P04    "  Y0IE:
MF-#[*)H#  !.#0  &0   'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6RUEVU/
MXS@0@/_**+<Z@<21.'T#KJW4%NX.K8"*PNYGDTQ;"R?NV6X+TOWX'2=MTEW2
M'%2[7QK;\<P\,QU[)MVUTL]FCFCA)9&IZ7ES:Q<7OF^B.2;<G*H%IO1FJG3"
M+4WUS#<+C3S.A!+IAT'0]A,N4J_?S=;&NM]52RM%BF,-9IDD7+\.4:IUSV/>
M=N%>S.;6+?C][H+/<(+V<3'6-/,++;%(,#5"I:!QVO,&[&+(.DX@V_%%X-KL
MC,&Y\J34LYM<QSTO<$0H,;).!:?'"D<HI=-$'/]NE'J%32>X.]YJ_RMSGIQY
MX@9'2GX5L9WWO#,/8ISRI;3W:OT/;AQJ.7V1DB;[A?5F;^!!M#16)1MA(DA$
MFC_YRR80.P+-?0+A1B#,N'-#&>4EM[S?U6H-VNTF;6Z0N9I)$YQ(W;\RL9K>
M"I*S_<G#W>@S# >3JTL8W=V,KVXG@X?KNUOX R:4 ?%2(J@I$$?T#&I11E+8
M5SBZ1,N%-,?P"7PP<Z[1@$CA,176G- BC6^$E"1DNKXE7&?4CS9HPQPMW(/6
M@!N5VKF!JS3&^'MYG]PL? VWO@[#6H4W7)]"@YU &(0M>)Q<PM&G[]#S1XVE
M1A'51F:IL<?2[3)Y0NT"-ZE0F;/F&IK5&MQAO# +'F'/H]-F4*_0Z__^&VL'
M?];P-0N^9IWV_A!G(DU%.J.,ECR-$([HK\K=/X;_*@.14^=Z6YE>=^)7_:#K
MKRI06@5*JQ;E;\U3B_&[ 5IO ,).P)K-:HIV0=&NI: 4.R0:[0_!= J83FWV
M?,VN$HK)8(6:KD:X>D$="8,PUB+"*I#.+TBFLP+W[(!DBI647!M8T#G( N@B
M69ZU*B=R,^W_SZWS@NS\W;EU $^NG 4[0)WV:?N\&HH%Y94;?#39#J#;&.F\
MDVZG(+"/9=\]NNKNB$=T'VNZ_9=<P@/J)$-_10(_KB1DOR K65@Z$M:&^2<Z
M4F_H/!<%QB#)*U;8@)B_UE425I825EL)MDE\ C_1GWJ+!_E3EA[6K,VOP6RF
M<<8MPC5!"^KO(OC"Y;+R7F.U=>S0%"IK$ZLO3F^NMA/8B^\.;*4+K?=>:ZRL
M5JR^7!4Y\7&:MR6+[:$IRQ6K+2\_W&>'0'7>A.A'*'^GQ4U0S[)&WD"DEJG-
MN]UBM?A8&.0M<KD]_]*@-I#^50,2IR0:G'8H&#IOWO.)58NL87Y2EMKO;#BG
M#Q[4;@.]GRIEMQ-GH/B$ZG\#4$L#!!0    ( #E"F5H<V1_HR@(  )L&   9
M    >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;(V5;6_:,!#'O\HIDZ9.&B2$
MIZV#2.&A6C6U(.B#JFDO3'(0"R?.; /EV\]V0L:F%/5-8CMW__O=V;X,#EQL
M98*HX#5EF1PZB5+YM>O**,&4R";/,=-?UERD1.FIV+@R%TABZY0RU_>\GIL2
MFCG!P*[-13#@.\5HAG,!<I>F1!Q'R/AAZ+2<T\*";A)E%MQ@D),-+E$]YG.A
M9VZE$M,4,TEY!@+70R=L78_ZQMX:/%$\R+,QF$Q6G&_-Y#8>.IX!0H:1,@I$
MO_8X1L:,D,;X76HZ54CC>#X^J=_8W'4N*R)QS-DSC54R=+XX$..:[)A:\,-W
M+//I&KV(,VF?<"AM/0>BG50\+9TU04JSXDU>RSJ<.;3Z;SCXI8-ON8M EG)"
M% D&@A] &&NM9@8V5>NMX6AF-F6IA/Y*M9\*E@^S\0\8A<OI!,:SN_GT?AD^
MW,[NH0%+?0#B'4/@:WBVV6'<"/<H]&9!*/4VYJ:P$AXEQJ X3*6BNDX(-X0*
M>")L9WV7BD=;F)7&5Q-4A#+Y:> JS6\HW*AD'16L_ANL;;CCF4HD3+,8XW_]
M79UWE;Q_2G[D7Q2\(Z()[=9G\#V_>T&O716S;?7:;Q4S(0(;(V+J,2='?785
MA$*0;(-V_#-<227T0?Q5EWRAW:G7-I?S6N8DPJ&C;Y]$L4<G^/BAU?.^72#O
M5.2=2^K!]#77UT1C/Z!(X8IF\()$U&_29:4>'(TG]""UFW4!KEO!==\']\09
M4911=:SC*D1:Q4DWS6@?>,V.WQZX^YK@O2IX[V+P!97;QHU A-M,H:Z\@H4^
MXW4 O3H K^-]K2?H5P3]]Z4_H7L:8Q;#"T46UQ'T:PE:G?]KX)XUC!3%QK9%
M"1'?9:KH'=5JU7G#HN'\-2_:MKY#&ZKO-<.U=O6:?;T-HFB%Q43QW+:?%5>Z
MF=EAHO\>*(R!_K[F7)TF)D#U/PK^ %!+ P04    "  Y0IE: NAW/* "  #,
M!0  &0   'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q]E&UOVD ,@/^*E553
M)[4$DD*W#B+QTFK51(N:=OTP[<.1&'+J)9?=7:"5]N/GNT#&*N!+XGNQ_=AG
MN[^6ZD5GB 9><U'H@9<94U[YODXRS)ENR1(+.EE(E3-#2[7T=:F0I4XI%W[0
M;O?\G/'"B_IN;Z:BOJR,X 7.%.@JSYEZ&Z&0ZX'7\;8;#WR9&;OA1_V2+3%&
M\U3.%*W\QDK*<RPTEP4H7 R\8>=JU+7WW84?'-=Z1P8;R5S*%[NX30=>VP*A
MP,18"XQ^*QRC$-808?S>V/0:EU9Q5]Y:OW&Q4RQSIG$LQ3-/33;P/GN0XH)5
MPCS(]3?<Q., $RFT^\)Z<[?M05)I(_.-,A'DO*C_['63AQV%,#R@$&P4 L==
M.W*4$V98U%=R#<K>)FM6<*$Z;8+CA7V4V"@ZY:1GHOCQ?OP=1L/X>@+C^^GL
M^BX>/M[>W\$YQ%0 :240Y +BC"D\'U'X*<S8&[V*@:%2K%BBE<]@:+/+S1N<
M3M P+O0G. $?M-73P MX*KC19[1)\I0+04^B^[ZA$"R(GVQP1S5N<  WA*DL
M3*;AND@Q_5_?I]";^(-M_*/@J,$I4RT(.V<0M(,N/,43.#W913_B(FQ2'#H7
MX:$4'\\=_!S.M5%4GK_VY:.V?;'?MFW9*UVR! <>]:1&M4(O^OBATVM_/4)^
MT9!?'+,>/;N:QO2<K5!1B\*2J VDS" L&%>P8J)R]4%UFKR +&VG:?AS,(%U
M3+772^?53HU5%'9:O6[?7^V![3:PW:.PC](P\0YK"^2X*?T$MH^G-MS;X?GR
MCL7?Z; <U=+-$0V)K I3-UNSVXRJ8=VA_Z[7<XXJ;LF)2>""5-NM2_*NZME1
M+XPL7;_.I:'N=V)&XQ:5O4#G"RG-=F$=- ,\^@M02P,$%     @ .4*96G*X
M-)[C P  *Q(  !D   !X;"]W;W)K<VAE971S+W-H965T-#8N>&ULQ5C;;MLX
M$/T50ELL6F 3W7Q)4UN [:3=H)O&J-+MPV(?:&EL$Y%$E:3MI%^_0TF1)5L1
M-JB"O-@2/7-TYO!0'G*TX^).K@$4N8^C1(Z-M5+IN6G*8 TQE:<\A01_67(1
M4X6W8F7*5  -LZ0X,AW+&I@Q98GAC;*QN?!&?*,BEL!<$+F)8RH>IA#QW=BP
MC<>!KVRU5GK ]$8I78$/ZELZ%WAGEB@ABR&1C"=$P')L3.SSF3W4"5G$WPQV
MLG)-="D+SN_TS54X-BS-""((E(:@^+6%&4211D(>/PI0HWRF3JQ>/Z)_S(K'
M8A94PHQ'WUFHUF/CS" A+.DF4E_Y[D\H"NIKO(!',OLDNR+6,DBPD8K'13(R
MB%F2?]/[0HA* N(T)SA%@G.8T'LBP2T2W*S0G%E6U@55U!L)OB-"1R.:OLBT
MR;*Q&I;H:?25P%\9YBG/O[V9?2;3B7]Y068WU_/++_[D]NKF"SDA/EHFW$1
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MSD,,B=>S:+V1K-3CW#V3.!SJ98+S.W E@.\7C,G-1CEH_R,P^0=02P,$%
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MT.B:DY.N@[J)%GG9M>9"FQY8#E/SZ*"T"F9](83>3FR ZAF+?@-02P,$%
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MC46-?9QCW0G2#,#W4R'TKF$FR"K9X"]02P,$%     @ .4*96EZ_(/:Y P
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M+S\,&9AV4%J#=!V:<Z7)M7I8ENYM0>,=W/E::SH8/D#W6F5_ %!+ P04
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M82@RB- 45B P"P%A%J'K>Z+L8$1DRB6F:,BEDNAP! H3*H\TX6PZ0H<'1^C
MT-P22O7FR9ZKM':CP T+G5>YSF"'SA:ZY4S%$EVS"*(:_+ 9[P<-!*XVK70N
M>'3N*FADO,7B!+7\CRCP@DZ=H&;X",(2WFZ0TRHWLF7YVCOX] [QC&GS4_R
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M3SJN<$/B#,4;VY@I5[K-[;+2[PH(XZ#/"\[5T3 !AI<J^0M02P,$%     @
M.4*96D2&%=+ !0  7!\  !D   !X;"]W;W)K<VAE971S+W-H965T-30N>&UL
MM5E=;]LV%/TKA%=T+=!5$N7/U#:0..EJ8$Z".%T?ACTP%FT+D42/I.-TV(\?
M*2FB)9&T#<@OB23?>WAX>7G/E3C<$?K,UAAS\!I'"1NUUIQO+AR'+=8X1NPS
MV>!$_+(D-$9<W-*5PS84HR!UBB,'NF[7B5&8M,;#]-D]'0_)ED=A@N\I8-LX
M1O3G%8[(;M3R6F\/'L+5FLL'SGBX02L\Q_S[YIZ*.Z= "<(8)RPD":!X.6I=
M>A<3OR\=4HL_0[QC>]= 3N6)D&=Y,PU&+5<RPA%>< F!Q+\7/,%1))$$CW]R
MT%8QIG3<OWY#_YI.7DSF"3$\(=&/,.#K4:O? @%>HFW$'\CN&\XGU)%X"Q*Q
M]"_8Y;9N"RRVC),X=Q8,XC#)_J/7/!![#@)'[P!S!UAU:!L<_-S!3R>:,4NG
M=8TX&@\IV0$JK06:O$ACDWJ+V82)7,8YI^+74/CQ\?SF]]G-[2.8WGZ]>YA=
M/D[O;L%O8"ZR)=A&&) EF..56#8.'O"&4!XF*S!-LO21R_#A&G,41NRC\/H^
MOP8?WGT$[T"8@%D81<* #1TN:,K!G$5.Z2JC! V4?# C"5\S<),$."C[.V)Z
MQ1SAVQROH!5PANAGX'N? '1A1\-G<KQ[VT+'+T+NIWB^*>36@/[UAS '4XYC
M]K<N=AEV6X\M-_T%VZ %'K7$KF:8ON#6^/TO7M?]HIMX0V"E,+2+,+1MZ.-I
MPK% Y2)9%B3&NKEF -T40-:CE['7'SHO^S.PFI1X=0I>'2NO1\)1)"K4"TZV
M6)N^F7]G?TPX@!5B.J,^U%/K%M2Z5FK76*S#(LP2!24!0+',H'^S!V*OA@E'
MR2I\$CL7,8:YEGZWSJQ7(:\Q,42U5U#O6:G/.5D\IP4W &*YA0JQE+6.8*\^
MNE\A6#>!KIY@OR#8/RX=\:LDAS\)LLDS6&+,TE 3OL94Q[9?9]NNL-68=/5L
M!P7;P0&V<L\ CE[U*3JHC>B[%5(:$U]/RG.5F+A66K?8MIUSY_TA^YT**XW-
MP#/0VM,XSTHKJ[1(;HN\^&KI64%.+:U-H96G#-64X1E%)@=O*A0-H95#H>36
ML\K8,4*3(Q@*7CX+JTV9F]) SRZ"A\4F!SB@-EHKD]QX2@H]NQ;^$"TXINS7
M4LD6-TRO+%Y=]&"U<NML3!M<Z:)G%\9O&$5\+1:8;2E*%MA"L2YM V]0Y5@W
MZO<-%=M3"N@=D$ 4"2UYC^+-%]'!B\#*;:GE6%>W;K5ZZVPZ!H9* CV[!DZB
M4-8,MMW(HF$)8EW0VK5UUMB8MHM2/<\N>Q-"!3/$17L3B)>AD'%J["(\C<#5
MU$9C8R )E0A"NPC.?S)16(LH9@L>B"T>D8U)>V!=]CK5/:ZQ:1N2$BIIA'9I
M;*:ES >Q]I0Z&U.LE<Q!JW:<U%;F4-:^4F-C:BRA$B!H%Z [4^L(-9)2)50W
M,?%1H@./?/,ZM=6%&I6I]KHZ&U.6*AV"=ATZU.["NJC4^EV=C:'AA4IXH%UX
M[ TOU.A(M01I;$P-+U12 ^U2<T_)$C/YJ4UT%[*C"H4FVKH,.]ZI#5]3:.79
M*QF#_3/VOM"JD2>'HB&T<BB48$*[8,Z/6?NZ"$*WVA+IC/;V?OE#F))*WRZ5
MUCP%_X'C7MSL@YS\3:PAM')(E"#[WCF_#C;Z#ML46CD42MS] ^)^1/+Z.L&N
M)J_.R)B\>Y]Q#[U7OKUM'%-A[6 GK\PYOMSZJH/PV^=,4FM[<G(H&D(KAT*U
M)KZ]-3DJ234?@]UNM1/06G4,W9ZO6A3?WJ*8T_3X FL=X>0%:PBM' _5&_F]
M<^9NHXU24VCE4*A&R;>_[Q^5N_WZ"8LF=W56M=QU]LXI8TQ7Z?$M$R]NVX1G
MQWG%T^R(^,J[F*0GJ97GE][%97I@ZBB8[-QYAN@J3!B(\%) NI][8CO1["@W
MN^%DDYZ&/A'.29Q>KC$*,)4&XO<E(?SM1@Y0'*B/_P=02P,$%     @ .4*9
M6H,RI"0] P  ]A,   T   !X;"]S='EL97,N>&ULW5A=;]HP%/TK4;I.K30U
M0-:4K("T(56:M$V5VH>]588XP9)C9X[I8+]^OG8('_5%K \;+*C$OL?GW&/[
MIG$[J/62TX<9I3I8E%S4PW"F=?4ABNKIC):DOI(5%0;)I2J)-EU51'6E*,EJ
M()4\ZG4Z2502)L+10,S+NU+7P53.A1Z&21L*W.US-@R[R?LP<')CF=%A^'3Q
M]L=<ZMLW@;N?O3L[ZSQ=WN[&+RQP&49>T>L#1*\ZN*[!,.GD,&FX]LG#A:6X
MV4YA*>=&S)'/,5K?0S.9UDSH8.3TP&GMG9,5CYI]'PUR*=;;'X<N8+*3D@;/
MA _#,>%LHABP<E(ROG3A'@2FDDL5:%-WQDX7(O4O!W==#TJRT2F9D,KF=AG<
M]Z09O@.L>F"0<=X:[(4N,!I41&NJQ)WIV,$V^ (*FO;CLC(."T66W=YUN";8
MFTDRD2JCJDW3#5>AT8#3'.PH5LS@KF45 :BU+$TC8Z20@E@/*T;3,+)3ROD#
M/*_?\RWM1;ZQKQW85=$VC:&FZ61<!_0WU9SVIFS\*MV@8L]2?YJ;Z0C;AVJA
M]XKF;&'[B[PU@*EW<75257SYD;-"E-1-_N"$HP%9\8*95.R7R0:E,C4!JL+@
MF2K-IIN1GXI4CW2A5^6TR''/O1/T_'?7N:""*L(W39O:/^95?K7C^.9?6;:_
M578->STV+^%C-WE]"B:34S!Y C49I\?OL3ER';O)XUS)J#ED;)QDMLXQ;32
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MVVNK-!2(E+J1^H *T@:/$&413OTP]J=,?XL7LV#J)GHG3O1F[H< TD(@K:M
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( #E"F5K(.'WO\P   "L"   1
M          "  <,   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( #E"
MF5J97)PC$ 8  )PG   3              "  >4!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ .4*96BX9A?'L!0  O!\  !@
M ("!)@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( #E"
MF5H#U?PH0 4  ,,5   8              " @4@.  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    "  Y0IE:7=I3^>L&   9(   &
M        @(&^$P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ .4*96L<UC3(@ P  9@L  !@              ("!WQH  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( #E"F5KQ'^LO/04  )@<   8
M              " @34>  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    "  Y0IE:#F5B*44(   2)P  &               @(&H(P  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ .4*96KP!-]0]$0
MOB\  !@              ("!(RP  'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( #E"F5IF@B V/04  'T-   8              " @98]
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  Y0IE:(AEN
MOID'  !J%@  &               @($)0P  >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ .4*96MU!O"!A!   \PH  !D
M ("!V$H  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    "  Y
M0IE: UBS7^4$  !/"P  &0              @(%P3P  >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( #E"F5K]?LZ#8P8   $0   9
M          " @8Q4  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#
M%     @ .4*96EWMF:7. P  8 @  !D              ("!)EL  'AL+W=O
M<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  Y0IE:INW)>]<#  !;
M"   &0              @($K7P  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM
M;%!+ 0(4 Q0    ( #E"F5J@&<5"A0,  (T(   9              " @3EC
M  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ .4*96G]_
MY#;_!   !0L  !D              ("!]68  'AL+W=O<FMS:&5E=',O<VAE
M970Q-BYX;6Q02P$"% ,4    "  Y0IE:9^<A"B,%  !:"P  &0
M    @($K;   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M #E"F5H]P(5?/@(  ),%   9              " @85Q  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ .4*96A.MA^M$ @  B@8  !D
M             ("!^G,  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    "  Y0IE:]&T@L+X+   "+0  &0              @(%U=@  >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( #E"F5KL)RW/Q00
M )P+   9              " @6J"  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ .4*96I1*N7F9 P  K@@  !D              ("!
M9H<  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  Y0IE:
MXF1H82\%  #:#P  &0              @($VBP  >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( #E"F5HFJ"5NLP,  ,\(   9
M      " @9R0  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ .4*96N4G>>::!0   0\  !D              ("!AI0  'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    "  Y0IE:R437&T0#   ?!P
M&0              @(%7F@  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( #E"F5J"".O_)@,  %8'   9              " @=*=  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ .4*96L%L>X3@
M @  608  !D              ("!+Z$  'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    "  Y0IE:9Y[S),X#  # !P  &0
M@(%&I   >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( #E"
MF5H"B$(P>@,  %4,   9              " @4NH  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ .4*96EHPOIYW!   U14  !D
M         ("!_*L  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    "  Y0IE:H\!USXH&  # *   &0              @(&JL   >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( #E"F5J2- 5N+@<   P^
M   9              " @6NW  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ .4*96MIL#6"L"0  )EH  !D              ("!T+X
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    "  Y0IE:6T:$
M-Y("  !<!@  &0              @(&SR   >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    ( #E"F5H">6C%XP(  ,\'   9
M  " @7S+  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
M.4*96N)J]*^9 @  IP@  !D              ("!ELX  'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    "  Y0IE:B?;+N)8#   K#   &0
M            @(%FT0  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( #E"F5HKRQ4BLP,  %D0   9              " @3/5  !X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ .4*96FT8)BQX @
M[04  !D              ("!'=D  'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    "  Y0IE:8^2^=@($  !G$P  &0              @(',
MVP  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( #E"F5J#
M=.J^.@0  !(2   9              " @07@  !X;"]W;W)K<VAE971S+W-H
M965T-#(N>&UL4$L! A0#%     @ .4*96IC0^RB: P  3@T  !D
M     ("!=N0  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #E"F5IM[7 !Q@(  -(&   9              "
M@6OV  !X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ .4*9
M6A2SY<T1 P  U0H  !D              ("!:/D  'AL+W=O<FMS:&5E=',O
M<VAE970T.2YX;6Q02P$"% ,4    "  Y0IE:7K\@]KD#  !B"P  &0
M        @(&P_   >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0
M   ( #E"F5J'@!OU.P(  +D$   9              " @:   0!X;"]W;W)K
M<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ .4*96ER-MKI2 P  MPP
M !D              ("!$@,! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q0
M2P$"% ,4    "  Y0IE:0:%5+C@"  "U!   &0              @(&;!@$
M>&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( #E"F5I$AA72
MP 4  %P?   9              " @0H) 0!X;"]W;W)K<VAE971S+W-H965T
M-30N>&UL4$L! A0#%     @ .4*96H,RI"0] P  ]A,   T
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;72YX;6Q02P4&     #X /@#I$   #!P!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>156</ContextCount>
  <ElementCount>263</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>51</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED</Role>
      <ShortName>CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - INVESTMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INVESTMENTS</Role>
      <ShortName>INVESTMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTS</Role>
      <ShortName>ACCRUED WORKERS' COMPENSATION COSTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - STOCK BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - RESTRUCTURING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/RESTRUCTURING</Role>
      <ShortName>RESTRUCTURING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/SEGMENTINFORMATION</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables</Role>
      <ShortName>CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - INVESTMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INVESTMENTSTables</Role>
      <ShortName>INVESTMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/INVESTMENTS</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSTables</Role>
      <ShortName>ACCRUED WORKERS' COMPENSATION COSTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTS</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - STOCK BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - RESTRUCTURING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/RESTRUCTURINGTables</Role>
      <ShortName>RESTRUCTURING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/RESTRUCTURING</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/SEGMENTINFORMATION</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Assets and Liabilities of the Trust (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Assets and Liabilities of the Trust (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Worksite Employee Changes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Worksite Employee Changes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails</Role>
      <ShortName>CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - INVESTMENTS - Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - INVESTMENTS - Schedule of Fair value of Debt Investments by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Fair value of Debt Investments by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - INVESTMENTS - Schedule of Available-for-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Available-for-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - INVESTMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails</Role>
      <ShortName>INVESTMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Loss Reserve Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails</Role>
      <ShortName>ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Loss Reserve Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails</Role>
      <ShortName>ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails</Role>
      <ShortName>ACCRUED WORKERS' COMPENSATION COSTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - STOCK BASED COMPENSATION - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails</Role>
      <ShortName>STOCK BASED COMPENSATION - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - STOCK BASED COMPENSATION - Schedule of RSU and RSA Activity under Equity-Based Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails</Role>
      <ShortName>STOCK BASED COMPENSATION - Schedule of RSU and RSA Activity under Equity-Based Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - STOCK BASED COMPENSATION - Schedule of stock option activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails</Role>
      <ShortName>STOCK BASED COMPENSATION - Schedule of stock option activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - STOCK BASED COMPENSATION - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofStockOptionsDetails</Role>
      <ShortName>STOCK BASED COMPENSATION - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - STOCK BASED COMPENSATION - Schedule of Share-Based Payment Arrangement, Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofShareBasedPaymentArrangementActivityDetails</Role>
      <ShortName>STOCK BASED COMPENSATION - Schedule of Share-Based Payment Arrangement, Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - STOCK BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails</Role>
      <ShortName>STOCK BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Schedule of Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.trinet.com/role/INCOMETAXES</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails</Role>
      <ShortName>EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - RESTRUCTURING - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/RESTRUCTURINGNarrativeDetails</Role>
      <ShortName>RESTRUCTURING - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - RESTRUCTURING - Schedule of Changes in Accrued Severance and Exit and Disposal Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails</Role>
      <ShortName>RESTRUCTURING - Schedule of Changes in Accrued Severance and Exit and Disposal Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - SEGMENT INFORMATION - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/SEGMENTINFORMATIONAdditionalInformationDetails</Role>
      <ShortName>SEGMENT INFORMATION - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="tnet-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - SEGMENT INFORMATION - Schedule of Segment Reporting Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails</Role>
      <ShortName>SEGMENT INFORMATION - Schedule of Segment Reporting Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="tnet-20250331.htm">tnet-20250331.htm</File>
    <File>tnet-20250331.xsd</File>
    <File>tnet-20250331_cal.xml</File>
    <File>tnet-20250331_def.xml</File>
    <File>tnet-20250331_lab.xml</File>
    <File>tnet-20250331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>tnet-20250331_g1.jpg</File>
    <File>tnet-20250331_g10.jpg</File>
    <File>tnet-20250331_g11.jpg</File>
    <File>tnet-20250331_g12.jpg</File>
    <File>tnet-20250331_g13.jpg</File>
    <File>tnet-20250331_g14.jpg</File>
    <File>tnet-20250331_g15.jpg</File>
    <File>tnet-20250331_g16.jpg</File>
    <File>tnet-20250331_g17.jpg</File>
    <File>tnet-20250331_g18.jpg</File>
    <File>tnet-20250331_g19.jpg</File>
    <File>tnet-20250331_g2.jpg</File>
    <File>tnet-20250331_g20.jpg</File>
    <File>tnet-20250331_g21.jpg</File>
    <File>tnet-20250331_g22.jpg</File>
    <File>tnet-20250331_g23.jpg</File>
    <File>tnet-20250331_g24.jpg</File>
    <File>tnet-20250331_g25.jpg</File>
    <File>tnet-20250331_g3.jpg</File>
    <File>tnet-20250331_g4.jpg</File>
    <File>tnet-20250331_g5.jpg</File>
    <File>tnet-20250331_g6.jpg</File>
    <File>tnet-20250331_g7.jpg</File>
    <File>tnet-20250331_g8.jpg</File>
    <File>tnet-20250331_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="599">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>102
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tnet-20250331.htm": {
   "nsprefix": "tnet",
   "nsuri": "http://www.trinet.com/20250331",
   "dts": {
    "inline": {
     "local": [
      "tnet-20250331.htm"
     ]
    },
    "schema": {
     "local": [
      "tnet-20250331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "tnet-20250331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "tnet-20250331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "tnet-20250331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tnet-20250331_pre.xml"
     ]
    }
   },
   "keyStandard": 236,
   "keyCustom": 27,
   "axisStandard": 22,
   "axisCustom": 1,
   "memberStandard": 31,
   "memberCustom": 18,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/dei/2024": 5,
    "http://fasb.org/us-gaap/2024": 1
   },
   "contextCount": 156,
   "entityCount": 1,
   "segmentCount": 51,
   "elementCount": 523,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 599,
    "http://xbrl.sec.gov/dei/2024": 30,
    "http://xbrl.sec.gov/ecd/2024": 4,
    "http://fasb.org/srt/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://www.trinet.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
     "longName": "9952151 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestIncomeOperating",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingInsuranceAndClaimsCostsProduction",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
     "longName": "9952152 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
     "longName": "9952153 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited",
     "longName": "9952154 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
     "longName": "9952155 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES",
     "longName": "9952156 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED",
     "longName": "9952157 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED",
     "shortName": "CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "tnet:CashCashEquivalentsAndInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "tnet:CashCashEquivalentsAndInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.trinet.com/role/INVESTMENTS",
     "longName": "9952158 - Disclosure - INVESTMENTS",
     "shortName": "INVESTMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTS",
     "longName": "9952159 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS",
     "shortName": "ACCRUED WORKERS' COMPENSATION COSTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.trinet.com/role/COMMITMENTSANDCONTINGENCIES",
     "longName": "9952160 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.trinet.com/role/STOCKBASEDCOMPENSATION",
     "longName": "9952161 - Disclosure - STOCK BASED COMPENSATION",
     "shortName": "STOCK BASED COMPENSATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.trinet.com/role/STOCKHOLDERSEQUITY",
     "longName": "9952162 - Disclosure - STOCKHOLDERS' EQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.trinet.com/role/INCOMETAXES",
     "longName": "9952163 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.trinet.com/role/EARNINGSPERSHARE",
     "longName": "9952164 - Disclosure - EARNINGS PER SHARE",
     "shortName": "EARNINGS PER SHARE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.trinet.com/role/RESTRUCTURING",
     "longName": "9952165 - Disclosure - RESTRUCTURING",
     "shortName": "RESTRUCTURING",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.trinet.com/role/SEGMENTINFORMATION",
     "longName": "9952166 - Disclosure - SEGMENT INFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R19": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "longName": "9955511 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables",
     "longName": "9955512 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables",
     "longName": "9955513 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Tables)",
     "shortName": "CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.trinet.com/role/INVESTMENTSTables",
     "longName": "9955514 - Disclosure - INVESTMENTS (Tables)",
     "shortName": "INVESTMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSTables",
     "longName": "9955515 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS (Tables)",
     "shortName": "ACCRUED WORKERS' COMPENSATION COSTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables",
     "longName": "9955516 - Disclosure - STOCK BASED COMPENSATION (Tables)",
     "shortName": "STOCK BASED COMPENSATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.trinet.com/role/STOCKHOLDERSEQUITYTables",
     "longName": "9955517 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.trinet.com/role/EARNINGSPERSHARETables",
     "longName": "9955518 - Disclosure - EARNINGS PER SHARE (Tables)",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.trinet.com/role/RESTRUCTURINGTables",
     "longName": "9955519 - Disclosure - RESTRUCTURING (Tables)",
     "shortName": "RESTRUCTURING (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.trinet.com/role/SEGMENTINFORMATIONTables",
     "longName": "9955520 - Disclosure - SEGMENT INFORMATION (Tables)",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails",
     "longName": "9955521 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:PrepaidInsurance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails",
     "longName": "9955522 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Assets and Liabilities of the Trust (Details)",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Assets and Liabilities of the Trust (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails",
     "longName": "9955523 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Worksite Employee Changes (Details)",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Worksite Employee Changes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncreaseDecreaseInAccountsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:IncreaseDecreaseInContractWithCustomerAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
     "longName": "9955524 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Details)",
     "shortName": "CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:RestrictedCashAndInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails",
     "longName": "9955525 - Disclosure - INVESTMENTS - Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis (Details)",
     "shortName": "INVESTMENTS - Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-74",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-74",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails",
     "longName": "9955526 - Disclosure - INVESTMENTS - Schedule of Fair value of Debt Investments by Contractual Maturity (Details)",
     "shortName": "INVESTMENTS - Schedule of Fair value of Debt Investments by Contractual Maturity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails",
     "longName": "9955527 - Disclosure - INVESTMENTS - Schedule of Available-for-Sale Securities (Details)",
     "shortName": "INVESTMENTS - Schedule of Available-for-Sale Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails",
     "longName": "9955528 - Disclosure - INVESTMENTS - Additional Information (Details)",
     "shortName": "INVESTMENTS - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-118",
      "name": "us-gaap:NotesPayableFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-118",
      "name": "us-gaap:NotesPayableFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails",
     "longName": "9955529 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Loss Reserve Activity (Details)",
     "shortName": "ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Loss Reserve Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails",
     "longName": "9955530 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Liabilities (Details)",
     "shortName": "ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails",
     "longName": "9955531 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Additional Information (Details)",
     "shortName": "ACCRUED WORKERS' COMPENSATION COSTS - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "tnet:CollateralHeldByInsuranceCarriers",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "tnet:CollateralHeldByInsuranceCarriers",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
     "longName": "9955532 - Disclosure - STOCK BASED COMPENSATION - Additional Information (Details)",
     "shortName": "STOCK BASED COMPENSATION - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-122",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-122",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails",
     "longName": "9955533 - Disclosure - STOCK BASED COMPENSATION - Schedule of RSU and RSA Activity under Equity-Based Plans (Details)",
     "shortName": "STOCK BASED COMPENSATION - Schedule of RSU and RSA Activity under Equity-Based Plans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-126",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-126",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails",
     "longName": "9955534 - Disclosure - STOCK BASED COMPENSATION - Schedule of stock option activity (Details)",
     "shortName": "STOCK BASED COMPENSATION - Schedule of stock option activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofStockOptionsDetails",
     "longName": "9955535 - Disclosure - STOCK BASED COMPENSATION - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options (Details)",
     "shortName": "STOCK BASED COMPENSATION - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofShareBasedPaymentArrangementActivityDetails",
     "longName": "9955536 - Disclosure - STOCK BASED COMPENSATION - Schedule of Share-Based Payment Arrangement, Activity (Details)",
     "shortName": "STOCK BASED COMPENSATION - Schedule of Share-Based Payment Arrangement, Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails",
     "longName": "9955537 - Disclosure - STOCK BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)",
     "shortName": "STOCK BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails",
     "longName": "9955538 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Common Stock (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Schedule of Common Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
     "longName": "9955539 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.trinet.com/role/INCOMETAXESDetails",
     "longName": "9955540 - Disclosure - INCOME TAXES (Details)",
     "shortName": "INCOME TAXES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails",
     "longName": "9955541 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock (Details)",
     "shortName": "EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.trinet.com/role/RESTRUCTURINGNarrativeDetails",
     "longName": "9955542 - Disclosure - RESTRUCTURING - Narrative (Details)",
     "shortName": "RESTRUCTURING - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails",
     "longName": "9955543 - Disclosure - RESTRUCTURING - Schedule of Changes in Accrued Severance and Exit and Disposal Costs (Details)",
     "shortName": "RESTRUCTURING - Schedule of Changes in Accrued Severance and Exit and Disposal Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-149",
      "name": "us-gaap:RestructuringCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-149",
      "name": "us-gaap:RestructuringCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.trinet.com/role/SEGMENTINFORMATIONAdditionalInformationDetails",
     "longName": "9955544 - Disclosure - SEGMENT INFORMATION - Additional Information (Details)",
     "shortName": "SEGMENT INFORMATION - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R54": {
     "role": "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails",
     "longName": "9955545 - Disclosure - SEGMENT INFORMATION - Schedule of Segment Reporting Information (Details)",
     "shortName": "SEGMENT INFORMATION - Schedule of Segment Reporting Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestIncomeOperating",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-155",
      "name": "us-gaap:InterestIncomeOperating",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20250331.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "tnet_A2029NotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "A2029NotesPayableMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029 Notes",
        "label": "2029 Notes Payable [Member]",
        "documentation": "2029 Notes Payable"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_A2031NotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "A2031NotesPayableMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2031 Notes",
        "label": "2031 Notes Payable [Member]",
        "documentation": "2031 Notes Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesMember",
     "presentation": [
      "http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and other current liabilities",
        "label": "Accounts Payable and Accrued Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and other current liabilities",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r995"
     ]
    },
    "tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll tax liabilities and other payroll withholdings",
        "verboseLabel": "Payroll tax liabilities and other payroll withholdings",
        "label": "Accrued Payroll Tax Liabilities And Other Payroll Withholdings",
        "documentation": "Accrued Payroll Tax Liabilities And Other Payroll Withholdings"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedSalariesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedSalariesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued wages",
        "verboseLabel": "Accrued wages",
        "label": "Accrued Salaries, Current",
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r781"
     ]
    },
    "tnet_AccruedSalariesCurrentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "AccruedSalariesCurrentMember",
     "presentation": [
      "http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued wages",
        "label": "Accrued Salaries, Current [Member]",
        "documentation": "Accrued Salaries, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r15",
      "r65",
      "r160",
      "r613",
      "r656",
      "r660"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r8",
      "r15",
      "r488",
      "r491",
      "r529",
      "r651",
      "r652",
      "r971",
      "r972",
      "r973",
      "r981",
      "r982",
      "r983",
      "r985"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Awards effectively repurchased for required employee withholding taxes",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r417"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash used in operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_AggregateIntrinsicValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "AggregateIntrinsicValueRollForward",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Intrinsic Value",
        "label": "Aggregate Intrinsic Value [Roll Forward]",
        "documentation": "Aggregate Intrinsic Value"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r865",
      "r875",
      "r885",
      "r917"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r868",
      "r878",
      "r888",
      "r920"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r913"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r869",
      "r879",
      "r889",
      "r913",
      "r921",
      "r925",
      "r933"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total stock based compensation expense",
        "terseLabel": "Stock based compensation",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r447",
      "r452"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r224"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r106",
      "r155",
      "r186",
      "r228",
      "r236",
      "r261",
      "r265",
      "r309",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r483",
      "r485",
      "r514",
      "r609",
      "r708",
      "r792",
      "r793",
      "r829",
      "r856",
      "r1031",
      "r1032",
      "r1083"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "verboseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "terseLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r163",
      "r186",
      "r309",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r483",
      "r485",
      "r514",
      "r829",
      "r1031",
      "r1032",
      "r1083"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "verboseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Unrealized Gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r282"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r283"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r319",
      "r608"
     ]
    },
    "tnet_AvailableForSaleMarketableSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "AvailableForSaleMarketableSecuritiesMember",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available-for-sale marketable securities",
        "label": "Available-for-Sale Marketable Securities [Member]",
        "documentation": "Available-for-Sale Marketable Securities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesAbstract",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities",
        "label": "Debt Securities, Available-for-Sale [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over five years through ten years",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r605"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over one year through five years",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r287",
      "r604"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over ten years",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r606"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total fair value",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date."
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1004",
      "r1094"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "One year or less",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r286",
      "r603"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Debt Securities, Available-for-Sale",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r319",
      "r500",
      "r599",
      "r817",
      "r821",
      "r996",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Axis]",
        "label": "Statement of Financial Position Location, Balance [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r1097",
      "r1098"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Domain]",
        "label": "Statement of Financial Position Location, Balance [Domain]",
        "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r340",
      "r1097",
      "r1098"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation and Basis of Consolidation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES",
        "label": "Business Description and Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82"
     ]
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payable for purchase of property and equipment",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r23"
     ]
    },
    "us-gaap_CapitalLossCarryforwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalLossCarryforwardMember",
     "presentation": [
      "http://www.trinet.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital Loss Carryforward",
        "label": "Capital Loss Carryforward [Member]",
        "documentation": "Deductions derived from capital losses that cannot be utilized on the tax return during a period that have been carried forward to reduce taxable income or taxes payable in a future year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Abstract]",
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails": {
       "parentTag": "us-gaap_RestrictedCashAndInvestments",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "netLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r152",
      "r778"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsMember",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents [Member]",
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "tnet_CashCashEquivalentsAndInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "CashCashEquivalentsAndInvestmentsTextBlock",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED",
        "label": "Cash, Cash Equivalents And Investments [Text Block]",
        "documentation": "Cash, Cash Equivalents and Investments [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning of period",
        "periodEndLabel": "End of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r78",
      "r184"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents, unrestricted and restricted:",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in cash and cash equivalents, unrestricted and restricted",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r78"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents:",
        "label": "Cash Equivalents, at Carrying Value",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r969",
      "r1095"
     ]
    },
    "us-gaap_CertificatesOfDepositMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CertificatesOfDepositMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Certificate of deposit",
        "label": "Certificates of Deposit [Member]",
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r850",
      "r851",
      "r852",
      "r853"
     ]
    },
    "tnet_ChangeInVariableInterestEntityAssetsAndLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "ChangeInVariableInterestEntityAssetsAndLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in WSE and TriNet Trust related assets and liabilities, net",
        "verboseLabel": "Change in WSE and TriNet Trust related assets and liabilities, net",
        "label": "Change In Variable Interest Entity Assets And Liabilities, Net",
        "documentation": "Change In Variable Interest Entity Assets And Liabilities, Net"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r157",
      "r158",
      "r159",
      "r186",
      "r210",
      "r214",
      "r221",
      "r223",
      "r230",
      "r231",
      "r309",
      "r359",
      "r361",
      "r362",
      "r363",
      "r366",
      "r367",
      "r386",
      "r387",
      "r389",
      "r392",
      "r399",
      "r514",
      "r665",
      "r666",
      "r667",
      "r668",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r696",
      "r717",
      "r736",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r944",
      "r978",
      "r986"
     ]
    },
    "tnet_ClientSupportCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "ClientSupportCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Client support costs",
        "label": "Client Support Costs",
        "documentation": "Client Support Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "tnet_CollateralByTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "CollateralByTypeDomain",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collateral, by Type [Domain]",
        "label": "Collateral, by Type [Domain]",
        "documentation": "Collateral, by Type [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_CollateralHeldByInsuranceCarriers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "CollateralHeldByInsuranceCarriers",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collateral held by insurance carriers",
        "label": "Collateral Held By Insurance Carriers",
        "documentation": "Collateral Held by Insurance Carriers"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued health insurance costs, net",
        "label": "Collateral Paid To Insurance Carriers, Net Of Health Benefit Loss Reserves, Current",
        "documentation": "Collateral Paid To Insurance Carriers, Net Of Health Benefit Loss Reserves, Current"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collateral paid, current",
        "label": "Collateral Paid To Insurance Carriers, Net Of Workers' Compensation Loss Reserves, Current",
        "documentation": "Collateral Paid to Insurance Carriers, Net of Workers' Compensation Loss Reserves, Current"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collateral paid, noncurrent",
        "label": "Collateral Paid To Insurance Carriers, Net Of Workers' Compensation Loss Reserves, Noncurrent",
        "documentation": "Collateral Paid To Insurance Carriers, Net Of Workers' Compensation Loss Reserves, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_CollateralbyTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "CollateralbyTypeAxis",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collateral, by Type [Axis]",
        "label": "Collateral, by Type [Axis]",
        "documentation": "Collateral, by Type [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r98",
      "r611",
      "r695"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.trinet.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENCIES",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r353",
      "r354",
      "r762",
      "r1021",
      "r1027"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Class A",
        "label": "Common Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockDividendsPerShareCashPaid",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends paid (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockIncludingAdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock and Additional Paid-In Capital",
        "label": "Common Stock Including Additional Paid in Capital [Member]",
        "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock and additional paid-in capital",
        "label": "Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r696"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "periodStartLabel": "Shares issued and outstanding, beginning balance (in shares)",
        "periodEndLabel": "Shares issued and outstanding, ending balance (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Shares issued and outstanding, beginning balance (in shares)",
        "periodEndLabel": "Shares issued and outstanding, ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r59",
      "r696",
      "r714",
      "r1133",
      "r1134"
     ]
    },
    "us-gaap_CommonStocksIncludingAdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStocksIncludingAdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock and additional paid-in capital",
        "label": "Common Stocks, Including Additional Paid in Capital",
        "documentation": "Amount of par value plus amounts in excess of par value or issuance value for common stock issued."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60",
      "r87"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r910"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r909"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r908"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r166",
      "r168",
      "r173",
      "r600",
      "r621",
      "r622"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r28",
      "r49",
      "r50",
      "r273",
      "r761"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r28",
      "r49",
      "r50",
      "r273",
      "r662",
      "r761"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r28",
      "r49",
      "r50",
      "r273",
      "r761",
      "r951"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent of concentration risk (less than)",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r28",
      "r49",
      "r50",
      "r273"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r28",
      "r49",
      "r50",
      "r273",
      "r761"
     ]
    },
    "srt_CondensedCashFlowStatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CondensedCashFlowStatementTable",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Cash Flow Statement [Table]",
        "label": "Condensed Cash Flow Statement [Table]",
        "documentation": "Disclosure of information about condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r188",
      "r945"
     ]
    },
    "srt_CondensedCashFlowStatementsCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CondensedCashFlowStatementsCaptionsLineItems",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Cash Flow Statements",
        "label": "Condensed Cash Flow Statements, Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r188",
      "r945"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Axis]",
        "label": "Consolidated Entities [Axis]",
        "documentation": "Information by consolidated entity or group of entities."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r135",
      "r188",
      "r483",
      "r484",
      "r485",
      "r486",
      "r530",
      "r767",
      "r965",
      "r966",
      "r967",
      "r1030",
      "r1033",
      "r1034"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Domain]",
        "label": "Consolidated Entities [Domain]",
        "documentation": "Entity or group of entities consolidated into reporting entity."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r135",
      "r188",
      "r483",
      "r484",
      "r485",
      "r486",
      "r530",
      "r767",
      "r965",
      "r966",
      "r967",
      "r1030",
      "r1033",
      "r1034"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r782"
     ]
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll funds receivable",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r403",
      "r406"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Client deposits and other client liabilities",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r402",
      "r406"
     ]
    },
    "tnet_CorporateAdministrationExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "CorporateAdministrationExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate administration",
        "label": "Corporate Administration Expenses",
        "documentation": "Corporate Administration Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate bonds",
        "label": "Corporate Debt Securities [Member]",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r810",
      "r812",
      "r817",
      "r830",
      "r846",
      "r1130"
     ]
    },
    "tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of providing services",
        "label": "Cost Of Goods And Service, Excluding Depreciation, Depletion, And Amortization, And Operating Insurance And Claims Costs, Production",
        "documentation": "Cost Of Goods And Service, Excluding Depreciation, Depletion, And Amortization, And Operating Insurance And Claims Costs, Production"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSoldDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 7.0
      },
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization of intangible assets",
        "label": "Cost, Depreciation and Amortization",
        "documentation": "Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service."
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cost of providing services",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total costs and operating expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r51",
      "r52",
      "r95",
      "r97",
      "r188",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r828",
      "r979",
      "r1022",
      "r1023",
      "r1024",
      "r1079",
      "r1080"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r188",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r828",
      "r979",
      "r1022",
      "r1023",
      "r1024",
      "r1079",
      "r1080"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleRealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AFS securities, gross realized gain (loss)",
        "label": "Debt Securities, Available-for-Sale, Realized Gain (Loss)",
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross realized losses",
        "label": "Debt Securities, Available-for-Sale, Realized Loss",
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails",
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-sale [Table]",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Available-for-Sale Securities",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred taxes",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r457",
      "r610"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "label": "Deferred Income Taxes and Tax Credits",
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsCapitalLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital loss carryforwards",
        "label": "Deferred Tax Assets, Capital Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "STOCK BASED COMPENSATION",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r420",
      "r449",
      "r450",
      "r451",
      "r814"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsCommonStockCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsCommonStockCash",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash dividend declared, but not yet paid",
        "label": "Dividends, Common Stock, Cash",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_DividendsCommonStockStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsCommonStockStock",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Common stock dividends",
        "label": "Dividends, Common Stock, Stock",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in stock."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsPayableAmountPerShare",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends payable (in dollars per share)",
        "label": "Dividends Payable, Amount Per Share",
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income per share:",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic EPS (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r194",
      "r195",
      "r197",
      "r198",
      "r199",
      "r201",
      "r207",
      "r210",
      "r221",
      "r222",
      "r223",
      "r227",
      "r479",
      "r482",
      "r497",
      "r498",
      "r601",
      "r623",
      "r784"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted EPS (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r194",
      "r195",
      "r197",
      "r198",
      "r199",
      "r201",
      "r210",
      "r221",
      "r222",
      "r223",
      "r227",
      "r479",
      "r482",
      "r497",
      "r498",
      "r601",
      "r623",
      "r784"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.trinet.com/role/EARNINGSPERSHARE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EARNINGS PER SHARE",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r224",
      "r225",
      "r226"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.trinet.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r816"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total stock based compensation capitalized",
        "label": "Share-Based Payment Arrangement, Amount Capitalized",
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r146",
      "r169",
      "r170",
      "r171",
      "r189",
      "r190",
      "r191",
      "r193",
      "r199",
      "r202",
      "r204",
      "r229",
      "r310",
      "r313",
      "r337",
      "r400",
      "r469",
      "r470",
      "r476",
      "r477",
      "r478",
      "r480",
      "r481",
      "r482",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r496",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r522",
      "r524",
      "r529",
      "r619",
      "r651",
      "r652",
      "r653",
      "r671",
      "r736"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r907"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r865",
      "r875",
      "r885",
      "r917"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r862",
      "r872",
      "r882",
      "r914"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r913"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1070",
      "r1071"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r499",
      "r501",
      "r502",
      "r503",
      "r504",
      "r507",
      "r508",
      "r510",
      "r534",
      "r535",
      "r536",
      "r803",
      "r804",
      "r810",
      "r811",
      "r812",
      "r817",
      "r821"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r501",
      "r502",
      "r504",
      "r817",
      "r1073",
      "r1076"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r408",
      "r413",
      "r501",
      "r508",
      "r534",
      "r810",
      "r811",
      "r812",
      "r817"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r408",
      "r413",
      "r501",
      "r502",
      "r508",
      "r535",
      "r803",
      "r804",
      "r810",
      "r811",
      "r812",
      "r817"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r501",
      "r502",
      "r504",
      "r817",
      "r1073",
      "r1076"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r499",
      "r501",
      "r502",
      "r503",
      "r504",
      "r507",
      "r508",
      "r510",
      "r534",
      "r535",
      "r536",
      "r803",
      "r804",
      "r810",
      "r811",
      "r812",
      "r817",
      "r821"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement on a Recurring Basis",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r817",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1076"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r320",
      "r321",
      "r322",
      "r384",
      "r397",
      "r493",
      "r511",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r548",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r620",
      "r799",
      "r817",
      "r819",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r830",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1069",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r869",
      "r879",
      "r889",
      "r921"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r869",
      "r879",
      "r889",
      "r921"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r869",
      "r879",
      "r889",
      "r921"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r869",
      "r879",
      "r889",
      "r921"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r869",
      "r879",
      "r889",
      "r921"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r902"
     ]
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfAssets1",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss from disposition of assets",
        "label": "Gain (Loss) on Disposition of Assets",
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "us-gaap_GainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Losses on investments",
        "label": "Gain (Loss) on Investments",
        "documentation": "Amount of realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r943"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r720"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeographicConcentrationRiskMember",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Sales",
        "label": "Geographic Concentration Risk [Member]",
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r761"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r325",
      "r598",
      "r793",
      "r801",
      "r818",
      "r829",
      "r1017",
      "r1018"
     ]
    },
    "tnet_HealthBenefitClaimsCollateralMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "HealthBenefitClaimsCollateralMember",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collateral for health benefits claims",
        "label": "Health Benefit Claims Collateral [Member]",
        "documentation": "Health Benefit Claims Collateral [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HealthCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HealthCareMember",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Health Care",
        "label": "Health Care [Member]",
        "documentation": "Service provided for prevention, maintenance, diagnosis or treatment of physical and mental health."
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "tnet_HealthInsuranceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "HealthInsuranceCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Health insurance costs",
        "label": "Health Insurance Costs",
        "documentation": "Health Insurance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before tax",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r100",
      "r105",
      "r602",
      "r617",
      "r786",
      "r792",
      "r988",
      "r990",
      "r991",
      "r992",
      "r993"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r340",
      "r345",
      "r505",
      "r506",
      "r509",
      "r648",
      "r650",
      "r721",
      "r775",
      "r820",
      "r1099"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r345",
      "r505",
      "r506",
      "r509",
      "r648",
      "r650",
      "r721",
      "r775",
      "r820",
      "r1099"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.trinet.com/role/INCOMETAXES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INCOME TAXES",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r455",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r465",
      "r471",
      "r473",
      "r474",
      "r475",
      "r670",
      "r816"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r112",
      "r203",
      "r204",
      "r228",
      "r244",
      "r265",
      "r458",
      "r459",
      "r472",
      "r624",
      "r816"
     ]
    },
    "tnet_IncomeTaxesDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "IncomeTaxesDisclosureLineItems",
     "presentation": [
      "http://www.trinet.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes Disclosure [Line Items]",
        "label": "Income Taxes Disclosure [Line Items]",
        "documentation": "Income Taxes Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_IncomeTaxesDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "IncomeTaxesDisclosureTable",
     "presentation": [
      "http://www.trinet.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes Disclosure [Table]",
        "label": "Income Taxes Disclosure [Table]",
        "documentation": "Income Taxes Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes paid, net",
        "label": "Income Taxes Paid, Net",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r183",
      "r466",
      "r467"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and other liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accounts receivable, net",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedSalaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedSalaries",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued wages",
        "label": "Increase (Decrease) in Accrued Salaries",
        "documentation": "The increase (decrease) during the period in accrued salaries."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payroll funds receivable",
        "label": "Increase (Decrease) in Contract with Customer, Asset",
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Client deposits and other client liabilities",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r566",
      "r976"
     ]
    },
    "us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInHealthCareInsuranceLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued health insurance costs, net",
        "label": "Increase (Decrease) in Health Care Insurance Liabilities",
        "documentation": "The increase (decrease) in health care insurance liability balances during the period."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r953",
      "r976"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll taxes liabilities and other payroll withholdings",
        "label": "Increase (Decrease) in Other Employee-Related Liabilities",
        "documentation": "Amount of increase (decrease) in employer-related costs classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets",
        "label": "Increase (Decrease) in Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "tnet_IncreaseDecreaseInOtherPayrollAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "IncreaseDecreaseInOtherPayrollAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other payroll assets",
        "label": "Increase Decrease In Other Payroll Assets",
        "documentation": "Increase Decrease In Other Payroll Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses, net",
        "negatedTerseLabel": "Prepaid expenses, net",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInWorkersCompensationLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued workers' compensation costs, net",
        "label": "Increase (Decrease) in Workers' Compensation Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amount due for insurance (or actual expenses) to cover the medical expenses and lost income for employees that are injured during the course of doing work-related activities."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive effect of stock options and restricted stock units (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r212",
      "r213",
      "r223",
      "r419"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r869",
      "r879",
      "r889",
      "r913",
      "r921",
      "r925",
      "r933"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r861",
      "r937"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r861",
      "r937"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r861",
      "r937"
     ]
    },
    "us-gaap_InsuranceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InsuranceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance [Abstract]",
        "label": "Insurance [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_InsuranceCarriersSecurityDepositsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "InsuranceCarriersSecurityDepositsMember",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other security deposits",
        "label": "Insurance Carriers Security Deposits [Member]",
        "documentation": "Insurance Carriers Security Deposits [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_InsurancePremiumsAndOtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "InsurancePremiumsAndOtherPayables",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance premiums and other payables",
        "label": "Insurance Premiums And Other Payables",
        "documentation": "Insurance Premiums and Other Payables"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_InsuranceServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "InsuranceServicesMember",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance service revenues",
        "label": "Insurance Services [Member]",
        "documentation": "Insurance Services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software and other intangible assets, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r1019",
      "r1020"
     ]
    },
    "tnet_InterestExpenseBankFeesAndOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "InterestExpenseBankFeesAndOther",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense, bank fees and other",
        "terseLabel": "Interest expense, bank fees and other",
        "label": "Interest Expense, Bank Fees and Other",
        "documentation": "Interest Expense, Bank Fees and Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeOperating",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest income",
        "terseLabel": "Interest income",
        "label": "Interest Income, Operating",
        "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r718",
      "r749",
      "r750",
      "r792",
      "r854",
      "r855",
      "r974",
      "r1139"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest paid",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r181",
      "r182"
     ]
    },
    "us-gaap_InterimPeriodCostsNotAllocableDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterimPeriodCostsNotAllocableDomain",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interim Period, Costs Not Allocable [Domain]",
        "label": "Interim Period, Costs Not Allocable [Domain]",
        "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair value of Debt Investments by Contractual Maturity",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]",
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVESTMENTS",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r114",
      "r275",
      "r277",
      "r512",
      "r513",
      "r1092"
     ]
    },
    "us-gaap_InvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Investments [Member]",
        "documentation": "Assets held for their financial return, rather than for the entity's operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r186",
      "r309",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r484",
      "r485",
      "r486",
      "r514",
      "r694",
      "r785",
      "r856",
      "r1031",
      "r1083",
      "r1084"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities &amp; stockholders' equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r99",
      "r615",
      "r829",
      "r980",
      "r1013",
      "r1077"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and stockholders' equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "terseLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r151",
      "r186",
      "r309",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r484",
      "r485",
      "r486",
      "r514",
      "r829",
      "r1031",
      "r1083",
      "r1084"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "verboseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACCRUED WORKERS' COMPENSATION COSTS",
        "label": "Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]",
        "documentation": "The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments."
       }
      }
     },
     "auth_ref": [
      "r642",
      "r643"
     ]
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Paid",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails": {
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Current year",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r645",
      "r841"
     ]
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails": {
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prior years",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r645",
      "r841"
     ]
    },
    "tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1": {
       "parentTag": "us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails",
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Collateral paid to carriers and offset against accrued costs",
        "terseLabel": "Collateral paid to carriers and offset against loss reserves",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense, Collateral",
        "documentation": "Liability for Unpaid Claims and Claims Adjustment Expense, Collateral"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total incurred",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process."
       }
      }
     },
     "auth_ref": [
      "r841",
      "r1102"
     ]
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incurred",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1": {
       "parentTag": "us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails",
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Total accrued costs, beginning of period",
        "periodEndLabel": "Total accrued costs, end of period",
        "terseLabel": "Total accrued costs, end of period",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Adjustments",
        "documentation": "Sum of adjustments to the estimated reserve for unpaid claims and claims adjustment expense."
       }
      }
     },
     "auth_ref": [
      "r1101"
     ]
    },
    "us-gaap_LiabilityReserveEstimatePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityReserveEstimatePolicy",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Health Insurance Costs",
        "label": "Liability Reserve Estimate, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for estimating its liability as of the balance sheet date for the ultimate cost of settling reported and unreported claims incurred and claims adjustment expenses (including effects of inflation and other societal and economic factors)."
       }
      }
     },
     "auth_ref": [
      "r1100"
     ]
    },
    "us-gaap_LinesOfCreditCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LinesOfCreditCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving credit agreement borrowings",
        "label": "Line of Credit, Current",
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r95"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Long-term debt, noncurrent",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r118",
      "r120",
      "r121",
      "r123",
      "r144",
      "r145",
      "r355",
      "r356",
      "r357",
      "r358",
      "r414",
      "r453",
      "r504",
      "r565",
      "r647",
      "r649",
      "r661",
      "r686",
      "r687",
      "r741",
      "r743",
      "r745",
      "r746",
      "r748",
      "r773",
      "r774",
      "r798",
      "r807",
      "r813",
      "r821",
      "r822",
      "r826",
      "r827",
      "r840",
      "r1035",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r118",
      "r120",
      "r121",
      "r123",
      "r144",
      "r145",
      "r355",
      "r356",
      "r357",
      "r358",
      "r414",
      "r453",
      "r504",
      "r565",
      "r647",
      "r649",
      "r661",
      "r686",
      "r687",
      "r741",
      "r743",
      "r745",
      "r746",
      "r748",
      "r773",
      "r774",
      "r798",
      "r807",
      "r813",
      "r821",
      "r822",
      "r826",
      "r840",
      "r1035",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market mutual funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "us-gaap_NatureOfExpenseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NatureOfExpenseAxis",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Expense [Axis]",
        "label": "Nature of Expense [Axis]",
        "documentation": "Information by type of cost or expense."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "tnet_NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net cash used in financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities, Amounts Reclassified",
        "documentation": "Net Cash Provided by (Used in) Financing Activities, Amounts Reclassified"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r79",
      "r80"
     ]
    },
    "tnet_NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities, Amounts Reclassified",
        "documentation": "Net Cash Provided by (Used in) Operating Activities, Amounts Reclassified"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "terseLabel": "Net income",
        "verboseLabel": "Net income",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r80",
      "r101",
      "r149",
      "r164",
      "r167",
      "r171",
      "r186",
      "r192",
      "r194",
      "r195",
      "r197",
      "r198",
      "r199",
      "r203",
      "r204",
      "r219",
      "r309",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r479",
      "r482",
      "r498",
      "r514",
      "r618",
      "r716",
      "r734",
      "r735",
      "r855",
      "r1031"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net income",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r194",
      "r195",
      "r197",
      "r198",
      "r207",
      "r208",
      "r220",
      "r223",
      "r482"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r209",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r223"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Issued Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r869",
      "r879",
      "r889",
      "r913",
      "r921"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r913"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "us-gaap_NonUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonUsMember",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-US",
        "label": "Non-US [Member]",
        "documentation": "Countries excluding the United States of America (US)."
       }
      }
     },
     "auth_ref": [
      "r1135",
      "r1136",
      "r1137",
      "r1138"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental schedule of noncash investing and financing activities",
        "label": "Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable from sale of business",
        "label": "Noncash or Part Noncash Divestiture, Amount of Consideration Receivable",
        "documentation": "Noncash or Part Noncash Divestiture, Amount of Consideration Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayableFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayableFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of notes payable",
        "label": "Notes Payable, Fair Value Disclosure",
        "documentation": "Fair value portion of notes payable."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r51",
      "r52",
      "r1071",
      "r1075"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails",
      "http://www.trinet.com/role/SEGMENTINFORMATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r787",
      "r797",
      "r989"
     ]
    },
    "us-gaap_OperatingInsuranceAndClaimsCostsProduction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingInsuranceAndClaimsCostsProduction",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance costs",
        "label": "Operating Insurance and Claims Costs, Production",
        "documentation": "Insurance and claims costs directly related to goods produced and sold, or services rendered, during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r68"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, noncurrent",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use asset",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of ROU asset, lease modification, impairment, and abandonment",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAmortizationOfDeferredCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAmortizationOfDeferredCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of deferred costs",
        "label": "Amortization of Other Deferred Charges",
        "documentation": "Amount of amortization of other deferred costs recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r70"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r829"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss), net of income taxes",
        "verboseLabel": "Other comprehensive income (loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r8",
      "r92",
      "r165",
      "r168",
      "r199"
     ]
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization of intangible assets",
        "label": "Other Depreciation and Amortization",
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r35",
      "r70"
     ]
    },
    "us-gaap_OtherExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Expenses",
        "documentation": "Amount of expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "tnet_OtherPayrollAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "OtherPayrollAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other payroll assets",
        "label": "Other Payroll Assets Current",
        "documentation": "Other Payroll Assets Current"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r867",
      "r877",
      "r887",
      "r919"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r870",
      "r880",
      "r890",
      "r922"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r870",
      "r880",
      "r890",
      "r922"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total paid",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r841",
      "r1103"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of common stock",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_PaymentsOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDividends",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends paid",
        "label": "Payments of Dividends",
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Awards effectively repurchased for required employee withholding taxes",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireMarketableSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of marketable securities",
        "label": "Payments to Acquire Marketable Securities",
        "documentation": "Amount of cash outflow for purchase of marketable security."
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisitions of property and equipment and software",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "tnet_PayrollFundsCollectedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "PayrollFundsCollectedMember",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll funds collected",
        "label": "Payroll Funds Collected [Member]",
        "documentation": "Payroll Funds Collected [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r913"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "tnet_PerformanceBasedRestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "PerformanceBasedRestrictedStockUnitsMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance-Based Restricted Stock Units",
        "label": "Performance-Based Restricted Stock Units [Member]",
        "documentation": "Performance-Based Restricted Stock Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Performance-based RSUs and RSAs",
        "label": "Performance-Based Restricted Stock Units and Restricted Stock Awards [Member]",
        "documentation": "Performance-Based Restricted Stock Units and Restricted Stock Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock",
        "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r386"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r696"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r386"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r696",
      "r714",
      "r1133",
      "r1134"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r612",
      "r829"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses, net",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r323",
      "r324",
      "r779"
     ]
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayments offsetting accrued health insurance costs",
        "label": "Prepaid Insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r780",
      "r800",
      "r1016"
     ]
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of business",
        "label": "Proceeds from Divestiture of Businesses",
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds from maturities",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r176",
      "r177",
      "r997"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale and maturity of marketable securities",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds from sales",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r176",
      "r276",
      "r308"
     ]
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product Information [Line Items]",
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r142",
      "r269",
      "r567",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r646",
      "r776",
      "r808",
      "r839",
      "r840",
      "r842",
      "r845",
      "r847",
      "r968",
      "r1028",
      "r1029",
      "r1037",
      "r1096",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1131",
      "r1132"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r142",
      "r269",
      "r567",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r646",
      "r776",
      "r808",
      "r839",
      "r840",
      "r842",
      "r845",
      "r847",
      "r968",
      "r1028",
      "r1029",
      "r1037",
      "r1096",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1131",
      "r1132"
     ]
    },
    "tnet_ProfessionalServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "ProfessionalServicesMember",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional service revenues",
        "label": "Professional Services [Member]",
        "documentation": "Professional Services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r527",
      "r607",
      "r616",
      "r829"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r118",
      "r120",
      "r121",
      "r123",
      "r144",
      "r145",
      "r355",
      "r356",
      "r357",
      "r358",
      "r407",
      "r414",
      "r443",
      "r444",
      "r445",
      "r453",
      "r504",
      "r537",
      "r549",
      "r565",
      "r647",
      "r649",
      "r661",
      "r686",
      "r687",
      "r741",
      "r743",
      "r745",
      "r746",
      "r748",
      "r773",
      "r774",
      "r798",
      "r807",
      "r813",
      "r821",
      "r822",
      "r826",
      "r827",
      "r840",
      "r848",
      "r1025",
      "r1035",
      "r1073",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r118",
      "r120",
      "r121",
      "r123",
      "r144",
      "r145",
      "r355",
      "r356",
      "r357",
      "r358",
      "r407",
      "r414",
      "r443",
      "r444",
      "r445",
      "r453",
      "r504",
      "r537",
      "r549",
      "r565",
      "r647",
      "r649",
      "r661",
      "r686",
      "r687",
      "r741",
      "r743",
      "r745",
      "r746",
      "r748",
      "r773",
      "r774",
      "r798",
      "r807",
      "r813",
      "r821",
      "r822",
      "r826",
      "r827",
      "r840",
      "r848",
      "r1025",
      "r1035",
      "r1073",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r862",
      "r872",
      "r882",
      "r914"
     ]
    },
    "tnet_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment",
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Systems development and programming",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r454",
      "r775",
      "r792",
      "r1091"
     ]
    },
    "srt_RestatementAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RestatementAdjustmentMember",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassified amounts",
        "label": "Revision of Prior Period, Adjustment [Member]",
        "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r201",
      "r202",
      "r227",
      "r496",
      "r497",
      "r523",
      "r946",
      "r947",
      "r948",
      "r949",
      "r952",
      "r956",
      "r957",
      "r994"
     ]
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RestatementAxis",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revision of Prior Period [Axis]",
        "label": "Revision of Prior Period [Axis]",
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r147",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r227",
      "r311",
      "r312",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r495",
      "r496",
      "r497",
      "r498",
      "r521",
      "r523",
      "r528",
      "r529",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r663",
      "r994"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r863",
      "r873",
      "r883",
      "r915"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r864",
      "r874",
      "r884",
      "r916"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r871",
      "r881",
      "r891",
      "r923"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RestatementDomain",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revision of Prior Period [Domain]",
        "label": "Revision of Prior Period [Domain]",
        "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r147",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r227",
      "r311",
      "r312",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r495",
      "r496",
      "r497",
      "r498",
      "r521",
      "r523",
      "r528",
      "r529",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r663",
      "r994"
     ]
    },
    "tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "RestrictedCashAndCashEquivalentsAndInvestmentsMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Cash, Cash Equivalents and Investments",
        "label": "Restricted Cash, and Cash Equivalents and Investments [Member]",
        "documentation": "Restricted Cash, and Cash Equivalents and Investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndCashEquivalentsItemsLineItems",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Cash and Cash Equivalents Items [Line Items]",
        "label": "Restricted Cash and Cash Equivalents Items [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "us-gaap_RestrictedCashAndInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Restricted Cash and Investments",
        "documentation": "Cash and investments whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements. For use in an unclassified balance sheet."
       }
      }
     },
     "auth_ref": [
      "r759",
      "r760"
     ]
    },
    "us-gaap_RestrictedCashAndInvestmentsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndInvestmentsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails": {
       "parentTag": "us-gaap_RestrictedCashAndInvestments",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, cash equivalents and investments",
        "netLabel": "Restricted cash, cash equivalents and investments",
        "verboseLabel": "Total restricted cash, cash equivalents and investments",
        "label": "Restricted Cash and Investments, Current",
        "documentation": "The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal."
       }
      }
     },
     "auth_ref": [
      "r759",
      "r760",
      "r970"
     ]
    },
    "us-gaap_RestrictedCashAndInvestmentsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndInvestmentsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails": {
       "parentTag": "us-gaap_RestrictedCashAndInvestments",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, cash equivalents and investments, noncurrent",
        "verboseLabel": "Collateral for workers' compensation claims",
        "label": "Restricted Cash and Investments, Noncurrent",
        "documentation": "The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal."
       }
      }
     },
     "auth_ref": [
      "r759",
      "r760"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock from vested restricted stock units",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.trinet.com/role/RESTRUCTURING"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RESTRUCTURING",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r342",
      "r344",
      "r347",
      "r352"
     ]
    },
    "us-gaap_RestructuringCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring balance",
        "label": "Restructuring Charges",
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r348",
      "r349",
      "r1026"
     ]
    },
    "tnet_RestructuringChargesAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "RestructuringChargesAdditions",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(+) Additions",
        "label": "Restructuring Charges, Additions",
        "documentation": "Restructuring Charges, Additions"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_RestructuringChargesPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "RestructuringChargesPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(-) Payments",
        "label": "Restructuring Charges, Payments",
        "documentation": "Restructuring Charges, Payments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost and Reserve [Line Items]",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r349",
      "r350",
      "r351"
     ]
    },
    "us-gaap_RestructuringCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/RESTRUCTURINGNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Costs",
        "label": "Restructuring Costs",
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r87",
      "r614",
      "r655",
      "r660",
      "r669",
      "r697",
      "r829"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained Earnings (Accumulated Deficit)",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r189",
      "r190",
      "r191",
      "r193",
      "r199",
      "r202",
      "r204",
      "r310",
      "r313",
      "r337",
      "r469",
      "r470",
      "r476",
      "r477",
      "r478",
      "r480",
      "r481",
      "r482",
      "r487",
      "r489",
      "r490",
      "r492",
      "r496",
      "r522",
      "r524",
      "r651",
      "r653",
      "r671",
      "r1133"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service revenues",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104",
      "r228",
      "r237",
      "r238",
      "r259",
      "r265",
      "r269",
      "r271",
      "r273",
      "r404",
      "r405",
      "r567"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total revenues",
        "terseLabel": "Total revenues",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104",
      "r172",
      "r186",
      "r228",
      "r237",
      "r238",
      "r259",
      "r265",
      "r269",
      "r271",
      "r273",
      "r309",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r514",
      "r602",
      "r792",
      "r1031"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r950"
     ]
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofWorksiteEmployeeChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "As previously reported",
        "label": "Previously Reported [Member]",
        "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r189",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r204",
      "r227",
      "r477",
      "r479",
      "r480",
      "r481",
      "r482",
      "r495",
      "r496",
      "r497",
      "r521",
      "r523",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r663",
      "r952",
      "r954",
      "r955",
      "r956",
      "r984",
      "r994",
      "r1014",
      "r1015",
      "r1068",
      "r1081",
      "r1082"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails",
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289"
     ]
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash, Cash Equivalents and Investments",
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Issued and Outstanding Common Stock",
        "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in common stock outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/EARNINGSPERSHARETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r987"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Activities in Liability for Unpaid Claims and Claims Adjustment Expenses",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims."
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Product Information [Table]",
        "label": "Nature of Operation, Product Information, Concentration of Risk [Table]",
        "documentation": "Disclosure of information about concentration risk of product within nature of operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTable",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restrictions on Cash and Cash Equivalents [Table]",
        "label": "Restrictions on Cash and Cash Equivalents [Table]",
        "documentation": "Disclosure of information about cash and cash equivalents restricted as to withdrawal or usage."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r93",
      "r1095"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost [Table]",
        "label": "Restructuring Cost [Table]",
        "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r349",
      "r350",
      "r351"
     ]
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "presentation": [
      "http://www.trinet.com/role/RESTRUCTURINGTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Accrued Severance and Exit and Disposal Costs",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r84"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r34"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r34"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-Based Payment Arrangement, Activity",
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r11",
      "r89"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r416",
      "r418",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of RSU Activity under Equity-Based Plans",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of stock option activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r11",
      "r88"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Variable Interest Entities [Table]",
        "label": "Variable Interest Entity [Table]",
        "documentation": "Disclosure of information about variable interest held, whether or not such variable interest entity (VIE) is included in consolidated financial statements."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r483",
      "r484",
      "r485",
      "r486",
      "r545",
      "r546",
      "r547"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets and Liabilities in our Consolidated Balance Sheet",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r43",
      "r44",
      "r45",
      "r46"
     ]
    },
    "tnet_ScheduleOfWorksiteEmployeeChangesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "ScheduleOfWorksiteEmployeeChangesTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Worksite Employee Changes",
        "label": "Schedule of Worksite Employee Changes [Table Text Block]",
        "documentation": "Schedule of Worksite Employee Changes"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r106",
      "r228",
      "r233",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r249",
      "r250",
      "r251",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r265",
      "r266",
      "r267",
      "r273",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r346",
      "r351",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r789",
      "r792",
      "r793",
      "r801",
      "r844",
      "r1096",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1131",
      "r1132"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r119",
      "r122",
      "r124",
      "r131",
      "r132",
      "r133",
      "r134",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r271",
      "r272",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r683",
      "r684",
      "r685",
      "r742",
      "r744",
      "r747",
      "r751",
      "r758",
      "r763",
      "r764",
      "r765",
      "r766",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r777",
      "r809",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r843",
      "r848",
      "r1037",
      "r1096",
      "r1104",
      "r1105",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1131",
      "r1132"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEGMENT INFORMATION",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r228",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r248",
      "r250",
      "r251",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r273",
      "r787",
      "r790",
      "r791",
      "r792",
      "r794",
      "r796",
      "r797"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r268",
      "r271",
      "r788",
      "r789",
      "r795"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and marketing",
        "label": "Selling and Marketing Expense",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "tnet_SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales &amp; marketing",
        "label": "Selling And Marketing Expense, Excluding Stock Based Compensation And Other",
        "documentation": "Selling And Marketing Expense, Excluding Stock Based Compensation And Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Sales and marketing",
        "label": "Selling and Marketing Expense [Member]",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance period for 2025 and 2024 awards",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period",
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance (in shares)",
        "periodEndLabel": "Balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r433"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Number of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance (in dollars per share)",
        "periodEndLabel": "Balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r433"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Vested (in shares)",
        "terseLabel": "Issuance of common stock from vested restricted stock units (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected Dividend Yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r444"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected Volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-Free Interest Rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r416",
      "r418",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Remaining Contractual Term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted, Weighted Average Remaining Contractual Term (in years)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Granted, Weighted Average Remaining Contractual Term",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Granted, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "tnet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants In Period, Intrinsic Value",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants In Period, Intrinsic Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofShareBasedPaymentArrangementActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average grant date fair value of stock options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, Aggregate Intrinsic Value",
        "periodEndLabel": "Ending balance, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r425"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in dollars per share)",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r425"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based Payment Arrangement, Tranche One",
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of shares that are expected to vesting percentage",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, expiration period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected Term (in Years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r442"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofstockoptionactivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Remaining Contractual Term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofShareBasedPaymentArrangementActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total fair value of options granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent of share value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Awards effectively repurchased for required employee withholding taxes (in shares)",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r106",
      "r148",
      "r228",
      "r233",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r249",
      "r250",
      "r251",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r265",
      "r266",
      "r267",
      "r273",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r339",
      "r346",
      "r351",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r789",
      "r792",
      "r793",
      "r801",
      "r844",
      "r1096",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1131",
      "r1132"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r157",
      "r158",
      "r159",
      "r186",
      "r210",
      "r214",
      "r221",
      "r223",
      "r230",
      "r231",
      "r309",
      "r359",
      "r361",
      "r362",
      "r363",
      "r366",
      "r367",
      "r386",
      "r387",
      "r389",
      "r392",
      "r399",
      "r514",
      "r665",
      "r666",
      "r667",
      "r668",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r696",
      "r717",
      "r736",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r944",
      "r978",
      "r986"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r59",
      "r62",
      "r63",
      "r146",
      "r169",
      "r170",
      "r171",
      "r189",
      "r190",
      "r191",
      "r193",
      "r199",
      "r202",
      "r204",
      "r229",
      "r310",
      "r313",
      "r337",
      "r400",
      "r469",
      "r470",
      "r476",
      "r477",
      "r478",
      "r480",
      "r481",
      "r482",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r496",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r522",
      "r524",
      "r529",
      "r619",
      "r651",
      "r652",
      "r653",
      "r671",
      "r736"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r119",
      "r122",
      "r124",
      "r131",
      "r132",
      "r133",
      "r134",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r271",
      "r272",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r683",
      "r684",
      "r685",
      "r742",
      "r744",
      "r747",
      "r751",
      "r758",
      "r763",
      "r764",
      "r765",
      "r766",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r777",
      "r809",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r843",
      "r848",
      "r1037",
      "r1096",
      "r1104",
      "r1105",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1131",
      "r1132"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r229",
      "r524",
      "r567",
      "r664",
      "r682",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r696",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r715",
      "r719",
      "r720",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r736",
      "r849"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionLocationActivityAccrualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionLocationActivityAccrualAxis",
     "presentation": [
      "http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position Location, Activity, Accrual [Axis]",
        "label": "Statement of Financial Position Location, Activity, Accrual [Axis]",
        "documentation": "Information by location in statement of financial position in which disaggregated accrual activity has been included."
       }
      }
     },
     "auth_ref": [
      "r1067",
      "r1078"
     ]
    },
    "us-gaap_StatementOfFinancialPositionLocationActivityAccrualDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionLocationActivityAccrualDomain",
     "presentation": [
      "http://www.trinet.com/role/RESTRUCTURINGScheduleofChangesinAccruedSeveranceandExitandDisposalCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position Location, Activity, Accrual [Domain]",
        "label": "Statement of Financial Position Location, Activity, Accrual [Domain]",
        "documentation": "Location in statement of financial position in which disaggregated accrual activity has been included."
       }
      }
     },
     "auth_ref": [
      "r1067",
      "r1078"
     ]
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r229",
      "r274",
      "r524",
      "r567",
      "r664",
      "r682",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r696",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r715",
      "r719",
      "r720",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r736",
      "r849"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r866",
      "r876",
      "r886",
      "r918"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock from exercise of stock options (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r58",
      "r59",
      "r87",
      "r429"
     ]
    },
    "us-gaap_StockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockOptionMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock from exercise of stock options",
        "label": "Equity Option [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)."
       }
      }
     },
     "auth_ref": [
      "r848"
     ]
    },
    "srt_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, authorized amount",
        "label": "Share Repurchase Program, Authorized, Amount",
        "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount",
        "label": "Share Repurchase Program, Remaining Authorized, Amount",
        "documentation": "Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repurchase of common stock",
        "label": "Stock Repurchased and Retired During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r58",
      "r59",
      "r87"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repurchase of common stock (in shares)",
        "label": "Stock Repurchased During Period, Shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r58",
      "r59",
      "r87",
      "r668",
      "r736",
      "r755"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r62",
      "r63",
      "r83",
      "r698",
      "r714",
      "r737",
      "r738",
      "r829",
      "r856",
      "r980",
      "r1013",
      "r1077",
      "r1133"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "STOCKHOLDERS' EQUITY",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r185",
      "r385",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r398",
      "r400",
      "r494",
      "r739",
      "r740",
      "r757"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosures of cash flow information",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails": {
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current year",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r644",
      "r841"
     ]
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails": {
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior years",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r644",
      "r841"
     ]
    },
    "tnet_SystemSupportAndDevelopmentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "SystemSupportAndDevelopmentExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "System support &amp; development",
        "label": "System Support And Development Expenses",
        "documentation": "System Support And Development Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_SystemsDevelopmentAndProgrammingCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "SystemsDevelopmentAndProgrammingCostsMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Systems development and programming costs",
        "label": "Systems Development And Programming Costs [Member]",
        "documentation": "Primary financial statement caption encompassing systems development and programming costs."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r912"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carryforward",
        "label": "Tax Credit Carryforward, Amount",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAxis",
     "presentation": [
      "http://www.trinet.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Credit Carryforward [Axis]",
        "label": "Tax Credit Carryforward [Axis]",
        "documentation": "Information by specific tax credit related to an unused tax credit."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardNameDomain",
     "presentation": [
      "http://www.trinet.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Credit Carryforward, Name [Domain]",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "documentation": "The name of the tax credit carryforward."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "tnet_TimeBasedRestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "TimeBasedRestrictedStockUnitsMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Time-Based Restricted Stock Units",
        "label": "Time-Based Restricted Stock Units [Member]",
        "documentation": "Time-Based Restricted Stock Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r384",
      "r397",
      "r493",
      "r511",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r548",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r620",
      "r817",
      "r819",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r830",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1069",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "tnet_TriNetTrustMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "TriNetTrustMember",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "TriNet Trust",
        "label": "TriNet Trust [Member]",
        "documentation": "TriNet Trust"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_TrustForOurHRISUsersCollateralMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "TrustForOurHRISUsersCollateralMember",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trust for our HRIS Users",
        "label": "Trust For our HRIS Users Collateral [Member]",
        "documentation": "Trust For our HRIS Users Collateral"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agency securities",
        "label": "US Government Agencies Debt Securities [Member]",
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB)."
       }
      }
     },
     "auth_ref": [
      "r783",
      "r810",
      "r1093"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. treasuries",
        "label": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r783",
      "r810",
      "r812",
      "r817",
      "r1093"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r30",
      "r31",
      "r108",
      "r109",
      "r110",
      "r111"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in valuation allowance",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r464"
     ]
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity [Line Items]",
        "label": "Variable Interest Entity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r484",
      "r485",
      "r486",
      "r545",
      "r546",
      "r547"
     ]
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingAxis",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Axis]",
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingDomain",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Domain]",
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares of common stock outstanding - diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r223"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average shares:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares of common stock outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r223"
     ]
    },
    "tnet_WorkersCompensationClaimsCollateralMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "WorkersCompensationClaimsCollateralMember",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collateral for workers' compensation claims",
        "label": "Workers' Compensation Claims Collateral [Member]",
        "documentation": "Workers' Compensation Claims Collateral [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_WorkersCompensationCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20250331",
     "localname": "WorkersCompensationCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Workers' compensation costs",
        "label": "Workers' Compensation Costs",
        "documentation": "Workers' Compensation Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WorkersCompensationLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WorkersCompensationLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails": {
       "parentTag": "us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued workers' compensation costs, net",
        "verboseLabel": "Payable in less than 1 year (net of collateral paid to carriers)",
        "label": "Workers' Compensation Liability, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WorkersCompensationLiabilityCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total accrued costs, net of carrier collateral offset",
        "terseLabel": "Total accrued costs, net of carrier collateral offset",
        "label": "Workers' Compensation Liability",
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r55",
      "r96"
     ]
    },
    "us-gaap_WorkersCompensationLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WorkersCompensationLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails": {
       "parentTag": "us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued workers' compensation costs, noncurrent, net",
        "verboseLabel": "Payable in more than 1 year (net of collateral paid to carriers)",
        "label": "Workers' Compensation Liability, Noncurrent",
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the noncurrent portion of the liabilities (due beyond one year; or beyond one operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478353/942-405-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "270",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-8"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-9"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/942-320/tableOfContent"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "b",
   "Publisher": "SEC"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "M",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-11"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-10"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/420/tableOfContent"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/944-40/tableOfContent"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-4"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478600/954-210-50-2"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-7"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-17"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "39",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477346/946-830-45-39"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-11"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482047/420-10-45-3"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483507/832-10-50-3"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/940-320/tableOfContent"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/944-40/tableOfContent"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>103
<FILENAME>0000937098-25-000073-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000937098-25-000073-xbrl.zip
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MCQ%JE=NNLNW-CZWOZ]2?X>VA8__6TC\!4$L#!!0    ( #E"F5JNRGSV$08
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MQJ6(\0VE-V;;!$>F%:GSL(2)[8]A-6<A\%^)3ZW&F5W_W/LA1%L-O!( !P)
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M253:_Y:A$5']Y/UO#N ME].?W_*-DR?6P^\)?K3''(DGBG.4R+$*.9HKL.(
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M2[WDF.%=\HJ25SP+=WJ:5_1J[))+%ZN08KDHUE?-84N.<:Q0;^X_1+;D&,>
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MA[%,>P+SS*/.0#@V'/+\QR9W%S[RL.QSN/BH%SK6_(>6\(% YS\50*[C)8O
M.C#F @E@JR23^PN?C[S);(03&V@$WHVWBN8M=V$]8[Y 1EX8( 3F/\:F% N?
M><BO@74L?*%P>_%C[\\E&_*%6)C.'RT[/BJ)+NX6UAP *TSPBI-[[@! XKT_
MV,["$A]P_"1[\ %3'(YU0F'UY.(GBKI'^Z"B+W6$A$P1'D[7T%<-J(5*CA(_
M7$.'NLA/!;M:(0TB#0,**Z:$2S2Z[WRFD$$O1497R1D5#(F:*,'"@ *P8L@P
MQ/+D<'_ 4+A,?,J[IZKE<1$!(E5ACERX&.[@$=WOVE?#3(AA]S__BAP-&.,=
M0 2[*@M; E4-A3DU02"G@1$WE,\CL1 06!\2U4S8@/OZ\>4[(<<O\DFX-)VH
MM9<DL[PNBX(]*&/^HO!;]?X:ZB1V_!\\9Z?J6_KOYIZG]BH 1?A$PI&,HU(K
M^&KB.*(2*S3CPTB0-\<.&"(3K%7063!7",N/:LX"IY.XU<AM1"<2!-CM"AZ$
MTW"%_VX>8'H9S)N5?\*6NC "_%\_KO'>-N&XZ(J/<[?(HB?P7W@F-.%RP!%L
M%U@M6?H6=I^ 2(0'B:=3FX4?4R;<D3I*77078"=Q;0I],(S)'W*Z,=12(W:8
MP@7M5XNJV6!=&S:0'H=UTVT"ZQH(5PSA>'4RFH_ Y 3 JHB;F0 .V?Y:),+-
MWGM..-;K QY.O8\(3V*T<+@]5GN=^Y % $!+'UH\+X8@1&<G;?][# ]!KL&*
M3BB.2M3!HQ6R5 /M_0A;F,5[5=@(X!>,XMW.H2H-!!P& (F][/0ZQ@*SR[5@
M 1P;WH87D5A M%#,14D%P[CZ'0")REG#R.^TYU)9?AFQQF@ST3)FI(_\(L2I
MT#]*Q ]7'LY&\@AL#KB*-T#)(H58M+3E(XXXS(H.5!H->3W!R8LI0Z$Q"2MQ
M:68U^$1U4H#]T"$&-NW DL354&K"&54B=Y(11<S'%8KLDN2HH!1A,R[!GN&N
M[0()! 3"Z*:)Q<"(@MQY^KVC9A @Z6@@Q'XDF]IO56@9T>]4K]!"^1P(1'5Q
M? =GPGVJ[J*0+V)QP&?3DT;1,/IP^%0C&Z-:4O0J_/'W>JW1;2,&,!^;M45A
M##YV9[;FXQC>L:&#;".^XM38 #O/ M6BJGYC()]H\1"8@\L><%03J1TT9 2<
MMU"[;I[OP// NWP1X7CTE^W.3DQQ^YB+1\!0KX R#T!%E-+4J84FS69]/QQ/
MU"8>E%!(?$=,2':$\6;$,;MZWVF<=;"G.;R&N$ZLG9 )UC1CLP2B@4,7/GPN
M2&D%,6RDKP!\2F. B4&"0:0,T-4)QZ)Z*L/5^5=H6[I+);VE.29^2>,-'>]!
M.ZA M9YXA%RS T9F>T\"];M$F$&2'8(6H60XO2HM+\8GJY<9H5,E&IQPD-Y8
MQD=JA55-K\8HRH"LS_"F0I9)[(H$=#ARQ!6.).#@+8IE0BO,P11IJ@^O3GM:
M21X%RH7<'*&"$$L/EHT<CR%&XHH141""BI%JF1)HWB.B=F;ZBR_6B8:(O)8J
M=THW*@H*BCW$$AE"]-QU<?F+2O9_QZ$K4X&R+8FO'X0IQ@-8;-.H(!-H < =
M^!SU0:7P75[0(&(@0[1>&$UZKLW>X&3T1CP!J.Y*?E6W+^Z63R8P&?Y-%B$:
M$NX]>D)+WS=XBWY4T(B$<. $5[!O9IPK/KGRY5DQV%@XWE9)V,1:O@*?9%=7
M%;6H;G1EIG=?>?&6T],8Y['M9&9DR,%AI%<4:?GIG>N[0_$C=6^ P JH16(
M<-<Q_RY22*:-+#'ZD&P5T2AP2 ];_FK$7%!T]$T>NHKUP6/*-$%7BI:^])&D
M9#":4XMA2T5")8D!=:*^L2"NCY410Y5B#%W@YC-.2AN@K<(F=/F266""3$J5
M=-0@J/) C1S'&D;PP97@C>V-X1"%>V]+3TG]GGHRFE/$<B$<;CA9KG'!J+,=
MD KQ'V)B(.K1]4WKBHY1BW#Z"DH*'BGM(Z5C.)Z2D),!<^K.Q.;.4Q0\(N5
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MYDO8$O#O O%5(9\?V53IB$?*06UY9CCS_BIJ_P"Z-54&AW]J[-R=:N./+V*
M);UZ!*249V^-IXX>CN,!K>B-XKH]GXBGQ.C(NY!+V+/NA:VI*NGHQ#!*?'A
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M4<YX!7O,$F9=Z#W^P"Y&W+T3FQ#J-IGR-DW%V7:L"\CU Q"2J*W+!Z#7LY?
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MUAE/#,O'6<2C,$/4="@G2+@^(3M-56.W(]@L^RZFRT^".BG!7/&9P=?WMGA
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M 56MPJ,U/7@VMA?Z:$/"5X"' 0Z2>3*R*;IW'IFUXF=K1!X1PEPJ0YB?P@^
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MF]%1,T5':J<KB*7")A).0,)1,RNDO+D=HF<A44AQ+ "@:4\X9A9I0/DZ[XU
MJDY5X1=L2V "69P%&Z5-86*T&:AV!W#SPF.6>BC%#SV9@JH""D").)9E#X=
MXG2LW)0>8 ;"Z/>+SXQJ8,4<S$^2,Z7BBCNI$B-5,FZ4"X??TTS"222BZLU&
M.# ;VU+EG]/;7LAK''HF(NX=9H0ET3F9.I5*D 9<#6$UE+-'68HT KX>[5QE
M;-W9B&\ZE3"Q4IPWL>WXG +=P15I_7$2G<4]=T+*P=>)\?AU,N>1,G_A;T7D
M">)D'F4YAR[L5/@Z?9'RGG'861W>Z%)19SNWSA0,D9=$=0*P*>7C:AHI*Z;A
MQ&7%M#0$RHII9<6T76S4,-*,J*R8MFV98DW%M++XV9,\M2Q^-H>E9?&SLOA9
M#HN?Y5:EPSHR'E4.$:H$T#T6J<)B4$-0[*A*"!R!I0T%[HBJ<FG!?E;BJH)2
MO\2R3J@PH$')YPX(]HE27DHE5E5/EM2HBFJ6P"A6".J#A06HO E5+$I4G?%4
M/3?2O'$\>%P9$=3T8V4/6*.'S:P'^'I2*T,5!6U:I'TESP2T'AMVQ,V_0MO7
MQC.I:R*E-*&$?D46#[T5#Q6=:,9(UQJ&D@;PL?K5MBT"]A@T16D",W!%4,5K
MO]YL&O]SUZC].;D[ =4R^.6D;X(B[/HC+R!38K7>JAH&,YJ->KNG'DL+X<TZ
M,*7G7&R=T];DD6Z/#<N@MIK+"G ?LD[?E>N'DBC@P@,JN4%,9&^N+FZ*6ZD/
M%J]*\R6K[D7U^0"L9NB0N8?[RHA#6P;6:,='03VP%.^(/HKL#Y&-B$P$ P%$
M?Z\+VN"T0 IC+R#C#"-.[0= (;H<G[8U)^9@@01&-#-+\('MV,&42C/A\6E;
MA;("Q 83I%_;_Y[<7G'M;W"*DU":([2\/WCR.QS9CRS9PY<.9R2 P$>S2E.F
MI^U-:*G3G Y \@V/7%ELXG.>@#1BVB(R^]JSEW4=*8[F(6Z/?0WV<$+GKRO)
M6? OLCS5MG2,QBQ5K7$.6RJ1]2TJ+P32 9RI/01&@A7JL.*;;H8*+],*@/WK
M5ZE@W.QI9\HXE6V:%>W"_5'SK.Z[Z##P7):?6&)I:F.S6XW0%CT':62,L'L8
MERM3 T=3/@D0+--DW=-89#RU'X4UL^9%QL3SI(&=N].TVV*>_O@@NGV!K+"8
M'MHIX9QM.#BJG#9TU!F1K8V*44JDPHJVJ>,T.*[R^<"UH?NVPSI@ZLBJOG1J
M54\JZ]1J J3_],1Z28F9"TNFBK+P0(:AXTRK=&#B:02,J$_9?WT?2Z42TT4&
MAICB>#["0!'=WPTVQHIN:!T6FBR99YJA)*LJ>Y.@15!0A?Q)%0%#6RYY>XBI
MZLJGZU X-J)KV06KBKFZ(M]WUWM [AW8#M4!Q;$T'1&=BB!PA*680()A3^ X
M;#/0Q>X4&@&SB:J68;%!5_D)J#Y: OF&4OP5POZF*(/Y<)](')*,S3AKS%D
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M7N0#:ULK[=MT^,Q2AEVCUC*>++R7:2BC66MVU[MV,@]EU'K&DT,=(M"H>/4
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MOM>Y3@Q#%-.-Q*ND*>.30$L^UWVZ4QWBH\;*U-^X'[>)KT2]OW6!C-]O5))
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M2$1>-7$W-;&QOXE/E^5@-UH[6,'34,DNG^IXE4-+HQ2GL[;Z9=3WW4K5_9J
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M ;94S!V(#]WCH_[P,-C!^BZL@O :2L4 &.L^$@9V5H[^6CY/UO\\UL!Y\PS
MV/0_K\8I: 8O<[#[R]9!  L3P9]<,A5TP$DD'!,0_E97!G"3$SQ-$&D0"+8#
M*DXP^A,V@@CCTJ? PHD'2).>[YIBX_Z$^!&2!0RW# <8$$,^T+ 17H$IIM7Q
M:0VB15%(OVN@[=$9<7DW) [NB>,!L02NRUKR)M_$9C8",?*%(%"\\2OW(?,^
MV.["6(7EX\$+UPSY+(<[\]$U;X&9/KKP[I!9FCS.B=HHX76[L'7<R=BTX?Q-
ME ?H&10<%A&*5?\:W@+WCD^V#+VCG/TP)()GXA7?/#:L@^6T!7 D+H?['+$
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MTU#9R.,Q==D0;D^Y_WQ9Q__@I$PS-OEW>8[LRC3,[1T3JSL">1%CYS.%PZ'
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M:5O7[#F.ZF!NK<Y^+="Y!9W-WY$MR:N?RFACT7\E#/RO.CL*<L!EVUK*\>O
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M&(391S,QVW->.Z:OGI",+[P5:2S00DQ\'=C&'>($?.T&U/@RQX@-!H;V)D:
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M(T'B?;,ML"C=Y9WF>-K,73Z8CF>C6/L=N_*^VP:X'8Z_P=B.(SGZ%Q6!"HC
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M5.G*LOQQT[XI-!]OPOYW!)7&NXE?'AX'CW</@U_)RW PO/]Z_XA]6Q+%7U&
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M.E_,+-:_D5N7".[46$37B"_XX^6>V99<Q;US?"%OZRA5-= 4$S 1-=-MD@=
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MS7([+E9N=@OBAW[KZK8CY&8EZ"0/N9G0J_9P.L$*UZB"%8*S4H+S9>FX=.X
M";S1F;7 ]$8F1!>V]6IK\SG&;<9XZ':Q<C1AEN/A_!$[\$C(T9K*T7:K*#I1
M2AJ,56$Q6HM:I1U';JS^P$DXXL\:EJE>E"^G>'B%0GPY*(^B1$(;1$)M8^%E
M!,*KQQ\Y1<$KQ!_'*\W"7%05CW=SBH"?7_A[,\-4CL3[0UL1_;'N"G>L+0RX
M %,*4Q5=';$]E9 [Q\SN.0;V\U;=^22RWJUI<3"W/-.-DV6UF]]SG$ YWAHX
M$\8]IIZWMHQ;N$U1(N-V,_OMI^:C:IDII^^_)( MMG$5<DIRM8W44:Y.5S4C
MIZJ:>7P:WI-NDV0LC$$C=6K-@*F=>U:F\6BY=-W@*%KHTN]S>6>8'H@>U_\.
MG[Q9_O(R?+K[^]^>?OU\__SR7W_JR5+W([G_[?>'X?_L[ @>U/6$J^C7KX57
M5+=FZ8[/"&+;F4N=$G\@G]JTGK7X;,UF7RP;BV_BFYAU6JTZUR$--\8:^?4[
M4^N=S\L:45@JCDUEYT.4[0@X6&Q4NA-,:S(<Q\,");C"6F\<V1CBA-5,^$"7
M%2/,>3$"71<C;,X=8,_"7.T#1RGYC0!J48RD-M6$:MJTCY):336G:B3VJ.X9
MEB/%=F<XYUH?UN&Q,O4^9SYLZ215-"<!\X*J:,IW?9F#ZNS0JXV04O8U<?KQ
M (<<FE0]D,='?VZ'!#8R.!X>OVS;?2%KCV_W ]OMC2$[-Z8WO]8MUCH GQ1M
M[==I2<6O+&2-9EZ>?'7;[C=4N=M06W$)?'4(,19\/)."2:K))QGC9O'4*+5*
M8A2EA*4=PRGMJUNUU>ATVHUV-R[V+BIK\B[FWC7Z3FXUY4C?\GY1P_#BN0B)
M'%4K^KB;CJQMS<D;:P!)<):1;;"1@_Q')&AGTV4]Y]3)'6S;EA/X]N".O#Q>
M]F#"MGOXI?/D3JD]G&IF;&?.S#) Q>SE;D..&=%3+<TH<C0S$:125X+$<^!.
MJR%)O0M/!KT\'4-_4'ML.'LZVE^L?FDGL3-N%S=3/WLV; 'G/FXC\@!_,+B-
M[_$68TZ,'U2__@^UK3B>[*)L[LF2_%$HB4I054Y*0BV8JE*(^Q[X((UNZ]*%
M_>G/L@6P0HVG%33/=.'9XZGF1!3YV6GJG[(*U30B=;U_,7(ULPCM@\7<D*56
MH]V*.G&13FY"4QZ U6[I6)5:@-5^M]'K1FN+R\"ID)T%D=Z -[6EDPG%28%T
MMB3VFG!8UHB-O6QM^!!TNR7OACO%!"J>L/*#GI]'E+N<97=]TPS]BV4/M1]_
MK'<0OHB/?F3F4>GJMMUI].2N$+NG$;ME(%D&#Z7?D-O1F487(X<S)&P7TLA_
M0XCW2Q/@\9(J(55A,V,PM9S.;8NKP?^YA+UZ)1Z&2MD/:S,O[[!C9*D-6J;7
M4, 85*6H$*IX1"Y/T9%OSL.YL%HNL4"YI.0A22UA:<>(@0[+B5"[2D/JIL@>
MJ@?M5ZH:IHJ5%7PTR=J!=TA2%G[<>*Q3%#,,6$U"3$%! XL/;' =-8?\.4ME
M84*CM*U0QS?>0.N9SC4#$S0'GCNU;*P87%_#:P=C9H5V)"P>[$0C',$@ G"%
M_><2P^35%*SL7?/?PJMW8 /R@-"QW1W0K8%:@9)&K(3@Q":LC:ZT:QQR *Y?
M7F*9KQ;K),_(<AT>"-J5-8^I$2F/JSX;;P:8Z+J3<KG*YG*5DW*7)+,)[&0!
MWB71-D^K=1^P1,H[;'QW2*&MMC!XTIWF3-'AC=-=_:M;#'!%N6E!;<*4*W+1
M_]-,3[.73$@T"4 (B[!P.3/-YETDHH Z!T.ZP6O*-J1K\+0EZ@W.7NMG16"4
M6PS&[EX@78N,?,3Y4L.AL"J=_!L =^$R (9!O^6=Q<[635N\V3FD>#,#?1=7
MS]G+6L_Y8 *1T*'V8T\)9T>6(B6<\%VTA//A\>[IZST9#OYY_W)(T29_Z*ZY
M?Z<0&D\@P>^'STSS[F09T!DC:F>3"_=!S'B%@&?-I7=\3T!?/ $+L*UQ5IQS
M+:\1(H,.BIJT?V$AC(SK[!:Y3O#$8R*J?UD55$X,VW&W>7E5/]G '-5%$%MO
M$JSVA+7:%/6G+P[@[=PP6M@ @PV()YKKVL;(XP64($" 6 PS=)?V V2*22>&
MZQ V3QM$)5Q&?XQGGLYN,ABP_A [? '> YI[83E^DWLMLI#UA;BD!@ S<:A+
M1LOM:\.OWQZ3%^[[L]LRV,D4MZQ>+OM]I6G@J?9&@WY&!,2- Q]L>SGA)<K)
MJBF:]Y+00QT(]@Y4H>'>A=X3-,#(9OC)[=U=U7VCKTG AM>0:KT9FR3$"$/S
MQVZ"4O:P,-EP HIOD'=*7EDC<"1";0%&X0]XO8M'2?ENQ&<ZH3;L!&S(P '"
M#!J"_ I(".]-RM/-T+:H5[?14%;$%MZ#=.8'H(V<IV]3'+R=/4VB X#?I\9X
M2M[A$Z]WX_)E87"S#61;MYEC;"]B(<3S'R%YOC,;S]LXOE9G0?9-80P,\J;-
M?#- PTK^(*DT&_WOIX9_!*\8!&_8IH^[*69+/Y@'RH9N,A.$&1_IP::3&>@V
MM@44I/&<RP#V?H1?]U?(-(;&:!BNU5PRUY;$M%PTC&$?64N?L!Z#YSG[A&PS
M,2!2Q78/DLJI"9T"QQO]B^V<Q?8&R.CWYDN33*B^FJCP!J: !=*6:V7\!OLC
MS<B_/-MP=(/AQVG@7-EW"DP*_[W33$W7V*4/IFYHW)^"MUF@D?%5X<<[L /&
MQ!CCT%K^"M]DP/70'P"QR:TB;NG ETNJV0YPOM3G#_!&#OVWA[W+V2^I_!=_
MC[>&OX-18K"YT(P&P%3:.0[>QVMK?8LV<JR9Y^Z^)5*_79.)\8K<E)1\NDG
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M62+1C+N=XZRK?F;^!\\NX//&Y]KWT&FYGZO@T(VC7'_:'$]/"-T=R=F@$WA
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MK[+@89"MQW*J '0A^$%-T'H]:PSY)2T@Y@''"XL7E[E4FV-M4' ;'^WKEXX
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M#6$9H&>P@1W?[(CED][5K2*2NJI!'H5+SNSDT>?MDH08S=?O7SHNG:_L31X
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MIXMOFNT2J4$>L-Q2&C2"";XX?&U%+W]/G(6:K*N.Q?UJU]AS;@P77C).LX\
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MJP*O_ '^#UQ].FUZ>C]87'6"Z,+I%RBN$F@75PFTBZL$VL55 NWB*H%V<95
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MOQ5)E_RJ9K)??\Z;R;_>OR1E734KJ=5E8+P8YK<KV**,2M<[/]D1(Q5ZI/B
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M:AM3H4%^7W[B1_N%-S[[H8UDNR[%%E.XXL'2\O7Z)5+0\*]__']02P,$%
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MZ]K1$!>N27^<XMOK,?J*L[5LOH %XH@D$C0I F!:@57E3#2G&*@WEM/:=-D
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MPFLO)P=6"-6U:5U#\AU$3*MF%K<9RY_%3RL(6(4@7=:4/$6[AU[\%*2@4K@
MS$6#8Z(2[<NL0!+-G&=1H<WYZICZQ.*G@R'J)DKMHOAI-/X\&KM)^GY+F1L
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MW5J"%9MCSNZE77F9]8T=,6V/]K 9[3!.>\OVM)0Q&4*!EE[O(A /+M@$6;#
M(OXRFMA*_UM#>6EDV:UN*K;/G*(_'O11-!?7GXML9D3/3CJ9#0,=(@-1FOM9
MY0AH1HSSLI3#K\U96?'9+TWW6TJO8G?*&9S1&(&X2;I[D?G-U<*(3;-HA'*0
MK24@>$1L(E&8)LBB_\K9_0C/*LT^_J 7I^:*<GVH<UWA;O@Y!7%)N7-W^0T^
MIJ0TN<3&'2E]4HD"YTP &6@45 471;L9W>)A+TWWM>7[4/]F^WZMS>0\_SP:
MQ;LG7!>C 8+]/$ZAO]ANCJZ*A/YWUD97)^6H21J(-Z)<?R8 ER>$CX9KBLR%
MK&H?!CT)Z LBU.X4]I!E=NOZJ7;WU]/H'&*1P%R.I2=S!"^HAD@8]2(J:5/M
M#NWMD+U 'G6@DB6AI*WCBE,K]V:QC$$99P@OA3^(AE +/O)B_&KTHU16FM<^
M9OH.P ODP=,%O$3=VYTU+<*9<S1OW/#W=RDU-[Y.PMU11!9!JN1!*%S.O&8"
MC%,IQY@X%^VJ8=8\Z 5IN;I<ERA]ZRR"F[Y)"X!IB#*?]#P3TBL1@5.IT1VR
M"DSR%&(VWA'EK.7USPZ60GE!C*@I]"5DV/K"H+,T/\XH'=)Z$=>;3!(#HTH%
M3^DJC:PT$'24N!I11JM;!-\!>(&*?[J EZA;/%HC-7^Y?/%H8/S;/_U_4$L#
M!!0    ( #E"F5J-;LV1@0X  "(I   4    =&YE="TR,#(U,#,S,5]G,2YJ
M<&?M5WDXE&W;O\:,;9)]7QH&$6G,V"=,$B*2)9&M809C7Z/0I%ZIB1BBYT'9
MDB2FA1;9B;1)E%VVLI1"R#KSCIZ>GO=]O^>/[_V^]WB_[SC>^=W'==SG==WG
M??ZNWWE=USWG,+H90X#?PM3<%$ @$)#"O !CF'_")(KD!8"5%5 ! ' !&&0G
M8&-:<&;'(H$$8$P;PK3MLR]OW($P /S/IZ0!)W.,A]DW9#8@/?7]71988($%
M%EA@X3\41H&!>%E+$CX( /84Z/=:8J-FR$^!_;3OI5*_VU ]# "IJ7_8?]05
M7!D;L5AU!0LLL, ""RS\9P.CCM' JFMBT6A9=3VLI@Y60_-/QY@5" AD7G@@
M"RP!B7EG5B* ,;Q)VB<\/!B+0@6&[< 3@CR(.SR# E!1^& 4>H<Z"NCCHH+Q
MGG[$<%D/HC<IT$#IRZ-:)5D2P4#ID):5NE6P,=&'M/=X*-'N^'Y[S^-^GGH$
M)9SA9KA^%#8J(#B &(Z7C0KP#PS#1AD@OT?',NV-81324#^4X(6UW6/ZPX/9
M,T#^F$MD9.2.2(T=0:'>*+2>GAY*'8/"8-28'FIAQP+#\5%J@6'R/P+L(89Y
MAI*"PTE!@;(;?;Q'4$2X 3(B@D3 >N&]M#P(!"TU#[P&00V-)N#5\ 0-M!I!
M0X.@HX76Q7BA/9 _Z F>/]F#(T+]OW,3/%%$?V( ,3 \C)D-- J)^M=R,E/T
MD_1/T\_4R/3!&H<2\>'$/<QFN+&T:NJ:S,#VOR_M#CV,IC[J'_ST4?\PT?^#
M;!GJ$SRQGAMS"@K]C=Z.&/*_6VU_DN'/0OHWB<R1WPQF;.;&X^;FUD?]+>U_
MS0/JQ[YC6C]W*?--V7\#6"0L$A8)BX1%PB)AD?S_(OFCTB4&,LO;2&8=R^@#
MQH"3G9V#'<;)P<[!Q<G)!1?8Q*PQX")\_#P"XB*2$N(BXF)26Y3DI&049<3$
MD3N0BLK;5+>K2LJB-% J&"45596-(!!.+BXX-UQXTR9A%6EQ:95_&HPZ(, %
M3$ -%(($; (0J "$T000 $#8(=_Q^]\!"!L4QL[!R<4-W\1TJ. ';! HE T&
M96>'P9A/8YG/ 4R 75 .;<0A9(/G1(8(8^*H>5SRNV_7B]BVSRAH>(2>XH:+
MBHE+2"IN55+>IJ*II:VCJX<UWF-B:K;7W,+._J##(4>GPYX$HI>W#\DW+#SB
M:&34L>.G_Q)_)N'L.4IJVL7TC$N__)J97W"U\%K1]>(;=^Z65]R[_^!A94-C
MT^/FEB>M3U]W=+YYV]7=TSL\,CKV_L/XQ.34[-S7^87%;TO+*QNZ(  *^1U_
MJDN J8L-!H/".#=T0=@B-QP$8.QR: Y!(QM.?(@0$A/');R;FG>[GEM>PW9&
MQ".T'2ZJH#FL.+LA[;NR_YZP4_\C93^%_:&K%_! (<S%@PH '%@QI2CGLE&:
MWE9Y#]-X!Q6O59<Y3G[C$T_W>'C9AB*XRW]+#^R$\+K0XQK$K,*=EEP_T>/G
M&_(*15\G=/-9CEXCYQ5Y^\7=-A&V!?D499!?U3$2U/Q"?OC%_.&@[L(W6GKR
M7P]SC0G<M#@>&",MU VBQD83)]>TEXH+UBSN/L#&V/8,]@ZUD="PD\<QU&\)
M-1PXE1KST*_.NW92E/.9\U+^F_;B;959P5+@H-["M$7?_C,.W:DN3P2<;F<3
MOK7X7FD\>.N-YH,%->QGJ:QMPG=<]M133RH(\@V1>GJ'G//OX(957^$FT-X,
M0(XW1 CYI#U/:;S1VZJ0*") A-U6 O"6/CLZ\5M6K-N=5;[/7H7"-H=_B1>V
MV850/M&9,V>O^645:L( !==*:3UF]-U7MC) F38#K BGGU^U);<>Z*C]M%F,
M?B&S*L=\EN-N;GEIWE17KY\E2.GIKU*LF[Q\U5L"=_DX.ME 1 "1.W^H!0&O
M"AJI-ALI2IC6XA/ZJ./0X1J?*K' [2I]9,;^'E?9H\646?>SX;BS;T5[MU87
M3[XR3)=.$BD<HZJB,P\XQLMZ YY5^(=%OJR,4<-?\VMT9BZU\ E&>396CE@5
M#_I6EH[V%69G)C6^S+@.J_$\V;36GPO-FPJ[SU'4R !B2\E.2X^&Q]]H#>R>
M>%&\6\%IATL)6V/2PV:#2KN5JO3/=?/NR62N->.;4155-L./S#I'*I,$1P:W
M$,]1CYX2JTSAW+\\6AU(;ZO=I$7C['?WHRN<_W1([$!LIA3&Z$C6:3%_:5Y[
M@%V8="%/\XV\$YC($?*L:*]8M[.^CXW9CR^O3E7H=YH[6@S5Y_4C+WK/;GU(
M\W63<PUSZM12/*/,XS$W^8'+/&8T1/<EYWN'Y?7DE.3<Z[0,PZU+#. RTS8M
M%)(4=-!J2_/<4R=_V2JJ1U23S<Y<J[X305GRXGIZQ:57EZIG;[X@%[EI)Q4$
M]4F>&^P5Q$2Q&Y'0_7,:DZ_O+.YHO9_;=MV'EJ95>\9=Y(2,<\W=(M^O \;<
M PJ9Q+&;3ZOW8?@Q!E&&"U/O8(:HUM$^4CF97[S+N<):?2]%)+!@\@'O<^XQ
M7G4CF9E"B_8/YRNA73YEWBV#.U_3$5%>5NX. ZJB<]/3!;+Z<ULH&J\BE6[)
MO(0L/]W) !0&D%K@?M^Q-;/-PJ'.\8-?M./R\#Y>0F!LV^N+VQZJ5O,CG-K=
MM[?-6(_4QA=@,\Z5J36]*@[-C%TKD9-/!4?R:BZOJ]Y:,IYM6'7L$FIPVVFM
M9-^//S59@"Y/I7%L$T.HSAP;5?"4F!I00XD%*ZP7,\"8<3L#?%)D@/(KCQ"G
M^<\GQU4**PR9!Z@([O0R$VDYT<D <W(3#+ HR "]UFYA0PP B7%Y$Z.(CQX.
MXG=S)FG(:;>;W32'Y_8;02!U8Y+M)A84JVZANY4&HW01K>1UV&?<E_BRPU:2
M!M"1_3E%C:J6U(&^E$_J^YVL%XKI DNXD4,):\X1$:/57E.KUM%B%W0_= Z.
M<5M24X[>EI7)>_CM6UF6XTQ&<?0L_)UC'%*;V@:]C<'?R@IK&78W2*RSNY8_
MT>)<^@AA'/?\QDN["\AKV;3HP,B+-B;'Q]O8_^1\EKC?Q27,!T3;SL(_9EI=
MN'KK,231S5FAGAN5'<@I4;=V??W&=D)RBZ36LON ==$QE5B+O<_)\T?6/JHN
MAL]FY R3I5V=?+\6EMXK >>\TQOR]UY-[[?>981?0%9O=MT,BS7P'DJ&D[JH
MKI-T\?;20'Q ^PN.'$$LXD!]Z.:8GK_[%M24F@LZ-C8_G6B4NS@FN;QO\2H#
MI.85D;LE4>LR6OB$@,Y.[YPU[(Q)6Q.?1)]/QIPXDHCIWR\6F2ZXH+O0"J*I
M[HY1Y*'DN!B="%(D\6JKXD)VB>8A.Y<G+MAY71XQFK]'5=JBW?VD*J,1U53<
M,9F;Z.)%+P_R/,3=RJ[)_I*.RI&8Y%4K<JOC>7K]+0:8"')%?"I@ #EK(7*7
M%'D=;C&.(]&6507(W=J(]<T?"]8ODL>VC02MC 8Q0)[YX6=+;'J(1$G26S)I
MWS0Z+*OOD53(A5I]==H"K:Q\ -NUMT.M?-U0Y-3;MUH4Y<XC*G$G5=_GR)!;
MAWH9H-M['P.\DJ65?)1L&Z#,B2?F=9:<?-H($T@QB:$..^^9H4T[9D@>/^8P
MZWNW7MJOW3,B6&P"RO>TY@'M(N[##/FS!@/<L2U8O)0B2'_=V^?K+AB^SNOT
M7/2HZ(1KUO8;<]EWAT*#\V*7M*8RQ9IQ?QF4?E6JF:3J[AB@)B_07((/6TI;
MK3'74UC)G$/T:EC37RX]YLB+#!H_[.9LO,TR18'K*(80JFO3T7FHC/2.S5#<
MMY=X+P]?M$^KXKG?=EO%^:L8*K6]Q#PT6O>KB^FE-=27,SGS&.9IBF]C'F%:
M3HWVTJ5&R6_)VZN,AYP7,ASBK9Y3ZQ4LMYHNNX_;I-WW>4*?CFY9TVAIS%F!
MN9"'_&O7#MJE#24TG*TX.U\<<,]7\/&XF7]OXBDSR]%@J8<2,C?P*@<B#TD\
MH[^J3//#<50I%M?HN+W87-]2TG>7?'@^Z!1BSJ2*^0%Q(3! .\T%-:U8\+@P
M1G%F_<IE*;4K.=$BY;[F 6=O8<O,%P]@_.XL;3HF,UX?P&]JY -[]02R>E/Q
M1&T<YVPA:J@D$MKNDT_Y\-MO-449&K]4,3-I*+^TJ[L1:51\N/8R4?/77BEQ
MY6ZZJ+3W;? U$7%!WV@X(*RAZP6)-GE)%%-<A\F#TZ<&Q*-/N^=J]GA<\'D>
MAGR2],:%@&BX7^14[YR+X%^3N6(SZ]=(Y78Q[;IAP;'3FK/B**Y":2U]\TYZ
M73MY8K)D2C<\27O02$$R]N9^7F,%%=[84':7&Q'K=#_(UT-_OT=7'"BJDFGC
ME]01\O0.]SD') /<\L>M2'69K2HSP!.[IG<+S>\88'=J37I^103-.K4N)F^4
MMJPOY;[*,TE>@8DLQ H[A.5@]MUBC\EC )W3#!"2LYY:0\L_:YU*/Q)<*WI"
MJG$6T4#VI.R=7MCG@.GN-[^<]ZC \_)-W=&\C0RPO3*4C5H=2IS._5AI9W4D
M<?!@Q=O=I_;O,U$>.MUV?9&CYO[U,K4C52<;(V%A30.V]CQ%,UH'BHG/%,,Y
M7UZJK?"?<Q3NB%&FNF&&W?PZD-L8(%Q6;9E2-/-UN(52(Q_U&2<9LUM,P,E,
M^>+VH<>*]6XV E%]XKJMH_)QG=1Y5UK"O)]$59\:LF'0<CQ&^TF"X4.V<M*J
M8Z&/*N3ETI<&4;K.C!7]='"#/!;*\X !#B*S"T+ZY'/\NYZM;*T>?7<2^_YQ
M.CVK\NG[.S.6FXSTI+GE4\)UU]7%"3RQ\5:IFAF8U/Q*'79'@N0O]N]=2ETA
M8SF;Z#K]:WMG15ZFU" HS<[1G)6"4J^G/I6=O[_%_:GAB:KYL@]MS=PA6NE5
M;P-D7O2<2Q>T&C*=/?,NFQ<BM[?%MJ;B84!1C],C@\)L?HU@2QN5M&5XUC.C
M1.1LQX5T3$C0'NCU?,I)N'+^/]5PC)Z_ E!+ P04    "  Y0IE:+;^ 3.11
M   >8P  %0   '1N970M,C R-3 S,S%?9S$P+FIP9^R\9U13:]0N&J0W4>E%
MHM*[] XJ @(;D-Z)4J1W$)! $ 6D*U*VU$WO1$KH$#H"TGNH22B"!!(4"":$
MR_[.+7_N.?<[YXX[[I]O9LQW)&.MK#6?=[Z9\WG>L4:NEJ^V +?T=?1T &0W
MR  OKE^ JR/ S<<N?DZN %? M9%=K0*T #?(_K5_QQO_&@7YOR,E!04Y!14E
M%=5_.#4MS;534U'1T-/0TOUKU^\8Z.D8_OWP[T7^VU=O4)*34])14U'3_4_;
M52_@-@W9%ED;.=D#P(W;9.2WR:X& <#K&"G_(SPRP/]N9#?(*2BIJ*_#H+\^
M 7;K.GQR\NN@*:\COCX:>7T<0'&;\LY]Z<=4S"8OJ1\$L,B\_51$P_>DH8_5
M= ;++^L4&$-+Q\;.P<DE("@D+"(J)Z^@J*2LHO546T?WF9Z^F;F%I96UC:VS
MB^LK-W</SZ#@D->A8>%OWKV/C8O_D)"8_CDC,RO[[R\YQ26E9>45E575C4W-
ML);6MO:._H'!H>&1;Z-CLW/S"XM+RRL() J]O;.[]V/_ '?RZ_?IV3G^XL^_
MN,@ Y&3_A_W?XKI]C>O&OSF@_A<7V8W0?T^X34%Y7YKJSF,3ZI<!S ]DWM*P
M//E4U-!'RR=KBF5U"IRA8^.70PK@_H7V'\C^<\!B_I>0_9_ _B]<"  #.=EU
M\LAO S0!E\3B1&' _]]>>2Q)F5_:ZMWYWJ0ID[J>RE._K@[RC>N8U.UR!9@V
M_&O5Q(>5(B_=;0((T-RJZ*'"8W!>>G@3X(#=):^#PW;JQI\]D]2G-FR"_J64
MU+NKS1&?'."84(([WNI,CS3PSA:;O]@45!^.N=M=-COX\EF+Z]]?U0VB->)G
MX2H:7#:.>'KD1BQ![\>T=!L6/OCA95Z%E1E#T'#%ZL-GZIKAJ:>8S9:H&E>"
M=M0\K\AG@S;V-XK1/1QK#GQ%8ZK<$&G[B 1?%/!L' %GZ O8O#6/K.Z9]4#E
M[1.4 T>V<GQZ[&Q6S/+7X5KGWR$ _QU)X>*J.2^:(C.$;@Z(ATLOR/'GE_G8
MS"N &<9OI15=7DC0!0LVX*%E^"@?2>Z5O03O(Z$[,G]ONPCY W@P$Z&9N+3#
M'=RIYJLIO* A=/";N','W%#_9$D/]G=^NOUHZ#V'Y3W/Z,E']SZ^OR&;,XX]
M?WL%V"K14,4K:7JL&B.,#+S&\Y4..D)CTV\U3'@U=Q"+P/]\CV9]4GK+*NB&
MD<8F];!L*B@VJ43E=$='WNU;R=%0G5UG8F=HLR7T2(.9N^]YEFMB>AV#!J_\
MCGYNY?9%:4&"C=Z*F*.Q]GEA@ E(X$=A"R0E2O(*T*=)M,,%_=7%I9FLIE#C
M$1[B%"V5N_O$,MCRV_,?^'N_7RRC60?#GD!6:] 5A[57@&8*8'.0>PM"\DNX
M1F&%C2VFT-+NU<=Q\3E)A0;A'S4Q;8\_REC_7D"#F3.5D,*33?E2WNWA5FWY
M^1>EM7.V=2$S#GD9;<P\):;68[]_5%J<2>5^(6 $Z\;9@^=F]LOKOQ$B!GOX
MIXE )&&3-2S7-'7*:*[.$75VY/1ZZ,Z-[R-WHUF_@54NB[H8<<Y(C3)<6F_
M^MH^FR#VZ=*M"ZF@,W\#F7?IU<MH?^KYFYDG1"!KCT+4/ AKF (9LHI23AVW
MP%YBMGGO=Q%DWM4L:WDZ%(F6T$T*)=\!7 &L"D[9B<SP/CBK!/S5U)TPU!4
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M ? BB@.;0-*,'I9NJH_](^UI3;[*JD/$MGN9>U=OZBW)@/N/J-7\6!=)LU>
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M">V/1V5\]J+IN?:'<9*1L9.><X,HR[O5615T&? @E5#+J!41/87ZXV)C0Y7
MK3!0/"Y<0K3-6VQ02/]4R AZ7&2*@#JM.<T[9,)\O*"@8DTOT*KST\N,D#KZ
MI_,D(,@KW>NK(;^F<Z?U&(N+0YMHZ!W[8*C*%2"^U!/TV\-1EKAZ!4A>8KX"
M4/K,2S9/)6DRR#NH#-7OMNKMQ"#4/LN*8UD?1QOI ?R9;']> 9!P3:_C/[I+
M29I8^N=7@&W]N8<H^V$>W>1^ V[1A^5;Q25:B VLX7IE"^RXFYA\LL$Q[C9@
M+6[_4!JJ4NWK:YWFZL;97)N7_N;U:OW>+(120V 4%X^,R\0]\*/;<$^I&N&[
M*WD%N SF=@W#KMWL5 S^H1TBGX3=''RSF:P!="\0PPG%E<_ & WT8W8)>FV6
M=VS&<''NUBHU-THSE0&X;ZPP4-6+M;+WY3N2;F-0L<!-0\PL8;5\9!N_0(,6
M%1[X%*2J0URK/C;R;4%<AO[']OB+_\&6./FV,5YDLQ?(A1\PQZ:-2%&%/3!F
MUD*V,Z@<Q;,8\AEZ"]B8']HWW7^@'?G/1PZ>%W?4]G06>IC![KBS=UM3*YLD
MVG-/YQS#'H$NG&.A7("-2Z5XH[;D@CGWJ-0O1;+GO$P_&%FQ%_$4T\.O8-(?
MJXNKV]HKC)A#4[([181&@V$S:X3OG:DU6XV)UB*S@<$9&?S51G2S2YO)MF8[
M?NL+UOB]LZQK>ET/WRH#T8=T<_?GO$<X9&57Z,ICNC/2*+A]ZR<Y>Q%ME,9"
M1;S-QZO._;SBBW#?XW>VNVG(%)VCL<DKP%^*H5F+IGHL9"'J@YV5]_V5E=5N
M>AWJBWGK4L\,F@X.(&"8&IWZ<5U>4&BDV<[:".-PYM=3_P7UQ*CAY,JC4]/=
M\Y:9>I^T-,VM(M)MG-L'30_(NXZL=]>7_[,Q9992?R1^6)IY#^@3O;/RF+Y7
MJ*"_;6HUUQ97&'<%V"K>H,4Q#6S>;('66O_(4F1[8ZJQV+6B/B?WZ$S\;?1!
M8!@%#A1A%4,T^7?["#VURM=?V Q+2VS&RVTRK?0Q#N?+Z.V-.7N,BCY:G<I1
M*1CNJN='VEM86-;?,3*%.B:OU^:QJ"_.O5&5" $)OB'*#K7I2V;RN#AS/"]R
MI#OW]/7[HEU6W3FG^TMW"M)L/,B4 ,*:2'&'66UM#L!C>NY/BS?7G.7:PY<D
MZ"(_+8O**I-[B@J#;X0JO[@1 U!OQ01L@>Y,$<!@KGDU3:2/#OJO.2N#U(CQ
M"!'^1$K#)UJ_VB@DV2FV?^_V?"ON=.TSODTW-^1D?["0KZP/KO+0(S28&(U/
M;#I,T@3T#Q@E/VRSH),KLKP=+^M[:M4M)%B_L6@YYXR:0FCU@=C@KS17]32]
M-2F(JMTXS7AY@Q##5ZM&*?F8T59K?DL$[:,G_(G;/A(GZ:J_X,PAF@F:6#.I
MI(([TVK2V,_6V/.8+E75\6K//X,",HURKQP#FEN6^XM%G SN^,NV'ML*#V+_
M"F 5,[7^(B[O63 ;W.Y<6Y_;?&[B([BT-OTR[,#Z3;"7FKBC:(JFJQ%4KCDE
MS\Q_951P-O3TKPL_$ET%MO_<%J]81O3$KDA[DJ@62MKL/I#^K([]*$TS;?S
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M1C(*IK;*RG[_IU\_#SQVVOZ!/ B:>Y<<W/T[<,/NQQ^Q'W\\DM%M3ONH5]@
MBP:Y"U%#?5N87[BN.Z;ZX/"H TG\"_<)'X$]M\5UO;$_G_5XX]UZ:WGUZ93
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MD\!F6\:W/'8W+@]K3^GMGM4>)QMQR3[08];\+'SOD.PM8^*?(@N3)P^B ;T
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MZ<&C8D_63&([RY5YHFJ"XX3(8A5PL\(1[SF64!"8P@IB(F+E\Q^_?3>G%)C
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MT])N=A\C;FLN*VEX*7A'IZ=A]OMT4=\ZL7RAR8JY7!TF*:K._ 8.,]B=CJO
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MVV3TI07=+V([-DQ><;)F:WA\S";DAPTN+DX[,HB8=85/\NBO_8:Z#G>N^+&
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M"$(W0J_K#\2N1_6U'!Z*$O))7Q8)O^=[(#_@S(LV%N#G]NM;H6-(F&[KC23
M4FGB>*("P=,]V>6PV:>37ZZ'1^LGYN/1O BWUG"S14-^$C$E\V:Z08)',;9
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M970Y:O><!5<KIJJ<?FAFM"#/HD6FGFR/UKKK=*OD2Y;"R1*,NC).!,?1T\H
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M&D:S]LSQ>T#FOT8^GJ1G-SSEC(G;VGE_^'FVUX%!J?INMYFFQ\S#_&">@>,
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M2K=.Q"]*/KR@*WFQY]I;*97]UE>C/LP14N7$MZW[7<(=*;H8X[Y.HJH<BY6
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MG('J0_H5ANNYM#*7][1F([;/&U8G:^5S5S>/%1*]J 6L71CRB2X&\%[G6MA
ML/<*]>6N7T+^8:D:F^</YJWA[Y)'R2WO<1^%O)=FMW>S6B?2B_6U'91*3*#9
M60^PY"\I9'T016+M1IR@O54V\".9.418']I;'/UQ=^OH)XD+$;\.N@K-I6'E
MC*/;C!P3VYMUR:HD1"2J:G,A+AB"E5WOT1%YD/\UPU5ITF^U^J2LK$A"RVA7
MY)'5 +V]I.8PV 93A3)H; J]<9@!O/5)6YT7S^A\R534,>UAT&P@4H3TQ>5J
M%PHDSW$ZA^P8E$[FI'G5;,_R003T&A*U*@(G+C<N%6_4+==E/?=6D5C_[CG-
M ='L<3M)3"[(M^<\(">I^N#$%GX%DYQLW7QE!%V\@<$QFZR*S=TXSAA!0D1/
M TQ%>W]UXY,:E6QDZ?'V5? ISX+>2K,@87B3E9B%BXDM %,(9G$F:8GHD-K?
MP0,ZH\[*HQH98NI*-X3%9\-VT=D(&2Q]P(H!L/7%.'$U0:OH D[NA09N:M4Y
M,#>OESM[\R&;-!(&JNK;S6Q;D*!%%GU_"3$LK+2?'%5FHT*E_J"H_;:=_LT
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MS@#>GYQ\,XE"]$*W?5"\F(W<;YC?Q@<>'$"R><*VU<OHIQ!WZ+O]R"47,ZH
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M_1M)Y?7M,JRDMU7?.V?+D]%<4V7?XTC#V% Z5P]Q%6^[@5Q<3XJ!5/=L<G[
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MMRZ\$3!TI#<E%A0! 94N2&PT$1#I($2D@Q@1:1H210&ID:XH1 1$I$GOA(Z
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MNF-@;5WJ3,O+.^6EM-.OW]UL.&:1)_XJ+7$ZA,0"8M$R:&_A+^.=.$&#(^2
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MNT^?%_9/J]W[8;X?JU :7+%D\,WZA[C0Y*J)5O<XT3G<.8FF_*MQ*=NL]VK
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M.-XUM:Z^+;8'^\$RA5)/8 %K+B1O<EB79C-%%LSUN_5+6-2I7Q1^(;#,;CI
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M5#-&DIQ#(R.;R>N7*]LRW9)7YE^BN1,V7;ROV[H_)%@AS<"7=U8F,B'MX>F
M#V "^2+!JJ<5W9FK!"8ME;@Z7"5KMVGA>.>O:\2,AW!P?8C,T_[ W5)<:/7R
MB%#X:^%7N(#-V0?$3XOB;Q@QL!M0#GP ^D#(/)^@2?>9WGII9B\8\-:2KZ_8
M__.+;1^8SLR:3? GV\IN#_6?\ ]]:^@EW!<7JO\(S@<#"4^X.NU9F?F-!< I
MVN7G6Z9# AH7OE&9M\1B,R,.U'U=<WW'RY^]/8R!D8T6P:/?V85R@!.X3MFA
M&I"_Q]%=B;P>:4[3(7(EPV=6\N,.79@]QJ?=)WL0 /;$_V8!,UE4.T8N"_!
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MVSI)?# V!=98P.V*F2-6C"86X(&50WUL4Z.TX 7D=4>O=>Y<'R^]5''K4N6
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MP\D3+,"SLC;Z8!3TM'>$PJRL\D:HM^Z@J)G6R#_^0>?_)T!8,_\-4$L#!!0
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MI_39=EFUR=E++!!G"E8GI%<WT(3#V K0?M'YJU:*.78.CF""_@9_TJ^ZVW>
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M*SP526>DT>]Z\N%9,_>%X6E"? GO;&.,VY B:Z@G@UAYH]!]S4B%$G+!^.H
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M/.DK($MQ]3CQRD(/9>)[P7NIV(F;6@@]($*V02GP1NCY:9<J=^-=>K,5/C5
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MF)[V .28&WJ@?$'7=?/[APC0'VIP07UR7-B=O*7FM=/51L8##8R0,78'N;H
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M*/G)E5W-8,EDWL?$$JN8NF,8V0BYXK&17J@(:CLHO@9\'J*6J**LW]XW:8D
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M1JA-9=B?6BGC&"&S4.*JTRSK<"7.JP>+B+T34.W9GN:<U%WI9P4UK:W-=_Y
M,.!1]Q7!:F2NH9M07&+<F/?2$<D NG>V'\<BE*8\SK'Y[M%8@'#A8O)4FNIH
MR]F%JG*2;;,TJ%76P:INR_MM3HF6V?'QP I&*VWOUZ;_/ [5#CTK(< EK1?\
MC='%*158D3UC=P;+I5=4B^\J7R[U_Q80;M'9OU@O.=>M"E Z\,7LK7?%70.
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M+J%XHD*II3! 4K1Y$1,K *BO"H@DGAZZI6]<B3X3;7J!:F9!G:JLU6@AQ.7
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MJW3VU#JUA9W>:79OGKR:\?),?*.>?D[J+^_F_-\R@F#LOP%02P,$%     @
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MO?I*7.(!O'M?2&)B,YN\C^VIJS/MSBD/S7B*_/#1T7'OA1/_:3VZ03=N0?Z
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M^L^>4&Z,Z\(4@FX(ULUHGLUV?^[WB8J-RU\H$,.ZUWI4*4>B]W:/EH35>*%
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M/C"D<3P;YMMN%T=,@#W\32Z7NO9="GK(R!MQ7AZG-<:./9<]!2'W3$8]VOZ
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M=*D6]X\2GB9:SK$EFO/>VP=E^KK.E.Y.GI/43S%.2K'2F$UT-4:_8($P"E%
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MO>"_"^F3;RW3Z$_X3U '-_BF]MB)+?P&8A/'*PL7[4[:3H"Z6,/])9_D6&W
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MHMIHP-T,(0)XFQ%0?,0I$,_( GEJ2JK*_G'R]#"45/.IOL [0[<]0)]:S(B
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MZ0?NB^<_/Z-;_0)O'Y5MBRB^D=X4"&]#G3?($>RZ7?;(SQ'!8N'&_TGUO>=
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M->&/@GRW/VMN:ARN7-5(/^TG&6/5C\ZM[M^5*OT[@"?^,B!1"-"D@0_O;#2
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MT1)SJ"O$ /EH;-(31._B(KZ1,1)U1^\CQQ.J#<PU/SFN/[$*:4S^B]5;=(G
MOT6=+.L_-OJYA@![_3BCHJ%<-O"7O@)=+2C&(T[H]T?$'XHYJO]RKSB"DS1(
MU?IBI%$#5 ^=#A'/O^^C:A'Z/52HI?@)<"+/^7; $P'1WQHQ>HD0/_1##!M2
M-3J%G)?V=T_&SCY^+\[EX#K&O*/]V'NE0N=OY1.4BH![1YZ<E_PK3398MSJ=
M[*$_W=US. ;--[[A_1L^9XT$ZSVVEJMVK_AU/KPFD/(XO4-G_^73_)K[:BND
M05H! P3/3L*T8AY5$:4E-1B@E&X+/KC<#_?G+L*OXQ@@C3FIY_?S3MJ>O7!"
M&D)^2>LVD41^P-(:'U9];J2:X0U?Y3M4!-75?B^75GZV:>B&2;K8-*H ,D=&
M ?)QG 0(<Z8;] !SQ*ZKT0B]E]HW/+>/'(OW]3"[G14-UIE\[Y2L<CPG3]>'
M'.T+)#"/A9*JNAK-E0LL.K\FE3T-N/4P_R/79$4 ZQ<,I&SX^9ZR>N7%DBN=
M>6&:&6KA/U0TME6\/OZVAC__JR2?>);O7)!+CY7CM1^W\F*F-F=U%=N4#3TU
MZZE0^2W40@#Y.Q! L=_6*Q6=OIN^Q#MT3DC"?ZI-KF+L^,VZJ;>414N6ASR#
MQEQCKU&MFX1#8@<YA&2$$D";S1A=QEO*6^1:3?.\ZN _&V]A,'CZ1)*S3SQW
MG[P)-^ED.< <)/:8*5T9%C8P]L#%FR!WW%5/+)F;6Y8!BJ;\FNTMG6: ?"<3
M3"0 4BS%WNI@%)KCGQ_3V.A<7[8D._)83=/I]LT'43?YYNH+_(N="E?5;JG,
MQ#>:=U6>;X#<@GTJZ] [N&>4,:&*NUI]NBRCT38TZ3Y/W:E3,()L<5;L3P;H
M_IR!P$(7G4>1B%D[R!P=/&H]*%F01#53@3>[!=]NE!E449^JS1!</7*O.>-A
MOW+:%B28 5HT[&. FGT+93!IW=JOMEM@Z7<^#U<;W1QJBKF9OVSA=&($T@G;
M,.R)L*;5,T"KU>?!:<BC'C&=%LE*K46.LV79W!$R104QJ7L-PS<=D43L_;LH
MJH@RE!3:1@D']&R)HX.+D\<P*>IUE>U3)SONB4^G+J]/)QDXQI_^)LUN, J7
M17B6.."Z;9R=;>\TU#B]+JOX^G7]?4-)WEQ7^8^:W>G5;UD=PKB:\[;%RJ:S
M-9<GKQL:6I0LU'9!8IWK=UN]JHES=)X68@<^8,A8 +=<1!R%MK^=BX3%<FDJ
M%Q[)Z6Y6Y;A][@ZO+[ZWIC&[5Y#^3?@'2NJV"3]]&MP26K):8N=0JOCE#Y=Z
M.U?%O:'+>3,E&2LJ>1XL*?(2:N2C<2E<_LZ_U#7<7(95?V;4,4!1NY5'SSWU
MZHTRT<YH_F#BEEXIJ6]Q\6SFW+YQ74#CL(2&43T]8!+=%D!@@' K"SYX8_1@
MB2NNC=ZBNY$I]J) K&/L.,MZ_NDBJR>VWLH0@FLQ:A!GI,T F1\VHE;'(,!2
M# -$%=D9%J-STCH0 FO6M:ZE&F#3+_N^\>=8*JZW2=7PQ$>S)0U',4#$0V@R
MZK=YY I5(+D7+#$</;_Y]H,NXHM^X'1)F?AEV^TE:O=D=_^=+ XW#E[AE'&_
MM+SK$;96+=4!R&6DQ12JQ6*T"X*UP"6BA-41&A'EHXJ_9U>\NYX9)DBPWKL@
M+?W7]85K-I1Z&2BCF"''WR"NTXK;+(WT&E<6C3?R8+%P>-AFC.-YW:[#M'$]
M@OZMC'/?BD,Y-VS =)[R-8(4.7868;"F(M&KXKYM/CZP8:/K8RHEMF24D\35
M?-$YUY_#,N,Q$A&7B=2:"+<2N95=<RKBRV:FE_/QF>:>E[F=N3:Z8D^^!B.<
M^?D^_/IV.69]9DW6JO?3M7??JFWWYG*#/W%7%>?"+<H.UD5_]2;A&2!L2A^J
M22_51 MQD]3Q?$V^[&--T.=SN2&"7SXK^9A?SN!\3-O@Y^?FS7Z:N[;"BF0.
M>;\%"J:5W.Q)/4U")E1:E'\;$V6 'K5)7?<I<"S&#0F][MLJ$LHMJ9WPQ>A+
M>>N/\J;4FJ</ND0&#V+-><Z$MY%AA6.+GIY/IKJV?))7N[V4,N_O"%]V+'=:
M& ]U=.CIL,LG0&U$%[]J>MIU!C;F8VYI+4KA(4.38D#*JA9!@.U,=.U@V$<U
MZ"-'8=7!$UG1Z]<&.,U/)%]@U8P^#(_.9"5GT%H8H!!4JM>)5EH^PKD"L!A8
M!D<*+6V?VW*_,YQH;A[H%[+?5.3]RMDA66&UE0%J.+2Y*LHS<_)\;MWZ\>D,
MU]9N$YWI($VOSL/://K+C=^DMBUO9=MBE5?CSHK*NP3(PZI<>%%5J>WHXE/7
M#RM-*,(MDNL(6KC;E**-G&IWJ64.JX!ZMEAYD.3+9?7;M7+-5<)1GQKJ'G!<
MC)8*1XP.,$!M:$(-28K\G#37)Y LV9X;HW-^I#RDXL9V^^E1CO00]D7ET@W]
M ZN+B:9=*$UN%QV[S)^/<($N&:K6BU;V#@X',VO=?E);^U4%GO"0B]+<Q=;B
MC\I.36<W)08;&,1F'<.&Y;6YS'F8Y/>F?/OM.K3"APG*QFZNH@EQE<A/D%9T
MN@X#)(3=B1(<*!";;5*!&@F)?.Z\+.6#%,V;:[G)?S08.0MI6QEYA KFPOAK
M):X(_A8X8@KG@X:2((]<SDA-*!RYPSN>]:K+S>'..\TKWSBO,D!S=54&"))V
MM>/9S,N6TT&G*!:OH>*:<U'AUF9V?SCU\GWXU%6=GOI9SCJ+%*6TN.L1?\']
M_*2VX](O(]X175T8H/A$0'N-OPBW#PZ6M!M"L05S)6\.W;^1GZ-8<=OJ\-'J
MI4_OS3>NFKCN_8R&$S(I[E3H%%([<*6Y<?<C^^OH6N?KF1NUD<<LR4XGU%_5
MGE Y<_R7S',/'G..",]P_#=1Z>;KX[^#IUN?BB@*(!UC5=S>CM,D\[KFOZ=P
MKM5NY/3?VG&LB39X-X+\[MT1T>F8V5DM1;[Z-S\-Z(1B]<A]M"P3#2!B --6
MD*:3+0+X#'VY;>,^(&(&2[Z<DY>ODGJFP-PO\D0MHD*V"-W!28@DP?HPTCI:
M"XLXK?16.%=O>1#?W^RT/]_-1$Q@G:^6Y#HMCG-/Y"GD@T*PEIMHJ?5K=YQA
MLXFX\^$9BK8.5L%.LQ!8_A?WZH\P^9?2W$6SHXYE%RL-!NK\]&<RBJK6CBKL
M3WR,[I%<[UD>G6U;8X!:480  28=B6^!>1$GB?B#$5DMDEQKX;VD@.CVODO<
M4LLN+HM/&K.?9I@/Y;&BU8&P6E2_N1$O2<N,J?>.;:%$NV5JSA?1S*[D?])I
M?_2&?^+4]>QG+_9X"UQ863DK]['3?1AAZE'*#4" W$H,&+3Q&,9ZI5>:%+W^
M<9^/ _:J6?/:^9&S0Z*="H*G^1!Y[W6S;@U=W[6U4YUW=U89USTI\<Y4[[B5
M=>$=ZU+M5J@M+'2JUW,P6EHS0E*_<Z;6_-JV%8^NI&.Q]^&M<X?*O&,>7AZ[
MS[=1S?L$BQ?(+W]EZXB ][[IG)$QBFR,NMCS] JY6:9/</7HN-7YGZ]-S=GN
M*F+X&: @-. .:=5+Z^4%S/J]D+FK@',D2E3&^CO%1SKN^2VAGV;<+-YKS]!9
MSP^[<*48D@#9&7 FH<BU0 I.+5L !A&,7.T5)))?%H6*X2U#?5VBW[_G"=!H
M>Z!X,]3$;[*#/E8J2 3OEA,]+(F3PP+26W]=TQ#FF\ZS#%"[[O6RTMB:II](
MTL.XA&#I /7C#)!HA._"'BSKNKONYIA*C6UKH4.W0:6D0U#MY9D.PV;;J2]S
M%BZ1C_TD4+,[.-RDA/YTN:BRFEV^=KW"='>>VD^U]D8-N,_2JPH+2Y'SI_UN
M/39]+Y>/,848\*B\?/ _%8 P^2OQ((,!\H,N>EC0&G[;'+'^*&#?E1Q4>OJB
M^H! RS</;12KI:!Z!=&Z7;LUC;+W>J=0+!4?HA3'.51HW%#F<[=(\_9^R.SU
M2JBY.=MILEQO;&HXF$!E"[I8W5)CZU##[4YMR?JTY-+X:RM.F9?$^;?GF57=
M#XJ5\TG5R).Q$1<]*OX:BZ_/ !-K$*JH^?1EDE8*%4JT=OZBVR@P$2SL2>RM
M]HN OZH83M78B$$Z@LJNB<9P6/M=Z9=NI J'CQ^L-1+"\!BLQ;!DYE,]>]ZB
M9ZU?.YWT2NX.(R]]6A,)*["9WQXWAFV_98!NK2PH:3A1/)&L@4KVE'8=/N])
M6KA&B^QBV#4=^+PU&4$<'?40R$8*$7<+G6FI.7-639'6',\?OWAZ.3OG@<^#
M"LT[][[[]YZ]H3VB7[PCD#DZ6^U2<C[-ZY.F@[5U1&T5;24]GQQ*;EL@-^&S
M> 9]HXOY/<TK)?-.O8VU5!GK@;\_]"WHJ8LAW*V/79#$M'=0"U'9F%T/]"'/
M+SB@L$(M?,0 ->7_8H!,TWK325K)K>#C6WI(<9)Y[E%R21QWVL]/.#V%]_=K
M^?$U "]N\B%2/!!"3*<:$=M*LZL//^K-[WK/E_KX1/C,K"*=R<[-P7_TJ_(#
M*][)6]FW=W3E[6-'AZ<^;3GBSK^S3M\LN3[3F]^<6;^\\149CES!M.TR0)(F
MZI9$3DN2SU8OYQ==!UC]MN#0EZ*Q<H2UFER$0MB;D_+2VIKX&$],>>1&%+2I
M<;<I-D*1L-F'YA]3_R*>;]'$UB7\Q'+/LL'DS%A+!D4K2YC510>_@OGX<=_B
M,&[I-GWV-04:T1+_J[L@Y=<IGS._*QTMD?L%!4L%OV*QGG$E,J7M/=FJM&RF
MJ]R?S^TG!:ZTK/2ETRXM;SL1?NW]3CWF0<E,;&VY<D'BI-T+$ AT7/0[-]X&
M3#9C,D,I;/D44*90B$S :T<9W2^_L!NO]D;Q&.C%DY=^9]I9^ME^BY(%DB!^
MJ(7ION63;:2 1!/^0/=[E7XG8ZT7/4XW7YJ75XV]<X4*"\ ']#<FH21TYEO1
M:;*LTVUO0^;;,(LWV7'*#:/'?3]QW#$/^Q@3&>UC-+3^]*3!5-)MW2N?"A1\
M:WY6AKHI[3=TP-[_"0JS-4O^&":<J&:;K%1<YEKJ$&E0L3\IEM?Z9>P0+1HM
M[S;-U$> JCI$B"[S'&ZDAR/)3 1[6<L](Q#BU7 /3ACWLYCVJT9D'66FQGZ*
M]N8/5 386R/[$FU[[W[D&,&=(+E4R^)#_17@CW8/,QPV-QPFWLBSJ4PNKAQ%
M"E+/ ,858V74TT23DI<>5W&;UE)WZK7YDQ;W#60X\&$W-MHH<O0/O?*SH52S
M!NHQ(FWI#^U#@7B!TP)'3.4]];W1=^J6RC-SLLH)+8??(]^TA@EFWK[L=JU>
M*T:IDBP?$G.O9Q?;N5#R-E0'MQ4P$^9,G,Z3UE69+@='CNG3WGE-%,6Z_S T
MGL)!F^8(0A0>JFS3%Q,^A-)<I&$)##JC00B-M.[AOU;@T)63&.CY:."$_T##
MG1>E%2VR+6O*A'VM/CML\-PJ S0,3JFM MPW=/(AHNG/%8/DHM\^O=3TVZU%
M"G3]044&4>U+J]8"F!Q _-01@(<(4(6)M$I:TH<H,5?[ZP^(XQD2,G;>7&QQ
M:N5 -C$75S!,4]2!I/9R3D=V!3YKY4;=EBGSF2F/^Z[\SE';JU=<!5]\[NJ;
MF5K'RO/AZ?&)8/FT96''KM;2G]D]F[5&"*^(@>BZ'_A:AWH747E%/4=8B25!
M7Q^KES9E[K6?_PAP)8^0&*!$!NAV-K:QSX2=AF[,:M)X=ETS$G9=QL'ZJL(]
M]@>*<I<U/8Y_7U-PW?(+8X#X3$ (<4#3/Q<7-1BG99Z_?F\R L;AGQ-14F4^
MD3>I_TG;,RF*N&>9,0'#-SU;&'%N.F9[(_65HFA@99Q74<>[39)F;/P'(G!#
MC.-8)I^1>[:A;7AX5.Z]*5BS!QB-(CIFQEH2.PA+JP+".U^>-DVWQBEM_QGR
M(P_+5H?OW<NR&Q=@K8^=HQHUDA49H+)>%%6I 04LW1\=TEK86<T>S@R&"%$M
M 9\*F"L16]_JZDHN6_+F^R (OO!IE,X&XZ4?;R3;,T OV7&-5/$TTLG'85[0
M(F^209R[4=[FQZ"1D%JUNT'(@"X3.9STJ$H_+D+2^7#++/_W.EO)TLI0$34Y
M$-W& /6%P%:1+:3]P66Y*.)R@D[^P5GCHK[]\R]/)QV[4/D\H^DU6;'S3^.G
M2>$?8.E>Y6\P3 >Y9'71,.3<Y(C@Y'IE<VO0B9O.U.:W^3I^J0H1!Z57BTN^
M(_-0@V?HDVO]:&+#Z$#(\4 H5HGZX^+< <?F33N=ACL>@:PF>9]_8/B-V"NB
MI>BBI<]Q,B8" D66&K;9,LWI$;R;]T6VS$)O__T^57JG*F+H<R5?9/2 #AY+
M#MKQ\-.XEW%?;24N<LK7R//)G=:=:WWV3]<=@R"!LT^CPJ9C)FK;VJ=M$'JC
M$##U#,62Z85,NJ$DY<%*[T([WF^#M4&XG[.NP0D(B\7'X[&UI];T&Z69\ 6C
MSX/9Z(((J1FZ%-6-9!48=>YOZQS9Z9O'E:FE@:T'22KU!2[FA_<?3V2LKFU!
MLJ!,^_+ B(5R%F'VF<Z#.-WQIFO6R%#5.#_%?WAOZ=HNB[#B?*A^WZ12]R*9
MG_;,"+P&7KBG=13Y&<,^N(0%\G]Z>,2AK)_P/LK)U[SVQM79VU!:.FHXYFVW
MGK"F6O_XL81&::.G%3,E!B8P&$QG9;AJTEKG_C,C5UX3H9&1L%=O?@Y='E%U
M<)9[!Z_<J\AOFHNLGS9:))_^ L<$3BZ"\0$CV?P+DT$OEN:WPP:CU'UO-2SZ
MJL[3M8\'R!>''(BNKS1O#JX\E(S*0#@1Y\A50"[>CC48ZS=0V3&O>P;&ERT1
MF6_ G4J_>2_/B(-MK1UE:R2P*L!&U2;^]A(!4#B8#-@V*5VQ,JESI"C;19_R
M(6Q".O?;G#%)C1P$\)(2G#SA>+N!>GGG7F=>\H]Z\H?Q\VI7$K59YH]=(%RV
M$SC#RYU26*SJFKAM&QSL]2FT_EU^Z<_UYG74_2T1JL6@D;]<4;5C"?= \8G5
M-<*)&F@>97EGHVO#4VRRYI? [DD<>B$ 2BO_ Q6D"J?C=>EE+SR^<<[]F>@*
MNDMY=N-0]<-%A;)BOYPKGT1R,RM<H+NRKU&K%6#QZUD7=]Y"#H[']WXB"@Q"
M00CUSRG)2&D 8C=UVVP?%F>RX,,/C&S(%]QF^25=>OXKA!<A"MBM9A_?!@LB
M%%>/ZMG-_H'J4:R=VCMX=4>?G\BW^;@2\<IG3VUZ@!BJ+"#-NQ%_-WB\8L9[
M3?Q#?6#]O6G7=^O>P!SOHWSC\)G@-I4O"4^?5KSSW%>N^MNET>BSMH*=I#OF
M$>=H!'$&R%JQ'K4(\:!E]\K1I\(0*@ #M+HB%.WJFK;@8R=KJGYG@/A42TC^
M(/YZNI]><WSUB3S0VG8/:K5Z "4";$S@H8^Z6:J687^C\L@R[K%WIOO7FWRQ
M2^U-"G%!*\=Z^1"G@$$?,30)TB?IU2$M03&$NB='1\SYT+Y/(H2*'8>(R2:5
MZK=]5,/)?_(N2XP6:I[RR/?T9H!Z9%Q-<6\GM:I=CZSSY)!%/)55+,VM;%8*
MC14P71I@S^Q/-O)VD!84P1AGQX]\O](JO7PFVW5&8WBIO3#)^\XT^[E?;/Y9
M-YT4WHQ,38Y?T/U*7Y)E^XPX14%B@=&UH_2F*L!B6 @[_G<D\Z3EBTOMU@$J
M%(^G=UW\0"79?8=)<1CF[ P!A(BQ#G$^N,:!C_*6/7=5X#?;E_2=OE[*SK>/
M?7!!]]W:?O(R"*@L0Q]%7"8BT?77"Y;;_R:]?B^$Z7XGX;+SBT\6-I&2$EV0
M>VW0JL)'V47W%ONDJGV833AE\GF-TF&OR_R?:KRYF,%7]6M!M@[7*JTB$#FU
MNDIHO<YW3@G6!<B.;P#KJ,D1VD,M$_DMR%$CPS5TF@GDW=<2GW@;3K>V=QXQ
MOC=?HWM3691K;U)?\%'NCQ*6\) %"P^@XP7U).TE@@5O<WYS-ZRR('MW/4LQ
M>>'7>PBD.%W)C"/[N^*CU?7>5 !&T:&R Y#7Y]X1%W%>.970LR*4N^<H5<Y&
MHF[2_Y&F\0X,#Q[ )#- 8G>3/O<J1LO;S!)\O*<L7KG7)2L9B9D;E8U*.!Z-
MFEK]</ML]V4U^TRKYO3U:XO5$S+EREHQRX1?<'%B:5SHN;Y)W4'GGABG2@G-
M  ?5XNFV=5%PI/M8^'9%K_PO[5$Z> KC#TY#RG;3,E%!,53G5\%1^A2Q)REW
M0V78[,=]?&3Z'K<<313H>O_==3NNRW9V:TY%[.*#]Z_#67T>"\R^M4M!-Z_L
M_B&6N\G* RABMOET&QN;!2*?[COE>W,WAE?D_2I!7G?Y??REP FAMT)Y^G(]
M7D*X8@M^FK>SHLAKG:_Z!OH7QY8_A72-=6$N3\.5,Z++CPZA73/UQ\:?/,FS
M?'7J$\%]F]M\RFJBH>'O,@.DNJ-,EV(E[R0,UM!S5M$)HY]Z]T67&SP2C;/F
MKMXD=SR^>_^G3,0@\@CPG%1$?CZ+-% 0WB[DR(Y&:,+W>-J:AS?J! 05PH]X
ML&1UD:@!D%#$24"&.+EJFQ[S@GJ6^.MZ_RNH[OHOZRB-H98/?4<("G4?HEDS
MUFKV(CY176F9&/^5S%XUJ!23JOW8R;5-+A[OX<H=05\O\"C\]+ST#,37;@N2
MZ!N.B4GAVKC^3:Y6SS9RW=%964+O_6&9ZAW+GQW!8;!\TM>JW[?_A.^=G3BM
M/VK%4W&:5,US=UVDY^5Z<;"M383B_6;'C=96&PU' PR@1&_!&\/)1L3*R53E
M?-=T@KV[M8%BX;+A\V-G<A<N8(V?NK[["A$ 4&;$JI0@7./1(/OK/\BGU<_=
MN]>4F'5\YJ;JP\\LKFJ$G\4R5[O4RI**WY7HFVL<A%E"B2;"^B/3'UJ"@;<6
M^;K*IQ07+#O@0RHOTWX+Z#.WH/\__O<)ZE<:6K?''PZHHJBB_ ,A7C]6WQ"C
M!LM]>&^<L0Y?%NSV/Y.!.WM!^?C81J\64]]X49DB,R&D.X;"BM F11$PI+F!
M.PB7WL]+5)A8"\5TIS/DRU+<2WNV_,_;.:/</X=0JB\S;JX5SRTRB5)T30T"
MJ"I313:]NHCYU:)973B!E-277F.WY(9?Z2"%NK-,6?.&*F\DW4S$/>+DZ(UF
M?J -?1E%O I?F*1SSQ$;5PL(II0ST<4 91#+ED]7T@.W(&M?04I#_<.*DMZ$
M:;T?>^_S _L 8@-9+4'Q,4"W&*!D5(L2.H0!8B-]K8L$)Y]OJ(F)J]H^'Y"A
MI;L86X36?O_6MZO[;:GYT&,157!PLR#(H#&B48K&!,B@[ 4,N1S0A:1C_+)Y
M@@N5DUI#PN/4*'I.1-VYE Q7.?T&A3/8;X/"(G+K=L]JVYZ]'5.=)UO]KZUA
MXT>X*'(&TYI-*"']PO_93\*L5OP5V'U'3,&Y#JDUIG@)STA=F=+4HGKB8X_C
MX\QCOL^RGFB/=W-1B ?QO3CCS^;=*9"%:@V@BL3B1G=%B;!^"-C([66T,KYC
M"),M*3Z8?8QJ3;S2VIDL(T?>N]FY5!S.';):NK%\?,TYQ\VG</,DY_L7K+^5
MTJA_ $\*BNI(RS4!T[^6<@&C)$Y7 */7EPW^42H#N#4$YY-K:J/;&2#7:?7J
M-Y^KSH5=%CFPC(O._ZAJ7M\V>#8S<6Y^I1G^T$0;<8Y6W"V/$\"JX7U[3Y-V
M)2]:KX$%WS^JB7@U?K6ESBKM]1OSO:E+9W)$@HJ+G[!L/76X#$*,4I#(23#1
M?N519WL.*9;.?4BY[1[-ZD6<+5+%##) (H#+48M!NEHN\D_6GA-EYVIV[L=$
M,1 IX7T1G;N(:<^Y$\@$ (8_*H\'#[[K9B=%X:I:$1!2+*[G>__W*5U=SMM-
MYU"Q0>=K+?G*3SZX*=$N!K%VW8121>3&4*MH!HCH#'[(=&L8GE?-Q,;A'D=P
M @,DO9:]G@9O6_]M8^O5_Z)46^K#H)S(E7Z6=R":R/^"KURPDG[1N<LH3&/2
M;UQ ?D%K-9%&]9MV<Z]JH/ <N:2U(<F2Y.<D%[6@M3=$__)V^A?ZN.&W"FYM
M&\.),"X^GB&9Y&,]172N.*(/KH, 9JZA?A*Z+SM=5B1]%,6J!$S@>PQ7">BT
MJ8:U;J)G;R4#=&S4O$#3Q<#11^0Y7ZF[B'SPVBX$JTSFI:5A8)EP&Y(>P9"B
M%BTP6IB? RZHVC91(7[L61H2"M58YU:X.*(QA%9_DO@DS*L(-WD4B.I?!C<3
MT8EW>374K*9#'!=MIW46K\4OS[+9UXB$O>!Y]!K$\^_LD3WG1L 0 \2)T"1R
M9B,5@U'-ROT:LJ,XNUW#U:78D<?1L7;M_FTDU^&@NZD-+X7;W1J^OVE6]5S(
M>!EG?J;D,U\D^@UZ5 N+[EMI@_:ADZ'"*%@]?$TIFW(!.:E7:D+BN[_QO.J2
MD=[KOKL+[,,)UQ<O>D]OB.\?Z==ZGISDYCMV$[D%W")JXY3[T3S;)MQ T*J'
MAO;56=TBFH=KN_T76N]?<D#I'O[>XQ:KG^]WK[\S8.-_P#)"_\@ O8'LAE!.
M1J>XDJ"[4Y3S *P?F_^.*\&AYXOZ^/N0H<P3[1E-)I??WM,\D7W[UCO>QRJL
M<Z^8:UYM?1_0 .]^0L'L ,7-$7BB>US11)UR0O5LM\ZM]WF1-H;BY%X/?N="
MC\AL^=;$NTJ]954?^5R%='N&K$B=>7<CW]^,/I$P8\^9SIP7!I @9]H;!NCF
M?B*Z=:@CW7@SG<I9[;7#_VQ@6TXTB\0!Z0K/U:)RML4Z(^.8Q[_[J#6(6G#%
M9^]Z1JG54EEH9=V>JQ-<BK??3 ]O+H9\EZ!S4FXDV2$D:6POCJ2I_"\*M0D3
M'>0"A 7)T8I%I7:[=V#KW#C-I_I*5_4.H&P*%@L+=DT-Q9H"HEFO:VZM;FJ.
MW<"/;K@AG5,B27D^MKQUA=;3GBM/9OZ<M[B;:=W%;G_64O](-\<:N76N.^BE
M^XX)UYL4N]:>=LNR)S=L3O.]6&6 N.3UY3G9A K7VC!BT45#65#/N8:&YHCV
MH%2'WUX)1-'#6?CH6[X682.=4U:1)[YYTF8*[\$\>L 'ME!"L?J/FJF#7%>[
M<COX]B@K11S08D[@E@"J*)0\.$>UJ=0M&,Q.=44*D903=?OE=(2W3U5U2Q9;
M">9K;>SZ_,Q@F9F;+4"WN@Y*.5XZG_1UM/O<;<AOX[9?'T5_7L\^IIV*67)*
M=/V(^:C5MY$?XDD]);]L1S!</??X,G]N[1EUD!)7'P,TE3=LR@0]$>#425Z]
M9(2=A+'=?/U[\--#FMID/0.TAH<<C/YJ+%;; =0@'R*^>N(+$<7MS>W4.6K.
M4@$^&!_S[J_''Y,?7S"A^PMK#I'6/;'V39.Q/9H7.><F!#P+F/09J!7OI1&9
M?A% EX_)T][[=U_WA;^T;,M>AQ8_=5V2S?F;)YWS\7B^A.C79.>GWX5V;!L_
M"G A;('45>Y+I7RDALJJ!^'>;5U^F9CEJP3XD"09E8(FVF-2):4L DB\IBUS
M&B.LW_K8VT:,D?8.O46N.Q? O@Y>,<1&<AE@2 HK;_YL=$5#EW-$I^<JE[_R
M5+C5^[BGN5XI%]A%'/Z+<!V#M@E01<7=@%C*E6_(87 3>K<<#\Z&BK?6R\FX
M#KOS9S>Z;V'MDC64)!YLNU=^#B2LY]D"N&LQ$B:W^1I6!>H#&Q]C_/8!5;MT
M:A3%'DMG<D[[W.[#>J8A:ZS?RMV1Y?VRCW *:@R256EY(*S?-%/O?,P2;^^Y
M&O@UCP4>7$_:H?,TK5G#L=906C;FIM;\Z!"X52"[6Y1/B\0! XNX!\J"B8,?
MNEZVO?NJF?=YZ6SF\J6P+A#7I^^1]@)-KQIS&" _%*#J7T-2)N>DDQ5IS<PG
M(()4-F#PU0_MX%)QXEY;PR),TC5U%\_V >M?$RRF]ES.WNN*E?SK7PEM \3.
M?:IH%[F7E$*P(4608;0<S.K3OW/#T;T"T6F+%B3Q1X3>,X&%JCK3BQI#OF:O
MN!;S- ZL'W8\.<L.BEN_C"BC'&?B@R/3J/::1!>136@O,?Y:HM2C  8'Y[/
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M'UZ[MH4)GI0$/VJR88# \@ZP1^VMSP_?>'.W_M:_?5=W&]-<0#U6AY"G53!
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MRSM@H$!A=-;')?B?Z[NS,4EIKQ9OF]Z<%OW%M>KS%;7:+DECTI-A8SR*:"W
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MRSX0?U7I4,6B%-0-(4IZ3IH<S(2XEGH?V"LOP%.]+?-/<U@:6VN.0O9GE?O
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M E%##K6;_W1GP)(0?QJ?80^4O_,^H"ZL;B$L9?U,F@XKP3&.XQ0Y,.XK]%X
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M*$8Q]*AKH_>QB?3K%8:^+2[ZFCL2G4PJRBQF!EYIZHHWCVZ!0K9 #V$2=S"
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M\MSCU3&2>?A=52C4V=S/Q389DD4^>-$R/Z5(^7&49H9?$XTS6C*'HTMN@78
MZ*\S.X+7,!.KO??MT_3/92CDW.]R'CXP<?1)"C@M)R4Q[Y,EW]<B60'<?+3
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MQ;EO@U,H%<"(ZB(=%U5QNSC8Y./V((N-'[W9NTAW+^D-H@]@.JQY^WB];3J
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MP4''F"NU@U7W I\D&NB_(V8]Z;-4>SWF_Z^+1/[_^+\W!+8F_A-02P,$%
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MI(P&*[^I/=N="(&SF@_9!2_G5K8.<,AJW2 (>45.<PK+:>/DB?]"^P]D_VO
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M%[4NK2J8K6]"+*C6=-J5S%M>T1?0:\ZNO9QL?2_YUGA$@YB>[8BX%;:XA/A
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M\^"NDO=3RB(C;]ROM.X453LV6!1(UM3*C^_'7M2;6PJ) TO3YI$'!:@4]'X
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MM.@&-N&%^UC?MT4&T^(*:JB\FR'V15AP!OP^-;/O7/T>E0RBC72A.YPS$!)
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M!W[K R,NY#%69:@B-+X.RL4T#0_S"Z7 ^GEG5T\V0A5SR6._9K?VVTJ@!!_
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M%MG_4. :>+75=<F1^_D5T]]26"<LQ=:(_#+0$ZU'17^);[1!AS["NAH^4FD
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M41+(,T Z#=M%APH8B2*T=T&>XUI2VE-^4TC]V6:7-PE100,=9],LN7)9F1Q
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M=YP0_4*17+FT^M48%Y?S=@(RGJ;UZ\+]=]DMD,%@J_^(D:[)1U.P[L#1CK.
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MHW?W8I\Q)YX\NPC10-014^K!";?!S97"')CE961"W6"14@H5M,DB#[Q+9QR
MO$B+"B:=Q2J7:?8TBJ] /1/TJU+$$DX'O"SUJBQUM,X&#X$:$!JM+(!\"_8E
M#,)!,[@^(G"+5C(_8&QNHMI^WB<@$!JJ-NOQYJJ[3N_]>S;?'E8))!AB$8S7
M+& N UTAO^)#"AJ48 ZP@*K9..* U^X-$UU/C\$/34W&<M(I(XKE>?'$NH^W
MOG5;Z11GXA1ZLFF3<^'MF)>$0SH0BFGW+$_-&/+2G,1TXR#7<J)&A&;]+\^L
MB8!H3B#UN4'T+ZZPLVV+3[6+%7*>\ORG4IQU=!S]OEIB%?[Q-ZK'19EIM=I(
ME7[HPB76K1'I<\/<D,=$3ZO?SWH!1[]:R *L[%G &PD6T#R&[C1";SH3MN-Q
MNS.PM^A.Y?G!';"YZTO";6O\9@&T2"2(>I<PVS? 1#R*RC.#I;  RF$,PR:
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MRC$6L'D33 O0-20&,@R[:V;PKZ]H8P&'U5B )1_S#GJKE\(0HG((HCO)(,Y
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M5QDL!V"_F#B$IO1!B9>1-BP@&UP^^;<L8#YY(U1H$2Q/2XA<%G 1 :6+P%A
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M/"(RZM'CZ(3$9TG)*<]?I.;DYKUZG5]06%167E%95?V^IK:YI;6MO>-#9]?
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M.D9SW\LIRN.Q7T#7S)3T=O>+IO99];"XI!J\JH!_8+.X<L=C+9M2.[?:H+S
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M4QV'T4VJGS" E>NU#*"_Y(KG/^S]A,D=5,$)^GG3#EK,"=CV(7%*)N8S%,)
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M+@\-*,32?;U /4D#OJW#\+E(*1J@CXZ'@@$40QKP:8)AO<'V&;I;%32A1M$
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MZ-ZS=FZ5&)K4H"A@Z#&0S>OQ\*E&!<=Y&</G.4T9#)TZ_MX<R_O]?ERH(1K
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M"_2BO6/&QNS)ITB1,.0'U*WFA9]Z$MM&_+O[78JX/ECBH@15CG)JLOT\4H$
M8QYJ%5L\+/,*<2,G/9-P"$-J<S6OT(!;[20]J-ZH$1\]I?U[8OL,$4B]FD>
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M2D,? FL4]$$8:A+#&#0/Z\/R4H^"H4;@H]!0\;>7VN21PEVW'R=ER_5('8+
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M-W _"D[7CE96U\<FBI:V"K*W4Q)_NG1&+MS;>J"SW4E&B\.6"A:%=>5_4(5
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MOUL+GJ^^^Z\=!OKO9(!DDOC+C\E#,'<U/MA1Y[A)O:4RX0\U.%8H>S(GGK%
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MN6,3-6&;7$MPG.+22G+!J>D&5H%QJY$)1NFR#@]>YH_*\OTJ/5U7EX[PLV0
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M\D]VR(#[W0[N:<@;U3\US&6&XS<S*,;QQBA[PW/DD/39CU]#N1'5:#B1.^E
M =UECQ+]@>;VF>[^ TU2;<BB :8-,CZ=+^8OD6*&V5H7+AK\XDH&@"K+.#1
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MO(PV+3_D9A-9FH"6!X;"4,8Z ^\#^?B(;5&8\:Q4V6KIB6XV')P8IVI2I?\
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MP,I;J9<-J^F XD$PE:W8_X'YO8H7H"XZ8$WJBA]6-K#590JS(['1&D69?L)
M-:(""'-G8H@.6,Q.;]JY=GH#2C"&@H";P\!P.*WZ\GFDFH$G&MC%WR$_XU;5
M! ZLEH_?%=)"<#G0 0=$B2)(XN8$AP)R=]93$OE5>#"<=LC@0=4Z&J0]2XVY
MC5I_-,@]H3&F;H*A?@:MGY=H>76ELL"=[ .?"FK20MQBI? F#$2LUQU4NDQ[
MM7"'#DB_5,[X@N-9&?RW(0,3FG<E<%^2I6CW8!I5#JJQ&R#<WCN:AZY4%*/G
MD?&;TWQK=8S5&H47T2HO,?38<EW^@9PCPHH8KWB3R7&RE6SM\Q/9IW\%NGLX
M[","FJJ#T(C!'K%[.,+%,_\!/+L('\F=D*T7LR\*<D;.%V=*,S;Q8M$II*O1
MDP0ZX.OP]5U(F@\4#N;KELE4B-T[M!J7I\1&S K=KVAFI*'[X3.!07Q3_+CR
MMD;]POO$U^\8=G,UVV@FI$(6Z;@:NOV(ESCSE/$A,BHC0;2G6IZ=<JU-^*P3
M=( ;9DTUUC8DL\E"GC8&GPG0Y/M*\L7[/J%8!VYI ELLY$K\/[:[%GJSY20Z
M'N,?+C14T#FW LXI5NM[K=JIU+>N?L>$3T!)V*6=P3._?O\/.;@#SR"'1W1)
M8*</3A9MK:*PF]+>=B>*T[)&NKRW'!S3/#OR ?4IV^VJ5QNNWA <_\[:QPNK
MAS)YN?.1GFUQD!+MW&4'ZRH3OM:<S'0]4UMSU4-L;DO[UHL$P9V@8&+]* ,&
M2J,HG 1X#!HT?Q[7A.+U.XI_65D9JWFYV=C:\K(WXBY7>T^6H;9HYX%1X;B7
M@'WC@*!5+80'V8W"0^!\1L"UH*&#[INWZN!*Q(I$;^_\]K$K+?TR1ZZP74B[
M+.(J"3#4!O^$VFD3>3-+NQ_C6DQ^&A1]CMV1K)6Q._M*I*FN4G)'6V,V%; 9
M\+=2_GO4#Y3+A/-DJ[XR:'2J?0%727G"Y+7^0?8&MVL_.$L^5S>=.RMWN9B%
M-;^8?4MK4!G$3A$@Q?OB@P1N#:)Y+4>9OWN-D+D\/943U0NK0\.[!;6?QG<0
M3RI&PT88 6O6/2YM8KL5&HT[?)S$]$8VMB1WP<7CPT*J]O-=[_+WIXF98\7-
M0M;%NFU0+YY:OCZ*,TF6Z-N0C!'5L'>K._IA#GTB9*)83EZR+M&TLN]Z9=+A
M8^*MA25+S"+1;Z;PZ,5WCS38MT3%)$"EF6'02NV7LAHH4A+282?#82C0GTQ:
M5UTE9\JI;'<%+O^I3G?\=I;D^ T!BYCL:!O7KGX5!DH%W]H?]S752?5CFK[Y
MS7=5G:LQ8H#>H>3UUC%0A?="PL*#@F"M4JN<?+(E0K)G"@R-D9EJ"[R9707:
MX1"N=1H_ZXT,US;J93C9Z9>4$_)XLZA-AB,J8O-0KS?=1YHF#%_3 6+8FN1\
M.L"F@A.SJ^CZL":3PFO;8*R-&Z()8XOAE</,9^*^7AV8ZVM7U,OD%(,KNW]K
M>VT*[9BGW(R@,!X'9]XRAA_!(1MT[S7)9CYZ(=9K]"&3RJQ%=4GHAXZ_R]!(
M2ENR (8O/]_@T5%Z'RRN13.;ZYO0& [LTQ_4W[B__L'#WI3C@^J\P.[[X- >
M^*OSE<O=1 ?CA]^=!\\[O"G[&/V8#D R8<$%P0,@?N5R\=G6X9"X7>^;RW3
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M"]9%F@?K+$-"B^=I)WN6E:WE5L#+D)6S,JI'*J:])8Y%8> OH:6@9<T\"M<
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MN=PQ,O/B6B%73,<;2O7*PWV;6G]VE4%OH[J&X)PJ.!_"CQ0X7G)J@ )_/V+
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MJ8-M"\2A54\7\:L4"#[WK 0D)GC K8TO@+@H-B1O8GA;9AF4(ADPVX@C&5*
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M5[_<\P@P>:AS\@5,18I#7TCO!KB5Z& NP&?):JX\I]>KLS3[I,[VO=]V4T7
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M"#FH<T6(T*MA7)I8-?!MM+ZCG_N-S$>[:]\=Y-3:#A]JT]K[0GCHC?JJC0.
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M(B.E!SJUADZ?!/?_;/ W;$4@XY'I7>*</&+%P2[3;JF$:?WS+RIAZM#+A]E
M(J$)1A.$\KDK'NEHUXJ@6!#791BGV<#%62Q3JG>UXL\9?FQ @CB9$I3!:IH=
M8VY;9;3TK[RE9I#<;AL>_)[J8!6[:N'99R ]Y.YHW/NL_,JEM\<OX8-<2@B&
M;" ZE &5R:>5+5C0_CP;B,?$U%:'L7)L"$(%H4C/"9:AH^\8O?3=XB0FL.4\
M%ZOJ\U-$(5WC\K,:0=2R([VKHN@K%NYOMP*5,,$U$/*8D4\"&Z"4OF$#,HCQ
M4<@0J'9Y4\=8$G8(,C*,#0@/LW+&UJ&J^ ;&Q0:V*;.>(]9-V4 5OE-.G"F(
M;7C'@A+OTS"9R-A;C&W&@8'$.L2&+#J0#42F=()=?WT #^,P?N,!E*8PULR_
MKH0IP]1G(PT[Y<.:A%$YL3-0NWL?2\]C4+N0GZ89!F,D/'-KC0$;J&^;9KC_
MZA\858XX T4UA4B_AVV$=,W#L:"0+.0NM_RFO7AGQ));I%BQHL;DV,"XJQ]+
MZV<+:T[$PZ&Z[[@4>7,CM[3\,V'^X"L+AY'$Q7>=122B +%7X NYIG+>AT<V
MU-!I*) (?^OM\O7G;GS^-W[ZQ1.,%TQ;,/,NW>6_4BG<4#FK9N WIE,6L1'8
M%1UPD0WPJ^&I3X1BOA%>_<;!/SF1:R+D7],06![[I4FJUOA)7>WYJ@OXS8G/
M'3UT.A5,49S&LN93#_)? $DACP0M "MCL5,<_R37L3 VX$ZXB2\E-O#_L*(<
MV60A6S<JV6->-%I6?&'+)<$110]\NID4I>2)FTM]!*H-X08#U709HM,T OA0
ML@X7,58.%P5?S?06^T/-2VQ#>F9D\(OZ?/MG%;$VKRI1%7S\HEO0*NJ?1 _#
MC+O.N\WST(W0XLP40Z%9+ SA[G,G=8<X)3K:^_9&3>6+5%6^5+Y\<2YXPH>V
M ADU@[)-I\PXWRI=G)&V/"(M!I3_$Q><\JPJ?OCT>YK^:.6+.C=7-Z[.P,"
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M;^93T#Y'%+\4W,<OH:@SI43Z8=J_6_:O&1;U?V79'X;]IUTX0)"#C>4\#F$
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M(>F3IIJ0KF-N:?;RT3;AT,JZU? 9'"'US/#LX(;\%TG/ 56WS220_9[F8P^
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M"&PVJTFE#WXCQTM+R3\^;6MKUB5#H[BZ3O.&1S<V=<N3U#^1/-D^+8F:R7>
M#U&ODO.W7>]>U=G?>,OM3$A;$-54*JF.Y5Y:64'(;FY[V\6'?8"20*B28UG"
M[Z,H\MWA:X'YWS*N&\Y1W@Y6\@_D)5U_+0355Y\)Q[:T@A$ZM)ODPM-!(L2Z
MF%M]$B/C!A7^HP_ F7C:\SL9D!7+4O N5B\;J!KKT)4X1\-W30L:F-@Y-:M?
MPY:OX"UUAIW.Y="<'3:X6[W(2G[6ZH56<5<B0Q/<XK_7V!ADSC]T:2ZQ)<""
M0"7G4&G.'P.<L>:%;^!^][S70^6"(/Z6WSZ,T)>#-B$WF<6HF0(VP,6P)EO
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MI]35@K,>,>@+/E,W6NUE+M)[[)U$I'63>_KIPH1AO4:]E-VG]\3L%/Q-FB+
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MK(P"A'(ULY0E[Y^SBQ9.3((X-8[Z9FX+Y/QP:WS\9NH<I>?-Y,E6[\&4IMV
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M:U] W;8LGAGN.5BX7EZZ$5FT6D"0OY0@J?=<[$0;,//0E0AC0%)9PC V8'&
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MCS)D.;U&U.82;-L)=/1OL;: J.5L(/4^Q95YUX+UP.I'#\L%6GSRC\_E&*@
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ME:=:*P-[S:J/QGJ9:W<@+SRO'Y?<_:7IU:&/5[BM-)-I0O3C##GF:Z3L!"*
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MU[!ED\]OT(9!I)V3NRV5CV 3D4<"6\4I((8<B)@-;;_1&:)32+9NEU-*#0[
M([87)V_1'7:<OW%9M@?/\^A=E&C43;H7:QRB3KM)L6$#/JAQ?>)E]"R(8-IU
M^Y0LH>]S;:],*E%3L?74[07<C0=-O?:"]R87,J-RI?CV/ (%,M-0@=A83*W
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MQ1J"$R'*(_O<YD^F\ 2C7MN(2.1'6TD<C0$9;J1)<?WPXZ0D,X]19+NU'8C
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M]_4*<.GTR#8IVA8I"GP87_F61+QX/*G_R_MD(?,I&ZLNKZ5AK>7UB15KZ=X
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M33WV5 \K[*32TO=D?NANKEQ-F,G4ED?UI)6/6]4D9E:0,U-5].E,89=6++&
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MO^75AK'?..HOKL!TH8>M8Y8PU?\MIAM,L\'R:[\Q?=\V"-EGY ,5VH1WM71
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M@7*.>#TAH-0!*=^T.38IJB@]?2KVD@GI!VV6*\1!;UQ02F$A+W'-3OHCK2&
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M83%A$=&?PGVW34QTV\\//Y7\SZ6\ GQ\ J)"@D*B_VGAO >DA'G/ A-\/'L
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M<]=/J]Q78#TQ*6 _5]S4-:1VL^P_RA^91PZO.N JI[\:AZYVUPR;XQXQ3W,
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M0,$19VKDM<7Q'QH(U6]H>60+!ZBR>VIJ$43!RX:=H*H/9X=JO ST9R6&91
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MRNG)5L#P92<6S0<[?$,TFZU:95(E3B9^ITZ L%:4383*/7^N)61S.KYX.#O
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MAD5EBYKR Y=+2M7*2_F1CQ>W2KR)VKI3E29X+438!BT^T7+@UHTMU8ZR4Y(
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M-DWHPV5W HN4&F8CIAQWBBT<:U!FFC$,L[;4#?M)V])D>N%I!UYRN7;-YU9
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M;$,W?8Q%Y._VWH)K3HJN-R*FI''OSUY5A-CHR_5>7$.D?DT0#L4IKR#G-+K
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MH XD4YO%_\7>>T8UN;7KPE%0!,3004"B4BPT48H"$ETLFH@H*B M2B]"1$1
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M!V5J)G9BZ"ZAK[M5YZV^E>_>-OUZ$2HX-H90@/LB;B.J$7=7^9!-J)O N6=
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MU!5[ZW^>=9R4881SY [W81)K,978Q17:HR,1L9TX0E$<<BF(OC-#"V[CDK/
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M%G\;K76\[I>%\:OT]TIR2VLB?1^4M :;U5%W?,'G?TKA!-82EX )Q$WLZ.G
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M6&9LOB5T]GK10G(](H54B6F#[N"U\B$2&&^<+.HF-Q&]DQ!?3V_6:(>#7!V
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MH&*W(3EX1+P&X17PX?WKA;TQ4?M:5H!]_ZV],X]J*OGR>!!DAPC(+K)%ED9
M605" B@J(.#2@H"(HFS2B,@6("8"LA,0&*!9(YNHK";L6U@"B+1$P&:)#2%!
MP08"B6A\F(6)<^;/WYR9<V;FOS[GW3_KU*NZ]7WW<ZM.O8O=\F-; BZC,''
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M"6!80,J-WSEWG[//O^^W]SGWW/_Y__OLR3,G:V6M-=<[QAQCO&.$M:!_HR^
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MB[P#[.[]EHL)Q,ST/]O?E(N'(=>!WVO ]ELNI@-AOT_@86$]H7*0]Z(EV\U
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MB->:?G_R)H^Q@GWZPP]S=%#TXV] &7:'X$3\C!\K>EBG:'UI$%O+]TIO]F5
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MIG":RJ3LA?3;=44 \_^_"0!02P,$%     @ .4*96G\GH^K#60  #&L  !0
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M73-GVR@+MB>HC^WP"Q$=\GNUC6+_HHW\9D]:6=V0&L*6<A%$#7#$14CDXB6
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MFQ=?$VZ(2E%]?57.GNL5]/K)>#7B$C!RC!@: [9')<%=@;%(%G.=^1\?2N-
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MPB.TX>7TL&I=HTQDQO)X]767PU*'=,P&I#\)"R3+![[C -QD%%)Q6E!@NF)
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MKOV;9_^:8^'_2Y[]'X[]5[_F #9Z.EKRZ+D ,$ FY<5* O]_F*6B$GAP-$D
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M5?6?>PSEQ<X;P<*6?2!,78VGM2)Z'7 C/%">(>GG UP1EX[]UB?[=ROBZL-
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MKSWU3DB/ON G-EX8NG&Z39XGU;1<6*VJ6* BIK_GUM,:Z-*@9S).<%/P_LU
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M,H;RT)R2_EZ+YJ+TATRE8[;/[5!^_6'ESIBRV):)9^SDOO/Y\LIS^W&?%2K
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M6?X^,/.Z(%MOD01/HO'#9P>+>H+-JK6.^6$Q]66+(IDTZ;12=B*;]&9;$94
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M[CYURCEJ:BE^D2W$4L$K"8CNPF[]_90%X0J)059+;/E\@1L2]"JL?C9-CL3
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M6C%G@3&U"&?ODZN(8]U6*H!5I!O[207HPX1<D<)*Z+E+([<#\-%O%(5EN:D
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M%]\-> Q2SHQ7^=7<?Y)8[^-E;WU1OSY);SG)5.7G AA-Z42MJN*BUV")MX?
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MK"K<Y/+SK-VH?SY-ZC4W <KA(6C<@L-,6-$<,0::ILN+!_"D$BSU["@9CK,
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MF_;NJ9[_$'!S$RSZZO\#K_1_782UR?\%4$L#!!0    ( #E"F5KW3V[R"BD
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M92.PA$6<02,^'JO62M"Y@ \C?E^0RVG/-B.'S2<]JV2UXUWO.EVV,;@<NIJ
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MF5\:R"5['Q@\*LK;>],C\SCU<WNN;TRF,#OQUO'0NZS*7K]WQFOAS.03VW1
M&N&%GE<87.8C?$XE'#< .5&4H_VG:,<)LK/\%SQYTN^?[!'Z4=-W-2D;=IFC
M?LU#DS<.T>-G(!$Y@I2$N^&HRGUT0$S?#:.^H-"-/FQ4XQ^.S1GK>+ 2JZ9M
M"9K[^A&VS&TTK<[W]C9(WTK(?[2=K8&:C<"4Y:[TH*,@#5Q(O*5Z0BXXT6)G
MBW >9FX@ X/T)08L:^::^3KL^A>]B<T!-QZ>Y0S 7[SXY#3U@U@%\S2-@R'_
M)0-Y"&WR@<).*MDM\FU;? \=$(:-]F4?S#Y42Q^T>T#,>7W);3UO$=JP^,J#
MLT+ J\1KGD-0]E7RH_;W6BLD5?>!C1@_A$\B>FZQ?V8%95".6_NPTW4&_>15
MXGTK",)SJ'JXA [4IEP-+Q*\=G.X+NL2N]5)<"RX'KUK37:$?>N'X*^O+++U
MR?303D+C#L;C:,QPZ81-,X4HOQ#V0.VOA7_\NC,=T'2Q_F3D5_8/QMGPC%^C
M@P6G\==0=( U=BL2]+% K!9*X]URX4%]M):&+Y\@!^O>K[]!([2()'27Z1QZ
M98+)!<C6JPH407N<,W+7$ >95R">HSYM3$DRD"-%%-_8!@O46@_,. HC"R7F
M%GSUY HV=1:@<K%7BXY5)23%EM[,[VHGRT1._5Y$^8T_7# >6HD[G9N9F56L
M/59*2W[M^%B;6^9Z8X&9;[M$1?0?3V&>"29SAVQV/Y5F9J:\/0WF1/B 8D#X
MZX@D R7JHZZS%-'9QG$AF%MO-EBR@X7@LFK3V()?+H26Y9E).7[T583L\HW[
MLXTS[[!@WN9P\IU&8);5>4AY%M0G^JZKYN&#Y?W$+@W2KU7_H$N$Z_7"PZ_G
MAZN&V:=D8DZQ%Q>8R.78G )D13U$99F_'B@6/>3X1Z ,,/*FZ<A99(-]/-KK
M">*.>CRD,7:\AYL#_"@=-C/D,E'8E&)'R*JAOE)!U^U\?6T; _*,-7P7Q;31
M-L)VI"5ELHKR@<&"1(D@F17#+/J1*.1N#EG5>W:%5QL9#UI \D0J^^@>SLWO
MK'V2]MW8X/G[9V"B>T_CO$H0%*)M]M(ON83YDR>$I$P'>B'SO':D,.Z-: ,Y
MBF,>SN8!;W37"5,H=P,?S 7W64[ZV/2.S:)10$VA]^C"@H"L1K_-:6=?-BQZ
M$+FH3(0PI'A*T:4^ 7N!%MS,2+-%E!MXM<Z:"Q4IAQTW<YMCU8)1 8.F5L,=
ME2H!^L2$<UN?C\@,/9_3ZW(C,9,#OH#Q5U/FV%8]AQ Q*USPD%J*W%2D%AUP
MBQQV$2%$%%2K(%T+1L":]^1,U6]/6,%J%1YK_HH[DV,3D&GZPX(D"]UE([.1
M\E;':)WWR18D)&YO5X]PR0)*ND+QK8'+$N23/;GSZ[6'B$8YQ%T#B0CPM8?*
M@H];[K^ WOMJ:\-<W\$0/Y8VU\6(2%&-E./47#3VO ^2A\9-*H7[^DK1@<2:
MW5D[0O),BK>$]I0=IB/+CE.V3DMMX$XKU\VJ,N8P!-Z^=G%U"%F'W-FMVH2@
M/)[XOX:[S<)57VU'"DRJ">J+7\LOF^^<*7[M'/U,=?<VH.CZ)$"^.8;YLZ0G
M;:Y-OC&<#K#$41-_M*N>V/95EN+$P3K;$Y9RE8/DL\L.\V!<=?C.#XOU#%W!
MHQ>_$<488CZ#^<P2ZZA5^KSD\W#%F>_CCT%<VA%GM1B+^G-3>]IC.GW""^[O
MQXY:%$B0L/&!]TME+RZ[]R^[Q2\DO 3=CQQ<X>^P)\03+Y!L"="A[.&0U[!R
M;%-L]1<=C>XZE>8P7?C1JU@^EO/.<[L TPL>Y8^^&PP[=\425ON0^&OC,8X6
MNT=J-D7:.B*!"33*ON] =2!A86ME?J9W81EW]G-F[CJ??V:/K8<8>[[R9AN@
M6)3PCU&;10>PWY%X<]Z#LQ845".2=JF8!C*E X<93EZ<00=&]1SHP)KN >B'
M60)Z\Q":QE%)!]XBS]&:\+54-@913P,=^"6S?45Y'4V*4* <O41[:DT'5'8]
MZ<"S33H0_Q'1HP7>7 ?OOY]!_.))^2LV\0>+O>COH$N,X#;)Z"6E\I^6!SRM
M=I(.O&3$=-+)<CIP O0%RKC^$,%+D;"@ VFZB,59VI%&L@I#OLL=+*#8+@.X
M00/2?G)W/;&O2[79*,5JHK\4/L$U46\PQ,%LY.1V]TH:BS&NEB0'I1R='42C
M M+)QV I1#O\U IW@WD0V=,"7W+;ZZ7XT^'K2V\GWM:;:SB4+LDFO5NL-SW&
M_Q[1MP7&Y(*^WT/^\O0%4^*-*0;IM".%=,"8X=Y9H8SH_3884773E@Z<%Z(#
M>%L+VF7PS#+C\N4!B'0:20=D(=07"$P*F*'XO 1N+'X(,H\F&N$W8BA.I7WZ
M=N*?D><FS3C,CQHJ'C+-B?1:RE@+UFYT9YBEG>&7".^5!CYJI0K:/85K:/71
MZZ:6W*H!];3<:MX\2R=S.N#A5!\);6"/:>_R7VQ][?1W[?FW1J=:X6H/@%H&
M]RK$_O&_&>TF:AD8\P)<)[(;CR.#'X,:$#O?BDG9-^LFK^5+O_KVR?&3^>V;
MC/P@W%M&1YB<J).N1MI_%TH9,FC'\K+#K+$_8X/W#I&.]MF)GTXLGC?T+-D2
M=RYR6G18'"R4B5/\P)(L=)[)!@  ^S$D_L"")!]/E2RG.2R,TX'C$W2 ES'%
M1GDA)D80Z_FOZ,"^%&@[6PCQ@05!$6)X7BKOC^98Q*9!/(V;X1C#("M+B"H=
M^#\>GPA30WCSW^O[?Q&05AEH3P7L?V=+X%]\=, )9D^+WD1@%A"4U!]R0OLK
M?Z_OOY7OH'0 \IV)$>)9;!C#<XGJCX4<\#+:1'LS.C6>RK TA!.^'_]+?B>T
M/T[1;Z95U-)N(JACYT'6EA"&Z_>-(K83Z,#Z$!WX-(7XJQK3#^V_;F/\U^WM
MC%/T63!TX F-#XWG3:& H56;"R4&UPK+EPZYY6ORS/1(WF$FV;\'X?=7#HK0
MOP+IP$_MOZH $>:&<(9RO SK5S$FNVP0'0BR_)OZ=;:I*?M1\'].)A'FYUD$
M+?\N0*,1@I:0S>.TB-A_A>(OE%,,"LC&/"WJ+W<C'6:WW2,=/OS#M!U2F?G+
M$U*9\:]]N66B-$\8"M&B0!MS_^ ;+Q/5Q))!&8'<//:7K[[K^9%EC!,@:&GX
M;T+H( >2%7*0\Z<Q_C3&/VD,:0NR7>00F),.^$E)&$\8R).B^V?XO;(UQ[V6
MQ6>2\_1,JE[)'G>"]28]"/KBP@B#/";4=#JP641A!/!>+)HT'1%O",#O_YT'
M(/Q:RCR8EJ ^ *:H2="!9/NYX.ML0\B_O6WY)],_F?[)]/]7IC#$3BV9"2Y&
M?=9A44E"89$)^FZ(H.H;JJ7O(F4)G"Z7*R0-+*]4V+V5/+@35GOW'RQSE'-(
MG80\K'VW^B%GBCEI?'7W5-\#[BR6P?*J3X]7N59"1-K;I84$A=VZ6=M\?JD3
M'T]^IP./$7A;]".&?#29A:$@[))(=RXC'X*?=0TM?-DZ6YRUS'_\TOZP+)^>
M24S4]3K7Z#'@ ;0'2E*TV DG7X!]!L<AN"(U#74>!ZB^(SY00Q6M>.OHI#Y*
M(Q)6+G#>!)ANNW%W*[R4[V1;Y1T$QX$! TD?I(B!!FED\CS^<S)[MN6TNIE@
MDH#0>5N6_)S'MH8LSY\!LKBN>XS\<\I;US![1ZF& JFW:2:$/0P9DW' 2]<*
M\#;,^Q1;-3W5. (Z?8?'[:0!'NKZ%$+C]"?KD#AQH!W/573*LA[2H7-:7QGS
M=K)O0;*M'SGO&++HK!B^WG139DDPI^@;)'3*=D%P[1EO4P\7,W./I*5Y/-6*
M#K0I3?VS/Y0QO:.XD,;PU1B11VHT>8HG@9B#[60=/;1J/1UP.3 .VI:XM)3"
MD<"I@6%VB< [T3B.DJ5I'US.IF"1?:"D5'.<1&+0N8+$5YO-"^9C:[?N=':$
M?;@X"P WGO?=/;)YI%:36J1%!>- %"$H!M&'?DRL^T0*,\3+HW$0GAO.%5YJ
M(9OKS3$FURGUIH=Y/AX_EJ%RX]8W,T8J7?$Q.%%]SMJ)A+Y3"<7M 5]RC5"8
M<RZR(._Z::-2?\G; @9^;R4';2(PRWT R(CB2AK"#V'8^I*M<1N#8#%'+VG)
MB4*!;=W2K=NI41<K.%ZB4!H<%2]1 L#A%_97V6^)2K/CNF09 [08.48[1(HG
MBY'V5G\^W9B!AEAPD#2U\,1XM3H%HEU^Z.P5Z5_^V>P_#>6].F:7&H5"8\\J
M[#Y'3*N3BQY*_7MV>%V<R-=I(P9<U/*&&IYM.M!_,!ZG;XV5,FT$L<)F^^PY
MA0N+G37][L5.IYF46*3=<+YBTL'_C+V<\)/8V$BZ0 !=)$E@U&,B3Y!B5U?X
MME#;H06B^$]-;R2<#41NK'6TMK3G*MY*?!>2;'K;^?T'[J #!8J@-6:<HK@G
M27$C/<'6\I.N?,.^+M-"BY-T[.N3?SB=NT!!HQ8O/WM+^"01K751)'G$]+.Z
MS L -IX,QJ2"A?5]"4IH+UYAVD*VBRRAIJRN;)L8JML<Y5_3<:YR>8Z[:7\[
M5#BM?*'$ADG8-MBK6_0P=^/WC5UGLKX#;7H%Y9D ]H3PP\J<Y=4%MQ*]0ZKF
M'>.]3%)E55)1M_:?]P3$UP2!6=%^\QWW"0$K&/L!.O!06H7DALMWNI3M@!]+
M2?"L*U#U>"]OF#><^_Z^I6?BNZ1AYLP0>^XH36/N,(:SF.$[7/A:2017LC;E
M? =)Q[VRLW1\(/%.W6D/K1?=/X<]B<@F4X]ZYIQ^2+ PQ_F7O)69H177'W!9
MS<; (ZDMUEBV@3$0)J5O?/[G($2 <J$:9F?!K]T<+?ZNYG5!,V< 2N_F.%^?
MR9QSR09KIS(FNS]%@&*/9T$G=3CAXR%X[9W)40E2>/]80 ".?>!2\_Q:ZA]]
MJ7$*;"^NLSG]4UXAM 8&(7R=(#$@_N_JC[H.D8QQZH]=SA%X\@S*O;$IW*.^
M3(V3V)"G9J-YB:U%<>P=0S>FLN0^[0(?6,87XHF6>,_=<Z5>8?8TA1FX!@[)
MOFU>03HUV"7><J.16WPKW2U#[56:X0EX6N^VE2$FZ:'Q6)<6P_4O4VX0:OO+
MJ"_UG<@^SK#TP:;<P;SJ^;GMY2--37AB>?BMTXNCE7..5Y ^J=</.]A.% .W
M^$[/HKR0>$N+:#"^N".(D()3B.LPQBJ/Q[4]_TCQQ2RYC.A,^_U@VZ>-^PM<
MDAFZ&\ UP>ZBHZ3PO.-I8"'>ESB6-X04WJ6QP"$D)MQXG('2=,/9$"37'*DL
M7 PWXX>[X]"1\VHC4QC6\?;=L[/VMG?G9&2!X)7&L!V")]D^<JQ D9H/-\3E
M!#_OL"Y3+9VI=O>1*CQQ^5F]T5CTB!M+FW3CYG:[C>(Y5N7U/#3I)"06AX\=
M'TKDG:_%L6STM*N:[ZI%JCC)/4%IE'QFZS(#-U#KS;2?2;X_07[YQHHEW'Z7
MGVQ,^8.:8\#Z!=3 UA\!H<GFFC_+E6LXOH[.Q!]K?N@I8*I<7\2UJIIV_O!#
M'F+">A<KQ?8C39<BA$\9'..]VE)?3XB/\].N-M.K+[MQHJW9=$;GI(E*8?>9
MU1-MN?_<5M__! )RH9J8B??<V4(4+\*@V';2**XVL2C='*\>$_RXV(EZ_;@
M.$>/][NOXA,!LU/YC\_V^#'O[^V"R-JD(8S(SK@[(65U*&'G!U($AB8FX:$)
M7>H^3>S#Y0N+9:7^4*D73+^$LX;7!E_1@5.W4&['>,O17B"2 G(GE6P)-VXD
MM1+:L5V%5;"$41-GM4DK%.%I3?GS&F'C9Y<%WF_+#OZ2>K*8GIIV5R,,V[PC
M0U:&*Y("<8B8R*,D=Y5E"4+2174!;]V?CT.X'?7Z.49$=&:/B@Z*4GL[,#^
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MG+,'K9#S^$EA4<5J#T7O?:<6J^?"341ZJX,\21>1T@0_(3G7 2B)+8$3B1O
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M[]P?ARMX6*S7E,*/:DZ.;P#U02=*I?BY(JJSCK 2C.&69LJ0>=B3FEI/4]-
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M@'T1O(X(+%&I"6:^EI%-TX YQ@J]\. &O',JE9;@0K%LU;AC(M"#J,N^(HP
M0QIJJ[\M!WWK*G2."E0&#W%$"_EKUL)*,0#JM!?]E%C $ZU:4FN@6G +0KAU
MYBMRHIDG*=!(2^>S_.G\E/:X[%D8E5HSD?W#J$*6]!CM45H6-E1FL[?'4-:
MN/%E1I"N',@]S$<=K%,*EKX5D_3#(M+&(CAM+ZQ1=Z*ZYO"'%7!@XTR<+VEY
M')J#<^9:>= G3?^*R+O_'94-UAZ_H,K:177-@]2//OX-4J4"JZ$RG>3XW1"Y
M8J+%+]+2ZJ>N3[= -#W&\F\!*=!!8\$-=P3JDV5C\?U!4*[01:62NOH =&S9
M]LBM>O4@L&7]GEE-:EET#Z+2-']'4,5"[B<"(L G6/XS/?Q<5\D"Y(C__K6+
M I4SJ KG0<O,@Q6W.EW0U=-X@?W<K/VH_L>B05(C2#9/.^:U,:)?6$=6HAV"
M'&+Z6?PJ#,K8+T%Q[8EL[N6DNK;(ZU:AF_,/AIQ=6[E]DQNKY74#<$E,& 0*
M]M(K^IIOD Z"@W*F>DTK;3.+#?.+&8DV(]; $GEY&5E'@=NM;\[V.AX12D&2
M2K1CS/4*S">TW?3FRU&UFASA3@&.7__6ULRO.TX!A<-'@H"<L$U/3<9859 7
M)=@(R6IY-IM[A1$O\7SYFK1?>9@GX#4L+%*Z;M];<R[@MX6\>P-8H GM&Y-G
MZBF./F)6'Y&VR749=['0&:Y+B(,FZY2>9F9!I@W2DTKXYF3I#-1#AC[>CH#_
M#/0?4.+,M>%LP9%K:PSI6K(ZT!190XM/O1L 8B,K?V.3.&BY8)!NV&YF5:AP
M79%ST4IXP+40YL&6!-VMWY'M"-K$/>\)R6<9+-CRJ7;+5G@,_B!;:,V0L$-=
MNSNF*\G$5BBL_X[S;D? -WQO$=.U'218WQ2_BF)#6B[#5\U'T97IS#P?6]04
MY/<^G_L,I\)A+P0ADT+! >_+'QNAQUL,LMBS.T9 16'3>::_9W$LD _F5S^J
MJ>S3*VWEN@3*1:*VEYTW"G#^*H)Q:!?4WF JAF\]1IFD9#^C!Z%+B=\S:IR&
M\$AJR8BM(AI?J,@W:$HY31 \#"','04NIR(V<$4W@,T\V&9NA]&MQ5E 4Z&I
M(WYH[9R<=Z2JCB[!QI8G5CQ6)WP&PA;4 R>CA*=>!8M:5^HL:22MBSI-,HD(
MN"!'QQ7V?9XG5YH&,"@1L]2A9VKNC0N>:WN>V( -8!I9V"*:P_4&JI0NTH@>
M"66##3$CC<*C_K:U,I?*M8-LJ<_;,;GH\1=/^8/H4[BLF '9V^]S?Q?%A;.A
M[L&N:?!;?3+[9A\J.>,L2Y_KAYK1?F86ERRT5?!49&(:'@_C40_8;'E.' F9
M5/-0M\/79D'*97)DPJR\3!Q3_C%CWO)I5!3I4536G&?MA.X8[.A\U7(]74*Y
M'..0HT/PG&N:&\  GC"U]W%2R/A8;M2R6\92F[[X#.N[BFX9&KIW@&VD,.0X
M *5C.G\#<( QA8_77TLO> 2P$W9?'8]'/,F[7VOK(",J*+\WAD/+_U'2DUD^
M@8ODQA%UB%DK[R-8T/XV)*&5%P-'ZZM!"SKHQR 49+[2WLZ*O A:6SVT!DH'
MZ:V=-^4N=Y6/ Y':,,K@N-X;0,.3M3R$!]&E7HN*<)N/5X0[LM6(HH4"VOUH
MX^+$UNZVWT,@]9.NE9!*6Q0Y\<I\E8OC0?;W2A6R:5[,<#98)W$YW6OE\CD4
M.=46"6'CT8[V)C'Q.OQ1>:]\X(2[)*@V&WJUL@<9E*N>E,SXFC._I^<%C%L:
M'AG5]0KUKSN?O*8)[7U\ XB#N410N^*ED.,[49.(O\O';5D9_8Y)<,O:P!9F
MH\@GC^3.(0EX2@Q6 _<5<@-XC6,Y-_X5 .2TLET>E-9^:N^;X=*U;.&[^C8^
MQ.Q ?U!7 )'2BEPPFE$A"RZ<U$ I?V">AK*K42/[>XU=*,E]R:6)@2TO5],B
MI97UT::X6[$"*V)&J_!318V:_2*<-,%=>(&4U=]_'.CXNDUS_'@C%++ONE<E
M5)6^+Y2Z8)XD,:EY+C:\K^:;+' V-RV%UKM&A:SGFEI:+H,ZNR!\6RRR/LR%
M ;;>2=42OBGU.=#D5O[&9E'//YV7,R <?<G!X\#WI?!]2_6J'C>G-Q\MNZ-V
M4F1?594L NZ!YV[MN3UR(?[:!/OH@"4H5EDUM-):(.FDU%54C,/EOIAGCWT%
M"2$O.3;A*B0!1Z8X4KG'K&Y-F,.=_]8S>YWG(BE#OC+#A<[O'D>0GO6\Y\+?
M0^_U!DB<Z._4][;W=9*)1*P6.WB^U72'ODHOC9Q_TE-/0$[I2Z58H>I^1'9B
M=KN?=_.^6>CZ^:C&>!F2!?.(GTO%O#,Q&!;X9?;%P$KY+H<YTFWID:_M^BKT
MV(ZM%R1K/E\[^_<DXLS/<F]OZ#@*:P;6P'U2>7#;>];#<%D=-M^U<)5RZ\L/
M(UTU>._+GT@JZ';ZK76EXO)O &_.:,$AF&@P635^(IP;V<BCG[V'U3=VD:*)
MT<RY4(L2"((X#(0.T%^TJE*Z*+X0_)7R>D>C($>@/K+#3,\K<:_U]^<%FNW/
M8T=FV=8EEF7KJM"\QB);8-Q.'5+AFIN3 [:1%\$!76<.IMHL6T_HX@Q^/X$Y
M-OB9PGZ,*JD787)*]!-T-DSY[C/\UPK5CD[$%:MZ=3*L;[CTI+[+K4TKM;49
MX&^H ,I(/](@K^9M9WA48DHP*3IFX#-#<;E*WZ-"7,-"+_D(_.9@DW_9/],>
M;AB4Z:#PW1YK@1?'1S\ZCSZ:&4)X2U8F?4LWL2[-\#%-*KM76MJ^"OY>,W1-
M@-$L!Y-@E+Z !6?$7QR5++W)W1"?DCT>U'(D_.'&_I/]_9V.(CPI\X8J7,$&
MJ9>ZE;HT.F#+%7GYK"T-JLNH-LN7?+;I$0,<U>#PT=!OC7R9UO)H(.R!>IB>
M$E_OEK1+]D";]XZ!GOB$<M-.PWG]'TN9'4GF-9%[!:(3;L9%,IF96;/YD/&
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MEDN[2^"NUXKC2R<:6[:,WM(\XJL5UOO!^-H\Q.]CHDSB3!/J=_H\H0>?*0
M*U_F 'E_:YIA$ZT$*C\2;.4W?-<ETR+/_.ZW\A&E(I5<B=U?ZM3$0G)45_B;
M"VFHSIVQ+#J1'0DFQS//#GDE..,R%0>#HEY&6":OY(XPX%&YPR$2IC>Z/QG(
M)]M"O78S/,I6E1_B)4$>YUQE'R2S&-X+3<,UK61U:X/7O9FUI9J1,>+F1?X!
MUF<5Y\/BGI7N3+U5W^'T2N:*3Z]1NKHVB*=*8510;;0M!&KD3&6!!7,MO?CM
M/$DV(RVF:5#S=)J6M!MD7]F6UK_E%/K/$VWX4ZT$21NM3PA1]$8FEH38VIE
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M-XZ0"1RG,%-0U^WY_4R=[(?!)-68F>RUO$=SD)8Y[L!P:YYECIL%@%+&E]5
M:90D*VUF18\JM$]8\R/@OXYV6C[PCR@VQ^)@!&3S->T,O;7G+U=:9!T^!@VH
MP$HC@_[7=^C_]DZ^8.8_ %!+ P04    "  Y0IE:!!6H+*53  "0<   %
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M;'T4';$+_6DV&Q6E'.:WD7[[N,#9159-5?C#VYXT2%ZAQP!,FE%69[4[3N&
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MI'!&'VMHV*]B/A0;;ZSSXWK,?=:70@8Y:J>/#3"P?^'C*RT%C(D(2FP9V9A
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MG#L&)@N(^82QCC"5#A@C4F).B,W"2&5=#?W,QDBESE?3\J"J>R%ZY^*4P:;
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M!:AM1RA^ 0-(H2@""*J]&DCQQ.%;CEP8LLZT- V"5H+A^='D]^W4,QDL-,C
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M)@;1/^( $.3;XQ4LE]8?J40_E$OF-=,H:1[9V%U7X\[)PSW63&^AY&NRN,Y
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MUAQ=N5ZM\:F**$*,K#-:5.@4%^2 )*UC963NWG XBAC?G^<P@V:[ TF<BRC
MW]X''-\A-H%#&J=+#41M7A\<LXLY.' M&B*]/G>5<;IKQ4(UR@:'8@7P#]:Q
MT#8L4N<>*+:PH6;-+IP%[8,JF2O8,9+,_N@X=G-YM91L(U^28?W#K?O*=6C
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M/?AD#'C.I CJ7$6^\BI%W/QW($(%W5.@^7GC;E6D;8NN6GO#V\2B7 5M2_+
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M4O:_^NAJM);PRKOC?'LG6^*7K[6Y$]5!8]>)+6ZVXMYBZ$,?3\5L:/?]AX7
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M$Q&TD<YM$S;851HL>&>H8$PFB*\K[CMJ<&N\[\"3KICO.3(5BZ -': (OR+
MSR6[C1ES!GV!"0?+!LK?[OWV[KDOV:%IOR'5DMU18>6*;FSO760GYKX]K(G&
M,50*/_(EU+<.U5/(0[X8J7IH-/RV\9<WX/?JE4O1ZV)'E+XS_#G%F8C&YQ(O
MF!.0Z\X$LTVM]Z)=D7<EW.[EZWBVGM@TVE8;>1KJ9+R\>/\FDSZ;2<Y*\Z;
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M^9L'O!M;?[/.P4%*E(9_J:MKMNCX*L@V8J3&\$4!Q%N@=.="G4(?<G:JK]
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M@0>,^F4?.L#?E(19&>:E'"QCM#.)_M=C%_];#%($B]+!F,M*=,"DDC&YG>C
MGANR)P2'WMLVI0-,Y8R&O/,C?\/ S[]A$L/RLYAV-)>3#HPP+!<4-J&Y2/^I
MH7].0_N/BY*4]F[0BO_%1M%#!@#U8A%&^><+WO%!I:U/2?^)T[4=C7]W"ICD
M["L683Z;4LA_;[*8E#-*S$@=E>6OM90Z]/@@I>[%@23%_Q@81P8W&,=_?V/8
M7AA#="J+R<C;O[>%["]*HI!-/I_Y:]@\9$"]^(>B_MXRKK2C\:<R_C]1!O,
M'0@:^;J"1:['%E_?5^A9X(/E=ZD(_'!?E^SV&*T+"!1V?OA0*4S,/MWV'K37
M!#L@78ND"D&2D.!E73H@@7[+F 3I?U-=3#N<05:@ Z-F(,,'Q'4CB17D0TD
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MX##UO!3!$9(%]76[S SE,CA'6+@T863F5Z*:&UCN#O:[C'UT29;Y<)PC($+
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MQYGBMSH+O<6?J-4%FA#,(:"">:R/5/9+N- DONKJ2'9((-&P)[PO3_;9R5\
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MR_9>;*:(C.>SRT4E%?H>?[]B<J%<Y+0.G9M37K.(9IS$A,.$J.+C-,)2#[&
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M&HAME3S367^R7)J!L-W4FLEM9E_?LJCJ>;7M-N\Y^]NJK-1/;2E>Z&.?(1Q
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M7^0#4J]\WK+9[$CG"[I\XN"9%Z"62'Y>3V( A%.\:OH&58]<.A+2K<CA6FK
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M!2Y7>%ZSW&PG?%W(Y?^0;H5\WVQZ-PVU>YKY5$8(@<=AD D?(M5@E 1^#$6
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M%,,L2E6UC?0^,.,)#/W$\VE*?19X^E/OC](9W?_8$@9E0QD4_(4O5KI%JD-
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M>FNP)SK;9(^;\P-.%JR\TRDG>]".'W4Z84T[0_IEN?BZGA:31"BD<8RA\),
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MO8&CXC7U8$T^J.F?@:+9IT [E^E1+3 '>)Y&X) 7=G+Z L'HH38N+(:=Z =
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M41%B520RI:"XN(/6P%ZC(A5$CM?N1U1CMX][$AAF]89HC;%OZCL-W8N@D7^
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MFW40M2ZJJYJ]@M4BX+0LIYK]OPRB;3M7ZU^#,-?[]_67LLW!!K/F_2*X[=^
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M$<$*1%6J:!I%*:>@!IWSV!GZ7K.Z2F.GKM*<Q_N>^0[LO,AXFH4YFI[[R4'
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MGGB_2&9.+^#,#\OE)G80]B\^6G::AC#/U;^U?3-;G@!-KBVA&O<8)D )>$
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MZMJ5D^M=KY(?9?/?+ZO:3_RQ7NHUJF8HTO?U<JE-@)F2=)>$24Y5F*%$F;'
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MPHA]Z.W;/]P'/^N#V8[UUJ8A>WJHT.[VZ]GG=38$J4-KM>>H&9]0.$P+4+)
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M7)69W\^0T$^6LRY::DFX_YZ.-9OO[-!=7XA^=PY*<0&$%",X*LN5;XZ %Y&
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M)+C 4U1 =.8@5"I=3L1#SD1*[J4UM/9(ARU)[/D2R'KX63]MO+ZJ&@BI;_M
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M>0]EVHY1Q(9(:M=>-W]CUBLBK[:*FL?=R60<EGP1*9@*&/:RR P(ZAF@YQ)
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MG8OY_K:/.+.0-6.%F[*"LHG@M,.X-3 4<%:EI;RRL=J*P'YNAWXMQ[P[734
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M9*X'T5#FO,_ @^6X/>0RVI$[")%&G7'M$U>[N&4["O\TZ89M4+7=,/6]E-;
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M;50VSB&_THK7/UX1'@@,5'(!H@<O%B6F)E52*^*5]$IYR!NUE]JE^-<?+7-
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MY8&LT7XB+NU]_WL\^3.NE!H#^-%T+HU%+2Z4CN)($&#::T 1A4#J$)T$A&R
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M/W[DPV!V8S!EAE,'"&(BQJF* ^D- BY(HR'72I'\CV%K26F&IN.[U<ZI@0J
M]&;0R(V+9C% CX'DJ:HWC;Z.&T "*QR+1A-AE-T#>D- ,] <W[UW=VEGZ['?
MNF!QOO;4V_]Y._[^O[QUB^5/TGC6Z\%=E-;+9,ZW1*^K1'P#F]>++A!CW0M0
MUG]AS\K#UL1W+"F,G[I9?.5N_HEG&+46Q^856UJ"UPO^.KH?I$6O(]L_Q7_\
M,PN9[U<MDHRS4Q=/N[611 K:[C?T^=FWL<NLKY4UBZ2UM-/6>FE4HJN+^-G9
MY&[D/@_U;19-O5VQ2%))*SVME40E6DH[_G0T=9-\:EI9LDBZ1VOK]UX6E2CJ
M7^._7NC+:P$W+%TD*:.5XK;+IK "G\_4P9UWG\>3=-?WNQYVWF[;UBV2YK"7
MZAI(I8:--SV-;K*_'C^3.Y]HEV_W[5B_2-K!_ENPF92JU6=/:BR3$9!)>Y4H
M[<O(#;X/W%/W_"Z*6EFJ;%"V7>;C70(HO96&PQ>ZGFJ].VVB=0L6T] &F8^;
M":"":\[%_H\_O&/3M'K#?;-VV6"YT2[:*I0*E+7^%?CUB-R?'M]/T$W,O' T
M<A=#/?JJ[_RRVCFOSGLAL6B)VGHPK-8\]JB9"H!W=G<_'#]Z/\\*/K]/O.TT
MY:U&Q&[\3MDJQ3ZUNSH[=I>H*X##G+:3^Y<TJ,LT0WEZ=7)YU0LL=G^O;('A
M >'16/2E_;YUAVYTA!*'^8.HIX6+),AV#Z-6Y%*#ZGX;N<GP\?9E1O#)W:R[
MWM:N6B:1='^M;1-)#2H[^S&Q%Y/!UH$D#?7TLE29!,O]E?..^1HT\G,\ 6:?
M],Q_UH/)[WKXD$$U:]8LD\"XOXXVBZ.PLM[N[,=?_YS-H73Z;71[8;N9O1U+
ME\DLW$MUS813OF_X^DR6L\G\O:"G%)SWJV=)O]E!=(;4FTMOQ]_]Y/$\O/O6
M.S"TPGVC#W38LLM5GS[3_7)^[8+%[A7WT<_KS;I-+(6-;)J:LFQME\Z SI?T
MZ]8KIJ^M<A\W$L+?^OFD%^^DJ5+^>3CYY^%D+]U\'8^^^G$.I;Q=J=Q#XS99
MCW<P7M&YXN.2=X/18A!*_,ML!\R[A8L9M;:>01,QE39YM[>S)5.=;YO>+E4L
M ;2MMM:+HK!^G@@:Z>'C=##-D]NT<=%BR: =?>^-XBFLO:O9GQ<3>SZYGD[.
MIK/!HGHG9Y9\HP\4RQ1MJ]5]Q%98P^</LVCC1_-VIOE,Z>95BZ6.MM7E3@'5
M<P!^'<_^\,\GM<^5QMWD \4R23,<ECO%5EC#G^.BXY%_XC3'@^B&)8MEE+;5
MXG;1U*6W3P_^>KRL;XY\IFI8.W>MNQK;?;Y3[+$[DX:;"+%"M?\^& _G8CX/
M_QK?^=/QPV@V>?Q%_]6'[K=^K-S#>4X$-)%GA3"('/_G00\'86"7U%_K'\M>
M!YV3)5I]L-Q3?4XX-)5K79"(9FRH1TN"O]S=ISD#D0$S& YFCWE\MW9?+)<;
MD D4^TFVG@@LIXNW9=ER"009@K Z?;TU!&:.HU>7+=,1*+,2ZPJE7U]WC_TT
MQH67_C\/@\FS7<ECE/?X3)D./KF>#)K)L-8LH(OO?64 O5TY2_;/%F(S9/Y<
MZ,??IQ=^,F_@-+(^=^)/D_4[[.LHG.ZY/L^+%'MPW4,+KW?D*O>E'X1^>/LP
M&WSWI]%,W(XGCYU31]:O6$Y-J_(>-V2^]$7R<+A*WL!G2B+9O'"Y[*NMJACO
M)Y?"JKOPXPQZ>EFE9$[);EF/MS!>/LDGDO0UBSI6URI7"[VG4C8(X9]<Q4.>
M-/_D)_Z3G[B?;MQ_78_G\7C7[?%VI6)I5-MVQUIF2RM@.'PF*\_66%VNW+&^
M5MSC)KR75LKM[6Q>M32:CG[7<?->/=S=+>ZMIK/1M1E^'D].[H=F^,<DA\[V
M_EI)3VV3QL89Q%>!VA/-D<7IU7=[.IUETN[:14MZ=@V5N$T8I8.?W'IJK:-^
M-MHNZ8^;B:(2+5U,)MD5M;IFN?W40E<;!%+ZENX_L\>3OR9NFDC,H*IUZY7K
ML-S([&T102W*Z=D=V><[Y>[QMJAIG3:/Q@=YPUB:L7L;/:C+^\G,O6<A]PYM
M]KER19I[ZGQO"196_1^3LY'[G-I=G(=G)GZ>C!+AI]\G[H])>DMW\VG,OXV^
M3V<N P!:?[2.K;^??L?YA%T8*RF\^C):TK]*Z2H_T=GX8Y+C/&__U3J,1FNT
M=!9W8;C\'AF\_31;B_?(1_SG9]AG@,G^7ROF%.:!1VOQUF-%3J;G8<G&>9@C
M^)F-S.AH_=%B99[9;4@K89=.8WXB?$'OR+T_-Q>&[_/0S7D['8_<]-,D_B87
M<C*14*RP- ^.\BJB,*H^?7=N>CXYGWV;G$4*IQ?N?/3,S==9^ON_II=A:!-;
MU[-A$E :[)$+4CF^7ZRX-0^>,JJ@]% <KU->7.>GS-?K%#MTMCUDKF&T]$7O
MDMH\N=+O5RN7;=$M_;*VLI/3\94?>COS;HFASA4GZU<L]_[?3E];Y5(ZO2R2
MXIYSL<Y#&-BX[N=1GKVV>_5R)K"=+AO+J[3-]'[R\V3\</]E.GW(J-%MZQ;S
M?=O:T=TR*FU1OZ7>_>Z9T%Q:W+9N,8^SK77=+:/B>W%\G:9\YRC?6UVK6)>4
MUGMNK2S*:^C$SA[T</AXH0<NDZ+6+5FL'TI[?6V13.F<JO3D'BF<1XV93..F
M-8NU.6FIN!VR*>UV/B7TGWR_S68;-RY:KD-)6R]SAW@JTMZ<LE<6(J<2UZU=
MKKU(!EUN$58-IO29U.P&=>/*Y1J#=+&KNP15/,_G83![3*--%J*,X<W=?(3;
MIT&(Q/C(;2[M[OFI<GU"6JJ[G2A+AXTK9N;WZ?P0F0]_^S8>1BE?SG)%DOM]
MJER+D=9W=VU$69W^O_K9EY$=WV6Z0V_T@7*=1K+I>K/8JM/PNTOFOC2]Y4.-
M-%[5W5$+,1;6_!KSDSA?7G[E47K3;S32=TVW3WL*K[I-?C[[YB<][^_UWVBD
MZIHNKO847NE=K<W#4$]^&4QG&9^Z-Z_:2)TU76?M%%!I!;ZW+%UO0C8LV2A;
MH:;+K.VB*7[S_V3\\RMPU]J--%G3559#8154Z=-\\F?'_9?Q=%N^5ILQ\&_7
M;J3$6BZPMHJGN+>SXGEWW7YK%VRDKIHNH+:)I72'VN10)8XR*6S=>HWT5=.%
MT1:AU'#%GV6JV>N%&BFHIEN>=6(H[H2,.Z=*/JW12!\UW<&L,%]'FG=G=>R;
MKXIKNB:I,$UU//HY.BY+PC[YJ9T,YL\PF?)4=R_?2(DU78 T%UGQ<\D-$EUZ
M2"'^_L)=KN?G7:LWTFQ-=R&-!5;Z6!M-1S^-PBR5$&7+/]ZP9J.:@)IN178(
MIW@&P4OU5[Y4@?5K-E)=3=<@.X13Z_2!+Z/I( KS>J+GDR<GDY0WG:8JK-P
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M.M:8H-N[NK9E%JETSYB1NEQ_D<,.&P;1R,<"F'G3=#X!,B[9AUIV"TK3Y""
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M,!^HC3XU%N:,G3)X CP"+OISV][$53S@$D+O+=(OG,O7'Z;P[Z(/I$T9**B
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M[_<@0RY7UX3FG+K"Y#/*G.FVQX4OK]^G721"UT9O:.RNIZ9P@TOA>+$-.(3
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MU.)-!?H]:36C.?9WMK[X8N["%"5[S/*39#I7.J+V!_//Y^,/-(?D4 _7!EG
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MX7F/D9DX1H9"#D;A3\S:I/)R:;R2 D]D$5C8:6*QO&Q$_MT^)F3\B$K1'1P
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MP#]@8!,U1PYKKQ0=DF7'5=35"C5];2-V4T+S4AM&RO.$)"T].54]2=$\$.2
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MQ'.VIY0]!,E@BEY8NGV^&+:X<?=E9VXANE)D,*)Z:Q0I)5>!.-K2C0FF9TY
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M7\&.3:]Y? 390*5I&=^8FS2D7*,DP&YY7'3MZG7:1J=U922!QNZY7K@/@A1
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M^+%637L0F/R!Q$3U((,;^\T]')M(T,F$"UY+6WBND("7("A@A)U%Y=^#=.W
M)!3!CM[>D^Q44 ,S*TGGVA?&L3&2@FR90N2B;$6I]U8Q,H#'K7$Z+7A]_:H:
M6B'E:(SLC)L[&+1HLZX=[^J"<B@#9!>BMYBAI9YN&ZW8[CQO:-9Z9K297!-_
MRE5RMT'80A<'9^/JS4'=8="$KE9<!ZF6+=4?!5;AR([&>Z@?M7^OE:=1G550
MSR7^NBOJ"F6JS&*7)Y0NKLYL7/UL](4CQ_H7KQS\4N?98RP0G-CI?U_.\9G+
M.2CJLKW^PK4<?D@;Q[OK# )C7QW_,G-&-9D>5!?98P^ET\)'AO+&A9- :3..
M([P\ETOHH5DP6PA4;X@JTY Z"&,)9>#YGWKO[3GXYLGST"=%576!87Y2MS I
M,"[#H2K#DX)9] ;)I_61<-V_\8&+-;[8)/\$N8"O=(^%][#S3"D+'Z[;-HYT
MZU-@1MZ[49SR*' !-][3$'9&@7RA%( 73?RA[PA+;[W?_N3@^.#HZ"01>H!@
M7MR]'G_O32'2L4NS%AR@ /\^T\9 +-6LO[P/T^3Q@_^EEH2L"89C%U18%V9S
MQ"(N^\5*(#.'F\*,<9V2G'D>/!>PHV'[DF;\^ZZQTQO:N!B^;/#SP';AS>;>
MS% [9ZF1S9.#S>![*&4(X:I6ZKU&QO:X21[:0ZZ762YER=?8_4=I<I*J#B 9
M"_T*EM1,D9R+JDXE_$+N1F11>E$(/00TDE<UH52I' 3/WO@"<K%G%O\JOA+/
M1T1# ?^_:]CDCGZ?EZ$AO)VW]>9G\]=[QD^/&7XB_*[72X[H8.4D55ZY##5M
MP-X,4GIN+JP':H&@Y_92Y+1$'&15EW8]JE&PT^/\O*H:":I+@DB N/BN.55(
M=JQY\?$N(^29E4#Z;L2<@5'?3P6F*0KMZ"$CSVC0^,%^ CXO& W43X'8T[,@
MCHLG$TV;=<_#9 ;,NISP,KI=[/\=1_6FUROQ55U3+!4-QW^:>DE'WZOR]ZYD
MN.];6^1V\36$]]""PM@[UCV.;68'E&^$&@2%' FL7@3QO]<NY?N6CE0Q%/OM
M'Z)X3H\$:QA#08LU8#2A.A0X^)& !S9&'JS ?:;C:\AT5&@I=:C4SV''2.CK
M]XYC8W(2^?P6A4[1G2K!8LI TV+HI ;MF:U)82-YRS "% CV>*$2B[J5-L?D
M0)6D\&4/7#NZK6*\,<A-X40C[%F,^M?6NL1% Q?0YT@I26:6AO;GA<D+DFHW
M*ZE#'6H9$QJ=;2$GC[4?:#*K&9K!"89Q*PPY8@;?8JBSI!_P$B3Z,26YLEY7
MU:2KB*25/5>NA%K9.18N^_8KO4#TYNF7U6Z(.$'7@IA\V++&$7/A@XR42VG<
M6+</+JH8TF!9'&<,Z')[5(V]N;/E&6:5T1O\N(*EP%,;5Q[3L53JQO5L7.=#
M8+MF9/2!-&S]BC O$;ROFG?D%\%+L.2$!(QR&74%FK?"W+NZ*ZJ0? A;W%?_
M./!\SRR[76Q*K!!AZ(I48"3VPK6AO.D7'(Y5?G[VB.*.K8TGD[,V?J;=]<9Q
M:^W>U<!-&"69G*&,X7+JWD0LI9@,@X^DLK2N#,)MJ0NAH_Y#78\:$O6'R"K%
M+#A>0Q0*:[*9+7G,9HF,K1SN]N&=B-(L2B(NS0<*S@7O)S29OB2S<_Q0.@<V
MO$R" _Y=(\^,PI-+8?$+&-'":6)UQ)=MK$I56FV95].0;85G@T>BX]7:N'J6
M<S:A6TFB"L[;VNK,S&QI%_E8H@EF$F>KJHG4 U\B=J)THK49:TU8JLC-\J<M
M1E<I*1'$PU!&L!8RSW+1\8@/B^L$1S@<FY0R/G/QK6:P%DM;GW'"BQ[L4T-P
M\,Z0*#)JY^O"25::^?:^ED]?9\W*_.H<F@YL/SCFYURLWTB$2.N#N_HBIVI+
M?;A12>1?\'/(>:8%YG=%9VL84@ZG4X)[_N2L9 KAX9X/)<,;,S],&2(_[ J:
MP,C7).!:(WZK8YJ$)YQ+.+XGJ[29D78/MBI/")U!?!X'7@*C"N%#PFB""BL&
MH9=815D+,F_)*+RTMWV]X7_HAC0L4H\&1X##NN.A@>1@DV:8+Q[DF C .]$0
M8.I8A@ZHH?)<.D*_"@*2:#!&\;VFDG OMHP73E*FJY7^=^BT:XT[;0X2"XRE
M.IJHQCHXJ"[!G3]?GT[N?/T1[3W2UC^92PXW_XH /OXGPOK.&#:UXX/W?=@-
MT1=1HJ8NL=:[67$Y4YU3[ TC;'!A'C@.9_2EHE;53N==@]([GU=UYJ ^?$;#
M[G3 -&:-XL+W"\R4C^EP(SS#CGC&'5:^Y/I,E*@C7R M-WA\B#-8P%K2]R!H
M=U7#G_-5,7H@X7?Y]+H8OU>\@+Z2=#=/$6YMGZD1= )3FA8"Y+H\MW3>>*T*
M=S;#$(KP\; Z6A6&-WR0=R%%SV>7&V!1S06:Q&CTZ[6OZ>M_<KKJ6=X*ZB]
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M\P933!QM9+P4-L<-0U\LZZQ'K7G+()EV[F]LEH5,IP!9%-[0638S=]>46;"
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M'2#;/,9VF5#L%5)FXE_%-**>EA+XEB91<UA?[/U#_@?XN^ LHC-<<6O'-(3
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M85:!Y/WG'P[_T)K/NEA^O[^L,<B3)I%1JDNTL?/+[_>B?7J$&<"]/$<&._1
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MLJJNP"9W4690#!XF79(-0F"\(@,;1R-IR_V][DXBT+;Z1#Z("400E$XQIXQ
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M.D[2X_*(9=78]1(!,H%[^C/<='!$7[(LY44H*-[(6XOXN='>.P1TU\5LOZ(
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M#M$B$:%@^PZQ>&5216$5-D(A3%I?3NBY?R]G&*BJ@X'[*]]!P% 4B)M<6ZW
MY%E4W)B.!-@TKR!$E@TN#3H3.W9_=8BH&?](KS.^JC&FI)8%_9>!C;OK&>A@
MRC1EWJOK+/B61A,;OFBLG[&.@YBO9)'V5^.XT*<70HM)'8OE;8DY0L*'-C^)
MO_WM^]L 7+5BF_1*);24=AF]N<!<=-4?C'5FN$S1-8L50B2H/*,@&$^N:S3O
M*$Y(BTP"8=K$PXB;96(J.LRH!Q2?%P,5;["5WC2A!NHY:K6DZ4LN*!:^U5$(
M[%PC,&@>AE5Q3G!GU-H(JC>WA@;%"FW9N5]?ZU(HV:@&QYKD1!5BGX V+Y+Z
ME 6H?.0EP>4GMY6\VL ^B#EFVS( Q!E$OCF,U> '&N(-^YH=OQMBYWU5GZ/I
MSR:>_7;$Z&O!R3G#_:E+B6K <7UI6 V8:$:D$8E8YBM7S!U(IQ-FYPWB7 F@
MUY=PG-(I@IY96R7.: BV>Z=^'#MP!?BJK@&1TM)J=HYK(JW?S FVHY>O:87#
MVL:$1[1"PYRA2H5IRE:;?8MSZN:EUB; @)N85I0_POJ4T36297*)>X]OZP/^
MU\))42,Q;XO5*#VJ@'O&$(6_1HUB29)H"5MW>Y0=-+S^63(Q$&-U47-'#B]P
M' PGL,F9$*@F<B"KL^1=@^9<[$NWZ<^' 2NB0@S,)YIZG.2BM)45)KWC$/;K
M@I)VA2:=<&<8< LK-==9D,6-KMP^A4<@Q.Y2CC&>5+A09;78^R$>GW,L26&K
M/ 9MZ_ ^DU\BY)V$DU:D!F92GB>4#EU[WBBDE-I&5;4)9_J_Z!$K3(R)0%AL
MM9H1R@1#3):&)]$U> S:IP&:1#V,#D]A@/L. QR-,DMS7$>_H5NX$^*SC7Q5
MNR-)A5M7.APG.FD6?N4@KY20B!0\GH(%JDK97-[P+&S7=&W.V"K96C:CF(:V
MLU7_\L?#H]>*(YWT[ZZQYNDBKU1-2SK>NSPH#59<T8QASU@J.$J;JV%[.;8%
M;5)F1$QLY@>V/";1/]./&H/KGA[USM([#<-TQB!GI<\;")M-F""\6/<N2Y53
M&TG#O,L,O1,0W4XBRF:?),X=]R^Y/[<(FTYS7BVN38/WIF1;LR_-QEHK2HM*
MUOA$Z\D"B/Z#XTTH5?)M%(:P8POK"EB,N+2-/!'J3W\K)<% R(=;2!.^7A.L
MWEHQ5"M;D?>!TNVMA=M+7$K!\:_. "J5&1(A&_L:= ]CLII21( (/I//5_.B
MC6933L/P,ZNBR V1';A0A(^\T?JCX5ZI#5$T%IJ%KATV9!SP)H-%,4"^PVC'
M<.?'8!#=H/<2WR).RB>=(<@E!8DT?[$6$BA)[*04&(AMG%,R)[ \9F89:WA3
M/,-/E-CB[GU5XW]Y4J;A W/_P1EU[QHXIU[=6SX2PS3>4I5P=*DEP0J]BB*F
M,<*NQC1FWZ?R*=7=#6[[]9Y:=]J"F)A#]L.2B5&RE8OADCY/\W31+#SR%-E_
M&,82%3\-JOC#$S)/%(;8,GV95J;2SQ8,/=#^-Y5MAV'YN#FP3/$V:#=PAQH;
M09$'2Z;/'1]<!F05(6UV#ZW.N0D*,ML9-;,F:57N8/K9,X83%IL>9S14_X_F
MLXRU\!2V'GO86H3#XP<2H@ CEJZ?.L6AE=W+]N"V/6$ZQHA5,NT\G)%4$B P
MA151'LM8_ 'X5 F(F^YU.K_^$^M@;"=6T 5T.P?6A4^Z19,4,.W9#I?:=_6,
M$JTMJ-8==-C1TGL< NUM][W.N>1I2S&]/-:_P\FAK4W%]"!G.\*3L%4A1 3%
M"@/WH&\E;<MYW1:^6493> ]'.Y#+!0QY1A]TQ.GP8HXII@Q;6I>.[L.4G4BX
M>:A;))FD/'@/FF/Z+;G0.+=@*<K;CC#K$<#6M>70UN2EYI:^S;NQ>X1'#$^H
MF5Z95<:NI>2AU@8KU1VC<Q4Y3NS TVG-X=82XVG$>6$!DE?AY-Z5TW2[=8!'
MHP.48!^,#QZ[V.2^=/LW'C4<HPMD>/[::[[=0Z:'0W&(;$"\Z#65GP0 O-$(
MD]G9/[ \K@/$CEC)C(>3"3^1TG1/CPWO'H'Q0-LLENQ0R&\'>I\XNGPO+4T:
M$#.2RDO2VDOM428 QD6%G\"X%F2.A$-W;G '<BQ1MB&FXTDJ3I%ZOEP6A@['
MY4(Y"=7#PX!>'9N.PL4 K\V8N("24#"NRZ)(3.L,[E?!.<?2PU^IRN<#D=/S
M8RIIE'JU9-#$NH=R'LR:L05Q,WIQX=AV-R'T)(=X,?6%8]8?)1'+R$KI_+:R
MU/5>LY*RQ/"N$QW+L-B>) [=,#5I:=MQFT_ W_%'"!D>?P75!8%P$9_=+5\T
M$- .LE'.LK"Q:D/<7OB2:*I;58LB.2!-!8U$G=!:[]A@VQ%;OT4O%$SW'Z"X
M+ T4\7+R5.);* Y*@%P**5,IEUT6S' -$63V2:M\+-,8Y-?R+YTC>H,R\PSA
M62P$$4$I/,(-&)O$7VG&>CG8B _B;Z,L_"UG_;,5!732RJ>HQF"[EU?>4;N>
M.G"Y2<'+6_W"\D$&CZ)D!<^EB\;[D=F#(Z/5PAIW0SJR$76M@%FF_O@LC+\H
MO8&U,?W.UK^Y\L/@5GBJ9HD/JD*XT3V.FN)%,W_DAI#?'P]B6QRH9:CEV[T/
M\4&"N8<OML:P/R9[:GRUR,>9FJJ%VC*QOE>NCEH^-MP0MMB!W?5T;DN,--,9
M!^'4 4I^K"62SXS=73/E44Z[SG,C,=Q:J=+X5HN-VQ[UFV/=O&=(YJV2:P5'
MXJ6^3VL-AQQE!6&#+)X,K)>4*T04G#(?M==I;:.#J/65HSV0VN/\^@ZF]A=\
M]0?44[)@;>CZQ>3YUH+7>#*.CPG]!*X#(<Y3A:B9[Y"> YV2-^IC46\[#7L_
MYR77[\  *?&8:'%HS2^YXU;8V\:;E*(,9B2.AJ )M'41=2MQ\OY"(U0][; .
M=_3K*/L<'PX?1BE*.":\ENB&<=:%Z:OHD)Z-;4YHEAX&K+#M_3/&0C]XLTJ*
M[6Z5L[GOP/?"5^_:*06//0*YAUO%5.]ZFT5F +=*STVTZ03J9R^%+9KIGN<A
MV[<.]OV+R;ZPL3"T'TDV,6_J\&@"+K2=VSAK[U>AU.W^5"U^=2UIJY:^>9Q;
M:'RIC3.,91;IMOMO8);O(9TS\YE2VD@X?5/O+YM6,X.@PUANA(N->^*0%I?.
MB'@LLLAS^!554IH27*W*W!49&//\$W*01C_"/EL]FW/];M%4U,T8G#P%1]3.
MGXZ>Q[ >N^@O<4>F'33YT;F3^.T"JR$B&+TR_86G*Z;6YDZN2/V-+1+D'*,.
MV!4& 0U E_ZZ*!++3U7M3J('0C1\D;#-[31#N#N?CVYWOM734E4?1Q8[N;]M
M:;[OUJ#)PT='^C):7@5KUUVEU[<^E;<^]E=,$Q<VIVX9<#A[U7B<'O#<UOWO
MQAI7W2+D"#?EB\G#!U7ON"O??<S4%3QXR\T!'VQ7FN\;U:[LA"M=R$IV:RM@
MZ9]_0;H99V5]RKG_UMO"G9*%N]>$=$_0$L-=S&/9;@W8/VPL;9%RO%:PL__Z
M5HE@-^H9WV/8\_,\)2^2.!WZC-\7#_V\,.CG?<UCU-HO1V=*?2B:D836SCY;
M,?O?@$E]^/-,FVK7CJ/M 4'Q># %-YX2P%LN=4&PTW2&>!6*N>'_5D.4>;:V
M/=-#F[Y'W6]OOWS=+LK1"*/65AR&89';F*H10>0&T''2D-9W*\SYLU/M?EZ'
M7D?QK%Q3!D$9F59\%D]MTJ:YL3*(8M* @Z1K;]+,=-\0!\87#B[$13,]0UA:
MY9-:^YNZ:^@04EQ7MK:63!9[7O<=U0^9>XW)UGC*_8V\4,@SZ-@_]ZTZ.54E
M[DRP3&&F>EC),3GOM8-S&Q)C!0LL-4J]6,%#CO#Q6: '7@;A84<P@ C;:FA@
M7/:" *.VGV'PHB4'WR#^R[=*KK!!9V'.9B9*N&1[!0Y3Q4>U/>N]SDM7!=$D
M5;ZYT>3IOQM4.U@3S> <<2Z8^8A?Z3=DYOZ3AB-ZW@K)>,P]CS +>#!"D]YA
M+A[%+KTSZJ3R4"=W09ETL20>#\'G@4D>&D6RW5/Y"4/RNP7_D6!-;CLEQ6\>
M=N+[O6C'/ CN))6G4#"]W^S].GS.)Y?FR:7Y.R(4#I[P0UNS[K\J !$9-Z-#
M$#VR'8G[<;R(H<>^'[\^Y)!V(^L<E%\&'?38&(EP![X8WPX<:PW'0^S"H#KC
MB^Q$I"S*DUO:$(2VJMN4?2&M%E5YS]-NKV%W5G"K27EWFYLPER5@][@"$JV0
M6:)ZC$?ER[$QO1B4VV/?HP-HOK[=:':@>LISCCW/Z;A%[UU=NBB'(4]=$X2A
M1H#F]^:GT [RE"/=K+$;"V&I"^8X*<HJU,=339S.F]YHD Z.>\36?'\!J-"6
M!,"PI8W0!2GR9TCBI^MT^\19TH5M8^%W*G#M#O/-\'NB7[@#?LET1@Y1QH3T
MP4D7C#,' QWGE-=#+\3X.@IN."$Z,T5'2\\4K/$S.M82?1+%5.4TR]O80YBZ
M,J6H00_ND%LP!3UU[FFDQTE"0HI%&S%30:T;MZ0U ^*KN3^Q9@DP\,(H+)""
M2TM%:U*<**D]'!OV[]T#WL5Y_;CV9WRQ-ZDM/DM!<0VT:L86.Y7.7)-'AIV9
M0V:S)A)2^\DW<1> OB3OK<KVON&<4S7[>%EB6NZ9J*8Y_??Z2RFJYU^ "7&\
M@)6W18U"1^QN1J"\#A<WU/78$<?&(6?;<]ZFO$--XH8,GT_4B\JT#43$,K'(
M6:+VXQ^.HY^+!*3ZO,G8>7M?%G--/095%DDC6:\;:7&=5@2NAL$I:MH58JZ+
M/-Q32S13,!N3J9N@UQ31]!'LPO'ALG%/O:QTB24B1G6C_DD2[(%XIQ<^3,!G
MBVCHYY.#;>Z1[=9[/6;M\-EPE=AS;W].<S@\*1+EHL-CBL89?77_/O[&$]*F
M5'D@B-56=<03QF1  )^(2NZ%J,1LX\>X=XZVBYH>V;XU2?]MTR\\W,'QE<$:
M*FHG- QL>+D=:I1'IP;&%U3\6565FETUE:[K;8.-SKP.WZDTL[1MJ2FL5V-*
M$3;=X1ZV>M^X_!5Y+GMA!4J S%SIZZ#Y=#0%4_/Y)SQZU3KWCG9PNK'GEM<X
MM&=+8PS(Q,'(I28UP"2=?A^8#94&3F4W5IO_R]0/FHXY.;P3H83%$H_Z)J<&
MUM%<XK#42X8;H(,7G<[2I50=F+Y?7JR58G37*FO(!4_S:Q@HO\L^>F729K#;
MZQ1T (8*2)\L&N%[H5FB7"XNDP1]JX8>T;O4CJP>0VE3')0 P@=L$.X)2N+E
MB";F%'#,4M<4)A2&3-T$-@Y6<,Y<:-Z-HOI\?J>GC.#6$T)[AS#LBUOLUV[$
MS#,@>)-RLSY/MU&D+%,IID'FKKT$[!)8*G@ZV>ZVWM=O46R:'9U@ZZ,)-@-T
M+Z!DA:^'4*CIPF@'U&BBYS1J,NAW@R*,X!LX/3DEBV?>P#^)#H%4B)[/O8Y9
ME B18" \/T5C"-L"IIX>Y[Z(\%;ORZ09)8TG-0I3>DMLZW3L&,ZT]C1Y6SH5
M:0"FN0;WSA &<0[C2G+,M<BD/O5XSE5SRN&NX+"\UAG>X256A.N:PJ31=5ID
M]LC"IV?ZDDU)OT]&V&LYH,Q.\3E&^_GZ4L35ML_B?BMP0#<@$>;FZUVR ]&E
MY$["P7CP,^4Q)T5")^$/)I$C$60^UT!^9^:9UQR!AN%?&UX?W!5SD/E\Q1OL
MFH\RU1"'30+F:@'/K%>2%D3S^1([\=;!I^(>O9;8,NYRV!F1P(OF*LVPZPHE
M;VKI49/ UJK0+E&T9ZJ!6CQJ0):O'(A?ZJ F2%88G$BT2]V>B<V.V6C- RG"
M"L$4;'SF3EAJFGH_]R8?A,@6:?D<6\7C7/_8/F?&JQ%3UA36L(Q-TZ(\\1_H
M]>^I7/,]>BW",TN<?O1 %*]<L^3VTXD;Q["9]0B]A1=/08/ 4X%?;3EBX'LH
M ]X_.0YP8]OL=R$R+3&S'@? -$9-"'6P7-E]?WYR[+R?^@KN=+J$/*&IQL1>
MFU*(>E@2DA)/X<T=AL<8@GOYM)M\E"9F@;>,(8HVVTX\5+8_,8.KDSL@(UPC
M;V[.Y7B]GCSTS_/0530M<K"H\&G4?B:D2K,O<#[+-OQU$9J[..J;A(/O)JX4
M,"I@2YH :5_@B&.UT659@"ZO5(8=>?%FE->4$!-5',U4-FL8UT[/-G=-5461
MLCL$I^Q'"2GVG_;W7\1'!R_A*0DJ;1L^SA@SEN9ST]T]Z.^-'87SJL&>GN]+
M1$:<@9+_1+<<@]/X2SE5N;T$QO@;K"=LADM\T@Y><5;K!=)SP4FU;+RP,3[Z
M![ 6%?7I_2>L10D[!VU<$&@;1L==1%M*H5"^04A@;>20[QDHZ4%5H#*T3"66
M?<N$]1X;MP&;#A/\?U\_;&&H:/;160??/5D'WGA^4]45;);Z*[$0W' _UTI@
M_0G^+;8P70_J'[(6[F;?M[J^F]P@I<<\@M'G0[A0;D.^!H_ZI6;NR;ZZ9_NJ
M59"QY;R')R!;L*5:XGD'>XIRWZ<FY]VU>0X.X\-71Y/]#<P>F4=O+'W6!HX/
M+* &)YN(3F .EF#A3&%['.YQ!AY6&BV.P)P#"XZ-.A(_C8N=K3%_Y#.';2^V
MNWY#VE'\?&H "$,[R4 'PVNCWW">,:E_\O[LV6_8?\3.4EL6PKS Y-!V<-:,
MQ\\EJ5KJ><:!4YRMXE.TW[LPH<5VAJH&P<#GF+QH$/_#M&4_8@7&;\\.6#'
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M*OUU6B0K^)^K>I']_?\'4$L#!!0    ( #E"F5JEB,UL' H  +XZ   8
M=&YE="TS,S$R-7AE>&AI8FET-#0N:'1M[5MM<]HZ%OZ^OT*;S/:F,T ">2%
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MBQCW@&WG%G24RIC<AB4G%##\4/$JY(K&S["ZH&1 ?N.$QK,2<?1" DPLI43
M]5L)MT=E0<#@FR0\AO^!51BT2\525VO;IC@&8UN\/;Z1<!OVI_(CS+A17G_L
M^([M>;9_MX,D_GAGN[;EE0BCP#5 .HA)HYU:,_#U-J.2QJF0BAP ?$,V@&Y"
M!+ZN/*=\R09,2B@!->BS2$S?DQ'4'X%NI&(@H ;[RH),$QQT';*(3UA>'WO*
M40>%A"_;D2U5DBVV'#>L+V'39J1VIJU'->>LPNY!Q?Y,K_F 2^ MM6P1%VN_
MW*65#9$9JZ;#XQ))I)CP$#U'V%K=%P?8T#A@6!WV,(LC/N:ZA^%0LB%T!HUX
M'/ $1J%CD<%R0=7CRBEX=<1C,8>.')'"ZH09PV$:6[S]6M!MV/IW^Z>-UBY3
M3SNBH/G$?;=_?-X"!UE$&=I*52+=;AM0!>[-="2B:$;$%(E'97T%R$-\KQ(6
M7=#5%H/'91&C"N8R%W9'D+1%L%G:>#0S%#C&V!+%HHA@I(CPX*E:^&>YR5I=
M?6RF*8L.!CSBFO<@@)$A2:A,9]B0@M\&8M- N];IB*8(S81)X+@E0NWL@.6Z
MYBH1BN-$M@%V)5!O#M['DEBXM.QKPH+4;&D0"05VQ6P?FB7M58C!=[S#+4(K
M( C"Y9@9^$QY.M)S69IS"4R@*:T>54X/Z/LYN\TA9="F]%=I0&Q<*:Z"$95#
M5C3)@<WF'UZ!_/;B,Q=V&["Y6Y2X!F3Y>JY0YEH/_*"*<3'I 1D&3.):5.LM
M1=I,@@/! ^W)91*]/1WSYKA5I%&IES1ZX6^U<JRQ"0\GJTC&DH.:&27A,8H+
M==K@$P)[_X^=ZSW#XIW9MU?F"].M'@Q7.:#T8J/0.<K2D9 PJM[%/,):#K"(
MSL2M2=,A1D26ZDX!.HH9G_Q.1"&3JAA=^[I;S[5.[Y'XN*0W/=<NE $\19:G
MP_+)8"0Z%!BXX")A\"+@LR1#(4Q@.J%11OL1>]F\E+-NP'BBU\@8+6X"7+#^
M-'B.Q31BX9"%IC+Z#ASF-\[2C*+_&H@)BW&?M:>*#LL\>&+_RC J@N\PG!Z]
MSV*(M--"[&)+0&\'X R+J0*<GZ_GIH2&&)V5(S8PN]+Z3BA0KIYO;.NJE<V1
M?>O%2C6*A0I9D.=1FQDLD,1F>Y=MFF@SANKF@S7>: 18(619GA3E(1E:>80D
MC^?:K5,VQK%2(T BL/^$:52-&8UA[@@K!<"8FX+Q2GIGO?KO%-)JNX*TW&BC
M^L^]N0V#S7_=D5Q0X"!#ED,2RV(\'.(F P[?9-%L(,58!V4K+JK)_&!CE0&Q
M+LH7_2/">8S1V2^"QN-=0>,M6"Z)3$&Z=+II&-YUO#7'J.2QT^V2*YO<]K[8
MKF-?DZNG$K&<:]+N.9[O/L"7CD.L=KOG7EM.&QOX=R5T&TC7>O1([T8_>[[E
MV_CBV(_DJ>=^^D7P=K(K>'NDVG4%:OB8R1D>>M)HX["S2<?S'FQ7 PI? 5">
M;]L$G<ZK)])Q7?M+KVU==9_(H]7Y DZHW],5;QZZ7=OSB?UW'X!*[FWW<\?W
M-3R)!4#N8",-043KDQ[  B2[G=L[7W?B=@#G4/OC@_ND(0RUNO8M?+QW>VW;
MONXXM\1R.Q[^VWOP$;P]E[AVU_+QDQ9DK=X8#?CFU>GYMF<>;Q\LUW)@JAYV
M:J9N.9[5]CN@5ZA<OOWY'H:"*>6+8>KAXR^B.Z>[HCL818.EQ.ACT^ZIOQP%
MT1E!'Q-,_(S$V;AO]#L0"99J)V!MG%HA-IY/YBXJ-)GECFQ?'Q="_#L$OR J
MD3YXN_C=^!1C\&:'3$=WDB62Z? 6?0U%Q\P$8#C2+P+0LUT!Z!VC6'<;P#G*
M12F<T'FVZ6T\F@"JC_=Q> P28)H:(WEP>B'"YRP_!=4GXN8ECF8E@A=T8I&:
M _)Y>@%/2+66?&]0[1MKV$-P%@LR!8T:BQ P"!I \(1#\B#5^I5/QX2$4*A/
M:Y6>69XY)[\&Z.N[ GI_D;;; MP7"<0Q?8:^ 4MS?LQS91+0)3$ F^DK2R8_
M/ $,0%"GX:8RS XCU&??PRUVAKEH& "/=(K>) LP=Z%0$5*J[Y28O$6IH'"3
M8IO70_49TQ#H6T0,@LK\R,VD[PHS8ZZ;;/^UH7?[C>J6G;MXL"C4'#31(2O2
MC)L]AFD<KT]Q+M\/+D[1FI)% .$)6[DQ7+3JBS05X^;1H@GM*[QSL-KD.Y>,
MS=^17!#GD)7[DM'G,AT LIHT HI6>S_Y8O/:&O.R__<V03R2WX(C^DRC=_,R
M 6YTTAC-@.H,Y5M\8<QCF(&*%S?&#"70N9W69\#F\A+M"^AV*O$8/E[5^[=7
MRZ3:Y\B00-=E6+6()HHUBX=6R%42T5F3QWKNNE%K3"4XG>4<3J>P4!,\'PMH
ME-.+9AI3G.]RHU$YJS=PHU.0)@V+@7,,5#0&#M-PM>SDO-(X6E]\5*FN+?M)
MW1YJD8W8L# JH?&'O>.];YR&YA&I:E^@Z.^-JK7D*U9>]B[0D*XLHTCV-H/M
M:@WOPKH=Q_;)K=M[N"]!B-RNZ,MT+V\P;T[_M(Q7,WT61#9$U2##6Y[/N_V3
M>DOIO^03PVRPGP$+PA/_H2/%6K6RD4-%O;0.1(IF<7=.=!]_EF-DMS6-@E4D
M7SA$(_?@B7$44(<4[1%G T+(#830<<"!BLW!_S?F9TX"AYK_?I!B7PTJ:M7%
MJKQEQWZS]F_6_N^P;WZ&83F?3(Z6M'N?[RWGJ40<"U.65I=8GM=K=_2;)O1O
M8K/?C/Z#C'Y-)SPD'ZE:7";<7DI<L/E.B;W$Y"_Y^Z=2]':$4X?F]Z.'^G>K
M_P%02P,$%     @ .4*96O"C>YWJ"0  \CD  !@   !T;F5T+3,S,3(U>&5X
M:&EB:70T-2YH=&WM6^]SVCP2_GY_A2Z9MV\Z P1(4@JDF7&(D]!2D[&=YO+I
M1M@"=#&63[*AW%]_NY)-2$G2SEW?P73:#ZEM_5JMGGVTNQ*GTW06G9U.&0W/
M_G;Z]VJ57(@@F[$X)8%D-&4AR12/)^0N9.J!5*MYK9Y(EI)/IBEIUILGY$[(
M!SZGICSE:<3.BGY.#\W[Z:$>Y'0DPN79:<CGA(<?]GBK40_:XW?UX];QR7%P
MTFBW6ZUF\S@,QNQXQ.HG_SQJ[4%;J&\:J709L0][,QY7IPP%Z+2:2=I=\#"=
M=AKU^A][NM[9Z5C$*8PFH;%Y-'UL])2RKVF51GP2=P(0E\D]T[8H#T0D9&>_
MKO]UL:0ZIC,>+3M_^GS&%''8@KAB1N,_*XK&JJJ8Y&-34?'_L$X#Y=.O"R/P
M,?03\9@5$VC46R#U9=_U?.+=WMP,[,^VXUL#TG<NX.'6M9].X7GA_Y6IE(^7
M7?V)QR',I7/T+DFW-1TN54J\+$DBAC"@$>EKH3+)R$$ZY8J\V7_?;-:[Q>3^
M(BEUCQT. O#@!^1^7N*_6,97)=)J:G3?5DBH[9$J(L;D,Y7!E)Q4C/V-6+I@
M+":^Y Y+R94465(!\8-:A5!RP2*ZH*#W0,A$2)IR$>,:L'(N05^IC,DRJ)S0
M."2W-:]&SFG\ -H%&P/JFR4T7E:(HQ4),+&4$@'7;Q5<GA3K,59B%?M&PC+H
MN/8CY+959K[K^X[M>;9_O8,\?'=MN[;E50BCP!= '(A)8V$:W?AZE5%)XU1(
M10X OB$;0S<AX;&IO*)MR<9,2BA)!3!.)!9OR13J3YEDJ1@+J,&^LB#3) 5=
MARSB<Y;7QYYRU$$AX>M[04F-I,3L;V43I*+&.\W_1Q622#'G(3IJL Y:V1S6
MF,8!P^J@\"R.^(SK'B83R2;0&33B<< 38# Z$QG,#:JV:HWFR1_$8S&'CAR1
MPE3"C,$P1XT2KY46M SK]&;_I-W=99[H113,E+AO]H_>=R^()Z(,-S95(8-!
M#U %_L1B*J)H2<0"64)E(P7(HW+Y#+O01VXI,7A<%C&J8"XK87<$226"S=K"
MXYY @6,,\2L6100#,X0'3Q50/VSE#-@KWU\VM8_--&71\9A'7/,>1 PR) F5
MZ1(;4G"R0&P::%\VG=(4H9DP"1R'U4?+;_:N\J+O@JM$*(X3*0/L*F#>'%R%
M-;%0M>QKPH+4+&D0"07[BED^W):T"R#&WW'E2H160% @XI@9^"QX.M5S69MS
M!;9 4]JHUTX.Z-L5NZT@9="F]%=I0&S\'JZ"*9435C3)@<U6'YZ!?'GQF0M;
M!FSN%B6^ +)<GQN4^:*[?-# 0)0,@0P#)E$7C597D1Z3X$#P0'MRF41O+\6F
M.6X5:==:%8U>^-NH'6ELPL/Q)I*QY*!I1DEXC.)"G1[XA,#>_V?G>LVP>&?6
M[9GYPG0;!Y--#J@\62ATCK)T*B2,JE<Q#X?6HR&B4U\OY,40(R)+=:< '<6,
M3WXMHI!)58RN?=W2<ZTSO",^JO1RZ-J%,8"GR/+\4SX9#!LG @,75!(&+P(^
M2S(1PD21<QIE=!2QI\TK.>L&C"=:1V;3XB8:A=V?!@^Q6$0LG+#05$;?@</\
M9EF:4?1? S%G,:ZS]E3185D%3^S?&49%\!V&TZ./6 QA<5J(72P)V.T8G&&Q
M4(#S]R]S4T)#C,ZJ$1N;5>E^)Q2H-MYO;>D:M>V1??>)IMJ%HD(6Y(G+3@8*
MDMAL[ZQ'$[V-H;GYL!MO-0*L$;(N3XKRD QW>80DCU?6K?,KQK%24T BL/^<
M:53-&(UA[@@K!<!8;06SC5S,R^:_4TAK[@K2\DT;S7_ES6T9;/[SCN0C!8XS
M9#DDL2P&\@RY25?#-UDT&TLQTT'9AHMJ,C_86&5 K(_EC_TCPGF,T=DO@L:C
M74'C%>Q<$IF"#.ABVS"\[GLO'%N2N_Y@0,YM<C7\8KN.?4'.[RO$<BY(;^AX
MOGL+7_H.L7J]H7MA.3ULX%]7T&T@ ^O.(\-+_>SYEF_CBV/?D?NA^^D7P=OQ
MKN#MCFK7%:CA8R:7>,I(HZW#SB9]S[NU70TH? 5 >;YM$W0ZS^])WW7M+\.>
M=3ZX)W=6_PLXH?Y05[R\'0QLSR?V/WP *KFQW<]]W]?P)!8 N8^-- 01K?=Z
M  N0[/:OKGW=B=L'G$/MC[?NO88PU!K85_#QQAWV;/NB[UP1R^U[^/_PUD?P
M#EWBV@/+QT]:D!?MQEC -Z_.T+<]\WAU:[F6 U/UL%,S=<OQK)[?![M"X_+M
MSS<P%$PI5X:IAX^_B.V<[(KM8!0-.R5&']MV3_WU*(@N"?J8L,4O29S-1L:^
M Y%@J78"7HQ3:\3&P\3<184FR]R1'>FS/8A_)^ 71!4R F\7OQN?8@;>[(3I
MZ$ZR1#(=WJ*OH>B,F0 ,1_I% /IN5P!ZS2C6+0,XI[DHA1.ZRC:]CD<30(WP
M @R/00),4V,D#TXO1/B<Y:>@^OC:O,31LD+P1DPL4G.:O4HOX FIMI+O#:I]
M8PU[",YB019@43,1 @;! @B><$@>I-J^\NF8D! *]6FMTC/+,^?DUP!]:U=
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M:6)I=#,Q,2YH=&U02P$"% ,4    "  Y0IE:$>3V9+T'  "\)   &@
M        @ 'U!P  =&YE="TP,S,Q,C5X97AH:6)I=#,Q,BYH=&U02P$"% ,4
M    "  Y0IE:KLI\]A$&  !''   &@              @ 'J#P  =&YE="TP
M,S,Q,C5X97AH:6)I=#,R,2YH=&U02P$"% ,4    "  Y0IE:Z7@M9P=  0"X
M<A( $0              @ $S%@  =&YE="TR,#(U,#,S,2YH=&U02P$"% ,4
M    "  Y0IE:5W7.\L /   XH0  $0              @ %I5@$ =&YE="TR
M,#(U,#,S,2YX<V102P$"% ,4    "  Y0IE:V<ELD-<?  #++0$ %0
M        @ %89@$ =&YE="TR,#(U,#,S,5]C86PN>&UL4$L! A0#%     @
M.4*96F8]VL^5.P  '88" !4              ( !8H8! '1N970M,C R-3 S
M,S%?9&5F+GAM;%!+ 0(4 Q0    ( #E"F5J-;LV1@0X  "(I   4
M      "  2K" 0!T;F5T+3(P,C4P,S,Q7V<Q+FIP9U!+ 0(4 Q0    ( #E"
MF5HMOX!,Y%$  !YC   5              "  =W0 0!T;F5T+3(P,C4P,S,Q
M7V<Q,"YJ<&=02P$"% ,4    "  Y0IE:^:_@+9E&  #]7@  %0
M    @ 'T(@( =&YE="TR,#(U,#,S,5]G,3$N:G!G4$L! A0#%     @ .4*9
M6FDCN2II.@  ]TT  !4              ( !P&D" '1N970M,C R-3 S,S%?
M9S$R+FIP9U!+ 0(4 Q0    ( #E"F5J\10V(<#4  %M&   5
M  "  5RD @!T;F5T+3(P,C4P,S,Q7V<Q,RYJ<&=02P$"% ,4    "  Y0IE:
MK;T=H8A>   !;P  %0              @ '_V0( =&YE="TR,#(U,#,S,5]G
M,30N:G!G4$L! A0#%     @ .4*96D27A@%Z5P  _V\  !4
M ( !NC@# '1N970M,C R-3 S,S%?9S$U+FIP9U!+ 0(4 Q0    ( #E"F5IW
M?[B%@78  (*    5              "  6>0 P!T;F5T+3(P,C4P,S,Q7V<Q
M-BYJ<&=02P$"% ,4    "  Y0IE:?K68V#UT  !9?@  %0
M@ $;!P0 =&YE="TR,#(U,#,S,5]G,3<N:G!G4$L! A0#%     @ .4*96L96
MUX6G/0  U$\  !4              ( !BWL$ '1N970M,C R-3 S,S%?9S$X
M+FIP9U!+ 0(4 Q0    ( #E"F5JH?EG9IR8  ' Z   5              "
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M '1N970M,C R-3 S,S%?9S(T+FIP9U!+ 0(4 Q0    ( #E"F5JB;[+@-9,
M &C;   5              "  3%!!@!T;F5T+3(P,C4P,S,Q7V<R-2YJ<&=0
M2P$"% ,4    "  Y0IE: K,:<C="  #85@  %               @ &9U 8
M=&YE="TR,#(U,#,S,5]G,RYJ<&=02P$"% ,4    "  Y0IE:?R>CZL-9   ,
M:P  %               @ $"%P< =&YE="TR,#(U,#,S,5]G-"YJ<&=02P$"
M% ,4    "  Y0IE:_#5GY3%C   Y>   %               @ 'W< < =&YE
M="TR,#(U,#,S,5]G-2YJ<&=02P$"% ,4    "  Y0IE:]T]N\@HI  "T.@
M%               @ %:U < =&YE="TR,#(U,#,S,5]G-BYJ<&=02P$"% ,4
M    "  Y0IE:#A*O+=]3  !:9   %               @ &6_0< =&YE="TR
M,#(U,#,S,5]G-RYJ<&=02P$"% ,4    "  Y0IE:!!6H+*53  "0<   %
M            @ &G40@ =&YE="TR,#(U,#,S,5]G."YJ<&=02P$"% ,4
M"  Y0IE:Y$R=5NXJ  !M/   %               @ %^I0@ =&YE="TR,#(U
M,#,S,5]G.2YJ<&=02P$"% ,4    "  Y0IE:]RSL8:_D  #T"@D %0
M        @ &>T @ =&YE="TR,#(U,#,S,5]L86(N>&UL4$L! A0#%     @
M.4*96H(" N8W@@  4A4& !4              ( !@+4) '1N970M,C R-3 S
M,S%?<')E+GAM;%!+ 0(4 Q0    ( #E"F5J6[ ]O!&<  +"4 @ 9
M      "  >HW"@!T;F5T+3,S,3(U>&5X:&EB:70Q,#$N:'1M4$L! A0#%
M  @ .4*96O>V>6+690  )XD" !D              ( !)9\* '1N970M,S,Q
M,C5X97AH:6)I=#$P,BYH=&U02P$"% ,4    "  Y0IE:Z:I^NMMN  "IX (
M&0              @ $R!0L =&YE="TS,S$R-7AE>&AI8FET,3 S+FAT;5!+
M 0(4 Q0    ( #E"F5JEB,UL' H  +XZ   8              "  41T"P!T
M;F5T+3,S,3(U>&5X:&EB:70T-"YH=&U02P$"% ,4    "  Y0IE:\*-[G>H)
M  #R.0  &               @ &6?@L =&YE="TS,S$R-7AE>&AI8FET-#4N
9:'1M4$L%!@     G "< 10H  +:("P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>tnet-20250331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:tnet="http://www.trinet.com/20250331"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="tnet-20250331.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <instant>2025-04-18</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:ProfessionalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:ProfessionalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:InsuranceServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:InsuranceServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">tnet:TriNetTrustMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2029NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2031NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2029NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2031NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tnet:SystemsDevelopmentAndProgrammingCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tnet:SystemsDevelopmentAndProgrammingCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOfFinancialPositionLocationActivityAccrualAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOfFinancialPositionLocationActivityAccrualAxis">tnet:AccruedSalariesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOfFinancialPositionLocationActivityAccrualAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOfFinancialPositionLocationActivityAccrualAxis">tnet:AccruedSalariesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:ProfessionalServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tnet:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:ProfessionalServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tnet:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:InsuranceServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tnet:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:InsuranceServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tnet:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tnet:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">tnet:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>tnet:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-26">0000937098</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-27">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-28">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-29">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-30">false</dei:AmendmentFlag>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1 contextRef="c-141" id="f-598">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2025-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-36373</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">TRINET GROUP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">95-3359658</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">One Park Place,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-10">Suite 600</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Dublin,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">94568</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">352-5000</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common stock par value $0.000025 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">TNET</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-19">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-20">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-21">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-22">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-23">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-24">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-25" unitRef="shares">48399165</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-3" decimals="-6" id="f-31" unitRef="usd">209000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-4" decimals="-6" id="f-32" unitRef="usd">214000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-6" id="f-33" unitRef="usd">1065000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-6" id="f-34" unitRef="usd">1050000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InterestIncomeOperating contextRef="c-1" decimals="-6" id="f-35" unitRef="usd">18000000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating contextRef="c-7" decimals="-6" id="f-36" unitRef="usd">18000000</us-gaap:InterestIncomeOperating>
    <us-gaap:Revenues contextRef="c-1" decimals="-6" id="f-37" unitRef="usd">1292000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-7" decimals="-6" id="f-38" unitRef="usd">1282000000</us-gaap:Revenues>
    <us-gaap:OperatingInsuranceAndClaimsCostsProduction contextRef="c-1" decimals="-6" id="f-39" unitRef="usd">942000000</us-gaap:OperatingInsuranceAndClaimsCostsProduction>
    <us-gaap:OperatingInsuranceAndClaimsCostsProduction contextRef="c-7" decimals="-6" id="f-40" unitRef="usd">907000000</us-gaap:OperatingInsuranceAndClaimsCostsProduction>
    <tnet:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction contextRef="c-1" decimals="-6" id="f-41" unitRef="usd">71000000</tnet:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction>
    <tnet:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction contextRef="c-7" decimals="-6" id="f-42" unitRef="usd">79000000</tnet:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction>
    <us-gaap:SellingAndMarketingExpense contextRef="c-1" decimals="-6" id="f-43" unitRef="usd">67000000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-7" decimals="-6" id="f-44" unitRef="usd">72000000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-6" id="f-45" unitRef="usd">46000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-7" decimals="-6" id="f-46" unitRef="usd">48000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-6" id="f-47" unitRef="usd">20000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-7" decimals="-6" id="f-48" unitRef="usd">18000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-1" decimals="-6" id="f-49" unitRef="usd">17000000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-7" decimals="-6" id="f-50" unitRef="usd">18000000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <tnet:InterestExpenseBankFeesAndOther contextRef="c-1" decimals="-6" id="f-51" unitRef="usd">14000000</tnet:InterestExpenseBankFeesAndOther>
    <tnet:InterestExpenseBankFeesAndOther contextRef="c-7" decimals="-6" id="f-52" unitRef="usd">16000000</tnet:InterestExpenseBankFeesAndOther>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-6" id="f-53" unitRef="usd">1177000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-7" decimals="-6" id="f-54" unitRef="usd">1158000000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-55" unitRef="usd">115000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-6" id="f-56" unitRef="usd">124000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-57" unitRef="usd">30000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-6" id="f-58" unitRef="usd">33000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-59" unitRef="usd">85000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-6" id="f-60" unitRef="usd">91000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-6" id="f-61" unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-6" id="f-62" unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-6" id="f-63" unitRef="usd">87000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-6" id="f-64" unitRef="usd">88000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-65"
      unitRef="usdPerShare">1.72</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-66"
      unitRef="usdPerShare">1.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-67"
      unitRef="usdPerShare">1.71</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-68"
      unitRef="usdPerShare">1.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-6" id="f-69" unitRef="shares">49000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-6" id="f-70" unitRef="shares">51000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-6" id="f-71" unitRef="shares">49000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-6" id="f-72" unitRef="shares">51000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-8" decimals="-6" id="f-73" unitRef="usd">349000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-9" decimals="-6" id="f-74" unitRef="usd">360000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-8" decimals="-6" id="f-75" unitRef="usd">1024000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-9" decimals="-6" id="f-76" unitRef="usd">1413000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-8" decimals="-6" id="f-77" unitRef="usd">21000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-9" decimals="-6" id="f-78" unitRef="usd">32000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent contextRef="c-8" decimals="-6" id="f-79" unitRef="usd">478000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent contextRef="c-9" decimals="-6" id="f-80" unitRef="usd">349000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-8" decimals="-6" id="f-81" unitRef="usd">60000000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-9" decimals="-6" id="f-82" unitRef="usd">64000000</us-gaap:PrepaidExpenseCurrent>
    <tnet:OtherPayrollAssetsCurrent contextRef="c-8" decimals="-6" id="f-83" unitRef="usd">881000000</tnet:OtherPayrollAssetsCurrent>
    <tnet:OtherPayrollAssetsCurrent contextRef="c-9" decimals="-6" id="f-84" unitRef="usd">916000000</tnet:OtherPayrollAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-8" decimals="-6" id="f-85" unitRef="usd">44000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-9" decimals="-6" id="f-86" unitRef="usd">46000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-8" decimals="-6" id="f-87" unitRef="usd">2857000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-9" decimals="-6" id="f-88" unitRef="usd">3180000000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-8" decimals="-6" id="f-89" unitRef="usd">134000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-9" decimals="-6" id="f-90" unitRef="usd">145000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-8" decimals="-6" id="f-91" unitRef="usd">9000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-9" decimals="-6" id="f-92" unitRef="usd">10000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-8" decimals="-6" id="f-93" unitRef="usd">22000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-9" decimals="-6" id="f-94" unitRef="usd">24000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-8" decimals="-6" id="f-95" unitRef="usd">461000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-9" decimals="-6" id="f-96" unitRef="usd">461000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-8" decimals="-6" id="f-97" unitRef="usd">146000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-9" decimals="-6" id="f-98" unitRef="usd">156000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-8" decimals="-6" id="f-99" unitRef="usd">146000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-9" decimals="-6" id="f-100" unitRef="usd">143000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-8" decimals="-6" id="f-101" unitRef="usd">3775000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-9" decimals="-6" id="f-102" unitRef="usd">4119000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-8" decimals="-6" id="f-103" unitRef="usd">82000000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-9" decimals="-6" id="f-104" unitRef="usd">89000000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:LinesOfCreditCurrent contextRef="c-8" decimals="-6" id="f-105" unitRef="usd">74000000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent contextRef="c-9" decimals="-6" id="f-106" unitRef="usd">75000000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-8" decimals="-6" id="f-107" unitRef="usd">49000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-9" decimals="-6" id="f-108" unitRef="usd">76000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="c-8" decimals="-6" id="f-109" unitRef="usd">544000000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="c-9" decimals="-6" id="f-110" unitRef="usd">580000000</us-gaap:AccruedSalariesCurrent>
    <tnet:CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent contextRef="c-8" decimals="-6" id="f-111" unitRef="usd">189000000</tnet:CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent>
    <tnet:CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent contextRef="c-9" decimals="-6" id="f-112" unitRef="usd">189000000</tnet:CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent contextRef="c-8" decimals="-6" id="f-113" unitRef="usd">45000000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent contextRef="c-9" decimals="-6" id="f-114" unitRef="usd">44000000</us-gaap:WorkersCompensationLiabilityCurrent>
    <tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings contextRef="c-8" decimals="-6" id="f-115" unitRef="usd">1645000000</tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings>
    <tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings contextRef="c-9" decimals="-6" id="f-116" unitRef="usd">1906000000</tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-8" decimals="-6" id="f-117" unitRef="usd">12000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-9" decimals="-6" id="f-118" unitRef="usd">13000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <tnet:InsurancePremiumsAndOtherPayables contextRef="c-8" decimals="-6" id="f-119" unitRef="usd">6000000</tnet:InsurancePremiumsAndOtherPayables>
    <tnet:InsurancePremiumsAndOtherPayables contextRef="c-9" decimals="-6" id="f-120" unitRef="usd">9000000</tnet:InsurancePremiumsAndOtherPayables>
    <us-gaap:LiabilitiesCurrent contextRef="c-8" decimals="-6" id="f-121" unitRef="usd">2646000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-9" decimals="-6" id="f-122" unitRef="usd">2981000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-8" decimals="-6" id="f-123" unitRef="usd">909000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-9" decimals="-6" id="f-124" unitRef="usd">908000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:WorkersCompensationLiabilityNoncurrent contextRef="c-8" decimals="-6" id="f-125" unitRef="usd">111000000</us-gaap:WorkersCompensationLiabilityNoncurrent>
    <us-gaap:WorkersCompensationLiabilityNoncurrent contextRef="c-9" decimals="-6" id="f-126" unitRef="usd">110000000</us-gaap:WorkersCompensationLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-8" decimals="-6" id="f-127" unitRef="usd">10000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-9" decimals="-6" id="f-128" unitRef="usd">11000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-8" decimals="-6" id="f-129" unitRef="usd">24000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-9" decimals="-6" id="f-130" unitRef="usd">26000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-8" decimals="-6" id="f-131" unitRef="usd">12000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-9" decimals="-6" id="f-132" unitRef="usd">14000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-8" decimals="-6" id="f-133" unitRef="usd">3712000000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-9" decimals="-6" id="f-134" unitRef="usd">4050000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-8" id="f-135" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-9" id="f-136" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockValue contextRef="c-8" decimals="-6" id="f-137" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-9" decimals="-6" id="f-138" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-8"
      decimals="INF"
      id="f-139"
      unitRef="usdPerShare">0.000025</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-9"
      decimals="INF"
      id="f-140"
      unitRef="usdPerShare">0.000025</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-8" decimals="INF" id="f-141" unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-9" decimals="INF" id="f-142" unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-8" decimals="INF" id="f-143" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-9" decimals="INF" id="f-144" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-9" decimals="INF" id="f-145" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-8" decimals="INF" id="f-146" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital contextRef="c-8" decimals="-6" id="f-147" unitRef="usd">1070000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital contextRef="c-9" decimals="-6" id="f-148" unitRef="usd">1056000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-9"
      decimals="INF"
      id="f-149"
      unitRef="usdPerShare">0.000025</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-8"
      decimals="INF"
      id="f-150"
      unitRef="usdPerShare">0.000025</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-9" decimals="INF" id="f-151" unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-8" decimals="INF" id="f-152" unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="INF" id="f-153" unitRef="shares">48397519</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-8" decimals="INF" id="f-154" unitRef="shares">48397519</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-9" decimals="INF" id="f-155" unitRef="shares">49527506</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-9" decimals="INF" id="f-156" unitRef="shares">49527506</us-gaap:CommonStockSharesIssued>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-8" decimals="-6" id="f-157" unitRef="usd">-1006000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-9" decimals="-6" id="f-158" unitRef="usd">-984000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-8" decimals="-6" id="f-159" unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-9" decimals="-6" id="f-160" unitRef="usd">-3000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-6" id="f-161" unitRef="usd">63000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-6" id="f-162" unitRef="usd">69000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-8" decimals="-6" id="f-163" unitRef="usd">3775000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-9" decimals="-6" id="f-164" unitRef="usd">4119000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-6" id="f-165" unitRef="usd">69000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-6" id="f-166" unitRef="usd">78000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-6" id="f-167" unitRef="usd">1056000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-6" id="f-168" unitRef="usd">976000000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-13" decimals="-6" id="f-169" unitRef="usd">14000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-14" decimals="-6" id="f-170" unitRef="usd">20000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity contextRef="c-15" decimals="-6" id="f-171" unitRef="usd">1070000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-16" decimals="-6" id="f-172" unitRef="usd">996000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-6" id="f-173" unitRef="usd">-984000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-6" id="f-174" unitRef="usd">-896000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-19" decimals="-6" id="f-175" unitRef="usd">85000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-20" decimals="-6" id="f-176" unitRef="usd">91000000</us-gaap:NetIncomeLoss>
    <us-gaap:DividendsCommonStockStock contextRef="c-19" decimals="-6" id="f-177" unitRef="usd">13000000</us-gaap:DividendsCommonStockStock>
    <us-gaap:DividendsCommonStockStock contextRef="c-20" decimals="-6" id="f-178" unitRef="usd">13000000</us-gaap:DividendsCommonStockStock>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-19" decimals="-6" id="f-179" unitRef="usd">90000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-20" decimals="-6" id="f-180" unitRef="usd">23000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-19" decimals="-6" id="f-181" unitRef="usd">4000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-20" decimals="-6" id="f-182" unitRef="usd">7000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-6" id="f-183" unitRef="usd">-1006000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-6" id="f-184" unitRef="usd">-848000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-6" id="f-185" unitRef="usd">-3000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-6" id="f-186" unitRef="usd">-2000000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-25" decimals="-6" id="f-187" unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-26" decimals="-6" id="f-188" unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-6" id="f-189" unitRef="usd">-1000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-6" id="f-190" unitRef="usd">-5000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-6" id="f-191" unitRef="usd">63000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-6" id="f-192" unitRef="usd">143000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-193" unitRef="usd">85000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-6" id="f-194" unitRef="usd">91000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherDepreciationAndAmortization contextRef="c-1" decimals="-6" id="f-195" unitRef="usd">17000000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization contextRef="c-7" decimals="-6" id="f-196" unitRef="usd">18000000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherAmortizationOfDeferredCharges contextRef="c-1" decimals="-6" id="f-197" unitRef="usd">12000000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges contextRef="c-7" decimals="-6" id="f-198" unitRef="usd">11000000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-6" id="f-199" unitRef="usd">2000000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-7" decimals="-6" id="f-200" unitRef="usd">2000000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-1" decimals="-6" id="f-201" unitRef="usd">-1000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-7" decimals="-6" id="f-202" unitRef="usd">0</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-6" id="f-203" unitRef="usd">13000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-6" id="f-204" unitRef="usd">20000000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnInvestments contextRef="c-1" decimals="-6" id="f-205" unitRef="usd">-1000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c-7" decimals="-6" id="f-206" unitRef="usd">0</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="c-1" decimals="-6" id="f-207" unitRef="usd">-1000000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="c-7" decimals="-6" id="f-208" unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-6" id="f-209" unitRef="usd">-1000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-7" decimals="-6" id="f-210" unitRef="usd">-1000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-6" id="f-211" unitRef="usd">-1000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-7" decimals="-6" id="f-212" unitRef="usd">1000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c-1" decimals="-6" id="f-213" unitRef="usd">-7000000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c-7" decimals="-6" id="f-214" unitRef="usd">14000000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-1" decimals="-6" id="f-215" unitRef="usd">6000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-7" decimals="-6" id="f-216" unitRef="usd">21000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <tnet:IncreaseDecreaseInOtherPayrollAssets contextRef="c-1" decimals="-6" id="f-217" unitRef="usd">0</tnet:IncreaseDecreaseInOtherPayrollAssets>
    <tnet:IncreaseDecreaseInOtherPayrollAssets contextRef="c-7" decimals="-6" id="f-218" unitRef="usd">-3000000</tnet:IncreaseDecreaseInOtherPayrollAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities contextRef="c-1" decimals="-6" id="f-219" unitRef="usd">-11000000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities contextRef="c-7" decimals="-6" id="f-220" unitRef="usd">24000000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-6" id="f-221" unitRef="usd">0</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-7" decimals="-6" id="f-222" unitRef="usd">-4000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccruedSalaries contextRef="c-1" decimals="-6" id="f-223" unitRef="usd">-17000000</us-gaap:IncreaseDecreaseInAccruedSalaries>
    <us-gaap:IncreaseDecreaseInAccruedSalaries contextRef="c-7" decimals="-6" id="f-224" unitRef="usd">-28000000</us-gaap:IncreaseDecreaseInAccruedSalaries>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities contextRef="c-1" decimals="-6" id="f-225" unitRef="usd">1000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities contextRef="c-7" decimals="-6" id="f-226" unitRef="usd">0</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities contextRef="c-1" decimals="-6" id="f-227" unitRef="usd">2000000</us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities>
    <us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities contextRef="c-7" decimals="-6" id="f-228" unitRef="usd">0</us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities>
    <us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities contextRef="c-1" decimals="-6" id="f-229" unitRef="usd">-10000000</us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities contextRef="c-7" decimals="-6" id="f-230" unitRef="usd">-7000000</us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-6" id="f-231" unitRef="usd">-3000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-7" decimals="-6" id="f-232" unitRef="usd">-4000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-6" id="f-233" unitRef="usd">95000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-6" id="f-234" unitRef="usd">91000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-1" decimals="-6" id="f-235" unitRef="usd">27000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-7" decimals="-6" id="f-236" unitRef="usd">95000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-1" decimals="-6" id="f-237" unitRef="usd">34000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-7" decimals="-6" id="f-238" unitRef="usd">66000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-6" id="f-239" unitRef="usd">16000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-7" decimals="-6" id="f-240" unitRef="usd">18000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinesses contextRef="c-1" decimals="-6" id="f-241" unitRef="usd">1000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses contextRef="c-7" decimals="-6" id="f-242" unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-6" id="f-243" unitRef="usd">-8000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-6" id="f-244" unitRef="usd">-47000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet contextRef="c-1" decimals="-6" id="f-245" unitRef="usd">388000000</tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet>
    <tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet contextRef="c-7" decimals="-6" id="f-246" unitRef="usd">213000000</tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-6" id="f-247" unitRef="usd">90000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-7" decimals="-6" id="f-248" unitRef="usd">23000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-6" id="f-249" unitRef="usd">4000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-7" decimals="-6" id="f-250" unitRef="usd">7000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfDividends contextRef="c-1" decimals="-6" id="f-251" unitRef="usd">12000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends contextRef="c-7" decimals="-6" id="f-252" unitRef="usd">0</us-gaap:PaymentsOfDividends>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-6" id="f-253" unitRef="usd">-494000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-6" id="f-254" unitRef="usd">-243000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-6" id="f-255" unitRef="usd">-407000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-6" id="f-256" unitRef="usd">-199000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-9" decimals="-6" id="f-257" unitRef="usd">1691000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-10" decimals="-6" id="f-258" unitRef="usd">1466000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-8" decimals="-6" id="f-259" unitRef="usd">1284000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-29" decimals="-6" id="f-260" unitRef="usd">1267000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-6" id="f-261" unitRef="usd">25000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-7" decimals="-6" id="f-262" unitRef="usd">26000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-6" id="f-263" unitRef="usd">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-7" decimals="-6" id="f-264" unitRef="usd">7000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:DividendsCommonStockCash contextRef="c-1" decimals="-6" id="f-265" unitRef="usd">13000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-7" decimals="-6" id="f-266" unitRef="usd">13000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-6" id="f-267" unitRef="usd">1000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-7" decimals="-6" id="f-268" unitRef="usd">3000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <tnet:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable contextRef="c-1" decimals="-6" id="f-269" unitRef="usd">6000000</tnet:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable>
    <tnet:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable contextRef="c-7" decimals="-6" id="f-270" unitRef="usd">0</tnet:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceivable>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="c-1" id="f-271">DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Description of Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;TriNet Group, Inc. (TriNet, or the Company, we, our and us) provides comprehensive HCM solutions for small and medium-size businesses under both a PEO model and an HRIS services model. These HCM solutions include multi-state payroll processing and tax administration, employee benefits programs, including health insurance and retirement plans, workers' compensation insurance and claims management, employment and benefit law compliance, and other HR-related services. Through our PEO service model, we are the employer of record for certain employment-related administrative and regulatory purposes for WSEs, including:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;compensation through wages and salaries,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;certain employer payroll-related tax payments, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;employee payroll-related tax withholdings and payments,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;employee benefit programs, including health and life insurance, and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;workers' compensation coverage. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our PEO clients are responsible for the day-to-day job responsibilities of the WSEs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through our HRIS and ASO services models, we provide cloud-based HCM services to SMBs that allows them to manage hiring, onboarding, employee information, payroll processing, payroll tax administration, health insurance, and other benefits, from a single cloud-based software platform. We are not the co-employer or employer of record for such employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate in one reportable segment. All of our service revenues are generated from external clients. Less than 1% of our revenue is generated outside of the U.S. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Basis of Presentation and Basis of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Rules and Regulations of the Securities and Exchange Commission. The unaudited condensed consolidated financial statements include the accounts of the Company and an entity consolidated under the variable interest model. Intercompany balances and transactions have been eliminated. Certain information and note disclosures included in our annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, that are normal and recurring in nature, necessary for fair financial statement presentation. The results of operations for the three months ended March&#160;31, 2025 are not necessarily indicative of the operating results anticipated for the full year. These financial statements should be read in conjunction with the audited Consolidated Financial Statements included in Part II, Item 8. Financial Statements and Supplementary Data of our Annual Report on Form 10-K for the year ended December&#160;31, 2024. Certain prior year amounts have been reclassified to conform to current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When entering into contractual arrangements with other entities, we assess whether we have a variable interest. If we determine that we have a variable interest, we then determine whether the arrangement is with a variable interest entity ("VIE"). If the arrangement is with a VIE, we assess whether we are the primary beneficiary of the VIE by identifying the most significant activities and determining who has the power over those activities and who has the obligation to absorb the majority of the losses or benefits of the VIE. We consolidate a VIE when we have the power to direct activities that most significantly affect the economic performance of the VIE and have the obligation to absorb the majority of their losses or benefits, making us the primary beneficiary. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, we assess whether any changes in our interest or relationship with the entity affect our determination of whether the entity is a VIE and, if so, whether we are the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, we created a trust ("TriNet Trust") for the purpose of holding ASO clients' payroll funds for the remittance to ASO Users, tax authorities and other recipients. TriNet Trust's assets are restricted and can only be used for payments on behalf of ASO clients, repayments of any advances from TriNet, or payments to TriNet of interest income earned on the balances of TriNet Trust. In the event of any losses, creditors to the Trust have &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recourse to TriNet Trust's property and not that of TriNet overall. The risks associated with the Trust are similar to those that currently exist for the Company such as banking losses in excess of FDIC insurance levels, interest rate and market conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined that TriNet Trust meets the definition of a variable interest entity and as the primary beneficiary we have both the power to direct TriNet Trust&#x2019;s activities that most significantly affect its performance and we have the right to receive benefits from TriNet Trust, in the form of interest income. As a result, TriNet Trust is consolidated into our financial statements.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2024, TriNet Trust assumed ownership and responsibility of certain bank accounts that hold HRIS client funds and assumed related liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the assets and liabilities of TriNet Trust which are included in our consolidated balance sheet. These amounts on any particular date can vary due to timing of cash receipts and remittances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.847%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;TriNet Trust&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;103&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;103&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts payable and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued wages&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payroll tax liabilities and other payroll withholdings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;87&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;103&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;103&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Income Statement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts on the Condensed Consolidated Statement of Income have been reclassified to conform to current period presentation. Specifically, interest income previously included in the former Other income (expense) category is now classified as a component of Total revenue. Similarly, Interest expense, bank fees and other has been reclassified as part of total expenses. These reclassifications eliminate the profitability measure of Operating Income on our Condensed Consolidated Statement of Income, which is not a key measure of profitability used by management.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Statement of Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts on the Condensed Consolidated Statement of Cash Flows have also been reclassified to conform to current period presentation, with no impact on the Condensed Consolidated Statements of Income and Comprehensive Income, Condensed Consolidated Statement of Balance Sheets and Condensed Consolidated Statements of Stockholders' Equity. In particular, changes in WSE related assets and liabilities were previously reported within operating activities and are now reclassified into financing activities to better reflect operating activities excluding the impact of client cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.110%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.943%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As previously reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reclassified&lt;br/&gt;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As revised&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payroll funds receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prepaid expenses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other payroll assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(410)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts payable and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Client deposits and other client liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued wages&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued health insurance costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued workers' compensation costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payroll taxes payable and other payroll withholdings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net cash used in operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in WSE and TriNet Trust related assets and liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net cash used in financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:11pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect certain reported amounts and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These estimates are based on historical experience and on various other assumptions that we believe to be reasonable from the facts available to us. Some of the assumptions are highly uncertain at the time of estimation. To the extent actual experience differs from the assumptions used, our condensed consolidated financial statements could be materially affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Accrued Health Insurance Costs &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sponsor and administer a number of employee benefit plans for our PEO WSEs, including group health, dental, and vision as an employer plan sponsor under section 3(5) of the ERISA. In the three months ended March&#160;31, 2025, the majority of our group health insurance costs were related to risk-based plans. Our remaining group health insurance costs were for guaranteed-cost policies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued health insurance costs are established to provide for the estimated unpaid costs of reimbursing the carriers for paying claims within the deductible layer in accordance with risk-based health insurance policies. These accrued costs include estimates for claims incurred but not paid. We assess accrued health insurance costs regularly based upon actuarial studies that include other relevant factors such as current and historical claims payment patterns, plan enrollment and medical trend rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain carrier contracts we are required to prepay our obligations for the expected claims activity for subsequent periods. These prepaid balances by agreement permit net settlement of obligations and offset the accrued health insurance costs. As of March&#160;31, 2025 and December&#160;31, 2024, prepayments and miscellaneous receivables offsetting accrued health insurance costs were $59 million and $60 million, respectively. When the prepaid amount is in excess of our recorded liability, the net asset position is included in prepaid expenses. As of March&#160;31, 2025 and December&#160;31, 2024, accrued health insurance costs offsetting prepaid expenses were $89 million and $90 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently issued accounting guidance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2024-03, Disaggregation of Income Statement Expenses, is to enhance the transparency and decision-usefulness of financial reporting by requiring public business entities to provide more detailed disclosures about the components of certain expense captions in their income statements. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2027. The Company is currently evaluating the provisions of this ASU.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances income tax disclosure requirements. The ASU mandates additional details in the income tax rate reconciliation, including quantitative thresholds for reconciling items, and requires disaggregation of income taxes paid by federal, state, and foreign jurisdictions, with further breakdowns for significant individual jurisdictions. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2024. The Company is currently evaluating the provisions of this ASU.</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-272">We operate in one reportable segment. All of our service revenues are generated from external clients. Less than 1% of our revenue is generated outside of the U.S.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-273"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-30" decimals="2" id="f-274" unitRef="number">0.01</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-276">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Rules and Regulations of the Securities and Exchange Commission. The unaudited condensed consolidated financial statements include the accounts of the Company and an entity consolidated under the variable interest model. Intercompany balances and transactions have been eliminated. Certain information and note disclosures included in our annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, that are normal and recurring in nature, necessary for fair financial statement presentation. The results of operations for the three months ended March&#160;31, 2025 are not necessarily indicative of the operating results anticipated for the full year. These financial statements should be read in conjunction with the audited Consolidated Financial Statements included in Part II, Item 8. Financial Statements and Supplementary Data of our Annual Report on Form 10-K for the year ended December&#160;31, 2024. Certain prior year amounts have been reclassified to conform to current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When entering into contractual arrangements with other entities, we assess whether we have a variable interest. If we determine that we have a variable interest, we then determine whether the arrangement is with a variable interest entity ("VIE"). If the arrangement is with a VIE, we assess whether we are the primary beneficiary of the VIE by identifying the most significant activities and determining who has the power over those activities and who has the obligation to absorb the majority of the losses or benefits of the VIE. We consolidate a VIE when we have the power to direct activities that most significantly affect the economic performance of the VIE and have the obligation to absorb the majority of their losses or benefits, making us the primary beneficiary. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, we assess whether any changes in our interest or relationship with the entity affect our determination of whether the entity is a VIE and, if so, whether we are the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, we created a trust ("TriNet Trust") for the purpose of holding ASO clients' payroll funds for the remittance to ASO Users, tax authorities and other recipients. TriNet Trust's assets are restricted and can only be used for payments on behalf of ASO clients, repayments of any advances from TriNet, or payments to TriNet of interest income earned on the balances of TriNet Trust. In the event of any losses, creditors to the Trust have &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recourse to TriNet Trust's property and not that of TriNet overall. The risks associated with the Trust are similar to those that currently exist for the Company such as banking losses in excess of FDIC insurance levels, interest rate and market conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined that TriNet Trust meets the definition of a variable interest entity and as the primary beneficiary we have both the power to direct TriNet Trust&#x2019;s activities that most significantly affect its performance and we have the right to receive benefits from TriNet Trust, in the form of interest income. As a result, TriNet Trust is consolidated into our financial statements.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2024, TriNet Trust assumed ownership and responsibility of certain bank accounts that hold HRIS client funds and assumed related liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-275">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Rules and Regulations of the Securities and Exchange Commission. The unaudited condensed consolidated financial statements include the accounts of the Company and an entity consolidated under the variable interest model. Intercompany balances and transactions have been eliminated. Certain information and note disclosures included in our annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, that are normal and recurring in nature, necessary for fair financial statement presentation. The results of operations for the three months ended March&#160;31, 2025 are not necessarily indicative of the operating results anticipated for the full year. These financial statements should be read in conjunction with the audited Consolidated Financial Statements included in Part II, Item 8. Financial Statements and Supplementary Data of our Annual Report on Form 10-K for the year ended December&#160;31, 2024. Certain prior year amounts have been reclassified to conform to current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When entering into contractual arrangements with other entities, we assess whether we have a variable interest. If we determine that we have a variable interest, we then determine whether the arrangement is with a variable interest entity ("VIE"). If the arrangement is with a VIE, we assess whether we are the primary beneficiary of the VIE by identifying the most significant activities and determining who has the power over those activities and who has the obligation to absorb the majority of the losses or benefits of the VIE. We consolidate a VIE when we have the power to direct activities that most significantly affect the economic performance of the VIE and have the obligation to absorb the majority of their losses or benefits, making us the primary beneficiary. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, we assess whether any changes in our interest or relationship with the entity affect our determination of whether the entity is a VIE and, if so, whether we are the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, we created a trust ("TriNet Trust") for the purpose of holding ASO clients' payroll funds for the remittance to ASO Users, tax authorities and other recipients. TriNet Trust's assets are restricted and can only be used for payments on behalf of ASO clients, repayments of any advances from TriNet, or payments to TriNet of interest income earned on the balances of TriNet Trust. In the event of any losses, creditors to the Trust have &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recourse to TriNet Trust's property and not that of TriNet overall. The risks associated with the Trust are similar to those that currently exist for the Company such as banking losses in excess of FDIC insurance levels, interest rate and market conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined that TriNet Trust meets the definition of a variable interest entity and as the primary beneficiary we have both the power to direct TriNet Trust&#x2019;s activities that most significantly affect its performance and we have the right to receive benefits from TriNet Trust, in the form of interest income. As a result, TriNet Trust is consolidated into our financial statements.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2024, TriNet Trust assumed ownership and responsibility of certain bank accounts that hold HRIS client funds and assumed related liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock contextRef="c-1" id="f-277">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.847%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;TriNet Trust&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;103&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;103&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts payable and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued wages&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payroll tax liabilities and other payroll withholdings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;87&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;103&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;103&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-31" decimals="-6" id="f-278" unitRef="usd">2000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-31" decimals="-6" id="f-279" unitRef="usd">101000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-31" decimals="-6" id="f-280" unitRef="usd">103000000</us-gaap:AssetsCurrent>
    <us-gaap:Assets contextRef="c-31" decimals="-6" id="f-281" unitRef="usd">103000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-31" decimals="-6" id="f-282" unitRef="usd">1000000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="c-31" decimals="-6" id="f-283" unitRef="usd">15000000</us-gaap:AccruedSalariesCurrent>
    <tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings contextRef="c-31" decimals="-6" id="f-284" unitRef="usd">87000000</tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings>
    <us-gaap:LiabilitiesCurrent contextRef="c-31" decimals="-6" id="f-285" unitRef="usd">103000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="c-31" decimals="-6" id="f-286" unitRef="usd">103000000</us-gaap:Liabilities>
    <tnet:ScheduleOfWorksiteEmployeeChangesTableTextBlock contextRef="c-1" id="f-287">In particular, changes in WSE related assets and liabilities were previously reported within operating activities and are now reclassified into financing activities to better reflect operating activities excluding the impact of client cash flows.&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.110%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.943%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As previously reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reclassified&lt;br/&gt;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As revised&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payroll funds receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prepaid expenses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other payroll assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(410)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts payable and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Client deposits and other client liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued wages&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued health insurance costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued workers' compensation costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payroll taxes payable and other payroll withholdings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net cash used in operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Change in WSE and TriNet Trust related assets and liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net cash used in financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</tnet:ScheduleOfWorksiteEmployeeChangesTableTextBlock>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-32" decimals="-6" id="f-288" unitRef="usd">-6000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-33" decimals="-6" id="f-289" unitRef="usd">7000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-7" decimals="-6" id="f-290" unitRef="usd">1000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="c-32" decimals="-6" id="f-291" unitRef="usd">20000000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="c-33" decimals="-6" id="f-292" unitRef="usd">-20000000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="c-7" decimals="-6" id="f-293" unitRef="usd">0</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c-32" decimals="-6" id="f-294" unitRef="usd">12000000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c-33" decimals="-6" id="f-295" unitRef="usd">2000000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c-7" decimals="-6" id="f-296" unitRef="usd">14000000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <tnet:IncreaseDecreaseInOtherPayrollAssets contextRef="c-32" decimals="-6" id="f-297" unitRef="usd">410000000</tnet:IncreaseDecreaseInOtherPayrollAssets>
    <tnet:IncreaseDecreaseInOtherPayrollAssets contextRef="c-33" decimals="-6" id="f-298" unitRef="usd">-413000000</tnet:IncreaseDecreaseInOtherPayrollAssets>
    <tnet:IncreaseDecreaseInOtherPayrollAssets contextRef="c-7" decimals="-6" id="f-299" unitRef="usd">-3000000</tnet:IncreaseDecreaseInOtherPayrollAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities contextRef="c-32" decimals="-6" id="f-300" unitRef="usd">20000000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities contextRef="c-33" decimals="-6" id="f-301" unitRef="usd">4000000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities contextRef="c-7" decimals="-6" id="f-302" unitRef="usd">24000000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-32" decimals="-6" id="f-303" unitRef="usd">-14000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-33" decimals="-6" id="f-304" unitRef="usd">10000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-7" decimals="-6" id="f-305" unitRef="usd">-4000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccruedSalaries contextRef="c-32" decimals="-6" id="f-306" unitRef="usd">23000000</us-gaap:IncreaseDecreaseInAccruedSalaries>
    <us-gaap:IncreaseDecreaseInAccruedSalaries contextRef="c-33" decimals="-6" id="f-307" unitRef="usd">-51000000</us-gaap:IncreaseDecreaseInAccruedSalaries>
    <us-gaap:IncreaseDecreaseInAccruedSalaries contextRef="c-7" decimals="-6" id="f-308" unitRef="usd">-28000000</us-gaap:IncreaseDecreaseInAccruedSalaries>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities contextRef="c-32" decimals="-6" id="f-309" unitRef="usd">-7000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities contextRef="c-33" decimals="-6" id="f-310" unitRef="usd">7000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities contextRef="c-7" decimals="-6" id="f-311" unitRef="usd">0</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities contextRef="c-32" decimals="-6" id="f-312" unitRef="usd">1000000</us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities>
    <us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities contextRef="c-33" decimals="-6" id="f-313" unitRef="usd">-1000000</us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities>
    <us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities contextRef="c-7" decimals="-6" id="f-314" unitRef="usd">0</us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities>
    <us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities contextRef="c-32" decimals="-6" id="f-315" unitRef="usd">173000000</us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities contextRef="c-33" decimals="-6" id="f-316" unitRef="usd">-180000000</us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities contextRef="c-7" decimals="-6" id="f-317" unitRef="usd">-7000000</us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities>
    <tnet:NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified contextRef="c-32" decimals="-6" id="f-318" unitRef="usd">-240000000</tnet:NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified>
    <tnet:NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified contextRef="c-33" decimals="-6" id="f-319" unitRef="usd">213000000</tnet:NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified>
    <tnet:NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified contextRef="c-7" decimals="-6" id="f-320" unitRef="usd">-27000000</tnet:NetCashProvidedByUsedInOperatingActivitiesAmountsReclassified>
    <tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet contextRef="c-32" decimals="-6" id="f-321" unitRef="usd">0</tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet>
    <tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet contextRef="c-33" decimals="-6" id="f-322" unitRef="usd">213000000</tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet>
    <tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet contextRef="c-7" decimals="-6" id="f-323" unitRef="usd">213000000</tnet:ChangeInVariableInterestEntityAssetsAndLiabilitiesNet>
    <tnet:NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified contextRef="c-32" decimals="-6" id="f-324" unitRef="usd">0</tnet:NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified>
    <tnet:NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified contextRef="c-33" decimals="-6" id="f-325" unitRef="usd">-213000000</tnet:NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified>
    <tnet:NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified contextRef="c-7" decimals="-6" id="f-326" unitRef="usd">-213000000</tnet:NetCashProvidedByUsedInFinancingActivitiesAmountsReclassified>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-327">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect certain reported amounts and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These estimates are based on historical experience and on various other assumptions that we believe to be reasonable from the facts available to us. Some of the assumptions are highly uncertain at the time of estimation. To the extent actual experience differs from the assumptions used, our condensed consolidated financial statements could be materially affected.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:LiabilityReserveEstimatePolicy contextRef="c-1" id="f-328">In the three months ended March&#160;31, 2025, the majority of our group health insurance costs were related to risk-based plans. Our remaining group health insurance costs were for guaranteed-cost policies. &lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued health insurance costs are established to provide for the estimated unpaid costs of reimbursing the carriers for paying claims within the deductible layer in accordance with risk-based health insurance policies. These accrued costs include estimates for claims incurred but not paid. We assess accrued health insurance costs regularly based upon actuarial studies that include other relevant factors such as current and historical claims payment patterns, plan enrollment and medical trend rates. &lt;/span&gt;&lt;/div&gt;In certain carrier contracts we are required to prepay our obligations for the expected claims activity for subsequent periods. These prepaid balances by agreement permit net settlement of obligations and offset the accrued health insurance costs.</us-gaap:LiabilityReserveEstimatePolicy>
    <us-gaap:PrepaidInsurance contextRef="c-8" decimals="-6" id="f-329" unitRef="usd">59000000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="c-9" decimals="-6" id="f-330" unitRef="usd">60000000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="c-34" decimals="-6" id="f-331" unitRef="usd">89000000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="c-35" decimals="-6" id="f-332" unitRef="usd">90000000</us-gaap:PrepaidInsurance>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-333">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently issued accounting guidance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2024-03, Disaggregation of Income Statement Expenses, is to enhance the transparency and decision-usefulness of financial reporting by requiring public business entities to provide more detailed disclosures about the components of certain expense captions in their income statements. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2027. The Company is currently evaluating the provisions of this ASU.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances income tax disclosure requirements. The ASU mandates additional details in the income tax rate reconciliation, including quantitative thresholds for reconciling items, and requires disaggregation of income taxes paid by federal, state, and foreign jurisdictions, with further breakdowns for significant individual jurisdictions. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2024. The Company is currently evaluating the provisions of this ASU.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <tnet:CashCashEquivalentsAndInvestmentsTextBlock contextRef="c-1" id="f-334">CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the agreements with certain of our workers' compensation and health benefit insurance carriers, we are required to maintain collateral in trust accounts for the benefit of specified insurance carriers and to reimburse the carriers&#x2019; claim payments within our deductible layer. We invest a portion of the collateral amounts in marketable securities. We report the current and noncurrent portions of these trust accounts as restricted cash, cash equivalents and investments on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We require our clients to prefund their payroll and related taxes and other withholding liabilities before payroll is processed or due for payment. This prefund, for PEO customers, as well as amounts held by our statutory trust for our HRIS Users, is included in restricted cash, cash equivalents and investments as payroll funds collected, which is designated to pay pending payrolls, payroll tax liabilities and other payroll withholdings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also invest available corporate funds, primarily in fixed income securities which meet the requirements of our corporate investment policy and are classified as AFS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total cash, cash equivalents and investments are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.091%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Available-for-sale marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Available-for-sale marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payroll funds collected&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;726&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;726&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral for health benefits claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral for workers' compensation claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trust for our HRIS Users&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other security deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total restricted cash, cash equivalents and investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments, noncurrent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral for workers' compensation claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;110&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;134&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,284&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,507&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</tnet:CashCashEquivalentsAndInvestmentsTextBlock>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock contextRef="c-1" id="f-335">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total cash, cash equivalents and investments are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.091%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Available-for-sale marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Available-for-sale marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payroll funds collected&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;726&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;726&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral for health benefits claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral for workers' compensation claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trust for our HRIS Users&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other security deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total restricted cash, cash equivalents and investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments, noncurrent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral for workers' compensation claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;110&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;134&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,284&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,507&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-36" decimals="-6" id="f-336" unitRef="usd">349000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-37" decimals="-6" id="f-337" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-8" decimals="-6" id="f-338" unitRef="usd">349000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-38" decimals="-6" id="f-339" unitRef="usd">360000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-39" decimals="-6" id="f-340" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-9" decimals="-6" id="f-341" unitRef="usd">360000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-40" decimals="-6" id="f-342" unitRef="usd">726000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-41" decimals="-6" id="f-343" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-42" decimals="-6" id="f-344" unitRef="usd">726000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-43" decimals="-6" id="f-345" unitRef="usd">1131000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-44" id="f-346" unitRef="usd" xsi:nil="true"/>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-45" decimals="-6" id="f-347" unitRef="usd">1131000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-46" decimals="-6" id="f-348" unitRef="usd">33000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-47" decimals="-6" id="f-349" unitRef="usd">113000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-48" decimals="-6" id="f-350" unitRef="usd">146000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-49" decimals="-6" id="f-351" unitRef="usd">34000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-50" decimals="-6" id="f-352" unitRef="usd">110000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-51" decimals="-6" id="f-353" unitRef="usd">144000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-52" decimals="-6" id="f-354" unitRef="usd">50000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-53" decimals="-6" id="f-355" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-54" decimals="-6" id="f-356" unitRef="usd">50000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-55" decimals="-6" id="f-357" unitRef="usd">49000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-56" decimals="-6" id="f-358" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-57" decimals="-6" id="f-359" unitRef="usd">49000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-58" decimals="-6" id="f-360" unitRef="usd">101000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-59" decimals="-6" id="f-361" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-60" decimals="-6" id="f-362" unitRef="usd">101000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-61" decimals="-6" id="f-363" unitRef="usd">87000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-62" decimals="-6" id="f-364" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-63" decimals="-6" id="f-365" unitRef="usd">87000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-64" decimals="-6" id="f-366" unitRef="usd">1000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-65" decimals="-6" id="f-367" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-66" decimals="-6" id="f-368" unitRef="usd">1000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-67" decimals="-6" id="f-369" unitRef="usd">2000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-68" decimals="-6" id="f-370" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-69" decimals="-6" id="f-371" unitRef="usd">2000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-36" decimals="-6" id="f-372" unitRef="usd">911000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-37" decimals="-6" id="f-373" unitRef="usd">113000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-8" decimals="-6" id="f-374" unitRef="usd">1024000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-38" decimals="-6" id="f-375" unitRef="usd">1303000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-39" decimals="-6" id="f-376" unitRef="usd">110000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-9" decimals="-6" id="f-377" unitRef="usd">1413000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-52" decimals="-6" id="f-378" unitRef="usd">24000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-53" decimals="-6" id="f-379" unitRef="usd">110000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-54" decimals="-6" id="f-380" unitRef="usd">134000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-55" decimals="-6" id="f-381" unitRef="usd">28000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-56" decimals="-6" id="f-382" unitRef="usd">117000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-57" decimals="-6" id="f-383" unitRef="usd">145000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestments contextRef="c-36" decimals="-6" id="f-384" unitRef="usd">1284000000</us-gaap:RestrictedCashAndInvestments>
    <us-gaap:RestrictedCashAndInvestments contextRef="c-37" decimals="-6" id="f-385" unitRef="usd">223000000</us-gaap:RestrictedCashAndInvestments>
    <us-gaap:RestrictedCashAndInvestments contextRef="c-8" decimals="-6" id="f-386" unitRef="usd">1507000000</us-gaap:RestrictedCashAndInvestments>
    <us-gaap:RestrictedCashAndInvestments contextRef="c-38" decimals="-6" id="f-387" unitRef="usd">1691000000</us-gaap:RestrictedCashAndInvestments>
    <us-gaap:RestrictedCashAndInvestments contextRef="c-39" decimals="-6" id="f-388" unitRef="usd">227000000</us-gaap:RestrictedCashAndInvestments>
    <us-gaap:RestrictedCashAndInvestments contextRef="c-9" decimals="-6" id="f-389" unitRef="usd">1918000000</us-gaap:RestrictedCashAndInvestments>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="c-1" id="f-390">INVESTMENTS&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our financial instruments by significant categories and fair value measurement on a recurring basis as of March&#160;31, 2025 and December&#160;31, 2024 and the amortized cost, gross unrealized gains, gross unrealized losses, fair value of our AFS investments: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.332%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.356%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Cash, Cash Equivalents and Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;116&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;110&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;226&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;116&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;110&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AFS Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total AFS Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.715%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.342%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.295%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.856%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.173%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.173%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.470%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Cash, Cash Equivalents and Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;571&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AFS Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificate of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total AFS Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use an independent pricing source to determine the fair value of our securities. The independent pricing source utilizes various pricing models for each asset class, including the market approach. The inputs and assumptions for the pricing models are market observable inputs including trades of comparable securities, dealer quotes, credit spreads, yield curves and other market-related data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have not adjusted the prices obtained from the independent pricing service and we believe the prices received from the independent pricing service are representative of the prices that would be received to sell the assets at the measurement date (exit price).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of the Company's cash equivalents and restricted cash equivalents approximate their fair values due to their short-term maturities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not have any Level 3 financial instruments recognized in our condensed consolidated balance sheets as of March&#160;31, 2025 and December&#160;31, 2024. There were no transfers between levels as of March&#160;31, 2025 and December&#160;31, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Sales and Maturities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of debt investments by contractual maturity are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;One year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Over one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;199&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Over five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Over ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross proceeds from sales and maturities of AFS securities and gross realized losses for the three months ended March&#160;31, 2025 and 2024 are presented below. We had immaterial gross realized gains from sales of investments for the three months ended March&#160;31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.707%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross realized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross proceeds from maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Fair Value of Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our 2029 Notes and 2031 Notes was obtained from a third-party pricing service and is based on observable market inputs. As such, the fair value of the Senior Notes is considered Level 2 in the hierarchy for fair value measurement. As of March&#160;31, 2025, our 2029 Notes and 2031 Notes were carried at their cost, net of issuance costs, and had a fair value of $454 million and $407 million, respectively. As of December&#160;31, 2024, our 2029 Notes and 2031 Notes were carried at their cost, net of issuance costs, and had a fair value of $453 million and $408 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our 2021 Revolver is a floating rate debt. At March&#160;31, 2025 and December&#160;31, 2024, the fair value of our 2021 Revolver approximated its carrying value (exclusive of issuance costs). The fair value of our floating rate debt is estimated based on a discounted cash flow, which incorporates credit spreads, market interest rates and contractual maturities to estimate the fair value and is considered Level 3 in the hierarchy for fair value measurement.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-391">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our financial instruments by significant categories and fair value measurement on a recurring basis as of March&#160;31, 2025 and December&#160;31, 2024 and the amortized cost, gross unrealized gains, gross unrealized losses, fair value of our AFS investments: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.332%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.356%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Cash, Cash Equivalents and Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;116&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;110&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;226&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;116&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;110&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AFS Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total AFS Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.715%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.342%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.295%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.856%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.173%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.173%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.470%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Cash, Cash Equivalents and Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;571&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AFS Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificate of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total AFS Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-70" decimals="-6" id="f-392" unitRef="usd">226000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-70" decimals="-6" id="f-393" unitRef="usd">226000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-71" decimals="-6" id="f-394" unitRef="usd">116000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-72" decimals="-6" id="f-395" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-73" decimals="-6" id="f-396" unitRef="usd">110000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-74" decimals="-6" id="f-397" unitRef="usd">226000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-74" decimals="-6" id="f-398" unitRef="usd">226000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-75" decimals="-6" id="f-399" unitRef="usd">116000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-76" decimals="-6" id="f-400" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-77" decimals="-6" id="f-401" unitRef="usd">110000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-78" decimals="-6" id="f-402" unitRef="usd">34000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-78" decimals="-6" id="f-403" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-78" decimals="-6" id="f-404" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-78" decimals="-6" id="f-405" unitRef="usd">34000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-79" decimals="-6" id="f-406" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-80" decimals="-6" id="f-407" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-81" decimals="-6" id="f-408" unitRef="usd">34000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-82" decimals="-6" id="f-409" unitRef="usd">13000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-82" decimals="-6" id="f-410" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-82" decimals="-6" id="f-411" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-82" decimals="-6" id="f-412" unitRef="usd">13000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-83" decimals="-6" id="f-413" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-84" decimals="-6" id="f-414" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-85" decimals="-6" id="f-415" unitRef="usd">13000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-86" decimals="-6" id="f-416" unitRef="usd">175000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-86" decimals="-6" id="f-417" unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-86" decimals="-6" id="f-418" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-86" decimals="-6" id="f-419" unitRef="usd">176000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-87" decimals="-6" id="f-420" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-88" decimals="-6" id="f-421" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-89" decimals="-6" id="f-422" unitRef="usd">176000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-74" decimals="-6" id="f-423" unitRef="usd">222000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-74" decimals="-6" id="f-424" unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-74" decimals="-6" id="f-425" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-74" decimals="-6" id="f-426" unitRef="usd">223000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-75" decimals="-6" id="f-427" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-76" decimals="-6" id="f-428" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-77" decimals="-6" id="f-429" unitRef="usd">223000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-90" decimals="-6" id="f-430" unitRef="usd">570000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-90" decimals="-6" id="f-431" unitRef="usd">570000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-91" decimals="-6" id="f-432" unitRef="usd">257000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-92" decimals="-6" id="f-433" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-93" decimals="-6" id="f-434" unitRef="usd">313000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-94" decimals="-6" id="f-435" unitRef="usd">1000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-94" decimals="-6" id="f-436" unitRef="usd">1000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-95" decimals="-6" id="f-437" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-96" decimals="-6" id="f-438" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-97" decimals="-6" id="f-439" unitRef="usd">1000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-98" decimals="-6" id="f-440" unitRef="usd">571000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-98" decimals="-6" id="f-441" unitRef="usd">571000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-99" decimals="-6" id="f-442" unitRef="usd">257000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-100" decimals="-6" id="f-443" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-101" decimals="-6" id="f-444" unitRef="usd">314000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-102" decimals="-6" id="f-445" unitRef="usd">35000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-102" id="f-446" unitRef="usd" xsi:nil="true"/>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-102" decimals="-6" id="f-447" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-102" decimals="-6" id="f-448" unitRef="usd">35000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-103" decimals="-6" id="f-449" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-104" id="f-450" unitRef="usd" xsi:nil="true"/>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-105" decimals="-6" id="f-451" unitRef="usd">35000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-106" decimals="-6" id="f-452" unitRef="usd">18000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-106" decimals="-6" id="f-453" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-106" decimals="-6" id="f-454" unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-106" decimals="-6" id="f-455" unitRef="usd">17000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-107" decimals="-6" id="f-456" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-108" id="f-457" unitRef="usd" xsi:nil="true"/>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-109" decimals="-6" id="f-458" unitRef="usd">17000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-110" decimals="-6" id="f-459" unitRef="usd">176000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-110" id="f-460" unitRef="usd" xsi:nil="true"/>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-110" decimals="-6" id="f-461" unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-110" decimals="-6" id="f-462" unitRef="usd">174000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-111" decimals="-6" id="f-463" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-112" id="f-464" unitRef="usd" xsi:nil="true"/>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-113" decimals="-6" id="f-465" unitRef="usd">174000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-114" decimals="-6" id="f-466" unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-114" decimals="-6" id="f-467" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-114" decimals="-6" id="f-468" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-114" decimals="-6" id="f-469" unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-115" decimals="-6" id="f-470" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-116" decimals="-6" id="f-471" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-117" decimals="-6" id="f-472" unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-98" decimals="-6" id="f-473" unitRef="usd">230000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-98" decimals="-6" id="f-474" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-98" decimals="-6" id="f-475" unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-98" decimals="-6" id="f-476" unitRef="usd">227000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-99" decimals="-6" id="f-477" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-100" decimals="-6" id="f-478" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-101" decimals="-6" id="f-479" unitRef="usd">227000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="c-1" id="f-480">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of debt investments by contractual maturity are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;One year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Over one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;199&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Over five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Over ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="c-8" decimals="-6" id="f-481" unitRef="usd">17000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue contextRef="c-8" decimals="-6" id="f-482" unitRef="usd">199000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue contextRef="c-8" decimals="-6" id="f-483" unitRef="usd">5000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue contextRef="c-8" decimals="-6" id="f-484" unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate contextRef="c-8" decimals="-6" id="f-485" unitRef="usd">223000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock contextRef="c-1" id="f-486">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross proceeds from sales and maturities of AFS securities and gross realized losses for the three months ended March&#160;31, 2025 and 2024 are presented below. We had immaterial gross realized gains from sales of investments for the three months ended March&#160;31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.707%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross realized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross proceeds from maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss contextRef="c-1" decimals="-6" id="f-487" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss contextRef="c-7" decimals="-6" id="f-488" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss contextRef="c-1" decimals="-6" id="f-489" unitRef="usd">-1000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss contextRef="c-7" decimals="-6" id="f-490" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt contextRef="c-1" decimals="-6" id="f-491" unitRef="usd">31000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt contextRef="c-7" decimals="-6" id="f-492" unitRef="usd">39000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities contextRef="c-1" decimals="-6" id="f-493" unitRef="usd">3000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities contextRef="c-7" decimals="-6" id="f-494" unitRef="usd">27000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-118" decimals="-6" id="f-495" unitRef="usd">454000000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-119" decimals="-6" id="f-496" unitRef="usd">407000000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-120" decimals="-6" id="f-497" unitRef="usd">453000000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-121" decimals="-6" id="f-498" unitRef="usd">408000000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock contextRef="c-1" id="f-499">ACCRUED WORKERS' COMPENSATION COSTS&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the accrued workers&#x2019; compensation cost activity for the three months ended March&#160;31, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total accrued costs, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;158&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes workers' compensation liabilities on the condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.473%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.614%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral paid to carriers and offset against accrued costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, net of carrier collateral offset&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;156&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payable in less than 1 year&lt;br/&gt;(net of collateral paid to carriers of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; at March&#160;31, 2025 and December&#160;31, 2024)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;45&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payable in more than 1 year &lt;br/&gt;(net of collateral paid to carriers of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; at March&#160;31, 2025 and December&#160;31, 2024)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;111&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, net of carrier collateral offset&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;156&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incurred claims related to prior years represent changes in estimates for ultimate losses on workers' compensation claims. For the three months ended March&#160;31, 2025, the favorable development is due to lower than expected reported claim frequency and severity for the more recent years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2025 and December&#160;31, 2024, we had $25 million and $26&#160;million of collateral held by insurance carriers, respectively, of which $4 million was offset against accrued workers' compensation costs as the agreements permit and are net settled of insurance obligations against collateral held.&lt;/span&gt;&lt;/div&gt;</us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense contextRef="c-1" id="f-500">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the accrued workers&#x2019; compensation cost activity for the three months ended March&#160;31, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total accrued costs, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;158&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes workers' compensation liabilities on the condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.473%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.614%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral paid to carriers and offset against accrued costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, net of carrier collateral offset&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;156&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payable in less than 1 year&lt;br/&gt;(net of collateral paid to carriers of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; at March&#160;31, 2025 and December&#160;31, 2024)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;45&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payable in more than 1 year &lt;br/&gt;(net of collateral paid to carriers of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; at March&#160;31, 2025 and December&#160;31, 2024)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;111&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, net of carrier collateral offset&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;156&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments contextRef="c-9" decimals="-6" id="f-501" unitRef="usd">158000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments contextRef="c-10" decimals="-6" id="f-502" unitRef="usd">175000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense contextRef="c-1" decimals="-6" id="f-503" unitRef="usd">14000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense contextRef="c-7" decimals="-6" id="f-504" unitRef="usd">16000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense contextRef="c-1" decimals="-6" id="f-505" unitRef="usd">-1000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense contextRef="c-7" decimals="-6" id="f-506" unitRef="usd">-4000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 contextRef="c-1" decimals="-6" id="f-507" unitRef="usd">13000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 contextRef="c-7" decimals="-6" id="f-508" unitRef="usd">12000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1 contextRef="c-1" decimals="-6" id="f-509" unitRef="usd">0</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1 contextRef="c-7" decimals="-6" id="f-510" unitRef="usd">1000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1 contextRef="c-1" decimals="-6" id="f-511" unitRef="usd">11000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1 contextRef="c-7" decimals="-6" id="f-512" unitRef="usd">11000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense contextRef="c-1" decimals="-6" id="f-513" unitRef="usd">11000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense contextRef="c-7" decimals="-6" id="f-514" unitRef="usd">12000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments contextRef="c-8" decimals="-6" id="f-515" unitRef="usd">160000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments contextRef="c-29" decimals="-6" id="f-516" unitRef="usd">175000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments contextRef="c-8" decimals="-6" id="f-517" unitRef="usd">160000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments contextRef="c-9" decimals="-6" id="f-518" unitRef="usd">158000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments>
    <tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral contextRef="c-8" decimals="-6" id="f-519" unitRef="usd">4000000</tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral>
    <tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral contextRef="c-9" decimals="-6" id="f-520" unitRef="usd">4000000</tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral>
    <us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent contextRef="c-8" decimals="-6" id="f-521" unitRef="usd">156000000</us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent contextRef="c-9" decimals="-6" id="f-522" unitRef="usd">154000000</us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent>
    <tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent contextRef="c-9" decimals="-6" id="f-523" unitRef="usd">1000000</tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent>
    <tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent contextRef="c-8" decimals="-6" id="f-524" unitRef="usd">1000000</tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent contextRef="c-8" decimals="-6" id="f-525" unitRef="usd">45000000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent contextRef="c-9" decimals="-6" id="f-526" unitRef="usd">44000000</us-gaap:WorkersCompensationLiabilityCurrent>
    <tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent contextRef="c-8" decimals="-6" id="f-527" unitRef="usd">3000000</tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent>
    <tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent contextRef="c-9" decimals="-6" id="f-528" unitRef="usd">3000000</tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent>
    <us-gaap:WorkersCompensationLiabilityNoncurrent contextRef="c-8" decimals="-6" id="f-529" unitRef="usd">111000000</us-gaap:WorkersCompensationLiabilityNoncurrent>
    <us-gaap:WorkersCompensationLiabilityNoncurrent contextRef="c-9" decimals="-6" id="f-530" unitRef="usd">110000000</us-gaap:WorkersCompensationLiabilityNoncurrent>
    <us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent contextRef="c-8" decimals="-6" id="f-531" unitRef="usd">156000000</us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent contextRef="c-9" decimals="-6" id="f-532" unitRef="usd">154000000</us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent>
    <tnet:CollateralHeldByInsuranceCarriers contextRef="c-8" decimals="-6" id="f-533" unitRef="usd">25000000</tnet:CollateralHeldByInsuranceCarriers>
    <tnet:CollateralHeldByInsuranceCarriers contextRef="c-9" decimals="-6" id="f-534" unitRef="usd">26000000</tnet:CollateralHeldByInsuranceCarriers>
    <tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral contextRef="c-8" decimals="-6" id="f-535" unitRef="usd">4000000</tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral>
    <tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral contextRef="c-9" decimals="-6" id="f-536" unitRef="usd">4000000</tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-537">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Contingencies &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We are and, from time to time, have been and may in the future become involved in various litigation matters, legal proceedings, regulatory investigations and claims arising in the ordinary course of our business, including disputes with our clients or various class action, collective action, representative action, and other proceedings arising from the nature of our co-employment relationship with our clients and WSEs in which we are named as a defendant. In addition, due to the nature of our co-employment relationship with our clients and WSEs, we could be subject to liability for federal and state law violations, even if we do not participate in such violations. While our agreements with our clients contain indemnification provisions related to the conduct of our clients, we may not be able to avail ourselves of such provisions in every instance. We have accrued our current best estimates of probable losses with respect to these matters, which are individually and in aggregate immaterial to our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the outcome of the matters described above cannot be predicted with certainty, management currently does not believe that any such claims or proceedings will have a materially adverse effect on our condensed consolidated financial position, results of operations, or cash flows. However, the unfavorable resolution of any particular matter or our reassessment of our exposure for any of the above matters based on additional information obtained in the future could have a material impact on our condensed consolidated financial position, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-538">STOCK BASED COMPENSATION&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units (RSUs)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Time-based RSUs generally vest over a four-year term. Performance-based RSUs are subject to vesting requirements and are earned, in part, based on certain financial performance metrics as defined in the grant notice. Actual number of shares earned under performance-based RSUs may range from 0% to 200% of the target award. Performance-based awards granted in 2025 and 2024 are earned based on a single-year performance period subject to subsequent multi-year time-based vesting with 50% of the shares earned vesting in one year after the performance period and the remaining shares in the year after. RSUs are generally forfeited if the participant terminates service prior to vesting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize RSU activity for the three months ended March&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Time-based RSUs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.030%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Number&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;of Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Grant Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,100,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;696,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(127,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at March&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,572,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Performance-based RSUs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.128%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.516%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.056%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Grant Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at March&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options are granted to eligible employees at exercise prices equal to the fair market value of our common stock on the dates of grant. Stock options generally have a maximum contractual term of 10 years. Stock options vest after 3 years, and are generally forfeited if the employee terminates service prior to vesting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity for the three months ended March&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.352%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number&lt;br/&gt;of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;270,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at March&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;270,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;76.69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;9.98&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimated the fair value of stock options using the Black-Scholes option-pricing model. Because we do not have significant exercise history for our stock options, we estimate the expected term using the simplified method.  We estimate expected volatility using the daily historical trading data of our common shares. The table below summarizes the assumptions used.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our RSUs and PSUs is equal to the fair value of our common stock on the grant date. The fair value of stock options is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.352%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Option Assumptions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Expected Term (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Expected Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Expected Dividend Yield&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:24.75pt;text-indent:-22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.922%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.878%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Additional Disclosures for Stock Options (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value of stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total fair value of options granted &lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-122" id="f-539">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent contextRef="c-123" decimals="2" id="f-540" unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent contextRef="c-124" decimals="2" id="f-541" unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-125" decimals="2" id="f-542" unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-125" id="f-543">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="c-1" id="f-544">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize RSU activity for the three months ended March&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Time-based RSUs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.030%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Number&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;of Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Grant Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,100,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;696,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(127,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at March&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,572,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Performance-based RSUs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.128%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.516%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.056%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Grant Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at March&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-126"
      decimals="INF"
      id="f-545"
      unitRef="shares">1100001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-126"
      decimals="2"
      id="f-546"
      unitRef="usdPerShare">97.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-122"
      decimals="INF"
      id="f-547"
      unitRef="shares">696745</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-122"
      decimals="2"
      id="f-548"
      unitRef="usdPerShare">76.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-122"
      decimals="INF"
      id="f-549"
      unitRef="shares">127243</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-122"
      decimals="2"
      id="f-550"
      unitRef="usdPerShare">90.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-122"
      decimals="INF"
      id="f-551"
      unitRef="shares">97243</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-122"
      decimals="2"
      id="f-552"
      unitRef="usdPerShare">65.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-127"
      decimals="INF"
      id="f-553"
      unitRef="shares">1572260</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-127"
      decimals="2"
      id="f-554"
      unitRef="usdPerShare">89.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-128"
      decimals="INF"
      id="f-555"
      unitRef="shares">179907</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-128"
      decimals="2"
      id="f-556"
      unitRef="usdPerShare">106.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-129"
      decimals="INF"
      id="f-557"
      unitRef="shares">74840</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-129"
      decimals="2"
      id="f-558"
      unitRef="usdPerShare">76.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-129"
      decimals="INF"
      id="f-559"
      unitRef="shares">22728</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-129"
      decimals="2"
      id="f-560"
      unitRef="usdPerShare">124.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-130"
      decimals="INF"
      id="f-561"
      unitRef="shares">232019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-130"
      decimals="2"
      id="f-562"
      unitRef="usdPerShare">83.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-131" id="f-563">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-132" id="f-564">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-565">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity for the three months ended March&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.352%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number&lt;br/&gt;of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;270,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at March&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;270,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;76.69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;9.98&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-9" decimals="INF" id="f-566" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-9"
      decimals="2"
      id="f-567"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-9" decimals="-6" id="f-568" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="INF" id="f-569" unitRef="shares">270144</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-570"
      unitRef="usdPerShare">76.69</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <tnet:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm contextRef="c-1" id="f-571">P9Y11M23D</tnet:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm>
    <tnet:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue contextRef="c-1" decimals="-6" id="f-572" unitRef="usd">1000000</tnet:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-8" decimals="INF" id="f-573" unitRef="shares">270144</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-8"
      decimals="2"
      id="f-574"
      unitRef="usdPerShare">76.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-575">P9Y11M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-8" decimals="-6" id="f-576" unitRef="usd">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-577">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our RSUs and PSUs is equal to the fair value of our common stock on the grant date. The fair value of stock options is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.352%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Option Assumptions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Expected Term (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Expected Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Expected Dividend Yield&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-1" id="f-578">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-1" decimals="3" id="f-579" unitRef="number">0.423</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-1" decimals="4" id="f-580" unitRef="number">0.0409</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-1" decimals="4" id="f-581" unitRef="number">0.0143</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="c-1" id="f-582">&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.922%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.878%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Additional Disclosures for Stock Options (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value of stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total fair value of options granted &lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-583"
      unitRef="usdPerShare">31.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c-1" decimals="-6" id="f-584" unitRef="usd">9000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-585">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock based compensation expense for stock-based awards made to our employees pursuant to our equity plans were as follows:&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.696%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of providing services&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Systems development and programming costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total stock based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total stock based compensation capitalized&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-133" decimals="-6" id="f-586" unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-134" decimals="-6" id="f-587" unitRef="usd">4000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-135" decimals="-6" id="f-588" unitRef="usd">2000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-136" decimals="-6" id="f-589" unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-137" decimals="-6" id="f-590" unitRef="usd">6000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-138" decimals="-6" id="f-591" unitRef="usd">12000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-139" decimals="-6" id="f-592" unitRef="usd">1000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-140" decimals="-6" id="f-593" unitRef="usd">1000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-6" id="f-594" unitRef="usd">13000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-7" decimals="-6" id="f-595" unitRef="usd">20000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount contextRef="c-1" decimals="-6" id="f-596" unitRef="usd">1000000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount contextRef="c-7" decimals="-6" id="f-597" unitRef="usd">1000000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-599">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the beginning and ending balances of our issued and outstanding common stock for the three months ended March&#160;31, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.597%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares issued and outstanding, beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;49,527,506&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,664,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock from vested restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;127,243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock from exercise of stock options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repurchase of common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1,210,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(197,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Awards effectively repurchased for required employee withholding taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(46,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares issued and outstanding, ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;48,397,519&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,573,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Stock Repurchases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2025, there was $162 million remaining in the total authorization of $2,715&#160;million of our ongoing stock repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We paid a common stock dividend of $0.25 per share in January 2025. We also declared common stock dividends of $0.275 per share to be paid in the second quarter of 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock contextRef="c-1" id="f-600">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the beginning and ending balances of our issued and outstanding common stock for the three months ended March&#160;31, 2025 and 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.597%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares issued and outstanding, beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;49,527,506&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,664,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock from vested restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;127,243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock from exercise of stock options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repurchase of common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1,210,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(197,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Awards effectively repurchased for required employee withholding taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(46,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares issued and outstanding, ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;48,397,519&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,573,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock>
    <us-gaap:CommonStockSharesIssued contextRef="c-9" decimals="INF" id="f-601" unitRef="shares">49527506</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-9" decimals="INF" id="f-602" unitRef="shares">49527506</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-10"
      decimals="INF"
      id="f-603"
      unitRef="shares">50664471</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-10"
      decimals="INF"
      id="f-604"
      unitRef="shares">50664471</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-142"
      decimals="INF"
      id="f-605"
      unitRef="shares">127243</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-143"
      decimals="INF"
      id="f-606"
      unitRef="shares">160118</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-144"
      decimals="INF"
      id="f-607"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-145"
      decimals="INF"
      id="f-608"
      unitRef="shares">5708</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c-1" decimals="INF" id="f-609" unitRef="shares">1210403</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c-7" decimals="INF" id="f-610" unitRef="shares">197872</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="INF" id="f-611" unitRef="shares">46827</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-7" decimals="INF" id="f-612" unitRef="shares">59249</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="INF" id="f-613" unitRef="shares">48397519</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-8" decimals="INF" id="f-614" unitRef="shares">48397519</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-29"
      decimals="INF"
      id="f-615"
      unitRef="shares">50573176</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-29"
      decimals="INF"
      id="f-616"
      unitRef="shares">50573176</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-8" decimals="-6" id="f-617" unitRef="usd">162000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-8" decimals="-6" id="f-618" unitRef="usd">2715000000</srt:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-1"
      decimals="2"
      id="f-619"
      unitRef="usdPerShare">0.25</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="c-8"
      decimals="3"
      id="f-620"
      unitRef="usdPerShare">0.275</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-621">INCOME TAXES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our ETR was 26% and 27% for the first quarter of 2025 and 2024, respectively. The decrease in the rate was primarily attributable to an increase in tax benefits related to excludable income for state tax purposes and a decrease in the state tax rate, offset by a decrease in tax benefits for stock-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We have capital loss carryforwards of $3&#160;million. As a result of the sale of Clarus this quarter, we generated approximately $9&#160;million of capital loss carryforwards totaling $12&#160;million which will begin to expire in 2027.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We have recorded an increase in the valuation allowance of $9&#160;million this quarter to reflect the estimated amount of deferred tax assets that may not be realized related to these capital loss carryforwards. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We are subject to tax in U.S. federal and various state and local jurisdictions, as well as Canada and India. We are open to federal and significant state income tax examinations for tax years 2019 and subsequent years.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="2" id="f-622" unitRef="number">0.26</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-7" decimals="2" id="f-623" unitRef="number">0.27</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-146" decimals="-6" id="f-624" unitRef="usd">3000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="c-146" decimals="-6" id="f-625" unitRef="usd">9000000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="c-8" decimals="-6" id="f-626" unitRef="usd">12000000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-6" id="f-627" unitRef="usd">9000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-628">EARNINGS PER SHARE&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic EPS is computed based on the weighted average shares of common stock outstanding during the period. Diluted EPS is computed based on those shares used in the basic EPS computation, plus potentially dilutive shares issuable under our equity-based compensation plans using the treasury stock method. Shares that are potentially anti-dilutive are excluded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the computation of our basic and diluted EPS attributable to our common stock:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;49&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1.72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;49&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;49&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1.71&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-629">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the computation of our basic and diluted EPS attributable to our common stock:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;49&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1.72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;49&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;49&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1.71&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-1" decimals="-6" id="f-630" unitRef="usd">85000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-7" decimals="-6" id="f-631" unitRef="usd">91000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-6" id="f-632" unitRef="shares">49000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-6" id="f-633" unitRef="shares">51000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-634"
      unitRef="usdPerShare">1.72</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-635"
      unitRef="usdPerShare">1.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-1" decimals="-6" id="f-636" unitRef="usd">85000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-7" decimals="-6" id="f-637" unitRef="usd">91000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-6" id="f-638" unitRef="shares">49000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-6" id="f-639" unitRef="shares">51000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-1" decimals="-6" id="f-640" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-7" decimals="-6" id="f-641" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-6" id="f-642" unitRef="shares">49000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-6" id="f-643" unitRef="shares">51000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-644"
      unitRef="usdPerShare">1.71</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-645"
      unitRef="usdPerShare">1.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-6" id="f-646" unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-7" decimals="-6" id="f-647" unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="c-1" id="f-648">RESTRUCTURING&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2024, we completed a detailed review of our strategy and made several decisions that will narrow and intensify our focus on our U.S. PEO business. This will include winding down the software-only HRIS product as well as other immaterial products not directly related to our U.S. PEO business.  In place of our software-only HRIS product, we will focus our ASO services to include both the software component, but also a significant service component similar to the types of services we provide to PEO clients. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with this adjustment to our product offerings, we have implemented changes to our operating expense structure, including our staffing and office footprint.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the restructuring initiatives, the Company incurred $1 million of restructuring costs for the three months ended March&#160;31, 2025. These expenses are classified in G&amp;amp;A in our Condensed consolidated statement of income and comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Severance costs include payments to colleagues, estimated reimbursements for COBRA payments and outplacement services. The following table is a summary of accrued severance and exit and disposal costs included within accounts payable and other current liabilities and accrued wages:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.221%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accounts payable and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued wages&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:6.75pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(+) Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:6.75pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(-) Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at March&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expect to make payments for these liabilities during 2025. We expect the restructuring efforts to continue through 2026 and may recognize additional expenses as they are incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCosts contextRef="c-1" decimals="-6" id="f-649" unitRef="usd">1000000</us-gaap:RestructuringCosts>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock contextRef="c-1" id="f-650">The following table is a summary of accrued severance and exit and disposal costs included within accounts payable and other current liabilities and accrued wages:&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.221%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accounts payable and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued wages&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:6.75pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(+) Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:6.75pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(-) Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at March&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringCharges contextRef="c-147" decimals="-6" id="f-651" unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-148" decimals="-6" id="f-652" unitRef="usd">14000000</us-gaap:RestructuringCharges>
    <tnet:RestructuringChargesAdditions contextRef="c-149" decimals="-6" id="f-653" unitRef="usd">0</tnet:RestructuringChargesAdditions>
    <tnet:RestructuringChargesAdditions contextRef="c-150" decimals="-6" id="f-654" unitRef="usd">0</tnet:RestructuringChargesAdditions>
    <tnet:RestructuringChargesPayments contextRef="c-149" decimals="-6" id="f-655" unitRef="usd">0</tnet:RestructuringChargesPayments>
    <tnet:RestructuringChargesPayments contextRef="c-150" decimals="-6" id="f-656" unitRef="usd">-4000000</tnet:RestructuringChargesPayments>
    <us-gaap:RestructuringCharges contextRef="c-149" decimals="-6" id="f-657" unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-150" decimals="-6" id="f-658" unitRef="usd">10000000</us-gaap:RestructuringCharges>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-659">SEGMENT INFORMATION&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate in one reportable segment. Our chief operating decision maker for segment reporting purposes is our CEO, who uses the profitability and significant expense detail to allocate resources and assess performance based on key functions such as customer acquisition, customer service, and indirect costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary measure of profit or loss that the CEO uses is net income. The significant expenses used in these profit or loss reports align with the primary functions of the corresponding teams, with the exception of non-cash expenses such as depreciation, amortization and stock-based compensation as these expenses are not necessarily indicative of our ongoing operations. In this expense reporting methodology, overhead-type expenses, such as facilities and technology support for colleagues, are classified consistent with the primary function of the corresponding teams and not allocated to other significant expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides the primary measure of profitability and detail regarding the significant expenses reviewed by our CEO.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.644%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional service revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;209&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Insurance service revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,065&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,292&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Workers' compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Health insurance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;919&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales &amp;amp; marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;60&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Client support costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;43&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate administration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;System support &amp;amp; development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization of intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, bank fees and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Other includes certain costs that are considered non-recurring such as restructuring costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-660"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-661">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides the primary measure of profitability and detail regarding the significant expenses reviewed by our CEO.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.644%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional service revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;209&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Insurance service revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,065&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,292&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Workers' compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Health insurance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;919&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales &amp;amp; marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;60&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Client support costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;43&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate administration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;System support &amp;amp; development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization of intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, bank fees and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Other includes certain costs that are considered non-recurring such as restructuring costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-151" decimals="-6" id="f-662" unitRef="usd">209000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-152" decimals="-6" id="f-663" unitRef="usd">214000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-153" decimals="-6" id="f-664" unitRef="usd">1065000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-154" decimals="-6" id="f-665" unitRef="usd">1050000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InterestIncomeOperating contextRef="c-155" decimals="-6" id="f-666" unitRef="usd">18000000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating contextRef="c-156" decimals="-6" id="f-667" unitRef="usd">18000000</us-gaap:InterestIncomeOperating>
    <us-gaap:Revenues contextRef="c-155" decimals="-6" id="f-668" unitRef="usd">1292000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-156" decimals="-6" id="f-669" unitRef="usd">1282000000</us-gaap:Revenues>
    <tnet:WorkersCompensationCosts contextRef="c-155" decimals="-6" id="f-670" unitRef="usd">23000000</tnet:WorkersCompensationCosts>
    <tnet:WorkersCompensationCosts contextRef="c-156" decimals="-6" id="f-671" unitRef="usd">21000000</tnet:WorkersCompensationCosts>
    <tnet:HealthInsuranceCosts contextRef="c-155" decimals="-6" id="f-672" unitRef="usd">919000000</tnet:HealthInsuranceCosts>
    <tnet:HealthInsuranceCosts contextRef="c-156" decimals="-6" id="f-673" unitRef="usd">886000000</tnet:HealthInsuranceCosts>
    <tnet:SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther contextRef="c-155" decimals="-6" id="f-674" unitRef="usd">60000000</tnet:SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther>
    <tnet:SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther contextRef="c-156" decimals="-6" id="f-675" unitRef="usd">65000000</tnet:SellingAndMarketingExpenseExcludingStockBasedCompensationAndOther>
    <tnet:ClientSupportCosts contextRef="c-155" decimals="-6" id="f-676" unitRef="usd">43000000</tnet:ClientSupportCosts>
    <tnet:ClientSupportCosts contextRef="c-156" decimals="-6" id="f-677" unitRef="usd">48000000</tnet:ClientSupportCosts>
    <tnet:CorporateAdministrationExpenses contextRef="c-155" decimals="-6" id="f-678" unitRef="usd">35000000</tnet:CorporateAdministrationExpenses>
    <tnet:CorporateAdministrationExpenses contextRef="c-156" decimals="-6" id="f-679" unitRef="usd">38000000</tnet:CorporateAdministrationExpenses>
    <tnet:SystemSupportAndDevelopmentExpenses contextRef="c-155" decimals="-6" id="f-680" unitRef="usd">52000000</tnet:SystemSupportAndDevelopmentExpenses>
    <tnet:SystemSupportAndDevelopmentExpenses contextRef="c-156" decimals="-6" id="f-681" unitRef="usd">46000000</tnet:SystemSupportAndDevelopmentExpenses>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-155" decimals="-6" id="f-682" unitRef="usd">17000000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-156" decimals="-6" id="f-683" unitRef="usd">18000000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-155" decimals="-6" id="f-684" unitRef="usd">13000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-156" decimals="-6" id="f-685" unitRef="usd">20000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:OtherExpenses contextRef="c-155" decimals="-6" id="f-686" unitRef="usd">1000000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="c-156" decimals="-6" id="f-687" unitRef="usd">0</us-gaap:OtherExpenses>
    <tnet:InterestExpenseBankFeesAndOther contextRef="c-155" decimals="-6" id="f-688" unitRef="usd">14000000</tnet:InterestExpenseBankFeesAndOther>
    <tnet:InterestExpenseBankFeesAndOther contextRef="c-156" decimals="-6" id="f-689" unitRef="usd">16000000</tnet:InterestExpenseBankFeesAndOther>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-155" decimals="-6" id="f-690" unitRef="usd">30000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-156" decimals="-6" id="f-691" unitRef="usd">33000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-155" decimals="-6" id="f-692" unitRef="usd">85000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-156" decimals="-6" id="f-693" unitRef="usd">91000000</us-gaap:NetIncomeLoss>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-1" id="f-694">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-1" id="f-695">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-1" id="f-696">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-1" id="f-697">false</ecd:NonRule10b51ArrAdoptedFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
